data_1oca_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oca _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.14 152.14 76.52 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.62 1.547 . . . . 0.0 109.875 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 m -111.18 156.47 21.37 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.58 163.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.208 1.003 . . . . 0.0 110.017 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -125.74 159.07 33.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 125.224 1.41 . . . . 0.0 109.657 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -146.12 118.24 8.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 107.011 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.03 96.85 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 mm -69.5 140.03 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.96 128.28 32.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.844 1.258 . . . . 0.0 109.827 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG11 ' HE2' ' A' ' 154' ' ' LYS . 22.6 t -95.95 109.48 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.43 13.76 0.99 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.634 1.574 . . . . 0.0 113.664 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.16 -11.78 26.62 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.72 1.629 . . . . 0.0 113.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.71 127.61 72.07 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 119.647 1.723 . . . . 0.0 107.201 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.83 119.13 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.724 1.616 . . . . 0.0 109.451 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -89.0 -32.8 17.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.484 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.09 162.87 10.39 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -68.62 147.85 51.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.21 154.3 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 126.966 2.107 . . . . 0.0 105.568 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.0 t -139.7 153.29 47.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.827 0.823 . . . . 0.0 109.182 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -142.17 155.48 45.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.324 1.05 . . . . 0.0 108.773 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 2.8 tp10 -107.32 146.69 31.23 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.479 1.511 . . . . 0.0 107.243 170.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.31 114.22 20.49 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -71.91 56.61 0.3 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.397 1.879 . . . . 0.0 113.198 -171.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.37 -28.85 13.67 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.628 1.571 . . . . 0.0 112.077 169.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -19.57 65.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.157 0.983 . . . . 0.0 112.04 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -125.45 -31.4 3.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 m -129.78 71.55 82.12 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.94 -43.06 26.94 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.611 2.207 . . . . 0.0 110.37 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -55.96 28.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -58.66 -46.88 86.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.56 0.744 . . . . 0.0 111.153 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.24 84.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.456 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.74 -43.74 83.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.716 1.206 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.82 -51.64 66.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 108.025 176.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -66.02 -44.89 83.41 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 124.162 0.914 . . . . 0.0 112.238 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -43.79 -59.1 2.38 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.656 1.582 . . . . 0.0 108.976 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.48 71.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.554 1.541 . . . . 0.0 113.308 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.39 -40.04 62.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.275 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -50.67 66.96 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 119.449 1.022 . . . . 0.0 111.066 173.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.1 p -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.397 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 5.95 89.04 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.168 0.89 . . . . 0.0 112.139 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -5.25 27.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.065 1.433 . . . . 0.0 113.954 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -96.96 12.96 30.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.711 1.205 . . . . 0.0 110.846 170.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.15 74.05 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 120.714 -1.241 . . . . 0.0 113.054 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.52 -165.31 1.52 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.871 2.068 . . . . 0.0 106.357 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.69 -138.18 13.47 Favored Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CZ ' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -81.55 -26.4 35.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.38 1.072 . . . . 0.0 113.486 -167.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -57.97 110.03 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.148 0.979 . . . . 0.0 108.966 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.71 90.18 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.952 1.263 . . . . 0.0 115.627 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -100.23 7.46 44.45 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.991 2.395 . . . . 0.0 114.078 -158.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 62.94 174.59 0.15 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 127.925 2.49 . . . . 0.0 116.183 159.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.56 121.03 38.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 112.136 -2.302 . . . . 0.0 106.566 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -108.47 -24.14 11.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.511 1.124 . . . . 0.0 111.03 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.8 105.36 8.19 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 mt -118.73 114.99 46.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.07 95.51 36.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -168.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -41.12 125.97 2.51 Favored 'Trans proline' 0 C--O 1.24 0.586 1 C-N-CA 125.418 4.078 . . . . 0.0 114.538 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.34 29.96 74.73 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.127 1.346 . . . . 0.0 111.777 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -135.84 -79.89 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.06 171.15 20.51 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.2 m -120.19 91.1 3.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.396 2.278 . . . . 0.0 109.379 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -79.93 139.14 37.19 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.486 1.915 . . . . 0.0 110.9 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.42 -171.41 17.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.813 1.673 . . . . 0.0 111.54 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.39 24.73 9.25 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.363 0.506 . . . . 0.0 112.595 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.75 76.07 9.98 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -98.61 -11.8 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -134.31 -10.35 2.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.72 1.208 . . . . 0.0 113.253 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.3 mmt-85 -138.61 -172.38 3.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.27 34.32 0.52 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.384 0.993 . . . . 0.0 112.481 -168.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -150.72 12.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.0 1.32 . . . . 0.0 111.838 -163.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.56 32.65 27.08 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 118.987 -0.896 . . . . 0.0 110.885 -175.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -135.76 1.57 2.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.572 1.186 . . . . 0.0 112.185 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.19 166.09 33.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 119.648 1.113 . . . . 0.0 110.725 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 147.03 14.0 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.569 1.094 . . . . 0.0 114.362 165.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.46 160.32 40.52 Favored 'General case' 0 C--O 1.238 0.474 1 C-N-CA 132.07 4.148 . . . . 0.0 104.4 -173.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.5 p -78.34 171.76 14.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.974 0.806 . . . . 0.0 110.831 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.5 -25.18 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.729 0.412 . . . . 0.0 111.406 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.01 -22.11 24.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.391 0.676 . . . . 0.0 111.143 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.94 172.43 28.24 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.191 0.884 . . . . 0.0 114.044 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.14 112.69 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.949 1.7 . . . . 0.0 108.225 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 48.38 161.41 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.66 1 C-N-CA 133.884 4.874 . . . . 0.0 115.099 -165.219 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -139.29 175.35 9.63 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.819 162.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -65.89 159.8 24.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.354 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 114.61 13.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 161.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.45 -56.62 16.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.893 1.277 . . . . 0.0 110.819 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -169.03 -177.82 3.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.429 1.492 . . . . 0.0 108.702 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -130.44 25.14 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.604 1.962 . . . . 0.0 109.128 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.84 -57.72 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.95 128.11 34.66 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.551 2.34 . . . . 0.0 105.476 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -119.93 165.36 14.74 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.919 1.288 . . . . 0.0 110.244 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -81.77 56.13 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.559 1.543 . . . . 0.0 110.343 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -66.06 -23.25 66.5 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.863 1.265 . . . . 0.0 113.614 -160.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.5 179.36 48.75 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.27 160.58 19.02 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.576 1.517 . . . . 0.0 110.318 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.5 4.23 64.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.637 -1.646 . . . . 0.0 112.46 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.1 mm -79.4 166.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 121.009 2.405 . . . . 0.0 108.09 166.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 132.08 27.8 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.067 1.347 . . . . 0.0 109.61 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 t -143.79 147.24 33.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.016 0.526 . . . . 0.0 111.172 -170.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 97.4 mmm -74.33 117.92 16.69 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.557 1.143 . . . . 0.0 109.984 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.66 139.11 56.77 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 162.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -144.06 -178.03 5.74 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.83 2.052 . . . . 0.0 108.215 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.09 16.86 24.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.462 1.105 . . . . 0.0 111.926 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.28 -160.91 21.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.325 1.441 . . . . 0.0 109.659 -167.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -60.94 150.21 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.978 1.785 . . . . 0.0 109.844 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 39.14 48.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.078 2.951 . . . . 0.0 114.13 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.5 p -138.82 21.25 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.909 1.284 . . . . 0.0 110.58 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.77 155.96 25.2 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.923 -1.11 . . . . 0.0 108.278 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.32 -66.53 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.468 1.031 . . . . 0.0 114.782 -166.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -156.22 -5.59 0.11 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.899 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -78.63 136.94 37.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CE2' ' CZ ' ' A' ' 48' ' ' TYR . 5.3 p90 -130.97 169.73 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 164.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -130.98 146.43 52.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.887 0.475 . . . . 0.0 109.807 160.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.3 mt -83.5 116.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 169.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 m -60.75 124.15 19.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -110.47 21.57 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.155 0.582 . . . . 0.0 109.683 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.28 179.03 8.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.64 91.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.3 p -83.76 50.73 1.87 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.096 0.862 . . . . 0.0 110.663 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -18.92 51.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.978 1.311 . . . . 0.0 112.797 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -67.02 -19.22 65.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.762 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.8 mt -95.54 -4.34 44.93 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.668 1.587 . . . . 0.0 112.325 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.15 129.27 39.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.607 1.094 . . . . 0.0 108.787 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.81 -1.98 83.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.747 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.6 -20.23 8.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.043 1.922 . . . . 0.0 112.912 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -139.42 153.05 47.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.361 0.982 . . . . 0.0 111.044 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.0 t -88.0 100.01 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.93 126.39 19.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -140.76 -0.7 1.5 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.14 -178.67 28.8 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 119.08 0.855 . . . . 0.0 111.667 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -149.63 153.89 37.76 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.418 1.487 . . . . 0.0 107.591 172.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.85 126.45 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 166.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.419 ' HZ3' ' CD ' ' A' ' 23' ' ' GLU . 23.9 ttmt -82.93 -52.17 6.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 164.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 162.34 40.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.227 -167.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.09 74.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.729 0.681 . . . . 0.0 113.45 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -38.91 75.27 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.329 1.564 . . . . 0.0 110.098 175.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -61.36 -25.11 66.94 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 172.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mm -77.72 -38.48 25.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.64 -39.84 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.777 0.717 . . . . 0.0 109.54 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -60.87 -34.78 75.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.944 -1.098 . . . . 0.0 111.808 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.39 63.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.384 0.993 . . . . 0.0 109.509 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 69.5 mtp -52.66 -42.26 64.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.236 1.015 . . . . 0.0 110.486 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -62.6 -34.47 77.08 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -30.05 70.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.616 1.098 . . . . 0.0 110.243 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -92.89 5.91 49.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.035 1.734 . . . . 0.0 111.86 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.75 -149.95 7.62 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 170.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 p -146.47 -61.51 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 141.75 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 1 C-N-CA 132.716 4.407 . . . . 0.0 109.726 -169.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 5.12 2.65 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 118.571 0.623 . . . . 0.0 111.454 164.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.54 -42.75 2.96 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 126.589 2.043 . . . . 0.0 111.556 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -60.24 123.89 18.59 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 61.3 p -72.98 164.04 27.28 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 124.343 1.027 . . . . 0.0 110.091 -167.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -88.5 -8.99 53.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.426 0.69 . . . . 0.0 111.239 163.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.444 ' HE2' HG11 ' A' ' 12' ' ' VAL . 15.3 tttt -152.81 149.24 28.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 109.934 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -75.06 123.0 24.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 -172.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 mt -112.62 126.49 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.54 175.84 9.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.151 -158.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.74 112.28 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.0 76.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -150.69 156.48 41.41 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.7 p -161.9 160.64 28.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.523 1.129 . . . . 0.0 109.722 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.93 -171.44 43.55 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -95.11 151.99 18.72 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.1 mt -125.66 42.5 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.601 1.191 . . . . 0.0 108.446 165.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.186 1.394 . . . . 0.0 111.822 176.313 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.03 157.37 57.52 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.517 1.22 . . . . 0.0 109.242 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.6 m -110.11 155.69 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 170.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.19 158.72 41.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.563 1.545 . . . . 0.0 107.536 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -135.34 159.61 41.02 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 123.446 0.698 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.629 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 64.4 m-85 -153.29 114.23 4.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.972 1.709 . . . . 0.0 108.596 -173.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -74.4 102.78 4.53 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 163.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.0 mm -67.38 143.02 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.99 129.48 22.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.336 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.498 HG11 ' HE2' ' A' ' 154' ' ' LYS . 78.6 t -93.05 101.13 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 127.409 2.284 . . . . 0.0 104.937 173.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 60.37 13.6 4.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.448 1.022 . . . . 0.0 113.754 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 0.26 53.58 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.407 1.479 . . . . 0.0 113.947 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 110.3 34.25 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 167.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.34 136.23 42.73 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.516 1.478 . . . . 0.0 110.001 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -104.61 -21.19 13.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.9 1.68 . . . . 0.0 110.61 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.39 156.22 7.19 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.045 0.839 . . . . 0.0 112.478 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.18 130.23 42.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.56 150.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.4 m -137.1 147.07 45.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 87.0 m-85 -135.63 136.36 40.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -173.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.39 152.35 39.54 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 162.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.2 mt -126.88 122.22 34.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -69.61 52.71 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.862 2.065 . . . . 0.0 112.065 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.87 -21.99 58.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.081 -1.637 . . . . 0.0 112.222 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.06 4.17 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.047 0.939 . . . . 0.0 113.37 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -125.98 -35.52 2.46 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.329 1.452 . . . . 0.0 110.605 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m -142.12 68.35 22.39 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.148 1.779 . . . . 0.0 108.886 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.03 -37.88 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.063 1.842 . . . . 0.0 113.194 -176.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -55.07 39.12 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.078 1.763 . . . . 0.0 109.773 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.95 -40.79 90.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 122.838 0.455 . . . . 0.0 110.008 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.14 -33.08 67.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.31 -50.09 49.83 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.812 1.645 . . . . 0.0 109.55 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -45.72 -51.37 12.61 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.042 1.737 . . . . 0.0 109.661 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.35 90.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -56.56 -59.25 5.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.753 1.221 . . . . 0.0 107.87 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.72 -50.22 25.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.77 1.228 . . . . 0.0 112.491 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.92 -29.24 68.27 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.951 -1.093 . . . . 0.0 111.547 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -77.62 -43.53 31.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.965 1.257 . . . . 0.0 112.612 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.1 p -65.71 -32.29 73.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 7.02 89.02 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.435 1.017 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.45 -16.93 64.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.842 1.657 . . . . 0.0 114.101 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 25.7 mmmt -83.02 -1.9 53.86 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.014 -1.054 . . . . 0.0 110.581 174.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.58 8.4 65.82 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.634 1.112 . . . . 0.0 112.842 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -156.18 -172.61 4.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.065 1.432 . . . . 0.0 110.434 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.87 -139.45 10.96 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-O 122.321 0.956 . . . . 0.0 113.417 160.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.629 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 7.3 t80 -62.76 -34.6 77.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.524 1.93 . . . . 0.0 108.69 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.99 124.86 19.13 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.595 1.088 . . . . 0.0 108.888 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.86 -0.39 21.65 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.105 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.1 m -64.36 115.21 4.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 120.949 2.374 . . . . 0.0 105.542 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.3 p -75.86 156.37 34.44 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.699 -0.626 . . . . 0.0 109.61 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -91.72 95.58 9.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.55 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -74.69 -21.05 59.6 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -166.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 82.76 1.85 Allowed 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 121.151 -0.968 . . . . 0.0 109.367 -169.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 mt -102.66 101.9 12.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.18 92.34 45.3 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -167.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -48.64 130.89 23.21 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.34 79.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.185 1.85 . . . . 0.0 112.114 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -142.03 -62.96 0.44 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.547 1.174 . . . . 0.0 109.434 -170.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -168.75 164.25 11.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.902 0.774 . . . . 0.0 112.347 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.9 m -113.32 93.1 4.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 108.277 159.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -76.89 142.99 39.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.002 0.921 . . . . 0.0 109.852 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.97 -164.5 12.56 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 124.85 1.214 . . . . 0.0 110.584 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.31 43.0 6.38 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.395 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.02 136.28 49.22 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 119.754 1.777 . . . . 0.0 107.929 159.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -134.39 5.95 3.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 127.91 2.484 . . . . 0.0 109.487 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -114.06 -53.49 2.67 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.391 1.477 . . . . 0.0 107.787 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -117.11 -165.9 1.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 158.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -174.22 46.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -166.85 20.82 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.158 2.183 . . . . 0.0 110.253 -170.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.58 -32.55 4.72 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.458 -1.19 . . . . 0.0 113.52 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.5 p -83.84 6.67 20.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.517 2.158 . . . . 0.0 114.673 -161.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -115.8 -124.47 3.73 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.86 100.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 127.187 2.327 . . . . 0.0 113.547 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -129.34 146.43 51.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.468 1.907 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.0 p -80.84 -178.4 6.81 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.993 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.419 ' HB ' ' HE2' ' A' ' 44' ' ' LYS . 36.6 pt -76.73 -6.84 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.472 168.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -90.78 -3.16 57.63 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.16 0.891 . . . . 0.0 112.057 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.76 91.17 1.92 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.267 10.7 tp10 62.17 -133.63 0.54 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.381 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -103.37 131.31 50.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.685 1.13 . . . . 0.0 110.871 -160.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -98.08 169.8 9.36 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.852 0.835 . . . . 0.0 110.107 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -66.7 170.57 6.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.51 1.524 . . . . 0.0 111.226 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -85.95 113.93 22.45 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -43.56 -55.65 4.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.96 1.304 . . . . 0.0 110.989 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -172.52 177.57 2.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.793 2.437 . . . . 0.0 106.479 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -125.49 32.09 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.661 1.184 . . . . 0.0 109.293 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.71 -55.78 20.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.2 mt -84.4 130.02 34.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.155 1.382 . . . . 0.0 107.566 -170.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -120.8 165.27 15.38 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 126.947 2.099 . . . . 0.0 109.449 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -85.7 65.76 9.31 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.557 0.743 . . . . 0.0 110.598 -164.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 p -70.97 -19.2 62.58 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -162.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.01 178.8 48.92 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 119.361 0.982 . . . . 0.0 111.918 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -62.1 158.69 37.95 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.545 2.163 . . . . 0.0 110.304 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.6 -6.84 36.26 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 116.974 -2.014 . . . . 0.0 112.934 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.69 156.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-N 121.46 2.63 . . . . 0.0 108.11 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.426 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -134.05 131.14 38.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.172 0.989 . . . . 0.0 110.852 176.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.82 150.23 33.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.29 1.036 . . . . 0.0 110.955 -164.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.62 138.14 54.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.0 50.92 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -59.99 163.35 4.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.065 1.412 . . . . 0.0 109.681 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.48 14.24 13.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.6 -165.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.81 -167.22 27.73 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.713 2.102 . . . . 0.0 107.98 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.44 143.66 58.52 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.284 1.989 . . . . 0.0 110.232 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 m120 50.11 47.78 23.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.551 2.34 . . . . 0.0 112.7 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 p -120.37 23.0 11.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.871 1.268 . . . . 0.0 111.638 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -69.42 135.85 50.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.322 1.049 . . . . 0.0 108.885 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.0 -78.45 0.02 OUTLIER Glycine 0 C--N 1.337 0.588 0 CA-C-N 118.436 0.562 . . . . 0.0 112.867 -168.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -142.21 -47.13 0.35 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.543 0.737 . . . . 0.0 109.963 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -62.46 137.7 58.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 124.082 0.863 . . . . 0.0 108.676 -170.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.429 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 45.4 p90 -141.81 172.75 12.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.871 1.668 . . . . 0.0 107.316 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -141.86 151.1 42.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.423 0.63 . . . . 0.0 109.697 158.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.34 120.8 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.76 127.4 31.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.9 p -107.66 19.84 19.62 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.724 0.809 . . . . 0.0 110.023 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.8 -177.89 5.4 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 164.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -60.99 128.02 34.43 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 158.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.424 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 71.9 p -117.67 72.77 0.86 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.61 1.55 . . . . 0.0 110.074 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.42 -12.6 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.415 -0.803 . . . . 0.0 113.139 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.424 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 27.5 p90 -71.81 -13.86 61.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.377 0.671 . . . . 0.0 111.288 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.95 -8.12 14.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.751 1.221 . . . . 0.0 111.894 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 153.08 43.23 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.55 7.92 43.26 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.211 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -135.53 -40.31 0.72 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.169 1.485 . . . . 0.0 111.388 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -114.56 147.85 38.85 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.941 0.496 . . . . 0.0 111.487 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.13 105.79 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.041 1.736 . . . . 0.0 107.305 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.01 137.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 161.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.3 -3.83 0.72 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.294 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.49 176.83 27.11 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 119.691 1.132 . . . . 0.0 112.053 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.61 149.16 31.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.575 1.15 . . . . 0.0 108.153 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 62.5 t -58.88 126.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 164.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -93.64 -42.3 9.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.967 0.507 . . . . 0.0 109.769 165.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.05 156.7 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.711 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.17 21.26 61.13 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.481 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -52.31 -42.62 63.95 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.498 1.649 . . . . 0.0 111.311 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.77 -13.09 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.035 0.834 . . . . 0.0 112.925 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.6 mm -84.58 -36.46 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.427 1.091 . . . . 0.0 108.484 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.39 -40.78 90.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 121.442 -0.786 . . . . 0.0 108.945 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -62.67 -33.68 75.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.36 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.61 76.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 109.331 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.8 mtm -55.72 -46.07 77.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.45 0.568 . . . . 0.0 110.135 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.35 -36.13 73.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.167 0.587 . . . . 0.0 111.844 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -25.48 68.14 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.496 0.589 . . . . 0.0 111.546 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -97.88 -0.43 45.03 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.076 1.75 . . . . 0.0 112.15 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.18 -173.5 47.46 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 167.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 p -162.37 159.66 25.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -63.17 -16.46 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -4.33 2.89 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 167.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.86 -25.27 2.19 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 127.339 2.399 . . . . 0.0 114.328 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.86 127.43 33.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 154' ' ' LYS . 16.5 p -66.41 168.44 8.94 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.637 1.175 . . . . 0.0 110.773 168.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.9 p -81.6 -16.54 51.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.806 159.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.498 ' HE2' HG11 ' A' ' 12' ' ' VAL . 41.4 mtpt -143.63 160.6 40.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.01 0.924 . . . . 0.0 111.414 -167.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HE2' ' CG2' ' A' ' 157' ' ' THR . 14.8 tttt -84.87 78.41 9.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.36 1.436 . . . . 0.0 109.697 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.7 133.27 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.483 0.658 . . . . 0.0 109.404 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.457 ' CG2' ' HE2' ' A' ' 155' ' ' LYS . 74.7 p -148.98 177.03 9.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.905 2.082 . . . . 0.0 110.105 -173.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 48' ' ' TYR . 3.1 mp -92.61 124.35 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 158.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.72 -55.3 10.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.68 161.96 39.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.079 0.552 . . . . 0.0 111.025 -169.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.8 171.28 7.39 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.3 -167.86 40.69 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.606 1.574 . . . . 0.0 109.83 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -95.91 148.5 22.56 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.544 1.137 . . . . 0.0 109.619 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.9 mt -126.87 43.07 3.19 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.534 1.934 . . . . 0.0 110.476 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 C--O 1.255 1.348 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 161.224 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.302 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.5 161.39 44.29 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 CA-C-N 120.661 1.272 . . . . 0.0 108.97 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.4 m -102.16 157.18 17.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.96 157.32 33.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.314 1.845 . . . . 0.0 107.648 164.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.66 151.2 30.44 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.543 0.737 . . . . 0.0 109.9 165.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 23.4 m-30 -133.85 104.51 6.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.118 2.167 . . . . 0.0 106.179 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.82 107.16 8.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mm -75.29 142.85 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 109.535 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.78 159.79 27.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.019 0.914 . . . . 0.0 109.554 161.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.0 96.37 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 56.07 14.03 1.34 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.629 1.572 . . . . 0.0 112.889 -169.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.65 -13.55 29.94 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.57 1.557 . . . . 0.0 113.18 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.41 127.59 85.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 120.389 2.094 . . . . 0.0 106.627 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.6 108.53 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.675 2.25 . . . . 0.0 109.755 -170.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.6 tp -84.56 -28.04 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.519 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.54 162.27 10.12 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 118.806 0.73 . . . . 0.0 114.458 167.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -77.7 113.96 16.08 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.65 0.78 . . . . 0.0 109.803 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.15 159.36 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 106.215 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.8 m -150.11 152.93 35.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.129 -1.607 . . . . 0.0 110.41 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.25 133.57 29.82 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.006 0.922 . . . . 0.0 109.235 -166.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.71 139.84 35.92 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.08 121.89 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -82.6 62.53 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.961 0.904 . . . . 0.0 112.38 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.05 40.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.941 0.896 . . . . 0.0 112.806 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -9.42 59.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.419 1.088 . . . . 0.0 111.589 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -117.81 -54.23 2.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.422 1.489 . . . . 0.0 108.84 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 m -126.95 72.23 75.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 125.194 1.398 . . . . 0.0 107.711 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.67 -39.39 88.22 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.252 1.968 . . . . 0.0 112.319 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CA ' ' HE3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.99 -53.47 56.89 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.445 1.475 . . . . 0.0 109.195 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 m -64.39 -41.01 96.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.899 0.879 . . . . 0.0 110.365 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.46 -50.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.556 0.742 . . . . 0.0 112.2 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.69 -40.55 95.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 110.093 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -51.58 -60.46 3.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.086 1.354 . . . . 0.0 109.427 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -60.77 -31.05 70.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.513 HH11 ' NE2' ' A' ' 163' ' ' GLN . 38.1 ttp85 -55.69 -64.53 0.82 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.358 1.863 . . . . 0.0 110.181 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.7 74.9 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.833 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.29 -34.58 77.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.541 -0.724 . . . . 0.0 111.028 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -69.5 -27.16 64.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.66 0.784 . . . . 0.0 111.625 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.3 p -90.21 -23.71 21.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.267 0.94 . . . . 0.0 111.283 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.41 -1.97 74.1 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.144 1.354 . . . . 0.0 112.707 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.39 -20.38 64.68 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.419 1.888 . . . . 0.0 113.427 -164.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -81.65 11.95 4.29 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.555 -0.716 . . . . 0.0 111.678 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.42 78.09 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 124.175 0.893 . . . . 0.0 112.274 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.09 167.98 26.57 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 125.493 1.517 . . . . 0.0 107.339 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 175.01 34.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 117.796 -2.145 . . . . 0.0 113.328 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 40.8 t80 -61.6 -32.42 72.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 127.794 2.437 . . . . 0.0 111.558 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -45.47 122.35 3.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.71 1.204 . . . . 0.0 109.875 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.35 26.23 61.47 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 116.33 -2.372 . . . . 0.0 115.689 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -66.66 -54.32 24.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 122.128 2.964 . . . . 0.0 107.44 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 32.8 t 113.9 161.91 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 1 C-N-CA 132.393 4.277 . . . . 0.0 106.951 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.97 101.64 12.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -77.45 -15.74 59.16 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.95 111.11 6.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.2 mt -129.96 105.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.9 mt -116.05 97.96 50.35 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -50.15 126.61 17.63 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 123.552 2.834 . . . . 0.0 112.726 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.85 71.55 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 126.707 2.098 . . . . 0.0 112.033 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.64 -80.36 0.27 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.473 1.136 . . . . 0.0 108.059 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.78 166.65 26.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.278 0.631 . . . . 0.0 111.673 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.8 m -124.06 100.78 6.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.309 2.644 . . . . 0.0 109.284 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -84.36 135.01 34.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.066 1.746 . . . . 0.0 111.101 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.27 -174.15 21.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 126.489 1.995 . . . . 0.0 109.139 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.32 6.18 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 117.405 0.603 . . . . 0.0 113.628 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -110.72 23.76 13.8 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -159.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.593 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 43.2 p90 -58.52 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.182 1 C-N-CA 131.827 4.051 . . . . 0.0 116.101 -176.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.3 t -148.39 -12.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.237 2.215 . . . . 0.0 112.179 161.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -146.19 -173.93 4.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.291 2.236 . . . . 0.0 106.199 -168.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -169.94 45.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -155.45 -7.33 0.12 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.67 5.29 51.47 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 117.686 -1.619 . . . . 0.0 114.413 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -91.52 -96.01 0.13 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.453 2.126 . . . . 0.0 107.272 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 41.52 -158.88 0.04 OUTLIER Glycine 0 CA--C 1.531 1.038 0 C-N-CA 127.157 2.313 . . . . 0.0 114.672 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.86 117.66 1.3 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-O 121.562 0.535 . . . . 0.0 111.97 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.593 ' HE3' ' CE2' ' A' ' 67' ' ' PHE . 4.0 ptpt -145.56 -170.52 3.47 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.685 2.394 . . . . 0.0 107.187 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.3 p -140.81 177.14 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.475 1.034 . . . . 0.0 110.673 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt -74.64 -0.64 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 111.624 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -108.39 -1.18 20.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.053 1.341 . . . . 0.0 111.363 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.56 -113.8 1.77 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.58 -139.32 0.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.426 0.613 . . . . 0.0 109.469 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -70.05 166.25 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.318 1.047 . . . . 0.0 108.808 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -134.1 -179.65 5.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.761 2.024 . . . . 0.0 106.874 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.45 159.95 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.284 1.04 . . . . 0.0 112.572 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 89.84 1.96 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.238 1.415 . . . . 0.0 107.882 172.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.21 -52.73 64.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.767 1.227 . . . . 0.0 112.867 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -150.19 174.38 12.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 162.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.64 32.05 5.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.964 2.105 . . . . 0.0 110.045 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.81 -48.31 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.25 1.024 . . . . 0.0 108.456 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.64 133.82 35.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.809 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -132.25 171.26 13.92 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.114 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -84.78 87.19 7.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -164.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.2 p -77.7 -17.98 57.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.827 -171.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.9 -178.2 46.73 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.858 1.208 . . . . 0.0 112.671 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.27 142.0 97.14 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.969 1.78 . . . . 0.0 108.917 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.77 -3.44 56.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 117.644 -1.642 . . . . 0.0 112.587 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.51 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 121.103 2.452 . . . . 0.0 109.072 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.72 130.34 54.95 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.142 1.377 . . . . 0.0 109.354 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 p -144.22 158.02 43.96 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.563 1.145 . . . . 0.0 112.686 176.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 95.4 mmm -75.37 131.01 39.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.811 1.245 . . . . 0.0 111.851 -168.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.23 81.62 8.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.504 1.522 . . . . 0.0 107.523 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -70.48 -179.71 2.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.43 1.092 . . . . 0.0 110.428 165.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.0 36.49 1.03 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.326 2.25 . . . . 0.0 109.244 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.89 -164.1 27.55 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 106.879 -2.488 . . . . 0.0 106.879 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.46 171.35 9.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 119.236 1.518 . . . . 0.0 108.566 159.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m120 41.11 38.23 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.818 2.447 . . . . 0.0 114.12 159.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -125.25 25.9 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.342 2.257 . . . . 0.0 109.108 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -74.96 105.49 6.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 129.961 3.305 . . . . 0.0 103.553 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.67 -93.26 1.24 Allowed Glycine 0 C--O 1.225 -0.456 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.5 p -139.33 -14.4 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.79 0.836 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -70.85 133.55 46.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.31 -179.42 7.53 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 108.151 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -144.06 152.66 41.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.116 0.484 . . . . 0.0 111.282 162.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.7 mt -83.68 113.37 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 165.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.8 m -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.816 1.246 . . . . 0.0 107.832 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.3 p -116.7 27.26 9.28 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.136 0.974 . . . . 0.0 108.695 172.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.53 178.59 10.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 162.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 120' ' ' GLU . 42.3 tttt -72.64 87.46 1.24 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 165.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.7 p -81.03 42.22 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.059 0.544 . . . . 0.0 112.3 -171.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 118' ' ' LYS . 15.0 pt-20 -70.63 -4.1 21.65 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 119.746 -1.846 . . . . 0.0 114.047 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -61.05 -19.7 61.7 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.018 -1.051 . . . . 0.0 110.734 161.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.2 mt -100.89 1.34 39.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.582 1.953 . . . . 0.0 111.78 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.57 138.88 58.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.231 1.012 . . . . 0.0 109.784 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.92 10.62 61.83 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 122.702 0.192 . . . . 0.0 112.908 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -129.26 -37.02 1.68 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.66 1.584 . . . . 0.0 109.567 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -114.09 121.1 42.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.932 0.893 . . . . 0.0 109.002 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.09 106.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.66 1.584 . . . . 0.0 107.467 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.37 131.68 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 166.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -138.54 -5.68 1.56 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.35 -179.46 31.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.72 -1.229 . . . . 0.0 111.664 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -156.8 148.81 22.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.55 122.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -87.09 -48.52 8.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -148.83 154.7 39.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.367 1.467 . . . . 0.0 111.362 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.55 24.88 27.14 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 123.886 0.755 . . . . 0.0 113.123 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.0 tpt -53.74 -39.9 65.7 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.899 1.349 . . . . 0.0 109.442 168.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -62.4 -27.67 69.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.2 mm -78.0 -39.42 25.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.13 -41.95 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.941 0.791 . . . . 0.0 109.288 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.7 -24.49 67.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.615 1.166 . . . . 0.0 112.644 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.22 -45.43 23.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.043 -1.035 . . . . 0.0 110.143 169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 52.0 mtp -54.74 -44.69 73.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.402 0.681 . . . . 0.0 110.931 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.61 -38.0 74.22 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.915 1.286 . . . . 0.0 112.035 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -69.71 -18.68 63.55 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.991 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -94.7 -2.55 50.98 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.204 1.002 . . . . 0.0 111.721 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.58 -166.96 41.07 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -156.01 163.46 39.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 163.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.16 -17.85 64.45 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -9.86 38.81 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 167.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 88.26 -23.21 15.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 127.044 2.259 . . . . 0.0 113.004 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.68 130.3 40.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.899 1.349 . . . . 0.0 107.693 175.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -70.68 165.36 23.1 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.44 1.496 . . . . 0.0 111.304 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.0 p -97.21 -14.39 21.45 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.6 1.16 . . . . 0.0 111.477 163.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -137.77 154.24 49.61 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.575 1.15 . . . . 0.0 110.739 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -81.02 85.98 6.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.107 1.363 . . . . 0.0 107.78 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.59 119.87 34.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -132.74 174.25 10.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.0 1.32 . . . . 0.0 109.669 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.18 96.97 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.64 -50.21 72.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.613 1.965 . . . . 0.0 109.195 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.2 164.66 33.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 108.041 175.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.7 p -165.93 164.81 18.43 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.031 0.532 . . . . 0.0 110.821 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.48 -174.15 45.99 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.513 ' NE2' HH11 ' A' ' 37' ' ' ARG . 6.9 tp60 -81.22 146.31 30.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.74 1.616 . . . . 0.0 110.172 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.43 43.31 2.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 111.091 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 3.6 pt-20 . . . . . 0 C--O 1.248 0.993 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 . . . . . 0 C--O 1.234 0.238 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.99 152.87 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 N-CA-C 108.815 -1.264 . . . . 0.0 108.815 159.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.1 m -99.47 152.93 19.44 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.19 150.79 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.473 1.509 . . . . 0.0 107.685 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -121.81 158.71 28.29 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.643 1.177 . . . . 0.0 109.722 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -149.34 109.46 4.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.651 1.58 . . . . 0.0 108.284 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.67 100.95 9.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.3 mm -73.75 139.78 18.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.7 127.26 36.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.332 1.053 . . . . 0.0 109.837 169.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.67 111.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.68 13.37 0.49 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.012 2.125 . . . . 0.0 114.88 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.05 -12.15 14.59 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.331 1.443 . . . . 0.0 113.28 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.21 130.11 55.63 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 119.774 1.787 . . . . 0.0 106.826 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.36 115.36 3.64 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.346 1.364 . . . . 0.0 108.818 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.1 tp -86.83 -32.13 20.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.438 -0.315 . . . . 0.0 110.493 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.55 171.15 13.63 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 123.748 0.689 . . . . 0.0 111.476 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -85.75 141.16 29.9 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 109.683 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.5 160.41 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 127.938 2.495 . . . . 0.0 106.166 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -148.73 148.9 30.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 120.923 -1.111 . . . . 0.0 109.864 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.55 160.77 33.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.311 1.044 . . . . 0.0 108.458 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -124.45 135.37 53.19 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.844 2.457 . . . . 0.0 105.593 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.32 110.51 12.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.104 0.962 . . . . 0.0 109.767 -163.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -74.63 64.2 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.236 1.814 . . . . 0.0 113.681 -167.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.5 -25.62 64.61 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.204 1.002 . . . . 0.0 112.636 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.75 -0.67 44.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.238 1.415 . . . . 0.0 112.795 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -118.1 -37.42 3.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.87 1.268 . . . . 0.0 110.703 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.6 m -138.87 79.92 26.28 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.619 2.368 . . . . 0.0 108.551 -175.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.95 -46.1 17.43 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.754 1.636 . . . . 0.0 112.864 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -70.5 -41.75 72.23 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -168.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.7 m -66.48 -43.39 85.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 111.434 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.69 -44.24 74.39 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 120.902 -1.124 . . . . 0.0 111.506 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -70.87 -31.77 68.55 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.366 0.666 . . . . 0.0 111.139 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -52.19 -59.18 4.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.022 0.929 . . . . 0.0 110.138 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -66.08 -35.53 80.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' CZ ' HE22 ' A' ' 163' ' ' GLN . 0.2 OUTLIER -50.94 -59.77 3.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.649 1.58 . . . . 0.0 109.293 170.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.54 -41.94 91.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.214 1.005 . . . . 0.0 113.009 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.64 -43.06 63.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.704 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 p -62.35 -35.83 80.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.889 1.222 . . . . 0.0 111.3 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 p -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.567 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.85 10.35 86.14 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 118.991 0.814 . . . . 0.0 111.595 -166.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -24.2 66.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.964 1.382 . . . . 0.0 112.009 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.51 0.84 24.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.663 1.585 . . . . 0.0 114.098 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.63 11.46 82.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.071 0.851 . . . . 0.0 111.283 -171.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -152.4 169.92 21.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.43 1.892 . . . . 0.0 105.958 159.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 153.88 -175.86 32.02 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 122.096 0.831 . . . . 0.0 111.959 -171.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.59 -17.45 38.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.428 1.491 . . . . 0.0 113.384 -158.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -53.15 126.6 21.39 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.211 1.004 . . . . 0.0 109.337 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.91 79.4 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.846 -1.53 . . . . 0.0 114.218 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 m -85.18 154.42 22.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 120.07 1.935 . . . . 0.0 107.298 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.0 t -81.28 170.28 16.25 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 164.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.82 112.73 25.15 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -79.8 -18.43 50.96 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.57 111.66 9.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.836 1.198 . . . . 0.0 108.3 -170.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.3 mt -136.4 117.9 19.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.6 mt -127.1 89.27 52.32 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -167.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -48.3 121.76 6.65 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.521 2.814 . . . . 0.0 114.985 -167.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.5 67.59 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.222 1.391 . . . . 0.0 112.103 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -137.37 -78.72 0.39 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.72 1.26 . . . . 0.0 108.551 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.97 163.33 29.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.545 0.688 . . . . 0.0 111.736 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 95.02 3.97 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.126 1.771 . . . . 0.0 107.832 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -76.86 141.74 40.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.432 1.11 . . . . 0.0 110.185 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.4 -156.59 8.54 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.41 -13.24 67.03 Favored Glycine 0 C--O 1.229 -0.187 0 O-C-N 121.542 -0.975 . . . . 0.0 112.42 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -84.04 88.49 7.17 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.76 -0.847 . . . . 0.0 109.749 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -74.32 3.42 7.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.876 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.4 p -125.65 -58.39 1.41 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 120.102 1.319 . . . . 0.0 113.843 -159.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -103.94 -158.37 0.66 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.34 41.04 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.5 0.666 . . . . 0.0 109.426 159.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -122.94 -51.59 1.9 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.952 0.901 . . . . 0.0 111.645 -163.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.28 -9.44 0.17 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.812 -1.549 . . . . 0.0 114.256 -169.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.7 p -104.24 -19.99 13.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.498 2.149 . . . . 0.0 112.295 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.25 -170.93 2.29 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 124.711 1.148 . . . . 0.0 115.758 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.57 -172.2 41.13 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 123.75 1.75 . . . . 0.0 115.753 -168.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.31 156.53 38.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.311 3.044 . . . . 0.0 107.254 -171.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.8 p -78.1 166.26 23.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.97 0.89 . . . . 0.0 109.541 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 pt -59.66 -29.91 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.518 167.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -77.93 -10.11 59.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 111.638 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 143.21 12.47 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.5 1.524 . . . . 0.0 109.889 -171.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 34.48 -133.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.658 2.383 . . . . 0.0 113.029 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -120.47 143.38 48.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -173.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.72 -176.62 3.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.865 0.866 . . . . 0.0 109.644 -167.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -63.06 137.94 58.41 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.119 0.961 . . . . 0.0 109.792 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.02 86.57 6.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.08 -65.55 0.39 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.749 2.02 . . . . 0.0 113.437 -159.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -158.2 178.78 9.81 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.009 0.924 . . . . 0.0 109.892 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -129.48 36.07 4.16 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.698 1.999 . . . . 0.0 109.401 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.56 -55.98 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -84.07 132.24 34.73 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -122.69 168.91 11.61 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.57 1.548 . . . . 0.0 109.91 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.445 ' HD1' ' N ' ' A' ' 123' ' ' ASP . 36.5 m80 -74.33 81.64 1.87 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.0 p -80.27 -11.27 59.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.603 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.61 -173.96 43.88 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.601 1.091 . . . . 0.0 112.593 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 165.27 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.809 2.339 . . . . 0.0 110.822 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.58 -17.94 6.19 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 117.315 -1.825 . . . . 0.0 112.261 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.28 151.62 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 121.355 2.577 . . . . 0.0 108.29 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.03 128.01 53.96 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 120.934 -1.104 . . . . 0.0 109.639 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 t -140.34 145.97 37.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.436 1.095 . . . . 0.0 110.496 -172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 89.9 mmm -78.38 121.95 25.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.486 0.714 . . . . 0.0 109.965 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.62 87.51 1.23 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 164.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -76.59 -169.88 1.37 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.168 0.987 . . . . 0.0 108.584 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.41 24.5 4.8 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 110.607 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.45 -159.87 21.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -164.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -64.45 162.56 30.25 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 CA-C-N 119.558 1.679 . . . . 0.0 109.805 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 34.16 53.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 128.967 2.907 . . . . 0.0 113.382 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.1 p -140.63 23.29 2.3 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.072 1.349 . . . . 0.0 111.382 -175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -88.25 142.99 27.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 170.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.5 -58.31 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -162.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.06 -39.87 0.2 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.76 0.824 . . . . 0.0 110.904 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -62.54 135.77 57.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.141 1.376 . . . . 0.0 109.567 -173.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -147.09 174.5 11.51 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.331 1.452 . . . . 0.0 108.559 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -136.53 153.85 50.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.918 0.866 . . . . 0.0 111.488 159.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.31 117.41 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 162.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.31 124.43 23.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -112.96 23.63 13.2 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.069 0.548 . . . . 0.0 109.748 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.5 177.75 10.23 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -70.53 87.55 0.66 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -74.1 43.4 0.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.382 2.273 . . . . 0.0 110.903 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -66.39 -18.16 65.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 119.699 -1.876 . . . . 0.0 113.128 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.427 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 45.7 p90 -67.28 -13.74 62.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.129 0.972 . . . . 0.0 111.217 170.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.427 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -108.95 -6.89 15.53 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.262 1.825 . . . . 0.0 111.8 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.445 ' N ' ' HD1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -70.16 135.62 49.3 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.01 -4.66 82.38 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.477 -1.179 . . . . 0.0 113.084 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -94.51 -40.29 9.95 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.189 1.994 . . . . 0.0 110.435 166.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -131.64 158.12 41.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.155 0.582 . . . . 0.0 111.76 -161.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.67 101.11 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -169.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.81 132.81 32.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -139.21 -2.09 1.67 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.05 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.75 -171.02 30.48 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.181 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -155.34 166.37 33.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.323 1.049 . . . . 0.0 109.806 163.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.77 126.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 164.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.4 -55.87 3.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.75 162.48 37.53 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.808 0.692 . . . . 0.0 111.921 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.24 28.05 60.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.731 1.158 . . . . 0.0 112.685 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 10.6 tpt -56.55 -38.38 71.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.237 1.519 . . . . 0.0 111.414 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -64.54 -28.5 69.69 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.169 -0.957 . . . . 0.0 112.329 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.1 mm -70.84 -44.99 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.49 -38.46 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.98 -29.61 66.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.946 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.95 -44.15 50.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.711 1.204 . . . . 0.0 109.787 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.9 mtp -50.85 -42.35 58.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.675 0.79 . . . . 0.0 110.005 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.57 -34.36 76.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.389 1.075 . . . . 0.0 112.905 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -67.49 -27.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 119.418 1.008 . . . . 0.0 110.275 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -89.44 8.16 32.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 111.862 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.4 -151.91 4.04 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.653 1.12 . . . . 0.0 110.318 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -137.8 -70.36 0.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.85 -0.794 . . . . 0.0 110.069 166.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 143.44 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 1 C-N-CA 133.379 4.671 . . . . 0.0 110.934 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.84 -25.36 66.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.063 159.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 118.08 -40.76 2.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 124.86 1.219 . . . . 0.0 110.644 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.36 124.11 20.91 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.8 p -64.11 152.18 41.18 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.282 1.033 . . . . 0.0 110.621 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.4 p -72.62 -28.62 62.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.991 163.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -135.96 140.09 43.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -73.16 103.01 3.75 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 119.907 -1.745 . . . . 0.0 109.849 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.42 136.31 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.32 166.13 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.651 1.581 . . . . 0.0 108.703 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 mt -106.48 105.87 19.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.84 -51.09 66.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -149.81 155.63 40.43 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.5 p -156.5 161.96 39.98 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.881 0.873 . . . . 0.0 109.712 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.45 -172.98 44.93 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.551 HE21 ' HB3' ' A' ' 165' ' ' GLU . 1.6 mt-30 -96.8 147.99 23.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.877 0.871 . . . . 0.0 109.744 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.09 43.16 3.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.639 0.776 . . . . 0.0 109.003 165.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.551 ' HB3' HE21 ' A' ' 163' ' ' GLN . 13.1 pt-20 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 117.232 -1.366 . . . . 0.0 113.849 -172.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 117.364 -1.303 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -64.04 144.74 88.38 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 121.357 1.52 . . . . 0.0 109.416 167.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.9 m -103.98 143.66 32.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.04 156.92 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -125.23 159.13 32.35 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.656 0.782 . . . . 0.0 110.197 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.604 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 54.6 m-85 -145.94 104.71 3.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.613 2.365 . . . . 0.0 107.58 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.5 94.07 3.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 167.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.6 mm -66.73 150.06 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.241 1.016 . . . . 0.0 109.625 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.25 160.74 34.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.704 1.601 . . . . 0.0 110.808 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.8 t -127.37 98.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.075 2.55 . . . . 0.0 105.23 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 50.88 12.94 0.12 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.558 1.943 . . . . 0.0 114.772 -165.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.7 -13.8 13.12 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.424 1.488 . . . . 0.0 113.247 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -72.82 116.65 52.25 Favored Pre-proline 0 C--O 1.23 0.075 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.93 116.98 3.9 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.615 1.543 . . . . 0.0 110.036 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.0 tp -87.28 -27.6 22.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.214 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.83 162.77 10.08 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.2 ttm105 -75.68 143.23 42.27 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.84 152.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 128.534 2.734 . . . . 0.0 104.724 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -143.34 140.57 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.215 0.461 . . . . 0.0 109.949 175.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -114.14 159.87 19.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.333 1.053 . . . . 0.0 108.764 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -120.37 137.88 54.05 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.121 2.169 . . . . 0.0 105.573 170.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.6 mt -125.02 119.11 27.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -164.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.61 63.18 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.13 1.372 . . . . 0.0 112.123 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -17.06 59.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.893 -1.129 . . . . 0.0 111.881 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 -13.0 59.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.059 1.343 . . . . 0.0 112.94 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -111.91 -44.41 3.46 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.014 1.279 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m -134.07 68.75 74.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.066 1.346 . . . . 0.0 108.897 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.66 -38.8 92.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.201 1.934 . . . . 0.0 113.107 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -50.67 70.89 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.588 1.085 . . . . 0.0 108.965 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -62.53 -45.46 92.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.66 1.184 . . . . 0.0 109.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.96 61.95 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.377 1.071 . . . . 0.0 112.164 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -60.69 -41.99 96.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.663 1.185 . . . . 0.0 110.177 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.41 -51.21 67.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.538 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -64.43 -40.32 95.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 ttp85 -56.2 -59.13 5.37 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.32 1.848 . . . . 0.0 110.901 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.86 69.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.814 0.446 . . . . 0.0 112.165 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -74.49 -32.41 62.53 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.871 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.4 m -68.32 -47.04 68.61 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.819 1.247 . . . . 0.0 110.616 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.4 p -64.45 -38.76 92.14 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.62 11.69 82.67 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -166.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -63.57 -20.22 65.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.793 1.296 . . . . 0.0 111.857 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.534 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.85 -1.44 86.38 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.444 1.02 . . . . 0.0 112.172 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -154.5 172.49 17.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.874 1.27 . . . . 0.0 109.073 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.13 -151.77 19.77 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.902 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.604 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.3 t80 -54.14 -29.44 45.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.347 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -59.28 101.71 0.11 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.557 1.071 . . . . 0.0 110.007 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.08 72.59 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 116.848 -2.084 . . . . 0.0 115.295 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 p -64.55 -58.28 6.82 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.424 2.612 . . . . 0.0 110.609 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.8 t 105.39 161.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.264 3.826 . . . . 0.0 108.292 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -115.97 123.94 49.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -104.87 -17.09 14.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.163 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.95 97.78 3.72 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.7 mt -124.13 117.61 51.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.19 103.08 14.1 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.5 134.12 45.15 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 124.532 3.488 . . . . 0.0 112.804 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.07 25.36 69.44 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.758 0.694 . . . . 0.0 111.531 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -138.9 -78.29 0.34 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.54 162.81 21.94 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 94.2 m -122.52 96.51 5.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.556 2.343 . . . . 0.0 109.802 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -85.61 132.63 34.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.772 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.64 22.98 0.55 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.528 0.585 . . . . 0.0 114.437 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.18 -3.94 88.56 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.349 -1.089 . . . . 0.0 114.097 -170.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.87 73.25 10.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.173 0.986 . . . . 0.0 108.567 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -66.3 -2.44 4.41 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.503 -1.373 . . . . 0.0 112.126 166.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -121.83 -50.72 2.05 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.328 2.251 . . . . 0.0 111.256 -169.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -106.29 -149.23 0.42 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.19 69.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.273 1.397 . . . . 0.0 107.677 158.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.6 -77.12 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.788 -0.57 . . . . 0.0 110.134 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.91 5.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 119.03 -0.872 . . . . 0.0 113.9 -161.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.9 p -83.6 -73.47 0.41 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 163.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.3 169.89 10.4 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 121.065 3.186 . . . . 0.0 121.065 158.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.78 158.72 28.32 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 109.97 -3.115 . . . . 0.0 115.963 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' H ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -86.53 -175.7 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.272 3.429 . . . . 0.0 110.314 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -93.29 -179.04 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.557 0.617 . . . . 0.0 109.614 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.0 pt -72.87 -36.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 120.436 -1.415 . . . . 0.0 110.285 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -73.95 -22.18 59.75 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.822 0.449 . . . . 0.0 110.869 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.71 -105.93 0.28 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.311 -3.116 . . . . 0.0 105.311 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 10.4 tt0 -113.99 -175.79 2.76 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.55 1.167 . . . . 0.0 109.454 -171.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.465 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 94.9 mttt -64.07 123.84 20.09 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 125.878 1.671 . . . . 0.0 109.102 -165.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -99.65 160.35 14.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.741 1.258 . . . . 0.0 110.516 -169.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.46 162.66 22.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.883 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.67 89.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.08 1.752 . . . . 0.0 109.066 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -55.06 -48.44 73.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.281 1.032 . . . . 0.0 111.526 -159.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.45 HD21 HG13 ' A' ' 89' ' ' ILE . 2.2 p-10 -178.51 155.18 0.84 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 128.128 2.571 . . . . 0.0 106.982 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.84 32.15 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.037 1.335 . . . . 0.0 109.317 -168.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.45 HG13 HD21 ' A' ' 87' ' ' ASN . 15.7 mt -52.25 -41.46 34.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 126.211 1.805 . . . . 0.0 109.761 172.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.98 125.68 41.58 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.74 165.41 11.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.19 1.796 . . . . 0.0 109.134 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -80.63 97.1 7.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.0 p -82.46 -26.46 32.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.753 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.0 -177.07 47.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.147 0.885 . . . . 0.0 112.742 -173.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.81 144.54 97.02 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.105 1.87 . . . . 0.0 109.322 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.93 14.87 60.19 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.729 -1.595 . . . . 0.0 112.689 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mm -86.13 158.42 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 121.046 2.423 . . . . 0.0 108.36 162.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 139.39 53.74 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.374 1.47 . . . . 0.0 109.315 168.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -149.23 162.18 40.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.404 1.082 . . . . 0.0 110.49 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.64 117.08 19.45 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.715 1.206 . . . . 0.0 109.733 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.57 62.66 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.117 0.961 . . . . 0.0 109.364 171.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -68.34 -179.25 1.25 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.749 1.261 . . . . 0.0 109.081 170.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.05 16.0 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 126.472 1.909 . . . . 0.0 111.606 -171.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.09 177.06 14.68 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.707 1.622 . . . . 0.0 109.11 -166.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.47 131.93 49.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.831 2.354 . . . . 0.0 110.78 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 71.43 9.39 6.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.225 1.81 . . . . 0.0 114.154 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.4 p -92.14 39.58 1.02 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.209 -1.557 . . . . 0.0 111.082 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -82.86 105.56 13.97 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.85 -109.69 2.68 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -18.56 13.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.415 1.086 . . . . 0.0 111.307 172.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -59.07 113.92 2.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.81 1.244 . . . . 0.0 107.979 172.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.469 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 15.4 p90 -127.43 168.95 14.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.208 2.203 . . . . 0.0 107.139 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -143.45 155.59 44.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.583 0.706 . . . . 0.0 111.398 160.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.4 mt -83.83 125.11 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 164.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.7 m -75.29 115.59 15.1 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 166.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -103.04 22.28 14.25 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.312 0.645 . . . . 0.0 109.917 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.91 -178.43 7.24 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.343 1.057 . . . . 0.0 108.314 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -66.92 96.22 0.41 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 163.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 p -80.24 63.66 4.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.454 1.121 . . . . 0.0 109.594 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.92 -21.14 66.0 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.936 -1.102 . . . . 0.0 112.232 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.438 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 19.2 p90 -70.85 -7.89 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.586 1.154 . . . . 0.0 110.878 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.438 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.5 mt -122.49 6.4 9.54 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 126.617 1.967 . . . . 0.0 111.212 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.96 130.62 42.22 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 166.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.9 -4.68 29.03 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.122 -1.376 . . . . 0.0 114.728 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -93.82 -34.15 13.28 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.144 2.472 . . . . 0.0 110.811 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -143.83 134.2 24.63 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.184 0.594 . . . . 0.0 109.74 -164.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.99 107.33 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 126.287 1.835 . . . . 0.0 107.57 -170.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.14 131.09 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -135.79 -4.72 2.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.11 33.22 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.341 0.973 . . . . 0.0 111.62 -176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -147.66 152.54 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 109.122 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 32.8 t -65.8 110.2 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 164.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -71.61 -50.55 29.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.47 157.45 45.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.537 1.935 . . . . 0.0 110.159 -167.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.67 18.3 79.1 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.854 0.74 . . . . 0.0 114.026 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -35.16 68.74 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.96 1.88 . . . . 0.0 110.677 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -20.5 65.95 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.452 -1.405 . . . . 0.0 113.598 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.8 -37.07 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -37.16 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.767 . . . . 0.0 109.735 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.29 -25.57 67.7 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.448 -1.407 . . . . 0.0 112.65 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.15 -46.96 30.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.815 -1.178 . . . . 0.0 109.733 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.7 mtp -52.3 -41.21 62.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.329 0.968 . . . . 0.0 111.377 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -60.62 -37.03 80.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 112.343 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -71.24 -23.08 61.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.541 1.064 . . . . 0.0 110.638 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -90.45 12.25 19.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.329 1.451 . . . . 0.0 111.637 172.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.39 -150.49 6.66 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.164 1.364 . . . . 0.0 110.296 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.9 p -143.63 -103.3 0.12 Allowed 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 159.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -153.7 -27.03 0.14 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.176 1.79 . . . . 0.0 110.196 159.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -66.53 -19.74 65.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.011 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.27 -30.12 6.41 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.429 1.49 . . . . 0.0 111.514 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 124.48 20.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.092 1.446 . . . . 0.0 107.763 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -66.84 130.0 41.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.269 1.028 . . . . 0.0 108.291 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.17 -22.37 64.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.058 0.943 . . . . 0.0 111.599 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -118.87 175.4 5.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 159.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -72.93 145.06 47.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 164.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 24.2 mm -129.37 123.23 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 178.19 8.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.837 -159.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.74 102.18 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.29 -43.31 74.08 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.39 166.4 28.22 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 117.971 0.35 . . . . 0.0 110.606 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.3 p -170.34 172.64 6.05 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 123.566 0.746 . . . . 0.0 110.487 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.34 -169.49 42.53 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.445 HE21 ' C ' ' A' ' 165' ' ' GLU . 41.1 tt0 -110.66 136.25 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.108 1.363 . . . . 0.0 108.437 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 mt -116.42 43.12 2.26 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.49 1.138 . . . . 0.0 109.644 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.445 ' C ' HE21 ' A' ' 163' ' ' GLN . 2.0 tp10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 128.248 2.619 . . . . 0.0 108.272 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.376 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.16 165.7 16.38 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.996 1.797 . . . . 0.0 110.079 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 m -131.18 157.44 43.17 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 m -143.7 142.18 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.138 1.375 . . . . 0.0 108.024 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -89.94 155.78 18.89 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.462 0.574 . . . . 0.0 109.457 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -137.76 105.42 5.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.0 103.68 11.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.86 139.45 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.91 158.79 28.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.917 0.887 . . . . 0.0 110.254 163.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.55 105.17 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 54.72 14.04 0.8 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.873 2.069 . . . . 0.0 113.939 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 6.96 60.4 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.551 -1.343 . . . . 0.0 114.066 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.32 123.14 84.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 159.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.7 113.04 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.21 -38.09 52.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.26 -173.39 36.86 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -110.72 151.41 27.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.982 0.896 . . . . 0.0 110.079 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.31 162.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.536 3.134 . . . . 0.0 105.852 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.5 t -147.13 149.8 33.72 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.98 136.41 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.174 0.99 . . . . 0.0 109.453 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -84.57 147.0 27.24 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 160.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.48 118.55 26.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 90' ' ' LEU . 14.1 m-85 -75.26 52.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.353 2.261 . . . . 0.0 112.016 -172.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -13.75 29.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 120.541 -1.349 . . . . 0.0 113.335 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.42 -7.41 59.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.358 0.981 . . . . 0.0 112.953 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.87 -25.25 1.43 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.569 1.077 . . . . 0.0 113.347 -171.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.51 72.32 37.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.051 1.74 . . . . 0.0 107.045 161.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -47.2 -52.27 8.11 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.352 2.701 . . . . 0.0 112.602 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -46.58 86.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.841 0.746 . . . . 0.0 109.872 -169.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.8 m -66.72 -51.21 58.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 125.095 1.358 . . . . 0.0 110.489 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -39.16 80.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.836 0.455 . . . . 0.0 112.142 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.73 -44.3 90.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.112 1.765 . . . . 0.0 109.807 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -56.97 -53.67 55.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.154 0.982 . . . . 0.0 109.715 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.69 -37.22 80.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.865 0.866 . . . . 0.0 112.783 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -54.06 -64.38 0.85 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.235 1.414 . . . . 0.0 109.281 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.29 66.37 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.714 0.634 . . . . 0.0 112.412 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 mt -69.78 -33.51 72.49 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.192 -0.943 . . . . 0.0 111.426 171.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 m -68.49 -49.38 60.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.814 0.734 . . . . 0.0 109.255 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.6 p -64.14 -30.99 72.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.364 0.529 . . . . 0.0 110.523 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.02 -3.88 68.89 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 119.695 1.134 . . . . 0.0 112.068 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.89 -1.38 14.11 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.82 2.048 . . . . 0.0 113.008 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.66 7.8 13.78 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.464 -0.772 . . . . 0.0 112.623 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.04 2.54 89.45 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.087 0.851 . . . . 0.0 111.555 -166.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -174.45 173.26 2.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.3 1.84 . . . . 0.0 106.546 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.62 -167.39 28.12 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -88.7 -8.0 55.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -162.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -64.32 115.02 4.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.743 1.611 . . . . 0.0 108.034 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.07 11.64 85.38 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 -173.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.2 t -66.41 119.09 11.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 163.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.82 139.17 43.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -74.21 99.63 3.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -73.77 -57.09 4.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.9 112.17 24.19 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -168.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.48 105.27 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.42 97.28 42.91 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -53.0 134.07 54.3 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.935 2.423 . . . . 0.0 113.213 -171.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.4 78.17 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.129 1.823 . . . . 0.0 112.918 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -122.9 -75.98 0.59 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.305 1.553 . . . . 0.0 106.816 -173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.55 18.2 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.141 0.976 . . . . 0.0 109.377 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.8 t -125.75 105.96 9.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -93.84 138.25 32.2 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.672 1.989 . . . . 0.0 110.798 -172.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.55 -168.82 12.83 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.172 1.844 . . . . 0.0 110.109 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.33 9.96 69.01 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.969 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.292 29.9 t0 -84.45 46.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.619 2.209 . . . . 0.0 113.062 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -53.3 -42.65 66.83 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.337 0.655 . . . . 0.0 112.722 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.452 ' HB ' ' HE3' ' A' ' 76' ' ' LYS . 3.6 t -72.79 -35.1 67.31 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.396 0.678 . . . . 0.0 111.419 -171.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -125.06 -139.12 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -170.06 23.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.621 1.555 . . . . 0.0 112.948 159.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -134.81 8.69 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.199 1.4 . . . . 0.0 112.742 -159.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.09 -9.29 66.93 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.721 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.5 p -84.16 -18.44 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.827 1.814 . . . . 0.0 111.185 171.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.49 -154.34 7.47 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 124.833 1.206 . . . . 0.0 113.077 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.52 120.57 2.23 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -162.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.452 ' HE3' ' HB ' ' A' ' 68' ' ' THR . 13.1 pttp -142.77 158.03 44.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 158.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -91.22 177.74 6.17 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 124.066 0.854 . . . . 0.0 110.465 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.6 pt -62.62 -31.06 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.607 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -82.68 1.66 37.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.385 1.474 . . . . 0.0 111.605 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.88 156.41 29.11 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -170.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.259 3.1 tm-20 33.79 -142.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.802 2.841 . . . . 0.0 113.429 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -115.0 150.83 35.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.467 1.107 . . . . 0.0 108.115 -167.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.94 175.8 6.72 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.89 154.54 25.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.291 0.567 . . . . 0.0 109.823 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -80.33 88.37 5.55 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 167.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -46.88 -51.61 16.34 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -158.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.83 160.48 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.727 -1.578 . . . . 0.0 114.023 168.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.32 24.82 10.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.452 2.301 . . . . 0.0 110.603 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.8 mt -50.47 -46.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.187 0.995 . . . . 0.0 108.994 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.414 HD11 ' CD2' ' A' ' 25' ' ' PHE . 96.1 mt -89.29 126.92 35.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.433 1.111 . . . . 0.0 108.278 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -108.86 172.12 7.03 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 126.811 2.044 . . . . 0.0 109.044 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.48 ' HD1' ' HA ' ' A' ' 123' ' ' ASP . 80.3 m80 -87.61 73.59 9.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.946 0.898 . . . . 0.0 108.879 -166.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 p -75.29 -4.52 39.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -160.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.86 -179.15 33.79 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.4 1.0 . . . . 0.0 111.886 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.08 159.77 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.072 1.848 . . . . 0.0 110.159 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.31 71.36 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.233 -1.315 . . . . 0.0 112.674 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.63 162.11 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.934 1.867 . . . . 0.0 107.5 166.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.03 132.28 44.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.1 1.76 . . . . 0.0 107.138 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 34.5 t -146.11 169.8 17.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.883 0.849 . . . . 0.0 110.029 -172.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.455 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 7.5 ttm -111.67 120.67 42.82 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.298 1.439 . . . . 0.0 109.1 -161.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.15 94.72 2.47 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -85.31 170.28 12.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 158.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.02 20.31 18.08 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.215 1.406 . . . . 0.0 111.506 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.65 -165.83 25.21 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 -159.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.4 153.75 76.81 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 119.88 1.84 . . . . 0.0 109.672 167.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 45.16 34.36 1.36 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.689 2.796 . . . . 0.0 113.497 169.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -132.53 32.5 3.89 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.932 -1.105 . . . . 0.0 111.573 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.455 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 15.4 p30 -66.29 -154.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.936 2.095 . . . . 0.0 110.916 166.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.14 -81.7 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.6 m -133.83 -16.43 2.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -72.78 139.78 47.29 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.401 1.455 . . . . 0.0 108.201 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -141.56 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.579 1.152 . . . . 0.0 108.511 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 99' ' ' SER . 43.5 p90 -146.17 153.03 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 122.332 1.063 . . . . 0.0 110.852 165.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -84.01 119.33 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 167.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.74 119.88 15.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.8 p -106.94 19.63 20.19 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 109.964 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.08 179.81 8.71 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 166.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.13 102.29 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 160.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.7 p -92.98 58.45 2.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.902 0.858 . . . . 0.0 109.711 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.58 -16.63 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.705 -1.247 . . . . 0.0 114.291 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -69.01 -17.75 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.256 -0.903 . . . . 0.0 111.079 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 36.3 mt -100.94 -10.26 20.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.069 1.347 . . . . 0.0 110.711 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.48 ' HA ' ' HD1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -60.52 127.85 33.73 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.401 1.081 . . . . 0.0 109.585 178.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.73 -8.98 25.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.924 1.25 . . . . 0.0 113.631 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -99.56 -42.44 6.91 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.328 1.451 . . . . 0.0 110.278 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -115.4 155.13 27.98 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.908 1.283 . . . . 0.0 110.967 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.21 104.19 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -174.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.84 122.13 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -134.76 -2.05 2.69 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.441 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.26 26.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.417 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -142.46 147.31 35.9 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.889 1.675 . . . . 0.0 109.203 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.2 t -66.22 110.37 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 158.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -46.68 31.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -146.81 159.12 43.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.358 1.063 . . . . 0.0 108.551 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.2 18.57 60.55 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.532 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 25.7 tpp -51.79 -34.45 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.812 . . . . 0.0 110.709 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.3 -33.45 65.56 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.094 -1.004 . . . . 0.0 113.536 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 119.416 1.007 . . . . 0.0 109.067 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.7 t -59.56 -41.59 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.192 0.905 . . . . 0.0 110.188 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.91 -37.83 83.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.901 0.88 . . . . 0.0 110.856 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.41 72.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.192 -0.943 . . . . 0.0 109.863 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 76.7 mtp -57.79 -44.63 86.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.8 0.84 . . . . 0.0 110.483 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.4 -32.85 72.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.57 -15.0 59.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.214 0.606 . . . . 0.0 111.475 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -97.09 6.41 48.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.694 1.598 . . . . 0.0 111.388 165.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.85 -173.78 46.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.5 p -157.1 158.61 36.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -70.06 -16.23 63.11 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -166.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -29.87 68.99 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.152 0.282 . . . . 0.0 111.36 167.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.65 -29.73 7.05 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 127.871 2.653 . . . . 0.0 112.439 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -68.6 130.94 44.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.774 1.787 . . . . 0.0 109.044 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.5 p -70.88 154.76 41.55 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.919 0.888 . . . . 0.0 110.107 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 p -74.45 -16.62 60.86 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.44 0.696 . . . . 0.0 111.54 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -130.8 169.92 15.07 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.605 1.162 . . . . 0.0 110.848 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -74.42 139.19 43.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 162.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.4 mt -136.52 118.44 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -132.9 160.8 35.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 -169.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -74.05 112.66 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 158.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.78 -56.05 14.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -143.92 155.2 43.98 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.893 0.877 . . . . 0.0 109.354 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -145.82 168.81 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.762 1.625 . . . . 0.0 107.991 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.18 47.16 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' A' ' 165' ' ' GLU . 6.5 tt0 -87.81 155.38 19.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -172.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 55.1 mt -139.99 43.28 1.94 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.559 1.143 . . . . 0.0 109.717 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.444 ' HB3' HE21 ' A' ' 163' ' ' GLN . 10.0 pm0 . . . . . 0 C--O 1.249 1.079 0 C-N-CA 125.404 1.481 . . . . 0.0 114.244 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 C--O 1.235 0.317 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -63.48 135.58 50.29 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.9 m -92.91 155.62 17.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.162 -2.532 . . . . 0.0 104.162 161.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.03 167.16 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.952 1.301 . . . . 0.0 108.556 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.45 158.04 37.07 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.74 0.816 . . . . 0.0 111.477 165.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.41 113.79 13.57 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.116 2.966 . . . . 0.0 104.435 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.85 104.71 15.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 170.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -71.3 148.01 10.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.33 27.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 111.145 159.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' CG1' ' HE2' ' A' ' 154' ' ' LYS . 5.4 t -128.31 94.32 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 126.354 1.862 . . . . 0.0 107.434 -164.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 50.75 24.48 1.74 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.085 -1.634 . . . . 0.0 111.611 -160.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.21 -4.93 35.64 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.055 1.312 . . . . 0.0 114.146 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 39.4 tt0 -81.44 109.06 12.58 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 127.81 2.444 . . . . 0.0 107.74 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.95 99.2 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.051 2.501 . . . . 0.0 112.054 -168.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.7 tp -79.39 -28.91 41.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.55 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.66 157.28 8.19 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.602 0.637 . . . . 0.0 113.228 171.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -74.8 135.24 41.67 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.419 1.088 . . . . 0.0 108.761 170.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 t -127.21 143.24 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.31 146.05 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.746 0.703 . . . . 0.0 109.238 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -141.27 150.27 42.38 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 109.144 -164.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.15 147.16 26.57 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 163.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.7 mt -127.92 115.04 17.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.445 1.498 . . . . 0.0 107.237 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.36 58.22 1.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.078 1.751 . . . . 0.0 112.638 -169.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -19.05 51.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.678 1.191 . . . . 0.0 113.267 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.82 -30.4 66.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.056 0.843 . . . . 0.0 110.762 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -98.84 -50.55 4.17 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.65 0.78 . . . . 0.0 109.613 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.98 76.19 71.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 125.912 1.685 . . . . 0.0 107.702 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.3 -40.74 56.23 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.672 2.248 . . . . 0.0 111.517 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 1.3 mmpt? -66.43 -47.37 73.44 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -170.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -62.4 -49.69 74.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.961 1.304 . . . . 0.0 110.173 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.51 -46.77 78.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -64.84 -40.12 94.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.482 1.113 . . . . 0.0 110.752 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -54.64 -53.6 52.59 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 124.267 1.027 . . . . 0.0 109.484 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.9 -40.82 91.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 123.612 0.57 . . . . 0.0 112.079 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -50.71 -60.56 2.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.822 2.049 . . . . 0.0 110.099 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.05 63.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.585 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.48 -15.82 36.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.386 1.074 . . . . 0.0 111.808 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -42.72 12.18 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 120.006 1.276 . . . . 0.0 109.884 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -63.54 -33.18 75.03 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 172.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 10.55 74.73 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -16.72 63.74 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.418 1.487 . . . . 0.0 112.4 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -74.01 -3.74 31.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.204 1.402 . . . . 0.0 112.64 170.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.87 90.68 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 119.812 1.187 . . . . 0.0 112.571 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.08 173.08 17.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.067 2.147 . . . . 0.0 106.371 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.62 -179.18 34.46 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.803 -164.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -68.26 -19.5 64.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -51.42 118.61 3.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.446 1.021 . . . . 0.0 108.784 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.84 86.98 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.593 -1.67 . . . . 0.0 114.832 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -76.92 146.34 37.65 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 121.342 2.571 . . . . 0.0 107.738 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.21 148.39 22.24 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -93.67 81.06 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -74.06 -17.94 60.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.964 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.75 84.85 2.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.344 0.974 . . . . 0.0 110.61 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.98 97.06 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.89 104.74 23.29 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.51 142.11 83.22 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.911 1.741 . . . . 0.0 110.483 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.79 14.01 81.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.718 1.151 . . . . 0.0 112.929 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -140.67 -81.26 0.25 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.768 1.284 . . . . 0.0 109.047 -170.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.02 167.77 20.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.485 0.714 . . . . 0.0 112.411 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.3 m -123.43 97.61 5.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.818 2.047 . . . . 0.0 109.415 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.12 138.24 31.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.229 1.412 . . . . 0.0 110.824 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.62 72.35 0.09 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-O 118.635 -1.091 . . . . 0.0 113.524 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.29 14.32 1.45 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.262 1.531 . . . . 0.0 116.274 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -91.03 113.49 25.77 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 164.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -96.29 35.7 1.43 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.759 1.623 . . . . 0.0 110.312 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -155.0 -67.07 0.13 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.198 1.399 . . . . 0.0 107.976 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -85.98 168.59 14.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.126 2.17 . . . . 0.0 105.288 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -139.53 31.76 2.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -167.0 4.7 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.984 -158.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.583 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 111.65 -20.19 22.88 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 120.463 1.483 . . . . 0.0 114.903 175.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 p -84.53 9.14 14.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.825 1.813 . . . . 0.0 113.865 -169.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.81 -153.58 6.94 Favored Glycine 0 C--N 1.333 0.399 0 O-C-N 120.798 -1.188 . . . . 0.0 113.14 -162.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.96 174.34 46.84 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -158.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -166.91 154.26 9.15 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 125.461 1.505 . . . . 0.0 107.529 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.2 p -76.68 144.96 39.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.37 -25.13 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 122.156 0.183 . . . . 0.0 111.151 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -79.9 -13.74 59.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 113.788 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.67 -95.18 0.14 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 120.692 1.587 . . . . 0.0 111.833 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -159.23 112.43 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.212 1.005 . . . . 0.0 109.015 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt 63.4 158.25 0.07 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.824 3.25 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.71 171.33 15.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.769 0.795 . . . . 0.0 109.013 170.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.02 158.38 16.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.058 1.743 . . . . 0.0 113.265 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.99 90.86 2.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 158.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.64 -59.89 4.5 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.45 HD21 HG13 ' A' ' 89' ' ' ILE . 10.1 p-10 -161.49 158.35 26.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.795 1.283 . . . . 0.0 112.561 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.21 31.04 5.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.617 2.367 . . . . 0.0 109.553 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.45 HG13 HD21 ' A' ' 87' ' ' ASN . 21.2 mt -52.67 -40.02 32.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.586 1.154 . . . . 0.0 108.572 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.76 125.16 34.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -102.84 169.22 8.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.01 1.324 . . . . 0.0 108.899 168.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -73.82 89.26 1.82 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.7 p -72.43 -28.56 63.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.34 44.09 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.839 1.209 . . . . 0.0 111.091 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.53 162.43 10.3 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.315 2.01 . . . . 0.0 111.945 169.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.33 77.37 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.198 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.3 mm -77.07 162.46 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 120.139 1.969 . . . . 0.0 108.834 171.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.66 54.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 108.134 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -146.21 147.62 31.65 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.214 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 12.8 mtp -85.54 128.6 34.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.909 1.338 . . . . 0.0 111.423 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.42 73.09 4.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.5 2.32 . . . . 0.0 108.724 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -69.26 -179.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.392 158.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.38 20.44 8.81 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.043 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 134.79 -163.01 24.77 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.62 147.04 89.96 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.053 1.836 . . . . 0.0 109.602 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 46.81 32.01 1.64 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.672 1.989 . . . . 0.0 115.789 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.1 p -118.28 23.56 11.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.536 -1.353 . . . . 0.0 111.503 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -63.12 104.3 0.56 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.21 -75.28 1.03 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.605 1.093 . . . . 0.0 111.383 -170.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.1 p -155.74 -21.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.835 1.254 . . . . 0.0 111.486 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.583 HE22 ' HA2' ' A' ' 72' ' ' GLY . 58.8 mt-30 -64.2 143.08 58.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.47 169.32 18.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.563 1.545 . . . . 0.0 106.833 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -136.04 152.84 51.32 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.781 0.8 . . . . 0.0 110.366 163.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.79 113.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 166.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -62.73 124.95 22.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.7 p -115.1 31.67 6.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.898 1.332 . . . . 0.0 108.665 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.71 169.45 19.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 110.03 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -73.24 86.68 1.44 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 163.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -76.81 58.01 1.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.073 0.949 . . . . 0.0 110.219 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.89 -30.5 65.93 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.037 -1.665 . . . . 0.0 111.816 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -70.91 -15.24 62.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.081 1.352 . . . . 0.0 110.541 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.2 mt -98.97 -12.49 20.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.372 1.069 . . . . 0.0 111.172 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.44 144.04 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.363 0.983 . . . . 0.0 109.605 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.06 -4.64 37.96 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.829 1.204 . . . . 0.0 113.728 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.96 -59.65 1.99 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 126.515 1.926 . . . . 0.0 108.978 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -96.69 129.28 44.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.891 1.276 . . . . 0.0 108.396 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.8 t -80.11 104.4 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -170.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.97 127.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -140.74 -0.22 1.55 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.603 1.19 . . . . 0.0 113.441 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.92 -176.56 32.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.636 -1.269 . . . . 0.0 112.065 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.29 151.48 34.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.01 127.42 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -94.51 -38.33 10.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.933 0.893 . . . . 0.0 110.389 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -139.29 153.48 47.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 109.829 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.71 72.18 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.241 -0.755 . . . . 0.0 113.011 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.0 tpp -54.85 -36.39 65.0 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.304 1.552 . . . . 0.0 110.004 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -58.8 -27.88 65.47 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.534 1.061 . . . . 0.0 113.643 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.7 mm -75.17 -42.77 44.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 124.484 1.114 . . . . 0.0 108.268 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.35 -41.33 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.46 -34.23 70.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.018 1.327 . . . . 0.0 111.154 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.05 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.695 0.798 . . . . 0.0 110.636 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.6 mtm -55.77 -45.32 78.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.555 0.616 . . . . 0.0 110.128 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.49 -36.86 72.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.599 1.159 . . . . 0.0 112.683 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -69.56 -14.89 63.08 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.105 -0.997 . . . . 0.0 111.306 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 14.18 25.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 126.793 2.037 . . . . 0.0 111.291 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.94 -172.21 31.47 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.6 p -154.52 164.32 38.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.738 -0.86 . . . . 0.0 109.435 165.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.26 -33.91 63.59 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -71.64 -13.59 61.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.3 -26.68 21.05 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 127.274 2.368 . . . . 0.0 113.361 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -66.52 130.04 41.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.6 1.7 . . . . 0.0 108.779 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.6 p -65.7 153.86 40.54 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.594 0.758 . . . . 0.0 110.102 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.8 p -69.32 -25.5 64.24 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.299 -0.875 . . . . 0.0 110.586 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HE2' ' CG1' ' A' ' 12' ' ' VAL . 42.7 mtpt -130.76 174.46 9.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.284 1.434 . . . . 0.0 111.518 -170.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -63.65 139.28 58.75 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 102.903 -2.999 . . . . 0.0 102.903 158.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -129.06 122.6 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 101.217 -3.623 . . . . 0.0 101.217 160.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.53 153.17 43.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -166.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -74.09 110.83 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.43 -46.48 73.0 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.517 0.599 . . . . 0.0 109.468 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -151.03 163.32 39.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.643 0.377 . . . . 0.0 110.045 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 m -148.43 171.1 16.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 171.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.26 174.82 46.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 160.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.438 ' HG2' ' H ' ' A' ' 165' ' ' GLU . 47.0 tt0 -87.11 154.82 20.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.225 1.01 . . . . 0.0 109.93 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.1 mt -136.94 43.41 2.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.18 2.592 . . . . 0.0 109.915 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.438 ' H ' ' HG2' ' A' ' 163' ' ' GLN . 3.5 tm-20 . . . . . 0 C--O 1.246 0.892 0 C-N-CA 127.182 2.193 . . . . 0.0 106.155 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 156.41 66.2 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 121.18 1.253 . . . . 0.0 110.985 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -117.09 151.63 36.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.34 150.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 119.301 0.955 . . . . 0.0 109.434 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -108.21 161.55 14.89 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.124 0.969 . . . . 0.0 108.811 166.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 4.1 m-85 -144.37 108.76 4.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.052 2.141 . . . . 0.0 107.361 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 98.29 9.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.23 138.54 22.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.93 149.99 42.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.827 1.299 . . . . 0.0 108.514 161.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.31 80.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 170.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' OD2' ' HE3' ' A' ' 154' ' ' LYS 0.378 3.7 p30 61.74 14.09 5.88 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.41 -9.25 15.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -73.99 121.6 85.56 Favored Pre-proline 0 C--N 1.338 0.099 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 164.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.12 103.23 1.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.81 2.34 . . . . 0.0 107.732 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.8 tp -83.0 -34.11 26.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.704 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.5 165.7 11.74 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.507 -1.33 . . . . 0.0 114.993 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.27 136.14 44.53 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.3 t -120.05 158.77 21.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 130.232 3.413 . . . . 0.0 105.823 165.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -152.11 155.35 37.71 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.679 -1.888 . . . . 0.0 111.812 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -141.85 145.28 34.48 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.949 1.299 . . . . 0.0 110.079 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -90.77 150.54 21.56 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.437 1.495 . . . . 0.0 107.315 160.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -128.74 128.5 44.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.017 1.327 . . . . 0.0 108.249 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -81.13 49.54 1.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.6 1.56 . . . . 0.0 112.546 -166.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -4.63 7.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.907 1.283 . . . . 0.0 114.379 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.15 -16.78 36.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.98 1.264 . . . . 0.0 111.974 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -121.94 -30.31 4.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.64 1.176 . . . . 0.0 113.258 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.88 73.31 81.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 124.685 1.194 . . . . 0.0 107.858 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.75 -39.25 43.96 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.575 2.183 . . . . 0.0 113.434 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -51.34 67.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.499 1.045 . . . . 0.0 108.211 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.8 m -61.55 -49.1 78.05 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.257 1.023 . . . . 0.0 110.732 -170.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.2 -45.4 70.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 112.242 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -63.4 -42.04 98.76 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.466 0.306 . . . . 0.0 111.302 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -56.98 -47.97 79.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.121 1.368 . . . . 0.0 109.439 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.1 -38.64 88.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.856 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -55.23 -58.17 8.79 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.767 0.712 . . . . 0.0 109.135 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.96 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.245 1.418 . . . . 0.0 113.652 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.8 mt -84.04 -26.96 28.67 Favored 'General case' 0 N--CA 1.457 -0.078 0 O-C-N 121.567 -0.708 . . . . 0.0 111.599 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 m -77.52 -43.43 32.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.581 0.752 . . . . 0.0 110.326 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -63.96 -27.35 69.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.89 7.51 62.16 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.41 -27.85 69.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.59 1.156 . . . . 0.0 111.189 -171.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 29.3 mmmt -65.49 -14.71 61.6 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.959 -1.02 . . . . 0.0 112.26 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.93 4.17 48.44 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.251 1.405 . . . . 0.0 112.228 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -163.6 175.99 10.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.078 1.751 . . . . 0.0 107.968 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.77 -149.49 19.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-O 122.029 0.794 . . . . 0.0 112.831 165.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.453 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -59.96 -44.74 94.24 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 127.14 2.176 . . . . 0.0 109.655 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -44.62 112.83 0.46 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.015 1.326 . . . . 0.0 110.004 170.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.05 3.64 88.92 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.097 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.3 m -63.86 -62.76 1.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.907 2.354 . . . . 0.0 110.8 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 t 122.85 167.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 131.774 4.03 . . . . 0.0 106.583 -168.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -119.68 91.96 3.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.583 1.953 . . . . 0.0 106.198 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -73.76 -18.34 60.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -164.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.26 104.08 4.22 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.58 103.09 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.0 mt -119.03 91.0 42.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -48.24 122.62 7.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.01 3.14 . . . . 0.0 114.859 -167.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.56 21.27 77.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.133 1.349 . . . . 0.0 112.37 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.11 -75.57 0.55 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.38 170.99 19.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.227 1.011 . . . . 0.0 109.413 167.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 p -130.77 107.97 9.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.797 0.839 . . . . 0.0 110.411 168.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -86.96 140.86 29.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 129.028 2.931 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.75 -163.09 10.66 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 124.959 1.266 . . . . 0.0 110.845 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.453 ' HA3' ' CE1' ' A' ' 48' ' ' TYR . . . 91.96 10.68 61.04 Favored Glycine 0 N--CA 1.463 0.496 0 CA-C-N 117.717 0.758 . . . . 0.0 114.89 166.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.82 103.91 13.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 107.552 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -115.45 9.94 15.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.478 1.511 . . . . 0.0 111.747 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.6 t -139.15 -35.41 0.56 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.596 1.158 . . . . 0.0 113.629 -166.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -129.87 -36.54 1.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -167.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.5 m170 61.4 56.8 2.52 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.673 1.189 . . . . 0.0 112.078 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -164.51 -54.05 0.03 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.015 1.326 . . . . 0.0 110.169 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.94 -21.44 0.18 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.751 1.643 . . . . 0.0 113.242 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -84.55 12.12 7.57 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.875 1.837 . . . . 0.0 111.57 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.48 -165.13 15.77 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 124.727 1.156 . . . . 0.0 110.696 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.47 103.75 0.17 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -136.3 144.36 44.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.592 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -70.62 164.4 25.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.256 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.429 ' HB ' ' HE2' ' A' ' 44' ' ' LYS . 41.9 pt -61.32 -31.64 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 121.563 -0.711 . . . . 0.0 110.018 163.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.82 -14.53 61.11 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.516 0.726 . . . . 0.0 112.277 -172.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.01 -85.71 0.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -156.17 132.19 9.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 108.593 163.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttt 52.31 149.88 0.0 OUTLIER 'General case' 0 C--N 1.342 0.281 1 C-N-CA 132.618 4.367 . . . . 0.0 115.375 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -128.69 -172.56 2.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.27 152.37 43.34 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 167.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.64 101.02 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 159.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -63.65 -51.02 66.98 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.448 -168.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -151.67 176.24 11.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.373 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -127.78 30.26 5.32 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.618 2.367 . . . . 0.0 109.462 172.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.8 mt -57.27 -46.5 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 99.0 mt -74.57 112.57 10.89 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -82.17 164.26 21.38 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.942 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.78 98.41 4.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.2 p -77.87 -32.93 52.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.798 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.6 -174.98 47.35 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 118.964 0.802 . . . . 0.0 113.851 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.72 160.02 26.37 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.486 2.124 . . . . 0.0 110.457 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.29 -5.93 40.01 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.836 -1.536 . . . . 0.0 112.465 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.92 156.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.925 2.362 . . . . 0.0 107.584 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.17 129.33 54.94 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.641 1.177 . . . . 0.0 108.421 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.1 t -138.53 148.98 44.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.026 0.829 . . . . 0.0 109.28 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 12.9 ttt -100.45 130.44 46.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -162.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.54 155.64 35.87 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.813 1.245 . . . . 0.0 108.842 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -165.38 -169.1 1.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.922 1.689 . . . . 0.0 108.029 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -119.61 13.66 12.55 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.457 1.103 . . . . 0.0 113.049 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.42 -142.39 13.77 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -168.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.03 157.3 62.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.873 1.715 . . . . 0.0 109.521 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 34.18 51.04 0.4 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 128.163 2.585 . . . . 0.0 112.999 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 p -140.63 13.92 2.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.713 0.805 . . . . 0.0 113.069 -173.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -57.79 96.61 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.754 1.622 . . . . 0.0 110.826 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.19 -84.66 1.08 Allowed Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.048 -1.032 . . . . 0.0 111.529 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -156.29 -17.43 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -55.61 140.52 40.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 167.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.88 169.98 16.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -132.34 147.35 52.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.865 0.84 . . . . 0.0 111.663 166.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.4 mt -83.37 117.43 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 102.413 -3.18 . . . . 0.0 102.413 171.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.1 m -64.38 120.91 13.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.0 p -106.88 22.16 16.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.127 0.571 . . . . 0.0 109.629 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.39 -179.56 7.8 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 163.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -64.12 117.27 6.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 159.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.424 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 49.8 p -114.21 56.88 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.175 0.898 . . . . 0.0 111.327 -174.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -61.31 -25.08 66.88 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 120.86 -1.15 . . . . 0.0 113.959 -169.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.424 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 37.3 p90 -66.11 -21.82 66.37 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.814 0.846 . . . . 0.0 110.708 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.65 -16.89 31.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.657 0.783 . . . . 0.0 110.569 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.77 149.0 38.07 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.34 69.84 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.611 -0.328 . . . . 0.0 112.34 -169.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.91 -45.11 0.47 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.179 0.99 . . . . 0.0 109.473 164.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -103.82 144.67 31.19 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.863 1.265 . . . . 0.0 109.486 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.3 102.15 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.05 121.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -142.14 1.36 1.43 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.024 -169.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.79 -177.25 35.64 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.973 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 157.84 43.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.138 0.495 . . . . 0.0 109.954 162.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.03 124.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -84.82 -48.01 9.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.329 160.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -146.06 158.29 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.681 1.192 . . . . 0.0 110.292 -168.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.46 20.08 64.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -34.89 60.57 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.539 1.67 . . . . 0.0 111.186 174.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -32.95 69.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.6 mm -78.14 -34.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 119.541 1.064 . . . . 0.0 109.492 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.21 -40.77 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.143 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.18 -37.01 81.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.672 0.789 . . . . 0.0 111.095 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.79 83.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.204 1.366 . . . . 0.0 108.288 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.0 mtm -52.41 -48.53 65.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 118.003 0.365 . . . . 0.0 110.568 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.03 -34.12 72.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -76.92 -15.67 59.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.892 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -89.46 -5.42 57.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.011 0.924 . . . . 0.0 111.806 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.51 -167.98 42.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.852 1.692 . . . . 0.0 109.782 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 51.2 p -161.49 155.74 22.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -18.88 65.54 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -69.43 -7.19 35.59 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.32 -30.29 10.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 127.787 2.613 . . . . 0.0 113.016 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -63.11 129.78 41.82 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.061 0.944 . . . . 0.0 110.56 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 p -80.01 157.97 26.65 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.824 1.25 . . . . 0.0 109.72 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -76.19 -17.73 59.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.286 1.035 . . . . 0.0 111.786 167.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.472 ' HE3' ' OD2' ' A' ' 13' ' ' ASP . 12.3 mtpt -140.85 165.3 27.9 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.407 1.483 . . . . 0.0 109.572 -168.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -85.69 80.14 9.09 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.995 1.725 . . . . 0.0 107.515 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -73.87 131.24 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 p -145.69 167.34 23.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 123.488 1.613 . . . . 0.0 110.063 -167.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.02 114.56 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 158.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.59 -55.04 12.91 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.04 153.01 33.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.619 1.568 . . . . 0.0 107.076 -161.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 8' ' ' PHE . 7.5 m -159.71 174.16 14.95 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.951 1.701 . . . . 0.0 109.156 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.25 -172.01 44.84 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 165.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -83.49 160.4 21.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.123 0.969 . . . . 0.0 108.578 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.2 mt -128.27 43.28 3.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.197 0.999 . . . . 0.0 108.877 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 N--CA 1.435 -1.218 0 C-N-CA 131.638 3.975 . . . . 0.0 109.821 -168.698 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--O 1.24 0.58 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.84 156.26 66.89 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.863 1.709 . . . . 0.0 109.279 165.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.1 m -135.82 158.77 43.58 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.85 155.43 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 119.493 -2.004 . . . . 0.0 109.228 -169.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -124.38 157.3 35.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.874 1.269 . . . . 0.0 109.947 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -147.16 106.23 3.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.204 2.202 . . . . 0.0 107.738 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.49 93.56 3.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.17 143.7 15.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.6 133.54 47.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.443 1.097 . . . . 0.0 110.19 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 t -99.76 96.19 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 128.094 2.558 . . . . 0.0 104.603 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 58.71 17.96 5.56 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.763 2.025 . . . . 0.0 114.037 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.36 -9.72 24.37 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.319 1.914 . . . . 0.0 112.518 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.96 131.94 52.47 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.22 113.67 2.94 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.82 1.68 . . . . 0.0 109.659 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.3 tp -79.59 -37.28 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.554 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.28 171.03 14.0 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -81.68 139.8 34.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.92 153.41 35.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 127.066 2.146 . . . . 0.0 105.395 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.72 139.03 11.15 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 -166.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -134.04 149.76 51.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.621 0.769 . . . . 0.0 111.006 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -87.12 151.67 23.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 158.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 mt -127.46 109.48 11.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -68.97 61.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.84 2.456 . . . . 0.0 112.049 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.38 -30.17 38.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.463 1.905 . . . . 0.0 112.222 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 -19.55 62.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.901 1.681 . . . . 0.0 110.818 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -38.89 2.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.353 2.261 . . . . 0.0 110.664 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.24 72.71 26.55 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.758 2.023 . . . . 0.0 108.645 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.59 -41.43 39.73 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.845 2.363 . . . . 0.0 113.712 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -57.73 11.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.351 1.432 . . . . 0.0 107.69 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 m -57.77 -44.08 85.92 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.712 0.632 . . . . 0.0 109.841 -169.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.48 67.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.799 0.84 . . . . 0.0 113.257 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -66.75 -39.96 88.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.713 0.688 . . . . 0.0 110.574 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -55.99 -52.53 63.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.75 1.22 . . . . 0.0 109.712 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.511 ' CE2' ' CE2' ' A' ' 112' ' ' PHE . 2.3 t80 -56.12 -49.86 72.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.601 0.36 . . . . 0.0 110.679 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 -50.96 -60.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.011 1.324 . . . . 0.0 109.926 -173.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.54 -27.12 68.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -77.12 -33.85 56.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.922 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.5 p -69.95 -45.55 67.19 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.98 1.264 . . . . 0.0 111.093 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.0 p -64.68 -36.8 85.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.565 0.746 . . . . 0.0 109.085 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.23 14.31 82.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.24 -28.29 67.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.15 1.38 . . . . 0.0 112.031 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -72.33 8.96 1.14 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.529 1.132 . . . . 0.0 112.917 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -3.69 83.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.885 1.231 . . . . 0.0 112.805 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.2 176.45 12.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.5 1.65 . . . . 0.0 108.65 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.55 -146.88 17.6 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.561 ' CE1' ' CE2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -61.24 -38.69 87.59 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.213 1.405 . . . . 0.0 112.532 -163.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -47.15 116.78 1.49 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.398 1.079 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.98 4.24 90.34 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.427 -1.763 . . . . 0.0 115.728 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -64.24 -35.21 80.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 121.502 2.651 . . . . 0.0 113.589 -162.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.4 m 86.0 164.93 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.611 2.764 . . . . 0.0 107.868 -158.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -119.01 101.57 8.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 164.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.194 0.907 . . . . 0.0 113.043 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.12 114.25 13.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.81 120.69 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.89 99.95 34.39 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.2 136.45 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.107 1.871 . . . . 0.0 110.52 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 22.93 78.58 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.766 1.65 . . . . 0.0 112.198 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -146.93 -81.89 0.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.805 1.303 . . . . 0.0 109.144 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.77 168.72 22.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.724 0.693 . . . . 0.0 112.301 174.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.0 m -120.84 108.44 13.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.212 1.805 . . . . 0.0 108.003 170.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -95.44 133.4 39.45 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 110.342 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 177.86 29.87 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.02 20.11 4.57 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.492 1.044 . . . . 0.0 112.62 -174.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -84.03 28.88 0.58 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.619 1.968 . . . . 0.0 111.975 -164.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 10.6 p90 -63.34 1.25 0.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.516 1.926 . . . . 0.0 115.731 -167.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.435 HG22 ' HE2' ' A' ' 76' ' ' LYS . 2.1 p -139.21 -69.08 0.43 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.305 1.842 . . . . 0.0 109.57 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -118.75 162.47 18.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 166.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -148.25 33.77 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.582 1.953 . . . . 0.0 108.063 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -144.96 16.27 1.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.838 3.255 . . . . 0.0 109.525 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.65 -28.05 12.37 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.365 1.459 . . . . 0.0 113.57 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.8 p -83.74 12.39 6.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.099 1.95 . . . . 0.0 113.103 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.56 168.8 13.27 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.743 1.163 . . . . 0.0 111.794 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.95 165.17 30.16 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HE2' HG22 ' A' ' 68' ' ' THR . 3.5 pttt 170.69 -177.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.129 4.172 . . . . 0.0 103.914 -160.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.9 p -127.25 178.6 5.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.455 1.025 . . . . 0.0 110.311 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.14 -22.89 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.131 168.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.93 1.78 56.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.514 1.525 . . . . 0.0 111.681 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.69 -112.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.24 -133.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.83 2.052 . . . . 0.0 110.389 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -102.74 154.67 18.94 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.331 -1.48 . . . . 0.0 109.261 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -111.0 165.45 11.86 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 109.888 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 156.17 31.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.175 0.988 . . . . 0.0 110.863 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 101.82 2.78 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.13 -48.98 77.34 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.465 1.106 . . . . 0.0 110.62 -164.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -170.12 176.28 4.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.24 2.216 . . . . 0.0 107.96 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.45 43.21 3.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.72 1.208 . . . . 0.0 108.357 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.0 mt -60.56 -65.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -72.67 143.64 48.03 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.954 1.835 . . . . 0.0 107.32 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -131.55 161.6 32.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 127.057 2.143 . . . . 0.0 109.008 -170.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -84.97 73.13 10.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.597 1.159 . . . . 0.0 109.055 -164.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 p -66.07 -31.58 72.54 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.832 0.853 . . . . 0.0 113.003 -165.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.28 171.34 31.38 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.75 -1.028 . . . . 0.0 110.965 -166.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.8 135.96 54.97 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.314 2.009 . . . . 0.0 111.669 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.35 -8.01 30.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.065 -1.409 . . . . 0.0 111.731 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.5 mm -72.31 148.3 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 121.124 2.462 . . . . 0.0 108.662 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.51 131.45 55.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.403 1.081 . . . . 0.0 108.263 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.3 t -140.51 159.82 41.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.857 0.863 . . . . 0.0 110.005 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.31 137.56 32.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -163.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.48 71.48 6.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.11 163.62 27.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.411 158.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.08 16.47 12.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.664 1.586 . . . . 0.0 111.646 -168.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.27 -170.81 28.05 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 -159.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -65.11 172.26 7.7 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 CA-C-N 119.898 1.849 . . . . 0.0 109.86 165.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.93 14.7 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 131.12 3.768 . . . . 0.0 116.221 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -108.63 27.26 9.59 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.857 -1.777 . . . . 0.0 111.03 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.408 2.683 . . . . 0.0 106.459 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.59 -93.75 0.32 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -172.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.5 t -144.34 -11.25 0.63 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.45 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -79.48 135.22 36.59 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CE2' ' CE1' ' A' ' 48' ' ' TYR . 37.1 p90 -145.29 177.27 8.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.679 1.192 . . . . 0.0 108.449 174.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -142.08 151.57 42.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.872 1.32 . . . . 0.0 112.587 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.81 101.9 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 101.569 -3.493 . . . . 0.0 101.569 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.68 94.42 0.3 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.4 p -87.1 25.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.804 0.842 . . . . 0.0 111.009 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.15 -178.22 7.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 163.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -67.2 130.84 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 158.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.6 p -131.62 57.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -14.37 61.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.183 0.993 . . . . 0.0 112.408 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -69.57 -7.95 43.0 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.106 -0.996 . . . . 0.0 111.055 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -109.46 -8.68 14.99 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.479 1.512 . . . . 0.0 111.996 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 149.05 30.17 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.059 0.943 . . . . 0.0 111.011 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.14 18.65 49.34 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.27 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -144.25 -34.33 0.38 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.576 1.15 . . . . 0.0 110.449 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -118.09 139.36 51.35 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.389 1.076 . . . . 0.0 108.194 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.76 96.87 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -167.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.17 127.02 22.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -134.83 -6.5 2.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.049 -0.977 . . . . 0.0 113.256 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.13 -179.28 31.05 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.28 -1.438 . . . . 0.0 112.855 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -153.65 138.3 16.93 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -53.73 114.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 125.059 1.344 . . . . 0.0 108.388 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -83.26 -52.27 6.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.83 160.05 40.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.715 1.143 . . . . 0.0 112.116 -168.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.69 77.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.526 1.06 . . . . 0.0 112.098 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -37.99 71.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.86 1.33 . . . . 0.0 110.843 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.22 -29.15 68.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.946 -1.096 . . . . 0.0 112.508 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.6 mm -72.51 -35.46 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.614 1.166 . . . . 0.0 108.98 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.36 -44.05 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.983 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -27.44 68.91 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.962 -1.086 . . . . 0.0 112.779 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.84 -46.32 68.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.939 -1.101 . . . . 0.0 108.474 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 15.8 mtm -53.08 -46.7 68.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.374 0.534 . . . . 0.0 111.234 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -52.29 -42.49 63.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.469 1.108 . . . . 0.0 111.842 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.47 -19.52 64.56 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.922 -0.486 . . . . 0.0 110.822 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -98.02 5.01 49.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.692 1.597 . . . . 0.0 111.664 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.2 -163.93 37.94 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 98.5 p -152.41 163.57 39.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.9 mtm-85 -67.03 -22.4 65.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.25 -1.531 . . . . 0.0 113.462 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -75.33 -15.69 60.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 168.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 102.06 -27.98 17.98 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-O 117.644 -1.642 . . . . 0.0 114.259 171.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -66.95 124.63 23.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.209 2.005 . . . . 0.0 107.246 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.9 p -73.31 147.85 44.08 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.924 0.889 . . . . 0.0 109.895 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.0 p -77.61 -9.98 59.25 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.23 -0.919 . . . . 0.0 111.784 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -136.96 152.32 50.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.968 1.307 . . . . 0.0 109.546 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -73.06 109.08 6.33 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.88 130.45 51.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.2 p -141.84 173.36 11.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.55 1.94 . . . . 0.0 110.552 -170.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mt -106.61 116.55 50.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 167.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.12 -60.01 4.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -163.01 176.55 10.01 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.735 1.614 . . . . 0.0 111.388 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.4 p -169.5 172.4 7.06 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.425 1.09 . . . . 0.0 110.628 -159.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.82 -172.23 45.11 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.63 160.47 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.115 0.966 . . . . 0.0 110.327 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 39.0 mt -136.9 43.66 2.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.595 1.558 . . . . 0.0 109.011 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.745 -176.041 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.6 m120 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -76.36 149.95 31.92 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 N-CA-C 109.283 -1.084 . . . . 0.0 109.283 165.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -101.48 151.15 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.78 163.7 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.537 1.535 . . . . 0.0 108.252 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -134.09 158.42 43.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.15 0.98 . . . . 0.0 110.471 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -128.86 123.77 33.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.856 2.462 . . . . 0.0 106.317 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -78.19 98.92 6.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.8 mm -70.28 140.14 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.151 -0.968 . . . . 0.0 109.562 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.49 50.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.581 1.152 . . . . 0.0 110.4 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.448 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 6.7 t -132.74 100.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -165.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.24 13.69 0.65 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.599 1.959 . . . . 0.0 112.86 -161.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.19 38.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.525 1.536 . . . . 0.0 113.298 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -80.51 126.87 77.54 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 120.015 1.908 . . . . 0.0 106.188 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 115.89 3.65 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.822 1.681 . . . . 0.0 109.078 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.9 tp -85.2 -39.6 17.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.563 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.97 158.34 9.01 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.495 -0.383 . . . . 0.0 112.218 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -68.97 146.43 52.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 164.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.2 t -135.33 143.29 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -137.02 153.18 50.72 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.166 0.586 . . . . 0.0 110.031 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -146.54 146.69 30.58 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.477 1.111 . . . . 0.0 108.909 -165.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.03 145.88 27.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 165.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -118.65 146.78 44.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 108.734 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -97.54 61.66 1.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.543 1.537 . . . . 0.0 111.102 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.2 42.05 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.29 0.636 . . . . 0.0 112.236 171.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.58 -0.89 39.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.931 2.093 . . . . 0.0 113.307 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -127.83 -37.27 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.142 1.337 . . . . 0.0 110.716 166.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.07 73.68 74.69 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.148 1.379 . . . . 0.0 107.457 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.38 -43.09 36.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -49.88 67.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.924 0.783 . . . . 0.0 109.828 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.7 m -55.21 -46.66 75.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.991 1.316 . . . . 0.0 109.769 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -51.9 55.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.621 0.769 . . . . 0.0 111.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.59 -39.0 93.27 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.322 1.049 . . . . 0.0 111.618 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -51.88 -60.92 2.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.191 1.396 . . . . 0.0 109.718 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -66.12 -28.27 68.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.221 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -53.88 -64.11 0.93 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.206 1.402 . . . . 0.0 109.16 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.9 -16.62 61.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.58 -31.37 16.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.879 1.272 . . . . 0.0 110.903 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -79.36 -24.39 42.72 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 111.761 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.6 p -79.24 -39.06 34.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.24 19.72 78.07 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.0 -16.05 63.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.806 1.303 . . . . 0.0 112.942 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -87.48 9.43 20.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.213 1.005 . . . . 0.0 112.032 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.04 16.47 79.53 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.419 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.83 -173.73 4.69 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.968 1.707 . . . . 0.0 108.678 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 67' ' ' PHE . . . 111.71 -146.19 17.89 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 168.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CE2' HD13 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -64.04 -27.99 69.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.791 1.636 . . . . 0.0 111.767 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 11.3 tmtt? -62.01 109.64 1.34 Allowed 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.879 -0.513 . . . . 0.0 110.164 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.57 89.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 116.938 -2.035 . . . . 0.0 115.061 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -68.13 151.28 47.24 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 121.89 2.845 . . . . 0.0 108.324 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 65.2 m -86.15 171.09 11.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 159.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -116.09 120.08 37.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -73.67 -45.41 52.71 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.73 102.05 6.4 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 123.807 0.692 . . . . 0.0 110.877 -157.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.8 mt -130.06 108.42 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -170.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.43 97.47 50.18 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -55.05 128.79 32.04 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.299 1.999 . . . . 0.0 112.705 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 46.31 85.42 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 125.011 1.291 . . . . 0.0 110.156 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -153.55 -79.23 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.58 168.4 16.43 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.805 1.242 . . . . 0.0 109.668 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.81 109.49 7.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.201 . . . . 0.0 111.551 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -101.64 143.02 32.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.439 2.696 . . . . 0.0 110.774 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.34 20.02 0.63 Allowed Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.55 3.39 42.79 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 119.136 1.468 . . . . 0.0 116.045 -159.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -83.98 23.86 0.98 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.485 2.142 . . . . 0.0 112.833 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.4 ' CD2' ' HA2' ' A' ' 47' ' ' GLY . 31.5 p90 -33.37 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 1 C-N-CA 133.515 4.726 . . . . 0.0 119.989 -158.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.75 -22.28 24.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.865 1.666 . . . . 0.0 111.265 173.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -133.19 177.98 7.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 128.998 2.919 . . . . 0.0 106.867 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.17 44.03 0.42 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.84 1.256 . . . . 0.0 108.651 -168.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -140.34 -8.36 1.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 110.824 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.45 56.98 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 117.828 -1.54 . . . . 0.0 113.801 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.2 p -135.57 65.85 1.53 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.375 2.088 . . . . 0.0 110.077 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.17 -154.1 6.95 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.86 170.67 44.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.115 0.864 . . . . 0.0 112.78 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 150.88 9.97 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.879 1.272 . . . . 0.0 109.327 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 79' ' ' TYR . 83.2 p -89.63 35.2 0.82 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -166.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 pt 42.1 -3.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 130.645 3.578 . . . . 0.0 118.049 -162.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.461 ' H ' ' C ' ' A' ' 77' ' ' SER . 20.3 m-85 -134.28 12.21 3.85 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.644 2.377 . . . . 0.0 110.774 -167.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.15 -156.82 27.38 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -68.5 -132.91 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.444 1.498 . . . . 0.0 108.446 160.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -74.69 170.57 15.55 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.092 -1.63 . . . . 0.0 111.257 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -130.6 178.5 6.58 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.96 1.704 . . . . 0.0 108.038 169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.74 172.84 2.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.198 0.999 . . . . 0.0 112.11 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -79.46 99.19 7.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 160.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.063 1.345 . . . . 0.0 112.269 -166.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -160.6 175.7 12.4 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.009 1.324 . . . . 0.0 108.32 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.41 26.67 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.169 1.388 . . . . 0.0 109.557 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.38 -46.61 81.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.62 132.25 34.2 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -133.67 154.94 50.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.331 1.853 . . . . 0.0 109.224 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.517 ' CD2' ' HG1' ' A' ' 119' ' ' THR . 80.7 m80 -75.84 85.5 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.047 1.339 . . . . 0.0 110.27 -168.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -7.83 59.63 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 113.962 -172.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.71 -178.8 33.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.37 156.06 53.71 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.864 1.709 . . . . 0.0 110.514 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.85 89.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.981 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.85 160.94 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.241 2.02 . . . . 0.0 107.8 169.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.21 136.59 54.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.239 1.416 . . . . 0.0 107.303 169.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -127.08 138.29 53.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.8 mtp -67.57 152.86 44.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 158.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.89 154.72 36.73 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.531 1.532 . . . . 0.0 108.874 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -138.49 -171.19 3.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.132 2.173 . . . . 0.0 107.301 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.94 25.15 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.76 1.624 . . . . 0.0 110.593 -175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.67 -161.58 24.79 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.2 154.86 60.1 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 120.474 2.137 . . . . 0.0 109.4 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 43.99 43.66 5.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.716 2.406 . . . . 0.0 114.136 159.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.6 p -132.59 29.79 4.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.258 1.423 . . . . 0.0 110.048 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -71.39 107.69 4.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.79 -95.21 1.55 Allowed Glycine 0 C--O 1.225 -0.423 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 p -129.65 1.7 4.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.787 1.635 . . . . 0.0 110.893 170.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -58.3 141.84 49.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.905 1.682 . . . . 0.0 108.359 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.61 174.39 15.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -147.35 161.08 41.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 158.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.39 129.05 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 159.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.45 118.19 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.442 ' HG1' ' CD ' ' A' ' 143' ' ' GLU . 22.7 p -108.09 21.32 17.54 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.673 1.589 . . . . 0.0 109.521 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -156.57 174.75 14.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 167.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -71.53 85.41 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 162.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.517 ' HG1' ' CD2' ' A' ' 92' ' ' HIS . 12.4 p -78.18 60.34 2.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.273 1.029 . . . . 0.0 110.781 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.34 -15.1 62.99 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.667 -1.27 . . . . 0.0 112.453 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -76.87 -18.04 58.59 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.104 1.361 . . . . 0.0 111.944 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.2 mt -97.74 -7.94 29.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.179 1.392 . . . . 0.0 110.402 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.62 138.3 56.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.93 -11.29 1.97 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.586 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -93.76 -39.0 10.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.666 1.733 . . . . 0.0 108.421 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -130.92 155.6 46.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.092 0.472 . . . . 0.0 111.433 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.29 93.54 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.531 1.532 . . . . 0.0 108.195 -165.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.59 131.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 1.18 0.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.248 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -163.27 -175.16 33.98 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -153.0 150.93 29.71 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.838 0.855 . . . . 0.0 110.016 165.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.98 117.56 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.574 1.549 . . . . 0.0 107.653 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -72.62 -48.31 40.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.318 167.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -149.23 160.29 43.51 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 109.064 -162.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.02 16.29 76.62 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.515 0.579 . . . . 0.0 113.392 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -37.74 67.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.816 1.808 . . . . 0.0 111.195 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.0 -21.08 65.07 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.056 -1.028 . . . . 0.0 113.752 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.4 mm -81.79 -34.43 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.186 1.394 . . . . 0.0 108.835 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.44 -37.1 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.668 -1.27 . . . . 0.0 109.348 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -69.79 -23.75 63.39 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 120.546 -1.346 . . . . 0.0 112.595 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.63 -42.85 77.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.965 -1.084 . . . . 0.0 109.626 168.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 23.0 mtp -62.32 -46.9 86.65 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 122.331 -0.231 . . . . 0.0 110.972 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.442 ' CD ' ' HG1' ' A' ' 116' ' ' THR . 13.7 mt-10 -66.14 -29.69 70.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -76.49 -15.99 59.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.328 0.967 . . . . 0.0 112.46 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -95.05 18.82 11.39 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 127.088 2.155 . . . . 0.0 112.285 163.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.49 -147.89 15.36 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.418 1.961 . . . . 0.0 110.616 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.3 p -146.14 -81.86 0.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.451 0.625 . . . . 0.0 110.807 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 169.06 -21.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 131.529 3.932 . . . . 0.0 111.215 167.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -19.57 63.93 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.776 1.171 . . . . 0.0 109.855 159.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.03 -26.91 10.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.565 -1.131 . . . . 0.0 111.894 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -70.83 123.63 22.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 119.416 1.608 . . . . 0.0 107.054 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.8 p -72.18 153.98 41.31 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.205 1.802 . . . . 0.0 111.553 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.82 -5.02 59.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.782 1.233 . . . . 0.0 112.426 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.448 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 20.4 mmtt -137.97 161.23 37.22 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.793 2.037 . . . . 0.0 109.212 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -75.1 89.07 2.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 163.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.58 130.7 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.73 162.81 36.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.055 0.942 . . . . 0.0 111.743 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.417 HD13 ' CE2' ' A' ' 48' ' ' TYR . 3.9 mp -91.37 119.55 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 158.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.98 -58.92 6.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 164.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -152.79 167.62 28.42 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 49' ' ' LYS . 15.6 p -162.04 171.83 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.52 0.6 . . . . 0.0 111.414 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.32 176.54 48.06 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -76.25 158.38 31.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.575 1.55 . . . . 0.0 109.284 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.1 mt -137.4 42.74 2.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.102 0.953 . . . . 0.0 109.098 159.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.247 0.959 0 C-N-CA 125.143 1.377 . . . . 0.0 107.862 -177.768 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 117.422 -1.275 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -65.19 133.36 35.02 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 CA-C-N 120.774 1.312 . . . . 0.0 109.66 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -89.41 152.3 21.56 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -135.91 157.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.019 -1.051 . . . . 0.0 109.036 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -124.65 153.5 42.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.227 1.011 . . . . 0.0 108.727 170.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -132.86 117.96 18.37 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.496 1.918 . . . . 0.0 106.053 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.02 97.16 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.7 mm -68.77 147.54 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.72 153.37 45.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.309 1.844 . . . . 0.0 109.577 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.92 108.36 19.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.27 13.95 4.29 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 114.236 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.49 -0.5 63.45 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.55 1.071 . . . . 0.0 112.889 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.12 146.71 90.15 Favored Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 159.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 130.55 27.29 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 N-CA-C 107.819 -1.646 . . . . 0.0 107.819 160.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 tp -91.87 -41.69 10.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 108.98 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.46 156.8 8.16 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 118.115 0.416 . . . . 0.0 112.99 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -82.56 114.08 20.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.801 1.24 . . . . 0.0 109.126 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.08 155.65 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.797 1.639 . . . . 0.0 107.082 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -142.14 148.51 38.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 123.46 1.6 . . . . 0.0 111.322 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -131.71 159.61 37.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 113.524 -1.671 . . . . 0.0 107.899 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -120.52 144.41 48.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.785 1.634 . . . . 0.0 106.785 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.85 114.81 16.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -170.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.56 64.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.854 1.662 . . . . 0.0 110.885 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.85 -14.18 60.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 112.607 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -71.02 -36.21 72.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.506 1.122 . . . . 0.0 110.791 168.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -85.77 -56.18 3.61 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.953 0.901 . . . . 0.0 108.907 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.14 71.01 80.23 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.226 1.81 . . . . 0.0 109.385 -165.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 -30.76 78.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.577 2.185 . . . . 0.0 113.626 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -52.3 57.98 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.786 1.63 . . . . 0.0 108.032 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.6 m -63.38 -44.82 93.63 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.577 1.151 . . . . 0.0 110.607 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.26 91.86 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.818 -0.551 . . . . 0.0 111.871 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.37 -44.71 78.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.433 1.093 . . . . 0.0 110.651 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -54.32 -48.39 71.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.678 1.191 . . . . 0.0 109.604 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -64.35 -36.44 84.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.425 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -57.79 -63.35 1.28 Allowed 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.283 1.033 . . . . 0.0 109.521 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.84 71.81 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.806 0.692 . . . . 0.0 111.205 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.0 mt -67.06 -36.09 81.27 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 121.375 -0.828 . . . . 0.0 110.845 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -68.22 -28.76 67.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.345 0.975 . . . . 0.0 111.999 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -93.95 -26.01 17.03 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.076 0.55 . . . . 0.0 111.201 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 -0.29 86.77 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.902 0.774 . . . . 0.0 112.561 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -38.83 77.45 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.552 1.141 . . . . 0.0 111.991 -165.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -72.55 3.85 4.5 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.08 4.54 84.17 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 119.528 1.058 . . . . 0.0 111.506 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.58 169.8 19.52 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.754 1.621 . . . . 0.0 107.167 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.46 -178.51 36.45 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-O 122.775 1.208 . . . . 0.0 110.633 -167.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -84.73 -23.88 29.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.124 -1.538 . . . . 0.0 111.6 -159.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -46.62 111.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.04 2.136 . . . . 0.0 109.569 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.38 9.69 83.25 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 117.668 -1.629 . . . . 0.0 116.244 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.1 m -68.64 -21.87 64.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.736 2.768 . . . . 0.0 113.209 -174.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.2 t 67.11 132.81 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 129.273 3.029 . . . . 0.0 112.474 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -77.67 76.87 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.52 1.528 . . . . 0.0 108.326 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -74.1 -7.32 52.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.239 1.416 . . . . 0.0 113.56 -174.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -123.63 128.43 49.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 159.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.6 mt -134.49 106.64 8.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 161.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.5 mt -111.52 98.09 39.12 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.51 124.59 14.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 123.921 3.081 . . . . 0.0 113.11 -170.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.419 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . 66.66 38.54 93.3 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.886 1.707 . . . . 0.0 111.237 -178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -143.13 -81.36 0.19 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.769 1.284 . . . . 0.0 108.624 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.31 169.91 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.328 168.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m -121.08 107.92 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.249 1.819 . . . . 0.0 108.329 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -99.05 138.26 36.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.13 0.972 . . . . 0.0 108.495 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.02 1.98 0.5 Allowed Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.509 -1.162 . . . . 0.0 115.936 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.12 51.4 4.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.773 1.787 . . . . 0.0 115.284 -162.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.16 69.12 1.34 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.334 1.067 . . . . 0.0 110.896 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.545 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 31.9 p90 -70.14 -6.08 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.095 0.958 . . . . 0.0 112.812 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -113.9 -38.99 4.07 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 120.871 -1.143 . . . . 0.0 110.625 -160.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -128.44 -17.78 4.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.203 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 45.27 35.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.977 2.111 . . . . 0.0 112.916 175.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -140.78 10.14 2.21 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.386 -0.821 . . . . 0.0 111.961 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.3 -1.9 79.14 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.966 -1.463 . . . . 0.0 112.884 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 p -95.96 -6.48 38.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 120.007 1.903 . . . . 0.0 110.975 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.32 179.1 38.96 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 118.993 0.815 . . . . 0.0 112.315 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.61 115.69 2.21 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 125.471 1.51 . . . . 0.0 111.245 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.545 ' HE3' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -133.76 169.44 17.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.495 1.918 . . . . 0.0 107.234 166.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.3 p -83.74 -175.18 5.69 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.606 0.639 . . . . 0.0 109.532 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.4 pt -83.48 -20.17 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.841 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -79.74 -35.08 39.34 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.567 0.621 . . . . 0.0 109.422 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.1 -142.07 6.67 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 107.029 -2.428 . . . . 0.0 107.029 -167.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -68.82 -156.22 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.033 0.916 . . . . 0.0 110.664 168.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.0 mttt -64.96 126.89 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 120.415 -1.428 . . . . 0.0 109.91 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -89.5 175.73 7.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -77.92 175.28 10.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 11.3 t70 -86.75 104.34 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.883 2.873 . . . . 0.0 108.001 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.15 -41.23 81.88 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.631 -162.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 159.07 157.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 129.354 3.062 . . . . 0.0 111.604 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -106.59 30.14 6.31 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.42 1.888 . . . . 0.0 110.614 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.1 mt -53.01 -48.39 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.209 1.003 . . . . 0.0 108.472 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.89 130.4 36.12 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -130.54 169.57 15.4 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.265 1.426 . . . . 0.0 110.687 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.436 ' CD2' ' HG1' ' A' ' 119' ' ' THR . 63.6 m80 -82.19 81.58 8.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.131 1.372 . . . . 0.0 108.896 -173.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.0 p -75.84 -32.01 59.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.054 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.22 -178.74 44.37 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.628 1.585 . . . . 0.0 110.884 -175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.21 165.1 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.833 2.355 . . . . 0.0 111.226 171.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.44 8.47 75.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.251 -1.305 . . . . 0.0 112.923 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.0 mm -85.61 151.46 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 121.012 2.406 . . . . 0.0 108.953 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.46 131.2 57.0 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.367 -1.458 . . . . 0.0 108.924 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.8 t -148.47 158.27 44.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.497 0.719 . . . . 0.0 111.385 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.2 mtp -83.49 135.34 34.7 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 124.283 1.033 . . . . 0.0 111.664 -171.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.08 71.23 5.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 123.088 1.423 . . . . 0.0 107.558 168.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -75.66 -172.75 1.97 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.27 160.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.21 16.32 9.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.29 1.836 . . . . 0.0 111.423 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.56 -175.37 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.293 1.901 . . . . 0.0 108.782 -164.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.48 142.71 91.41 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.829 1.686 . . . . 0.0 110.017 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' H ' ' HB2' ' A' ' 85' ' ' ASP . 31.3 m-20 64.14 38.26 8.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.931 2.092 . . . . 0.0 112.19 167.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 p -127.87 38.14 4.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.633 0.773 . . . . 0.0 109.81 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -89.88 110.61 21.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.959 1.304 . . . . 0.0 109.139 -172.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.16 -132.57 5.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.2 p -85.49 -18.5 33.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.582 0.753 . . . . 0.0 111.46 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -67.84 126.02 28.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.224 1.012 . . . . 0.0 108.757 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -154.03 171.06 19.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 107.73 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -141.19 157.95 44.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.433 1.111 . . . . 0.0 112.046 169.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.25 103.91 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 166.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 9.2 m -60.4 126.12 26.26 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.9 p -116.6 23.15 12.23 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.799 1.24 . . . . 0.0 109.006 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -150.69 175.85 11.57 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.624 -0.673 . . . . 0.0 109.883 162.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -64.69 84.87 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 159.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.436 ' HG1' ' CD2' ' A' ' 92' ' ' HIS . 8.3 p -82.1 53.4 2.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.086 0.554 . . . . 0.0 111.161 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -63.63 -20.91 66.07 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.148 -1.595 . . . . 0.0 113.159 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -69.98 -4.7 21.95 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.265 1.426 . . . . 0.0 112.079 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.6 mt -105.32 -8.17 18.41 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.897 1.279 . . . . 0.0 111.275 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.46 152.47 43.86 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.631 1.105 . . . . 0.0 109.122 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.39 -1.52 65.27 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.726 1.155 . . . . 0.0 113.421 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -132.22 -56.97 0.97 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.891 1.677 . . . . 0.0 108.283 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -99.47 129.29 45.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -170.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.39 104.99 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.92 132.71 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.29 -4.79 1.66 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.8 -173.13 27.9 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.973 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -155.54 146.37 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.507 1.123 . . . . 0.0 108.669 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.68 116.67 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -86.1 -49.95 7.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.99 162.67 34.33 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.211 1.004 . . . . 0.0 112.923 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.98 15.76 66.63 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.142 0.877 . . . . 0.0 112.816 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.3 tpt -55.87 -28.67 57.68 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.749 1.775 . . . . 0.0 111.958 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -62.82 -35.32 79.53 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.244 -0.91 . . . . 0.0 113.194 172.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.98 -39.15 81.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.89 -41.3 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.757 0.708 . . . . 0.0 109.732 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.32 -27.46 69.04 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.703 -1.248 . . . . 0.0 113.244 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.03 -46.57 42.59 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.165 -0.959 . . . . 0.0 109.218 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 79.5 mtp -53.06 -47.58 68.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.249 1.02 . . . . 0.0 110.036 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 59' ' ' GLY . 10.5 mt-10 -62.36 -30.68 71.35 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.702 0.801 . . . . 0.0 112.647 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -24.04 64.45 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.52 -0.738 . . . . 0.0 111.372 174.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -97.08 6.59 48.28 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.872 1.669 . . . . 0.0 112.099 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.07 -173.38 35.92 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 169.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.4 p -157.62 158.88 36.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 166.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.28 -22.39 64.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -6.07 53.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.177 0.899 . . . . 0.0 112.779 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.24 -30.66 9.93 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.09 2.281 . . . . 0.0 112.875 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.04 138.03 26.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.076 0.95 . . . . 0.0 109.498 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.1 p -98.25 138.6 35.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -18.67 63.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.831 0.852 . . . . 0.0 112.12 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.59 161.0 32.51 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.109 0.964 . . . . 0.0 108.875 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 134.78 48.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 mt -132.35 113.56 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -132.48 175.41 9.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.623 1.169 . . . . 0.0 109.657 -166.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.33 105.61 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.22 -46.22 87.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.776 0.83 . . . . 0.0 109.976 172.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -151.24 157.4 42.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.0 p -162.68 163.04 27.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.948 0.404 . . . . 0.0 110.64 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.47 -173.01 45.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 0.0 OUTLIER -84.78 154.6 22.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.494 1.917 . . . . 0.0 109.358 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.2 mt -131.9 43.69 3.0 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.768 1.27 . . . . 0.0 110.65 160.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 39.7 tp10 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 102.093 -3.299 . . . . 0.0 102.093 166.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.525 ' CB ' HE22 ' A' ' 163' ' ' GLN . 12.8 Cg_endo -59.24 135.92 68.97 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.694 1.596 . . . . 0.0 110.62 -176.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.481 ' H ' ' HB3' ' A' ' 165' ' ' GLU . 52.5 m -94.96 145.04 25.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 m -130.53 149.98 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 171.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -110.65 161.06 16.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.457 1.103 . . . . 0.0 108.779 168.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -139.41 163.17 33.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.153 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.37 99.47 5.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 170.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.4 mm -68.72 148.68 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.0 143.73 51.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.892 0.877 . . . . 0.0 110.421 170.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.99 99.87 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 127.953 2.501 . . . . 0.0 104.338 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.62 13.95 1.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.577 1.951 . . . . 0.0 113.696 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.34 0.49 58.23 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.107 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.22 121.04 81.9 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 159.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.24 112.96 2.24 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 107.364 -1.821 . . . . 0.0 107.364 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.73 -29.42 36.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.029 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.21 167.81 13.84 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.409 0.549 . . . . 0.0 113.145 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -75.57 139.07 41.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 108.886 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -130.24 157.93 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -150.74 155.45 39.31 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.728 -1.233 . . . . 0.0 110.478 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -142.23 154.13 44.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.522 1.129 . . . . 0.0 109.447 -170.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.09 141.2 30.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.47 117.69 30.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.968 1.307 . . . . 0.0 107.518 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.29 53.88 0.14 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.906 2.482 . . . . 0.0 114.072 -168.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.47 -28.08 42.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.685 1.994 . . . . 0.0 115.062 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -27.71 67.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.575 1.08 . . . . 0.0 110.151 177.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -120.36 -21.96 6.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.097 0.959 . . . . 0.0 112.5 -164.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 71.63 25.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.68 1.592 . . . . 0.0 107.758 167.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.82 -45.88 37.59 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.951 2.434 . . . . 0.0 111.819 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -54.62 37.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.147 0.885 . . . . 0.0 110.959 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -38.48 86.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.855 -0.528 . . . . 0.0 110.487 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.38 -39.81 64.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.851 -0.531 . . . . 0.0 112.184 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -62.14 -45.81 91.8 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.594 1.158 . . . . 0.0 108.863 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.96 -56.37 16.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.745 0.818 . . . . 0.0 108.961 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -26.91 67.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 ttm-85 -55.0 -67.24 0.29 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.497 1.499 . . . . 0.0 107.74 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.28 -38.74 59.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.816 1.246 . . . . 0.0 112.336 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.64 -42.52 86.6 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.619 -0.676 . . . . 0.0 111.132 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -70.71 -34.43 71.93 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.506 -0.746 . . . . 0.0 111.179 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.9 p -79.13 -26.89 42.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.858 -0.526 . . . . 0.0 110.465 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.47 83.08 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.589 1.09 . . . . 0.0 111.834 -176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.73 -27.82 69.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.854 0.862 . . . . 0.0 112.949 -159.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -74.65 3.56 7.65 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.57 9.3 75.58 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.156 0.889 . . . . 0.0 112.154 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -156.6 174.68 15.09 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.148 1.779 . . . . 0.0 107.601 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.68 -171.07 34.21 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-O 122.808 1.227 . . . . 0.0 114.442 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.27 -25.07 62.3 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.587 2.755 . . . . 0.0 110.369 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -52.49 108.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.568 2.347 . . . . 0.0 107.606 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.08 75.66 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.639 -1.089 . . . . 0.0 115.751 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 t -68.12 -10.46 54.24 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.514 1.657 . . . . 0.0 113.323 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t 60.18 176.58 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.82 1.248 . . . . 0.0 110.533 -161.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.05 125.69 46.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 162.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -78.88 -40.0 33.58 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -139.74 110.78 6.9 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 -159.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.3 mt -128.06 98.14 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -173.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.4 mt -111.12 96.06 28.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -168.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.11 126.64 20.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.051 2.5 . . . . 0.0 112.388 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 36.06 60.4 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.697 1.617 . . . . 0.0 111.77 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -150.32 -76.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.371 1.085 . . . . 0.0 108.545 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.4 171.59 18.8 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.629 0.772 . . . . 0.0 111.121 171.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 30.3 p -128.99 111.64 13.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.309 0.644 . . . . 0.0 111.17 161.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -86.3 135.1 33.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.921 2.489 . . . . 0.0 110.822 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.89 -161.35 9.95 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.751 2.119 . . . . 0.0 108.524 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.79 6.55 67.35 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.086 0.943 . . . . 0.0 113.229 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.72 123.1 29.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 166.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -128.2 7.31 5.96 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.183 1.356 . . . . 0.0 111.989 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.5 p -125.03 -13.24 6.87 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.761 1.625 . . . . 0.0 112.203 168.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -132.38 -175.96 3.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 130.171 3.389 . . . . 0.0 105.84 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -164.53 54.0 0.13 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 166.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -159.08 -1.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.415 . . . . 0.0 113.921 -166.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.91 3.12 49.13 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 117.605 -1.664 . . . . 0.0 115.476 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.1 p -131.12 17.67 5.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.095 2.448 . . . . 0.0 115.65 -165.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.35 -94.29 0.64 Allowed Glycine 0 C--N 1.338 0.659 0 O-C-N 120.287 -1.508 . . . . 0.0 112.125 -165.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -7.12 112.63 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 129.077 3.227 . . . . 0.0 115.519 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -127.47 155.52 43.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 128.792 2.837 . . . . 0.0 108.683 -161.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.0 p -72.15 172.59 9.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.91 1.338 . . . . 0.0 110.389 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.8 pt -75.53 -20.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.061 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -77.71 -36.71 50.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.196 0.998 . . . . 0.0 110.195 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.59 109.05 0.89 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.336 0.1 OUTLIER 37.25 -133.5 0.09 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.148 1.779 . . . . 0.0 113.041 177.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.17 161.9 17.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 121.116 1.78 . . . . 0.0 112.234 -176.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -126.52 165.81 18.44 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.144 1.778 . . . . 0.0 110.206 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.78 154.48 36.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.665 0.745 . . . . 0.0 111.968 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.34 123.17 21.07 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.297 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.26 -50.59 69.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.506 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -176.75 171.31 2.26 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.986 2.914 . . . . 0.0 107.502 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -123.03 38.01 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.726 1.61 . . . . 0.0 109.295 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 mt -63.53 -44.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 74.4 mt -81.05 128.3 33.57 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -136.46 163.37 30.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.362 -167.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.588 ' CG ' ' HG1' ' A' ' 119' ' ' THR . 31.3 m80 -78.17 90.78 4.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.528 1.131 . . . . 0.0 111.694 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.92 35.07 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.855 -1.153 . . . . 0.0 111.679 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -60.62 165.93 10.71 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.852 2.368 . . . . 0.0 111.75 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.36 -0.16 49.9 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.525 1.059 . . . . 0.0 112.955 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.08 164.31 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.627 1.713 . . . . 0.0 107.914 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.7 128.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.919 -1.113 . . . . 0.0 109.593 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -143.41 165.29 27.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.328 0.585 . . . . 0.0 110.585 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 108' ' ' ASN . 6.5 ttm -104.75 127.48 52.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -166.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.69 74.99 5.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.052 1.341 . . . . 0.0 108.422 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -70.01 175.05 4.71 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.235 158.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.22 19.73 4.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.264 1.425 . . . . 0.0 111.77 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.84 -167.91 29.34 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.83 159.92 43.42 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-N 119.361 1.58 . . . . 0.0 108.433 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 33.61 54.77 0.52 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.107 3.363 . . . . 0.0 111.944 175.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -131.84 22.49 4.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.743 1.217 . . . . 0.0 111.813 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.415 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 67.8 m-80 -67.29 109.69 3.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.787 2.435 . . . . 0.0 107.69 177.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.05 -85.42 0.91 Allowed Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.315 0.961 . . . . 0.0 111.727 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.0 t -155.92 -30.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.831 1.652 . . . . 0.0 109.381 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -53.91 125.57 19.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.513 1.525 . . . . 0.0 106.983 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -148.74 170.95 17.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.602 1.561 . . . . 0.0 108.079 -168.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -142.03 151.65 42.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.945 0.498 . . . . 0.0 110.86 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.53 122.68 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.43 118.86 12.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.1 p -112.53 27.92 9.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.1 0.952 . . . . 0.0 109.169 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.8 176.04 13.09 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.908 1.283 . . . . 0.0 107.54 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.51 89.17 0.23 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 162.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.588 ' HG1' ' CG ' ' A' ' 92' ' ' HIS . 1.8 p -74.77 57.6 0.77 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.449 1.099 . . . . 0.0 111.123 -178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.34 -20.58 66.46 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.604 -1.31 . . . . 0.0 112.719 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.401 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 29.1 p90 -74.52 -10.57 59.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.994 1.718 . . . . 0.0 111.574 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.7 mt -113.77 -6.65 13.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.205 1.402 . . . . 0.0 111.226 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -76.52 148.76 36.92 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.037 0.935 . . . . 0.0 109.579 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.09 18.6 57.86 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.081 -170.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -140.11 -35.0 0.52 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.488 1.144 . . . . 0.0 109.985 -171.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -112.99 157.95 20.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.366 1.066 . . . . 0.0 109.333 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.3 t -90.18 102.62 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.94 127.61 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 162.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.46 1.79 2.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.396 -0.811 . . . . 0.0 112.341 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.47 -177.54 35.58 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 119.632 1.106 . . . . 0.0 112.612 172.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -150.27 153.11 35.59 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.071 1.348 . . . . 0.0 108.253 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.8 t -60.88 125.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -82.21 -49.79 9.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 162.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -152.08 159.82 43.58 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.948 0.899 . . . . 0.0 111.668 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.94 24.74 61.28 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -54.96 -36.69 65.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.541 1.17 . . . . 0.0 110.704 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -62.18 -27.74 69.18 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.57 -39.91 47.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 CA-C-N 119.788 1.176 . . . . 0.0 108.828 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.98 -44.23 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.45 -29.15 70.21 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.349 -0.845 . . . . 0.0 112.586 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.05 64.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 120.587 -1.32 . . . . 0.0 109.604 173.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.3 mtp -57.62 -45.06 85.87 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.49 -32.79 73.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.469 1.108 . . . . 0.0 113.584 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -72.11 -22.57 61.32 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.538 1.517 . . . . 0.0 110.667 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -94.83 8.94 41.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.359 1.464 . . . . 0.0 111.652 170.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.54 -169.27 41.62 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 126.082 1.801 . . . . 0.0 109.083 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.3 p -156.94 159.21 37.87 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 160.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.4 mtm-85 -69.45 -16.16 63.42 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.228 -1.545 . . . . 0.0 114.516 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -71.94 -14.56 61.95 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.18 -0.95 . . . . 0.0 112.969 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.48 -20.11 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.878 2.18 . . . . 0.0 114.31 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -71.44 128.72 36.8 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.211 2.005 . . . . 0.0 108.104 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.1 p -67.62 159.34 30.12 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 110.99 167.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -70.71 -41.3 72.13 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 158.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -99.5 157.97 16.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 0.0 111.869 -168.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -69.49 123.78 22.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 158.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.1 mt -120.42 136.04 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.288 1.858 . . . . 0.0 107.924 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.82 169.16 24.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.663 -158.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.83 113.39 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 163.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.71 -53.12 52.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -156.75 165.39 36.37 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.192 1.397 . . . . 0.0 108.897 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.8 p -178.51 165.16 1.72 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.553 1.541 . . . . 0.0 109.726 -168.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.58 -175.71 46.61 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.525 HE22 ' CB ' ' A' ' 4' ' ' PRO . 35.6 tp60 -79.72 152.06 30.08 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.441 1.496 . . . . 0.0 109.879 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 40.0 mt -137.95 42.73 2.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 120.432 1.469 . . . . 0.0 111.77 159.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.491 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 2.7 tm-20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.956 2.502 . . . . 0.0 107.521 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--O 1.235 0.337 0 CA-C-O 116.508 -1.71 . . . . 0.0 108.619 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.99 140.06 92.61 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 CA-C-N 121.339 1.514 . . . . 0.0 110.063 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.403 ' CG2' ' HE3' ' A' ' 133' ' ' LYS . 76.1 m -106.0 144.47 32.67 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 165.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.47 134.11 17.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -94.59 157.87 15.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.903 0.881 . . . . 0.0 110.865 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -145.63 112.95 6.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.097 1.359 . . . . 0.0 107.799 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.26 97.55 6.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.6 mm -66.5 146.53 13.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.284 1.034 . . . . 0.0 109.152 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.13 168.89 18.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.647 1.179 . . . . 0.0 110.389 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.2 109.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 57.04 13.92 1.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.754 1.622 . . . . 0.0 113.131 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.22 -5.71 31.94 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.63 1.586 . . . . 0.0 113.849 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -81.95 113.26 41.83 Favored Pre-proline 0 CA--C 1.52 -0.187 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.4 121.68 9.57 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.318 1.345 . . . . 0.0 110.241 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.8 tp -93.36 -25.56 17.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.675 0.79 . . . . 0.0 110.922 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.25 162.74 9.6 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.665 0.65 . . . . 0.0 112.034 168.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -79.26 142.21 36.39 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.77 158.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 128.008 2.523 . . . . 0.0 105.808 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -140.58 153.43 46.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.337 1.065 . . . . 0.0 109.137 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -135.28 159.86 40.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.324 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -110.57 145.26 38.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 167.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.3 128.99 50.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.296 1.438 . . . . 0.0 108.685 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.21 61.79 7.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.261 1.025 . . . . 0.0 112.984 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -9.95 25.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.017 -1.052 . . . . 0.0 113.554 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.36 -16.51 58.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.247 1.419 . . . . 0.0 112.138 171.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -47.89 1.07 Allowed 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 0.0 110.511 -166.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.37 78.38 45.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.374 1.47 . . . . 0.0 107.345 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.71 -45.8 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.371 2.047 . . . . 0.0 110.386 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -36.64 84.81 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.242 1.383 . . . . 0.0 109.191 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -69.52 -52.69 24.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.496 0.589 . . . . 0.0 109.805 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.59 91.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.304 0.642 . . . . 0.0 112.242 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.54 -51.32 70.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.259 1.423 . . . . 0.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.04 -49.06 74.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.892 1.277 . . . . 0.0 110.488 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.07 -40.12 94.21 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.345 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -52.85 -56.92 12.28 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.152 0.887 . . . . 0.0 109.476 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.8 48.86 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.412 1.485 . . . . 0.0 113.15 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.29 -32.46 38.13 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.761 0.824 . . . . 0.0 111.431 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 p -78.53 -38.25 40.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.383 0.992 . . . . 0.0 113.293 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -64.08 -31.06 72.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.49 11.71 72.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.98 -33.18 70.38 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.012 1.725 . . . . 0.0 110.716 -172.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -71.46 -4.88 28.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.33 1.052 . . . . 0.0 112.696 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.76 16.12 46.63 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.419 1.009 . . . . 0.0 112.104 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -169.96 175.32 5.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.938 1.695 . . . . 0.0 109.1 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.49 -142.29 13.62 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-O 121.925 0.736 . . . . 0.0 113.307 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CE1' HD12 ' A' ' 158' ' ' ILE . 0.6 OUTLIER -63.31 -28.34 69.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.889 2.076 . . . . 0.0 110.997 -167.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.5 tttt -57.41 124.07 17.64 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.683 -0.636 . . . . 0.0 109.389 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 10.37 52.77 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.358 -1.245 . . . . 0.0 114.412 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.6 m -68.01 104.4 1.74 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.117 1.959 . . . . 0.0 106.071 165.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.409 ' SG ' ' HE2' ' A' ' 155' ' ' LYS . 52.8 m -75.38 131.68 40.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -73.69 105.1 4.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.082 0.944 . . . . 0.0 109.068 -169.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -81.01 -32.68 34.09 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.093 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -127.79 86.73 2.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.134 0.879 . . . . 0.0 108.833 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.3 mt -104.45 109.53 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.32 99.73 52.75 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.98 144.36 99.48 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.551 1.501 . . . . 0.0 112.448 -172.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . 56.87 31.43 61.11 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 126.539 2.018 . . . . 0.0 112.168 -168.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -142.4 -79.93 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.487 1.644 . . . . 0.0 108.545 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 165.15 25.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.798 0.839 . . . . 0.0 110.635 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.0 m -127.1 92.46 3.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.696 1.998 . . . . 0.0 108.77 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.04 132.3 42.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.964 1.306 . . . . 0.0 110.572 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.19 -169.48 11.89 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.074 1.797 . . . . 0.0 108.964 168.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.27 5.49 89.57 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.632 -0.922 . . . . 0.0 114.432 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.97 92.51 7.85 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 166.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -106.24 -5.84 18.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.509 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.6 p -122.29 -24.63 5.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.595 1.558 . . . . 0.0 111.551 -173.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -124.88 179.47 5.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 158.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.8 72.01 0.5 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 169.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -168.79 -10.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.886 2.474 . . . . 0.0 111.235 -172.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.41 -6.4 28.34 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.069 -1.406 . . . . 0.0 112.85 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.3 p -84.09 -24.33 30.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.741 1.77 . . . . 0.0 112.933 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.92 -135.3 8.09 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 122.515 1.064 . . . . 0.0 114.772 -159.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.11 168.37 4.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.67 1.605 . . . . 0.0 111.776 -162.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -169.59 149.09 3.83 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.1 p -70.56 164.57 24.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.6 pt -56.88 -29.61 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 110.267 162.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -79.25 6.35 10.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.466 1.506 . . . . 0.0 112.584 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.16 -53.76 0.75 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.192 1.36 . . . . 0.0 113.064 166.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -147.72 -139.26 0.1 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -161.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -75.97 166.57 23.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.314 0.961 . . . . 0.0 108.897 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -142.22 177.8 7.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.11 148.19 51.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.192 0.996 . . . . 0.0 113.204 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.96 73.95 0.89 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.897 2.479 . . . . 0.0 108.01 161.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.82 -59.85 3.99 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.255 1.822 . . . . 0.0 112.659 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.48 172.84 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.303 159.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.27 26.44 7.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.264 2.225 . . . . 0.0 110.797 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 mt -57.56 -48.23 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 120.927 -1.108 . . . . 0.0 110.182 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.68 123.72 23.85 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -103.26 165.26 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.072 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -77.91 75.81 4.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.076 1.351 . . . . 0.0 109.581 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -66.01 -27.54 68.2 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.42 -177.35 45.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.95 0.795 . . . . 0.0 111.751 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -59.23 147.14 92.13 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.868 1.712 . . . . 0.0 109.7 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.91 70.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.432 -1.205 . . . . 0.0 112.362 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.67 163.56 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 120.446 2.123 . . . . 0.0 108.9 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.14 127.96 37.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.033 1.333 . . . . 0.0 109.205 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.6 t -140.94 164.24 30.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.773 0.797 . . . . 0.0 110.49 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.99 140.54 29.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 -167.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.08 57.12 1.45 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.68 1.228 . . . . 0.0 108.614 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -61.35 170.51 1.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.951 158.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.23 13.94 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.62 1.168 . . . . 0.0 111.713 -169.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.27 -171.92 27.01 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -160.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -60.6 157.02 38.92 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.145 1.897 . . . . 0.0 110.037 171.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER 34.56 47.27 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.17 2.588 . . . . 0.0 113.716 173.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 p -124.19 22.38 8.65 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.811 0.844 . . . . 0.0 111.599 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -64.52 122.82 17.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.043 1.737 . . . . 0.0 108.762 173.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.49 -97.2 0.57 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.1 p -134.33 -23.77 1.65 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.079 0.952 . . . . 0.0 112.248 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.02 135.01 57.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -141.83 176.19 9.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -139.69 152.27 46.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 109.857 162.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.8 mt -83.17 122.98 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 163.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.3 m -68.5 113.61 6.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 167.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.2 p -108.36 30.68 6.21 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.51 173.51 14.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.814 1.645 . . . . 0.0 107.649 165.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.86 89.82 0.28 Allowed 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 162.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.29 53.75 0.53 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.387 1.475 . . . . 0.0 110.276 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -64.67 -21.74 66.81 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 119.921 -1.737 . . . . 0.0 112.39 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -73.31 -2.22 21.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.532 1.133 . . . . 0.0 111.969 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -115.42 -5.42 12.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.234 1.414 . . . . 0.0 111.528 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.82 142.44 57.94 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.061 0.846 . . . . 0.0 111.45 -172.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.57 12.61 61.84 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.268 -1.296 . . . . 0.0 113.709 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.37 -24.06 1.42 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.2 2.0 . . . . 0.0 113.34 -169.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -125.19 140.96 52.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.961 0.904 . . . . 0.0 110.085 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 63.2 t -78.89 101.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -171.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.51 123.49 16.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 164.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.02 -1.45 2.66 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.4 -173.04 27.33 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 119.296 0.953 . . . . 0.0 111.727 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -154.28 145.25 22.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.031 1.332 . . . . 0.0 108.729 -172.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.43 115.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 161.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.403 ' HE3' ' CG2' ' A' ' 5' ' ' THR . 12.4 ttmm -74.12 -54.38 7.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -153.98 167.09 30.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.322 2.249 . . . . 0.0 109.242 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.33 69.47 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.517 -0.739 . . . . 0.0 112.733 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.6 tpt -55.87 -35.51 66.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.633 1.217 . . . . 0.0 110.9 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -62.92 -31.31 72.36 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.829 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.74 -39.73 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.53 -37.37 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.686 -0.634 . . . . 0.0 109.942 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.485 ' CD ' HH21 ' A' ' 144' ' ' ARG . 3.1 mm-40 -57.86 -42.96 85.59 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 110.529 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.19 95.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.881 0.764 . . . . 0.0 109.027 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.8 mtm -54.94 -44.85 74.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.228 0.211 . . . . 0.0 110.987 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 59' ' ' GLY . 8.1 mt-10 -58.42 -37.46 75.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.485 HH21 ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -66.4 -24.82 66.53 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.828 1.195 . . . . 0.0 110.35 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -91.03 10.81 25.15 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.475 1.11 . . . . 0.0 112.017 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.67 -153.44 6.04 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.855 1.207 . . . . 0.0 111.502 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.5 p -141.62 -86.51 0.17 Allowed 'General case' 0 C--O 1.223 -0.306 0 O-C-N 122.044 -0.68 . . . . 0.0 110.081 160.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 178.14 -17.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 129.798 3.239 . . . . 0.0 110.343 161.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -68.35 -27.06 65.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.001 0.818 . . . . 0.0 110.013 158.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 123.25 -35.3 3.39 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-O 118.606 -1.108 . . . . 0.0 111.748 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -65.13 124.36 21.92 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.391 1.096 . . . . 0.0 108.195 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.0 p -64.25 154.04 36.27 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 110.261 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.0 p -68.41 -26.79 65.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.296 0.639 . . . . 0.0 110.789 167.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -132.98 169.76 16.34 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.415 1.086 . . . . 0.0 111.093 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HE2' ' SG ' ' A' ' 52' ' ' CYS . 75.8 tttt -83.89 84.85 7.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 121.089 1.768 . . . . 0.0 109.677 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.0 mm -73.79 126.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.34 163.52 32.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.346 1.069 . . . . 0.0 110.969 -163.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.45 HD12 ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -94.98 115.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 159.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.97 13.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.404 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 1.4 t70 -148.62 163.26 37.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.086 0.554 . . . . 0.0 109.65 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.8 p -167.91 167.9 12.52 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.278 0.631 . . . . 0.0 111.933 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.16 178.52 42.44 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.489 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.3 tp60 -76.24 147.02 38.61 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.829 1.652 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 12.9 mt -137.87 43.3 2.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.235 1.014 . . . . 0.0 112.455 162.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.489 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 19.7 mt-10 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 123.887 0.875 . . . . 0.0 110.913 168.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.56 137.93 48.08 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.415 1.41 . . . . 0.0 110.301 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.503 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 88.2 m -95.14 147.33 23.55 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.08 153.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.689 1.195 . . . . 0.0 107.864 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -128.55 157.3 41.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.432 1.093 . . . . 0.0 109.792 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.425 ' CE1' ' CD2' ' A' ' 48' ' ' TYR . 68.9 m-85 -147.81 120.13 8.4 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.056 1.342 . . . . 0.0 107.714 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -85.41 95.53 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.1 mm -71.29 135.84 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.59 163.27 18.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.403 1.881 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 t -138.06 95.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 57.32 13.94 1.94 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.005 1.722 . . . . 0.0 112.963 -169.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.9 -9.13 29.64 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.958 1.742 . . . . 0.0 113.116 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -77.04 125.5 86.72 Favored Pre-proline 0 CA--C 1.518 -0.282 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.29 113.44 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 120.91 1.074 . . . . 0.0 109.495 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.25 -35.23 23.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.305 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 163.31 10.08 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 167.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -80.28 146.35 31.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.52 154.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.3 2.64 . . . . 0.0 105.419 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -144.99 152.03 39.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.493 1.139 . . . . 0.0 109.904 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -136.45 153.31 51.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.344 1.458 . . . . 0.0 108.406 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -97.25 146.06 25.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.455 1.902 . . . . 0.0 107.111 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.45 129.35 53.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.395 1.478 . . . . 0.0 107.529 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.61 57.11 1.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.842 1.657 . . . . 0.0 111.812 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.11 60.95 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.247 -1.533 . . . . 0.0 113.429 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -62.29 -53.35 56.41 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.875 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.24 -49.37 8.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.857 0.863 . . . . 0.0 110.541 -169.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 m -127.11 68.37 72.08 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.235 2.214 . . . . 0.0 108.737 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.48 -36.25 98.74 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.536 2.157 . . . . 0.0 112.579 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -52.6 56.73 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.716 1.144 . . . . 0.0 109.191 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 m -64.83 -39.45 93.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.46 0.704 . . . . 0.0 110.102 -174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.21 69.37 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.435 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.56 -43.08 97.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.488 1.115 . . . . 0.0 110.881 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -50.68 -60.02 3.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.365 1.466 . . . . 0.0 109.066 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -65.43 -26.46 67.97 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.418 ' HG3' HE22 ' A' ' 163' ' ' GLN . 43.1 ttp85 -60.58 -61.72 2.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.447 1.099 . . . . 0.0 109.858 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.09 69.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.74 0.65 . . . . 0.0 111.823 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -71.4 -37.06 71.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.782 -0.574 . . . . 0.0 111.063 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.5 m -70.08 -36.69 75.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.476 0.71 . . . . 0.0 110.86 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -79.6 -18.44 51.61 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.752 0.421 . . . . 0.0 111.378 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.5 7.15 72.74 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 120.554 -1.342 . . . . 0.0 111.518 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.96 4.04 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.774 1.629 . . . . 0.0 113.808 -163.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -116.94 12.65 14.73 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.332 1.453 . . . . 0.0 111.216 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.08 84.66 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.396 0.522 . . . . 0.0 112.305 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -156.93 171.99 19.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.72 39.13 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 116.99 -2.529 . . . . 0.0 114.464 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 8' ' ' PHE . 1.1 t80 -65.64 -27.07 68.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.454 2.301 . . . . 0.0 109.38 175.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -52.21 136.95 29.41 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.827 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 -0.12 46.44 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.671 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -68.74 119.36 13.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.739 2.27 . . . . 0.0 107.561 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.7 t -72.33 137.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.33 104.61 5.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -74.07 -21.51 59.89 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.41 116.72 11.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.7 mt -133.44 115.88 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.93 100.7 39.91 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.32 134.25 60.3 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.872 2.381 . . . . 0.0 111.761 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.67 32.61 83.62 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.131 1.824 . . . . 0.0 112.006 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -150.89 -74.02 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.427 1.113 . . . . 0.0 109.307 -172.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.83 167.01 31.75 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.0 m -128.13 100.25 5.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.35 1.86 . . . . 0.0 108.501 166.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -93.07 131.67 37.88 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.136 1.775 . . . . 0.0 109.437 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.99 50.73 0.22 Allowed Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.286 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.99 12.54 24.5 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 118.148 0.974 . . . . 0.0 111.773 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -85.22 23.37 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.479 1.912 . . . . 0.0 113.458 -167.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD1' HG22 ' A' ' 68' ' ' THR . 11.2 p90 -41.16 -2.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 1 C-N-CA 132.563 4.345 . . . . 0.0 118.754 -176.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.414 HG22 ' CD1' ' A' ' 67' ' ' PHE . 12.1 p -126.39 -49.49 1.54 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.969 2.508 . . . . 0.0 112.144 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 -128.21 89.1 2.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -84.24 61.43 6.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.747 3.219 . . . . 0.0 107.751 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -173.45 -22.94 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 129.235 3.014 . . . . 0.0 107.966 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.24 43.62 2.16 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 126.852 2.168 . . . . 0.0 111.436 161.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.3 p -110.96 39.01 2.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 159.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.06 -174.59 14.97 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 122.548 1.082 . . . . 0.0 112.747 -161.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.33 75.75 0.41 Allowed Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 113.069 -1.566 . . . . 0.0 111.493 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 165.87 11.97 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 111.617 -2.291 . . . . 0.0 108.75 158.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.0 p -84.16 177.91 8.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.766 0.793 . . . . 0.0 109.2 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.7 pt -70.03 -27.25 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.994 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -84.86 -21.15 29.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.141 0.976 . . . . 0.0 111.521 -169.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.57 -99.42 0.19 Allowed Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 105.023 -3.231 . . . . 0.0 105.023 -164.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.13 -157.61 0.81 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.208 1.004 . . . . 0.0 109.745 172.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -63.76 142.16 58.5 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.75 2.82 . . . . 0.0 110.107 -159.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -120.15 177.12 5.13 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.38 1.472 . . . . 0.0 108.923 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.58 163.41 27.37 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.24 87.65 0.82 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 108.988 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -46.38 -53.86 10.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.955 1.302 . . . . 0.0 112.248 -163.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.26 169.62 21.82 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.752 0.421 . . . . 0.0 110.222 158.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.79 13.74 16.18 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.757 1.223 . . . . 0.0 112.91 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 mt -53.22 -40.96 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.621 0.768 . . . . 0.0 109.899 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.77 121.03 29.69 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -110.82 170.18 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 109.433 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -74.18 87.04 1.92 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.742 0.817 . . . . 0.0 109.021 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.4 p -73.77 -11.1 60.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.623 0.769 . . . . 0.0 112.113 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.78 -169.79 38.87 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.011 -1.056 . . . . 0.0 111.708 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.95 158.63 32.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.527 1.485 . . . . 0.0 110.68 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.15 85.13 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 117.927 -1.485 . . . . 0.0 112.248 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -79.35 168.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.185 1.993 . . . . 0.0 108.564 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.68 133.47 27.22 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.319 1.448 . . . . 0.0 109.509 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 t -150.19 158.4 44.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.812 0.445 . . . . 0.0 111.346 -167.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.7 mtp -80.8 122.37 27.1 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.828 0.851 . . . . 0.0 111.203 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -75.27 61.47 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.645 1.578 . . . . 0.0 109.161 161.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -65.98 -178.18 0.57 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.43 1.11 . . . . 0.0 108.329 159.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.44 14.41 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.206 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.22 -157.45 23.89 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -66.81 148.63 82.86 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.179 1.92 . . . . 0.0 109.634 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 34.21 57.27 0.64 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.449 3.1 . . . . 0.0 111.353 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.5 p -131.88 26.4 4.63 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 109.871 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -75.0 88.74 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.293 1.837 . . . . 0.0 106.947 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.45 -92.44 1.9 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -174.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.8 p -151.01 -13.12 0.22 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 167.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.8 137.71 57.57 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -143.81 170.92 14.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.749 1.22 . . . . 0.0 108.299 -167.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -141.77 154.58 45.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.397 0.679 . . . . 0.0 110.325 158.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.51 125.02 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 161.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 16.5 m -70.91 117.56 12.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 167.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 p -108.7 26.5 10.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.662 0.785 . . . . 0.0 109.576 170.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.38 172.11 17.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -65.52 88.45 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 163.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -80.48 63.42 4.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.058 1.409 . . . . 0.0 109.663 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -69.85 -10.43 58.45 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.802 1.641 . . . . 0.0 112.794 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 13.4 p90 -84.78 -11.0 56.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 168.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.5 mt -107.87 -8.63 15.92 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 110.913 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.48 146.82 33.93 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.67 1.188 . . . . 0.0 110.503 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.24 0.91 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.192 0.901 . . . . 0.0 114.829 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -93.68 -50.14 5.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 107.876 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.23 132.08 53.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.62 0.768 . . . . 0.0 109.478 -165.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.45 106.95 16.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 126.071 1.748 . . . . 0.0 106.607 -169.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.49 126.81 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 172.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -137.76 -0.4 2.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.59 -178.43 35.51 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 119.443 1.019 . . . . 0.0 112.844 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -150.02 156.12 41.13 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.665 0.786 . . . . 0.0 110.315 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.83 118.88 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -78.71 -47.38 17.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.583 -0.698 . . . . 0.0 109.248 163.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -141.98 139.64 32.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.81 1.244 . . . . 0.0 108.654 -158.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.51 25.13 40.21 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.285 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.2 tpt -52.95 -37.26 60.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.261 2.03 . . . . 0.0 110.992 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -64.81 -29.09 70.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.214 0.915 . . . . 0.0 113.091 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.05 -45.94 85.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.42 -39.54 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -67.6 -28.19 67.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.801 -1.187 . . . . 0.0 112.543 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -43.11 60.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.919 1.288 . . . . 0.0 109.4 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.7 mtp -53.12 -42.45 66.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.693 0.797 . . . . 0.0 109.974 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.82 -33.34 75.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.735 1.614 . . . . 0.0 114.477 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -62.52 -30.77 71.53 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 120.342 1.428 . . . . 0.0 109.019 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -91.64 18.76 7.06 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.795 1.238 . . . . 0.0 111.617 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.24 -168.76 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 p -152.8 155.42 37.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -64.69 -23.16 67.17 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.27 -1.519 . . . . 0.0 113.125 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.06 8.82 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.201 1.0 . . . . 0.0 112.753 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.88 18.27 66.24 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 126.355 1.931 . . . . 0.0 113.949 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -87.49 144.66 26.61 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 120.706 2.253 . . . . 0.0 109.927 158.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.13 153.5 43.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.901 0.88 . . . . 0.0 109.349 162.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 p -105.2 -13.85 15.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.035 1.334 . . . . 0.0 111.355 164.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -135.0 156.11 49.6 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.834 1.254 . . . . 0.0 109.694 169.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -77.14 85.46 3.62 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.445 -0.784 . . . . 0.0 109.488 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.89 120.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 173.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.77 149.72 50.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.524 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -81.48 104.65 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 163.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.58 -53.29 19.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.63 164.72 31.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 7.8 p -172.91 170.45 4.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.421 0.688 . . . . 0.0 111.97 -171.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.9 -162.39 33.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 8.3 tp60 -87.77 154.23 20.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.829 1.651 . . . . 0.0 110.178 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.38 42.79 2.84 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.081 1.309 . . . . 0.0 109.535 158.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.503 ' HB2' ' H ' ' A' ' 5' ' ' THR . 15.4 tp10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.159 1.784 . . . . 0.0 109.342 168.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.43 132.59 51.64 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.201 1.934 . . . . 0.0 109.359 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -93.94 152.5 18.81 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.86 142.93 29.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.489 1.515 . . . . 0.0 107.227 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.44 159.3 20.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.32 1.048 . . . . 0.0 110.122 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -148.28 114.17 5.76 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.085 1.354 . . . . 0.0 108.522 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.23 97.93 5.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 165.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.62 144.6 13.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.56 139.07 43.62 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.405 1.082 . . . . 0.0 108.741 171.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.11 114.57 43.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.35 13.82 2.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.922 0.889 . . . . 0.0 113.149 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.23 56.04 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.193 . . . . 0.0 113.386 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -74.79 121.53 85.47 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.85 112.87 1.94 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.694 1.596 . . . . 0.0 110.084 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -78.33 -37.2 45.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.17 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.32 169.9 14.51 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -84.86 142.64 29.59 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.483 0.659 . . . . 0.0 109.971 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.2 t -122.79 160.95 24.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 128.94 2.896 . . . . 0.0 105.982 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -148.7 158.46 44.16 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 164.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -136.74 155.75 49.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.237 1.415 . . . . 0.0 108.391 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -108.22 134.37 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -111.54 120.67 42.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -69.04 59.11 0.1 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.571 1.949 . . . . 0.0 112.836 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.88 43.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 112.59 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -23.29 59.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.307 0.503 . . . . 0.0 111.296 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -113.6 -30.14 6.92 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.645 0.778 . . . . 0.0 112.241 -169.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.44 73.17 11.8 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.037 1.735 . . . . 0.0 107.946 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 -45.42 14.73 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.142 1.895 . . . . 0.0 112.805 -167.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.51 -53.37 58.95 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.029 1.286 . . . . 0.0 109.331 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -44.82 79.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.547 1.139 . . . . 0.0 111.243 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.56 65.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.66 0.784 . . . . 0.0 111.953 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -63.98 -40.72 97.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.792 0.837 . . . . 0.0 111.376 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -58.58 2.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.672 1.589 . . . . 0.0 108.96 167.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.99 -39.68 90.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.046 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -53.14 -58.24 7.69 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.098 1.359 . . . . 0.0 109.243 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -21.35 64.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.185 1.394 . . . . 0.0 113.77 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -89.79 -23.97 21.6 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.878 0.871 . . . . 0.0 111.389 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 m -83.4 -37.77 22.82 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.009 1.324 . . . . 0.0 110.779 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 p -67.05 -32.5 73.73 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.422 0.689 . . . . 0.0 109.823 170.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.73 14.81 81.08 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.089 0.852 . . . . 0.0 111.087 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.26 -21.8 66.78 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.572 1.186 . . . . 0.0 112.755 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -80.26 0.25 33.5 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 111.852 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 9.74 86.49 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.778 1.18 . . . . 0.0 112.437 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -156.6 179.04 9.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.499 1.52 . . . . 0.0 108.889 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.35 -142.54 13.86 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 121.723 0.624 . . . . 0.0 112.696 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -27.22 63.76 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.435 1.894 . . . . 0.0 110.873 -160.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.0 tttt -64.88 124.12 21.17 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.87 7.08 69.22 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.958 -1.468 . . . . 0.0 112.87 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -67.36 129.49 40.08 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 120.423 2.111 . . . . 0.0 106.244 167.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -76.12 161.7 28.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 163.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.95 114.1 28.11 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -79.2 -49.09 13.08 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.34 128.12 44.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.4 mm -137.2 106.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.2 mt -114.91 93.32 33.89 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.1 117.89 4.02 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.602 2.868 . . . . 0.0 112.006 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.09 14.67 57.32 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.659 1.123 . . . . 0.0 112.952 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CD1' ' HG3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -133.11 -72.89 0.5 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.417 ' HG3' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -166.05 157.74 13.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.1 m -100.64 139.5 36.23 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.96 1.704 . . . . 0.0 108.426 160.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -135.06 122.21 21.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.567 1.531 . . . . 0.0 109.087 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.99 16.85 1.95 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.638 -0.535 . . . . 0.0 114.212 -161.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.72 11.02 53.22 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.053 0.927 . . . . 0.0 114.249 -168.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.72 97.8 9.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 166.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -100.97 -1.03 35.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 p -140.03 -51.68 0.5 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -83.84 -23.85 31.19 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.443 -0.786 . . . . 0.0 112.324 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.0 m170 59.95 31.81 20.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.905 1.682 . . . . 0.0 112.977 169.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -154.07 2.95 0.25 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.91 17.94 4.87 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.141 1.337 . . . . 0.0 113.942 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.4 p -139.33 10.19 2.52 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.229 1.015 . . . . 0.0 112.017 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.97 155.92 49.87 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 120.791 -1.193 . . . . 0.0 113.497 -163.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.9 -156.68 49.54 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 113.56 -1.32 . . . . 0.0 111.582 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.67 160.83 10.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.989 2.116 . . . . 0.0 107.685 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.7 p -71.45 23.16 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.475 1.91 . . . . 0.0 114.605 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.288 1.2 pp 46.29 -19.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 1 C-N-CA 132.234 4.214 . . . . 0.0 117.046 -159.04 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -92.65 -22.22 19.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 119.884 1.22 . . . . 0.0 112.748 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.56 101.07 0.26 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.342 14.5 tt0 41.23 -132.8 0.35 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.291 1.036 . . . . 0.0 111.901 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -88.78 149.06 23.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.831 1.252 . . . . 0.0 109.776 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -117.48 -176.74 3.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.985 1.714 . . . . 0.0 108.274 170.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -81.34 166.02 20.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.069 1.304 . . . . 0.0 114.122 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.37 87.68 3.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 107.582 -172.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -40.13 -64.37 0.51 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.985 2.114 . . . . 0.0 111.586 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.45 156.38 1.53 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.299 0.639 . . . . 0.0 110.844 174.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -111.75 30.29 7.12 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.726 1.61 . . . . 0.0 110.054 -171.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.86 -55.23 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.618 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.71 135.82 35.49 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.78 1.632 . . . . 0.0 107.188 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -122.88 167.2 13.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.667 1.587 . . . . 0.0 109.868 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -84.15 60.31 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.344 1.457 . . . . 0.0 110.849 -162.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 p -62.39 -29.46 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -158.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.4 -179.08 48.71 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 119.232 0.924 . . . . 0.0 112.094 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.11 153.08 54.67 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.411 2.074 . . . . 0.0 110.426 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.59 1.61 71.98 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 117.782 -1.566 . . . . 0.0 112.971 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.16 163.19 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.79 2.295 . . . . 0.0 107.824 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.32 131.07 39.71 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.744 1.218 . . . . 0.0 109.487 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -138.15 158.38 44.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 109.365 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.403 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 6.6 ptm -88.13 151.26 22.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.522 0.677 . . . . 0.0 110.913 -173.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.09 59.22 0.83 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.347 1.059 . . . . 0.0 109.134 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -57.79 161.2 3.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.748 163.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.82 19.84 1.14 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.661 2.384 . . . . 0.0 111.904 -166.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.05 176.79 25.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.16 1.362 . . . . 0.0 110.481 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.6 138.77 71.94 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 119.848 1.824 . . . . 0.0 109.664 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.4 55.81 5.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.944 2.098 . . . . 0.0 109.977 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -112.19 23.36 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.592 -1.317 . . . . 0.0 111.305 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -72.34 91.38 1.33 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 107.472 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.76 -142.83 11.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p -84.0 -15.65 46.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.859 0.863 . . . . 0.0 112.782 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.03 138.91 57.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.41 0.684 . . . . 0.0 109.619 -164.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 12.7 p90 -149.87 167.67 25.93 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -141.01 148.42 40.26 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 124.386 1.054 . . . . 0.0 109.315 162.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -83.69 116.46 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.3 m -64.16 130.85 45.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -118.22 23.94 11.28 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.466 1.106 . . . . 0.0 109.046 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.63 179.49 9.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.998 0.919 . . . . 0.0 108.577 163.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 82.1 tttt -67.83 92.1 0.34 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 160.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.5 p -83.47 58.6 4.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.75 0.705 . . . . 0.0 110.153 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.406 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 15.6 pt-20 -74.01 -8.01 54.53 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.182 -1.574 . . . . 0.0 113.767 -171.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -66.37 -10.3 42.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.397 -0.814 . . . . 0.0 110.846 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.4 mt -107.53 0.46 22.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.379 1.872 . . . . 0.0 111.28 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 127.27 32.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.974 0.806 . . . . 0.0 112.443 -162.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.82 3.23 20.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.222 0.915 . . . . 0.0 113.22 -168.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -93.9 -53.51 3.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -99.97 157.18 16.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.583 0.753 . . . . 0.0 110.619 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t -98.71 101.68 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.35 128.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -142.46 0.06 1.27 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.77 176.38 29.35 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 119.526 1.057 . . . . 0.0 111.639 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -146.43 155.59 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.81 123.8 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -86.76 -41.98 13.69 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.868 0.867 . . . . 0.0 109.297 170.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.54 160.16 43.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.663 0.385 . . . . 0.0 111.065 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.6 36.1 82.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.075 0.845 . . . . 0.0 111.91 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -45.42 78.35 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.704 1.252 . . . . 0.0 108.28 171.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.61 -26.54 61.7 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.1 mm -76.8 -36.96 27.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-N 118.784 0.72 . . . . 0.0 109.143 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.02 -47.27 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.303 0.956 . . . . 0.0 108.759 170.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.55 68.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.188 0.995 . . . . 0.0 111.507 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.48 -42.61 52.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 120.952 -1.093 . . . . 0.0 109.833 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 44.3 mtm -55.65 -48.85 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 118.444 0.565 . . . . 0.0 109.542 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.64 -39.85 71.42 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.948 1.699 . . . . 0.0 111.249 176.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -67.84 -18.04 64.7 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.594 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -94.92 -1.21 53.03 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.557 1.072 . . . . 0.0 112.178 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.32 -163.3 39.24 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 120.871 1.669 . . . . 0.0 112.199 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.3 p -152.14 154.97 36.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -66.73 -20.59 66.0 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.154 -1.591 . . . . 0.0 112.877 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.64 9.16 4.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.428 1.091 . . . . 0.0 112.878 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.51 -28.87 7.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 126.128 1.823 . . . . 0.0 113.65 167.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -69.86 145.16 52.25 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 120.445 2.122 . . . . 0.0 110.91 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.2 p -64.05 145.86 55.16 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.873 1.669 . . . . 0.0 111.425 159.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.4 p -75.92 -43.83 43.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.357 0.663 . . . . 0.0 109.653 158.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -124.47 162.73 23.32 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.43 1.492 . . . . 0.0 110.931 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.61 88.28 2.17 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.128 -0.983 . . . . 0.0 110.358 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.49 124.88 31.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 p -146.09 165.67 28.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.699 0.761 . . . . 0.0 111.453 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.83 127.33 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 159.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.54 -46.68 8.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.613 0.642 . . . . 0.0 109.734 168.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -147.38 158.51 44.0 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -172.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -172.56 172.46 4.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.098 0.959 . . . . 0.0 113.096 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.35 -178.4 46.19 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.199 1.381 . . . . 0.0 109.906 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -78.83 149.09 32.62 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 110.511 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.7 mt -128.68 43.29 3.17 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.954 0.902 . . . . 0.0 109.419 159.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.252 1.199 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.217 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--O 1.238 0.472 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.774 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 17.9 Cg_endo -64.57 147.66 90.28 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 N-CA-C 107.551 -1.75 . . . . 0.0 107.551 174.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 m -110.51 150.48 28.85 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.92 160.96 29.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.746 0.818 . . . . 0.0 108.841 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -124.95 159.16 31.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.364 1.466 . . . . 0.0 109.998 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -146.56 107.82 4.23 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.69 2.396 . . . . 0.0 106.846 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.01 101.44 3.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.46 134.66 29.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.46 141.4 47.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.84 0.856 . . . . 0.0 109.008 164.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.2 t -96.32 91.28 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 163.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.279 1.3 p30 62.54 14.18 6.84 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.58 -9.64 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 117.442 -1.755 . . . . 0.0 111.406 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -70.48 124.88 91.66 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 162.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.0 117.75 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 N-CA-C 107.261 -1.861 . . . . 0.0 107.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp -88.73 -35.26 16.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.567 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 147.0 161.56 9.43 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -74.59 146.91 42.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.659 0.743 . . . . 0.0 109.233 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.01 151.85 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 128.114 2.566 . . . . 0.0 104.609 171.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.451 ' HB2' ' CG ' ' A' ' 134' ' ' GLU . 21.5 m -146.48 146.65 30.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.212 1.006 . . . . 0.0 109.76 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -120.23 156.61 30.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.956 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -95.74 151.25 19.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 158.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -127.31 121.38 30.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -75.2 51.49 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.936 2.094 . . . . 0.0 112.754 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.26 28.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.963 -1.085 . . . . 0.0 113.365 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.09 -26.52 60.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.124 0.874 . . . . 0.0 111.714 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -111.99 -34.04 6.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.526 1.13 . . . . 0.0 111.635 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.08 71.6 68.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.449 1.9 . . . . 0.0 109.037 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.65 -44.2 27.9 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.593 2.195 . . . . 0.0 113.844 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -49.4 77.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.203 1.365 . . . . 0.0 109.592 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -62.45 -48.39 79.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.854 0.862 . . . . 0.0 109.28 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.66 -48.57 81.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.62 0.768 . . . . 0.0 111.468 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -46.01 91.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.725 1.21 . . . . 0.0 111.688 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -57.28 -51.09 70.79 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.106 0.962 . . . . 0.0 108.609 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.28 -31.68 72.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 18.3 ttm105 -55.65 -56.81 16.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.963 1.256 . . . . 0.0 108.938 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.23 49.1 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.673 1.189 . . . . 0.0 111.16 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.33 -29.4 69.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.31 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 m -75.17 -10.23 59.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.236 1.414 . . . . 0.0 112.104 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.8 p -112.43 -29.61 7.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.411 0.684 . . . . 0.0 111.725 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.14 82.67 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.356 -0.691 . . . . 0.0 113.56 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -28.81 64.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.499 1.92 . . . . 0.0 113.503 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.59 2.49 1.8 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.519 0.728 . . . . 0.0 112.848 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.48 62.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.871 1.224 . . . . 0.0 111.397 -170.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.35 172.82 12.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.59 2.356 . . . . 0.0 106.728 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.54 -177.18 23.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -81.67 -6.59 59.16 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.881 2.072 . . . . 0.0 112.247 -163.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -59.59 117.87 5.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.2 -0.938 . . . . 0.0 108.588 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.49 5.65 87.96 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 116.92 -2.044 . . . . 0.0 115.766 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.6 m -71.26 -65.77 0.7 Allowed 'General case' 0 C--N 1.342 0.256 0 CA-C-N 121.638 2.719 . . . . 0.0 112.322 -163.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.6 t 130.14 144.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.184 3.793 . . . . 0.0 109.659 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.03 92.03 6.65 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.043 2.137 . . . . 0.0 106.823 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -18.4 58.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -164.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -140.02 78.25 1.65 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.161 1.346 . . . . 0.0 111.64 -167.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.51 106.34 18.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.805 1.642 . . . . 0.0 107.008 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.6 91.41 12.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.31 120.84 7.4 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.843 3.029 . . . . 0.0 113.114 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.47 11.52 60.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.839 1.685 . . . . 0.0 113.253 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -133.94 -79.61 0.46 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.936 1.294 . . . . 0.0 108.802 -170.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.69 167.95 28.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.799 0.84 . . . . 0.0 110.713 172.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -132.38 98.15 4.3 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.91 1.684 . . . . 0.0 109.04 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.7 146.79 44.18 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.426 1.09 . . . . 0.0 109.985 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.98 -173.64 25.68 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 125.719 1.628 . . . . 0.0 109.88 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.84 -13.23 41.78 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.326 1.441 . . . . 0.0 113.324 170.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -84.07 95.09 8.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.892 0.846 . . . . 0.0 110.709 -167.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -95.08 3.5 54.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.178 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.0 p -137.16 -45.95 0.57 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.893 1.224 . . . . 0.0 113.248 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -88.34 -27.05 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.79 -0.569 . . . . 0.0 111.472 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 54.25 12.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.953 2.901 . . . . 0.0 114.595 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -117.86 -8.04 10.86 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.188 0.995 . . . . 0.0 112.868 -170.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 -3.36 27.36 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.439 -1.2 . . . . 0.0 113.088 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.2 p -84.27 -32.29 24.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.77 1.785 . . . . 0.0 111.04 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.88 165.91 9.35 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-O 123.153 1.419 . . . . 0.0 114.054 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.31 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.469 1.594 . . . . 0.0 111.669 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.58 -178.84 2.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 128.951 2.901 . . . . 0.0 108.814 -160.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.1 p -84.99 -175.1 5.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.76 -23.09 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.033 -1.042 . . . . 0.0 111.745 163.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -82.13 -23.67 35.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.023 0.929 . . . . 0.0 111.149 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.8 -145.72 10.18 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 -166.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -128.75 115.2 17.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.38 148.42 0.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.228 2.611 . . . . 0.0 111.88 -165.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -135.12 173.6 11.54 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 159.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -63.84 154.01 34.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.132 0.968 . . . . 0.0 109.714 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.03 99.47 1.82 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 172.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -49.77 -57.31 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.241 1.416 . . . . 0.0 114.516 -158.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.69 154.02 5.25 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.239 1.816 . . . . 0.0 108.846 162.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.98 25.24 10.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.56 1.544 . . . . 0.0 110.049 -169.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mt -45.2 -59.59 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 126.541 1.936 . . . . 0.0 108.556 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.9 mt -74.91 113.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.421 1.488 . . . . 0.0 107.87 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -80.2 157.85 26.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.154 171.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.36 83.76 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.5 p -68.73 -23.53 64.36 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.479 -0.763 . . . . 0.0 112.853 -166.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.76 -176.7 40.54 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.861 1.21 . . . . 0.0 111.86 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.46 149.52 89.24 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 121.732 1.621 . . . . 0.0 110.691 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 10.91 85.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.977 -1.457 . . . . 0.0 112.467 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 mm -82.58 166.2 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 120.674 2.237 . . . . 0.0 108.336 164.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.57 127.94 26.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.097 1.359 . . . . 0.0 108.175 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.8 t -141.29 147.16 37.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.63 -167.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.9 tpp -77.25 113.97 15.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.177 2.191 . . . . 0.0 108.562 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.56 98.17 2.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 165.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -78.83 -178.2 5.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 159.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.92 15.1 25.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.384 1.874 . . . . 0.0 112.149 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.01 175.73 14.17 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.539 1.543 . . . . 0.0 109.312 -163.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.34 130.21 31.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.198 1.932 . . . . 0.0 111.32 -170.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.81 57.81 3.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 127.495 2.318 . . . . 0.0 111.853 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -142.25 41.74 1.64 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.086 0.555 . . . . 0.0 111.315 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.22 125.85 22.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.266 1.426 . . . . 0.0 109.565 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.75 -125.5 2.31 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 120.695 1.589 . . . . 0.0 112.335 -171.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -89.13 -25.14 22.01 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.606 1.203 . . . . 0.0 112.796 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -85.23 148.26 26.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.715 0.769 . . . . 0.0 111.178 -158.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -142.96 176.67 8.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -141.24 152.8 44.85 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 160.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.1 mt -83.46 119.42 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 163.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.3 m -65.15 122.56 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.8 p -114.86 28.5 8.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.222 1.01 . . . . 0.0 108.553 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.32 178.63 10.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.157 1.783 . . . . 0.0 107.628 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -70.39 92.11 0.79 Allowed 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 161.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 p -78.72 59.36 2.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.694 0.679 . . . . 0.0 109.939 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.01 -13.37 62.41 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.83 1.252 . . . . 0.0 112.914 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -74.1 -15.92 61.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.286 1.035 . . . . 0.0 111.317 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -103.61 -4.59 23.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.854 1.261 . . . . 0.0 111.129 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 126.97 29.75 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.589 1.156 . . . . 0.0 111.129 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.41 1.19 34.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.717 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -103.11 -25.8 13.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.61 1.705 . . . . 0.0 110.553 168.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -137.14 160.96 37.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.111 1.364 . . . . 0.0 108.98 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -110.46 103.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.58 127.46 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.65 -2.08 1.99 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.827 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.75 -176.44 28.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 119.41 1.005 . . . . 0.0 111.974 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -153.37 140.22 19.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.97 103.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 159.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -63.68 -52.71 59.42 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.451 ' CG ' ' HB2' ' A' ' 21' ' ' SER . 10.4 pt-20 -146.87 154.47 41.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 123.356 0.662 . . . . 0.0 111.486 -159.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.88 25.14 67.68 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.884 0.754 . . . . 0.0 113.153 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 mmm -61.22 -29.21 69.68 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.623 2.212 . . . . 0.0 111.609 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -62.61 -30.65 71.5 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.834 -1.166 . . . . 0.0 111.635 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.02 -44.09 92.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.97 -42.26 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.265 0.626 . . . . 0.0 110.166 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -39.74 94.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 174.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.18 -41.52 70.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.919 1.288 . . . . 0.0 109.035 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.3 mtp -53.87 -42.59 68.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.079 1.352 . . . . 0.0 110.154 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.202 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.76 -36.01 81.68 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.402 1.456 . . . . 0.0 108.887 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.59 1.68 40.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.983 0.913 . . . . 0.0 112.783 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.4 -156.21 7.72 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.982 1.753 . . . . 0.0 110.411 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.2 p -142.18 -72.06 0.32 Allowed 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 121.65 -0.912 . . . . 0.0 111.591 168.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 140.67 -27.39 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.346 1 C-N-CA 133.864 4.865 . . . . 0.0 109.772 -173.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.65 -24.84 67.12 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.716 0.689 . . . . 0.0 110.283 158.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.74 -36.05 4.21 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 125.672 1.606 . . . . 0.0 111.764 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.06 131.91 47.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 p -62.77 152.21 36.48 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.908 1.283 . . . . 0.0 107.914 166.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.6 p -57.44 -48.06 80.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -73.43 175.76 6.68 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.943 1.697 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -95.63 139.48 31.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 101.969 -3.345 . . . . 0.0 101.969 157.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.4 mt -127.38 128.96 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.79 22.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.798 0.808 . . . . 0.0 111.542 -158.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mp -98.37 105.13 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.86 96.64 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.484 0.584 . . . . 0.0 109.521 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -157.32 158.82 36.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.575 1.15 . . . . 0.0 108.841 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 p -156.93 165.28 36.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.397 0.679 . . . . 0.0 110.543 174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.47 -169.18 40.7 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.97 148.85 25.71 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.943 1.297 . . . . 0.0 109.646 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.2 mt -128.37 43.26 3.17 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.253 1.421 . . . . 0.0 109.114 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 . . . . . 0 C--O 1.243 0.734 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 166.233 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -63.78 146.66 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 120.7 1.286 . . . . 0.0 110.34 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -104.97 146.87 28.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.76 156.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.166 1.386 . . . . 0.0 109.351 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.0 158.91 26.71 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.487 1.115 . . . . 0.0 110.12 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -144.37 111.72 5.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.345 1.858 . . . . 0.0 106.663 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 104.46 10.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 mm -79.34 140.87 16.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.21 162.56 29.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.007 169.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 9.2 t -137.18 92.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 60.21 18.64 8.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.739 1.216 . . . . 0.0 111.516 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.16 9.69 72.89 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.196 -0.94 . . . . 0.0 112.537 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -75.18 118.71 72.7 Favored Pre-proline 0 C--O 1.232 0.179 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 159.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.94 112.36 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.477 1.451 . . . . 0.0 109.436 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.2 tp -82.81 -27.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.112 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.55 169.53 11.75 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.436 1.493 . . . . 0.0 111.759 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.91 139.38 35.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.335 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.45 154.95 40.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.6 t -147.43 149.49 32.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.77 0.795 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -124.57 147.93 48.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.203 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -92.58 151.92 19.88 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 158.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 mt -126.7 122.56 35.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.883 1.673 . . . . 0.0 106.993 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.52 61.63 2.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.969 0.908 . . . . 0.0 111.846 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.37 -16.33 53.88 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.885 -1.76 . . . . 0.0 113.611 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.33 -16.21 57.94 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.076 0.95 . . . . 0.0 111.918 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -121.95 -39.53 2.6 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.733 1.213 . . . . 0.0 111.3 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.74 70.51 79.09 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.911 1.685 . . . . 0.0 107.457 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -50.18 -48.37 20.15 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.146 2.564 . . . . 0.0 112.657 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -55.66 -58.51 7.49 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -174.392 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 -46.43 89.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.391 1.477 . . . . 0.0 111.165 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.57 82.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.083 0.553 . . . . 0.0 111.385 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.38 -43.54 81.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.626 1.17 . . . . 0.0 110.453 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -51.09 -51.08 56.89 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.147 1.379 . . . . 0.0 109.38 170.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.94 -44.21 90.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.423 0.452 . . . . 0.0 112.073 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -53.93 -59.65 4.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.733 1.613 . . . . 0.0 109.108 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.96 -47.8 74.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.465 0.706 . . . . 0.0 110.611 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.67 -23.39 66.77 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -73.3 -48.13 37.12 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.299 0.954 . . . . 0.0 109.303 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 p -66.62 -26.1 66.92 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.989 -0.444 . . . . 0.0 111.913 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.61 -0.11 71.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.436 1.017 . . . . 0.0 112.058 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -59.78 -23.21 63.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.701 1.6 . . . . 0.0 112.632 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -85.47 9.69 15.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.109 1.364 . . . . 0.0 112.095 -172.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.05 81.63 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.846 -0.974 . . . . 0.0 112.423 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.32 172.72 13.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.983 1.713 . . . . 0.0 107.407 166.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.63 174.39 37.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.427 -1.368 . . . . 0.0 113.674 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -73.24 -8.03 54.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -56.08 124.68 18.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.72 4.34 65.82 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.613 -1.659 . . . . 0.0 114.529 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -73.14 156.75 38.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.99 2.395 . . . . 0.0 107.988 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.1 t -106.21 139.89 40.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -74.83 88.99 2.31 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -73.5 -27.55 61.43 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.406 1.882 . . . . 0.0 111.617 -166.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 86.01 2.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.442 HG21 ' HG ' ' A' ' 62' ' ' CYS . 86.3 mt -103.71 112.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 171.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -125.17 97.47 37.59 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -170.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.68 125.45 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.948 2.432 . . . . 0.0 111.027 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.2 5.4 63.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.81 1.671 . . . . 0.0 113.338 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -136.57 -75.64 0.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.105 1.453 . . . . 0.0 108.98 -167.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.1 167.61 18.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 112.08 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.442 ' HG ' HG21 ' A' ' 56' ' ' ILE . 75.1 m -122.15 94.74 4.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.744 2.018 . . . . 0.0 108.383 168.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.37 144.32 25.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.532 1.933 . . . . 0.0 109.961 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.12 1.82 0.13 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.84 35.46 3.38 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 -158.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.329 19.3 p-10 -122.73 144.36 49.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.912 2.856 . . . . 0.0 111.292 164.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.28 -3.09 3.08 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.183 2.593 . . . . 0.0 111.317 -160.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -125.6 -19.84 4.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 129.247 3.019 . . . . 0.0 112.173 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -137.46 176.37 8.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 131.538 3.935 . . . . 0.0 103.439 169.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -145.11 53.81 1.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -152.91 -67.37 0.16 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.201 1.4 . . . . 0.0 110.679 -176.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.401 ' N ' HE22 ' A' ' 111' ' ' GLN . . . 173.69 -11.81 0.04 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 118.374 -1.237 . . . . 0.0 115.262 -159.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -127.44 17.04 7.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.285 1.543 . . . . 0.0 113.227 -161.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.27 -86.4 0.37 Allowed Glycine 0 CA--C 1.503 -0.662 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -17.09 113.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.553 0 C-N-CA 128.074 2.749 . . . . 0.0 111.932 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -136.9 155.32 49.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.213 1.805 . . . . 0.0 109.918 -158.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 p -77.94 165.5 24.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 124.293 0.996 . . . . 0.0 109.451 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.93 -24.75 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.596 170.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.39 8.31 25.11 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.166 1.787 . . . . 0.0 111.533 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.29 142.09 12.96 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.403 1.478 . . . . 0.0 109.813 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.26 6.2 pt-20 34.06 -133.8 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.796 2.438 . . . . 0.0 114.343 162.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -75.05 157.97 33.95 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.498 0.59 . . . . 0.0 110.385 165.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -132.13 176.53 8.31 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.66 1.984 . . . . 0.0 107.644 164.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.79 161.17 28.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.071 0.462 . . . . 0.0 110.713 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.57 131.33 48.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -47.08 83.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -173.08 176.13 3.06 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.726 1.211 . . . . 0.0 108.721 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -126.09 56.36 1.43 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.563 1.945 . . . . 0.0 106.144 163.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.55 -39.52 70.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 171.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.1 mt -95.6 142.24 28.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.447 1.499 . . . . 0.0 107.334 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -120.49 160.21 23.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.433 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -76.26 64.62 2.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.494 2.318 . . . . 0.0 109.666 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.426 1.49 . . . . 0.0 113.494 -161.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 175.49 38.23 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.583 1.083 . . . . 0.0 112.891 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -59.68 137.58 78.0 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.158 1.906 . . . . 0.0 108.147 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.73 64.38 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.512 -1.716 . . . . 0.0 112.623 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.42 159.44 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 120.923 2.361 . . . . 0.0 107.687 169.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.39 131.98 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.456 1.502 . . . . 0.0 108.497 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 32.3 t -148.62 160.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.848 0.459 . . . . 0.0 110.68 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.4 mtp -84.58 120.95 26.94 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.618 0.767 . . . . 0.0 110.421 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 141.73 58.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 162.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -152.46 -172.57 4.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.364 1.066 . . . . 0.0 109.691 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.62 15.08 10.25 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.011 1.724 . . . . 0.0 112.64 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.28 -179.6 17.24 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -167.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.47 141.04 79.1 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.539 2.159 . . . . 0.0 110.481 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.51 46.12 26.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.164 1.786 . . . . 0.0 111.885 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.7 p -123.89 14.07 9.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.301 -0.874 . . . . 0.0 111.262 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -73.69 128.02 34.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.52 -65.31 0.16 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.7 p -144.54 -13.76 0.58 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.401 HE22 ' N ' ' A' ' 72' ' ' GLY . 78.9 mt-30 -65.4 130.9 44.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -170.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -134.43 162.39 32.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 107.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 99' ' ' SER . 44.9 p90 -144.56 153.39 41.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 O-C-N 124.683 1.239 . . . . 0.0 110.263 166.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.79 123.84 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 160.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.14 125.39 24.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.3 p -110.77 32.39 5.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.52 173.11 13.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.341 1.057 . . . . 0.0 109.192 167.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -68.59 89.85 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 158.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 p -83.38 65.88 8.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.819 -0.551 . . . . 0.0 109.892 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -59.22 -23.21 62.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.11 0.964 . . . . 0.0 112.306 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -68.49 -14.82 63.27 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.761 1.224 . . . . 0.0 110.749 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.1 mt -104.0 -6.24 21.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.243 1.417 . . . . 0.0 111.54 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.16 145.13 53.54 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.714 0.688 . . . . 0.0 110.498 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.49 16.06 48.7 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.96 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.22 -52.01 1.41 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.924 2.09 . . . . 0.0 108.414 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -105.18 146.69 28.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.814 -173.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.45 100.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -171.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.1 t -59.06 127.29 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 165.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -138.25 -3.45 1.75 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.59 -174.19 30.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.36 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -149.83 149.99 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.659 1.183 . . . . 0.0 108.44 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 118.31 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 165.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -75.13 -50.27 16.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -143.34 146.4 33.51 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 126.133 1.773 . . . . 0.0 107.275 -171.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.27 22.34 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.464 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 28.6 tpp -56.61 -35.94 68.85 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 119.526 1.663 . . . . 0.0 110.706 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -62.67 -20.51 64.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.852 1.205 . . . . 0.0 113.391 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.4 mm -83.05 -43.77 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.551 1.14 . . . . 0.0 108.677 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.37 -35.9 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 121.586 -0.696 . . . . 0.0 109.579 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.37 -44.26 84.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.084 1.753 . . . . 0.0 110.913 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.08 85.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 38.4 mtm -53.26 -47.93 68.7 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.734 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -53.24 -42.14 66.12 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 144' ' ' ARG . 15.0 mtt85 -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.085 -177.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.04 5.24 51.62 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.801 1.24 . . . . 0.0 112.446 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.2 -150.89 4.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 120.473 1.488 . . . . 0.0 111.74 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.0 p -142.59 -96.05 0.12 Allowed 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.589 -0.948 . . . . 0.0 108.798 165.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -162.2 -23.4 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 125.858 1.663 . . . . 0.0 110.764 164.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -16.07 58.25 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.977 0.808 . . . . 0.0 111.432 165.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.27 -24.84 6.84 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 118.556 -1.136 . . . . 0.0 113.174 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.14 123.47 17.77 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.224 1.012 . . . . 0.0 108.764 -174.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.3 p -74.93 159.99 31.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 108.837 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -10.66 59.64 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.031 -1.668 . . . . 0.0 111.362 166.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.415 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -140.73 160.31 40.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 110.117 -161.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.52 80.2 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.67 119.16 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 p -139.22 165.74 26.38 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.508 1.123 . . . . 0.0 110.766 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 102.41 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 166.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.4 77.09 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -145.43 161.48 39.6 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 p -162.26 158.17 23.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.282 1.433 . . . . 0.0 108.556 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.71 -176.34 42.96 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -83.05 159.55 22.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.856 -0.79 . . . . 0.0 110.722 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.0 mt -135.58 43.63 2.59 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 158.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.148 0.979 . . . . 0.0 111.458 175.419 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.3 m120 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.23 138.82 48.17 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 N-CA-C 106.502 -2.153 . . . . 0.0 106.502 158.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 m -104.7 147.91 27.16 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.5 140.43 44.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -113.71 150.91 32.61 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 123.936 0.894 . . . . 0.0 110.164 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.431 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 19.3 m-85 -146.13 113.56 6.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.481 1.512 . . . . 0.0 109.317 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.21 101.11 3.88 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 159.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.19 140.93 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 171.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.78 148.06 49.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.929 1.292 . . . . 0.0 108.37 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.35 115.76 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 53.5 13.76 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 0.0 114.489 -167.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.3 57.79 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.381 1.467 . . . . 0.0 112.859 -175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.27 133.23 81.18 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.22 120.19 7.17 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.2 -40.49 30.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.85 177.28 19.56 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 123.68 0.657 . . . . 0.0 112.364 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -77.32 136.62 38.48 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.726 0.81 . . . . 0.0 110.068 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -121.92 158.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 126.578 1.951 . . . . 0.0 106.316 164.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -147.99 140.34 24.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.965 -0.459 . . . . 0.0 110.244 161.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -109.14 162.72 14.0 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -123.38 112.76 17.95 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.479 2.712 . . . . 0.0 104.433 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 mt -97.61 134.65 40.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -169.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.429 ' CD2' HD12 ' A' ' 90' ' ' LEU . 18.0 m-85 -82.16 51.76 1.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.998 -1.064 . . . . 0.0 112.42 -171.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.9 -27.36 42.42 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.252 -0.905 . . . . 0.0 112.061 173.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -71.39 -7.08 44.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.721 1.608 . . . . 0.0 113.758 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.82 -25.25 0.46 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.032 0.833 . . . . 0.0 112.933 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 75.1 33.64 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.562 1.945 . . . . 0.0 106.793 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.81 -52.65 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.29 1.993 . . . . 0.0 111.644 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -42.95 99.53 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.883 1.22 . . . . 0.0 109.83 -173.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -60.92 -48.21 82.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.433 0.693 . . . . 0.0 110.332 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.78 -51.29 57.47 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.131 0.972 . . . . 0.0 111.764 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.6 -32.41 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.213 2.205 . . . . 0.0 112.085 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -61.98 2.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.019 1.728 . . . . 0.0 108.579 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.07 -30.93 71.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.203 -0.311 . . . . 0.0 111.56 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -53.19 -62.37 1.7 Allowed 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.038 1.335 . . . . 0.0 109.784 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.9 -26.34 68.11 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.95 -32.39 34.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.866 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 m -69.67 -40.87 76.17 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.926 0.89 . . . . 0.0 109.853 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.0 p -70.87 -34.7 71.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.4 -0.6 88.9 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.623 1.106 . . . . 0.0 110.949 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -70.64 -12.07 61.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.037 1.335 . . . . 0.0 112.887 -162.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -75.57 -4.55 40.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.148 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.07 6.42 55.86 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.486 1.041 . . . . 0.0 111.463 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -163.23 170.54 17.56 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.349 1.86 . . . . 0.0 106.146 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.53 178.62 35.62 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 118.217 -1.944 . . . . 0.0 114.052 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.431 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 75.2 t80 -70.68 -17.63 62.84 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 130.51 3.524 . . . . 0.0 113.283 -170.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -55.74 121.8 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 23.72 73.0 Favored Glycine 0 CA--C 1.538 1.496 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.063 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -25.3 67.98 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.853 2.326 . . . . 0.0 110.288 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.4 m 56.38 175.99 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.308 1.443 . . . . 0.0 110.515 -159.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.6 117.99 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -74.27 -39.75 62.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.202 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 125.54 40.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -158.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.2 mm -142.33 114.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.9 mt -125.89 108.84 25.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.19 124.22 13.58 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.36 3.373 . . . . 0.0 114.015 -173.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.64 27.02 69.13 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.215 1.388 . . . . 0.0 112.442 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -125.1 -83.89 0.64 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.22 172.55 15.57 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.497 0.719 . . . . 0.0 110.188 170.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.99 115.84 17.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.231 1.413 . . . . 0.0 109.834 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -101.1 138.22 38.42 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.24 2.216 . . . . 0.0 111.528 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.22 -156.07 7.33 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.863 1.697 . . . . 0.0 109.279 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.8 90.13 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 119.284 -0.731 . . . . 0.0 114.401 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 70' ' ' HIS . 31.5 t0 -83.86 138.9 32.97 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 159.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -132.53 6.83 4.11 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.398 1.079 . . . . 0.0 111.326 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.6 -31.57 0.86 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.468 1.107 . . . . 0.0 113.73 -174.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -127.84 -10.95 5.48 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.306 1.412 . . . . 0.0 112.964 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.403 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 97.7 m-70 58.44 30.57 19.86 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.235 1.814 . . . . 0.0 113.091 171.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -147.04 -27.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.74 2.57 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.889 1.222 . . . . 0.0 114.469 -170.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.9 p -83.89 -4.32 58.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.596 1.198 . . . . 0.0 112.282 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -103.13 -108.34 3.25 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -8.46 91.17 0.01 OUTLIER Glycine 0 C--N 1.334 0.453 0 C-N-CA 129.082 3.23 . . . . 0.0 115.633 -170.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -77.24 150.1 35.41 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 128.224 2.61 . . . . 0.0 110.013 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -84.89 44.93 1.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.26 1.424 . . . . 0.0 112.768 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.257 36.6 pt 49.27 -43.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 1 C-N-CA 133.486 4.714 . . . . 0.0 114.562 -158.921 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -82.04 -4.43 56.76 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.844 1.257 . . . . 0.0 113.724 -159.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.66 -85.36 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 170.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -127.84 -133.23 0.23 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 127.255 2.222 . . . . 0.0 105.381 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.83 155.67 18.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.379 1.445 . . . . 0.0 108.902 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -122.76 177.75 5.33 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.083 0.856 . . . . 0.0 110.565 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HA ' HD21 ' A' ' 106' ' ' ASN . 15.9 pt-20 -57.47 164.31 1.98 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 112.679 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -64.22 120.01 11.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 158.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -67.2 -48.09 68.95 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.767 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.72 156.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.417 2.687 . . . . 0.0 110.706 170.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -104.61 22.55 14.83 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.923 1.689 . . . . 0.0 110.655 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.34 -49.39 64.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 124.33 1.052 . . . . 0.0 109.853 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 25' ' ' PHE . 96.3 mt -80.67 129.32 34.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.95 160.57 14.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.122 1.769 . . . . 0.0 109.368 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -77.08 85.24 3.58 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 172.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 p -76.47 -24.14 53.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 118.877 -0.582 . . . . 0.0 111.216 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.1 -170.57 43.55 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.041 0.829 . . . . 0.0 112.705 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.95 158.89 19.54 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.629 2.219 . . . . 0.0 110.64 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.65 -4.2 57.36 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 117.084 -1.954 . . . . 0.0 113.06 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -67.84 148.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 121.2 2.5 . . . . 0.0 107.823 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.83 125.33 54.23 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 p -131.73 159.82 37.3 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 122.799 1.285 . . . . 0.0 110.048 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttm -86.71 127.44 34.97 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.376 -163.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.62 41.79 0.34 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.884 2.474 . . . . 0.0 112.346 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -63.03 167.62 4.7 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.868 1.318 . . . . 0.0 110.409 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.36 15.26 13.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.374 -1.739 . . . . 0.0 111.75 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.61 -167.7 32.61 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 -167.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -64.75 171.62 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 119.328 1.564 . . . . 0.0 108.965 158.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.409 HD21 ' HA ' ' A' ' 84' ' ' GLU . 6.8 m120 48.85 24.43 0.84 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.458 2.303 . . . . 0.0 115.188 168.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -128.2 29.15 5.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.399 1.48 . . . . 0.0 109.858 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.473 HD22 HG22 ' A' ' 127' ' ' VAL . 85.7 m-20 -69.19 101.24 1.43 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.902 1.681 . . . . 0.0 107.324 172.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.92 -137.59 7.76 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -90.08 -10.87 43.14 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.733 0.813 . . . . 0.0 112.624 163.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -81.69 146.63 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.743 1.217 . . . . 0.0 111.286 -158.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -154.32 171.75 18.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.28 1.032 . . . . 0.0 109.492 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -135.49 154.66 51.34 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.341 0.591 . . . . 0.0 109.965 159.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.25 117.46 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 36.0 m -65.72 130.3 42.81 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.625 1.17 . . . . 0.0 108.078 168.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.9 p -111.66 22.07 15.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.944 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.95 -176.14 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 161.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.54 93.22 0.23 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 161.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -81.08 55.74 2.59 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.634 1.974 . . . . 0.0 110.014 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.869 -1.144 . . . . 0.0 113.673 -171.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -73.15 -4.47 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.0 mt -114.82 -2.88 12.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.229 1.811 . . . . 0.0 110.89 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.47 143.16 58.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.174 1.39 . . . . 0.0 111.529 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.5 20.26 58.82 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.254 0.93 . . . . 0.0 112.084 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.04 -51.91 0.67 Allowed 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -96.58 117.62 31.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 108' ' ' ASN . 18.6 t -71.23 107.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -170.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.89 122.55 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.384 1.474 . . . . 0.0 108.037 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -145.13 9.27 1.26 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.24 -173.08 37.29 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 121.296 -0.878 . . . . 0.0 111.783 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -147.67 158.36 43.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.144 0.978 . . . . 0.0 109.631 168.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.15 105.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -52.34 62.56 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.41 157.69 44.13 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.977 0.911 . . . . 0.0 111.056 -167.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.7 24.93 54.91 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.458 1.028 . . . . 0.0 112.592 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.8 tpp -55.75 -35.09 65.81 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.554 1.677 . . . . 0.0 110.109 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -57.6 -30.95 65.73 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.424 1.465 . . . . 0.0 113.379 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.8 mm -76.39 -35.07 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.906 0.776 . . . . 0.0 109.483 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.35 -39.4 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.387 0.994 . . . . 0.0 109.645 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.423 ' CD ' HH12 ' A' ' 144' ' ' ARG . 1.3 tm-20 -62.49 -31.44 72.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.117 1.367 . . . . 0.0 111.456 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -44.44 28.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.823 1.249 . . . . 0.0 109.215 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 62.5 mtp -49.77 -44.01 48.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.872 1.269 . . . . 0.0 110.316 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -33.31 71.22 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.02 0.928 . . . . 0.0 113.489 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.423 HH12 ' CD ' ' A' ' 140' ' ' GLU . 12.5 mmp_? -65.64 -25.73 67.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.699 1.136 . . . . 0.0 110.975 175.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -91.98 5.12 51.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.43 -167.81 34.05 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 125.007 1.289 . . . . 0.0 111.721 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 p -153.75 152.55 30.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.262 1.425 . . . . 0.0 107.372 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -63.85 -22.15 66.78 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.198 -1.564 . . . . 0.0 113.16 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -77.04 -6.48 52.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 16.69 68.94 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.355 -1.247 . . . . 0.0 113.243 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 176.13 8.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.583 1.691 . . . . 0.0 109.141 158.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.4 p -125.04 129.97 51.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.72 -31.65 70.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.4 0.546 . . . . 0.0 110.575 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -111.75 176.94 4.82 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.163 0.585 . . . . 0.0 109.972 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.66 103.4 15.78 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.3 mm -79.9 126.24 39.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -142.85 172.61 12.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.995 1.318 . . . . 0.0 111.412 -168.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.5 mt -124.0 109.69 23.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.85 87.33 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.375 1.047 . . . . 0.0 110.528 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -160.86 162.2 32.1 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.4 p -160.2 163.52 33.53 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.215 0.462 . . . . 0.0 111.9 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.34 29.34 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -110.05 143.95 39.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.01 1.324 . . . . 0.0 110.092 -172.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.26 43.55 3.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.811 1.645 . . . . 0.0 109.789 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.941 0 O-C-N 121.03 -1.044 . . . . 0.0 111.001 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 117.366 -1.302 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 165' ' ' GLU . 42.8 Cg_exo -63.04 166.77 13.62 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 CA-C-N 121.623 1.615 . . . . 0.0 112.139 158.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 m -131.11 152.26 50.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 158.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.1 m -139.01 154.9 26.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 108.121 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -109.83 159.96 16.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.862 0.865 . . . . 0.0 110.612 171.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -144.5 105.02 4.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.831 1.652 . . . . 0.0 107.437 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.29 97.15 5.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 164.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -68.69 141.7 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.01 159.9 30.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.397 1.094 . . . . 0.0 109.206 169.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.99 88.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -168.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.44 13.07 1.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.898 1.279 . . . . 0.0 112.35 -165.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.55 -9.43 30.44 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.705 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.68 112.44 8.7 Favored Pre-proline 0 N--CA 1.441 -0.924 0 C-N-CA 126.656 1.982 . . . . 0.0 105.696 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.86 118.63 5.53 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.7 -25.08 30.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.6 -152.03 23.43 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -124.27 114.87 20.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.151 0.975 . . . . 0.0 110.611 159.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.1 t -82.19 161.0 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.732 2.013 . . . . 0.0 108.33 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.7 m -151.4 141.85 22.52 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.315 -1.49 . . . . 0.0 110.205 170.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -117.6 143.47 46.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.894 0.878 . . . . 0.0 109.342 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -87.98 142.28 27.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 161.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -127.39 116.77 21.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -79.64 52.77 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.359 1.064 . . . . 0.0 113.555 -167.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 -16.17 64.1 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -172.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.36 -28.37 65.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.903 1.683 . . . . 0.0 110.705 168.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.27 -32.08 11.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.991 1.716 . . . . 0.0 112.449 -174.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.8 74.14 22.78 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.469 1.508 . . . . 0.0 109.022 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.53 -43.21 22.9 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.813 2.342 . . . . 0.0 112.342 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -52.2 66.17 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 119.868 1.213 . . . . 0.0 108.515 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 m -60.81 -47.65 85.39 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.641 1.177 . . . . 0.0 111.157 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.76 -33.9 46.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.06 -42.81 68.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.436 1.016 . . . . 0.0 110.014 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -45.15 -55.58 5.59 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.548 1.139 . . . . 0.0 108.561 164.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.82 -29.64 70.14 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -61.26 -55.27 33.84 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.984 1.266 . . . . 0.0 109.532 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.38 72.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.191 1.396 . . . . 0.0 111.434 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 mt -67.13 -38.57 85.79 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.414 -0.804 . . . . 0.0 111.935 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.9 m -71.2 -36.82 72.05 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.822 0.849 . . . . 0.0 110.836 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -73.96 -23.88 59.55 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.272 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.31 74.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.262 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.78 -25.59 63.23 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.61 1.564 . . . . 0.0 113.565 -159.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -88.56 1.31 55.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.944 1.298 . . . . 0.0 112.089 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.89 15.6 59.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.259 0.933 . . . . 0.0 112.449 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -160.43 177.52 10.49 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.7 -147.45 17.56 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -84.06 -24.04 30.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 117.928 -1.035 . . . . 0.0 113.593 -159.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -56.57 120.07 7.15 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 57.33 43.72 93.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.65 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -96.18 -5.37 40.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.671 1.736 . . . . 0.0 113.612 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m 47.11 170.29 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.072 2.149 . . . . 0.0 113.831 -159.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.74 146.5 30.77 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 159.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -106.48 -30.52 9.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.096 -170.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.5 124.13 18.37 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 mm -130.83 109.42 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -121.71 95.02 48.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.62 122.98 11.24 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.455 2.77 . . . . 0.0 112.576 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.79 65.65 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 124.66 1.124 . . . . 0.0 112.446 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -134.56 -76.29 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.59 170.03 21.7 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.023 0.929 . . . . 0.0 110.343 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 122.31 28.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.848 1.659 . . . . 0.0 107.61 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.444 HE22 ' CB ' ' A' ' 101' ' ' ALA . 30.6 tp60 -111.92 133.71 53.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 128.339 2.655 . . . . 0.0 110.384 -165.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.37 -173.31 13.98 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.484 1.992 . . . . 0.0 112.566 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.7 29.25 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 124.231 0.919 . . . . 0.0 115.369 161.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.08 68.48 3.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.247 1.523 . . . . 0.0 109.134 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.84 2.62 44.08 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 113.267 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -139.29 -60.66 0.56 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.595 1.089 . . . . 0.0 109.143 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -83.54 162.92 20.72 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 159.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -124.01 21.89 8.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.686 1.194 . . . . 0.0 108.978 -166.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -162.46 -0.9 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.418 1.087 . . . . 0.0 113.468 -158.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.8 14.21 19.91 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.202 1.365 . . . . 0.0 115.581 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.1 p -118.69 16.28 13.61 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.116 1.458 . . . . 0.0 112.866 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.26 -152.64 5.68 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.95 173.32 47.68 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -166.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -153.45 144.0 22.53 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.722 -0.869 . . . . 0.0 110.715 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.463 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 69.5 p -73.74 22.57 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 130.033 3.333 . . . . 0.0 113.835 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 pt 49.16 -22.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 1 C-N-CA 132.204 4.202 . . . . 0.0 116.127 -158.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.409 ' H ' ' C ' ' A' ' 77' ' ' SER . 49.1 m-85 -89.41 -19.89 24.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.484 1.914 . . . . 0.0 110.675 175.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.65 128.96 3.13 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 126.036 1.779 . . . . 0.0 109.336 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.331 48.3 tt0 50.1 -132.57 1.77 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -116.12 171.54 7.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.584 1.554 . . . . 0.0 109.408 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 77' ' ' SER . 0.7 OUTLIER -139.24 -177.48 4.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.597 1.559 . . . . 0.0 110.073 175.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -56.62 164.93 1.28 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.538 2.335 . . . . 0.0 113.207 -176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.92 75.44 10.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 164.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -45.99 -56.86 4.96 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -159.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.73 153.68 32.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 160.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.2 16.27 26.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.414 2.286 . . . . 0.0 111.207 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 mt -50.76 -53.17 14.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.882 1.273 . . . . 0.0 109.126 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.33 123.06 23.89 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -118.32 170.56 8.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.409 1.484 . . . . 0.0 109.377 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -81.5 54.12 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.504 1.921 . . . . 0.0 111.007 -167.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.4 p -69.67 -9.72 55.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -158.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.86 177.13 44.65 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.05 1.295 . . . . 0.0 111.802 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.25 155.31 46.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.645 1.563 . . . . 0.0 110.266 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.32 4.54 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.505 -1.72 . . . . 0.0 113.216 -171.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.06 162.32 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 120.795 2.298 . . . . 0.0 107.366 163.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.17 124.74 22.21 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 109.649 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 157.52 43.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.895 0.855 . . . . 0.0 110.941 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 91.4 mmm -64.07 156.01 29.56 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.108 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.444 ' CB ' HE22 ' A' ' 63' ' ' GLN . . . -112.42 136.51 51.81 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -146.2 172.24 13.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.35 1.46 . . . . 0.0 107.822 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.06 15.85 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.239 1.416 . . . . 0.0 111.656 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.63 -165.49 26.79 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -168.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -64.28 166.38 17.19 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 118.95 1.375 . . . . 0.0 110.048 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 37.67 43.91 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.287 3.035 . . . . 0.0 113.55 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -133.31 33.17 3.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.556 1.542 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -79.97 108.06 13.25 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.5 -100.62 2.09 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 89.9 p -145.77 33.88 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.315 0.646 . . . . 0.0 110.674 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -121.06 142.49 49.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -157.24 155.5 30.92 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -165.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -134.68 147.34 50.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.504 167.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.1 mt -83.85 117.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 29.1 m -63.69 129.01 38.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 p -117.79 26.3 9.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.19 0.995 . . . . 0.0 109.299 171.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.96 11.88 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 163.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -68.47 96.42 0.69 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 159.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.5 p -83.13 60.1 5.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.116 0.871 . . . . 0.0 109.835 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.64 -14.63 59.0 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.5 1.52 . . . . 0.0 113.086 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -76.45 -10.38 59.35 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.934 -1.104 . . . . 0.0 111.711 169.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.6 mt -104.69 -5.89 20.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.807 1.643 . . . . 0.0 110.99 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -63.99 132.12 49.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.48 17.74 74.81 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 122.113 -0.367 . . . . 0.0 113.089 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -128.04 -34.32 2.13 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.003 1.321 . . . . 0.0 110.854 176.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -140.35 162.63 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.224 0.92 . . . . 0.0 110.542 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.94 105.86 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.979 2.112 . . . . 0.0 107.434 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.53 131.95 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 166.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -138.33 -0.47 2.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.33 -177.7 27.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.344 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.93 148.17 36.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.261 1.424 . . . . 0.0 107.417 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.9 106.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 162.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -70.05 -50.36 41.98 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 159.19 42.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.53 0.732 . . . . 0.0 110.918 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.84 24.41 60.12 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.146 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -35.2 68.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.969 1.885 . . . . 0.0 110.343 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -64.99 -21.58 66.87 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.77 -34.0 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.156 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.88 -41.52 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.093 167.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.93 -29.1 70.53 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.185 -0.947 . . . . 0.0 112.302 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.46 -42.85 74.36 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.216 0.916 . . . . 0.0 109.566 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.8 mtm -56.28 -45.72 80.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.269 0.486 . . . . 0.0 110.867 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.58 -40.76 65.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 112.47 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -68.82 -20.58 64.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.052 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -91.32 3.99 53.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.013 0.925 . . . . 0.0 112.75 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.78 -148.37 14.82 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 121.058 1.754 . . . . 0.0 112.727 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.3 p -163.89 161.2 22.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.314 1.446 . . . . 0.0 107.235 158.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -59.54 -29.99 68.29 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.406 -1.434 . . . . 0.0 114.528 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -75.37 -7.71 54.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.36 -26.38 20.36 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 126.197 1.856 . . . . 0.0 113.726 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.06 123.93 20.76 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.393 1.077 . . . . 0.0 109.418 -171.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.3 p -75.81 143.88 41.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.862 1.665 . . . . 0.0 110.641 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.6 p -84.85 -13.65 50.34 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.106 -1.621 . . . . 0.0 111.938 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -146.84 157.46 43.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.164 1.785 . . . . 0.0 108.748 -168.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.438 ' HE2' HG23 ' A' ' 157' ' ' THR . 81.3 tttt -76.31 84.56 3.09 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.502 1.046 . . . . 0.0 108.296 174.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.6 mm -73.2 117.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.438 HG23 ' HE2' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -138.72 172.16 13.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.541 1.137 . . . . 0.0 110.585 -170.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.52 118.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 159.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.33 -49.62 26.42 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 167.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.3 152.67 40.28 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.092 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.8 p -164.08 165.5 22.26 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.83 0.852 . . . . 0.0 109.546 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.7 -170.21 43.33 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.464 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.8 tp60 -79.88 146.55 32.11 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.34 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 60.8 mt -138.31 42.91 2.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.437 1.495 . . . . 0.0 110.424 161.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.464 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 5.8 mt-10 . . . . . 0 C--O 1.248 0.987 0 O-C-N 120.971 -1.08 . . . . 0.0 111.212 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -62.94 136.76 58.7 Favored 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 121.395 1.396 . . . . 0.0 108.947 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.8 m -98.5 145.93 26.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.68 133.82 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -87.94 157.84 18.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.134 0.968 . . . . 0.0 109.135 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -132.49 149.59 52.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -129.55 93.32 3.52 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 mm -77.18 141.62 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.69 160.82 28.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.635 1.574 . . . . 0.0 108.568 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.02 113.27 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 58.68 14.39 3.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.836 1.254 . . . . 0.0 114.258 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.36 -3.85 40.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.676 2.084 . . . . 0.0 113.17 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.85 115.46 61.0 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -57.83 120.27 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.132 1.888 . . . . 0.0 109.788 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -82.91 -43.46 16.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.44 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.21 152.62 7.03 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -76.78 152.34 35.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -141.33 160.43 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 126.803 2.041 . . . . 0.0 105.93 -174.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -142.87 152.39 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 122.129 0.966 . . . . 0.0 109.622 172.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.88 147.82 49.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.864 1.266 . . . . 0.0 108.857 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.8 139.4 39.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.95 1.7 . . . . 0.0 106.49 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.63 131.6 53.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.944 1.298 . . . . 0.0 107.814 -177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.21 52.64 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.014 0.926 . . . . 0.0 113.316 -166.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -18.89 56.68 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.897 -1.752 . . . . 0.0 115.628 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.15 0.27 53.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.734 1.152 . . . . 0.0 111.801 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -128.52 -29.54 2.41 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.466 1.506 . . . . 0.0 112.628 173.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.79 72.74 76.96 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.515 1.526 . . . . 0.0 108.9 167.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -56.36 -42.72 62.91 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.153 1.902 . . . . 0.0 114.194 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -53.6 53.35 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.5 m -62.13 -48.83 78.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.3 1.44 . . . . 0.0 109.983 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.87 -46.49 74.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -37.47 81.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.471 0.578 . . . . 0.0 109.801 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -56.95 -53.05 62.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -66.01 -32.8 74.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -51.75 -63.9 0.99 Allowed 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 124.351 1.06 . . . . 0.0 109.137 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.979 0.912 . . . . 0.0 113.242 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -71.38 -33.01 69.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.404 1.002 . . . . 0.0 111.523 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -65.55 -51.41 60.01 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.429 1.468 . . . . 0.0 108.965 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -63.83 -33.64 76.14 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.498 0.719 . . . . 0.0 110.432 -171.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.34 90.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.08 -24.28 67.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.713 1.257 . . . . 0.0 112.102 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -68.06 1.62 2.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.588 1.555 . . . . 0.0 112.395 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.82 5.83 84.55 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.644 1.116 . . . . 0.0 112.006 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -153.01 173.97 14.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.657 2.383 . . . . 0.0 106.537 167.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.95 -162.93 29.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 121.713 0.618 . . . . 0.0 111.967 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.402 ' CE1' ' HA2' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -69.36 -15.33 63.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.326 2.65 . . . . 0.0 112.631 177.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -62.85 100.06 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.029 -1.045 . . . . 0.0 108.578 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.2 80.01 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.142 -1.921 . . . . 0.0 115.473 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.8 p -64.3 -48.71 74.59 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.206 2.503 . . . . 0.0 111.528 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.4 m 106.76 144.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 1 C-N-CA 133.175 4.59 . . . . 0.0 108.343 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.65 136.2 33.47 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 162.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -119.68 -10.18 9.63 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.6 119.42 15.21 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.23 110.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 170.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.7 mt -116.55 94.65 43.86 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -54.92 121.06 9.18 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.814 3.01 . . . . 0.0 112.999 -168.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.73 26.35 46.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.933 1.254 . . . . 0.0 111.416 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -143.07 -68.8 0.34 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.383 1.092 . . . . 0.0 108.564 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -161.08 161.61 31.31 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.83 117.18 24.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -122.34 132.58 54.46 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.271 1.828 . . . . 0.0 109.339 -166.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.52 32.21 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.402 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 142.03 49.86 0.04 OUTLIER Glycine 0 N--CA 1.466 0.674 0 CA-C-N 119.526 1.663 . . . . 0.0 112.593 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -143.0 113.79 7.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -160.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.43 ' CE1' ' HE3' ' A' ' 76' ' ' LYS . 53.7 p90 -130.25 12.27 5.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.702 1.601 . . . . 0.0 110.745 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -122.98 -67.91 0.92 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.906 1.283 . . . . 0.0 108.834 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -106.07 -20.14 13.51 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 60.45 -3.81 0.13 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 119.03 2.974 . . . . 0.0 119.03 166.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -112.15 0.97 16.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.474 1.51 . . . . 0.0 112.842 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.443 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 118.45 -22.74 9.34 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.056 1.788 . . . . 0.0 112.382 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.1 p -85.25 20.54 1.94 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.413 1.106 . . . . 0.0 112.319 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.63 166.16 32.73 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 113.778 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.53 126.84 3.64 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 128.588 2.994 . . . . 0.0 105.996 -159.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HE3' ' CE1' ' A' ' 67' ' ' PHE . 3.5 pttt -143.54 152.87 41.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.085 2.554 . . . . 0.0 105.97 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.0 p -72.38 168.62 18.04 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.972 0.795 . . . . 0.0 109.856 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 pt -64.84 -18.65 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 123.784 0.834 . . . . 0.0 112.222 166.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -96.5 -6.76 36.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.79 -171.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.77 -84.57 0.13 Allowed Glycine 0 C--N 1.34 0.769 0 CA-C-N 119.921 1.237 . . . . 0.0 111.071 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -132.44 -137.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.888 1.675 . . . . 0.0 107.784 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -75.89 154.22 36.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.692 0.797 . . . . 0.0 109.908 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -125.63 177.01 6.48 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.122 0.963 . . . . 0.0 109.005 168.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.0 170.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.956 1.302 . . . . 0.0 112.326 -172.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.6 106.32 2.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 159.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.67 -44.87 92.48 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.264 0.625 . . . . 0.0 111.004 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.16 153.75 1.65 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 125.529 1.768 . . . . 0.0 114.133 158.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.68 15.26 29.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.254 2.222 . . . . 0.0 111.126 -169.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.8 mt -37.57 -46.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 128.045 2.538 . . . . 0.0 110.636 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.2 mt -92.15 121.94 34.17 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.164 1.786 . . . . 0.0 106.87 -173.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 123' ' ' ASP . 25.3 mttt -97.16 169.3 9.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 110.45 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -82.27 80.91 8.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 108.055 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -79.74 -20.75 45.64 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.99 175.4 36.37 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.954 1.252 . . . . 0.0 112.768 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.97 134.66 40.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.069 1.846 . . . . 0.0 110.449 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.53 -11.4 28.16 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.311 1.91 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 120.299 2.05 . . . . 0.0 109.185 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.97 132.16 53.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 126.156 1.783 . . . . 0.0 108.556 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.7 t -142.04 153.45 44.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.634 . . . . 0.0 110.304 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 92.4 mmm -80.21 137.66 36.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.074 0.55 . . . . 0.0 110.324 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.74 124.3 30.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 169.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.65 150.63 51.57 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.632 1.173 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.62 14.05 12.57 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.696 1.598 . . . . 0.0 113.068 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.07 -165.24 28.94 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 -165.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -63.45 164.71 19.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 119.249 1.524 . . . . 0.0 109.748 167.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 33.62 48.71 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 131.159 3.784 . . . . 0.0 112.478 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.9 p -138.99 30.84 2.22 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.359 -1.463 . . . . 0.0 112.136 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -86.23 149.71 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.747 -1.221 . . . . 0.0 107.865 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.16 -66.18 0.01 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.7 t -146.5 -28.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.096 0.958 . . . . 0.0 111.092 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.443 HE22 ' HA2' ' A' ' 72' ' ' GLY . 19.8 mt-30 -61.54 128.33 35.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -134.52 174.74 10.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.304 1.042 . . . . 0.0 108.265 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 99' ' ' SER . 20.3 p90 -139.58 149.73 44.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.22 1.01 . . . . 0.0 110.847 164.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.1 mt -83.22 116.85 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 100.696 -3.816 . . . . 0.0 100.696 164.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.8 m -67.81 108.13 2.86 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.5 p -102.56 28.46 6.01 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.322 1.049 . . . . 0.0 108.988 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.71 175.75 11.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.723 1.609 . . . . 0.0 107.466 166.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -71.78 86.62 0.95 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 166.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 p -74.87 40.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.239 2.216 . . . . 0.0 112.384 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.24 -20.96 61.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.015 -1.678 . . . . 0.0 114.08 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -68.37 -15.53 63.59 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.414 0.686 . . . . 0.0 111.103 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.5 mt -95.7 -3.22 46.4 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.58 1.552 . . . . 0.0 111.353 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -64.03 157.53 24.97 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.237 -0.914 . . . . 0.0 110.028 169.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.45 -0.0 14.97 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.295 1.426 . . . . 0.0 113.785 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -129.32 -47.92 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.507 1.523 . . . . 0.0 109.015 -172.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.15 146.12 40.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.458 0.647 . . . . 0.0 111.028 -167.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 t -95.35 100.99 11.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.04 126.83 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -138.87 2.36 2.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.66 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.28 -173.06 34.32 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.086 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -149.84 160.84 43.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.405 1.082 . . . . 0.0 110.724 164.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.25 115.71 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 166.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -49.91 28.6 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.33 159.19 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.994 2.518 . . . . 0.0 108.496 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.56 20.94 13.53 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.422 1.011 . . . . 0.0 113.236 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 33.6 tpp -54.61 -39.51 67.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.518 1.659 . . . . 0.0 111.813 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.34 69.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.806 1.639 . . . . 0.0 112.058 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.58 -45.16 52.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 118.954 0.797 . . . . 0.0 109.158 176.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.85 -47.03 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 0.0 110.368 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.81 -24.7 65.32 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.029 -1.044 . . . . 0.0 111.901 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.79 -43.83 57.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.958 -1.089 . . . . 0.0 109.182 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 66.9 mtp -56.36 -43.06 78.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.247 -0.908 . . . . 0.0 110.138 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.84 -37.21 83.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -71.87 -21.3 61.68 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 120.269 1.395 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -93.11 5.47 51.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.735 1.614 . . . . 0.0 111.519 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.57 48.07 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 108.424 -1.871 . . . . 0.0 108.424 167.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.1 p -151.86 163.34 39.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -61.84 -27.87 69.09 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 107.69 -27.03 16.03 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.374 1.464 . . . . 0.0 113.725 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 130.71 43.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.974 1.887 . . . . 0.0 108.015 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.0 p -70.86 138.19 50.02 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.7 p -64.11 -30.55 71.61 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.61 -0.681 . . . . 0.0 110.29 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -125.59 170.56 11.36 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.329 1.452 . . . . 0.0 109.044 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -86.99 87.75 7.54 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.783 -1.198 . . . . 0.0 108.676 -177.333 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.5 mm -75.6 120.19 24.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -142.71 172.77 12.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.525 1.155 . . . . 0.0 111.163 -173.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.03 113.81 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.78 -56.87 16.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -157.49 165.59 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.703 1.201 . . . . 0.0 109.873 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 54.3 m -141.6 163.65 32.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 127.327 2.251 . . . . 0.0 105.622 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.62 172.65 42.53 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.33 156.02 29.8 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.944 -0.739 . . . . 0.0 109.271 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 33.2 mt -136.63 43.0 2.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.882 0.373 . . . . 0.0 110.838 159.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 116.932 -1.907 . . . . 0.0 107.028 158.529 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tmm? . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -112.95 170.51 4.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.239 1.016 . . . . 0.0 109.358 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -71.87 127.49 90.65 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.758 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.14 152.14 76.52 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.62 1.547 . . . . 0.0 109.875 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 m -111.18 156.47 21.37 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.58 163.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.208 1.003 . . . . 0.0 110.017 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -125.74 159.07 33.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 125.224 1.41 . . . . 0.0 109.657 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -146.12 118.24 8.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 107.011 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.03 96.85 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 mm -69.5 140.03 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.96 128.28 32.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.844 1.258 . . . . 0.0 109.827 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG11 ' HE2' ' A' ' 154' ' ' LYS . 22.6 t -95.95 109.48 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.43 13.76 0.99 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.634 1.574 . . . . 0.0 113.664 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.16 -11.78 26.62 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.72 1.629 . . . . 0.0 113.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.71 127.61 72.07 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 119.647 1.723 . . . . 0.0 107.201 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.83 119.13 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.724 1.616 . . . . 0.0 109.451 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -89.0 -32.8 17.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.484 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.09 162.87 10.39 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -68.62 147.85 51.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.21 154.3 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 126.966 2.107 . . . . 0.0 105.568 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.0 t -139.7 153.29 47.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.827 0.823 . . . . 0.0 109.182 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -142.17 155.48 45.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.324 1.05 . . . . 0.0 108.773 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 2.8 tp10 -107.32 146.69 31.23 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.479 1.511 . . . . 0.0 107.243 170.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.31 114.22 20.49 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -71.91 56.61 0.3 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.397 1.879 . . . . 0.0 113.198 -171.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.37 -28.85 13.67 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.628 1.571 . . . . 0.0 112.077 169.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -19.57 65.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.157 0.983 . . . . 0.0 112.04 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -125.45 -31.4 3.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 m -129.78 71.55 82.12 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.94 -43.06 26.94 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.611 2.207 . . . . 0.0 110.37 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -55.96 28.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -58.66 -46.88 86.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.56 0.744 . . . . 0.0 111.153 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.24 84.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.456 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.74 -43.74 83.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.716 1.206 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.82 -51.64 66.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 108.025 176.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -66.02 -44.89 83.41 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 124.162 0.914 . . . . 0.0 112.238 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -43.79 -59.1 2.38 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.656 1.582 . . . . 0.0 108.976 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.48 71.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.554 1.541 . . . . 0.0 113.308 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.39 -40.04 62.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.275 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -50.67 66.96 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 119.449 1.022 . . . . 0.0 111.066 173.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.1 p -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.397 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 5.95 89.04 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.168 0.89 . . . . 0.0 112.139 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -5.25 27.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.065 1.433 . . . . 0.0 113.954 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -96.96 12.96 30.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.711 1.205 . . . . 0.0 110.846 170.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.15 74.05 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 120.714 -1.241 . . . . 0.0 113.054 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.52 -165.31 1.52 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.871 2.068 . . . . 0.0 106.357 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.69 -138.18 13.47 Favored Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CZ ' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -81.55 -26.4 35.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.38 1.072 . . . . 0.0 113.486 -167.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -57.97 110.03 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.148 0.979 . . . . 0.0 108.966 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.71 90.18 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.952 1.263 . . . . 0.0 115.627 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -100.23 7.46 44.45 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.991 2.395 . . . . 0.0 114.078 -158.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 62.94 174.59 0.15 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 127.925 2.49 . . . . 0.0 116.183 159.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.56 121.03 38.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 112.136 -2.302 . . . . 0.0 106.566 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -108.47 -24.14 11.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.511 1.124 . . . . 0.0 111.03 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.8 105.36 8.19 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 mt -118.73 114.99 46.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.07 95.51 36.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -168.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -41.12 125.97 2.51 Favored 'Trans proline' 0 C--O 1.24 0.586 1 C-N-CA 125.418 4.078 . . . . 0.0 114.538 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.34 29.96 74.73 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.127 1.346 . . . . 0.0 111.777 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -135.84 -79.89 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.06 171.15 20.51 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.2 m -120.19 91.1 3.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.396 2.278 . . . . 0.0 109.379 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -79.93 139.14 37.19 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.486 1.915 . . . . 0.0 110.9 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.42 -171.41 17.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.813 1.673 . . . . 0.0 111.54 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.39 24.73 9.25 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.363 0.506 . . . . 0.0 112.595 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.75 76.07 9.98 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -98.61 -11.8 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -134.31 -10.35 2.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.72 1.208 . . . . 0.0 113.253 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.3 mmt-85 -138.61 -172.38 3.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.27 34.32 0.52 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.384 0.993 . . . . 0.0 112.481 -168.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -150.72 12.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.0 1.32 . . . . 0.0 111.838 -163.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.56 32.65 27.08 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 118.987 -0.896 . . . . 0.0 110.885 -175.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -135.76 1.57 2.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.572 1.186 . . . . 0.0 112.185 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.19 166.09 33.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 119.648 1.113 . . . . 0.0 110.725 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 147.03 14.0 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.569 1.094 . . . . 0.0 114.362 165.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.46 160.32 40.52 Favored 'General case' 0 C--O 1.238 0.474 1 C-N-CA 132.07 4.148 . . . . 0.0 104.4 -173.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.5 p -78.34 171.76 14.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.974 0.806 . . . . 0.0 110.831 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.5 -25.18 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.729 0.412 . . . . 0.0 111.406 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.01 -22.11 24.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.391 0.676 . . . . 0.0 111.143 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.94 172.43 28.24 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.191 0.884 . . . . 0.0 114.044 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.14 112.69 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.949 1.7 . . . . 0.0 108.225 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 48.38 161.41 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.66 1 C-N-CA 133.884 4.874 . . . . 0.0 115.099 -165.219 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -139.29 175.35 9.63 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.819 162.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -65.89 159.8 24.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.354 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 114.61 13.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 161.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.45 -56.62 16.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.893 1.277 . . . . 0.0 110.819 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -169.03 -177.82 3.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.429 1.492 . . . . 0.0 108.702 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -130.44 25.14 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.604 1.962 . . . . 0.0 109.128 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.84 -57.72 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.95 128.11 34.66 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.551 2.34 . . . . 0.0 105.476 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -119.93 165.36 14.74 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.919 1.288 . . . . 0.0 110.244 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -81.77 56.13 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.559 1.543 . . . . 0.0 110.343 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -66.06 -23.25 66.5 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.863 1.265 . . . . 0.0 113.614 -160.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.5 179.36 48.75 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.27 160.58 19.02 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.576 1.517 . . . . 0.0 110.318 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.5 4.23 64.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.637 -1.646 . . . . 0.0 112.46 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.1 mm -79.4 166.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 121.009 2.405 . . . . 0.0 108.09 166.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 132.08 27.8 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.067 1.347 . . . . 0.0 109.61 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 t -143.79 147.24 33.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.016 0.526 . . . . 0.0 111.172 -170.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 97.4 mmm -74.33 117.92 16.69 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.557 1.143 . . . . 0.0 109.984 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.66 139.11 56.77 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 162.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -144.06 -178.03 5.74 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.83 2.052 . . . . 0.0 108.215 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.09 16.86 24.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.462 1.105 . . . . 0.0 111.926 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.28 -160.91 21.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.325 1.441 . . . . 0.0 109.659 -167.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -60.94 150.21 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.978 1.785 . . . . 0.0 109.844 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 39.14 48.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.078 2.951 . . . . 0.0 114.13 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.5 p -138.82 21.25 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.909 1.284 . . . . 0.0 110.58 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.77 155.96 25.2 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.923 -1.11 . . . . 0.0 108.278 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.32 -66.53 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.468 1.031 . . . . 0.0 114.782 -166.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -156.22 -5.59 0.11 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.899 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -78.63 136.94 37.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CE2' ' CZ ' ' A' ' 48' ' ' TYR . 5.3 p90 -130.97 169.73 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 164.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -130.98 146.43 52.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.887 0.475 . . . . 0.0 109.807 160.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.3 mt -83.5 116.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 169.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 m -60.75 124.15 19.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -110.47 21.57 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.155 0.582 . . . . 0.0 109.683 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.28 179.03 8.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.64 91.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.3 p -83.76 50.73 1.87 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.096 0.862 . . . . 0.0 110.663 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -18.92 51.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.978 1.311 . . . . 0.0 112.797 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -67.02 -19.22 65.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.762 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.8 mt -95.54 -4.34 44.93 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.668 1.587 . . . . 0.0 112.325 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.15 129.27 39.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.607 1.094 . . . . 0.0 108.787 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.81 -1.98 83.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.747 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.6 -20.23 8.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.043 1.922 . . . . 0.0 112.912 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -139.42 153.05 47.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.361 0.982 . . . . 0.0 111.044 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.0 t -88.0 100.01 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.93 126.39 19.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -140.76 -0.7 1.5 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.14 -178.67 28.8 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 119.08 0.855 . . . . 0.0 111.667 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -149.63 153.89 37.76 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.418 1.487 . . . . 0.0 107.591 172.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.85 126.45 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 166.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.419 ' HZ3' ' CD ' ' A' ' 23' ' ' GLU . 23.9 ttmt -82.93 -52.17 6.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 164.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 162.34 40.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.227 -167.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.09 74.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.729 0.681 . . . . 0.0 113.45 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -38.91 75.27 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.329 1.564 . . . . 0.0 110.098 175.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -61.36 -25.11 66.94 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 172.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mm -77.72 -38.48 25.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.64 -39.84 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.777 0.717 . . . . 0.0 109.54 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -60.87 -34.78 75.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.944 -1.098 . . . . 0.0 111.808 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.39 63.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.384 0.993 . . . . 0.0 109.509 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 69.5 mtp -52.66 -42.26 64.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.236 1.015 . . . . 0.0 110.486 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -62.6 -34.47 77.08 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -30.05 70.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.616 1.098 . . . . 0.0 110.243 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -92.89 5.91 49.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.035 1.734 . . . . 0.0 111.86 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.75 -149.95 7.62 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 170.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 p -146.47 -61.51 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 141.75 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 1 C-N-CA 132.716 4.407 . . . . 0.0 109.726 -169.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 5.12 2.65 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 118.571 0.623 . . . . 0.0 111.454 164.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.54 -42.75 2.96 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 126.589 2.043 . . . . 0.0 111.556 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -60.24 123.89 18.59 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 61.3 p -72.98 164.04 27.28 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 124.343 1.027 . . . . 0.0 110.091 -167.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -88.5 -8.99 53.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.426 0.69 . . . . 0.0 111.239 163.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.444 ' HE2' HG11 ' A' ' 12' ' ' VAL . 15.3 tttt -152.81 149.24 28.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 109.934 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -75.06 123.0 24.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 -172.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 mt -112.62 126.49 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.54 175.84 9.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.151 -158.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.74 112.28 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.0 76.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -150.69 156.48 41.41 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.7 p -161.9 160.64 28.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.523 1.129 . . . . 0.0 109.722 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.93 -171.44 43.55 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -95.11 151.99 18.72 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.1 mt -125.66 42.5 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.601 1.191 . . . . 0.0 108.446 165.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.186 1.394 . . . . 0.0 111.822 176.313 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.03 172.39 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.487 0.661 . . . . 0.0 110.079 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -80.86 108.76 10.94 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 161.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.03 157.37 57.52 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.517 1.22 . . . . 0.0 109.242 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.6 m -110.11 155.69 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 170.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.19 158.72 41.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.563 1.545 . . . . 0.0 107.536 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -135.34 159.61 41.02 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 123.446 0.698 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.629 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 64.4 m-85 -153.29 114.23 4.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.972 1.709 . . . . 0.0 108.596 -173.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -74.4 102.78 4.53 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 163.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.0 mm -67.38 143.02 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.99 129.48 22.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.336 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.498 HG11 ' HE2' ' A' ' 154' ' ' LYS . 78.6 t -93.05 101.13 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 127.409 2.284 . . . . 0.0 104.937 173.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 60.37 13.6 4.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.448 1.022 . . . . 0.0 113.754 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 0.26 53.58 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.407 1.479 . . . . 0.0 113.947 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 110.3 34.25 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 167.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.34 136.23 42.73 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.516 1.478 . . . . 0.0 110.001 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -104.61 -21.19 13.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.9 1.68 . . . . 0.0 110.61 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.39 156.22 7.19 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.045 0.839 . . . . 0.0 112.478 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.18 130.23 42.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.56 150.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.4 m -137.1 147.07 45.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 87.0 m-85 -135.63 136.36 40.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -173.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.39 152.35 39.54 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 162.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.2 mt -126.88 122.22 34.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -69.61 52.71 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.862 2.065 . . . . 0.0 112.065 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.87 -21.99 58.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.081 -1.637 . . . . 0.0 112.222 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.06 4.17 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.047 0.939 . . . . 0.0 113.37 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -125.98 -35.52 2.46 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.329 1.452 . . . . 0.0 110.605 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m -142.12 68.35 22.39 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.148 1.779 . . . . 0.0 108.886 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.03 -37.88 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.063 1.842 . . . . 0.0 113.194 -176.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -55.07 39.12 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.078 1.763 . . . . 0.0 109.773 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.95 -40.79 90.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 122.838 0.455 . . . . 0.0 110.008 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.14 -33.08 67.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.31 -50.09 49.83 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.812 1.645 . . . . 0.0 109.55 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -45.72 -51.37 12.61 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.042 1.737 . . . . 0.0 109.661 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.35 90.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -56.56 -59.25 5.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.753 1.221 . . . . 0.0 107.87 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.72 -50.22 25.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.77 1.228 . . . . 0.0 112.491 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.92 -29.24 68.27 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.951 -1.093 . . . . 0.0 111.547 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -77.62 -43.53 31.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.965 1.257 . . . . 0.0 112.612 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.1 p -65.71 -32.29 73.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 7.02 89.02 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.435 1.017 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.45 -16.93 64.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.842 1.657 . . . . 0.0 114.101 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 25.7 mmmt -83.02 -1.9 53.86 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.014 -1.054 . . . . 0.0 110.581 174.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.58 8.4 65.82 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.634 1.112 . . . . 0.0 112.842 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -156.18 -172.61 4.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.065 1.432 . . . . 0.0 110.434 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.87 -139.45 10.96 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-O 122.321 0.956 . . . . 0.0 113.417 160.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.629 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 7.3 t80 -62.76 -34.6 77.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.524 1.93 . . . . 0.0 108.69 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.99 124.86 19.13 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.595 1.088 . . . . 0.0 108.888 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.86 -0.39 21.65 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.105 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.1 m -64.36 115.21 4.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 120.949 2.374 . . . . 0.0 105.542 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.3 p -75.86 156.37 34.44 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.699 -0.626 . . . . 0.0 109.61 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -91.72 95.58 9.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.55 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -74.69 -21.05 59.6 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -166.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 82.76 1.85 Allowed 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 121.151 -0.968 . . . . 0.0 109.367 -169.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 mt -102.66 101.9 12.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.18 92.34 45.3 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -167.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -48.64 130.89 23.21 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.34 79.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.185 1.85 . . . . 0.0 112.114 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -142.03 -62.96 0.44 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.547 1.174 . . . . 0.0 109.434 -170.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -168.75 164.25 11.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.902 0.774 . . . . 0.0 112.347 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.9 m -113.32 93.1 4.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 108.277 159.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -76.89 142.99 39.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.002 0.921 . . . . 0.0 109.852 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.97 -164.5 12.56 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 124.85 1.214 . . . . 0.0 110.584 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.31 43.0 6.38 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.395 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.02 136.28 49.22 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 119.754 1.777 . . . . 0.0 107.929 159.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -134.39 5.95 3.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 127.91 2.484 . . . . 0.0 109.487 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -114.06 -53.49 2.67 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.391 1.477 . . . . 0.0 107.787 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -117.11 -165.9 1.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 158.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -174.22 46.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -166.85 20.82 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.158 2.183 . . . . 0.0 110.253 -170.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.58 -32.55 4.72 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.458 -1.19 . . . . 0.0 113.52 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.5 p -83.84 6.67 20.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.517 2.158 . . . . 0.0 114.673 -161.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -115.8 -124.47 3.73 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.86 100.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 127.187 2.327 . . . . 0.0 113.547 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -129.34 146.43 51.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.468 1.907 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.0 p -80.84 -178.4 6.81 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.993 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.419 ' HB ' ' HE2' ' A' ' 44' ' ' LYS . 36.6 pt -76.73 -6.84 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.472 168.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -90.78 -3.16 57.63 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.16 0.891 . . . . 0.0 112.057 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.76 91.17 1.92 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.267 10.7 tp10 62.17 -133.63 0.54 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.381 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -103.37 131.31 50.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.685 1.13 . . . . 0.0 110.871 -160.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -98.08 169.8 9.36 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.852 0.835 . . . . 0.0 110.107 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -66.7 170.57 6.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.51 1.524 . . . . 0.0 111.226 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -85.95 113.93 22.45 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -43.56 -55.65 4.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.96 1.304 . . . . 0.0 110.989 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -172.52 177.57 2.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.793 2.437 . . . . 0.0 106.479 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -125.49 32.09 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.661 1.184 . . . . 0.0 109.293 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.71 -55.78 20.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.2 mt -84.4 130.02 34.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.155 1.382 . . . . 0.0 107.566 -170.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -120.8 165.27 15.38 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 126.947 2.099 . . . . 0.0 109.449 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -85.7 65.76 9.31 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.557 0.743 . . . . 0.0 110.598 -164.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 p -70.97 -19.2 62.58 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -162.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.01 178.8 48.92 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 119.361 0.982 . . . . 0.0 111.918 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -62.1 158.69 37.95 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.545 2.163 . . . . 0.0 110.304 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.6 -6.84 36.26 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 116.974 -2.014 . . . . 0.0 112.934 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.69 156.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-N 121.46 2.63 . . . . 0.0 108.11 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.426 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -134.05 131.14 38.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.172 0.989 . . . . 0.0 110.852 176.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.82 150.23 33.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.29 1.036 . . . . 0.0 110.955 -164.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.62 138.14 54.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.0 50.92 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -59.99 163.35 4.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.065 1.412 . . . . 0.0 109.681 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.48 14.24 13.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.6 -165.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.81 -167.22 27.73 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.713 2.102 . . . . 0.0 107.98 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.44 143.66 58.52 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.284 1.989 . . . . 0.0 110.232 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 m120 50.11 47.78 23.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.551 2.34 . . . . 0.0 112.7 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 p -120.37 23.0 11.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.871 1.268 . . . . 0.0 111.638 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -69.42 135.85 50.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.322 1.049 . . . . 0.0 108.885 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.0 -78.45 0.02 OUTLIER Glycine 0 C--N 1.337 0.588 0 CA-C-N 118.436 0.562 . . . . 0.0 112.867 -168.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -142.21 -47.13 0.35 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.543 0.737 . . . . 0.0 109.963 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -62.46 137.7 58.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 124.082 0.863 . . . . 0.0 108.676 -170.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.429 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 45.4 p90 -141.81 172.75 12.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.871 1.668 . . . . 0.0 107.316 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -141.86 151.1 42.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.423 0.63 . . . . 0.0 109.697 158.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.34 120.8 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.76 127.4 31.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.9 p -107.66 19.84 19.62 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.724 0.809 . . . . 0.0 110.023 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.8 -177.89 5.4 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 164.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -60.99 128.02 34.43 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 158.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.424 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 71.9 p -117.67 72.77 0.86 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.61 1.55 . . . . 0.0 110.074 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.42 -12.6 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.415 -0.803 . . . . 0.0 113.139 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.424 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 27.5 p90 -71.81 -13.86 61.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.377 0.671 . . . . 0.0 111.288 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.95 -8.12 14.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.751 1.221 . . . . 0.0 111.894 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 153.08 43.23 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.55 7.92 43.26 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.211 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -135.53 -40.31 0.72 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.169 1.485 . . . . 0.0 111.388 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -114.56 147.85 38.85 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.941 0.496 . . . . 0.0 111.487 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.13 105.79 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.041 1.736 . . . . 0.0 107.305 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.01 137.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 161.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.3 -3.83 0.72 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.294 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.49 176.83 27.11 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 119.691 1.132 . . . . 0.0 112.053 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.61 149.16 31.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.575 1.15 . . . . 0.0 108.153 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 62.5 t -58.88 126.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 164.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -93.64 -42.3 9.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.967 0.507 . . . . 0.0 109.769 165.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.05 156.7 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.711 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.17 21.26 61.13 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.481 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -52.31 -42.62 63.95 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.498 1.649 . . . . 0.0 111.311 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.77 -13.09 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.035 0.834 . . . . 0.0 112.925 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.6 mm -84.58 -36.46 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.427 1.091 . . . . 0.0 108.484 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.39 -40.78 90.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 121.442 -0.786 . . . . 0.0 108.945 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -62.67 -33.68 75.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.36 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.61 76.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 109.331 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.8 mtm -55.72 -46.07 77.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.45 0.568 . . . . 0.0 110.135 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.35 -36.13 73.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.167 0.587 . . . . 0.0 111.844 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -25.48 68.14 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.496 0.589 . . . . 0.0 111.546 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -97.88 -0.43 45.03 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.076 1.75 . . . . 0.0 112.15 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.18 -173.5 47.46 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 167.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 p -162.37 159.66 25.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -63.17 -16.46 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -4.33 2.89 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 167.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.86 -25.27 2.19 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 127.339 2.399 . . . . 0.0 114.328 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.86 127.43 33.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 154' ' ' LYS . 16.5 p -66.41 168.44 8.94 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.637 1.175 . . . . 0.0 110.773 168.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.9 p -81.6 -16.54 51.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.806 159.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.498 ' HE2' HG11 ' A' ' 12' ' ' VAL . 41.4 mtpt -143.63 160.6 40.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.01 0.924 . . . . 0.0 111.414 -167.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.457 ' HE2' ' CG2' ' A' ' 157' ' ' THR . 14.8 tttt -84.87 78.41 9.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.36 1.436 . . . . 0.0 109.697 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.7 133.27 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.483 0.658 . . . . 0.0 109.404 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.457 ' CG2' ' HE2' ' A' ' 155' ' ' LYS . 74.7 p -148.98 177.03 9.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.905 2.082 . . . . 0.0 110.105 -173.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 48' ' ' TYR . 3.1 mp -92.61 124.35 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 158.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.72 -55.3 10.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.68 161.96 39.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.079 0.552 . . . . 0.0 111.025 -169.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.8 171.28 7.39 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.3 -167.86 40.69 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.606 1.574 . . . . 0.0 109.83 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -95.91 148.5 22.56 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.544 1.137 . . . . 0.0 109.619 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.9 mt -126.87 43.07 3.19 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.534 1.934 . . . . 0.0 110.476 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 C--O 1.255 1.348 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 161.224 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HE3' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 117.297 -1.335 . . . . 0.0 109.559 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.281 17.1 m 48.15 -172.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.741 1.155 . . . . 0.0 110.759 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.82 116.14 10.46 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 158.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.5 161.39 44.29 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 CA-C-N 120.661 1.272 . . . . 0.0 108.97 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.4 m -102.16 157.18 17.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.96 157.32 33.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.314 1.845 . . . . 0.0 107.648 164.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.66 151.2 30.44 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.543 0.737 . . . . 0.0 109.9 165.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 23.4 m-30 -133.85 104.51 6.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.118 2.167 . . . . 0.0 106.179 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.82 107.16 8.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mm -75.29 142.85 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 109.535 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.78 159.79 27.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.019 0.914 . . . . 0.0 109.554 161.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.0 96.37 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 56.07 14.03 1.34 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.629 1.572 . . . . 0.0 112.889 -169.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.65 -13.55 29.94 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.57 1.557 . . . . 0.0 113.18 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.41 127.59 85.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 120.389 2.094 . . . . 0.0 106.627 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.6 108.53 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.675 2.25 . . . . 0.0 109.755 -170.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.6 tp -84.56 -28.04 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.519 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.54 162.27 10.12 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 118.806 0.73 . . . . 0.0 114.458 167.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -77.7 113.96 16.08 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.65 0.78 . . . . 0.0 109.803 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.15 159.36 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 106.215 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.8 m -150.11 152.93 35.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.129 -1.607 . . . . 0.0 110.41 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.25 133.57 29.82 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.006 0.922 . . . . 0.0 109.235 -166.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.71 139.84 35.92 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.08 121.89 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -82.6 62.53 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.961 0.904 . . . . 0.0 112.38 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.05 40.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.941 0.896 . . . . 0.0 112.806 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -9.42 59.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.419 1.088 . . . . 0.0 111.589 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -117.81 -54.23 2.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.422 1.489 . . . . 0.0 108.84 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 m -126.95 72.23 75.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 125.194 1.398 . . . . 0.0 107.711 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.67 -39.39 88.22 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.252 1.968 . . . . 0.0 112.319 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CA ' ' HE3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.99 -53.47 56.89 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.445 1.475 . . . . 0.0 109.195 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 m -64.39 -41.01 96.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.899 0.879 . . . . 0.0 110.365 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.46 -50.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.556 0.742 . . . . 0.0 112.2 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.69 -40.55 95.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 110.093 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -51.58 -60.46 3.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.086 1.354 . . . . 0.0 109.427 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -60.77 -31.05 70.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.513 HH11 ' NE2' ' A' ' 163' ' ' GLN . 38.1 ttp85 -55.69 -64.53 0.82 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.358 1.863 . . . . 0.0 110.181 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.7 74.9 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.833 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.29 -34.58 77.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.541 -0.724 . . . . 0.0 111.028 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -69.5 -27.16 64.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.66 0.784 . . . . 0.0 111.625 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.3 p -90.21 -23.71 21.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.267 0.94 . . . . 0.0 111.283 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.41 -1.97 74.1 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.144 1.354 . . . . 0.0 112.707 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.39 -20.38 64.68 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.419 1.888 . . . . 0.0 113.427 -164.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -81.65 11.95 4.29 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.555 -0.716 . . . . 0.0 111.678 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.42 78.09 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 124.175 0.893 . . . . 0.0 112.274 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.09 167.98 26.57 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 125.493 1.517 . . . . 0.0 107.339 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 175.01 34.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 117.796 -2.145 . . . . 0.0 113.328 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 40.8 t80 -61.6 -32.42 72.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 127.794 2.437 . . . . 0.0 111.558 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -45.47 122.35 3.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.71 1.204 . . . . 0.0 109.875 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.35 26.23 61.47 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 116.33 -2.372 . . . . 0.0 115.689 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -66.66 -54.32 24.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 122.128 2.964 . . . . 0.0 107.44 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 32.8 t 113.9 161.91 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 1 C-N-CA 132.393 4.277 . . . . 0.0 106.951 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.97 101.64 12.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -77.45 -15.74 59.16 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.95 111.11 6.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.2 mt -129.96 105.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.9 mt -116.05 97.96 50.35 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -50.15 126.61 17.63 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 123.552 2.834 . . . . 0.0 112.726 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.85 71.55 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 126.707 2.098 . . . . 0.0 112.033 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.64 -80.36 0.27 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.473 1.136 . . . . 0.0 108.059 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.78 166.65 26.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.278 0.631 . . . . 0.0 111.673 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.8 m -124.06 100.78 6.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.309 2.644 . . . . 0.0 109.284 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -84.36 135.01 34.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.066 1.746 . . . . 0.0 111.101 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.27 -174.15 21.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 126.489 1.995 . . . . 0.0 109.139 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.32 6.18 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 117.405 0.603 . . . . 0.0 113.628 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -110.72 23.76 13.8 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -159.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.593 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 43.2 p90 -58.52 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.182 1 C-N-CA 131.827 4.051 . . . . 0.0 116.101 -176.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.3 t -148.39 -12.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.237 2.215 . . . . 0.0 112.179 161.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -146.19 -173.93 4.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.291 2.236 . . . . 0.0 106.199 -168.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -169.94 45.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -155.45 -7.33 0.12 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.67 5.29 51.47 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 117.686 -1.619 . . . . 0.0 114.413 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -91.52 -96.01 0.13 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.453 2.126 . . . . 0.0 107.272 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 41.52 -158.88 0.04 OUTLIER Glycine 0 CA--C 1.531 1.038 0 C-N-CA 127.157 2.313 . . . . 0.0 114.672 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.86 117.66 1.3 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-O 121.562 0.535 . . . . 0.0 111.97 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.593 ' HE3' ' CE2' ' A' ' 67' ' ' PHE . 4.0 ptpt -145.56 -170.52 3.47 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.685 2.394 . . . . 0.0 107.187 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.3 p -140.81 177.14 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.475 1.034 . . . . 0.0 110.673 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt -74.64 -0.64 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 111.624 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -108.39 -1.18 20.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.053 1.341 . . . . 0.0 111.363 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.56 -113.8 1.77 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.58 -139.32 0.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.426 0.613 . . . . 0.0 109.469 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -70.05 166.25 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.318 1.047 . . . . 0.0 108.808 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -134.1 -179.65 5.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.761 2.024 . . . . 0.0 106.874 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.45 159.95 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.284 1.04 . . . . 0.0 112.572 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 89.84 1.96 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.238 1.415 . . . . 0.0 107.882 172.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.21 -52.73 64.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.767 1.227 . . . . 0.0 112.867 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -150.19 174.38 12.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 162.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.64 32.05 5.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.964 2.105 . . . . 0.0 110.045 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.81 -48.31 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.25 1.024 . . . . 0.0 108.456 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.64 133.82 35.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.809 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -132.25 171.26 13.92 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.114 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -84.78 87.19 7.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -164.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.2 p -77.7 -17.98 57.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.827 -171.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.9 -178.2 46.73 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.858 1.208 . . . . 0.0 112.671 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.27 142.0 97.14 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.969 1.78 . . . . 0.0 108.917 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.77 -3.44 56.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 117.644 -1.642 . . . . 0.0 112.587 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.51 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 121.103 2.452 . . . . 0.0 109.072 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.72 130.34 54.95 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.142 1.377 . . . . 0.0 109.354 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 p -144.22 158.02 43.96 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.563 1.145 . . . . 0.0 112.686 176.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 95.4 mmm -75.37 131.01 39.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.811 1.245 . . . . 0.0 111.851 -168.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.23 81.62 8.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.504 1.522 . . . . 0.0 107.523 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -70.48 -179.71 2.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.43 1.092 . . . . 0.0 110.428 165.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.0 36.49 1.03 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.326 2.25 . . . . 0.0 109.244 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.89 -164.1 27.55 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 106.879 -2.488 . . . . 0.0 106.879 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.46 171.35 9.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 119.236 1.518 . . . . 0.0 108.566 159.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m120 41.11 38.23 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.818 2.447 . . . . 0.0 114.12 159.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -125.25 25.9 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.342 2.257 . . . . 0.0 109.108 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -74.96 105.49 6.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 129.961 3.305 . . . . 0.0 103.553 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.67 -93.26 1.24 Allowed Glycine 0 C--O 1.225 -0.456 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.5 p -139.33 -14.4 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.79 0.836 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -70.85 133.55 46.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.31 -179.42 7.53 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 108.151 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -144.06 152.66 41.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.116 0.484 . . . . 0.0 111.282 162.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.7 mt -83.68 113.37 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 165.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.8 m -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.816 1.246 . . . . 0.0 107.832 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.3 p -116.7 27.26 9.28 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.136 0.974 . . . . 0.0 108.695 172.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.53 178.59 10.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 162.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 120' ' ' GLU . 42.3 tttt -72.64 87.46 1.24 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 165.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.7 p -81.03 42.22 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.059 0.544 . . . . 0.0 112.3 -171.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 118' ' ' LYS . 15.0 pt-20 -70.63 -4.1 21.65 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 119.746 -1.846 . . . . 0.0 114.047 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -61.05 -19.7 61.7 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.018 -1.051 . . . . 0.0 110.734 161.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.2 mt -100.89 1.34 39.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.582 1.953 . . . . 0.0 111.78 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.57 138.88 58.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.231 1.012 . . . . 0.0 109.784 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.92 10.62 61.83 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 122.702 0.192 . . . . 0.0 112.908 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -129.26 -37.02 1.68 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.66 1.584 . . . . 0.0 109.567 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -114.09 121.1 42.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.932 0.893 . . . . 0.0 109.002 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.09 106.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.66 1.584 . . . . 0.0 107.467 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.37 131.68 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 166.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -138.54 -5.68 1.56 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.35 -179.46 31.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.72 -1.229 . . . . 0.0 111.664 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -156.8 148.81 22.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.55 122.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -87.09 -48.52 8.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -148.83 154.7 39.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.367 1.467 . . . . 0.0 111.362 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.55 24.88 27.14 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 123.886 0.755 . . . . 0.0 113.123 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.0 tpt -53.74 -39.9 65.7 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.899 1.349 . . . . 0.0 109.442 168.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -62.4 -27.67 69.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.2 mm -78.0 -39.42 25.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.13 -41.95 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.941 0.791 . . . . 0.0 109.288 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.7 -24.49 67.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.615 1.166 . . . . 0.0 112.644 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.22 -45.43 23.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.043 -1.035 . . . . 0.0 110.143 169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 52.0 mtp -54.74 -44.69 73.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.402 0.681 . . . . 0.0 110.931 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.61 -38.0 74.22 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.915 1.286 . . . . 0.0 112.035 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -69.71 -18.68 63.55 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.991 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -94.7 -2.55 50.98 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.204 1.002 . . . . 0.0 111.721 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.58 -166.96 41.07 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -156.01 163.46 39.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 163.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.16 -17.85 64.45 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -9.86 38.81 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 167.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 88.26 -23.21 15.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 127.044 2.259 . . . . 0.0 113.004 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.68 130.3 40.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.899 1.349 . . . . 0.0 107.693 175.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -70.68 165.36 23.1 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.44 1.496 . . . . 0.0 111.304 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.0 p -97.21 -14.39 21.45 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.6 1.16 . . . . 0.0 111.477 163.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -137.77 154.24 49.61 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.575 1.15 . . . . 0.0 110.739 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -81.02 85.98 6.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.107 1.363 . . . . 0.0 107.78 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.59 119.87 34.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -132.74 174.25 10.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.0 1.32 . . . . 0.0 109.669 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.18 96.97 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.64 -50.21 72.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.613 1.965 . . . . 0.0 109.195 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.2 164.66 33.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 108.041 175.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.7 p -165.93 164.81 18.43 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.031 0.532 . . . . 0.0 110.821 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.48 -174.15 45.99 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.513 ' NE2' HH11 ' A' ' 37' ' ' ARG . 6.9 tp60 -81.22 146.31 30.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.74 1.616 . . . . 0.0 110.172 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.43 43.31 2.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 111.091 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 3.6 pt-20 . . . . . 0 C--O 1.248 0.993 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.32 -176.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.211 1.004 . . . . 0.0 110.547 168.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -56.36 117.3 15.87 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.17 163.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.99 152.87 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 N-CA-C 108.815 -1.264 . . . . 0.0 108.815 159.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.1 m -99.47 152.93 19.44 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.19 150.79 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.473 1.509 . . . . 0.0 107.685 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -121.81 158.71 28.29 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.643 1.177 . . . . 0.0 109.722 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -149.34 109.46 4.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.651 1.58 . . . . 0.0 108.284 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.67 100.95 9.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.3 mm -73.75 139.78 18.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.7 127.26 36.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.332 1.053 . . . . 0.0 109.837 169.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.67 111.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.68 13.37 0.49 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.012 2.125 . . . . 0.0 114.88 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.05 -12.15 14.59 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.331 1.443 . . . . 0.0 113.28 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.21 130.11 55.63 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 119.774 1.787 . . . . 0.0 106.826 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.36 115.36 3.64 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.346 1.364 . . . . 0.0 108.818 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.1 tp -86.83 -32.13 20.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.438 -0.315 . . . . 0.0 110.493 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.55 171.15 13.63 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 123.748 0.689 . . . . 0.0 111.476 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -85.75 141.16 29.9 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 109.683 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.5 160.41 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 127.938 2.495 . . . . 0.0 106.166 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -148.73 148.9 30.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 120.923 -1.111 . . . . 0.0 109.864 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.55 160.77 33.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.311 1.044 . . . . 0.0 108.458 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -124.45 135.37 53.19 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.844 2.457 . . . . 0.0 105.593 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.32 110.51 12.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.104 0.962 . . . . 0.0 109.767 -163.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -74.63 64.2 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.236 1.814 . . . . 0.0 113.681 -167.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.5 -25.62 64.61 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.204 1.002 . . . . 0.0 112.636 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.75 -0.67 44.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.238 1.415 . . . . 0.0 112.795 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -118.1 -37.42 3.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.87 1.268 . . . . 0.0 110.703 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.6 m -138.87 79.92 26.28 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.619 2.368 . . . . 0.0 108.551 -175.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.95 -46.1 17.43 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.754 1.636 . . . . 0.0 112.864 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -70.5 -41.75 72.23 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -168.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.7 m -66.48 -43.39 85.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 111.434 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.69 -44.24 74.39 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 120.902 -1.124 . . . . 0.0 111.506 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -70.87 -31.77 68.55 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.366 0.666 . . . . 0.0 111.139 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -52.19 -59.18 4.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.022 0.929 . . . . 0.0 110.138 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -66.08 -35.53 80.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' CZ ' HE22 ' A' ' 163' ' ' GLN . 0.2 OUTLIER -50.94 -59.77 3.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.649 1.58 . . . . 0.0 109.293 170.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.54 -41.94 91.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.214 1.005 . . . . 0.0 113.009 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.64 -43.06 63.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.704 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 p -62.35 -35.83 80.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.889 1.222 . . . . 0.0 111.3 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 p -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.567 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.85 10.35 86.14 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 118.991 0.814 . . . . 0.0 111.595 -166.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -24.2 66.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.964 1.382 . . . . 0.0 112.009 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.51 0.84 24.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.663 1.585 . . . . 0.0 114.098 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.63 11.46 82.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.071 0.851 . . . . 0.0 111.283 -171.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -152.4 169.92 21.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.43 1.892 . . . . 0.0 105.958 159.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 153.88 -175.86 32.02 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 122.096 0.831 . . . . 0.0 111.959 -171.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.59 -17.45 38.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.428 1.491 . . . . 0.0 113.384 -158.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -53.15 126.6 21.39 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.211 1.004 . . . . 0.0 109.337 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.91 79.4 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.846 -1.53 . . . . 0.0 114.218 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 m -85.18 154.42 22.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 120.07 1.935 . . . . 0.0 107.298 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.0 t -81.28 170.28 16.25 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 164.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.82 112.73 25.15 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -79.8 -18.43 50.96 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.57 111.66 9.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.836 1.198 . . . . 0.0 108.3 -170.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.3 mt -136.4 117.9 19.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.6 mt -127.1 89.27 52.32 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -167.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -48.3 121.76 6.65 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.521 2.814 . . . . 0.0 114.985 -167.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.5 67.59 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.222 1.391 . . . . 0.0 112.103 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -137.37 -78.72 0.39 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.72 1.26 . . . . 0.0 108.551 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.97 163.33 29.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.545 0.688 . . . . 0.0 111.736 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 95.02 3.97 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.126 1.771 . . . . 0.0 107.832 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -76.86 141.74 40.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.432 1.11 . . . . 0.0 110.185 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.4 -156.59 8.54 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.41 -13.24 67.03 Favored Glycine 0 C--O 1.229 -0.187 0 O-C-N 121.542 -0.975 . . . . 0.0 112.42 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -84.04 88.49 7.17 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.76 -0.847 . . . . 0.0 109.749 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -74.32 3.42 7.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.876 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.4 p -125.65 -58.39 1.41 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 120.102 1.319 . . . . 0.0 113.843 -159.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -103.94 -158.37 0.66 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.34 41.04 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.5 0.666 . . . . 0.0 109.426 159.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -122.94 -51.59 1.9 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.952 0.901 . . . . 0.0 111.645 -163.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.28 -9.44 0.17 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.812 -1.549 . . . . 0.0 114.256 -169.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.7 p -104.24 -19.99 13.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.498 2.149 . . . . 0.0 112.295 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.25 -170.93 2.29 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 124.711 1.148 . . . . 0.0 115.758 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.57 -172.2 41.13 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 123.75 1.75 . . . . 0.0 115.753 -168.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.31 156.53 38.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.311 3.044 . . . . 0.0 107.254 -171.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.8 p -78.1 166.26 23.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.97 0.89 . . . . 0.0 109.541 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 pt -59.66 -29.91 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.518 167.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -77.93 -10.11 59.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 111.638 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 143.21 12.47 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.5 1.524 . . . . 0.0 109.889 -171.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 34.48 -133.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.658 2.383 . . . . 0.0 113.029 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -120.47 143.38 48.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -173.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.72 -176.62 3.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.865 0.866 . . . . 0.0 109.644 -167.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -63.06 137.94 58.41 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.119 0.961 . . . . 0.0 109.792 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.02 86.57 6.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.08 -65.55 0.39 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.749 2.02 . . . . 0.0 113.437 -159.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -158.2 178.78 9.81 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.009 0.924 . . . . 0.0 109.892 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -129.48 36.07 4.16 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.698 1.999 . . . . 0.0 109.401 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.56 -55.98 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -84.07 132.24 34.73 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -122.69 168.91 11.61 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.57 1.548 . . . . 0.0 109.91 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.445 ' HD1' ' N ' ' A' ' 123' ' ' ASP . 36.5 m80 -74.33 81.64 1.87 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.0 p -80.27 -11.27 59.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.603 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.61 -173.96 43.88 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.601 1.091 . . . . 0.0 112.593 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 165.27 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.809 2.339 . . . . 0.0 110.822 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.58 -17.94 6.19 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 117.315 -1.825 . . . . 0.0 112.261 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.28 151.62 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 121.355 2.577 . . . . 0.0 108.29 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.03 128.01 53.96 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 120.934 -1.104 . . . . 0.0 109.639 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 t -140.34 145.97 37.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.436 1.095 . . . . 0.0 110.496 -172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 89.9 mmm -78.38 121.95 25.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.486 0.714 . . . . 0.0 109.965 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.62 87.51 1.23 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 164.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -76.59 -169.88 1.37 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.168 0.987 . . . . 0.0 108.584 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.41 24.5 4.8 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 110.607 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.45 -159.87 21.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -164.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -64.45 162.56 30.25 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 CA-C-N 119.558 1.679 . . . . 0.0 109.805 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 34.16 53.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 128.967 2.907 . . . . 0.0 113.382 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.1 p -140.63 23.29 2.3 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.072 1.349 . . . . 0.0 111.382 -175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -88.25 142.99 27.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 170.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.5 -58.31 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -162.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.06 -39.87 0.2 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.76 0.824 . . . . 0.0 110.904 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -62.54 135.77 57.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.141 1.376 . . . . 0.0 109.567 -173.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -147.09 174.5 11.51 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.331 1.452 . . . . 0.0 108.559 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -136.53 153.85 50.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.918 0.866 . . . . 0.0 111.488 159.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.31 117.41 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 162.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.31 124.43 23.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -112.96 23.63 13.2 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.069 0.548 . . . . 0.0 109.748 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.5 177.75 10.23 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -70.53 87.55 0.66 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -74.1 43.4 0.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.382 2.273 . . . . 0.0 110.903 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -66.39 -18.16 65.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 119.699 -1.876 . . . . 0.0 113.128 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.427 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 45.7 p90 -67.28 -13.74 62.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.129 0.972 . . . . 0.0 111.217 170.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.427 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -108.95 -6.89 15.53 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.262 1.825 . . . . 0.0 111.8 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.445 ' N ' ' HD1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -70.16 135.62 49.3 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.01 -4.66 82.38 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.477 -1.179 . . . . 0.0 113.084 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -94.51 -40.29 9.95 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.189 1.994 . . . . 0.0 110.435 166.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -131.64 158.12 41.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.155 0.582 . . . . 0.0 111.76 -161.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.67 101.11 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -169.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.81 132.81 32.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -139.21 -2.09 1.67 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.05 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.75 -171.02 30.48 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.181 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -155.34 166.37 33.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.323 1.049 . . . . 0.0 109.806 163.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.77 126.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 164.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.4 -55.87 3.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.75 162.48 37.53 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.808 0.692 . . . . 0.0 111.921 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.24 28.05 60.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.731 1.158 . . . . 0.0 112.685 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 10.6 tpt -56.55 -38.38 71.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.237 1.519 . . . . 0.0 111.414 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -64.54 -28.5 69.69 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.169 -0.957 . . . . 0.0 112.329 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.1 mm -70.84 -44.99 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.49 -38.46 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.98 -29.61 66.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.946 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.95 -44.15 50.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.711 1.204 . . . . 0.0 109.787 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.9 mtp -50.85 -42.35 58.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.675 0.79 . . . . 0.0 110.005 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.57 -34.36 76.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.389 1.075 . . . . 0.0 112.905 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -67.49 -27.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 119.418 1.008 . . . . 0.0 110.275 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -89.44 8.16 32.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 111.862 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.4 -151.91 4.04 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.653 1.12 . . . . 0.0 110.318 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -137.8 -70.36 0.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.85 -0.794 . . . . 0.0 110.069 166.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 143.44 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 1 C-N-CA 133.379 4.671 . . . . 0.0 110.934 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.84 -25.36 66.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.063 159.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 118.08 -40.76 2.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 124.86 1.219 . . . . 0.0 110.644 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.36 124.11 20.91 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.8 p -64.11 152.18 41.18 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.282 1.033 . . . . 0.0 110.621 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.4 p -72.62 -28.62 62.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.991 163.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -135.96 140.09 43.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -73.16 103.01 3.75 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 119.907 -1.745 . . . . 0.0 109.849 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.42 136.31 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.32 166.13 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.651 1.581 . . . . 0.0 108.703 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 mt -106.48 105.87 19.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.84 -51.09 66.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -149.81 155.63 40.43 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.5 p -156.5 161.96 39.98 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.881 0.873 . . . . 0.0 109.712 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.45 -172.98 44.93 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.551 HE21 ' HB3' ' A' ' 165' ' ' GLU . 1.6 mt-30 -96.8 147.99 23.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.877 0.871 . . . . 0.0 109.744 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.09 43.16 3.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.639 0.776 . . . . 0.0 109.003 165.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.551 ' HB3' HE21 ' A' ' 163' ' ' GLN . 13.1 pt-20 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 117.232 -1.366 . . . . 0.0 113.849 -172.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.14 -176.58 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 125.487 1.515 . . . . 0.0 107.029 165.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -53.86 116.19 9.64 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 117.364 -1.303 . . . . 0.0 109.589 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -64.04 144.74 88.38 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 121.357 1.52 . . . . 0.0 109.416 167.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.9 m -103.98 143.66 32.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.04 156.92 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -125.23 159.13 32.35 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.656 0.782 . . . . 0.0 110.197 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.604 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 54.6 m-85 -145.94 104.71 3.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.613 2.365 . . . . 0.0 107.58 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.5 94.07 3.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 167.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.6 mm -66.73 150.06 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.241 1.016 . . . . 0.0 109.625 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.25 160.74 34.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.704 1.601 . . . . 0.0 110.808 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.8 t -127.37 98.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.075 2.55 . . . . 0.0 105.23 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 50.88 12.94 0.12 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.558 1.943 . . . . 0.0 114.772 -165.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.7 -13.8 13.12 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.424 1.488 . . . . 0.0 113.247 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -72.82 116.65 52.25 Favored Pre-proline 0 C--O 1.23 0.075 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.93 116.98 3.9 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.615 1.543 . . . . 0.0 110.036 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.0 tp -87.28 -27.6 22.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.214 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.83 162.77 10.08 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.2 ttm105 -75.68 143.23 42.27 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.84 152.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 128.534 2.734 . . . . 0.0 104.724 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -143.34 140.57 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.215 0.461 . . . . 0.0 109.949 175.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -114.14 159.87 19.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.333 1.053 . . . . 0.0 108.764 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -120.37 137.88 54.05 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.121 2.169 . . . . 0.0 105.573 170.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.6 mt -125.02 119.11 27.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -164.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.61 63.18 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.13 1.372 . . . . 0.0 112.123 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -17.06 59.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.893 -1.129 . . . . 0.0 111.881 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 -13.0 59.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.059 1.343 . . . . 0.0 112.94 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -111.91 -44.41 3.46 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.014 1.279 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m -134.07 68.75 74.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.066 1.346 . . . . 0.0 108.897 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.66 -38.8 92.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.201 1.934 . . . . 0.0 113.107 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -50.67 70.89 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.588 1.085 . . . . 0.0 108.965 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -62.53 -45.46 92.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.66 1.184 . . . . 0.0 109.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.96 61.95 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.377 1.071 . . . . 0.0 112.164 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -60.69 -41.99 96.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.663 1.185 . . . . 0.0 110.177 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.41 -51.21 67.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.538 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -64.43 -40.32 95.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 ttp85 -56.2 -59.13 5.37 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.32 1.848 . . . . 0.0 110.901 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.86 69.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.814 0.446 . . . . 0.0 112.165 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -74.49 -32.41 62.53 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.871 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.4 m -68.32 -47.04 68.61 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.819 1.247 . . . . 0.0 110.616 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.4 p -64.45 -38.76 92.14 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.62 11.69 82.67 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -166.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -63.57 -20.22 65.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.793 1.296 . . . . 0.0 111.857 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.534 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.85 -1.44 86.38 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.444 1.02 . . . . 0.0 112.172 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -154.5 172.49 17.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.874 1.27 . . . . 0.0 109.073 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.13 -151.77 19.77 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.902 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.604 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.3 t80 -54.14 -29.44 45.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.347 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -59.28 101.71 0.11 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.557 1.071 . . . . 0.0 110.007 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.08 72.59 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 116.848 -2.084 . . . . 0.0 115.295 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 p -64.55 -58.28 6.82 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.424 2.612 . . . . 0.0 110.609 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.8 t 105.39 161.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.264 3.826 . . . . 0.0 108.292 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -115.97 123.94 49.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -104.87 -17.09 14.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.163 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.95 97.78 3.72 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.7 mt -124.13 117.61 51.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.19 103.08 14.1 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.5 134.12 45.15 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 124.532 3.488 . . . . 0.0 112.804 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.07 25.36 69.44 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.758 0.694 . . . . 0.0 111.531 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -138.9 -78.29 0.34 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.54 162.81 21.94 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 94.2 m -122.52 96.51 5.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.556 2.343 . . . . 0.0 109.802 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -85.61 132.63 34.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.772 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.64 22.98 0.55 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.528 0.585 . . . . 0.0 114.437 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.18 -3.94 88.56 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.349 -1.089 . . . . 0.0 114.097 -170.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.87 73.25 10.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.173 0.986 . . . . 0.0 108.567 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -66.3 -2.44 4.41 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.503 -1.373 . . . . 0.0 112.126 166.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -121.83 -50.72 2.05 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.328 2.251 . . . . 0.0 111.256 -169.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -106.29 -149.23 0.42 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.19 69.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.273 1.397 . . . . 0.0 107.677 158.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.6 -77.12 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.788 -0.57 . . . . 0.0 110.134 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.91 5.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 119.03 -0.872 . . . . 0.0 113.9 -161.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.9 p -83.6 -73.47 0.41 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 163.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.3 169.89 10.4 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 121.065 3.186 . . . . 0.0 121.065 158.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.78 158.72 28.32 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 109.97 -3.115 . . . . 0.0 115.963 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' H ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -86.53 -175.7 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.272 3.429 . . . . 0.0 110.314 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -93.29 -179.04 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.557 0.617 . . . . 0.0 109.614 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.0 pt -72.87 -36.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 120.436 -1.415 . . . . 0.0 110.285 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -73.95 -22.18 59.75 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.822 0.449 . . . . 0.0 110.869 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.71 -105.93 0.28 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.311 -3.116 . . . . 0.0 105.311 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 10.4 tt0 -113.99 -175.79 2.76 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.55 1.167 . . . . 0.0 109.454 -171.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.465 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 94.9 mttt -64.07 123.84 20.09 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 125.878 1.671 . . . . 0.0 109.102 -165.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -99.65 160.35 14.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.741 1.258 . . . . 0.0 110.516 -169.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.46 162.66 22.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.883 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.67 89.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.08 1.752 . . . . 0.0 109.066 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -55.06 -48.44 73.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.281 1.032 . . . . 0.0 111.526 -159.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.45 HD21 HG13 ' A' ' 89' ' ' ILE . 2.2 p-10 -178.51 155.18 0.84 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 128.128 2.571 . . . . 0.0 106.982 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.84 32.15 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.037 1.335 . . . . 0.0 109.317 -168.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.45 HG13 HD21 ' A' ' 87' ' ' ASN . 15.7 mt -52.25 -41.46 34.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 126.211 1.805 . . . . 0.0 109.761 172.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.98 125.68 41.58 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.74 165.41 11.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.19 1.796 . . . . 0.0 109.134 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -80.63 97.1 7.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.0 p -82.46 -26.46 32.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.753 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.0 -177.07 47.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.147 0.885 . . . . 0.0 112.742 -173.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.81 144.54 97.02 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.105 1.87 . . . . 0.0 109.322 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.93 14.87 60.19 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.729 -1.595 . . . . 0.0 112.689 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mm -86.13 158.42 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 121.046 2.423 . . . . 0.0 108.36 162.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 139.39 53.74 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.374 1.47 . . . . 0.0 109.315 168.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -149.23 162.18 40.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.404 1.082 . . . . 0.0 110.49 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.64 117.08 19.45 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.715 1.206 . . . . 0.0 109.733 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.57 62.66 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.117 0.961 . . . . 0.0 109.364 171.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -68.34 -179.25 1.25 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.749 1.261 . . . . 0.0 109.081 170.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.05 16.0 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 126.472 1.909 . . . . 0.0 111.606 -171.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.09 177.06 14.68 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.707 1.622 . . . . 0.0 109.11 -166.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.47 131.93 49.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.831 2.354 . . . . 0.0 110.78 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 71.43 9.39 6.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.225 1.81 . . . . 0.0 114.154 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.4 p -92.14 39.58 1.02 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.209 -1.557 . . . . 0.0 111.082 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -82.86 105.56 13.97 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.85 -109.69 2.68 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -18.56 13.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.415 1.086 . . . . 0.0 111.307 172.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -59.07 113.92 2.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.81 1.244 . . . . 0.0 107.979 172.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.469 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 15.4 p90 -127.43 168.95 14.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.208 2.203 . . . . 0.0 107.139 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -143.45 155.59 44.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.583 0.706 . . . . 0.0 111.398 160.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.4 mt -83.83 125.11 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 164.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.7 m -75.29 115.59 15.1 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 166.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -103.04 22.28 14.25 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.312 0.645 . . . . 0.0 109.917 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.91 -178.43 7.24 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.343 1.057 . . . . 0.0 108.314 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -66.92 96.22 0.41 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 163.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 p -80.24 63.66 4.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.454 1.121 . . . . 0.0 109.594 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.92 -21.14 66.0 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.936 -1.102 . . . . 0.0 112.232 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.438 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 19.2 p90 -70.85 -7.89 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.586 1.154 . . . . 0.0 110.878 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.438 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.5 mt -122.49 6.4 9.54 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 126.617 1.967 . . . . 0.0 111.212 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.96 130.62 42.22 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 166.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.9 -4.68 29.03 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.122 -1.376 . . . . 0.0 114.728 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -93.82 -34.15 13.28 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.144 2.472 . . . . 0.0 110.811 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -143.83 134.2 24.63 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.184 0.594 . . . . 0.0 109.74 -164.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.99 107.33 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 126.287 1.835 . . . . 0.0 107.57 -170.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.14 131.09 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -135.79 -4.72 2.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.11 33.22 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.341 0.973 . . . . 0.0 111.62 -176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -147.66 152.54 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 109.122 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 32.8 t -65.8 110.2 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 164.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -71.61 -50.55 29.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.47 157.45 45.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.537 1.935 . . . . 0.0 110.159 -167.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.67 18.3 79.1 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.854 0.74 . . . . 0.0 114.026 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -35.16 68.74 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.96 1.88 . . . . 0.0 110.677 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -20.5 65.95 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.452 -1.405 . . . . 0.0 113.598 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.8 -37.07 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -37.16 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.767 . . . . 0.0 109.735 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.29 -25.57 67.7 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.448 -1.407 . . . . 0.0 112.65 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.15 -46.96 30.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.815 -1.178 . . . . 0.0 109.733 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.7 mtp -52.3 -41.21 62.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.329 0.968 . . . . 0.0 111.377 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -60.62 -37.03 80.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 112.343 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -71.24 -23.08 61.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.541 1.064 . . . . 0.0 110.638 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -90.45 12.25 19.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.329 1.451 . . . . 0.0 111.637 172.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.39 -150.49 6.66 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.164 1.364 . . . . 0.0 110.296 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.9 p -143.63 -103.3 0.12 Allowed 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 159.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -153.7 -27.03 0.14 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.176 1.79 . . . . 0.0 110.196 159.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -66.53 -19.74 65.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.011 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.27 -30.12 6.41 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.429 1.49 . . . . 0.0 111.514 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 124.48 20.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.092 1.446 . . . . 0.0 107.763 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -66.84 130.0 41.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.269 1.028 . . . . 0.0 108.291 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.17 -22.37 64.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.058 0.943 . . . . 0.0 111.599 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -118.87 175.4 5.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 159.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -72.93 145.06 47.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 164.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 24.2 mm -129.37 123.23 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 178.19 8.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.837 -159.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.74 102.18 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.29 -43.31 74.08 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.39 166.4 28.22 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 117.971 0.35 . . . . 0.0 110.606 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.3 p -170.34 172.64 6.05 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 123.566 0.746 . . . . 0.0 110.487 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.34 -169.49 42.53 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.445 HE21 ' C ' ' A' ' 165' ' ' GLU . 41.1 tt0 -110.66 136.25 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.108 1.363 . . . . 0.0 108.437 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 mt -116.42 43.12 2.26 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.49 1.138 . . . . 0.0 109.644 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.445 ' C ' HE21 ' A' ' 163' ' ' GLN . 2.0 tp10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 128.248 2.619 . . . . 0.0 108.272 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.935 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 3' ' ' ASN 0.305 5.5 p 50.66 -173.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.149 0.886 . . . . 0.0 111.688 -171.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.44 ' H ' HG23 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -94.93 108.02 35.25 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 158.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.16 165.7 16.38 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.996 1.797 . . . . 0.0 110.079 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 m -131.18 157.44 43.17 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 m -143.7 142.18 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.138 1.375 . . . . 0.0 108.024 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -89.94 155.78 18.89 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.462 0.574 . . . . 0.0 109.457 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -137.76 105.42 5.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.0 103.68 11.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.86 139.45 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.91 158.79 28.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.917 0.887 . . . . 0.0 110.254 163.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.55 105.17 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 54.72 14.04 0.8 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.873 2.069 . . . . 0.0 113.939 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 6.96 60.4 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.551 -1.343 . . . . 0.0 114.066 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.32 123.14 84.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 159.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.7 113.04 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.21 -38.09 52.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.26 -173.39 36.86 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -110.72 151.41 27.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.982 0.896 . . . . 0.0 110.079 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.31 162.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.536 3.134 . . . . 0.0 105.852 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.5 t -147.13 149.8 33.72 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.98 136.41 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.174 0.99 . . . . 0.0 109.453 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -84.57 147.0 27.24 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 160.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.48 118.55 26.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 90' ' ' LEU . 14.1 m-85 -75.26 52.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.353 2.261 . . . . 0.0 112.016 -172.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -13.75 29.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 120.541 -1.349 . . . . 0.0 113.335 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.42 -7.41 59.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.358 0.981 . . . . 0.0 112.953 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.87 -25.25 1.43 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.569 1.077 . . . . 0.0 113.347 -171.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.51 72.32 37.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.051 1.74 . . . . 0.0 107.045 161.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -47.2 -52.27 8.11 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.352 2.701 . . . . 0.0 112.602 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -46.58 86.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.841 0.746 . . . . 0.0 109.872 -169.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.8 m -66.72 -51.21 58.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 125.095 1.358 . . . . 0.0 110.489 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -39.16 80.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.836 0.455 . . . . 0.0 112.142 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.73 -44.3 90.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.112 1.765 . . . . 0.0 109.807 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -56.97 -53.67 55.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.154 0.982 . . . . 0.0 109.715 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.69 -37.22 80.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.865 0.866 . . . . 0.0 112.783 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -54.06 -64.38 0.85 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.235 1.414 . . . . 0.0 109.281 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.29 66.37 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.714 0.634 . . . . 0.0 112.412 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 mt -69.78 -33.51 72.49 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.192 -0.943 . . . . 0.0 111.426 171.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 m -68.49 -49.38 60.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.814 0.734 . . . . 0.0 109.255 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.6 p -64.14 -30.99 72.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.364 0.529 . . . . 0.0 110.523 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.02 -3.88 68.89 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 119.695 1.134 . . . . 0.0 112.068 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.89 -1.38 14.11 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.82 2.048 . . . . 0.0 113.008 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.66 7.8 13.78 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.464 -0.772 . . . . 0.0 112.623 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.04 2.54 89.45 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.087 0.851 . . . . 0.0 111.555 -166.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -174.45 173.26 2.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.3 1.84 . . . . 0.0 106.546 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.62 -167.39 28.12 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -88.7 -8.0 55.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -162.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -64.32 115.02 4.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.743 1.611 . . . . 0.0 108.034 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.07 11.64 85.38 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 -173.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.2 t -66.41 119.09 11.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 163.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.82 139.17 43.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -74.21 99.63 3.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -73.77 -57.09 4.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.9 112.17 24.19 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -168.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.48 105.27 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.42 97.28 42.91 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -53.0 134.07 54.3 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.935 2.423 . . . . 0.0 113.213 -171.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.4 78.17 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.129 1.823 . . . . 0.0 112.918 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -122.9 -75.98 0.59 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.305 1.553 . . . . 0.0 106.816 -173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.55 18.2 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.141 0.976 . . . . 0.0 109.377 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.8 t -125.75 105.96 9.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -93.84 138.25 32.2 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.672 1.989 . . . . 0.0 110.798 -172.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.55 -168.82 12.83 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.172 1.844 . . . . 0.0 110.109 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.33 9.96 69.01 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.969 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.292 29.9 t0 -84.45 46.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.619 2.209 . . . . 0.0 113.062 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -53.3 -42.65 66.83 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.337 0.655 . . . . 0.0 112.722 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.452 ' HB ' ' HE3' ' A' ' 76' ' ' LYS . 3.6 t -72.79 -35.1 67.31 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.396 0.678 . . . . 0.0 111.419 -171.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -125.06 -139.12 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -170.06 23.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.621 1.555 . . . . 0.0 112.948 159.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -134.81 8.69 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.199 1.4 . . . . 0.0 112.742 -159.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.09 -9.29 66.93 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.721 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.5 p -84.16 -18.44 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.827 1.814 . . . . 0.0 111.185 171.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.49 -154.34 7.47 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 124.833 1.206 . . . . 0.0 113.077 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.52 120.57 2.23 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -162.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.452 ' HE3' ' HB ' ' A' ' 68' ' ' THR . 13.1 pttp -142.77 158.03 44.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 158.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -91.22 177.74 6.17 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 124.066 0.854 . . . . 0.0 110.465 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.6 pt -62.62 -31.06 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.607 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -82.68 1.66 37.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.385 1.474 . . . . 0.0 111.605 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.88 156.41 29.11 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -170.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.259 3.1 tm-20 33.79 -142.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.802 2.841 . . . . 0.0 113.429 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -115.0 150.83 35.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.467 1.107 . . . . 0.0 108.115 -167.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.94 175.8 6.72 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.89 154.54 25.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.291 0.567 . . . . 0.0 109.823 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -80.33 88.37 5.55 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 167.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -46.88 -51.61 16.34 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -158.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.83 160.48 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.727 -1.578 . . . . 0.0 114.023 168.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.32 24.82 10.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.452 2.301 . . . . 0.0 110.603 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.8 mt -50.47 -46.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.187 0.995 . . . . 0.0 108.994 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.414 HD11 ' CD2' ' A' ' 25' ' ' PHE . 96.1 mt -89.29 126.92 35.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.433 1.111 . . . . 0.0 108.278 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -108.86 172.12 7.03 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 126.811 2.044 . . . . 0.0 109.044 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.48 ' HD1' ' HA ' ' A' ' 123' ' ' ASP . 80.3 m80 -87.61 73.59 9.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.946 0.898 . . . . 0.0 108.879 -166.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 p -75.29 -4.52 39.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -160.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.86 -179.15 33.79 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.4 1.0 . . . . 0.0 111.886 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.08 159.77 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.072 1.848 . . . . 0.0 110.159 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.31 71.36 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.233 -1.315 . . . . 0.0 112.674 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.63 162.11 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.934 1.867 . . . . 0.0 107.5 166.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.03 132.28 44.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.1 1.76 . . . . 0.0 107.138 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 34.5 t -146.11 169.8 17.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.883 0.849 . . . . 0.0 110.029 -172.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.455 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 7.5 ttm -111.67 120.67 42.82 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.298 1.439 . . . . 0.0 109.1 -161.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.15 94.72 2.47 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -85.31 170.28 12.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 158.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.02 20.31 18.08 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.215 1.406 . . . . 0.0 111.506 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.65 -165.83 25.21 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 -159.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.4 153.75 76.81 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 119.88 1.84 . . . . 0.0 109.672 167.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 45.16 34.36 1.36 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.689 2.796 . . . . 0.0 113.497 169.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -132.53 32.5 3.89 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.932 -1.105 . . . . 0.0 111.573 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.455 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 15.4 p30 -66.29 -154.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.936 2.095 . . . . 0.0 110.916 166.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.14 -81.7 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.6 m -133.83 -16.43 2.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -72.78 139.78 47.29 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.401 1.455 . . . . 0.0 108.201 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -141.56 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.579 1.152 . . . . 0.0 108.511 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 99' ' ' SER . 43.5 p90 -146.17 153.03 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 122.332 1.063 . . . . 0.0 110.852 165.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -84.01 119.33 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 167.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.74 119.88 15.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.8 p -106.94 19.63 20.19 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 109.964 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.08 179.81 8.71 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 166.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.13 102.29 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 160.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.7 p -92.98 58.45 2.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.902 0.858 . . . . 0.0 109.711 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.58 -16.63 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.705 -1.247 . . . . 0.0 114.291 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -69.01 -17.75 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.256 -0.903 . . . . 0.0 111.079 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 36.3 mt -100.94 -10.26 20.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.069 1.347 . . . . 0.0 110.711 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.48 ' HA ' ' HD1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -60.52 127.85 33.73 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.401 1.081 . . . . 0.0 109.585 178.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.73 -8.98 25.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.924 1.25 . . . . 0.0 113.631 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -99.56 -42.44 6.91 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.328 1.451 . . . . 0.0 110.278 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -115.4 155.13 27.98 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.908 1.283 . . . . 0.0 110.967 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.21 104.19 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -174.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.84 122.13 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -134.76 -2.05 2.69 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.441 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.26 26.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.417 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -142.46 147.31 35.9 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.889 1.675 . . . . 0.0 109.203 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.2 t -66.22 110.37 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 158.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -46.68 31.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -146.81 159.12 43.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.358 1.063 . . . . 0.0 108.551 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.2 18.57 60.55 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.532 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 25.7 tpp -51.79 -34.45 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.812 . . . . 0.0 110.709 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.3 -33.45 65.56 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.094 -1.004 . . . . 0.0 113.536 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 119.416 1.007 . . . . 0.0 109.067 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.7 t -59.56 -41.59 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.192 0.905 . . . . 0.0 110.188 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.91 -37.83 83.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.901 0.88 . . . . 0.0 110.856 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.41 72.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.192 -0.943 . . . . 0.0 109.863 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 76.7 mtp -57.79 -44.63 86.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.8 0.84 . . . . 0.0 110.483 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.4 -32.85 72.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.57 -15.0 59.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.214 0.606 . . . . 0.0 111.475 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -97.09 6.41 48.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.694 1.598 . . . . 0.0 111.388 165.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.85 -173.78 46.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.5 p -157.1 158.61 36.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -70.06 -16.23 63.11 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -166.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -29.87 68.99 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.152 0.282 . . . . 0.0 111.36 167.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.65 -29.73 7.05 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 127.871 2.653 . . . . 0.0 112.439 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -68.6 130.94 44.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.774 1.787 . . . . 0.0 109.044 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.5 p -70.88 154.76 41.55 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.919 0.888 . . . . 0.0 110.107 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 p -74.45 -16.62 60.86 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.44 0.696 . . . . 0.0 111.54 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -130.8 169.92 15.07 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.605 1.162 . . . . 0.0 110.848 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -74.42 139.19 43.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 162.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.4 mt -136.52 118.44 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -132.9 160.8 35.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 -169.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -74.05 112.66 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 158.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.78 -56.05 14.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -143.92 155.2 43.98 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.893 0.877 . . . . 0.0 109.354 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -145.82 168.81 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.762 1.625 . . . . 0.0 107.991 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.18 47.16 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' A' ' 165' ' ' GLU . 6.5 tt0 -87.81 155.38 19.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -172.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 55.1 mt -139.99 43.28 1.94 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.559 1.143 . . . . 0.0 109.717 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.444 ' HB3' HE21 ' A' ' 163' ' ' GLN . 10.0 pm0 . . . . . 0 C--O 1.249 1.079 0 C-N-CA 125.404 1.481 . . . . 0.0 114.244 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 m -126.32 -172.96 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.411 1.884 . . . . 0.0 108.156 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -36.34 112.4 0.52 Allowed Pre-proline 0 C--O 1.235 0.317 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.473 161.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -63.48 135.58 50.29 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.9 m -92.91 155.62 17.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.162 -2.532 . . . . 0.0 104.162 161.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.03 167.16 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.952 1.301 . . . . 0.0 108.556 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.45 158.04 37.07 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.74 0.816 . . . . 0.0 111.477 165.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.41 113.79 13.57 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.116 2.966 . . . . 0.0 104.435 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.85 104.71 15.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 170.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -71.3 148.01 10.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.33 27.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 111.145 159.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' CG1' ' HE2' ' A' ' 154' ' ' LYS . 5.4 t -128.31 94.32 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 126.354 1.862 . . . . 0.0 107.434 -164.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 50.75 24.48 1.74 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.085 -1.634 . . . . 0.0 111.611 -160.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.21 -4.93 35.64 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.055 1.312 . . . . 0.0 114.146 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 39.4 tt0 -81.44 109.06 12.58 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 127.81 2.444 . . . . 0.0 107.74 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.95 99.2 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.051 2.501 . . . . 0.0 112.054 -168.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.7 tp -79.39 -28.91 41.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.55 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.66 157.28 8.19 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.602 0.637 . . . . 0.0 113.228 171.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -74.8 135.24 41.67 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.419 1.088 . . . . 0.0 108.761 170.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 t -127.21 143.24 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.31 146.05 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.746 0.703 . . . . 0.0 109.238 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -141.27 150.27 42.38 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 109.144 -164.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.15 147.16 26.57 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 163.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.7 mt -127.92 115.04 17.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.445 1.498 . . . . 0.0 107.237 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.36 58.22 1.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.078 1.751 . . . . 0.0 112.638 -169.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -19.05 51.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.678 1.191 . . . . 0.0 113.267 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.82 -30.4 66.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.056 0.843 . . . . 0.0 110.762 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -98.84 -50.55 4.17 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.65 0.78 . . . . 0.0 109.613 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.98 76.19 71.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 125.912 1.685 . . . . 0.0 107.702 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.3 -40.74 56.23 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.672 2.248 . . . . 0.0 111.517 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 1.3 mmpt? -66.43 -47.37 73.44 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -170.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -62.4 -49.69 74.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.961 1.304 . . . . 0.0 110.173 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.51 -46.77 78.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -64.84 -40.12 94.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.482 1.113 . . . . 0.0 110.752 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -54.64 -53.6 52.59 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 124.267 1.027 . . . . 0.0 109.484 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.9 -40.82 91.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 123.612 0.57 . . . . 0.0 112.079 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -50.71 -60.56 2.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.822 2.049 . . . . 0.0 110.099 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.05 63.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.585 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.48 -15.82 36.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.386 1.074 . . . . 0.0 111.808 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -42.72 12.18 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 120.006 1.276 . . . . 0.0 109.884 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -63.54 -33.18 75.03 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 172.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 10.55 74.73 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -16.72 63.74 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.418 1.487 . . . . 0.0 112.4 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -74.01 -3.74 31.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.204 1.402 . . . . 0.0 112.64 170.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.87 90.68 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 119.812 1.187 . . . . 0.0 112.571 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.08 173.08 17.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.067 2.147 . . . . 0.0 106.371 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.62 -179.18 34.46 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.803 -164.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -68.26 -19.5 64.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -51.42 118.61 3.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.446 1.021 . . . . 0.0 108.784 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.84 86.98 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.593 -1.67 . . . . 0.0 114.832 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -76.92 146.34 37.65 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 121.342 2.571 . . . . 0.0 107.738 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.21 148.39 22.24 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -93.67 81.06 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -74.06 -17.94 60.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.964 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.75 84.85 2.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.344 0.974 . . . . 0.0 110.61 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.98 97.06 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.89 104.74 23.29 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.51 142.11 83.22 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.911 1.741 . . . . 0.0 110.483 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.79 14.01 81.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.718 1.151 . . . . 0.0 112.929 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -140.67 -81.26 0.25 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.768 1.284 . . . . 0.0 109.047 -170.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.02 167.77 20.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.485 0.714 . . . . 0.0 112.411 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.3 m -123.43 97.61 5.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.818 2.047 . . . . 0.0 109.415 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.12 138.24 31.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.229 1.412 . . . . 0.0 110.824 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.62 72.35 0.09 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-O 118.635 -1.091 . . . . 0.0 113.524 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.29 14.32 1.45 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.262 1.531 . . . . 0.0 116.274 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -91.03 113.49 25.77 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 164.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -96.29 35.7 1.43 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.759 1.623 . . . . 0.0 110.312 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -155.0 -67.07 0.13 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.198 1.399 . . . . 0.0 107.976 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -85.98 168.59 14.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.126 2.17 . . . . 0.0 105.288 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -139.53 31.76 2.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -167.0 4.7 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.984 -158.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.583 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 111.65 -20.19 22.88 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 120.463 1.483 . . . . 0.0 114.903 175.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 p -84.53 9.14 14.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.825 1.813 . . . . 0.0 113.865 -169.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.81 -153.58 6.94 Favored Glycine 0 C--N 1.333 0.399 0 O-C-N 120.798 -1.188 . . . . 0.0 113.14 -162.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.96 174.34 46.84 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -158.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -166.91 154.26 9.15 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 125.461 1.505 . . . . 0.0 107.529 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.2 p -76.68 144.96 39.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.37 -25.13 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 122.156 0.183 . . . . 0.0 111.151 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -79.9 -13.74 59.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 113.788 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.67 -95.18 0.14 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 120.692 1.587 . . . . 0.0 111.833 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -159.23 112.43 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.212 1.005 . . . . 0.0 109.015 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt 63.4 158.25 0.07 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.824 3.25 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.71 171.33 15.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.769 0.795 . . . . 0.0 109.013 170.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.02 158.38 16.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.058 1.743 . . . . 0.0 113.265 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.99 90.86 2.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 158.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.64 -59.89 4.5 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.45 HD21 HG13 ' A' ' 89' ' ' ILE . 10.1 p-10 -161.49 158.35 26.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.795 1.283 . . . . 0.0 112.561 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.21 31.04 5.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.617 2.367 . . . . 0.0 109.553 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.45 HG13 HD21 ' A' ' 87' ' ' ASN . 21.2 mt -52.67 -40.02 32.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.586 1.154 . . . . 0.0 108.572 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.76 125.16 34.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -102.84 169.22 8.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.01 1.324 . . . . 0.0 108.899 168.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -73.82 89.26 1.82 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.7 p -72.43 -28.56 63.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.34 44.09 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.839 1.209 . . . . 0.0 111.091 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.53 162.43 10.3 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.315 2.01 . . . . 0.0 111.945 169.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.33 77.37 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.198 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.3 mm -77.07 162.46 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 120.139 1.969 . . . . 0.0 108.834 171.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.66 54.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 108.134 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -146.21 147.62 31.65 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.214 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 12.8 mtp -85.54 128.6 34.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.909 1.338 . . . . 0.0 111.423 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.42 73.09 4.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.5 2.32 . . . . 0.0 108.724 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -69.26 -179.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.392 158.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.38 20.44 8.81 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.043 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 134.79 -163.01 24.77 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.62 147.04 89.96 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.053 1.836 . . . . 0.0 109.602 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 46.81 32.01 1.64 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.672 1.989 . . . . 0.0 115.789 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.1 p -118.28 23.56 11.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.536 -1.353 . . . . 0.0 111.503 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -63.12 104.3 0.56 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.21 -75.28 1.03 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.605 1.093 . . . . 0.0 111.383 -170.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.1 p -155.74 -21.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.835 1.254 . . . . 0.0 111.486 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.583 HE22 ' HA2' ' A' ' 72' ' ' GLY . 58.8 mt-30 -64.2 143.08 58.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.47 169.32 18.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.563 1.545 . . . . 0.0 106.833 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -136.04 152.84 51.32 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.781 0.8 . . . . 0.0 110.366 163.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.79 113.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 166.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -62.73 124.95 22.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.7 p -115.1 31.67 6.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.898 1.332 . . . . 0.0 108.665 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.71 169.45 19.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 110.03 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -73.24 86.68 1.44 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 163.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -76.81 58.01 1.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.073 0.949 . . . . 0.0 110.219 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.89 -30.5 65.93 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.037 -1.665 . . . . 0.0 111.816 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -70.91 -15.24 62.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.081 1.352 . . . . 0.0 110.541 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.2 mt -98.97 -12.49 20.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.372 1.069 . . . . 0.0 111.172 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.44 144.04 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.363 0.983 . . . . 0.0 109.605 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.06 -4.64 37.96 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.829 1.204 . . . . 0.0 113.728 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.96 -59.65 1.99 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 126.515 1.926 . . . . 0.0 108.978 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -96.69 129.28 44.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.891 1.276 . . . . 0.0 108.396 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.8 t -80.11 104.4 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -170.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.97 127.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -140.74 -0.22 1.55 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.603 1.19 . . . . 0.0 113.441 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.92 -176.56 32.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.636 -1.269 . . . . 0.0 112.065 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.29 151.48 34.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.01 127.42 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -94.51 -38.33 10.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.933 0.893 . . . . 0.0 110.389 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -139.29 153.48 47.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 109.829 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.71 72.18 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.241 -0.755 . . . . 0.0 113.011 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.0 tpp -54.85 -36.39 65.0 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.304 1.552 . . . . 0.0 110.004 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -58.8 -27.88 65.47 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.534 1.061 . . . . 0.0 113.643 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.7 mm -75.17 -42.77 44.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 124.484 1.114 . . . . 0.0 108.268 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.35 -41.33 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.46 -34.23 70.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.018 1.327 . . . . 0.0 111.154 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.05 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.695 0.798 . . . . 0.0 110.636 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.6 mtm -55.77 -45.32 78.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.555 0.616 . . . . 0.0 110.128 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.49 -36.86 72.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.599 1.159 . . . . 0.0 112.683 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -69.56 -14.89 63.08 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.105 -0.997 . . . . 0.0 111.306 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 14.18 25.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 126.793 2.037 . . . . 0.0 111.291 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.94 -172.21 31.47 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.6 p -154.52 164.32 38.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.738 -0.86 . . . . 0.0 109.435 165.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.26 -33.91 63.59 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -71.64 -13.59 61.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.3 -26.68 21.05 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 127.274 2.368 . . . . 0.0 113.361 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -66.52 130.04 41.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.6 1.7 . . . . 0.0 108.779 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.6 p -65.7 153.86 40.54 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.594 0.758 . . . . 0.0 110.102 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.8 p -69.32 -25.5 64.24 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.299 -0.875 . . . . 0.0 110.586 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HE2' ' CG1' ' A' ' 12' ' ' VAL . 42.7 mtpt -130.76 174.46 9.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.284 1.434 . . . . 0.0 111.518 -170.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -63.65 139.28 58.75 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 102.903 -2.999 . . . . 0.0 102.903 158.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -129.06 122.6 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 101.217 -3.623 . . . . 0.0 101.217 160.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.53 153.17 43.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -166.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -74.09 110.83 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.43 -46.48 73.0 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.517 0.599 . . . . 0.0 109.468 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -151.03 163.32 39.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.643 0.377 . . . . 0.0 110.045 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 m -148.43 171.1 16.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 171.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.26 174.82 46.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 160.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.438 ' HG2' ' H ' ' A' ' 165' ' ' GLU . 47.0 tt0 -87.11 154.82 20.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.225 1.01 . . . . 0.0 109.93 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.1 mt -136.94 43.41 2.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.18 2.592 . . . . 0.0 109.915 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.438 ' H ' ' HG2' ' A' ' 163' ' ' GLN . 3.5 tm-20 . . . . . 0 C--O 1.246 0.892 0 C-N-CA 127.182 2.193 . . . . 0.0 106.155 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 tmm? . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.316 28.4 m 50.12 -173.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.512 1.125 . . . . 0.0 111.515 -171.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.85 95.79 35.11 Favored Pre-proline 0 C--N 1.323 -0.559 0 O-C-N 120.49 -1.381 . . . . 0.0 107.953 165.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 156.41 66.2 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 121.18 1.253 . . . . 0.0 110.985 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -117.09 151.63 36.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.34 150.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 119.301 0.955 . . . . 0.0 109.434 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -108.21 161.55 14.89 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.124 0.969 . . . . 0.0 108.811 166.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 4.1 m-85 -144.37 108.76 4.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.052 2.141 . . . . 0.0 107.361 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 98.29 9.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.23 138.54 22.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.93 149.99 42.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.827 1.299 . . . . 0.0 108.514 161.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.31 80.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 170.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' OD2' ' HE3' ' A' ' 154' ' ' LYS 0.378 3.7 p30 61.74 14.09 5.88 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.41 -9.25 15.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -73.99 121.6 85.56 Favored Pre-proline 0 C--N 1.338 0.099 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 164.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.12 103.23 1.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.81 2.34 . . . . 0.0 107.732 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.8 tp -83.0 -34.11 26.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.704 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.5 165.7 11.74 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.507 -1.33 . . . . 0.0 114.993 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.27 136.14 44.53 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.3 t -120.05 158.77 21.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 130.232 3.413 . . . . 0.0 105.823 165.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -152.11 155.35 37.71 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.679 -1.888 . . . . 0.0 111.812 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -141.85 145.28 34.48 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.949 1.299 . . . . 0.0 110.079 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -90.77 150.54 21.56 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.437 1.495 . . . . 0.0 107.315 160.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -128.74 128.5 44.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.017 1.327 . . . . 0.0 108.249 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -81.13 49.54 1.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.6 1.56 . . . . 0.0 112.546 -166.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -4.63 7.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.907 1.283 . . . . 0.0 114.379 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.15 -16.78 36.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.98 1.264 . . . . 0.0 111.974 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -121.94 -30.31 4.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.64 1.176 . . . . 0.0 113.258 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.88 73.31 81.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 124.685 1.194 . . . . 0.0 107.858 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.75 -39.25 43.96 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.575 2.183 . . . . 0.0 113.434 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -51.34 67.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.499 1.045 . . . . 0.0 108.211 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.8 m -61.55 -49.1 78.05 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.257 1.023 . . . . 0.0 110.732 -170.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.2 -45.4 70.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 112.242 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -63.4 -42.04 98.76 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.466 0.306 . . . . 0.0 111.302 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -56.98 -47.97 79.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.121 1.368 . . . . 0.0 109.439 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.1 -38.64 88.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.856 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -55.23 -58.17 8.79 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.767 0.712 . . . . 0.0 109.135 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.96 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.245 1.418 . . . . 0.0 113.652 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.8 mt -84.04 -26.96 28.67 Favored 'General case' 0 N--CA 1.457 -0.078 0 O-C-N 121.567 -0.708 . . . . 0.0 111.599 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 m -77.52 -43.43 32.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.581 0.752 . . . . 0.0 110.326 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -63.96 -27.35 69.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.89 7.51 62.16 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.41 -27.85 69.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.59 1.156 . . . . 0.0 111.189 -171.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 29.3 mmmt -65.49 -14.71 61.6 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.959 -1.02 . . . . 0.0 112.26 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.93 4.17 48.44 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.251 1.405 . . . . 0.0 112.228 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -163.6 175.99 10.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.078 1.751 . . . . 0.0 107.968 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.77 -149.49 19.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-O 122.029 0.794 . . . . 0.0 112.831 165.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.453 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -59.96 -44.74 94.24 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 127.14 2.176 . . . . 0.0 109.655 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -44.62 112.83 0.46 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.015 1.326 . . . . 0.0 110.004 170.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.05 3.64 88.92 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.097 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.3 m -63.86 -62.76 1.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.907 2.354 . . . . 0.0 110.8 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 t 122.85 167.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 131.774 4.03 . . . . 0.0 106.583 -168.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -119.68 91.96 3.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.583 1.953 . . . . 0.0 106.198 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -73.76 -18.34 60.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -164.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.26 104.08 4.22 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.58 103.09 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.0 mt -119.03 91.0 42.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -48.24 122.62 7.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.01 3.14 . . . . 0.0 114.859 -167.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.56 21.27 77.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.133 1.349 . . . . 0.0 112.37 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.11 -75.57 0.55 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.38 170.99 19.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.227 1.011 . . . . 0.0 109.413 167.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 p -130.77 107.97 9.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.797 0.839 . . . . 0.0 110.411 168.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -86.96 140.86 29.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 129.028 2.931 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.75 -163.09 10.66 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 124.959 1.266 . . . . 0.0 110.845 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.453 ' HA3' ' CE1' ' A' ' 48' ' ' TYR . . . 91.96 10.68 61.04 Favored Glycine 0 N--CA 1.463 0.496 0 CA-C-N 117.717 0.758 . . . . 0.0 114.89 166.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.82 103.91 13.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 107.552 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -115.45 9.94 15.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.478 1.511 . . . . 0.0 111.747 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.6 t -139.15 -35.41 0.56 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.596 1.158 . . . . 0.0 113.629 -166.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -129.87 -36.54 1.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -167.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.5 m170 61.4 56.8 2.52 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.673 1.189 . . . . 0.0 112.078 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -164.51 -54.05 0.03 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.015 1.326 . . . . 0.0 110.169 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.94 -21.44 0.18 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.751 1.643 . . . . 0.0 113.242 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -84.55 12.12 7.57 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.875 1.837 . . . . 0.0 111.57 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.48 -165.13 15.77 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 124.727 1.156 . . . . 0.0 110.696 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.47 103.75 0.17 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -136.3 144.36 44.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.592 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -70.62 164.4 25.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.256 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.429 ' HB ' ' HE2' ' A' ' 44' ' ' LYS . 41.9 pt -61.32 -31.64 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 121.563 -0.711 . . . . 0.0 110.018 163.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.82 -14.53 61.11 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.516 0.726 . . . . 0.0 112.277 -172.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.01 -85.71 0.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -156.17 132.19 9.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 108.593 163.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttt 52.31 149.88 0.0 OUTLIER 'General case' 0 C--N 1.342 0.281 1 C-N-CA 132.618 4.367 . . . . 0.0 115.375 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -128.69 -172.56 2.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.27 152.37 43.34 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 167.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.64 101.02 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 159.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -63.65 -51.02 66.98 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.448 -168.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -151.67 176.24 11.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.373 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -127.78 30.26 5.32 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.618 2.367 . . . . 0.0 109.462 172.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.8 mt -57.27 -46.5 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 99.0 mt -74.57 112.57 10.89 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -82.17 164.26 21.38 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.942 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.78 98.41 4.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.2 p -77.87 -32.93 52.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.798 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.6 -174.98 47.35 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 118.964 0.802 . . . . 0.0 113.851 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.72 160.02 26.37 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.486 2.124 . . . . 0.0 110.457 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.29 -5.93 40.01 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.836 -1.536 . . . . 0.0 112.465 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.92 156.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.925 2.362 . . . . 0.0 107.584 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.17 129.33 54.94 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.641 1.177 . . . . 0.0 108.421 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.1 t -138.53 148.98 44.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.026 0.829 . . . . 0.0 109.28 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 12.9 ttt -100.45 130.44 46.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -162.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.54 155.64 35.87 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.813 1.245 . . . . 0.0 108.842 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -165.38 -169.1 1.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.922 1.689 . . . . 0.0 108.029 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -119.61 13.66 12.55 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.457 1.103 . . . . 0.0 113.049 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.42 -142.39 13.77 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -168.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.03 157.3 62.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.873 1.715 . . . . 0.0 109.521 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 34.18 51.04 0.4 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 128.163 2.585 . . . . 0.0 112.999 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 p -140.63 13.92 2.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.713 0.805 . . . . 0.0 113.069 -173.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -57.79 96.61 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.754 1.622 . . . . 0.0 110.826 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.19 -84.66 1.08 Allowed Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.048 -1.032 . . . . 0.0 111.529 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -156.29 -17.43 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -55.61 140.52 40.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 167.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.88 169.98 16.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -132.34 147.35 52.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.865 0.84 . . . . 0.0 111.663 166.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.4 mt -83.37 117.43 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 102.413 -3.18 . . . . 0.0 102.413 171.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.1 m -64.38 120.91 13.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.0 p -106.88 22.16 16.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.127 0.571 . . . . 0.0 109.629 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.39 -179.56 7.8 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 163.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -64.12 117.27 6.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 159.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.424 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 49.8 p -114.21 56.88 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.175 0.898 . . . . 0.0 111.327 -174.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -61.31 -25.08 66.88 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 120.86 -1.15 . . . . 0.0 113.959 -169.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.424 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 37.3 p90 -66.11 -21.82 66.37 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.814 0.846 . . . . 0.0 110.708 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.65 -16.89 31.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.657 0.783 . . . . 0.0 110.569 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.77 149.0 38.07 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.34 69.84 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.611 -0.328 . . . . 0.0 112.34 -169.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.91 -45.11 0.47 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.179 0.99 . . . . 0.0 109.473 164.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -103.82 144.67 31.19 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.863 1.265 . . . . 0.0 109.486 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.3 102.15 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.05 121.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -142.14 1.36 1.43 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.024 -169.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.79 -177.25 35.64 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.973 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 157.84 43.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.138 0.495 . . . . 0.0 109.954 162.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.03 124.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -84.82 -48.01 9.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.329 160.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -146.06 158.29 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.681 1.192 . . . . 0.0 110.292 -168.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.46 20.08 64.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -34.89 60.57 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.539 1.67 . . . . 0.0 111.186 174.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -32.95 69.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.6 mm -78.14 -34.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 119.541 1.064 . . . . 0.0 109.492 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.21 -40.77 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.143 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.18 -37.01 81.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.672 0.789 . . . . 0.0 111.095 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.79 83.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.204 1.366 . . . . 0.0 108.288 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.0 mtm -52.41 -48.53 65.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 118.003 0.365 . . . . 0.0 110.568 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.03 -34.12 72.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -76.92 -15.67 59.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.892 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -89.46 -5.42 57.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.011 0.924 . . . . 0.0 111.806 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.51 -167.98 42.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.852 1.692 . . . . 0.0 109.782 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 51.2 p -161.49 155.74 22.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -18.88 65.54 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -69.43 -7.19 35.59 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.32 -30.29 10.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 127.787 2.613 . . . . 0.0 113.016 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -63.11 129.78 41.82 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.061 0.944 . . . . 0.0 110.56 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 p -80.01 157.97 26.65 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.824 1.25 . . . . 0.0 109.72 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -76.19 -17.73 59.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.286 1.035 . . . . 0.0 111.786 167.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.472 ' HE3' ' OD2' ' A' ' 13' ' ' ASP . 12.3 mtpt -140.85 165.3 27.9 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.407 1.483 . . . . 0.0 109.572 -168.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -85.69 80.14 9.09 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.995 1.725 . . . . 0.0 107.515 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -73.87 131.24 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 p -145.69 167.34 23.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 123.488 1.613 . . . . 0.0 110.063 -167.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.02 114.56 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 158.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.59 -55.04 12.91 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.04 153.01 33.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.619 1.568 . . . . 0.0 107.076 -161.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 8' ' ' PHE . 7.5 m -159.71 174.16 14.95 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.951 1.701 . . . . 0.0 109.156 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.25 -172.01 44.84 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 165.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -83.49 160.4 21.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.123 0.969 . . . . 0.0 108.578 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.2 mt -128.27 43.28 3.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.197 0.999 . . . . 0.0 108.877 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 N--CA 1.435 -1.218 0 C-N-CA 131.638 3.975 . . . . 0.0 109.821 -168.698 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.58 178.29 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.564 1.146 . . . . 0.0 108.473 161.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -44.48 145.0 1.56 Allowed Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 126.976 2.111 . . . . 0.0 113.057 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.84 156.26 66.89 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.863 1.709 . . . . 0.0 109.279 165.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.1 m -135.82 158.77 43.58 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.85 155.43 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 119.493 -2.004 . . . . 0.0 109.228 -169.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -124.38 157.3 35.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.874 1.269 . . . . 0.0 109.947 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -147.16 106.23 3.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.204 2.202 . . . . 0.0 107.738 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.49 93.56 3.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.17 143.7 15.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.6 133.54 47.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.443 1.097 . . . . 0.0 110.19 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 t -99.76 96.19 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 128.094 2.558 . . . . 0.0 104.603 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 58.71 17.96 5.56 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.763 2.025 . . . . 0.0 114.037 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.36 -9.72 24.37 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.319 1.914 . . . . 0.0 112.518 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.96 131.94 52.47 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.22 113.67 2.94 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.82 1.68 . . . . 0.0 109.659 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.3 tp -79.59 -37.28 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.554 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.28 171.03 14.0 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -81.68 139.8 34.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.92 153.41 35.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 127.066 2.146 . . . . 0.0 105.395 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.72 139.03 11.15 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 -166.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -134.04 149.76 51.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.621 0.769 . . . . 0.0 111.006 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -87.12 151.67 23.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 158.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 mt -127.46 109.48 11.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -68.97 61.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.84 2.456 . . . . 0.0 112.049 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.38 -30.17 38.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.463 1.905 . . . . 0.0 112.222 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 -19.55 62.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.901 1.681 . . . . 0.0 110.818 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -38.89 2.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.353 2.261 . . . . 0.0 110.664 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.24 72.71 26.55 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.758 2.023 . . . . 0.0 108.645 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.59 -41.43 39.73 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.845 2.363 . . . . 0.0 113.712 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -57.73 11.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.351 1.432 . . . . 0.0 107.69 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 m -57.77 -44.08 85.92 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.712 0.632 . . . . 0.0 109.841 -169.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.48 67.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.799 0.84 . . . . 0.0 113.257 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -66.75 -39.96 88.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.713 0.688 . . . . 0.0 110.574 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -55.99 -52.53 63.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.75 1.22 . . . . 0.0 109.712 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.511 ' CE2' ' CE2' ' A' ' 112' ' ' PHE . 2.3 t80 -56.12 -49.86 72.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.601 0.36 . . . . 0.0 110.679 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 -50.96 -60.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.011 1.324 . . . . 0.0 109.926 -173.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.54 -27.12 68.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -77.12 -33.85 56.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.922 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.5 p -69.95 -45.55 67.19 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.98 1.264 . . . . 0.0 111.093 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.0 p -64.68 -36.8 85.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.565 0.746 . . . . 0.0 109.085 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.23 14.31 82.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.24 -28.29 67.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.15 1.38 . . . . 0.0 112.031 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -72.33 8.96 1.14 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.529 1.132 . . . . 0.0 112.917 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -3.69 83.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.885 1.231 . . . . 0.0 112.805 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.2 176.45 12.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.5 1.65 . . . . 0.0 108.65 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.55 -146.88 17.6 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.561 ' CE1' ' CE2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -61.24 -38.69 87.59 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.213 1.405 . . . . 0.0 112.532 -163.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -47.15 116.78 1.49 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.398 1.079 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.98 4.24 90.34 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.427 -1.763 . . . . 0.0 115.728 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -64.24 -35.21 80.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 121.502 2.651 . . . . 0.0 113.589 -162.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.4 m 86.0 164.93 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.611 2.764 . . . . 0.0 107.868 -158.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -119.01 101.57 8.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 164.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.194 0.907 . . . . 0.0 113.043 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.12 114.25 13.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.81 120.69 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.89 99.95 34.39 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.2 136.45 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.107 1.871 . . . . 0.0 110.52 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 22.93 78.58 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.766 1.65 . . . . 0.0 112.198 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -146.93 -81.89 0.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.805 1.303 . . . . 0.0 109.144 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.77 168.72 22.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.724 0.693 . . . . 0.0 112.301 174.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.0 m -120.84 108.44 13.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.212 1.805 . . . . 0.0 108.003 170.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -95.44 133.4 39.45 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 110.342 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 177.86 29.87 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.02 20.11 4.57 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.492 1.044 . . . . 0.0 112.62 -174.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -84.03 28.88 0.58 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.619 1.968 . . . . 0.0 111.975 -164.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 10.6 p90 -63.34 1.25 0.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.516 1.926 . . . . 0.0 115.731 -167.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.435 HG22 ' HE2' ' A' ' 76' ' ' LYS . 2.1 p -139.21 -69.08 0.43 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.305 1.842 . . . . 0.0 109.57 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -118.75 162.47 18.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 166.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -148.25 33.77 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.582 1.953 . . . . 0.0 108.063 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -144.96 16.27 1.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.838 3.255 . . . . 0.0 109.525 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.65 -28.05 12.37 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.365 1.459 . . . . 0.0 113.57 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.8 p -83.74 12.39 6.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.099 1.95 . . . . 0.0 113.103 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.56 168.8 13.27 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.743 1.163 . . . . 0.0 111.794 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.95 165.17 30.16 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HE2' HG22 ' A' ' 68' ' ' THR . 3.5 pttt 170.69 -177.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.129 4.172 . . . . 0.0 103.914 -160.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.9 p -127.25 178.6 5.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.455 1.025 . . . . 0.0 110.311 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.14 -22.89 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.131 168.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.93 1.78 56.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.514 1.525 . . . . 0.0 111.681 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.69 -112.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.24 -133.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.83 2.052 . . . . 0.0 110.389 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -102.74 154.67 18.94 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.331 -1.48 . . . . 0.0 109.261 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -111.0 165.45 11.86 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 109.888 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 156.17 31.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.175 0.988 . . . . 0.0 110.863 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 101.82 2.78 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.13 -48.98 77.34 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.465 1.106 . . . . 0.0 110.62 -164.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -170.12 176.28 4.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.24 2.216 . . . . 0.0 107.96 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.45 43.21 3.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.72 1.208 . . . . 0.0 108.357 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.0 mt -60.56 -65.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -72.67 143.64 48.03 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.954 1.835 . . . . 0.0 107.32 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -131.55 161.6 32.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 127.057 2.143 . . . . 0.0 109.008 -170.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -84.97 73.13 10.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.597 1.159 . . . . 0.0 109.055 -164.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 p -66.07 -31.58 72.54 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.832 0.853 . . . . 0.0 113.003 -165.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.28 171.34 31.38 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.75 -1.028 . . . . 0.0 110.965 -166.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.8 135.96 54.97 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.314 2.009 . . . . 0.0 111.669 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.35 -8.01 30.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.065 -1.409 . . . . 0.0 111.731 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.5 mm -72.31 148.3 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 121.124 2.462 . . . . 0.0 108.662 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.51 131.45 55.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.403 1.081 . . . . 0.0 108.263 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.3 t -140.51 159.82 41.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.857 0.863 . . . . 0.0 110.005 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.31 137.56 32.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -163.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.48 71.48 6.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.11 163.62 27.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.411 158.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.08 16.47 12.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.664 1.586 . . . . 0.0 111.646 -168.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.27 -170.81 28.05 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 -159.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -65.11 172.26 7.7 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 CA-C-N 119.898 1.849 . . . . 0.0 109.86 165.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.93 14.7 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 131.12 3.768 . . . . 0.0 116.221 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -108.63 27.26 9.59 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.857 -1.777 . . . . 0.0 111.03 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.408 2.683 . . . . 0.0 106.459 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.59 -93.75 0.32 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -172.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.5 t -144.34 -11.25 0.63 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.45 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -79.48 135.22 36.59 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CE2' ' CE1' ' A' ' 48' ' ' TYR . 37.1 p90 -145.29 177.27 8.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.679 1.192 . . . . 0.0 108.449 174.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -142.08 151.57 42.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.872 1.32 . . . . 0.0 112.587 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.81 101.9 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 101.569 -3.493 . . . . 0.0 101.569 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.68 94.42 0.3 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.4 p -87.1 25.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.804 0.842 . . . . 0.0 111.009 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.15 -178.22 7.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 163.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -67.2 130.84 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 158.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.6 p -131.62 57.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -14.37 61.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.183 0.993 . . . . 0.0 112.408 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -69.57 -7.95 43.0 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.106 -0.996 . . . . 0.0 111.055 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -109.46 -8.68 14.99 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.479 1.512 . . . . 0.0 111.996 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 149.05 30.17 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.059 0.943 . . . . 0.0 111.011 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.14 18.65 49.34 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.27 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -144.25 -34.33 0.38 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.576 1.15 . . . . 0.0 110.449 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -118.09 139.36 51.35 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.389 1.076 . . . . 0.0 108.194 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.76 96.87 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -167.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.17 127.02 22.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -134.83 -6.5 2.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.049 -0.977 . . . . 0.0 113.256 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.13 -179.28 31.05 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.28 -1.438 . . . . 0.0 112.855 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -153.65 138.3 16.93 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -53.73 114.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 125.059 1.344 . . . . 0.0 108.388 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -83.26 -52.27 6.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.83 160.05 40.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.715 1.143 . . . . 0.0 112.116 -168.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.69 77.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.526 1.06 . . . . 0.0 112.098 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -37.99 71.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.86 1.33 . . . . 0.0 110.843 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.22 -29.15 68.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.946 -1.096 . . . . 0.0 112.508 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.6 mm -72.51 -35.46 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.614 1.166 . . . . 0.0 108.98 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.36 -44.05 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.983 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -27.44 68.91 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.962 -1.086 . . . . 0.0 112.779 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.84 -46.32 68.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.939 -1.101 . . . . 0.0 108.474 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 15.8 mtm -53.08 -46.7 68.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.374 0.534 . . . . 0.0 111.234 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -52.29 -42.49 63.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.469 1.108 . . . . 0.0 111.842 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.47 -19.52 64.56 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.922 -0.486 . . . . 0.0 110.822 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -98.02 5.01 49.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.692 1.597 . . . . 0.0 111.664 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.2 -163.93 37.94 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 98.5 p -152.41 163.57 39.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.9 mtm-85 -67.03 -22.4 65.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.25 -1.531 . . . . 0.0 113.462 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -75.33 -15.69 60.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 168.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 102.06 -27.98 17.98 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-O 117.644 -1.642 . . . . 0.0 114.259 171.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -66.95 124.63 23.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.209 2.005 . . . . 0.0 107.246 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.9 p -73.31 147.85 44.08 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.924 0.889 . . . . 0.0 109.895 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.0 p -77.61 -9.98 59.25 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.23 -0.919 . . . . 0.0 111.784 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -136.96 152.32 50.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.968 1.307 . . . . 0.0 109.546 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -73.06 109.08 6.33 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.88 130.45 51.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.2 p -141.84 173.36 11.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.55 1.94 . . . . 0.0 110.552 -170.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mt -106.61 116.55 50.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 167.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.12 -60.01 4.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -163.01 176.55 10.01 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.735 1.614 . . . . 0.0 111.388 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.4 p -169.5 172.4 7.06 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.425 1.09 . . . . 0.0 110.628 -159.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.82 -172.23 45.11 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.63 160.47 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.115 0.966 . . . . 0.0 110.327 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 39.0 mt -136.9 43.66 2.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.595 1.558 . . . . 0.0 109.011 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.745 -176.041 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mmm . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 3' ' ' ASN . 4.9 p -65.86 -174.26 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.973 0.892 . . . . 0.0 109.005 166.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.415 ' H ' HG23 ' A' ' 2' ' ' VAL . 35.6 m120 -27.94 99.98 0.11 Allowed Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 129.466 3.106 . . . . 0.0 114.331 167.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -76.36 149.95 31.92 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 N-CA-C 109.283 -1.084 . . . . 0.0 109.283 165.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -101.48 151.15 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.78 163.7 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.537 1.535 . . . . 0.0 108.252 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -134.09 158.42 43.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.15 0.98 . . . . 0.0 110.471 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -128.86 123.77 33.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.856 2.462 . . . . 0.0 106.317 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -78.19 98.92 6.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.8 mm -70.28 140.14 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.151 -0.968 . . . . 0.0 109.562 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.49 50.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.581 1.152 . . . . 0.0 110.4 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.448 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 6.7 t -132.74 100.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -165.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.24 13.69 0.65 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.599 1.959 . . . . 0.0 112.86 -161.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.19 38.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.525 1.536 . . . . 0.0 113.298 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -80.51 126.87 77.54 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 120.015 1.908 . . . . 0.0 106.188 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 115.89 3.65 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.822 1.681 . . . . 0.0 109.078 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.9 tp -85.2 -39.6 17.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.563 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.97 158.34 9.01 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.495 -0.383 . . . . 0.0 112.218 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -68.97 146.43 52.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 164.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.2 t -135.33 143.29 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -137.02 153.18 50.72 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.166 0.586 . . . . 0.0 110.031 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -146.54 146.69 30.58 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.477 1.111 . . . . 0.0 108.909 -165.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.03 145.88 27.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 165.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -118.65 146.78 44.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 108.734 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -97.54 61.66 1.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.543 1.537 . . . . 0.0 111.102 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.2 42.05 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.29 0.636 . . . . 0.0 112.236 171.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.58 -0.89 39.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.931 2.093 . . . . 0.0 113.307 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -127.83 -37.27 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.142 1.337 . . . . 0.0 110.716 166.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.07 73.68 74.69 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.148 1.379 . . . . 0.0 107.457 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.38 -43.09 36.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -49.88 67.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.924 0.783 . . . . 0.0 109.828 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.7 m -55.21 -46.66 75.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.991 1.316 . . . . 0.0 109.769 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -51.9 55.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.621 0.769 . . . . 0.0 111.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.59 -39.0 93.27 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.322 1.049 . . . . 0.0 111.618 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -51.88 -60.92 2.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.191 1.396 . . . . 0.0 109.718 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -66.12 -28.27 68.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.221 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -53.88 -64.11 0.93 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.206 1.402 . . . . 0.0 109.16 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.9 -16.62 61.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.58 -31.37 16.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.879 1.272 . . . . 0.0 110.903 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -79.36 -24.39 42.72 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 111.761 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.6 p -79.24 -39.06 34.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.24 19.72 78.07 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.0 -16.05 63.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.806 1.303 . . . . 0.0 112.942 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -87.48 9.43 20.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.213 1.005 . . . . 0.0 112.032 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.04 16.47 79.53 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.419 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.83 -173.73 4.69 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.968 1.707 . . . . 0.0 108.678 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 67' ' ' PHE . . . 111.71 -146.19 17.89 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 168.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CE2' HD13 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -64.04 -27.99 69.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.791 1.636 . . . . 0.0 111.767 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 11.3 tmtt? -62.01 109.64 1.34 Allowed 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.879 -0.513 . . . . 0.0 110.164 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.57 89.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 116.938 -2.035 . . . . 0.0 115.061 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -68.13 151.28 47.24 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 121.89 2.845 . . . . 0.0 108.324 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 65.2 m -86.15 171.09 11.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 159.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -116.09 120.08 37.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -73.67 -45.41 52.71 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.73 102.05 6.4 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 123.807 0.692 . . . . 0.0 110.877 -157.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.8 mt -130.06 108.42 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -170.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.43 97.47 50.18 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -55.05 128.79 32.04 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.299 1.999 . . . . 0.0 112.705 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 46.31 85.42 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 125.011 1.291 . . . . 0.0 110.156 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -153.55 -79.23 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.58 168.4 16.43 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.805 1.242 . . . . 0.0 109.668 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.81 109.49 7.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.201 . . . . 0.0 111.551 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -101.64 143.02 32.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.439 2.696 . . . . 0.0 110.774 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.34 20.02 0.63 Allowed Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.55 3.39 42.79 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 119.136 1.468 . . . . 0.0 116.045 -159.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -83.98 23.86 0.98 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.485 2.142 . . . . 0.0 112.833 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.4 ' CD2' ' HA2' ' A' ' 47' ' ' GLY . 31.5 p90 -33.37 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 1 C-N-CA 133.515 4.726 . . . . 0.0 119.989 -158.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.75 -22.28 24.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.865 1.666 . . . . 0.0 111.265 173.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -133.19 177.98 7.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 128.998 2.919 . . . . 0.0 106.867 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.17 44.03 0.42 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.84 1.256 . . . . 0.0 108.651 -168.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -140.34 -8.36 1.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 110.824 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.45 56.98 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 117.828 -1.54 . . . . 0.0 113.801 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.2 p -135.57 65.85 1.53 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.375 2.088 . . . . 0.0 110.077 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.17 -154.1 6.95 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.86 170.67 44.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.115 0.864 . . . . 0.0 112.78 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 150.88 9.97 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.879 1.272 . . . . 0.0 109.327 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 79' ' ' TYR . 83.2 p -89.63 35.2 0.82 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -166.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 pt 42.1 -3.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 130.645 3.578 . . . . 0.0 118.049 -162.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.461 ' H ' ' C ' ' A' ' 77' ' ' SER . 20.3 m-85 -134.28 12.21 3.85 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.644 2.377 . . . . 0.0 110.774 -167.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.15 -156.82 27.38 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -68.5 -132.91 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.444 1.498 . . . . 0.0 108.446 160.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -74.69 170.57 15.55 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.092 -1.63 . . . . 0.0 111.257 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -130.6 178.5 6.58 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.96 1.704 . . . . 0.0 108.038 169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.74 172.84 2.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.198 0.999 . . . . 0.0 112.11 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -79.46 99.19 7.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 160.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.063 1.345 . . . . 0.0 112.269 -166.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -160.6 175.7 12.4 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.009 1.324 . . . . 0.0 108.32 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.41 26.67 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.169 1.388 . . . . 0.0 109.557 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.38 -46.61 81.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.62 132.25 34.2 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -133.67 154.94 50.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.331 1.853 . . . . 0.0 109.224 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.517 ' CD2' ' HG1' ' A' ' 119' ' ' THR . 80.7 m80 -75.84 85.5 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.047 1.339 . . . . 0.0 110.27 -168.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -7.83 59.63 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 113.962 -172.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.71 -178.8 33.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.37 156.06 53.71 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.864 1.709 . . . . 0.0 110.514 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.85 89.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.981 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.85 160.94 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.241 2.02 . . . . 0.0 107.8 169.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.21 136.59 54.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.239 1.416 . . . . 0.0 107.303 169.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -127.08 138.29 53.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.8 mtp -67.57 152.86 44.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 158.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.89 154.72 36.73 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.531 1.532 . . . . 0.0 108.874 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -138.49 -171.19 3.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.132 2.173 . . . . 0.0 107.301 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.94 25.15 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.76 1.624 . . . . 0.0 110.593 -175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.67 -161.58 24.79 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.2 154.86 60.1 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 120.474 2.137 . . . . 0.0 109.4 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 43.99 43.66 5.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.716 2.406 . . . . 0.0 114.136 159.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.6 p -132.59 29.79 4.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.258 1.423 . . . . 0.0 110.048 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -71.39 107.69 4.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.79 -95.21 1.55 Allowed Glycine 0 C--O 1.225 -0.423 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 p -129.65 1.7 4.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.787 1.635 . . . . 0.0 110.893 170.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -58.3 141.84 49.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.905 1.682 . . . . 0.0 108.359 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.61 174.39 15.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -147.35 161.08 41.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 158.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.39 129.05 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 159.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.45 118.19 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.442 ' HG1' ' CD ' ' A' ' 143' ' ' GLU . 22.7 p -108.09 21.32 17.54 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.673 1.589 . . . . 0.0 109.521 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -156.57 174.75 14.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 167.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -71.53 85.41 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 162.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.517 ' HG1' ' CD2' ' A' ' 92' ' ' HIS . 12.4 p -78.18 60.34 2.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.273 1.029 . . . . 0.0 110.781 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.34 -15.1 62.99 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.667 -1.27 . . . . 0.0 112.453 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -76.87 -18.04 58.59 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.104 1.361 . . . . 0.0 111.944 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.2 mt -97.74 -7.94 29.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.179 1.392 . . . . 0.0 110.402 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.62 138.3 56.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.93 -11.29 1.97 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.586 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -93.76 -39.0 10.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.666 1.733 . . . . 0.0 108.421 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -130.92 155.6 46.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.092 0.472 . . . . 0.0 111.433 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.29 93.54 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.531 1.532 . . . . 0.0 108.195 -165.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.59 131.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 1.18 0.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.248 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -163.27 -175.16 33.98 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -153.0 150.93 29.71 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.838 0.855 . . . . 0.0 110.016 165.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.98 117.56 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.574 1.549 . . . . 0.0 107.653 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -72.62 -48.31 40.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.318 167.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -149.23 160.29 43.51 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 109.064 -162.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.02 16.29 76.62 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.515 0.579 . . . . 0.0 113.392 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -37.74 67.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.816 1.808 . . . . 0.0 111.195 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.0 -21.08 65.07 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.056 -1.028 . . . . 0.0 113.752 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.4 mm -81.79 -34.43 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.186 1.394 . . . . 0.0 108.835 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.44 -37.1 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.668 -1.27 . . . . 0.0 109.348 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -69.79 -23.75 63.39 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 120.546 -1.346 . . . . 0.0 112.595 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.63 -42.85 77.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.965 -1.084 . . . . 0.0 109.626 168.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 23.0 mtp -62.32 -46.9 86.65 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 122.331 -0.231 . . . . 0.0 110.972 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.442 ' CD ' ' HG1' ' A' ' 116' ' ' THR . 13.7 mt-10 -66.14 -29.69 70.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -76.49 -15.99 59.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.328 0.967 . . . . 0.0 112.46 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -95.05 18.82 11.39 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 127.088 2.155 . . . . 0.0 112.285 163.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.49 -147.89 15.36 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.418 1.961 . . . . 0.0 110.616 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.3 p -146.14 -81.86 0.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.451 0.625 . . . . 0.0 110.807 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 169.06 -21.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 131.529 3.932 . . . . 0.0 111.215 167.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -19.57 63.93 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.776 1.171 . . . . 0.0 109.855 159.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.03 -26.91 10.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.565 -1.131 . . . . 0.0 111.894 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -70.83 123.63 22.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 119.416 1.608 . . . . 0.0 107.054 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.8 p -72.18 153.98 41.31 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.205 1.802 . . . . 0.0 111.553 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.82 -5.02 59.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.782 1.233 . . . . 0.0 112.426 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.448 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 20.4 mmtt -137.97 161.23 37.22 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.793 2.037 . . . . 0.0 109.212 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -75.1 89.07 2.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 163.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.58 130.7 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.73 162.81 36.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.055 0.942 . . . . 0.0 111.743 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.417 HD13 ' CE2' ' A' ' 48' ' ' TYR . 3.9 mp -91.37 119.55 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 158.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.98 -58.92 6.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 164.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -152.79 167.62 28.42 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 49' ' ' LYS . 15.6 p -162.04 171.83 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.52 0.6 . . . . 0.0 111.414 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.32 176.54 48.06 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -76.25 158.38 31.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.575 1.55 . . . . 0.0 109.284 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.1 mt -137.4 42.74 2.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.102 0.953 . . . . 0.0 109.098 159.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.247 0.959 0 C-N-CA 125.143 1.377 . . . . 0.0 107.862 -177.768 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.8 t -68.02 176.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 161.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -48.65 110.8 1.58 Allowed Pre-proline 0 C--O 1.236 0.345 0 CA-C-O 117.422 -1.275 . . . . 0.0 108.922 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -65.19 133.36 35.02 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 CA-C-N 120.774 1.312 . . . . 0.0 109.66 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -89.41 152.3 21.56 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -135.91 157.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.019 -1.051 . . . . 0.0 109.036 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -124.65 153.5 42.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.227 1.011 . . . . 0.0 108.727 170.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -132.86 117.96 18.37 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.496 1.918 . . . . 0.0 106.053 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.02 97.16 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.7 mm -68.77 147.54 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.72 153.37 45.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.309 1.844 . . . . 0.0 109.577 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.92 108.36 19.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.27 13.95 4.29 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 114.236 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.49 -0.5 63.45 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.55 1.071 . . . . 0.0 112.889 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.12 146.71 90.15 Favored Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 159.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 130.55 27.29 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 N-CA-C 107.819 -1.646 . . . . 0.0 107.819 160.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 tp -91.87 -41.69 10.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 108.98 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.46 156.8 8.16 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 118.115 0.416 . . . . 0.0 112.99 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -82.56 114.08 20.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.801 1.24 . . . . 0.0 109.126 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.08 155.65 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.797 1.639 . . . . 0.0 107.082 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -142.14 148.51 38.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 123.46 1.6 . . . . 0.0 111.322 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -131.71 159.61 37.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 113.524 -1.671 . . . . 0.0 107.899 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -120.52 144.41 48.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.785 1.634 . . . . 0.0 106.785 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.85 114.81 16.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -170.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.56 64.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.854 1.662 . . . . 0.0 110.885 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.85 -14.18 60.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 112.607 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -71.02 -36.21 72.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.506 1.122 . . . . 0.0 110.791 168.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -85.77 -56.18 3.61 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.953 0.901 . . . . 0.0 108.907 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.14 71.01 80.23 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.226 1.81 . . . . 0.0 109.385 -165.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 -30.76 78.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.577 2.185 . . . . 0.0 113.626 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -52.3 57.98 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.786 1.63 . . . . 0.0 108.032 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.6 m -63.38 -44.82 93.63 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.577 1.151 . . . . 0.0 110.607 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.26 91.86 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.818 -0.551 . . . . 0.0 111.871 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.37 -44.71 78.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.433 1.093 . . . . 0.0 110.651 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -54.32 -48.39 71.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.678 1.191 . . . . 0.0 109.604 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -64.35 -36.44 84.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.425 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -57.79 -63.35 1.28 Allowed 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.283 1.033 . . . . 0.0 109.521 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.84 71.81 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.806 0.692 . . . . 0.0 111.205 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.0 mt -67.06 -36.09 81.27 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 121.375 -0.828 . . . . 0.0 110.845 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -68.22 -28.76 67.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.345 0.975 . . . . 0.0 111.999 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -93.95 -26.01 17.03 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.076 0.55 . . . . 0.0 111.201 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 -0.29 86.77 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.902 0.774 . . . . 0.0 112.561 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -38.83 77.45 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.552 1.141 . . . . 0.0 111.991 -165.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -72.55 3.85 4.5 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.08 4.54 84.17 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 119.528 1.058 . . . . 0.0 111.506 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.58 169.8 19.52 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.754 1.621 . . . . 0.0 107.167 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.46 -178.51 36.45 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-O 122.775 1.208 . . . . 0.0 110.633 -167.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -84.73 -23.88 29.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.124 -1.538 . . . . 0.0 111.6 -159.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -46.62 111.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.04 2.136 . . . . 0.0 109.569 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.38 9.69 83.25 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 117.668 -1.629 . . . . 0.0 116.244 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.1 m -68.64 -21.87 64.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.736 2.768 . . . . 0.0 113.209 -174.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.2 t 67.11 132.81 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 129.273 3.029 . . . . 0.0 112.474 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -77.67 76.87 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.52 1.528 . . . . 0.0 108.326 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -74.1 -7.32 52.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.239 1.416 . . . . 0.0 113.56 -174.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -123.63 128.43 49.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 159.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.6 mt -134.49 106.64 8.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 161.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.5 mt -111.52 98.09 39.12 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.51 124.59 14.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 123.921 3.081 . . . . 0.0 113.11 -170.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.419 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . 66.66 38.54 93.3 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.886 1.707 . . . . 0.0 111.237 -178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -143.13 -81.36 0.19 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.769 1.284 . . . . 0.0 108.624 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.31 169.91 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.328 168.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m -121.08 107.92 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.249 1.819 . . . . 0.0 108.329 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -99.05 138.26 36.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.13 0.972 . . . . 0.0 108.495 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.02 1.98 0.5 Allowed Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.509 -1.162 . . . . 0.0 115.936 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.12 51.4 4.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.773 1.787 . . . . 0.0 115.284 -162.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.16 69.12 1.34 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.334 1.067 . . . . 0.0 110.896 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.545 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 31.9 p90 -70.14 -6.08 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.095 0.958 . . . . 0.0 112.812 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -113.9 -38.99 4.07 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 120.871 -1.143 . . . . 0.0 110.625 -160.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -128.44 -17.78 4.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.203 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 45.27 35.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.977 2.111 . . . . 0.0 112.916 175.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -140.78 10.14 2.21 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.386 -0.821 . . . . 0.0 111.961 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.3 -1.9 79.14 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.966 -1.463 . . . . 0.0 112.884 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 p -95.96 -6.48 38.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 120.007 1.903 . . . . 0.0 110.975 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.32 179.1 38.96 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 118.993 0.815 . . . . 0.0 112.315 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.61 115.69 2.21 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 125.471 1.51 . . . . 0.0 111.245 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.545 ' HE3' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -133.76 169.44 17.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.495 1.918 . . . . 0.0 107.234 166.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.3 p -83.74 -175.18 5.69 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.606 0.639 . . . . 0.0 109.532 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.4 pt -83.48 -20.17 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.841 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -79.74 -35.08 39.34 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.567 0.621 . . . . 0.0 109.422 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.1 -142.07 6.67 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 107.029 -2.428 . . . . 0.0 107.029 -167.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -68.82 -156.22 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.033 0.916 . . . . 0.0 110.664 168.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.0 mttt -64.96 126.89 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 120.415 -1.428 . . . . 0.0 109.91 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -89.5 175.73 7.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -77.92 175.28 10.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 11.3 t70 -86.75 104.34 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.883 2.873 . . . . 0.0 108.001 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.15 -41.23 81.88 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.631 -162.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 159.07 157.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 129.354 3.062 . . . . 0.0 111.604 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -106.59 30.14 6.31 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.42 1.888 . . . . 0.0 110.614 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.1 mt -53.01 -48.39 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.209 1.003 . . . . 0.0 108.472 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.89 130.4 36.12 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -130.54 169.57 15.4 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.265 1.426 . . . . 0.0 110.687 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.436 ' CD2' ' HG1' ' A' ' 119' ' ' THR . 63.6 m80 -82.19 81.58 8.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.131 1.372 . . . . 0.0 108.896 -173.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.0 p -75.84 -32.01 59.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.054 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.22 -178.74 44.37 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.628 1.585 . . . . 0.0 110.884 -175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.21 165.1 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.833 2.355 . . . . 0.0 111.226 171.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.44 8.47 75.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.251 -1.305 . . . . 0.0 112.923 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.0 mm -85.61 151.46 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 121.012 2.406 . . . . 0.0 108.953 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.46 131.2 57.0 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.367 -1.458 . . . . 0.0 108.924 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.8 t -148.47 158.27 44.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.497 0.719 . . . . 0.0 111.385 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.2 mtp -83.49 135.34 34.7 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 124.283 1.033 . . . . 0.0 111.664 -171.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.08 71.23 5.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 123.088 1.423 . . . . 0.0 107.558 168.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -75.66 -172.75 1.97 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.27 160.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.21 16.32 9.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.29 1.836 . . . . 0.0 111.423 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.56 -175.37 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.293 1.901 . . . . 0.0 108.782 -164.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.48 142.71 91.41 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.829 1.686 . . . . 0.0 110.017 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' H ' ' HB2' ' A' ' 85' ' ' ASP . 31.3 m-20 64.14 38.26 8.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.931 2.092 . . . . 0.0 112.19 167.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 p -127.87 38.14 4.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.633 0.773 . . . . 0.0 109.81 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -89.88 110.61 21.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.959 1.304 . . . . 0.0 109.139 -172.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.16 -132.57 5.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.2 p -85.49 -18.5 33.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.582 0.753 . . . . 0.0 111.46 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -67.84 126.02 28.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.224 1.012 . . . . 0.0 108.757 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -154.03 171.06 19.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 107.73 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -141.19 157.95 44.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.433 1.111 . . . . 0.0 112.046 169.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.25 103.91 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 166.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 9.2 m -60.4 126.12 26.26 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.9 p -116.6 23.15 12.23 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.799 1.24 . . . . 0.0 109.006 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -150.69 175.85 11.57 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.624 -0.673 . . . . 0.0 109.883 162.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -64.69 84.87 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 159.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.436 ' HG1' ' CD2' ' A' ' 92' ' ' HIS . 8.3 p -82.1 53.4 2.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.086 0.554 . . . . 0.0 111.161 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -63.63 -20.91 66.07 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.148 -1.595 . . . . 0.0 113.159 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -69.98 -4.7 21.95 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.265 1.426 . . . . 0.0 112.079 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.6 mt -105.32 -8.17 18.41 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.897 1.279 . . . . 0.0 111.275 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.46 152.47 43.86 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.631 1.105 . . . . 0.0 109.122 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.39 -1.52 65.27 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.726 1.155 . . . . 0.0 113.421 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -132.22 -56.97 0.97 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.891 1.677 . . . . 0.0 108.283 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -99.47 129.29 45.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -170.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.39 104.99 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.92 132.71 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.29 -4.79 1.66 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.8 -173.13 27.9 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.973 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -155.54 146.37 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.507 1.123 . . . . 0.0 108.669 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.68 116.67 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -86.1 -49.95 7.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.99 162.67 34.33 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.211 1.004 . . . . 0.0 112.923 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.98 15.76 66.63 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.142 0.877 . . . . 0.0 112.816 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.3 tpt -55.87 -28.67 57.68 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.749 1.775 . . . . 0.0 111.958 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -62.82 -35.32 79.53 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.244 -0.91 . . . . 0.0 113.194 172.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.98 -39.15 81.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.89 -41.3 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.757 0.708 . . . . 0.0 109.732 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.32 -27.46 69.04 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.703 -1.248 . . . . 0.0 113.244 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.03 -46.57 42.59 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.165 -0.959 . . . . 0.0 109.218 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 79.5 mtp -53.06 -47.58 68.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.249 1.02 . . . . 0.0 110.036 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 59' ' ' GLY . 10.5 mt-10 -62.36 -30.68 71.35 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.702 0.801 . . . . 0.0 112.647 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -24.04 64.45 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.52 -0.738 . . . . 0.0 111.372 174.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -97.08 6.59 48.28 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.872 1.669 . . . . 0.0 112.099 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.07 -173.38 35.92 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 169.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.4 p -157.62 158.88 36.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 166.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.28 -22.39 64.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -6.07 53.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.177 0.899 . . . . 0.0 112.779 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.24 -30.66 9.93 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.09 2.281 . . . . 0.0 112.875 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.04 138.03 26.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.076 0.95 . . . . 0.0 109.498 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.1 p -98.25 138.6 35.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -18.67 63.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.831 0.852 . . . . 0.0 112.12 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.59 161.0 32.51 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.109 0.964 . . . . 0.0 108.875 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 134.78 48.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 mt -132.35 113.56 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -132.48 175.41 9.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.623 1.169 . . . . 0.0 109.657 -166.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.33 105.61 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.22 -46.22 87.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.776 0.83 . . . . 0.0 109.976 172.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -151.24 157.4 42.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.0 p -162.68 163.04 27.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.948 0.404 . . . . 0.0 110.64 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.47 -173.01 45.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 0.0 OUTLIER -84.78 154.6 22.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.494 1.917 . . . . 0.0 109.358 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.2 mt -131.9 43.69 3.0 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.768 1.27 . . . . 0.0 110.65 160.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 39.7 tp10 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 102.093 -3.299 . . . . 0.0 102.093 166.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmm? . . . . . 0 CA--C 1.51 -0.567 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.11 155.96 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -65.39 124.8 88.1 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.525 ' CB ' HE22 ' A' ' 163' ' ' GLN . 12.8 Cg_endo -59.24 135.92 68.97 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.694 1.596 . . . . 0.0 110.62 -176.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.481 ' H ' ' HB3' ' A' ' 165' ' ' GLU . 52.5 m -94.96 145.04 25.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 m -130.53 149.98 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 171.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -110.65 161.06 16.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.457 1.103 . . . . 0.0 108.779 168.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -139.41 163.17 33.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.153 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.37 99.47 5.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 170.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.4 mm -68.72 148.68 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.0 143.73 51.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.892 0.877 . . . . 0.0 110.421 170.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.99 99.87 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 127.953 2.501 . . . . 0.0 104.338 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.62 13.95 1.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.577 1.951 . . . . 0.0 113.696 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.34 0.49 58.23 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.107 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.22 121.04 81.9 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 159.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.24 112.96 2.24 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 107.364 -1.821 . . . . 0.0 107.364 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.73 -29.42 36.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.029 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.21 167.81 13.84 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.409 0.549 . . . . 0.0 113.145 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -75.57 139.07 41.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 108.886 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -130.24 157.93 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -150.74 155.45 39.31 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.728 -1.233 . . . . 0.0 110.478 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -142.23 154.13 44.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.522 1.129 . . . . 0.0 109.447 -170.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.09 141.2 30.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.47 117.69 30.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.968 1.307 . . . . 0.0 107.518 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.29 53.88 0.14 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.906 2.482 . . . . 0.0 114.072 -168.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.47 -28.08 42.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.685 1.994 . . . . 0.0 115.062 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -27.71 67.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.575 1.08 . . . . 0.0 110.151 177.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -120.36 -21.96 6.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.097 0.959 . . . . 0.0 112.5 -164.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 71.63 25.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.68 1.592 . . . . 0.0 107.758 167.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.82 -45.88 37.59 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.951 2.434 . . . . 0.0 111.819 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -54.62 37.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.147 0.885 . . . . 0.0 110.959 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -38.48 86.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.855 -0.528 . . . . 0.0 110.487 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.38 -39.81 64.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.851 -0.531 . . . . 0.0 112.184 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -62.14 -45.81 91.8 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.594 1.158 . . . . 0.0 108.863 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.96 -56.37 16.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.745 0.818 . . . . 0.0 108.961 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -26.91 67.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 ttm-85 -55.0 -67.24 0.29 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.497 1.499 . . . . 0.0 107.74 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.28 -38.74 59.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.816 1.246 . . . . 0.0 112.336 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.64 -42.52 86.6 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.619 -0.676 . . . . 0.0 111.132 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -70.71 -34.43 71.93 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.506 -0.746 . . . . 0.0 111.179 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.9 p -79.13 -26.89 42.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.858 -0.526 . . . . 0.0 110.465 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.47 83.08 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.589 1.09 . . . . 0.0 111.834 -176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.73 -27.82 69.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.854 0.862 . . . . 0.0 112.949 -159.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -74.65 3.56 7.65 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.57 9.3 75.58 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.156 0.889 . . . . 0.0 112.154 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -156.6 174.68 15.09 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.148 1.779 . . . . 0.0 107.601 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.68 -171.07 34.21 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-O 122.808 1.227 . . . . 0.0 114.442 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.27 -25.07 62.3 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.587 2.755 . . . . 0.0 110.369 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -52.49 108.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.568 2.347 . . . . 0.0 107.606 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.08 75.66 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.639 -1.089 . . . . 0.0 115.751 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 t -68.12 -10.46 54.24 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.514 1.657 . . . . 0.0 113.323 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t 60.18 176.58 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.82 1.248 . . . . 0.0 110.533 -161.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.05 125.69 46.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 162.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -78.88 -40.0 33.58 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -139.74 110.78 6.9 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 -159.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.3 mt -128.06 98.14 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -173.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.4 mt -111.12 96.06 28.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -168.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.11 126.64 20.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.051 2.5 . . . . 0.0 112.388 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 36.06 60.4 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.697 1.617 . . . . 0.0 111.77 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -150.32 -76.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.371 1.085 . . . . 0.0 108.545 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.4 171.59 18.8 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.629 0.772 . . . . 0.0 111.121 171.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 30.3 p -128.99 111.64 13.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.309 0.644 . . . . 0.0 111.17 161.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -86.3 135.1 33.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.921 2.489 . . . . 0.0 110.822 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.89 -161.35 9.95 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.751 2.119 . . . . 0.0 108.524 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.79 6.55 67.35 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.086 0.943 . . . . 0.0 113.229 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.72 123.1 29.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 166.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -128.2 7.31 5.96 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.183 1.356 . . . . 0.0 111.989 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.5 p -125.03 -13.24 6.87 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.761 1.625 . . . . 0.0 112.203 168.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -132.38 -175.96 3.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 130.171 3.389 . . . . 0.0 105.84 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -164.53 54.0 0.13 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 166.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -159.08 -1.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.415 . . . . 0.0 113.921 -166.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.91 3.12 49.13 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 117.605 -1.664 . . . . 0.0 115.476 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.1 p -131.12 17.67 5.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.095 2.448 . . . . 0.0 115.65 -165.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.35 -94.29 0.64 Allowed Glycine 0 C--N 1.338 0.659 0 O-C-N 120.287 -1.508 . . . . 0.0 112.125 -165.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -7.12 112.63 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 129.077 3.227 . . . . 0.0 115.519 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -127.47 155.52 43.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 128.792 2.837 . . . . 0.0 108.683 -161.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.0 p -72.15 172.59 9.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.91 1.338 . . . . 0.0 110.389 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.8 pt -75.53 -20.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.061 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -77.71 -36.71 50.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.196 0.998 . . . . 0.0 110.195 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.59 109.05 0.89 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.336 0.1 OUTLIER 37.25 -133.5 0.09 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.148 1.779 . . . . 0.0 113.041 177.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.17 161.9 17.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 121.116 1.78 . . . . 0.0 112.234 -176.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -126.52 165.81 18.44 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.144 1.778 . . . . 0.0 110.206 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.78 154.48 36.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.665 0.745 . . . . 0.0 111.968 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.34 123.17 21.07 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.297 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.26 -50.59 69.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.506 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -176.75 171.31 2.26 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.986 2.914 . . . . 0.0 107.502 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -123.03 38.01 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.726 1.61 . . . . 0.0 109.295 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 mt -63.53 -44.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 74.4 mt -81.05 128.3 33.57 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -136.46 163.37 30.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.362 -167.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.588 ' CG ' ' HG1' ' A' ' 119' ' ' THR . 31.3 m80 -78.17 90.78 4.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.528 1.131 . . . . 0.0 111.694 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.92 35.07 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.855 -1.153 . . . . 0.0 111.679 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -60.62 165.93 10.71 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.852 2.368 . . . . 0.0 111.75 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.36 -0.16 49.9 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.525 1.059 . . . . 0.0 112.955 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.08 164.31 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.627 1.713 . . . . 0.0 107.914 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.7 128.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.919 -1.113 . . . . 0.0 109.593 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -143.41 165.29 27.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.328 0.585 . . . . 0.0 110.585 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.415 ' SD ' ' HB3' ' A' ' 108' ' ' ASN . 6.5 ttm -104.75 127.48 52.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -166.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.69 74.99 5.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.052 1.341 . . . . 0.0 108.422 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -70.01 175.05 4.71 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.235 158.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.22 19.73 4.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.264 1.425 . . . . 0.0 111.77 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.84 -167.91 29.34 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.83 159.92 43.42 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-N 119.361 1.58 . . . . 0.0 108.433 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 33.61 54.77 0.52 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.107 3.363 . . . . 0.0 111.944 175.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -131.84 22.49 4.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.743 1.217 . . . . 0.0 111.813 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.415 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 67.8 m-80 -67.29 109.69 3.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.787 2.435 . . . . 0.0 107.69 177.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.05 -85.42 0.91 Allowed Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.315 0.961 . . . . 0.0 111.727 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.0 t -155.92 -30.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.831 1.652 . . . . 0.0 109.381 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -53.91 125.57 19.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.513 1.525 . . . . 0.0 106.983 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -148.74 170.95 17.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.602 1.561 . . . . 0.0 108.079 -168.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -142.03 151.65 42.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.945 0.498 . . . . 0.0 110.86 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.53 122.68 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.43 118.86 12.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.1 p -112.53 27.92 9.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.1 0.952 . . . . 0.0 109.169 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.8 176.04 13.09 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.908 1.283 . . . . 0.0 107.54 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.51 89.17 0.23 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 162.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.588 ' HG1' ' CG ' ' A' ' 92' ' ' HIS . 1.8 p -74.77 57.6 0.77 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.449 1.099 . . . . 0.0 111.123 -178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.34 -20.58 66.46 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.604 -1.31 . . . . 0.0 112.719 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.401 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 29.1 p90 -74.52 -10.57 59.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.994 1.718 . . . . 0.0 111.574 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.7 mt -113.77 -6.65 13.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.205 1.402 . . . . 0.0 111.226 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -76.52 148.76 36.92 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.037 0.935 . . . . 0.0 109.579 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.09 18.6 57.86 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.081 -170.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -140.11 -35.0 0.52 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.488 1.144 . . . . 0.0 109.985 -171.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -112.99 157.95 20.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.366 1.066 . . . . 0.0 109.333 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.3 t -90.18 102.62 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.94 127.61 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 162.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.46 1.79 2.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.396 -0.811 . . . . 0.0 112.341 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.47 -177.54 35.58 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 119.632 1.106 . . . . 0.0 112.612 172.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -150.27 153.11 35.59 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.071 1.348 . . . . 0.0 108.253 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.8 t -60.88 125.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -82.21 -49.79 9.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 162.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -152.08 159.82 43.58 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.948 0.899 . . . . 0.0 111.668 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.94 24.74 61.28 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -54.96 -36.69 65.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.541 1.17 . . . . 0.0 110.704 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -62.18 -27.74 69.18 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.57 -39.91 47.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 CA-C-N 119.788 1.176 . . . . 0.0 108.828 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.98 -44.23 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.45 -29.15 70.21 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.349 -0.845 . . . . 0.0 112.586 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.05 64.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 120.587 -1.32 . . . . 0.0 109.604 173.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.3 mtp -57.62 -45.06 85.87 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.49 -32.79 73.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.469 1.108 . . . . 0.0 113.584 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -72.11 -22.57 61.32 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.538 1.517 . . . . 0.0 110.667 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -94.83 8.94 41.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.359 1.464 . . . . 0.0 111.652 170.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.54 -169.27 41.62 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 126.082 1.801 . . . . 0.0 109.083 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.3 p -156.94 159.21 37.87 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 160.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.4 mtm-85 -69.45 -16.16 63.42 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.228 -1.545 . . . . 0.0 114.516 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -71.94 -14.56 61.95 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.18 -0.95 . . . . 0.0 112.969 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.48 -20.11 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.878 2.18 . . . . 0.0 114.31 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -71.44 128.72 36.8 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.211 2.005 . . . . 0.0 108.104 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.1 p -67.62 159.34 30.12 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 110.99 167.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -70.71 -41.3 72.13 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 158.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -99.5 157.97 16.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 0.0 111.869 -168.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -69.49 123.78 22.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 158.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.1 mt -120.42 136.04 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.288 1.858 . . . . 0.0 107.924 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.82 169.16 24.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.663 -158.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.83 113.39 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 163.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.71 -53.12 52.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -156.75 165.39 36.37 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.192 1.397 . . . . 0.0 108.897 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.8 p -178.51 165.16 1.72 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.553 1.541 . . . . 0.0 109.726 -168.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.58 -175.71 46.61 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.525 HE22 ' CB ' ' A' ' 4' ' ' PRO . 35.6 tp60 -79.72 152.06 30.08 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.441 1.496 . . . . 0.0 109.879 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 40.0 mt -137.95 42.73 2.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 120.432 1.469 . . . . 0.0 111.77 159.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.491 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 2.7 tm-20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.956 2.502 . . . . 0.0 107.521 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 3' ' ' ASN . 9.9 p -147.25 -173.98 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.439 ' H ' HG23 ' A' ' 2' ' ' VAL . 1.1 m120 -48.87 112.02 2.2 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 116.508 -1.71 . . . . 0.0 108.619 162.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.99 140.06 92.61 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 CA-C-N 121.339 1.514 . . . . 0.0 110.063 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 ' CG2' ' HE3' ' A' ' 133' ' ' LYS . 76.1 m -106.0 144.47 32.67 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 165.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.47 134.11 17.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -94.59 157.87 15.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.903 0.881 . . . . 0.0 110.865 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -145.63 112.95 6.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.097 1.359 . . . . 0.0 107.799 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.26 97.55 6.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.6 mm -66.5 146.53 13.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.284 1.034 . . . . 0.0 109.152 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.13 168.89 18.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.647 1.179 . . . . 0.0 110.389 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.2 109.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 57.04 13.92 1.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.754 1.622 . . . . 0.0 113.131 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.22 -5.71 31.94 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.63 1.586 . . . . 0.0 113.849 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -81.95 113.26 41.83 Favored Pre-proline 0 CA--C 1.52 -0.187 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.4 121.68 9.57 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.318 1.345 . . . . 0.0 110.241 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.8 tp -93.36 -25.56 17.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.675 0.79 . . . . 0.0 110.922 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.25 162.74 9.6 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.665 0.65 . . . . 0.0 112.034 168.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -79.26 142.21 36.39 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.77 158.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 128.008 2.523 . . . . 0.0 105.808 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -140.58 153.43 46.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.337 1.065 . . . . 0.0 109.137 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -135.28 159.86 40.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.324 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -110.57 145.26 38.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 167.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.3 128.99 50.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.296 1.438 . . . . 0.0 108.685 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.21 61.79 7.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.261 1.025 . . . . 0.0 112.984 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -9.95 25.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.017 -1.052 . . . . 0.0 113.554 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.36 -16.51 58.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.247 1.419 . . . . 0.0 112.138 171.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -47.89 1.07 Allowed 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 0.0 110.511 -166.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.37 78.38 45.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.374 1.47 . . . . 0.0 107.345 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.71 -45.8 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.371 2.047 . . . . 0.0 110.386 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -36.64 84.81 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.242 1.383 . . . . 0.0 109.191 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -69.52 -52.69 24.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.496 0.589 . . . . 0.0 109.805 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.59 91.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.304 0.642 . . . . 0.0 112.242 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.54 -51.32 70.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.259 1.423 . . . . 0.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.04 -49.06 74.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.892 1.277 . . . . 0.0 110.488 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.07 -40.12 94.21 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.345 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -52.85 -56.92 12.28 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.152 0.887 . . . . 0.0 109.476 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.8 48.86 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.412 1.485 . . . . 0.0 113.15 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.29 -32.46 38.13 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.761 0.824 . . . . 0.0 111.431 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 p -78.53 -38.25 40.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.383 0.992 . . . . 0.0 113.293 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -64.08 -31.06 72.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.49 11.71 72.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.98 -33.18 70.38 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.012 1.725 . . . . 0.0 110.716 -172.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -71.46 -4.88 28.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.33 1.052 . . . . 0.0 112.696 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.76 16.12 46.63 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.419 1.009 . . . . 0.0 112.104 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -169.96 175.32 5.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.938 1.695 . . . . 0.0 109.1 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.49 -142.29 13.62 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-O 121.925 0.736 . . . . 0.0 113.307 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CE1' HD12 ' A' ' 158' ' ' ILE . 0.6 OUTLIER -63.31 -28.34 69.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.889 2.076 . . . . 0.0 110.997 -167.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.5 tttt -57.41 124.07 17.64 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.683 -0.636 . . . . 0.0 109.389 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 10.37 52.77 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.358 -1.245 . . . . 0.0 114.412 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.6 m -68.01 104.4 1.74 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.117 1.959 . . . . 0.0 106.071 165.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.409 ' SG ' ' HE2' ' A' ' 155' ' ' LYS . 52.8 m -75.38 131.68 40.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -73.69 105.1 4.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.082 0.944 . . . . 0.0 109.068 -169.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -81.01 -32.68 34.09 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.093 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -127.79 86.73 2.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.134 0.879 . . . . 0.0 108.833 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.3 mt -104.45 109.53 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.32 99.73 52.75 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.98 144.36 99.48 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.551 1.501 . . . . 0.0 112.448 -172.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . 56.87 31.43 61.11 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 126.539 2.018 . . . . 0.0 112.168 -168.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -142.4 -79.93 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.487 1.644 . . . . 0.0 108.545 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 165.15 25.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.798 0.839 . . . . 0.0 110.635 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.0 m -127.1 92.46 3.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.696 1.998 . . . . 0.0 108.77 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.04 132.3 42.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.964 1.306 . . . . 0.0 110.572 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.19 -169.48 11.89 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.074 1.797 . . . . 0.0 108.964 168.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.27 5.49 89.57 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.632 -0.922 . . . . 0.0 114.432 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.97 92.51 7.85 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 166.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -106.24 -5.84 18.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.509 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.6 p -122.29 -24.63 5.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.595 1.558 . . . . 0.0 111.551 -173.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -124.88 179.47 5.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 158.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.8 72.01 0.5 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 169.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -168.79 -10.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.886 2.474 . . . . 0.0 111.235 -172.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.41 -6.4 28.34 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.069 -1.406 . . . . 0.0 112.85 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.3 p -84.09 -24.33 30.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.741 1.77 . . . . 0.0 112.933 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.92 -135.3 8.09 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 122.515 1.064 . . . . 0.0 114.772 -159.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.11 168.37 4.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.67 1.605 . . . . 0.0 111.776 -162.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -169.59 149.09 3.83 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.1 p -70.56 164.57 24.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.6 pt -56.88 -29.61 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 110.267 162.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -79.25 6.35 10.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.466 1.506 . . . . 0.0 112.584 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.16 -53.76 0.75 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.192 1.36 . . . . 0.0 113.064 166.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -147.72 -139.26 0.1 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -161.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -75.97 166.57 23.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.314 0.961 . . . . 0.0 108.897 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -142.22 177.8 7.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.11 148.19 51.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.192 0.996 . . . . 0.0 113.204 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.96 73.95 0.89 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.897 2.479 . . . . 0.0 108.01 161.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.82 -59.85 3.99 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.255 1.822 . . . . 0.0 112.659 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.48 172.84 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.303 159.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.27 26.44 7.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.264 2.225 . . . . 0.0 110.797 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 mt -57.56 -48.23 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 120.927 -1.108 . . . . 0.0 110.182 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.68 123.72 23.85 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -103.26 165.26 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.072 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -77.91 75.81 4.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.076 1.351 . . . . 0.0 109.581 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -66.01 -27.54 68.2 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.42 -177.35 45.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.95 0.795 . . . . 0.0 111.751 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -59.23 147.14 92.13 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.868 1.712 . . . . 0.0 109.7 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.91 70.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.432 -1.205 . . . . 0.0 112.362 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.67 163.56 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 120.446 2.123 . . . . 0.0 108.9 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.14 127.96 37.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.033 1.333 . . . . 0.0 109.205 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.6 t -140.94 164.24 30.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.773 0.797 . . . . 0.0 110.49 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.99 140.54 29.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 -167.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.08 57.12 1.45 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.68 1.228 . . . . 0.0 108.614 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -61.35 170.51 1.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.951 158.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.23 13.94 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.62 1.168 . . . . 0.0 111.713 -169.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.27 -171.92 27.01 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -160.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -60.6 157.02 38.92 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.145 1.897 . . . . 0.0 110.037 171.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER 34.56 47.27 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.17 2.588 . . . . 0.0 113.716 173.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 p -124.19 22.38 8.65 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.811 0.844 . . . . 0.0 111.599 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -64.52 122.82 17.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.043 1.737 . . . . 0.0 108.762 173.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.49 -97.2 0.57 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.1 p -134.33 -23.77 1.65 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.079 0.952 . . . . 0.0 112.248 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.02 135.01 57.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -141.83 176.19 9.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -139.69 152.27 46.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 109.857 162.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.8 mt -83.17 122.98 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 163.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.3 m -68.5 113.61 6.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 167.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.2 p -108.36 30.68 6.21 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.51 173.51 14.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.814 1.645 . . . . 0.0 107.649 165.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.86 89.82 0.28 Allowed 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 162.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.29 53.75 0.53 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.387 1.475 . . . . 0.0 110.276 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -64.67 -21.74 66.81 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 119.921 -1.737 . . . . 0.0 112.39 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -73.31 -2.22 21.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.532 1.133 . . . . 0.0 111.969 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -115.42 -5.42 12.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.234 1.414 . . . . 0.0 111.528 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.82 142.44 57.94 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.061 0.846 . . . . 0.0 111.45 -172.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.57 12.61 61.84 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.268 -1.296 . . . . 0.0 113.709 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.37 -24.06 1.42 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.2 2.0 . . . . 0.0 113.34 -169.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -125.19 140.96 52.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.961 0.904 . . . . 0.0 110.085 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 63.2 t -78.89 101.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -171.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.51 123.49 16.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 164.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.02 -1.45 2.66 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.4 -173.04 27.33 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 119.296 0.953 . . . . 0.0 111.727 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -154.28 145.25 22.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.031 1.332 . . . . 0.0 108.729 -172.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.43 115.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 161.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.403 ' HE3' ' CG2' ' A' ' 5' ' ' THR . 12.4 ttmm -74.12 -54.38 7.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -153.98 167.09 30.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.322 2.249 . . . . 0.0 109.242 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.33 69.47 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.517 -0.739 . . . . 0.0 112.733 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.6 tpt -55.87 -35.51 66.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.633 1.217 . . . . 0.0 110.9 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -62.92 -31.31 72.36 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.829 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.74 -39.73 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.53 -37.37 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.686 -0.634 . . . . 0.0 109.942 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.485 ' CD ' HH21 ' A' ' 144' ' ' ARG . 3.1 mm-40 -57.86 -42.96 85.59 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 110.529 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.19 95.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.881 0.764 . . . . 0.0 109.027 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.8 mtm -54.94 -44.85 74.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.228 0.211 . . . . 0.0 110.987 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 59' ' ' GLY . 8.1 mt-10 -58.42 -37.46 75.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.485 HH21 ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -66.4 -24.82 66.53 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.828 1.195 . . . . 0.0 110.35 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -91.03 10.81 25.15 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.475 1.11 . . . . 0.0 112.017 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.67 -153.44 6.04 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.855 1.207 . . . . 0.0 111.502 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.5 p -141.62 -86.51 0.17 Allowed 'General case' 0 C--O 1.223 -0.306 0 O-C-N 122.044 -0.68 . . . . 0.0 110.081 160.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 178.14 -17.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 129.798 3.239 . . . . 0.0 110.343 161.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -68.35 -27.06 65.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.001 0.818 . . . . 0.0 110.013 158.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 123.25 -35.3 3.39 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-O 118.606 -1.108 . . . . 0.0 111.748 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -65.13 124.36 21.92 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.391 1.096 . . . . 0.0 108.195 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.0 p -64.25 154.04 36.27 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 110.261 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.0 p -68.41 -26.79 65.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.296 0.639 . . . . 0.0 110.789 167.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -132.98 169.76 16.34 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.415 1.086 . . . . 0.0 111.093 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HE2' ' SG ' ' A' ' 52' ' ' CYS . 75.8 tttt -83.89 84.85 7.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 121.089 1.768 . . . . 0.0 109.677 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.0 mm -73.79 126.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.34 163.52 32.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.346 1.069 . . . . 0.0 110.969 -163.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.45 HD12 ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -94.98 115.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 159.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.97 13.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.404 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 1.4 t70 -148.62 163.26 37.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.086 0.554 . . . . 0.0 109.65 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.8 p -167.91 167.9 12.52 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.278 0.631 . . . . 0.0 111.933 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.16 178.52 42.44 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.489 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.3 tp60 -76.24 147.02 38.61 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.829 1.652 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 12.9 mt -137.87 43.3 2.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.235 1.014 . . . . 0.0 112.455 162.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.489 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 19.7 mt-10 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 123.887 0.875 . . . . 0.0 110.913 168.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ppp? . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 71.4 t 63.89 175.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.855 1.662 . . . . 0.0 109.696 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.79 82.63 66.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 170.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.56 137.93 48.08 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.415 1.41 . . . . 0.0 110.301 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.503 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 88.2 m -95.14 147.33 23.55 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.08 153.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.689 1.195 . . . . 0.0 107.864 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -128.55 157.3 41.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.432 1.093 . . . . 0.0 109.792 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.425 ' CE1' ' CD2' ' A' ' 48' ' ' TYR . 68.9 m-85 -147.81 120.13 8.4 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.056 1.342 . . . . 0.0 107.714 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -85.41 95.53 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.1 mm -71.29 135.84 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.59 163.27 18.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.403 1.881 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 t -138.06 95.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 57.32 13.94 1.94 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.005 1.722 . . . . 0.0 112.963 -169.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.9 -9.13 29.64 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.958 1.742 . . . . 0.0 113.116 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -77.04 125.5 86.72 Favored Pre-proline 0 CA--C 1.518 -0.282 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.29 113.44 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 120.91 1.074 . . . . 0.0 109.495 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.25 -35.23 23.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.305 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 163.31 10.08 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 167.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -80.28 146.35 31.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.52 154.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.3 2.64 . . . . 0.0 105.419 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -144.99 152.03 39.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.493 1.139 . . . . 0.0 109.904 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -136.45 153.31 51.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.344 1.458 . . . . 0.0 108.406 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -97.25 146.06 25.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.455 1.902 . . . . 0.0 107.111 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.45 129.35 53.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.395 1.478 . . . . 0.0 107.529 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.61 57.11 1.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.842 1.657 . . . . 0.0 111.812 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.11 60.95 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.247 -1.533 . . . . 0.0 113.429 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -62.29 -53.35 56.41 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.875 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.24 -49.37 8.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.857 0.863 . . . . 0.0 110.541 -169.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 m -127.11 68.37 72.08 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.235 2.214 . . . . 0.0 108.737 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.48 -36.25 98.74 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.536 2.157 . . . . 0.0 112.579 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -52.6 56.73 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.716 1.144 . . . . 0.0 109.191 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 m -64.83 -39.45 93.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.46 0.704 . . . . 0.0 110.102 -174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.21 69.37 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.435 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.56 -43.08 97.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.488 1.115 . . . . 0.0 110.881 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -50.68 -60.02 3.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.365 1.466 . . . . 0.0 109.066 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -65.43 -26.46 67.97 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.418 ' HG3' HE22 ' A' ' 163' ' ' GLN . 43.1 ttp85 -60.58 -61.72 2.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.447 1.099 . . . . 0.0 109.858 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.09 69.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.74 0.65 . . . . 0.0 111.823 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -71.4 -37.06 71.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.782 -0.574 . . . . 0.0 111.063 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.5 m -70.08 -36.69 75.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.476 0.71 . . . . 0.0 110.86 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -79.6 -18.44 51.61 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.752 0.421 . . . . 0.0 111.378 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.5 7.15 72.74 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 120.554 -1.342 . . . . 0.0 111.518 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.96 4.04 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.774 1.629 . . . . 0.0 113.808 -163.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -116.94 12.65 14.73 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.332 1.453 . . . . 0.0 111.216 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.08 84.66 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.396 0.522 . . . . 0.0 112.305 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -156.93 171.99 19.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.72 39.13 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 116.99 -2.529 . . . . 0.0 114.464 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 8' ' ' PHE . 1.1 t80 -65.64 -27.07 68.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.454 2.301 . . . . 0.0 109.38 175.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -52.21 136.95 29.41 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.827 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 -0.12 46.44 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.671 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -68.74 119.36 13.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.739 2.27 . . . . 0.0 107.561 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.7 t -72.33 137.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.33 104.61 5.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -74.07 -21.51 59.89 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.41 116.72 11.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.7 mt -133.44 115.88 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.93 100.7 39.91 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.32 134.25 60.3 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.872 2.381 . . . . 0.0 111.761 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.67 32.61 83.62 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.131 1.824 . . . . 0.0 112.006 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -150.89 -74.02 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.427 1.113 . . . . 0.0 109.307 -172.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.83 167.01 31.75 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.0 m -128.13 100.25 5.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.35 1.86 . . . . 0.0 108.501 166.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -93.07 131.67 37.88 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.136 1.775 . . . . 0.0 109.437 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.99 50.73 0.22 Allowed Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.286 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.99 12.54 24.5 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 118.148 0.974 . . . . 0.0 111.773 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -85.22 23.37 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.479 1.912 . . . . 0.0 113.458 -167.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD1' HG22 ' A' ' 68' ' ' THR . 11.2 p90 -41.16 -2.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 1 C-N-CA 132.563 4.345 . . . . 0.0 118.754 -176.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.414 HG22 ' CD1' ' A' ' 67' ' ' PHE . 12.1 p -126.39 -49.49 1.54 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.969 2.508 . . . . 0.0 112.144 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 -128.21 89.1 2.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -84.24 61.43 6.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.747 3.219 . . . . 0.0 107.751 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -173.45 -22.94 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 129.235 3.014 . . . . 0.0 107.966 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.24 43.62 2.16 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 126.852 2.168 . . . . 0.0 111.436 161.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.3 p -110.96 39.01 2.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 159.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.06 -174.59 14.97 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 122.548 1.082 . . . . 0.0 112.747 -161.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.33 75.75 0.41 Allowed Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 113.069 -1.566 . . . . 0.0 111.493 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 165.87 11.97 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 111.617 -2.291 . . . . 0.0 108.75 158.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.0 p -84.16 177.91 8.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.766 0.793 . . . . 0.0 109.2 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.7 pt -70.03 -27.25 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.994 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -84.86 -21.15 29.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.141 0.976 . . . . 0.0 111.521 -169.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.57 -99.42 0.19 Allowed Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 105.023 -3.231 . . . . 0.0 105.023 -164.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.13 -157.61 0.81 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.208 1.004 . . . . 0.0 109.745 172.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -63.76 142.16 58.5 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.75 2.82 . . . . 0.0 110.107 -159.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -120.15 177.12 5.13 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.38 1.472 . . . . 0.0 108.923 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.58 163.41 27.37 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.24 87.65 0.82 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 108.988 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -46.38 -53.86 10.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.955 1.302 . . . . 0.0 112.248 -163.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.26 169.62 21.82 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.752 0.421 . . . . 0.0 110.222 158.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.79 13.74 16.18 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.757 1.223 . . . . 0.0 112.91 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 mt -53.22 -40.96 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.621 0.768 . . . . 0.0 109.899 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.77 121.03 29.69 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -110.82 170.18 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 109.433 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -74.18 87.04 1.92 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.742 0.817 . . . . 0.0 109.021 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.4 p -73.77 -11.1 60.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.623 0.769 . . . . 0.0 112.113 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.78 -169.79 38.87 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.011 -1.056 . . . . 0.0 111.708 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.95 158.63 32.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.527 1.485 . . . . 0.0 110.68 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.15 85.13 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 117.927 -1.485 . . . . 0.0 112.248 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -79.35 168.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.185 1.993 . . . . 0.0 108.564 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.68 133.47 27.22 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.319 1.448 . . . . 0.0 109.509 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 t -150.19 158.4 44.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.812 0.445 . . . . 0.0 111.346 -167.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.7 mtp -80.8 122.37 27.1 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.828 0.851 . . . . 0.0 111.203 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -75.27 61.47 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.645 1.578 . . . . 0.0 109.161 161.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -65.98 -178.18 0.57 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.43 1.11 . . . . 0.0 108.329 159.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.44 14.41 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.206 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.22 -157.45 23.89 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -66.81 148.63 82.86 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.179 1.92 . . . . 0.0 109.634 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 34.21 57.27 0.64 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.449 3.1 . . . . 0.0 111.353 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.5 p -131.88 26.4 4.63 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 109.871 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -75.0 88.74 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.293 1.837 . . . . 0.0 106.947 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.45 -92.44 1.9 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -174.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.8 p -151.01 -13.12 0.22 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 167.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.8 137.71 57.57 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -143.81 170.92 14.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.749 1.22 . . . . 0.0 108.299 -167.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -141.77 154.58 45.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.397 0.679 . . . . 0.0 110.325 158.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.51 125.02 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 161.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 16.5 m -70.91 117.56 12.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 167.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 p -108.7 26.5 10.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.662 0.785 . . . . 0.0 109.576 170.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.38 172.11 17.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -65.52 88.45 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 163.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -80.48 63.42 4.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.058 1.409 . . . . 0.0 109.663 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -69.85 -10.43 58.45 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.802 1.641 . . . . 0.0 112.794 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 13.4 p90 -84.78 -11.0 56.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 168.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.5 mt -107.87 -8.63 15.92 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 110.913 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.48 146.82 33.93 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.67 1.188 . . . . 0.0 110.503 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.24 0.91 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.192 0.901 . . . . 0.0 114.829 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -93.68 -50.14 5.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 107.876 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.23 132.08 53.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.62 0.768 . . . . 0.0 109.478 -165.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.45 106.95 16.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 126.071 1.748 . . . . 0.0 106.607 -169.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.49 126.81 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 172.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -137.76 -0.4 2.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.59 -178.43 35.51 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 119.443 1.019 . . . . 0.0 112.844 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -150.02 156.12 41.13 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.665 0.786 . . . . 0.0 110.315 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.83 118.88 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -78.71 -47.38 17.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.583 -0.698 . . . . 0.0 109.248 163.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -141.98 139.64 32.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.81 1.244 . . . . 0.0 108.654 -158.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.51 25.13 40.21 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.285 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.2 tpt -52.95 -37.26 60.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.261 2.03 . . . . 0.0 110.992 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -64.81 -29.09 70.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.214 0.915 . . . . 0.0 113.091 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.05 -45.94 85.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.42 -39.54 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -67.6 -28.19 67.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.801 -1.187 . . . . 0.0 112.543 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -43.11 60.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.919 1.288 . . . . 0.0 109.4 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.7 mtp -53.12 -42.45 66.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.693 0.797 . . . . 0.0 109.974 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.82 -33.34 75.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.735 1.614 . . . . 0.0 114.477 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -62.52 -30.77 71.53 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 120.342 1.428 . . . . 0.0 109.019 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -91.64 18.76 7.06 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.795 1.238 . . . . 0.0 111.617 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.24 -168.76 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 p -152.8 155.42 37.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -64.69 -23.16 67.17 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.27 -1.519 . . . . 0.0 113.125 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.06 8.82 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.201 1.0 . . . . 0.0 112.753 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.88 18.27 66.24 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 126.355 1.931 . . . . 0.0 113.949 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -87.49 144.66 26.61 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 120.706 2.253 . . . . 0.0 109.927 158.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.13 153.5 43.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.901 0.88 . . . . 0.0 109.349 162.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 p -105.2 -13.85 15.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.035 1.334 . . . . 0.0 111.355 164.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -135.0 156.11 49.6 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.834 1.254 . . . . 0.0 109.694 169.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -77.14 85.46 3.62 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.445 -0.784 . . . . 0.0 109.488 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.89 120.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 173.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.77 149.72 50.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.524 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -81.48 104.65 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 163.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.58 -53.29 19.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.63 164.72 31.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 7.8 p -172.91 170.45 4.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.421 0.688 . . . . 0.0 111.97 -171.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.9 -162.39 33.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 8.3 tp60 -87.77 154.23 20.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.829 1.651 . . . . 0.0 110.178 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.38 42.79 2.84 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.081 1.309 . . . . 0.0 109.535 158.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.503 ' HB2' ' H ' ' A' ' 5' ' ' THR . 15.4 tp10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.159 1.784 . . . . 0.0 109.342 168.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptm . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.297 10.8 m 48.16 -173.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.45 0 O-C-N 124.237 0.961 . . . . 0.0 109.557 -154.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -97.6 107.43 39.41 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.43 132.59 51.64 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.201 1.934 . . . . 0.0 109.359 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -93.94 152.5 18.81 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.86 142.93 29.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.489 1.515 . . . . 0.0 107.227 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.44 159.3 20.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.32 1.048 . . . . 0.0 110.122 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -148.28 114.17 5.76 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.085 1.354 . . . . 0.0 108.522 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.23 97.93 5.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 165.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.62 144.6 13.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.56 139.07 43.62 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.405 1.082 . . . . 0.0 108.741 171.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.11 114.57 43.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.35 13.82 2.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.922 0.889 . . . . 0.0 113.149 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.23 56.04 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.193 . . . . 0.0 113.386 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -74.79 121.53 85.47 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.85 112.87 1.94 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.694 1.596 . . . . 0.0 110.084 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -78.33 -37.2 45.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.17 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.32 169.9 14.51 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -84.86 142.64 29.59 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.483 0.659 . . . . 0.0 109.971 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.2 t -122.79 160.95 24.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 128.94 2.896 . . . . 0.0 105.982 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -148.7 158.46 44.16 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 164.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -136.74 155.75 49.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.237 1.415 . . . . 0.0 108.391 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -108.22 134.37 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -111.54 120.67 42.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -69.04 59.11 0.1 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.571 1.949 . . . . 0.0 112.836 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.88 43.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 112.59 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -23.29 59.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.307 0.503 . . . . 0.0 111.296 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -113.6 -30.14 6.92 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.645 0.778 . . . . 0.0 112.241 -169.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.44 73.17 11.8 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.037 1.735 . . . . 0.0 107.946 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 -45.42 14.73 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.142 1.895 . . . . 0.0 112.805 -167.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.51 -53.37 58.95 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.029 1.286 . . . . 0.0 109.331 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -44.82 79.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.547 1.139 . . . . 0.0 111.243 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.56 65.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.66 0.784 . . . . 0.0 111.953 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -63.98 -40.72 97.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.792 0.837 . . . . 0.0 111.376 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -58.58 2.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.672 1.589 . . . . 0.0 108.96 167.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.99 -39.68 90.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.046 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -53.14 -58.24 7.69 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.098 1.359 . . . . 0.0 109.243 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -21.35 64.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.185 1.394 . . . . 0.0 113.77 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -89.79 -23.97 21.6 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.878 0.871 . . . . 0.0 111.389 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 m -83.4 -37.77 22.82 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.009 1.324 . . . . 0.0 110.779 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 p -67.05 -32.5 73.73 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.422 0.689 . . . . 0.0 109.823 170.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.73 14.81 81.08 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.089 0.852 . . . . 0.0 111.087 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.26 -21.8 66.78 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.572 1.186 . . . . 0.0 112.755 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -80.26 0.25 33.5 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 111.852 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 9.74 86.49 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.778 1.18 . . . . 0.0 112.437 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -156.6 179.04 9.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.499 1.52 . . . . 0.0 108.889 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.35 -142.54 13.86 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 121.723 0.624 . . . . 0.0 112.696 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -27.22 63.76 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.435 1.894 . . . . 0.0 110.873 -160.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.0 tttt -64.88 124.12 21.17 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.87 7.08 69.22 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.958 -1.468 . . . . 0.0 112.87 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -67.36 129.49 40.08 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 120.423 2.111 . . . . 0.0 106.244 167.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -76.12 161.7 28.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 163.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.95 114.1 28.11 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -79.2 -49.09 13.08 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.34 128.12 44.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.4 mm -137.2 106.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.2 mt -114.91 93.32 33.89 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.1 117.89 4.02 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.602 2.868 . . . . 0.0 112.006 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.09 14.67 57.32 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.659 1.123 . . . . 0.0 112.952 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CD1' ' HG3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -133.11 -72.89 0.5 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.417 ' HG3' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -166.05 157.74 13.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.1 m -100.64 139.5 36.23 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.96 1.704 . . . . 0.0 108.426 160.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -135.06 122.21 21.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.567 1.531 . . . . 0.0 109.087 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.99 16.85 1.95 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.638 -0.535 . . . . 0.0 114.212 -161.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.72 11.02 53.22 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.053 0.927 . . . . 0.0 114.249 -168.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.72 97.8 9.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 166.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -100.97 -1.03 35.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 p -140.03 -51.68 0.5 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -83.84 -23.85 31.19 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.443 -0.786 . . . . 0.0 112.324 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.0 m170 59.95 31.81 20.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.905 1.682 . . . . 0.0 112.977 169.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -154.07 2.95 0.25 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.91 17.94 4.87 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.141 1.337 . . . . 0.0 113.942 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.4 p -139.33 10.19 2.52 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.229 1.015 . . . . 0.0 112.017 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.97 155.92 49.87 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 120.791 -1.193 . . . . 0.0 113.497 -163.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.9 -156.68 49.54 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 113.56 -1.32 . . . . 0.0 111.582 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.67 160.83 10.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.989 2.116 . . . . 0.0 107.685 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.7 p -71.45 23.16 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.475 1.91 . . . . 0.0 114.605 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.288 1.2 pp 46.29 -19.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 1 C-N-CA 132.234 4.214 . . . . 0.0 117.046 -159.04 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -92.65 -22.22 19.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 119.884 1.22 . . . . 0.0 112.748 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.56 101.07 0.26 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.342 14.5 tt0 41.23 -132.8 0.35 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.291 1.036 . . . . 0.0 111.901 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -88.78 149.06 23.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.831 1.252 . . . . 0.0 109.776 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -117.48 -176.74 3.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.985 1.714 . . . . 0.0 108.274 170.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -81.34 166.02 20.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.069 1.304 . . . . 0.0 114.122 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.37 87.68 3.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 107.582 -172.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -40.13 -64.37 0.51 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.985 2.114 . . . . 0.0 111.586 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.45 156.38 1.53 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.299 0.639 . . . . 0.0 110.844 174.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -111.75 30.29 7.12 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.726 1.61 . . . . 0.0 110.054 -171.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.86 -55.23 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.618 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.71 135.82 35.49 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.78 1.632 . . . . 0.0 107.188 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -122.88 167.2 13.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.667 1.587 . . . . 0.0 109.868 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -84.15 60.31 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.344 1.457 . . . . 0.0 110.849 -162.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 p -62.39 -29.46 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -158.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.4 -179.08 48.71 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 119.232 0.924 . . . . 0.0 112.094 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.11 153.08 54.67 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.411 2.074 . . . . 0.0 110.426 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.59 1.61 71.98 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 117.782 -1.566 . . . . 0.0 112.971 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.16 163.19 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.79 2.295 . . . . 0.0 107.824 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.32 131.07 39.71 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.744 1.218 . . . . 0.0 109.487 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -138.15 158.38 44.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 109.365 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.403 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 6.6 ptm -88.13 151.26 22.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.522 0.677 . . . . 0.0 110.913 -173.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.09 59.22 0.83 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.347 1.059 . . . . 0.0 109.134 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -57.79 161.2 3.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.748 163.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.82 19.84 1.14 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.661 2.384 . . . . 0.0 111.904 -166.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.05 176.79 25.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.16 1.362 . . . . 0.0 110.481 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.6 138.77 71.94 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 119.848 1.824 . . . . 0.0 109.664 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.4 55.81 5.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.944 2.098 . . . . 0.0 109.977 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -112.19 23.36 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.592 -1.317 . . . . 0.0 111.305 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -72.34 91.38 1.33 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 107.472 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.76 -142.83 11.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p -84.0 -15.65 46.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.859 0.863 . . . . 0.0 112.782 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.03 138.91 57.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.41 0.684 . . . . 0.0 109.619 -164.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 12.7 p90 -149.87 167.67 25.93 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -141.01 148.42 40.26 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 124.386 1.054 . . . . 0.0 109.315 162.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -83.69 116.46 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.3 m -64.16 130.85 45.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -118.22 23.94 11.28 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.466 1.106 . . . . 0.0 109.046 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.63 179.49 9.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.998 0.919 . . . . 0.0 108.577 163.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 82.1 tttt -67.83 92.1 0.34 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 160.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.5 p -83.47 58.6 4.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.75 0.705 . . . . 0.0 110.153 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.406 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 15.6 pt-20 -74.01 -8.01 54.53 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.182 -1.574 . . . . 0.0 113.767 -171.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -66.37 -10.3 42.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.397 -0.814 . . . . 0.0 110.846 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.4 mt -107.53 0.46 22.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.379 1.872 . . . . 0.0 111.28 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 127.27 32.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.974 0.806 . . . . 0.0 112.443 -162.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.82 3.23 20.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.222 0.915 . . . . 0.0 113.22 -168.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -93.9 -53.51 3.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -99.97 157.18 16.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.583 0.753 . . . . 0.0 110.619 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t -98.71 101.68 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.35 128.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -142.46 0.06 1.27 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.77 176.38 29.35 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 119.526 1.057 . . . . 0.0 111.639 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -146.43 155.59 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.81 123.8 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -86.76 -41.98 13.69 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.868 0.867 . . . . 0.0 109.297 170.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.54 160.16 43.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.663 0.385 . . . . 0.0 111.065 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.6 36.1 82.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.075 0.845 . . . . 0.0 111.91 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -45.42 78.35 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.704 1.252 . . . . 0.0 108.28 171.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.61 -26.54 61.7 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.1 mm -76.8 -36.96 27.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-N 118.784 0.72 . . . . 0.0 109.143 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.02 -47.27 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.303 0.956 . . . . 0.0 108.759 170.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.55 68.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.188 0.995 . . . . 0.0 111.507 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.48 -42.61 52.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 120.952 -1.093 . . . . 0.0 109.833 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 44.3 mtm -55.65 -48.85 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 118.444 0.565 . . . . 0.0 109.542 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.64 -39.85 71.42 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.948 1.699 . . . . 0.0 111.249 176.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -67.84 -18.04 64.7 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.594 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -94.92 -1.21 53.03 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.557 1.072 . . . . 0.0 112.178 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.32 -163.3 39.24 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 120.871 1.669 . . . . 0.0 112.199 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.3 p -152.14 154.97 36.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -66.73 -20.59 66.0 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.154 -1.591 . . . . 0.0 112.877 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.64 9.16 4.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.428 1.091 . . . . 0.0 112.878 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.51 -28.87 7.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 126.128 1.823 . . . . 0.0 113.65 167.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -69.86 145.16 52.25 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 120.445 2.122 . . . . 0.0 110.91 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.2 p -64.05 145.86 55.16 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.873 1.669 . . . . 0.0 111.425 159.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.4 p -75.92 -43.83 43.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.357 0.663 . . . . 0.0 109.653 158.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -124.47 162.73 23.32 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.43 1.492 . . . . 0.0 110.931 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.61 88.28 2.17 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.128 -0.983 . . . . 0.0 110.358 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.49 124.88 31.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 p -146.09 165.67 28.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.699 0.761 . . . . 0.0 111.453 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.83 127.33 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 159.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.54 -46.68 8.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.613 0.642 . . . . 0.0 109.734 168.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -147.38 158.51 44.0 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -172.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -172.56 172.46 4.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.098 0.959 . . . . 0.0 113.096 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.35 -178.4 46.19 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.199 1.381 . . . . 0.0 109.906 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -78.83 149.09 32.62 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 110.511 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.7 mt -128.68 43.29 3.17 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.954 0.902 . . . . 0.0 109.419 159.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.252 1.199 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.217 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.587 0.708 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.6 m -122.66 -173.13 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 129.596 3.159 . . . . 0.0 105.965 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -44.97 109.19 0.85 Allowed Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.774 158.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 17.9 Cg_endo -64.57 147.66 90.28 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 N-CA-C 107.551 -1.75 . . . . 0.0 107.551 174.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 m -110.51 150.48 28.85 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.92 160.96 29.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.746 0.818 . . . . 0.0 108.841 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -124.95 159.16 31.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.364 1.466 . . . . 0.0 109.998 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -146.56 107.82 4.23 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.69 2.396 . . . . 0.0 106.846 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.01 101.44 3.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.46 134.66 29.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.46 141.4 47.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.84 0.856 . . . . 0.0 109.008 164.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.2 t -96.32 91.28 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 163.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.279 1.3 p30 62.54 14.18 6.84 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.58 -9.64 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 117.442 -1.755 . . . . 0.0 111.406 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -70.48 124.88 91.66 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 162.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.0 117.75 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 N-CA-C 107.261 -1.861 . . . . 0.0 107.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp -88.73 -35.26 16.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.567 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 147.0 161.56 9.43 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -74.59 146.91 42.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.659 0.743 . . . . 0.0 109.233 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.01 151.85 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 128.114 2.566 . . . . 0.0 104.609 171.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.451 ' HB2' ' CG ' ' A' ' 134' ' ' GLU . 21.5 m -146.48 146.65 30.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.212 1.006 . . . . 0.0 109.76 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -120.23 156.61 30.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.956 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -95.74 151.25 19.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 158.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -127.31 121.38 30.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -75.2 51.49 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.936 2.094 . . . . 0.0 112.754 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.26 28.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.963 -1.085 . . . . 0.0 113.365 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.09 -26.52 60.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.124 0.874 . . . . 0.0 111.714 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -111.99 -34.04 6.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.526 1.13 . . . . 0.0 111.635 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.08 71.6 68.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.449 1.9 . . . . 0.0 109.037 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.65 -44.2 27.9 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.593 2.195 . . . . 0.0 113.844 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -49.4 77.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.203 1.365 . . . . 0.0 109.592 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -62.45 -48.39 79.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.854 0.862 . . . . 0.0 109.28 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.66 -48.57 81.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.62 0.768 . . . . 0.0 111.468 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -46.01 91.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.725 1.21 . . . . 0.0 111.688 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -57.28 -51.09 70.79 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.106 0.962 . . . . 0.0 108.609 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.28 -31.68 72.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 18.3 ttm105 -55.65 -56.81 16.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.963 1.256 . . . . 0.0 108.938 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.23 49.1 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.673 1.189 . . . . 0.0 111.16 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.33 -29.4 69.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.31 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 m -75.17 -10.23 59.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.236 1.414 . . . . 0.0 112.104 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.8 p -112.43 -29.61 7.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.411 0.684 . . . . 0.0 111.725 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.14 82.67 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.356 -0.691 . . . . 0.0 113.56 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -28.81 64.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.499 1.92 . . . . 0.0 113.503 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.59 2.49 1.8 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.519 0.728 . . . . 0.0 112.848 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.48 62.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.871 1.224 . . . . 0.0 111.397 -170.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.35 172.82 12.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.59 2.356 . . . . 0.0 106.728 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.54 -177.18 23.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -81.67 -6.59 59.16 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.881 2.072 . . . . 0.0 112.247 -163.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -59.59 117.87 5.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.2 -0.938 . . . . 0.0 108.588 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.49 5.65 87.96 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 116.92 -2.044 . . . . 0.0 115.766 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.6 m -71.26 -65.77 0.7 Allowed 'General case' 0 C--N 1.342 0.256 0 CA-C-N 121.638 2.719 . . . . 0.0 112.322 -163.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.6 t 130.14 144.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.184 3.793 . . . . 0.0 109.659 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.03 92.03 6.65 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.043 2.137 . . . . 0.0 106.823 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -18.4 58.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -164.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -140.02 78.25 1.65 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.161 1.346 . . . . 0.0 111.64 -167.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.51 106.34 18.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.805 1.642 . . . . 0.0 107.008 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.6 91.41 12.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.31 120.84 7.4 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.843 3.029 . . . . 0.0 113.114 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.47 11.52 60.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.839 1.685 . . . . 0.0 113.253 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -133.94 -79.61 0.46 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.936 1.294 . . . . 0.0 108.802 -170.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.69 167.95 28.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.799 0.84 . . . . 0.0 110.713 172.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -132.38 98.15 4.3 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.91 1.684 . . . . 0.0 109.04 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.7 146.79 44.18 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.426 1.09 . . . . 0.0 109.985 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.98 -173.64 25.68 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 125.719 1.628 . . . . 0.0 109.88 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.84 -13.23 41.78 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.326 1.441 . . . . 0.0 113.324 170.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -84.07 95.09 8.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.892 0.846 . . . . 0.0 110.709 -167.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -95.08 3.5 54.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.178 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.0 p -137.16 -45.95 0.57 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.893 1.224 . . . . 0.0 113.248 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -88.34 -27.05 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.79 -0.569 . . . . 0.0 111.472 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 54.25 12.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.953 2.901 . . . . 0.0 114.595 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -117.86 -8.04 10.86 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.188 0.995 . . . . 0.0 112.868 -170.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 -3.36 27.36 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.439 -1.2 . . . . 0.0 113.088 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.2 p -84.27 -32.29 24.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.77 1.785 . . . . 0.0 111.04 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.88 165.91 9.35 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-O 123.153 1.419 . . . . 0.0 114.054 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.31 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.469 1.594 . . . . 0.0 111.669 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.58 -178.84 2.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 128.951 2.901 . . . . 0.0 108.814 -160.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.1 p -84.99 -175.1 5.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.76 -23.09 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.033 -1.042 . . . . 0.0 111.745 163.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -82.13 -23.67 35.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.023 0.929 . . . . 0.0 111.149 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.8 -145.72 10.18 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 -166.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -128.75 115.2 17.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.38 148.42 0.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.228 2.611 . . . . 0.0 111.88 -165.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -135.12 173.6 11.54 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 159.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -63.84 154.01 34.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.132 0.968 . . . . 0.0 109.714 174.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.03 99.47 1.82 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 172.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -49.77 -57.31 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.241 1.416 . . . . 0.0 114.516 -158.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.69 154.02 5.25 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.239 1.816 . . . . 0.0 108.846 162.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.98 25.24 10.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.56 1.544 . . . . 0.0 110.049 -169.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mt -45.2 -59.59 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 126.541 1.936 . . . . 0.0 108.556 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.9 mt -74.91 113.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.421 1.488 . . . . 0.0 107.87 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -80.2 157.85 26.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.154 171.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.36 83.76 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.5 p -68.73 -23.53 64.36 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.479 -0.763 . . . . 0.0 112.853 -166.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.76 -176.7 40.54 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.861 1.21 . . . . 0.0 111.86 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.46 149.52 89.24 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 121.732 1.621 . . . . 0.0 110.691 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 10.91 85.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.977 -1.457 . . . . 0.0 112.467 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 mm -82.58 166.2 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 120.674 2.237 . . . . 0.0 108.336 164.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.57 127.94 26.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.097 1.359 . . . . 0.0 108.175 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.8 t -141.29 147.16 37.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.63 -167.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.9 tpp -77.25 113.97 15.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.177 2.191 . . . . 0.0 108.562 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.56 98.17 2.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 165.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -78.83 -178.2 5.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 159.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.92 15.1 25.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.384 1.874 . . . . 0.0 112.149 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.01 175.73 14.17 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.539 1.543 . . . . 0.0 109.312 -163.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.34 130.21 31.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.198 1.932 . . . . 0.0 111.32 -170.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.81 57.81 3.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 127.495 2.318 . . . . 0.0 111.853 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -142.25 41.74 1.64 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.086 0.555 . . . . 0.0 111.315 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.22 125.85 22.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.266 1.426 . . . . 0.0 109.565 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.75 -125.5 2.31 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 120.695 1.589 . . . . 0.0 112.335 -171.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -89.13 -25.14 22.01 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.606 1.203 . . . . 0.0 112.796 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -85.23 148.26 26.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.715 0.769 . . . . 0.0 111.178 -158.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -142.96 176.67 8.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -141.24 152.8 44.85 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 160.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.1 mt -83.46 119.42 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 163.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.3 m -65.15 122.56 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.8 p -114.86 28.5 8.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.222 1.01 . . . . 0.0 108.553 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.32 178.63 10.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.157 1.783 . . . . 0.0 107.628 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -70.39 92.11 0.79 Allowed 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 161.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 p -78.72 59.36 2.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.694 0.679 . . . . 0.0 109.939 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.01 -13.37 62.41 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.83 1.252 . . . . 0.0 112.914 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -74.1 -15.92 61.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.286 1.035 . . . . 0.0 111.317 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -103.61 -4.59 23.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.854 1.261 . . . . 0.0 111.129 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 126.97 29.75 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.589 1.156 . . . . 0.0 111.129 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.41 1.19 34.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.717 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -103.11 -25.8 13.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.61 1.705 . . . . 0.0 110.553 168.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -137.14 160.96 37.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.111 1.364 . . . . 0.0 108.98 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -110.46 103.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.58 127.46 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.65 -2.08 1.99 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.827 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.75 -176.44 28.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 119.41 1.005 . . . . 0.0 111.974 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -153.37 140.22 19.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.97 103.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 159.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -63.68 -52.71 59.42 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.451 ' CG ' ' HB2' ' A' ' 21' ' ' SER . 10.4 pt-20 -146.87 154.47 41.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 123.356 0.662 . . . . 0.0 111.486 -159.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.88 25.14 67.68 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.884 0.754 . . . . 0.0 113.153 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 mmm -61.22 -29.21 69.68 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.623 2.212 . . . . 0.0 111.609 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -62.61 -30.65 71.5 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.834 -1.166 . . . . 0.0 111.635 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.02 -44.09 92.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.97 -42.26 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.265 0.626 . . . . 0.0 110.166 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -39.74 94.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 174.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.18 -41.52 70.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.919 1.288 . . . . 0.0 109.035 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.3 mtp -53.87 -42.59 68.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.079 1.352 . . . . 0.0 110.154 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.202 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.76 -36.01 81.68 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.402 1.456 . . . . 0.0 108.887 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.59 1.68 40.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.983 0.913 . . . . 0.0 112.783 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.4 -156.21 7.72 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.982 1.753 . . . . 0.0 110.411 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.2 p -142.18 -72.06 0.32 Allowed 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 121.65 -0.912 . . . . 0.0 111.591 168.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 140.67 -27.39 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.346 1 C-N-CA 133.864 4.865 . . . . 0.0 109.772 -173.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.65 -24.84 67.12 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.716 0.689 . . . . 0.0 110.283 158.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.74 -36.05 4.21 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 125.672 1.606 . . . . 0.0 111.764 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.06 131.91 47.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 p -62.77 152.21 36.48 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.908 1.283 . . . . 0.0 107.914 166.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.6 p -57.44 -48.06 80.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -73.43 175.76 6.68 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.943 1.697 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -95.63 139.48 31.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 101.969 -3.345 . . . . 0.0 101.969 157.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.4 mt -127.38 128.96 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.79 22.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.798 0.808 . . . . 0.0 111.542 -158.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mp -98.37 105.13 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.86 96.64 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.484 0.584 . . . . 0.0 109.521 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -157.32 158.82 36.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.575 1.15 . . . . 0.0 108.841 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 p -156.93 165.28 36.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.397 0.679 . . . . 0.0 110.543 174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.47 -169.18 40.7 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.97 148.85 25.71 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.943 1.297 . . . . 0.0 109.646 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.2 mt -128.37 43.26 3.17 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.253 1.421 . . . . 0.0 109.114 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 . . . . . 0 C--O 1.243 0.734 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 166.233 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.3 19.6 m 46.65 -172.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 123.11 1.433 . . . . 0.0 114.007 166.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.16 104.9 54.07 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 158.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -63.78 146.66 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 120.7 1.286 . . . . 0.0 110.34 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -104.97 146.87 28.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.76 156.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.166 1.386 . . . . 0.0 109.351 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.0 158.91 26.71 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.487 1.115 . . . . 0.0 110.12 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -144.37 111.72 5.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.345 1.858 . . . . 0.0 106.663 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 104.46 10.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 mm -79.34 140.87 16.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.21 162.56 29.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.007 169.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 9.2 t -137.18 92.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 60.21 18.64 8.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.739 1.216 . . . . 0.0 111.516 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.16 9.69 72.89 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.196 -0.94 . . . . 0.0 112.537 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -75.18 118.71 72.7 Favored Pre-proline 0 C--O 1.232 0.179 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 159.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.94 112.36 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.477 1.451 . . . . 0.0 109.436 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.2 tp -82.81 -27.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.112 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.55 169.53 11.75 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.436 1.493 . . . . 0.0 111.759 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.91 139.38 35.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.335 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.45 154.95 40.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.6 t -147.43 149.49 32.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.77 0.795 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -124.57 147.93 48.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.203 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -92.58 151.92 19.88 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 158.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 mt -126.7 122.56 35.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.883 1.673 . . . . 0.0 106.993 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.52 61.63 2.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.969 0.908 . . . . 0.0 111.846 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.37 -16.33 53.88 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.885 -1.76 . . . . 0.0 113.611 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.33 -16.21 57.94 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.076 0.95 . . . . 0.0 111.918 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -121.95 -39.53 2.6 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.733 1.213 . . . . 0.0 111.3 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.74 70.51 79.09 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.911 1.685 . . . . 0.0 107.457 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -50.18 -48.37 20.15 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.146 2.564 . . . . 0.0 112.657 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -55.66 -58.51 7.49 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -174.392 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 -46.43 89.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.391 1.477 . . . . 0.0 111.165 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.57 82.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.083 0.553 . . . . 0.0 111.385 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.38 -43.54 81.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.626 1.17 . . . . 0.0 110.453 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -51.09 -51.08 56.89 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.147 1.379 . . . . 0.0 109.38 170.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.94 -44.21 90.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.423 0.452 . . . . 0.0 112.073 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -53.93 -59.65 4.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.733 1.613 . . . . 0.0 109.108 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.96 -47.8 74.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.465 0.706 . . . . 0.0 110.611 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.67 -23.39 66.77 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -73.3 -48.13 37.12 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.299 0.954 . . . . 0.0 109.303 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 p -66.62 -26.1 66.92 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.989 -0.444 . . . . 0.0 111.913 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.61 -0.11 71.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.436 1.017 . . . . 0.0 112.058 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -59.78 -23.21 63.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.701 1.6 . . . . 0.0 112.632 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -85.47 9.69 15.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.109 1.364 . . . . 0.0 112.095 -172.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.05 81.63 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.846 -0.974 . . . . 0.0 112.423 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.32 172.72 13.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.983 1.713 . . . . 0.0 107.407 166.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.63 174.39 37.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.427 -1.368 . . . . 0.0 113.674 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -73.24 -8.03 54.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -56.08 124.68 18.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.72 4.34 65.82 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.613 -1.659 . . . . 0.0 114.529 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -73.14 156.75 38.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.99 2.395 . . . . 0.0 107.988 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.1 t -106.21 139.89 40.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -74.83 88.99 2.31 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -73.5 -27.55 61.43 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.406 1.882 . . . . 0.0 111.617 -166.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 86.01 2.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.442 HG21 ' HG ' ' A' ' 62' ' ' CYS . 86.3 mt -103.71 112.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 171.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -125.17 97.47 37.59 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -170.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.68 125.45 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.948 2.432 . . . . 0.0 111.027 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.2 5.4 63.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.81 1.671 . . . . 0.0 113.338 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -136.57 -75.64 0.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.105 1.453 . . . . 0.0 108.98 -167.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.1 167.61 18.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 112.08 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.442 ' HG ' HG21 ' A' ' 56' ' ' ILE . 75.1 m -122.15 94.74 4.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.744 2.018 . . . . 0.0 108.383 168.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.37 144.32 25.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.532 1.933 . . . . 0.0 109.961 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.12 1.82 0.13 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.84 35.46 3.38 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 -158.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.329 19.3 p-10 -122.73 144.36 49.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.912 2.856 . . . . 0.0 111.292 164.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.28 -3.09 3.08 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.183 2.593 . . . . 0.0 111.317 -160.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -125.6 -19.84 4.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 129.247 3.019 . . . . 0.0 112.173 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -137.46 176.37 8.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 131.538 3.935 . . . . 0.0 103.439 169.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -145.11 53.81 1.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -152.91 -67.37 0.16 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.201 1.4 . . . . 0.0 110.679 -176.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.401 ' N ' HE22 ' A' ' 111' ' ' GLN . . . 173.69 -11.81 0.04 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 118.374 -1.237 . . . . 0.0 115.262 -159.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -127.44 17.04 7.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.285 1.543 . . . . 0.0 113.227 -161.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.27 -86.4 0.37 Allowed Glycine 0 CA--C 1.503 -0.662 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -17.09 113.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.553 0 C-N-CA 128.074 2.749 . . . . 0.0 111.932 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -136.9 155.32 49.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.213 1.805 . . . . 0.0 109.918 -158.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 p -77.94 165.5 24.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 124.293 0.996 . . . . 0.0 109.451 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.93 -24.75 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.596 170.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.39 8.31 25.11 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.166 1.787 . . . . 0.0 111.533 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.29 142.09 12.96 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.403 1.478 . . . . 0.0 109.813 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.26 6.2 pt-20 34.06 -133.8 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.796 2.438 . . . . 0.0 114.343 162.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -75.05 157.97 33.95 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.498 0.59 . . . . 0.0 110.385 165.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -132.13 176.53 8.31 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.66 1.984 . . . . 0.0 107.644 164.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.79 161.17 28.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.071 0.462 . . . . 0.0 110.713 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.57 131.33 48.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -47.08 83.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -173.08 176.13 3.06 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.726 1.211 . . . . 0.0 108.721 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -126.09 56.36 1.43 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.563 1.945 . . . . 0.0 106.144 163.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.55 -39.52 70.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 171.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.1 mt -95.6 142.24 28.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.447 1.499 . . . . 0.0 107.334 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -120.49 160.21 23.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.433 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -76.26 64.62 2.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.494 2.318 . . . . 0.0 109.666 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.426 1.49 . . . . 0.0 113.494 -161.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 175.49 38.23 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.583 1.083 . . . . 0.0 112.891 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -59.68 137.58 78.0 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.158 1.906 . . . . 0.0 108.147 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.73 64.38 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.512 -1.716 . . . . 0.0 112.623 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.42 159.44 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 120.923 2.361 . . . . 0.0 107.687 169.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.39 131.98 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.456 1.502 . . . . 0.0 108.497 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 32.3 t -148.62 160.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.848 0.459 . . . . 0.0 110.68 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.4 mtp -84.58 120.95 26.94 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.618 0.767 . . . . 0.0 110.421 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 141.73 58.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 162.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -152.46 -172.57 4.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.364 1.066 . . . . 0.0 109.691 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.62 15.08 10.25 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.011 1.724 . . . . 0.0 112.64 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.28 -179.6 17.24 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -167.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.47 141.04 79.1 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.539 2.159 . . . . 0.0 110.481 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.51 46.12 26.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.164 1.786 . . . . 0.0 111.885 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.7 p -123.89 14.07 9.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.301 -0.874 . . . . 0.0 111.262 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -73.69 128.02 34.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.52 -65.31 0.16 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.7 p -144.54 -13.76 0.58 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.401 HE22 ' N ' ' A' ' 72' ' ' GLY . 78.9 mt-30 -65.4 130.9 44.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -170.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -134.43 162.39 32.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 107.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 99' ' ' SER . 44.9 p90 -144.56 153.39 41.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 O-C-N 124.683 1.239 . . . . 0.0 110.263 166.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.79 123.84 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 160.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.14 125.39 24.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.3 p -110.77 32.39 5.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.52 173.11 13.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.341 1.057 . . . . 0.0 109.192 167.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -68.59 89.85 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 158.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 p -83.38 65.88 8.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.819 -0.551 . . . . 0.0 109.892 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -59.22 -23.21 62.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.11 0.964 . . . . 0.0 112.306 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -68.49 -14.82 63.27 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.761 1.224 . . . . 0.0 110.749 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.1 mt -104.0 -6.24 21.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.243 1.417 . . . . 0.0 111.54 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.16 145.13 53.54 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.714 0.688 . . . . 0.0 110.498 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.49 16.06 48.7 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.96 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.22 -52.01 1.41 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.924 2.09 . . . . 0.0 108.414 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -105.18 146.69 28.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.814 -173.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.45 100.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -171.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.1 t -59.06 127.29 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 165.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -138.25 -3.45 1.75 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.59 -174.19 30.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.36 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -149.83 149.99 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.659 1.183 . . . . 0.0 108.44 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 118.31 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 165.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -75.13 -50.27 16.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -143.34 146.4 33.51 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 126.133 1.773 . . . . 0.0 107.275 -171.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.27 22.34 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.464 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 28.6 tpp -56.61 -35.94 68.85 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 119.526 1.663 . . . . 0.0 110.706 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -62.67 -20.51 64.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.852 1.205 . . . . 0.0 113.391 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.4 mm -83.05 -43.77 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.551 1.14 . . . . 0.0 108.677 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.37 -35.9 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 121.586 -0.696 . . . . 0.0 109.579 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.37 -44.26 84.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.084 1.753 . . . . 0.0 110.913 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.08 85.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 38.4 mtm -53.26 -47.93 68.7 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.734 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -53.24 -42.14 66.12 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 144' ' ' ARG . 15.0 mtt85 -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.085 -177.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.04 5.24 51.62 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.801 1.24 . . . . 0.0 112.446 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.2 -150.89 4.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 120.473 1.488 . . . . 0.0 111.74 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.0 p -142.59 -96.05 0.12 Allowed 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.589 -0.948 . . . . 0.0 108.798 165.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -162.2 -23.4 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 125.858 1.663 . . . . 0.0 110.764 164.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -16.07 58.25 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.977 0.808 . . . . 0.0 111.432 165.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.27 -24.84 6.84 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 118.556 -1.136 . . . . 0.0 113.174 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.14 123.47 17.77 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.224 1.012 . . . . 0.0 108.764 -174.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.3 p -74.93 159.99 31.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 108.837 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -10.66 59.64 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.031 -1.668 . . . . 0.0 111.362 166.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.415 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -140.73 160.31 40.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 110.117 -161.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.52 80.2 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.67 119.16 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 p -139.22 165.74 26.38 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.508 1.123 . . . . 0.0 110.766 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 102.41 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 166.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.4 77.09 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -145.43 161.48 39.6 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 p -162.26 158.17 23.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.282 1.433 . . . . 0.0 108.556 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.71 -176.34 42.96 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -83.05 159.55 22.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.856 -0.79 . . . . 0.0 110.722 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.0 mt -135.58 43.63 2.59 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 158.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.148 0.979 . . . . 0.0 111.458 175.419 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HG3' ' H ' ' A' ' 2' ' ' VAL . 7.2 tpt . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.532 ' H ' ' HG3' ' A' ' 1' ' ' MET . 4.5 p -69.11 -174.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 164.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.494 ' H ' HG23 ' A' ' 2' ' ' VAL . 29.3 m120 -33.83 104.79 0.25 Allowed Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 127.994 2.518 . . . . 0.0 113.188 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.23 138.82 48.17 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 N-CA-C 106.502 -2.153 . . . . 0.0 106.502 158.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 m -104.7 147.91 27.16 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.5 140.43 44.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -113.71 150.91 32.61 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 123.936 0.894 . . . . 0.0 110.164 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.431 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 19.3 m-85 -146.13 113.56 6.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.481 1.512 . . . . 0.0 109.317 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.21 101.11 3.88 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 159.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.19 140.93 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 171.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.78 148.06 49.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.929 1.292 . . . . 0.0 108.37 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.35 115.76 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 53.5 13.76 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 0.0 114.489 -167.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.3 57.79 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.381 1.467 . . . . 0.0 112.859 -175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.27 133.23 81.18 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.22 120.19 7.17 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.2 -40.49 30.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.85 177.28 19.56 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 123.68 0.657 . . . . 0.0 112.364 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -77.32 136.62 38.48 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.726 0.81 . . . . 0.0 110.068 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -121.92 158.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 126.578 1.951 . . . . 0.0 106.316 164.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -147.99 140.34 24.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.965 -0.459 . . . . 0.0 110.244 161.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -109.14 162.72 14.0 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -123.38 112.76 17.95 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.479 2.712 . . . . 0.0 104.433 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 mt -97.61 134.65 40.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -169.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.429 ' CD2' HD12 ' A' ' 90' ' ' LEU . 18.0 m-85 -82.16 51.76 1.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.998 -1.064 . . . . 0.0 112.42 -171.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.9 -27.36 42.42 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.252 -0.905 . . . . 0.0 112.061 173.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -71.39 -7.08 44.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.721 1.608 . . . . 0.0 113.758 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.82 -25.25 0.46 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.032 0.833 . . . . 0.0 112.933 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 75.1 33.64 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.562 1.945 . . . . 0.0 106.793 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.81 -52.65 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.29 1.993 . . . . 0.0 111.644 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -42.95 99.53 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.883 1.22 . . . . 0.0 109.83 -173.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -60.92 -48.21 82.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.433 0.693 . . . . 0.0 110.332 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.78 -51.29 57.47 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.131 0.972 . . . . 0.0 111.764 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.6 -32.41 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.213 2.205 . . . . 0.0 112.085 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -61.98 2.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.019 1.728 . . . . 0.0 108.579 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.07 -30.93 71.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.203 -0.311 . . . . 0.0 111.56 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -53.19 -62.37 1.7 Allowed 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.038 1.335 . . . . 0.0 109.784 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.9 -26.34 68.11 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.95 -32.39 34.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.866 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 m -69.67 -40.87 76.17 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.926 0.89 . . . . 0.0 109.853 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.0 p -70.87 -34.7 71.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.4 -0.6 88.9 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.623 1.106 . . . . 0.0 110.949 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -70.64 -12.07 61.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.037 1.335 . . . . 0.0 112.887 -162.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -75.57 -4.55 40.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.148 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.07 6.42 55.86 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.486 1.041 . . . . 0.0 111.463 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -163.23 170.54 17.56 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.349 1.86 . . . . 0.0 106.146 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.53 178.62 35.62 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 118.217 -1.944 . . . . 0.0 114.052 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.431 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 75.2 t80 -70.68 -17.63 62.84 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 130.51 3.524 . . . . 0.0 113.283 -170.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -55.74 121.8 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 23.72 73.0 Favored Glycine 0 CA--C 1.538 1.496 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.063 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -25.3 67.98 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.853 2.326 . . . . 0.0 110.288 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.4 m 56.38 175.99 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.308 1.443 . . . . 0.0 110.515 -159.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.6 117.99 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -74.27 -39.75 62.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.202 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 125.54 40.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -158.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.2 mm -142.33 114.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.9 mt -125.89 108.84 25.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.19 124.22 13.58 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.36 3.373 . . . . 0.0 114.015 -173.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.64 27.02 69.13 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.215 1.388 . . . . 0.0 112.442 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -125.1 -83.89 0.64 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.22 172.55 15.57 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.497 0.719 . . . . 0.0 110.188 170.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.99 115.84 17.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.231 1.413 . . . . 0.0 109.834 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -101.1 138.22 38.42 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.24 2.216 . . . . 0.0 111.528 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.22 -156.07 7.33 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.863 1.697 . . . . 0.0 109.279 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.8 90.13 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 119.284 -0.731 . . . . 0.0 114.401 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 70' ' ' HIS . 31.5 t0 -83.86 138.9 32.97 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 159.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -132.53 6.83 4.11 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.398 1.079 . . . . 0.0 111.326 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.6 -31.57 0.86 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.468 1.107 . . . . 0.0 113.73 -174.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -127.84 -10.95 5.48 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.306 1.412 . . . . 0.0 112.964 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.403 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 97.7 m-70 58.44 30.57 19.86 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.235 1.814 . . . . 0.0 113.091 171.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -147.04 -27.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.74 2.57 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.889 1.222 . . . . 0.0 114.469 -170.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.9 p -83.89 -4.32 58.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.596 1.198 . . . . 0.0 112.282 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -103.13 -108.34 3.25 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -8.46 91.17 0.01 OUTLIER Glycine 0 C--N 1.334 0.453 0 C-N-CA 129.082 3.23 . . . . 0.0 115.633 -170.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -77.24 150.1 35.41 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 128.224 2.61 . . . . 0.0 110.013 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -84.89 44.93 1.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.26 1.424 . . . . 0.0 112.768 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.257 36.6 pt 49.27 -43.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 1 C-N-CA 133.486 4.714 . . . . 0.0 114.562 -158.921 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -82.04 -4.43 56.76 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.844 1.257 . . . . 0.0 113.724 -159.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.66 -85.36 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 170.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -127.84 -133.23 0.23 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 127.255 2.222 . . . . 0.0 105.381 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.83 155.67 18.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.379 1.445 . . . . 0.0 108.902 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -122.76 177.75 5.33 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.083 0.856 . . . . 0.0 110.565 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HA ' HD21 ' A' ' 106' ' ' ASN . 15.9 pt-20 -57.47 164.31 1.98 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 112.679 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -64.22 120.01 11.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 158.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -67.2 -48.09 68.95 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.767 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.72 156.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.417 2.687 . . . . 0.0 110.706 170.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -104.61 22.55 14.83 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.923 1.689 . . . . 0.0 110.655 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.34 -49.39 64.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 124.33 1.052 . . . . 0.0 109.853 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 25' ' ' PHE . 96.3 mt -80.67 129.32 34.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.95 160.57 14.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.122 1.769 . . . . 0.0 109.368 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -77.08 85.24 3.58 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 172.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 p -76.47 -24.14 53.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 118.877 -0.582 . . . . 0.0 111.216 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.1 -170.57 43.55 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.041 0.829 . . . . 0.0 112.705 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.95 158.89 19.54 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.629 2.219 . . . . 0.0 110.64 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.65 -4.2 57.36 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 117.084 -1.954 . . . . 0.0 113.06 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -67.84 148.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 121.2 2.5 . . . . 0.0 107.823 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.83 125.33 54.23 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 p -131.73 159.82 37.3 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 122.799 1.285 . . . . 0.0 110.048 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttm -86.71 127.44 34.97 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.376 -163.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.62 41.79 0.34 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.884 2.474 . . . . 0.0 112.346 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -63.03 167.62 4.7 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.868 1.318 . . . . 0.0 110.409 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.36 15.26 13.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.374 -1.739 . . . . 0.0 111.75 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.61 -167.7 32.61 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 -167.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -64.75 171.62 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 119.328 1.564 . . . . 0.0 108.965 158.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.409 HD21 ' HA ' ' A' ' 84' ' ' GLU . 6.8 m120 48.85 24.43 0.84 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.458 2.303 . . . . 0.0 115.188 168.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -128.2 29.15 5.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.399 1.48 . . . . 0.0 109.858 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.473 HD22 HG22 ' A' ' 127' ' ' VAL . 85.7 m-20 -69.19 101.24 1.43 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.902 1.681 . . . . 0.0 107.324 172.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.92 -137.59 7.76 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -90.08 -10.87 43.14 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.733 0.813 . . . . 0.0 112.624 163.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -81.69 146.63 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.743 1.217 . . . . 0.0 111.286 -158.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -154.32 171.75 18.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.28 1.032 . . . . 0.0 109.492 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -135.49 154.66 51.34 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.341 0.591 . . . . 0.0 109.965 159.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.25 117.46 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 36.0 m -65.72 130.3 42.81 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.625 1.17 . . . . 0.0 108.078 168.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.9 p -111.66 22.07 15.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.944 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.95 -176.14 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 161.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.54 93.22 0.23 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 161.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -81.08 55.74 2.59 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.634 1.974 . . . . 0.0 110.014 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.869 -1.144 . . . . 0.0 113.673 -171.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -73.15 -4.47 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.0 mt -114.82 -2.88 12.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.229 1.811 . . . . 0.0 110.89 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.47 143.16 58.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.174 1.39 . . . . 0.0 111.529 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.5 20.26 58.82 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.254 0.93 . . . . 0.0 112.084 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.04 -51.91 0.67 Allowed 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -96.58 117.62 31.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 108' ' ' ASN . 18.6 t -71.23 107.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -170.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.89 122.55 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.384 1.474 . . . . 0.0 108.037 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -145.13 9.27 1.26 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.24 -173.08 37.29 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 121.296 -0.878 . . . . 0.0 111.783 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -147.67 158.36 43.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.144 0.978 . . . . 0.0 109.631 168.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.15 105.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -52.34 62.56 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.41 157.69 44.13 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.977 0.911 . . . . 0.0 111.056 -167.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.7 24.93 54.91 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.458 1.028 . . . . 0.0 112.592 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.8 tpp -55.75 -35.09 65.81 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.554 1.677 . . . . 0.0 110.109 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -57.6 -30.95 65.73 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.424 1.465 . . . . 0.0 113.379 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.8 mm -76.39 -35.07 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.906 0.776 . . . . 0.0 109.483 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.35 -39.4 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.387 0.994 . . . . 0.0 109.645 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.423 ' CD ' HH12 ' A' ' 144' ' ' ARG . 1.3 tm-20 -62.49 -31.44 72.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.117 1.367 . . . . 0.0 111.456 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -44.44 28.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.823 1.249 . . . . 0.0 109.215 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 62.5 mtp -49.77 -44.01 48.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.872 1.269 . . . . 0.0 110.316 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -33.31 71.22 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.02 0.928 . . . . 0.0 113.489 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.423 HH12 ' CD ' ' A' ' 140' ' ' GLU . 12.5 mmp_? -65.64 -25.73 67.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.699 1.136 . . . . 0.0 110.975 175.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -91.98 5.12 51.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.43 -167.81 34.05 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 125.007 1.289 . . . . 0.0 111.721 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 p -153.75 152.55 30.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.262 1.425 . . . . 0.0 107.372 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -63.85 -22.15 66.78 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.198 -1.564 . . . . 0.0 113.16 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -77.04 -6.48 52.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 16.69 68.94 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.355 -1.247 . . . . 0.0 113.243 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 176.13 8.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.583 1.691 . . . . 0.0 109.141 158.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.4 p -125.04 129.97 51.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.72 -31.65 70.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.4 0.546 . . . . 0.0 110.575 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -111.75 176.94 4.82 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.163 0.585 . . . . 0.0 109.972 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.66 103.4 15.78 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.3 mm -79.9 126.24 39.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -142.85 172.61 12.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.995 1.318 . . . . 0.0 111.412 -168.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.5 mt -124.0 109.69 23.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.85 87.33 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.375 1.047 . . . . 0.0 110.528 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -160.86 162.2 32.1 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.4 p -160.2 163.52 33.53 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.215 0.462 . . . . 0.0 111.9 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.34 29.34 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -110.05 143.95 39.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.01 1.324 . . . . 0.0 110.092 -172.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.26 43.55 3.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.811 1.645 . . . . 0.0 109.789 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.941 0 O-C-N 121.03 -1.044 . . . . 0.0 111.001 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tmm? . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 74.6 t 52.42 179.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -142.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -58.42 120.07 41.34 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 119.948 -1.72 . . . . 0.0 109.905 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 165' ' ' GLU . 42.8 Cg_exo -63.04 166.77 13.62 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 CA-C-N 121.623 1.615 . . . . 0.0 112.139 158.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 m -131.11 152.26 50.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 158.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.1 m -139.01 154.9 26.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 108.121 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -109.83 159.96 16.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.862 0.865 . . . . 0.0 110.612 171.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -144.5 105.02 4.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.831 1.652 . . . . 0.0 107.437 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.29 97.15 5.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 164.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -68.69 141.7 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.01 159.9 30.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.397 1.094 . . . . 0.0 109.206 169.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.99 88.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -168.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.44 13.07 1.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.898 1.279 . . . . 0.0 112.35 -165.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.55 -9.43 30.44 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.705 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.68 112.44 8.7 Favored Pre-proline 0 N--CA 1.441 -0.924 0 C-N-CA 126.656 1.982 . . . . 0.0 105.696 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.86 118.63 5.53 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.7 -25.08 30.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.6 -152.03 23.43 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -124.27 114.87 20.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.151 0.975 . . . . 0.0 110.611 159.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.1 t -82.19 161.0 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.732 2.013 . . . . 0.0 108.33 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.7 m -151.4 141.85 22.52 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.315 -1.49 . . . . 0.0 110.205 170.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -117.6 143.47 46.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.894 0.878 . . . . 0.0 109.342 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -87.98 142.28 27.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 161.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -127.39 116.77 21.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -79.64 52.77 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.359 1.064 . . . . 0.0 113.555 -167.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 -16.17 64.1 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -172.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.36 -28.37 65.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.903 1.683 . . . . 0.0 110.705 168.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.27 -32.08 11.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.991 1.716 . . . . 0.0 112.449 -174.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.8 74.14 22.78 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.469 1.508 . . . . 0.0 109.022 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.53 -43.21 22.9 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.813 2.342 . . . . 0.0 112.342 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -52.2 66.17 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 119.868 1.213 . . . . 0.0 108.515 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 m -60.81 -47.65 85.39 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.641 1.177 . . . . 0.0 111.157 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.76 -33.9 46.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.06 -42.81 68.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.436 1.016 . . . . 0.0 110.014 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -45.15 -55.58 5.59 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.548 1.139 . . . . 0.0 108.561 164.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.82 -29.64 70.14 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -61.26 -55.27 33.84 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.984 1.266 . . . . 0.0 109.532 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.38 72.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.191 1.396 . . . . 0.0 111.434 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 mt -67.13 -38.57 85.79 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.414 -0.804 . . . . 0.0 111.935 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.9 m -71.2 -36.82 72.05 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.822 0.849 . . . . 0.0 110.836 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -73.96 -23.88 59.55 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.272 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.31 74.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.262 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.78 -25.59 63.23 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.61 1.564 . . . . 0.0 113.565 -159.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -88.56 1.31 55.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.944 1.298 . . . . 0.0 112.089 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.89 15.6 59.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.259 0.933 . . . . 0.0 112.449 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -160.43 177.52 10.49 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.7 -147.45 17.56 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -84.06 -24.04 30.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 117.928 -1.035 . . . . 0.0 113.593 -159.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -56.57 120.07 7.15 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 57.33 43.72 93.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.65 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -96.18 -5.37 40.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.671 1.736 . . . . 0.0 113.612 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m 47.11 170.29 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.072 2.149 . . . . 0.0 113.831 -159.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.74 146.5 30.77 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 159.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -106.48 -30.52 9.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.096 -170.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.5 124.13 18.37 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 mm -130.83 109.42 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -121.71 95.02 48.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.62 122.98 11.24 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.455 2.77 . . . . 0.0 112.576 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.79 65.65 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 124.66 1.124 . . . . 0.0 112.446 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -134.56 -76.29 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.59 170.03 21.7 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.023 0.929 . . . . 0.0 110.343 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 122.31 28.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.848 1.659 . . . . 0.0 107.61 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.444 HE22 ' CB ' ' A' ' 101' ' ' ALA . 30.6 tp60 -111.92 133.71 53.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 128.339 2.655 . . . . 0.0 110.384 -165.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.37 -173.31 13.98 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.484 1.992 . . . . 0.0 112.566 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.7 29.25 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 124.231 0.919 . . . . 0.0 115.369 161.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.08 68.48 3.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.247 1.523 . . . . 0.0 109.134 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.84 2.62 44.08 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 113.267 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -139.29 -60.66 0.56 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.595 1.089 . . . . 0.0 109.143 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -83.54 162.92 20.72 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 159.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -124.01 21.89 8.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.686 1.194 . . . . 0.0 108.978 -166.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -162.46 -0.9 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.418 1.087 . . . . 0.0 113.468 -158.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.8 14.21 19.91 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.202 1.365 . . . . 0.0 115.581 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.1 p -118.69 16.28 13.61 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.116 1.458 . . . . 0.0 112.866 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.26 -152.64 5.68 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.95 173.32 47.68 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -166.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -153.45 144.0 22.53 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.722 -0.869 . . . . 0.0 110.715 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.463 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 69.5 p -73.74 22.57 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 130.033 3.333 . . . . 0.0 113.835 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 pt 49.16 -22.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 1 C-N-CA 132.204 4.202 . . . . 0.0 116.127 -158.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.409 ' H ' ' C ' ' A' ' 77' ' ' SER . 49.1 m-85 -89.41 -19.89 24.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.484 1.914 . . . . 0.0 110.675 175.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.65 128.96 3.13 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 126.036 1.779 . . . . 0.0 109.336 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.331 48.3 tt0 50.1 -132.57 1.77 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -116.12 171.54 7.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.584 1.554 . . . . 0.0 109.408 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 77' ' ' SER . 0.7 OUTLIER -139.24 -177.48 4.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.597 1.559 . . . . 0.0 110.073 175.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -56.62 164.93 1.28 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.538 2.335 . . . . 0.0 113.207 -176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.92 75.44 10.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 164.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -45.99 -56.86 4.96 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -159.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.73 153.68 32.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 160.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.2 16.27 26.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.414 2.286 . . . . 0.0 111.207 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 mt -50.76 -53.17 14.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.882 1.273 . . . . 0.0 109.126 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.33 123.06 23.89 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -118.32 170.56 8.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.409 1.484 . . . . 0.0 109.377 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -81.5 54.12 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.504 1.921 . . . . 0.0 111.007 -167.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.4 p -69.67 -9.72 55.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -158.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.86 177.13 44.65 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.05 1.295 . . . . 0.0 111.802 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.25 155.31 46.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.645 1.563 . . . . 0.0 110.266 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.32 4.54 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.505 -1.72 . . . . 0.0 113.216 -171.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.06 162.32 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 120.795 2.298 . . . . 0.0 107.366 163.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.17 124.74 22.21 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 109.649 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 157.52 43.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.895 0.855 . . . . 0.0 110.941 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 91.4 mmm -64.07 156.01 29.56 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.108 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.444 ' CB ' HE22 ' A' ' 63' ' ' GLN . . . -112.42 136.51 51.81 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -146.2 172.24 13.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.35 1.46 . . . . 0.0 107.822 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.06 15.85 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.239 1.416 . . . . 0.0 111.656 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.63 -165.49 26.79 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -168.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -64.28 166.38 17.19 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 118.95 1.375 . . . . 0.0 110.048 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 37.67 43.91 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.287 3.035 . . . . 0.0 113.55 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -133.31 33.17 3.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.556 1.542 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -79.97 108.06 13.25 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.5 -100.62 2.09 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 89.9 p -145.77 33.88 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.315 0.646 . . . . 0.0 110.674 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -121.06 142.49 49.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -157.24 155.5 30.92 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -165.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -134.68 147.34 50.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.504 167.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.1 mt -83.85 117.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 29.1 m -63.69 129.01 38.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 p -117.79 26.3 9.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.19 0.995 . . . . 0.0 109.299 171.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.96 11.88 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 163.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -68.47 96.42 0.69 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 159.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.5 p -83.13 60.1 5.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.116 0.871 . . . . 0.0 109.835 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.64 -14.63 59.0 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.5 1.52 . . . . 0.0 113.086 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -76.45 -10.38 59.35 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.934 -1.104 . . . . 0.0 111.711 169.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.6 mt -104.69 -5.89 20.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.807 1.643 . . . . 0.0 110.99 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -63.99 132.12 49.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.48 17.74 74.81 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 122.113 -0.367 . . . . 0.0 113.089 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -128.04 -34.32 2.13 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.003 1.321 . . . . 0.0 110.854 176.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -140.35 162.63 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.224 0.92 . . . . 0.0 110.542 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.94 105.86 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.979 2.112 . . . . 0.0 107.434 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.53 131.95 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 166.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -138.33 -0.47 2.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.33 -177.7 27.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.344 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.93 148.17 36.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.261 1.424 . . . . 0.0 107.417 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.9 106.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 162.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -70.05 -50.36 41.98 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 159.19 42.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.53 0.732 . . . . 0.0 110.918 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.84 24.41 60.12 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.146 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -35.2 68.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.969 1.885 . . . . 0.0 110.343 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -64.99 -21.58 66.87 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.77 -34.0 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.156 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.88 -41.52 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.093 167.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.93 -29.1 70.53 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.185 -0.947 . . . . 0.0 112.302 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.46 -42.85 74.36 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.216 0.916 . . . . 0.0 109.566 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.8 mtm -56.28 -45.72 80.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.269 0.486 . . . . 0.0 110.867 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.58 -40.76 65.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 112.47 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -68.82 -20.58 64.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.052 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -91.32 3.99 53.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.013 0.925 . . . . 0.0 112.75 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.78 -148.37 14.82 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 121.058 1.754 . . . . 0.0 112.727 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.3 p -163.89 161.2 22.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.314 1.446 . . . . 0.0 107.235 158.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -59.54 -29.99 68.29 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.406 -1.434 . . . . 0.0 114.528 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -75.37 -7.71 54.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.36 -26.38 20.36 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 126.197 1.856 . . . . 0.0 113.726 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.06 123.93 20.76 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.393 1.077 . . . . 0.0 109.418 -171.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.3 p -75.81 143.88 41.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.862 1.665 . . . . 0.0 110.641 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.6 p -84.85 -13.65 50.34 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.106 -1.621 . . . . 0.0 111.938 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -146.84 157.46 43.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.164 1.785 . . . . 0.0 108.748 -168.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.438 ' HE2' HG23 ' A' ' 157' ' ' THR . 81.3 tttt -76.31 84.56 3.09 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.502 1.046 . . . . 0.0 108.296 174.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.6 mm -73.2 117.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.438 HG23 ' HE2' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -138.72 172.16 13.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.541 1.137 . . . . 0.0 110.585 -170.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.52 118.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 159.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.33 -49.62 26.42 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 167.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.3 152.67 40.28 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.092 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.8 p -164.08 165.5 22.26 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.83 0.852 . . . . 0.0 109.546 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.7 -170.21 43.33 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.464 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.8 tp60 -79.88 146.55 32.11 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.34 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 60.8 mt -138.31 42.91 2.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.437 1.495 . . . . 0.0 110.424 161.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.464 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 5.8 mt-10 . . . . . 0 C--O 1.248 0.987 0 O-C-N 120.971 -1.08 . . . . 0.0 111.212 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -55.96 169.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 157.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -29.08 98.24 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 127.496 2.318 . . . . 0.0 114.211 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -62.94 136.76 58.7 Favored 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 121.395 1.396 . . . . 0.0 108.947 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.8 m -98.5 145.93 26.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.68 133.82 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -87.94 157.84 18.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.134 0.968 . . . . 0.0 109.135 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -132.49 149.59 52.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -129.55 93.32 3.52 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 mm -77.18 141.62 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.69 160.82 28.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.635 1.574 . . . . 0.0 108.568 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.02 113.27 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 58.68 14.39 3.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.836 1.254 . . . . 0.0 114.258 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.36 -3.85 40.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.676 2.084 . . . . 0.0 113.17 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.85 115.46 61.0 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -57.83 120.27 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.132 1.888 . . . . 0.0 109.788 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -82.91 -43.46 16.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.44 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.21 152.62 7.03 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -76.78 152.34 35.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -141.33 160.43 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 126.803 2.041 . . . . 0.0 105.93 -174.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -142.87 152.39 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 122.129 0.966 . . . . 0.0 109.622 172.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.88 147.82 49.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.864 1.266 . . . . 0.0 108.857 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.8 139.4 39.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.95 1.7 . . . . 0.0 106.49 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.63 131.6 53.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.944 1.298 . . . . 0.0 107.814 -177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.21 52.64 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.014 0.926 . . . . 0.0 113.316 -166.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -18.89 56.68 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.897 -1.752 . . . . 0.0 115.628 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.15 0.27 53.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.734 1.152 . . . . 0.0 111.801 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -128.52 -29.54 2.41 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.466 1.506 . . . . 0.0 112.628 173.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.79 72.74 76.96 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.515 1.526 . . . . 0.0 108.9 167.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -56.36 -42.72 62.91 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.153 1.902 . . . . 0.0 114.194 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -53.6 53.35 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.5 m -62.13 -48.83 78.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.3 1.44 . . . . 0.0 109.983 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.87 -46.49 74.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -37.47 81.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.471 0.578 . . . . 0.0 109.801 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -56.95 -53.05 62.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -66.01 -32.8 74.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -51.75 -63.9 0.99 Allowed 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 124.351 1.06 . . . . 0.0 109.137 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.979 0.912 . . . . 0.0 113.242 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -71.38 -33.01 69.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.404 1.002 . . . . 0.0 111.523 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -65.55 -51.41 60.01 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.429 1.468 . . . . 0.0 108.965 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -63.83 -33.64 76.14 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.498 0.719 . . . . 0.0 110.432 -171.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.34 90.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.08 -24.28 67.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.713 1.257 . . . . 0.0 112.102 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -68.06 1.62 2.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.588 1.555 . . . . 0.0 112.395 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.82 5.83 84.55 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.644 1.116 . . . . 0.0 112.006 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -153.01 173.97 14.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.657 2.383 . . . . 0.0 106.537 167.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.95 -162.93 29.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 121.713 0.618 . . . . 0.0 111.967 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.402 ' CE1' ' HA2' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -69.36 -15.33 63.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.326 2.65 . . . . 0.0 112.631 177.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -62.85 100.06 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.029 -1.045 . . . . 0.0 108.578 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.2 80.01 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.142 -1.921 . . . . 0.0 115.473 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.8 p -64.3 -48.71 74.59 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.206 2.503 . . . . 0.0 111.528 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.4 m 106.76 144.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 1 C-N-CA 133.175 4.59 . . . . 0.0 108.343 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.65 136.2 33.47 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 162.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -119.68 -10.18 9.63 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.6 119.42 15.21 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.23 110.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 170.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.7 mt -116.55 94.65 43.86 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -54.92 121.06 9.18 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.814 3.01 . . . . 0.0 112.999 -168.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.73 26.35 46.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.933 1.254 . . . . 0.0 111.416 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -143.07 -68.8 0.34 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.383 1.092 . . . . 0.0 108.564 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -161.08 161.61 31.31 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.83 117.18 24.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -122.34 132.58 54.46 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.271 1.828 . . . . 0.0 109.339 -166.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.52 32.21 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 142.03 49.86 0.04 OUTLIER Glycine 0 N--CA 1.466 0.674 0 CA-C-N 119.526 1.663 . . . . 0.0 112.593 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -143.0 113.79 7.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -160.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.43 ' CE1' ' HE3' ' A' ' 76' ' ' LYS . 53.7 p90 -130.25 12.27 5.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.702 1.601 . . . . 0.0 110.745 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -122.98 -67.91 0.92 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.906 1.283 . . . . 0.0 108.834 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -106.07 -20.14 13.51 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 60.45 -3.81 0.13 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 119.03 2.974 . . . . 0.0 119.03 166.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -112.15 0.97 16.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.474 1.51 . . . . 0.0 112.842 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.443 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 118.45 -22.74 9.34 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.056 1.788 . . . . 0.0 112.382 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.1 p -85.25 20.54 1.94 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.413 1.106 . . . . 0.0 112.319 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.63 166.16 32.73 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 113.778 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.53 126.84 3.64 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 128.588 2.994 . . . . 0.0 105.996 -159.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HE3' ' CE1' ' A' ' 67' ' ' PHE . 3.5 pttt -143.54 152.87 41.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.085 2.554 . . . . 0.0 105.97 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.0 p -72.38 168.62 18.04 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.972 0.795 . . . . 0.0 109.856 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 pt -64.84 -18.65 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 123.784 0.834 . . . . 0.0 112.222 166.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -96.5 -6.76 36.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.79 -171.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.77 -84.57 0.13 Allowed Glycine 0 C--N 1.34 0.769 0 CA-C-N 119.921 1.237 . . . . 0.0 111.071 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -132.44 -137.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.888 1.675 . . . . 0.0 107.784 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -75.89 154.22 36.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.692 0.797 . . . . 0.0 109.908 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -125.63 177.01 6.48 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.122 0.963 . . . . 0.0 109.005 168.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.0 170.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.956 1.302 . . . . 0.0 112.326 -172.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.6 106.32 2.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 159.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.67 -44.87 92.48 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.264 0.625 . . . . 0.0 111.004 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.16 153.75 1.65 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 125.529 1.768 . . . . 0.0 114.133 158.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.68 15.26 29.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.254 2.222 . . . . 0.0 111.126 -169.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.8 mt -37.57 -46.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 128.045 2.538 . . . . 0.0 110.636 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.2 mt -92.15 121.94 34.17 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.164 1.786 . . . . 0.0 106.87 -173.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 123' ' ' ASP . 25.3 mttt -97.16 169.3 9.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 110.45 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -82.27 80.91 8.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 108.055 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -79.74 -20.75 45.64 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.99 175.4 36.37 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.954 1.252 . . . . 0.0 112.768 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.97 134.66 40.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.069 1.846 . . . . 0.0 110.449 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.53 -11.4 28.16 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.311 1.91 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 120.299 2.05 . . . . 0.0 109.185 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.97 132.16 53.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 126.156 1.783 . . . . 0.0 108.556 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.7 t -142.04 153.45 44.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.634 . . . . 0.0 110.304 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 92.4 mmm -80.21 137.66 36.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.074 0.55 . . . . 0.0 110.324 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.74 124.3 30.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 169.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.65 150.63 51.57 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.632 1.173 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.62 14.05 12.57 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.696 1.598 . . . . 0.0 113.068 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.07 -165.24 28.94 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 -165.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -63.45 164.71 19.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 119.249 1.524 . . . . 0.0 109.748 167.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 33.62 48.71 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 131.159 3.784 . . . . 0.0 112.478 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.9 p -138.99 30.84 2.22 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.359 -1.463 . . . . 0.0 112.136 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -86.23 149.71 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.747 -1.221 . . . . 0.0 107.865 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.16 -66.18 0.01 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.7 t -146.5 -28.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.096 0.958 . . . . 0.0 111.092 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.443 HE22 ' HA2' ' A' ' 72' ' ' GLY . 19.8 mt-30 -61.54 128.33 35.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -134.52 174.74 10.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.304 1.042 . . . . 0.0 108.265 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 99' ' ' SER . 20.3 p90 -139.58 149.73 44.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.22 1.01 . . . . 0.0 110.847 164.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.1 mt -83.22 116.85 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 100.696 -3.816 . . . . 0.0 100.696 164.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.8 m -67.81 108.13 2.86 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.5 p -102.56 28.46 6.01 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.322 1.049 . . . . 0.0 108.988 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.71 175.75 11.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.723 1.609 . . . . 0.0 107.466 166.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -71.78 86.62 0.95 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 166.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 p -74.87 40.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.239 2.216 . . . . 0.0 112.384 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.24 -20.96 61.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.015 -1.678 . . . . 0.0 114.08 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -68.37 -15.53 63.59 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.414 0.686 . . . . 0.0 111.103 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.5 mt -95.7 -3.22 46.4 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.58 1.552 . . . . 0.0 111.353 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -64.03 157.53 24.97 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.237 -0.914 . . . . 0.0 110.028 169.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.45 -0.0 14.97 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.295 1.426 . . . . 0.0 113.785 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -129.32 -47.92 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.507 1.523 . . . . 0.0 109.015 -172.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.15 146.12 40.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.458 0.647 . . . . 0.0 111.028 -167.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 t -95.35 100.99 11.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.04 126.83 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -138.87 2.36 2.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.66 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.28 -173.06 34.32 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.086 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -149.84 160.84 43.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.405 1.082 . . . . 0.0 110.724 164.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.25 115.71 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 166.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -49.91 28.6 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.33 159.19 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.994 2.518 . . . . 0.0 108.496 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.56 20.94 13.53 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.422 1.011 . . . . 0.0 113.236 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 33.6 tpp -54.61 -39.51 67.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.518 1.659 . . . . 0.0 111.813 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.34 69.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.806 1.639 . . . . 0.0 112.058 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.58 -45.16 52.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 118.954 0.797 . . . . 0.0 109.158 176.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.85 -47.03 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 0.0 110.368 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.81 -24.7 65.32 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.029 -1.044 . . . . 0.0 111.901 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.79 -43.83 57.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.958 -1.089 . . . . 0.0 109.182 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 66.9 mtp -56.36 -43.06 78.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.247 -0.908 . . . . 0.0 110.138 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.84 -37.21 83.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -71.87 -21.3 61.68 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 120.269 1.395 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -93.11 5.47 51.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.735 1.614 . . . . 0.0 111.519 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.57 48.07 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 108.424 -1.871 . . . . 0.0 108.424 167.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.1 p -151.86 163.34 39.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -61.84 -27.87 69.09 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 107.69 -27.03 16.03 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.374 1.464 . . . . 0.0 113.725 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 130.71 43.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.974 1.887 . . . . 0.0 108.015 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.0 p -70.86 138.19 50.02 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.7 p -64.11 -30.55 71.61 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.61 -0.681 . . . . 0.0 110.29 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -125.59 170.56 11.36 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.329 1.452 . . . . 0.0 109.044 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -86.99 87.75 7.54 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.783 -1.198 . . . . 0.0 108.676 -177.333 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.5 mm -75.6 120.19 24.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -142.71 172.77 12.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.525 1.155 . . . . 0.0 111.163 -173.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.03 113.81 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.78 -56.87 16.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -157.49 165.59 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.703 1.201 . . . . 0.0 109.873 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 54.3 m -141.6 163.65 32.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 127.327 2.251 . . . . 0.0 105.622 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.62 172.65 42.53 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.33 156.02 29.8 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.944 -0.739 . . . . 0.0 109.271 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 33.2 mt -136.63 43.0 2.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.882 0.373 . . . . 0.0 110.838 159.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 116.932 -1.907 . . . . 0.0 107.028 158.529 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.14 152.14 76.52 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.62 1.547 . . . . 0.0 109.875 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 m -111.18 156.47 21.37 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.58 163.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.208 1.003 . . . . 0.0 110.017 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -125.74 159.07 33.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 125.224 1.41 . . . . 0.0 109.657 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -146.12 118.24 8.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 107.011 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.03 96.85 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 mm -69.5 140.03 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.96 128.28 32.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.844 1.258 . . . . 0.0 109.827 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.497 HG12 ' HE2' ' A' ' 154' ' ' LYS . 22.6 t -95.95 109.48 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.43 13.76 0.99 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.634 1.574 . . . . 0.0 113.664 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.16 -11.78 26.62 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.72 1.629 . . . . 0.0 113.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.71 127.61 72.07 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 119.647 1.723 . . . . 0.0 107.201 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.83 119.13 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.724 1.616 . . . . 0.0 109.451 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -89.0 -32.8 17.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.484 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.09 162.87 10.39 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -68.62 147.85 51.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.21 154.3 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 126.966 2.107 . . . . 0.0 105.568 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.0 t -139.7 153.29 47.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.827 0.823 . . . . 0.0 109.182 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 60.4 m-85 -142.17 155.48 45.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.324 1.05 . . . . 0.0 108.773 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -107.32 146.69 31.23 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.479 1.511 . . . . 0.0 107.243 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.31 114.22 20.49 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -71.91 56.61 0.3 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.397 1.879 . . . . 0.0 113.198 -171.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.37 -28.85 13.67 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.628 1.571 . . . . 0.0 112.077 169.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -19.57 65.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.157 0.983 . . . . 0.0 112.04 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -125.45 -31.4 3.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 m -129.78 71.55 82.12 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.94 -43.06 26.94 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.611 2.207 . . . . 0.0 110.37 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -55.96 28.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -58.66 -46.88 86.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.56 0.744 . . . . 0.0 111.153 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.24 84.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.456 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.74 -43.74 83.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.716 1.206 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -55.82 -51.64 66.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 108.025 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -66.02 -44.89 83.41 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 124.162 0.914 . . . . 0.0 112.238 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -43.79 -59.1 2.38 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.656 1.582 . . . . 0.0 108.976 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.48 71.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.554 1.541 . . . . 0.0 113.308 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.39 -40.04 62.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.275 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -50.67 66.96 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 119.449 1.022 . . . . 0.0 111.066 173.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.1 p -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.397 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 5.95 89.04 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.168 0.89 . . . . 0.0 112.139 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -5.25 27.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.065 1.433 . . . . 0.0 113.954 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -96.96 12.96 30.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.711 1.205 . . . . 0.0 110.846 170.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.15 74.05 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 120.714 -1.241 . . . . 0.0 113.054 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.52 -165.31 1.52 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.871 2.068 . . . . 0.0 106.357 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.69 -138.18 13.47 Favored Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CZ ' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -81.55 -26.4 35.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.38 1.072 . . . . 0.0 113.486 -167.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -57.97 110.03 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.148 0.979 . . . . 0.0 108.966 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.71 90.18 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.952 1.263 . . . . 0.0 115.627 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -100.23 7.46 44.45 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.991 2.395 . . . . 0.0 114.078 -158.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 62.94 174.59 0.15 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 127.925 2.49 . . . . 0.0 116.183 159.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.56 121.03 38.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 112.136 -2.302 . . . . 0.0 106.566 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -108.47 -24.14 11.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.511 1.124 . . . . 0.0 111.03 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.8 105.36 8.19 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 mt -118.73 114.99 46.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.07 95.51 36.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -168.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -41.12 125.97 2.51 Favored 'Trans proline' 0 C--O 1.24 0.586 1 C-N-CA 125.418 4.078 . . . . 0.0 114.538 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.34 29.96 74.73 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.127 1.346 . . . . 0.0 111.777 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -135.84 -79.89 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.06 171.15 20.51 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.2 m -120.19 91.1 3.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.396 2.278 . . . . 0.0 109.379 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -79.93 139.14 37.19 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.486 1.915 . . . . 0.0 110.9 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.42 -171.41 17.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.813 1.673 . . . . 0.0 111.54 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.39 24.73 9.25 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.363 0.506 . . . . 0.0 112.595 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.75 76.07 9.98 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CD1' HG23 ' A' ' 68' ' ' THR . 1.5 p90 -98.61 -11.8 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.582 HG21 ' CE ' ' A' ' 76' ' ' LYS . 17.6 p -134.31 -10.35 2.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.72 1.208 . . . . 0.0 113.253 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.3 mmt-85 -138.61 -172.38 3.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.27 34.32 0.52 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.384 0.993 . . . . 0.0 112.481 -168.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -150.72 12.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.0 1.32 . . . . 0.0 111.838 -163.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.56 32.65 27.08 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 118.987 -0.896 . . . . 0.0 110.885 -175.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -135.76 1.57 2.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.572 1.186 . . . . 0.0 112.185 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.19 166.09 33.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 119.648 1.113 . . . . 0.0 110.725 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 147.03 14.0 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.569 1.094 . . . . 0.0 114.362 165.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' CE ' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -155.46 160.32 40.52 Favored 'General case' 0 C--O 1.238 0.474 1 C-N-CA 132.07 4.148 . . . . 0.0 104.4 -173.966 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.5 p -78.34 171.76 14.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.974 0.806 . . . . 0.0 110.831 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.5 -25.18 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.729 0.412 . . . . 0.0 111.406 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.01 -22.11 24.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.391 0.676 . . . . 0.0 111.143 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.94 172.43 28.24 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.191 0.884 . . . . 0.0 114.044 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.14 112.69 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.949 1.7 . . . . 0.0 108.225 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 48.38 161.41 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.66 1 C-N-CA 133.884 4.874 . . . . 0.0 115.099 -165.219 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -139.29 175.35 9.63 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.819 162.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -65.89 159.8 24.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.354 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 114.61 13.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 161.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.45 -56.62 16.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.893 1.277 . . . . 0.0 110.819 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -169.03 -177.82 3.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.429 1.492 . . . . 0.0 108.702 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -130.44 25.14 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.604 1.962 . . . . 0.0 109.128 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.84 -57.72 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.95 128.11 34.66 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.551 2.34 . . . . 0.0 105.476 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -119.93 165.36 14.74 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.919 1.288 . . . . 0.0 110.244 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -81.77 56.13 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.559 1.543 . . . . 0.0 110.343 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -66.06 -23.25 66.5 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.863 1.265 . . . . 0.0 113.614 -160.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.5 179.36 48.75 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.27 160.58 19.02 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.576 1.517 . . . . 0.0 110.318 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.5 4.23 64.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.637 -1.646 . . . . 0.0 112.46 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.1 mm -79.4 166.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 121.009 2.405 . . . . 0.0 108.09 166.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 132.08 27.8 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.067 1.347 . . . . 0.0 109.61 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 t -143.79 147.24 33.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.016 0.526 . . . . 0.0 111.172 -170.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 97.4 mmm -74.33 117.92 16.69 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.557 1.143 . . . . 0.0 109.984 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -67.66 139.11 56.77 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 162.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -144.06 -178.03 5.74 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.83 2.052 . . . . 0.0 108.215 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.09 16.86 24.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.462 1.105 . . . . 0.0 111.926 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.28 -160.91 21.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.325 1.441 . . . . 0.0 109.659 -167.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -60.94 150.21 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.978 1.785 . . . . 0.0 109.844 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 39.14 48.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.078 2.951 . . . . 0.0 114.13 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.5 p -138.82 21.25 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.909 1.284 . . . . 0.0 110.58 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.77 155.96 25.2 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.923 -1.11 . . . . 0.0 108.278 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.32 -66.53 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.468 1.031 . . . . 0.0 114.782 -166.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -156.22 -5.59 0.11 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.899 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.463 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 2.1 mm-40 -78.63 136.94 37.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CE2' ' CZ ' ' A' ' 48' ' ' TYR . 5.3 p90 -130.97 169.73 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 164.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -130.98 146.43 52.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.887 0.475 . . . . 0.0 109.807 160.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.3 mt -83.5 116.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 169.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 m -60.75 124.15 19.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -110.47 21.57 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.155 0.582 . . . . 0.0 109.683 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.28 179.03 8.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.64 91.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.3 p -83.76 50.73 1.87 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.096 0.862 . . . . 0.0 110.663 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -18.92 51.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.978 1.311 . . . . 0.0 112.797 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -67.02 -19.22 65.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.762 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.8 mt -95.54 -4.34 44.93 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.668 1.587 . . . . 0.0 112.325 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.15 129.27 39.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.607 1.094 . . . . 0.0 108.787 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.81 -1.98 83.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.747 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.6 -20.23 8.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.043 1.922 . . . . 0.0 112.912 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -139.42 153.05 47.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.361 0.982 . . . . 0.0 111.044 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.0 t -88.0 100.01 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.93 126.39 19.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -140.76 -0.7 1.5 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.14 -178.67 28.8 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 119.08 0.855 . . . . 0.0 111.667 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -149.63 153.89 37.76 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.418 1.487 . . . . 0.0 107.591 172.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.85 126.45 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 166.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.428 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 23.9 ttmt -82.93 -52.17 6.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 164.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 162.34 40.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.227 -167.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.09 74.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.729 0.681 . . . . 0.0 113.45 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -38.91 75.27 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.329 1.564 . . . . 0.0 110.098 175.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -61.36 -25.11 66.94 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 172.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mm -77.72 -38.48 25.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.64 -39.84 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.777 0.717 . . . . 0.0 109.54 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -60.87 -34.78 75.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.944 -1.098 . . . . 0.0 111.808 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.39 63.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.384 0.993 . . . . 0.0 109.509 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 69.5 mtp -52.66 -42.26 64.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.236 1.015 . . . . 0.0 110.486 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -62.6 -34.47 77.08 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -30.05 70.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.616 1.098 . . . . 0.0 110.243 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -92.89 5.91 49.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.035 1.734 . . . . 0.0 111.86 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.75 -149.95 7.62 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 170.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 p -146.47 -61.51 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 141.75 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 1 C-N-CA 132.716 4.407 . . . . 0.0 109.726 -169.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 5.12 2.65 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 118.571 0.623 . . . . 0.0 111.454 164.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.54 -42.75 2.96 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 126.589 2.043 . . . . 0.0 111.556 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -60.24 123.89 18.59 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 61.3 p -72.98 164.04 27.28 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 124.343 1.027 . . . . 0.0 110.091 -167.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -88.5 -8.99 53.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.426 0.69 . . . . 0.0 111.239 163.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.497 ' HE2' HG12 ' A' ' 12' ' ' VAL . 15.3 tttt -152.81 149.24 28.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 109.934 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -75.06 123.0 24.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 -172.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 mt -112.62 126.49 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.54 175.84 9.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.151 -158.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.74 112.28 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.0 76.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -150.69 156.48 41.41 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.7 p -161.9 160.64 28.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.523 1.129 . . . . 0.0 109.722 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.93 -171.44 43.55 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -95.11 151.99 18.72 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.1 mt -125.66 42.5 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.601 1.191 . . . . 0.0 108.446 165.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.186 1.394 . . . . 0.0 111.822 176.313 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.03 157.37 57.52 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.517 1.22 . . . . 0.0 109.242 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.439 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 32.6 m -110.11 155.69 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 170.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.19 158.72 41.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.563 1.545 . . . . 0.0 107.536 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -135.34 159.61 41.02 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 123.446 0.698 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.629 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 64.4 m-85 -153.29 114.23 4.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.972 1.709 . . . . 0.0 108.596 -173.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -74.4 102.78 4.53 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 163.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.0 mm -67.38 143.02 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.99 129.48 22.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.336 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.548 HG12 ' HE2' ' A' ' 154' ' ' LYS . 78.6 t -93.05 101.13 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 127.409 2.284 . . . . 0.0 104.937 173.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 60.37 13.6 4.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.448 1.022 . . . . 0.0 113.754 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 0.26 53.58 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.407 1.479 . . . . 0.0 113.947 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 110.3 34.25 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 167.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.34 136.23 42.73 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.516 1.478 . . . . 0.0 110.001 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -104.61 -21.19 13.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.9 1.68 . . . . 0.0 110.61 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.39 156.22 7.19 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.045 0.839 . . . . 0.0 112.478 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.18 130.23 42.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.56 150.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.4 m -137.1 147.07 45.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 87.0 m-85 -135.63 136.36 40.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -173.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.39 152.35 39.54 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 162.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.2 mt -126.88 122.22 34.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.416 ' CD2' HD13 ' A' ' 90' ' ' LEU . 57.1 m-85 -69.61 52.71 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.862 2.065 . . . . 0.0 112.065 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.87 -21.99 58.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.081 -1.637 . . . . 0.0 112.222 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.06 4.17 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.047 0.939 . . . . 0.0 113.37 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -125.98 -35.52 2.46 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.329 1.452 . . . . 0.0 110.605 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m -142.12 68.35 22.39 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.148 1.779 . . . . 0.0 108.886 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.03 -37.88 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.063 1.842 . . . . 0.0 113.194 -176.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -55.07 39.12 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.078 1.763 . . . . 0.0 109.773 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.95 -40.79 90.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 122.838 0.455 . . . . 0.0 110.008 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.14 -33.08 67.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.31 -50.09 49.83 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.812 1.645 . . . . 0.0 109.55 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -45.72 -51.37 12.61 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.042 1.737 . . . . 0.0 109.661 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.35 90.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -56.56 -59.25 5.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.753 1.221 . . . . 0.0 107.87 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.72 -50.22 25.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.77 1.228 . . . . 0.0 112.491 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.92 -29.24 68.27 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.951 -1.093 . . . . 0.0 111.547 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -77.62 -43.53 31.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.965 1.257 . . . . 0.0 112.612 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.1 p -65.71 -32.29 73.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 7.02 89.02 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.435 1.017 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.45 -16.93 64.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.842 1.657 . . . . 0.0 114.101 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -83.02 -1.9 53.86 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.014 -1.054 . . . . 0.0 110.581 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.58 8.4 65.82 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.634 1.112 . . . . 0.0 112.842 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -156.18 -172.61 4.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.065 1.432 . . . . 0.0 110.434 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.87 -139.45 10.96 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-O 122.321 0.956 . . . . 0.0 113.417 160.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.629 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 7.3 t80 -62.76 -34.6 77.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.524 1.93 . . . . 0.0 108.69 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.99 124.86 19.13 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.595 1.088 . . . . 0.0 108.888 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.86 -0.39 21.65 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.105 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.1 m -64.36 115.21 4.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 120.949 2.374 . . . . 0.0 105.542 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.3 p -75.86 156.37 34.44 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.699 -0.626 . . . . 0.0 109.61 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 62.1 m-85 -91.72 95.58 9.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.55 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -74.69 -21.05 59.6 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -166.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 82.76 1.85 Allowed 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 121.151 -0.968 . . . . 0.0 109.367 -169.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.487 HD12 ' CG2' ' A' ' 152' ' ' THR . 7.7 mt -102.66 101.9 12.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.18 92.34 45.3 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -167.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -48.64 130.89 23.21 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.34 79.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.185 1.85 . . . . 0.0 112.114 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -142.03 -62.96 0.44 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.547 1.174 . . . . 0.0 109.434 -170.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -168.75 164.25 11.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.902 0.774 . . . . 0.0 112.347 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.9 m -113.32 93.1 4.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 108.277 159.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -76.89 142.99 39.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.002 0.921 . . . . 0.0 109.852 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -152.97 -164.5 12.56 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 124.85 1.214 . . . . 0.0 110.584 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.31 43.0 6.38 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.395 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.02 136.28 49.22 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 119.754 1.777 . . . . 0.0 107.929 159.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -134.39 5.95 3.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 127.91 2.484 . . . . 0.0 109.487 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -114.06 -53.49 2.67 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.391 1.477 . . . . 0.0 107.787 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -117.11 -165.9 1.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 158.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -174.22 46.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -166.85 20.82 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.158 2.183 . . . . 0.0 110.253 -170.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.58 -32.55 4.72 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.458 -1.19 . . . . 0.0 113.52 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.5 p -83.84 6.67 20.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.517 2.158 . . . . 0.0 114.673 -161.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -115.8 -124.47 3.73 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.86 100.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 127.187 2.327 . . . . 0.0 113.547 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -129.34 146.43 51.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.468 1.907 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.0 p -80.84 -178.4 6.81 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.993 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.6 pt -76.73 -6.84 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.472 168.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -90.78 -3.16 57.63 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.16 0.891 . . . . 0.0 112.057 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.76 91.17 1.92 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.267 10.7 tp10 62.17 -133.63 0.54 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.381 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -103.37 131.31 50.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.685 1.13 . . . . 0.0 110.871 -160.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -98.08 169.8 9.36 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.852 0.835 . . . . 0.0 110.107 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -66.7 170.57 6.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.51 1.524 . . . . 0.0 111.226 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -85.95 113.93 22.45 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -43.56 -55.65 4.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.96 1.304 . . . . 0.0 110.989 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -172.52 177.57 2.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.793 2.437 . . . . 0.0 106.479 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -125.49 32.09 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.661 1.184 . . . . 0.0 109.293 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.71 -55.78 20.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.416 HD13 ' CD2' ' A' ' 25' ' ' PHE . 64.2 mt -84.4 130.02 34.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.155 1.382 . . . . 0.0 107.566 -170.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -120.8 165.27 15.38 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 126.947 2.099 . . . . 0.0 109.449 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -85.7 65.76 9.31 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.557 0.743 . . . . 0.0 110.598 -164.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 p -70.97 -19.2 62.58 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -162.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.01 178.8 48.92 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 119.361 0.982 . . . . 0.0 111.918 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -62.1 158.69 37.95 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.545 2.163 . . . . 0.0 110.304 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.6 -6.84 36.26 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 116.974 -2.014 . . . . 0.0 112.934 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.69 156.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-N 121.46 2.63 . . . . 0.0 108.11 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.426 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -134.05 131.14 38.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.172 0.989 . . . . 0.0 110.852 176.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.82 150.23 33.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.29 1.036 . . . . 0.0 110.955 -164.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.62 138.14 54.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.0 50.92 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -59.99 163.35 4.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.065 1.412 . . . . 0.0 109.681 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.48 14.24 13.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.6 -165.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.81 -167.22 27.73 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.713 2.102 . . . . 0.0 107.98 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.44 143.66 58.52 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.284 1.989 . . . . 0.0 110.232 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 50.11 47.78 23.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.551 2.34 . . . . 0.0 112.7 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 p -120.37 23.0 11.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.871 1.268 . . . . 0.0 111.638 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -69.42 135.85 50.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.322 1.049 . . . . 0.0 108.885 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.0 -78.45 0.02 OUTLIER Glycine 0 C--N 1.337 0.588 0 CA-C-N 118.436 0.562 . . . . 0.0 112.867 -168.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -142.21 -47.13 0.35 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.543 0.737 . . . . 0.0 109.963 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -62.46 137.7 58.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 124.082 0.863 . . . . 0.0 108.676 -170.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.429 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 45.4 p90 -141.81 172.75 12.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.871 1.668 . . . . 0.0 107.316 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 48.6 p90 -141.86 151.1 42.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.423 0.63 . . . . 0.0 109.697 158.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.34 120.8 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.76 127.4 31.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.9 p -107.66 19.84 19.62 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.724 0.809 . . . . 0.0 110.023 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.8 -177.89 5.4 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 164.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -60.99 128.02 34.43 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 158.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.43 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 71.9 p -117.67 72.77 0.86 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.61 1.55 . . . . 0.0 110.074 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.42 -12.6 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.415 -0.803 . . . . 0.0 113.139 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.43 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 27.5 p90 -71.81 -13.86 61.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.377 0.671 . . . . 0.0 111.288 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.446 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 61.0 mt -109.95 -8.12 14.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.751 1.221 . . . . 0.0 111.894 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 153.08 43.23 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.55 7.92 43.26 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.211 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -135.53 -40.31 0.72 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.169 1.485 . . . . 0.0 111.388 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -114.56 147.85 38.85 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.941 0.496 . . . . 0.0 111.487 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.13 105.79 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.041 1.736 . . . . 0.0 107.305 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.01 137.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 161.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.3 -3.83 0.72 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.294 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.49 176.83 27.11 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 119.691 1.132 . . . . 0.0 112.053 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.61 149.16 31.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.575 1.15 . . . . 0.0 108.153 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.417 HG22 ' CE2' ' A' ' 22' ' ' PHE . 62.5 t -58.88 126.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 164.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -93.64 -42.3 9.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.967 0.507 . . . . 0.0 109.769 165.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.05 156.7 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.711 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.17 21.26 61.13 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.481 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -52.31 -42.62 63.95 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.498 1.649 . . . . 0.0 111.311 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.77 -13.09 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.035 0.834 . . . . 0.0 112.925 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.6 mm -84.58 -36.46 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.427 1.091 . . . . 0.0 108.484 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.39 -40.78 90.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 121.442 -0.786 . . . . 0.0 108.945 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -62.67 -33.68 75.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.36 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.61 76.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 109.331 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.8 mtm -55.72 -46.07 77.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.45 0.568 . . . . 0.0 110.135 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.35 -36.13 73.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.167 0.587 . . . . 0.0 111.844 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -25.48 68.14 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.496 0.589 . . . . 0.0 111.546 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -97.88 -0.43 45.03 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.076 1.75 . . . . 0.0 112.15 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.18 -173.5 47.46 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 167.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 p -162.37 159.66 25.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -63.17 -16.46 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -4.33 2.89 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 167.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.86 -25.27 2.19 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 127.339 2.399 . . . . 0.0 114.328 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.86 127.43 33.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.487 ' CG2' HD12 ' A' ' 56' ' ' ILE . 16.5 p -66.41 168.44 8.94 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.637 1.175 . . . . 0.0 110.773 168.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.9 p -81.6 -16.54 51.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.806 159.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.548 ' HE2' HG12 ' A' ' 12' ' ' VAL . 41.4 mtpt -143.63 160.6 40.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.01 0.924 . . . . 0.0 111.414 -167.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.433 ' HE2' ' CG2' ' A' ' 157' ' ' THR . 14.8 tttt -84.87 78.41 9.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.36 1.436 . . . . 0.0 109.697 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 12' ' ' VAL . 57.0 mt -76.7 133.27 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.483 0.658 . . . . 0.0 109.404 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.433 ' CG2' ' HE2' ' A' ' 155' ' ' LYS . 74.7 p -148.98 177.03 9.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.905 2.082 . . . . 0.0 110.105 -173.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 48' ' ' TYR . 3.1 mp -92.61 124.35 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 158.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.72 -55.3 10.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.68 161.96 39.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.079 0.552 . . . . 0.0 111.025 -169.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.8 171.28 7.39 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.3 -167.86 40.69 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.606 1.574 . . . . 0.0 109.83 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -95.91 148.5 22.56 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.544 1.137 . . . . 0.0 109.619 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.9 mt -126.87 43.07 3.19 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.534 1.934 . . . . 0.0 110.476 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 5' ' ' THR . 9.2 tm-20 . . . . . 0 C--O 1.255 1.348 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 161.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.302 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.5 161.39 44.29 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 CA-C-N 120.661 1.272 . . . . 0.0 108.97 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.4 m -102.16 157.18 17.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.96 157.32 33.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.314 1.845 . . . . 0.0 107.648 164.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.66 151.2 30.44 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.543 0.737 . . . . 0.0 109.9 165.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 23.4 m-30 -133.85 104.51 6.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.118 2.167 . . . . 0.0 106.179 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.82 107.16 8.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mm -75.29 142.85 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 109.535 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -122.78 159.79 27.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.019 0.914 . . . . 0.0 109.554 161.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.0 96.37 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 56.07 14.03 1.34 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.629 1.572 . . . . 0.0 112.889 -169.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.65 -13.55 29.94 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.57 1.557 . . . . 0.0 113.18 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.41 127.59 85.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 120.389 2.094 . . . . 0.0 106.627 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.6 108.53 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.675 2.25 . . . . 0.0 109.755 -170.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.6 tp -84.56 -28.04 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.519 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.54 162.27 10.12 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 118.806 0.73 . . . . 0.0 114.458 167.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -77.7 113.96 16.08 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.65 0.78 . . . . 0.0 109.803 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.15 159.36 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 106.215 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.8 m -150.11 152.93 35.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.129 -1.607 . . . . 0.0 110.41 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.25 133.57 29.82 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.006 0.922 . . . . 0.0 109.235 -166.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.71 139.84 35.92 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.08 121.89 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -82.6 62.53 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.961 0.904 . . . . 0.0 112.38 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.05 40.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.941 0.896 . . . . 0.0 112.806 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -9.42 59.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.419 1.088 . . . . 0.0 111.589 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -117.81 -54.23 2.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.422 1.489 . . . . 0.0 108.84 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 m -126.95 72.23 75.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 125.194 1.398 . . . . 0.0 107.711 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.67 -39.39 88.22 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.252 1.968 . . . . 0.0 112.319 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' CA ' ' HE3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.99 -53.47 56.89 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.445 1.475 . . . . 0.0 109.195 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 m -64.39 -41.01 96.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.899 0.879 . . . . 0.0 110.365 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.46 -50.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.556 0.742 . . . . 0.0 112.2 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.69 -40.55 95.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 110.093 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -51.58 -60.46 3.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.086 1.354 . . . . 0.0 109.427 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -60.77 -31.05 70.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HD2' HE22 ' A' ' 163' ' ' GLN . 38.1 ttp85 -55.69 -64.53 0.82 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.358 1.863 . . . . 0.0 110.181 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.7 74.9 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.833 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.29 -34.58 77.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.541 -0.724 . . . . 0.0 111.028 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -69.5 -27.16 64.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.66 0.784 . . . . 0.0 111.625 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.3 p -90.21 -23.71 21.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.267 0.94 . . . . 0.0 111.283 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.41 -1.97 74.1 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.144 1.354 . . . . 0.0 112.707 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.39 -20.38 64.68 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.419 1.888 . . . . 0.0 113.427 -164.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -81.65 11.95 4.29 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.555 -0.716 . . . . 0.0 111.678 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.42 78.09 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 124.175 0.893 . . . . 0.0 112.274 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.09 167.98 26.57 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 125.493 1.517 . . . . 0.0 107.339 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 175.01 34.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 117.796 -2.145 . . . . 0.0 113.328 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 40.8 t80 -61.6 -32.42 72.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 127.794 2.437 . . . . 0.0 111.558 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -45.47 122.35 3.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.71 1.204 . . . . 0.0 109.875 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.35 26.23 61.47 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 116.33 -2.372 . . . . 0.0 115.689 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -66.66 -54.32 24.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 122.128 2.964 . . . . 0.0 107.44 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 32.8 t 113.9 161.91 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 1 C-N-CA 132.393 4.277 . . . . 0.0 106.951 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.97 101.64 12.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -77.45 -15.74 59.16 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.95 111.11 6.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.442 HD12 ' CG2' ' A' ' 152' ' ' THR . 22.2 mt -129.96 105.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.9 mt -116.05 97.96 50.35 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -50.15 126.61 17.63 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 123.552 2.834 . . . . 0.0 112.726 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.85 71.55 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 126.707 2.098 . . . . 0.0 112.033 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.64 -80.36 0.27 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.473 1.136 . . . . 0.0 108.059 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.78 166.65 26.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.278 0.631 . . . . 0.0 111.673 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.8 m -124.06 100.78 6.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.309 2.644 . . . . 0.0 109.284 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -84.36 135.01 34.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.066 1.746 . . . . 0.0 111.101 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.27 -174.15 21.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 126.489 1.995 . . . . 0.0 109.139 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.32 6.18 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 117.405 0.603 . . . . 0.0 113.628 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -110.72 23.76 13.8 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -159.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 43.2 p90 -58.52 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.182 1 C-N-CA 131.827 4.051 . . . . 0.0 116.101 -176.069 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.3 t -148.39 -12.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.237 2.215 . . . . 0.0 112.179 161.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -146.19 -173.93 4.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.291 2.236 . . . . 0.0 106.199 -168.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -169.94 45.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -155.45 -7.33 0.12 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.67 5.29 51.47 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 117.686 -1.619 . . . . 0.0 114.413 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -91.52 -96.01 0.13 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.453 2.126 . . . . 0.0 107.272 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 41.52 -158.88 0.04 OUTLIER Glycine 0 CA--C 1.531 1.038 0 C-N-CA 127.157 2.313 . . . . 0.0 114.672 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.86 117.66 1.3 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-O 121.562 0.535 . . . . 0.0 111.97 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.574 ' HE3' ' CE2' ' A' ' 67' ' ' PHE . 4.0 ptpt -145.56 -170.52 3.47 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.685 2.394 . . . . 0.0 107.187 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.3 p -140.81 177.14 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.475 1.034 . . . . 0.0 110.673 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt -74.64 -0.64 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 111.624 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -108.39 -1.18 20.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.053 1.341 . . . . 0.0 111.363 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.56 -113.8 1.77 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.58 -139.32 0.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.426 0.613 . . . . 0.0 109.469 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -70.05 166.25 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.318 1.047 . . . . 0.0 108.808 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -134.1 -179.65 5.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.761 2.024 . . . . 0.0 106.874 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.45 159.95 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.284 1.04 . . . . 0.0 112.572 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 89.84 1.96 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.238 1.415 . . . . 0.0 107.882 172.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.21 -52.73 64.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.767 1.227 . . . . 0.0 112.867 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -150.19 174.38 12.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 162.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.64 32.05 5.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.964 2.105 . . . . 0.0 110.045 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.81 -48.31 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.25 1.024 . . . . 0.0 108.456 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.64 133.82 35.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.809 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -132.25 171.26 13.92 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.114 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -84.78 87.19 7.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -164.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.2 p -77.7 -17.98 57.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.827 -171.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.9 -178.2 46.73 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.858 1.208 . . . . 0.0 112.671 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.27 142.0 97.14 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.969 1.78 . . . . 0.0 108.917 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.77 -3.44 56.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 117.644 -1.642 . . . . 0.0 112.587 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 128' ' ' VAL . 15.3 mm -74.51 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 121.103 2.452 . . . . 0.0 109.072 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.72 130.34 54.95 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.142 1.377 . . . . 0.0 109.354 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 p -144.22 158.02 43.96 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.563 1.145 . . . . 0.0 112.686 176.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 95.4 mmm -75.37 131.01 39.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.811 1.245 . . . . 0.0 111.851 -168.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.444 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -83.23 81.62 8.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.504 1.522 . . . . 0.0 107.523 168.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -70.48 -179.71 2.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.43 1.092 . . . . 0.0 110.428 165.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.0 36.49 1.03 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.326 2.25 . . . . 0.0 109.244 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.89 -164.1 27.55 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 106.879 -2.488 . . . . 0.0 106.879 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.46 171.35 9.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 119.236 1.518 . . . . 0.0 108.566 159.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m120 41.11 38.23 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.818 2.447 . . . . 0.0 114.12 159.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -125.25 25.9 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.342 2.257 . . . . 0.0 109.108 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -74.96 105.49 6.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 129.961 3.305 . . . . 0.0 103.553 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.67 -93.26 1.24 Allowed Glycine 0 C--O 1.225 -0.456 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.5 p -139.33 -14.4 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.79 0.836 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -70.85 133.55 46.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 13.2 p90 -152.31 -179.42 7.53 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 108.151 -174.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -144.06 152.66 41.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.116 0.484 . . . . 0.0 111.282 162.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.7 mt -83.68 113.37 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 165.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.8 m -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.816 1.246 . . . . 0.0 107.832 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.3 p -116.7 27.26 9.28 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.136 0.974 . . . . 0.0 108.695 172.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.53 178.59 10.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 162.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -72.64 87.46 1.24 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 165.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.7 p -81.03 42.22 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.059 0.544 . . . . 0.0 112.3 -171.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.63 -4.1 21.65 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 119.746 -1.846 . . . . 0.0 114.047 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -61.05 -19.7 61.7 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.018 -1.051 . . . . 0.0 110.734 161.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.2 mt -100.89 1.34 39.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.582 1.953 . . . . 0.0 111.78 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.57 138.88 58.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.231 1.012 . . . . 0.0 109.784 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.92 10.62 61.83 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 122.702 0.192 . . . . 0.0 112.908 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -129.26 -37.02 1.68 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.66 1.584 . . . . 0.0 109.567 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -114.09 121.1 42.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.932 0.893 . . . . 0.0 109.002 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.09 106.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.66 1.584 . . . . 0.0 107.467 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.412 HG13 HG23 ' A' ' 97' ' ' ILE . 67.9 t -70.37 131.68 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 166.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -138.54 -5.68 1.56 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.35 -179.46 31.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.72 -1.229 . . . . 0.0 111.664 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -156.8 148.81 22.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.55 122.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -87.09 -48.52 8.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -148.83 154.7 39.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.367 1.467 . . . . 0.0 111.362 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.55 24.88 27.14 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 123.886 0.755 . . . . 0.0 113.123 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.0 tpt -53.74 -39.9 65.7 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.899 1.349 . . . . 0.0 109.442 168.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -62.4 -27.67 69.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.2 mm -78.0 -39.42 25.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.13 -41.95 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.941 0.791 . . . . 0.0 109.288 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.7 -24.49 67.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.615 1.166 . . . . 0.0 112.644 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.22 -45.43 23.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.043 -1.035 . . . . 0.0 110.143 169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 52.0 mtp -54.74 -44.69 73.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.402 0.681 . . . . 0.0 110.931 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.61 -38.0 74.22 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.915 1.286 . . . . 0.0 112.035 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -69.71 -18.68 63.55 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.991 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -94.7 -2.55 50.98 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.204 1.002 . . . . 0.0 111.721 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.58 -166.96 41.07 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -156.01 163.46 39.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 163.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.16 -17.85 64.45 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -9.86 38.81 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 167.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 88.26 -23.21 15.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 127.044 2.259 . . . . 0.0 113.004 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.68 130.3 40.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.899 1.349 . . . . 0.0 107.693 175.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.442 ' CG2' HD12 ' A' ' 56' ' ' ILE . 1.2 p -70.68 165.36 23.1 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.44 1.496 . . . . 0.0 111.304 177.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.0 p -97.21 -14.39 21.45 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.6 1.16 . . . . 0.0 111.477 163.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -137.77 154.24 49.61 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.575 1.15 . . . . 0.0 110.739 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -81.02 85.98 6.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.107 1.363 . . . . 0.0 107.78 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.59 119.87 34.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -132.74 174.25 10.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.0 1.32 . . . . 0.0 109.669 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.18 96.97 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -56.64 -50.21 72.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.613 1.965 . . . . 0.0 109.195 -177.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.2 164.66 33.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 108.041 175.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.7 p -165.93 164.81 18.43 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.031 0.532 . . . . 0.0 110.821 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.48 -174.15 45.99 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.548 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.9 tp60 -81.22 146.31 30.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.74 1.616 . . . . 0.0 110.172 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.43 43.31 2.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 111.091 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 3.6 pt-20 . . . . . 0 C--O 1.248 0.993 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 . . . . . 0 C--O 1.234 0.238 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.99 152.87 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 N-CA-C 108.815 -1.264 . . . . 0.0 108.815 159.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.1 m -99.47 152.93 19.44 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.19 150.79 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.473 1.509 . . . . 0.0 107.685 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -121.81 158.71 28.29 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.643 1.177 . . . . 0.0 109.722 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -149.34 109.46 4.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.651 1.58 . . . . 0.0 108.284 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.67 100.95 9.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.3 mm -73.75 139.78 18.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.7 127.26 36.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.332 1.053 . . . . 0.0 109.837 169.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.67 111.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.68 13.37 0.49 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.012 2.125 . . . . 0.0 114.88 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.05 -12.15 14.59 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.331 1.443 . . . . 0.0 113.28 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.21 130.11 55.63 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 119.774 1.787 . . . . 0.0 106.826 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.36 115.36 3.64 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.346 1.364 . . . . 0.0 108.818 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.1 tp -86.83 -32.13 20.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.438 -0.315 . . . . 0.0 110.493 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.55 171.15 13.63 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 123.748 0.689 . . . . 0.0 111.476 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -85.75 141.16 29.9 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 109.683 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.5 160.41 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 127.938 2.495 . . . . 0.0 106.166 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -148.73 148.9 30.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 120.923 -1.111 . . . . 0.0 109.864 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.55 160.77 33.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.311 1.044 . . . . 0.0 108.458 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -124.45 135.37 53.19 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.844 2.457 . . . . 0.0 105.593 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.32 110.51 12.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.104 0.962 . . . . 0.0 109.767 -163.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -74.63 64.2 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.236 1.814 . . . . 0.0 113.681 -167.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.5 -25.62 64.61 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.204 1.002 . . . . 0.0 112.636 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.75 -0.67 44.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.238 1.415 . . . . 0.0 112.795 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -118.1 -37.42 3.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.87 1.268 . . . . 0.0 110.703 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' ' 129' ' ' PHE . 1.6 m -138.87 79.92 26.28 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.619 2.368 . . . . 0.0 108.551 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.95 -46.1 17.43 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.754 1.636 . . . . 0.0 112.864 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -70.5 -41.75 72.23 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -168.317 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.7 m -66.48 -43.39 85.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 111.434 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.69 -44.24 74.39 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 120.902 -1.124 . . . . 0.0 111.506 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -70.87 -31.77 68.55 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.366 0.666 . . . . 0.0 111.139 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -52.19 -59.18 4.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.022 0.929 . . . . 0.0 110.138 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -66.08 -35.53 80.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -59.77 3.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.649 1.58 . . . . 0.0 109.293 170.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.54 -41.94 91.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.214 1.005 . . . . 0.0 113.009 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.64 -43.06 63.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.704 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 p -62.35 -35.83 80.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.889 1.222 . . . . 0.0 111.3 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.705 HG21 HE21 ' A' ' 163' ' ' GLN . 35.3 p -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.567 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.85 10.35 86.14 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 118.991 0.814 . . . . 0.0 111.595 -166.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -24.2 66.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.964 1.382 . . . . 0.0 112.009 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.51 0.84 24.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.663 1.585 . . . . 0.0 114.098 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.63 11.46 82.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.071 0.851 . . . . 0.0 111.283 -171.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -152.4 169.92 21.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.43 1.892 . . . . 0.0 105.958 159.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 153.88 -175.86 32.02 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 122.096 0.831 . . . . 0.0 111.959 -171.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.59 -17.45 38.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.428 1.491 . . . . 0.0 113.384 -158.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -53.15 126.6 21.39 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.211 1.004 . . . . 0.0 109.337 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.91 79.4 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.846 -1.53 . . . . 0.0 114.218 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 m -85.18 154.42 22.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 120.07 1.935 . . . . 0.0 107.298 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.0 t -81.28 170.28 16.25 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 164.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.82 112.73 25.15 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -79.8 -18.43 50.96 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.57 111.66 9.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.836 1.198 . . . . 0.0 108.3 -170.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.3 mt -136.4 117.9 19.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.6 mt -127.1 89.27 52.32 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -167.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -48.3 121.76 6.65 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.521 2.814 . . . . 0.0 114.985 -167.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.5 67.59 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.222 1.391 . . . . 0.0 112.103 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -137.37 -78.72 0.39 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.72 1.26 . . . . 0.0 108.551 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.97 163.33 29.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.545 0.688 . . . . 0.0 111.736 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 95.02 3.97 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.126 1.771 . . . . 0.0 107.832 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -76.86 141.74 40.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.432 1.11 . . . . 0.0 110.185 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.4 -156.59 8.54 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.41 -13.24 67.03 Favored Glycine 0 C--O 1.229 -0.187 0 O-C-N 121.542 -0.975 . . . . 0.0 112.42 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -84.04 88.49 7.17 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.76 -0.847 . . . . 0.0 109.749 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -74.32 3.42 7.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.876 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.4 p -125.65 -58.39 1.41 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 120.102 1.319 . . . . 0.0 113.843 -159.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -103.94 -158.37 0.66 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.34 41.04 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.5 0.666 . . . . 0.0 109.426 159.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -122.94 -51.59 1.9 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.952 0.901 . . . . 0.0 111.645 -163.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.28 -9.44 0.17 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.812 -1.549 . . . . 0.0 114.256 -169.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.7 p -104.24 -19.99 13.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.498 2.149 . . . . 0.0 112.295 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.25 -170.93 2.29 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 124.711 1.148 . . . . 0.0 115.758 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.57 -172.2 41.13 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 123.75 1.75 . . . . 0.0 115.753 -168.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.31 156.53 38.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.311 3.044 . . . . 0.0 107.254 -171.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.8 p -78.1 166.26 23.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.97 0.89 . . . . 0.0 109.541 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 pt -59.66 -29.91 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.518 167.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -77.93 -10.11 59.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 111.638 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 143.21 12.47 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.5 1.524 . . . . 0.0 109.889 -171.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 34.48 -133.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.658 2.383 . . . . 0.0 113.029 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -120.47 143.38 48.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -173.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.72 -176.62 3.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.865 0.866 . . . . 0.0 109.644 -167.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -63.06 137.94 58.41 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.119 0.961 . . . . 0.0 109.792 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.02 86.57 6.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.08 -65.55 0.39 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.749 2.02 . . . . 0.0 113.437 -159.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -158.2 178.78 9.81 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.009 0.924 . . . . 0.0 109.892 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -129.48 36.07 4.16 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.698 1.999 . . . . 0.0 109.401 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.56 -55.98 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -84.07 132.24 34.73 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -122.69 168.91 11.61 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.57 1.548 . . . . 0.0 109.91 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.469 ' HD1' ' N ' ' A' ' 123' ' ' ASP . 36.5 m80 -74.33 81.64 1.87 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.0 p -80.27 -11.27 59.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.603 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.61 -173.96 43.88 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.601 1.091 . . . . 0.0 112.593 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 165.27 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.809 2.339 . . . . 0.0 110.822 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.58 -17.94 6.19 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 117.315 -1.825 . . . . 0.0 112.261 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.28 151.62 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 121.355 2.577 . . . . 0.0 108.29 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.03 128.01 53.96 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 120.934 -1.104 . . . . 0.0 109.639 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 t -140.34 145.97 37.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.436 1.095 . . . . 0.0 110.496 -172.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 89.9 mmm -78.38 121.95 25.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.486 0.714 . . . . 0.0 109.965 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.546 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -72.62 87.51 1.23 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 164.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -76.59 -169.88 1.37 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.168 0.987 . . . . 0.0 108.584 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.41 24.5 4.8 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 110.607 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.45 -159.87 21.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -164.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -64.45 162.56 30.25 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 CA-C-N 119.558 1.679 . . . . 0.0 109.805 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 34.16 53.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 128.967 2.907 . . . . 0.0 113.382 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.1 p -140.63 23.29 2.3 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.072 1.349 . . . . 0.0 111.382 -175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -88.25 142.99 27.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 170.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.5 -58.31 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -162.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.06 -39.87 0.2 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.76 0.824 . . . . 0.0 110.904 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.441 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 7.1 mm-40 -62.54 135.77 57.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.141 1.376 . . . . 0.0 109.567 -173.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.546 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 1.2 p90 -147.09 174.5 11.51 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.331 1.452 . . . . 0.0 108.559 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -136.53 153.85 50.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.918 0.866 . . . . 0.0 111.488 159.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.31 117.41 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 162.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.31 124.43 23.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -112.96 23.63 13.2 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.069 0.548 . . . . 0.0 109.748 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.5 177.75 10.23 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -70.53 87.55 0.66 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -74.1 43.4 0.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.382 2.273 . . . . 0.0 110.903 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -66.39 -18.16 65.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 119.699 -1.876 . . . . 0.0 113.128 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.444 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 45.7 p90 -67.28 -13.74 62.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.129 0.972 . . . . 0.0 111.217 170.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.444 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -108.95 -6.89 15.53 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.262 1.825 . . . . 0.0 111.8 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.469 ' N ' ' HD1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -70.16 135.62 49.3 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.01 -4.66 82.38 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.477 -1.179 . . . . 0.0 113.084 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -94.51 -40.29 9.95 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.189 1.994 . . . . 0.0 110.435 166.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -131.64 158.12 41.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.155 0.582 . . . . 0.0 111.76 -161.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.67 101.11 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -169.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.81 132.81 32.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.411 ' HA ' HG21 ' A' ' 29' ' ' VAL . 26.4 p90 -139.21 -2.09 1.67 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.05 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.75 -171.02 30.48 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.181 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -155.34 166.37 33.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.323 1.049 . . . . 0.0 109.806 163.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.77 126.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 164.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.4 -55.87 3.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.75 162.48 37.53 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.808 0.692 . . . . 0.0 111.921 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.24 28.05 60.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.731 1.158 . . . . 0.0 112.685 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 10.6 tpt -56.55 -38.38 71.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.237 1.519 . . . . 0.0 111.414 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -64.54 -28.5 69.69 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.169 -0.957 . . . . 0.0 112.329 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.1 mm -70.84 -44.99 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.49 -38.46 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.98 -29.61 66.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.946 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.95 -44.15 50.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.711 1.204 . . . . 0.0 109.787 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.9 mtp -50.85 -42.35 58.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.675 0.79 . . . . 0.0 110.005 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.57 -34.36 76.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.389 1.075 . . . . 0.0 112.905 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -67.49 -27.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 119.418 1.008 . . . . 0.0 110.275 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.406 ' HB2' HD11 ' A' ' 156' ' ' ILE . 27.6 m-85 -89.44 8.16 32.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 111.862 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.4 -151.91 4.04 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.653 1.12 . . . . 0.0 110.318 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -137.8 -70.36 0.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.85 -0.794 . . . . 0.0 110.069 166.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 143.44 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 1 C-N-CA 133.379 4.671 . . . . 0.0 110.934 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.84 -25.36 66.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.063 159.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 118.08 -40.76 2.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 124.86 1.219 . . . . 0.0 110.644 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.36 124.11 20.91 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.8 p -64.11 152.18 41.18 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.282 1.033 . . . . 0.0 110.621 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.4 p -72.62 -28.62 62.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.991 163.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -135.96 140.09 43.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -73.16 103.01 3.75 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 119.907 -1.745 . . . . 0.0 109.849 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 145' ' ' PHE . 1.7 mp -73.42 136.31 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 169.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.32 166.13 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.651 1.581 . . . . 0.0 108.703 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 mt -106.48 105.87 19.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.84 -51.09 66.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -149.81 155.63 40.43 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.5 p -156.5 161.96 39.98 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.881 0.873 . . . . 0.0 109.712 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.45 -172.98 44.93 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.705 HE21 HG21 ' A' ' 41' ' ' THR . 0.5 OUTLIER -96.8 147.99 23.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.877 0.871 . . . . 0.0 109.744 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.09 43.16 3.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.639 0.776 . . . . 0.0 109.003 165.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 117.232 -1.366 . . . . 0.0 113.849 -172.333 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 117.364 -1.303 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -64.04 144.74 88.38 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 121.357 1.52 . . . . 0.0 109.416 167.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.516 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 60.9 m -103.98 143.66 32.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.04 156.92 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -125.23 159.13 32.35 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.656 0.782 . . . . 0.0 110.197 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.604 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 54.6 m-85 -145.94 104.71 3.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.613 2.365 . . . . 0.0 107.58 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.5 94.07 3.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 167.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.6 mm -66.73 150.06 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.241 1.016 . . . . 0.0 109.625 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.25 160.74 34.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.704 1.601 . . . . 0.0 110.808 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 ' HE2' ' A' ' 154' ' ' LYS . 36.8 t -127.37 98.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.075 2.55 . . . . 0.0 105.23 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 50.88 12.94 0.12 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.558 1.943 . . . . 0.0 114.772 -165.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.7 -13.8 13.12 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.424 1.488 . . . . 0.0 113.247 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -72.82 116.65 52.25 Favored Pre-proline 0 C--O 1.23 0.075 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.93 116.98 3.9 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.615 1.543 . . . . 0.0 110.036 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.0 tp -87.28 -27.6 22.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.214 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.83 162.77 10.08 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.2 ttm105 -75.68 143.23 42.27 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.84 152.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 128.534 2.734 . . . . 0.0 104.724 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -143.34 140.57 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.215 0.461 . . . . 0.0 109.949 175.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -114.14 159.87 19.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.333 1.053 . . . . 0.0 108.764 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -120.37 137.88 54.05 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.121 2.169 . . . . 0.0 105.573 170.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.6 mt -125.02 119.11 27.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -164.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.61 63.18 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.13 1.372 . . . . 0.0 112.123 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -17.06 59.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.893 -1.129 . . . . 0.0 111.881 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 -13.0 59.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.059 1.343 . . . . 0.0 112.94 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -111.91 -44.41 3.46 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.014 1.279 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m -134.07 68.75 74.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.066 1.346 . . . . 0.0 108.897 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.66 -38.8 92.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.201 1.934 . . . . 0.0 113.107 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -50.67 70.89 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.588 1.085 . . . . 0.0 108.965 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -62.53 -45.46 92.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.66 1.184 . . . . 0.0 109.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.96 61.95 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.377 1.071 . . . . 0.0 112.164 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -60.69 -41.99 96.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.663 1.185 . . . . 0.0 110.177 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.41 -51.21 67.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.538 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -64.43 -40.32 95.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 ttp85 -56.2 -59.13 5.37 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.32 1.848 . . . . 0.0 110.901 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.86 69.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.814 0.446 . . . . 0.0 112.165 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -74.49 -32.41 62.53 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.871 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.4 m -68.32 -47.04 68.61 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.819 1.247 . . . . 0.0 110.616 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.4 p -64.45 -38.76 92.14 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.62 11.69 82.67 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -166.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -63.57 -20.22 65.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.793 1.296 . . . . 0.0 111.857 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.534 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.85 -1.44 86.38 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.444 1.02 . . . . 0.0 112.172 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -154.5 172.49 17.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.874 1.27 . . . . 0.0 109.073 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.13 -151.77 19.77 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.902 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.604 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.3 t80 -54.14 -29.44 45.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.347 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -59.28 101.71 0.11 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.557 1.071 . . . . 0.0 110.007 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.08 72.59 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 116.848 -2.084 . . . . 0.0 115.295 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 p -64.55 -58.28 6.82 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.424 2.612 . . . . 0.0 110.609 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.8 t 105.39 161.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.264 3.826 . . . . 0.0 108.292 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -115.97 123.94 49.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -104.87 -17.09 14.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.163 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.95 97.78 3.72 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.409 ' CG2' ' HA ' ' A' ' 143' ' ' GLU . 44.7 mt -124.13 117.61 51.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.19 103.08 14.1 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.5 134.12 45.15 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 124.532 3.488 . . . . 0.0 112.804 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.07 25.36 69.44 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.758 0.694 . . . . 0.0 111.531 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -138.9 -78.29 0.34 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.54 162.81 21.94 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 94.2 m -122.52 96.51 5.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.556 2.343 . . . . 0.0 109.802 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -85.61 132.63 34.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.772 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.64 22.98 0.55 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.528 0.585 . . . . 0.0 114.437 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.18 -3.94 88.56 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.349 -1.089 . . . . 0.0 114.097 -170.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.87 73.25 10.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.173 0.986 . . . . 0.0 108.567 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -66.3 -2.44 4.41 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.503 -1.373 . . . . 0.0 112.126 166.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -121.83 -50.72 2.05 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.328 2.251 . . . . 0.0 111.256 -169.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.4 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 3.9 mpt_? -106.29 -149.23 0.42 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.19 69.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.273 1.397 . . . . 0.0 107.677 158.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.6 -77.12 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.788 -0.57 . . . . 0.0 110.134 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.91 5.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 119.03 -0.872 . . . . 0.0 113.9 -161.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.9 p -83.6 -73.47 0.41 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 163.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 69' ' ' ARG . . . 71.3 169.89 10.4 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 121.065 3.186 . . . . 0.0 121.065 158.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.78 158.72 28.32 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 109.97 -3.115 . . . . 0.0 115.963 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' H ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -86.53 -175.7 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.272 3.429 . . . . 0.0 110.314 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -93.29 -179.04 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.557 0.617 . . . . 0.0 109.614 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.0 pt -72.87 -36.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 120.436 -1.415 . . . . 0.0 110.285 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -73.95 -22.18 59.75 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.822 0.449 . . . . 0.0 110.869 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.71 -105.93 0.28 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.311 -3.116 . . . . 0.0 105.311 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' LYS . 10.4 tt0 -113.99 -175.79 2.76 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.55 1.167 . . . . 0.0 109.454 -171.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 94.9 mttt -64.07 123.84 20.09 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 125.878 1.671 . . . . 0.0 109.102 -165.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -99.65 160.35 14.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.741 1.258 . . . . 0.0 110.516 -169.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.46 162.66 22.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.883 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.67 89.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.08 1.752 . . . . 0.0 109.066 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -55.06 -48.44 73.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.281 1.032 . . . . 0.0 111.526 -159.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.417 HD22 HG13 ' A' ' 89' ' ' ILE . 2.2 p-10 -178.51 155.18 0.84 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 128.128 2.571 . . . . 0.0 106.982 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.84 32.15 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.037 1.335 . . . . 0.0 109.317 -168.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.417 HG13 HD22 ' A' ' 87' ' ' ASN . 15.7 mt -52.25 -41.46 34.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 126.211 1.805 . . . . 0.0 109.761 172.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.98 125.68 41.58 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.74 165.41 11.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.19 1.796 . . . . 0.0 109.134 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -80.63 97.1 7.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.0 p -82.46 -26.46 32.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.753 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.0 -177.07 47.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.147 0.885 . . . . 0.0 112.742 -173.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.81 144.54 97.02 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.105 1.87 . . . . 0.0 109.322 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.93 14.87 60.19 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.729 -1.595 . . . . 0.0 112.689 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mm -86.13 158.42 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 121.046 2.423 . . . . 0.0 108.36 162.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 139.39 53.74 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.374 1.47 . . . . 0.0 109.315 168.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -149.23 162.18 40.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.404 1.082 . . . . 0.0 110.49 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.64 117.08 19.45 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.715 1.206 . . . . 0.0 109.733 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -76.57 62.66 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.117 0.961 . . . . 0.0 109.364 171.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -68.34 -179.25 1.25 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.749 1.261 . . . . 0.0 109.081 170.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.05 16.0 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 126.472 1.909 . . . . 0.0 111.606 -171.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.09 177.06 14.68 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.707 1.622 . . . . 0.0 109.11 -166.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.47 131.93 49.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.831 2.354 . . . . 0.0 110.78 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 71.43 9.39 6.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.225 1.81 . . . . 0.0 114.154 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.4 p -92.14 39.58 1.02 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.209 -1.557 . . . . 0.0 111.082 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -82.86 105.56 13.97 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.85 -109.69 2.68 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -18.56 13.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.415 1.086 . . . . 0.0 111.307 172.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -59.07 113.92 2.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.81 1.244 . . . . 0.0 107.979 172.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.469 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 15.4 p90 -127.43 168.95 14.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.208 2.203 . . . . 0.0 107.139 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -143.45 155.59 44.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.583 0.706 . . . . 0.0 111.398 160.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.4 mt -83.83 125.11 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 164.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.7 m -75.29 115.59 15.1 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 166.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -103.04 22.28 14.25 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.312 0.645 . . . . 0.0 109.917 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.91 -178.43 7.24 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.343 1.057 . . . . 0.0 108.314 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -66.92 96.22 0.41 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 163.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 p -80.24 63.66 4.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.454 1.121 . . . . 0.0 109.594 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.92 -21.14 66.0 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.936 -1.102 . . . . 0.0 112.232 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.43 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 19.2 p90 -70.85 -7.89 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.586 1.154 . . . . 0.0 110.878 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.43 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.5 mt -122.49 6.4 9.54 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 126.617 1.967 . . . . 0.0 111.212 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.96 130.62 42.22 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 166.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.9 -4.68 29.03 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.122 -1.376 . . . . 0.0 114.728 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -93.82 -34.15 13.28 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.144 2.472 . . . . 0.0 110.811 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -143.83 134.2 24.63 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.184 0.594 . . . . 0.0 109.74 -164.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.99 107.33 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 126.287 1.835 . . . . 0.0 107.57 -170.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.14 131.09 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -135.79 -4.72 2.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.11 33.22 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.341 0.973 . . . . 0.0 111.62 -176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -147.66 152.54 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 109.122 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 32.8 t -65.8 110.2 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 164.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -71.61 -50.55 29.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.47 157.45 45.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.537 1.935 . . . . 0.0 110.159 -167.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.67 18.3 79.1 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.854 0.74 . . . . 0.0 114.026 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -35.16 68.74 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.96 1.88 . . . . 0.0 110.677 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -20.5 65.95 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.452 -1.405 . . . . 0.0 113.598 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.8 -37.07 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -37.16 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.767 . . . . 0.0 109.735 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.29 -25.57 67.7 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.448 -1.407 . . . . 0.0 112.65 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.15 -46.96 30.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.815 -1.178 . . . . 0.0 109.733 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.7 mtp -52.3 -41.21 62.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.329 0.968 . . . . 0.0 111.377 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.409 ' HA ' ' CG2' ' A' ' 56' ' ' ILE . 1.4 mm-40 -60.62 -37.03 80.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 112.343 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -71.24 -23.08 61.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.541 1.064 . . . . 0.0 110.638 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.443 ' CB ' HD11 ' A' ' 156' ' ' ILE . 27.3 m-85 -90.45 12.25 19.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.329 1.451 . . . . 0.0 111.637 172.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.39 -150.49 6.66 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.164 1.364 . . . . 0.0 110.296 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.9 p -143.63 -103.3 0.12 Allowed 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 159.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -153.7 -27.03 0.14 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.176 1.79 . . . . 0.0 110.196 159.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -66.53 -19.74 65.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.011 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.27 -30.12 6.41 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.429 1.49 . . . . 0.0 111.514 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 124.48 20.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.092 1.446 . . . . 0.0 107.763 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -66.84 130.0 41.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.269 1.028 . . . . 0.0 108.291 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.17 -22.37 64.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.058 0.943 . . . . 0.0 111.599 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.572 ' HE2' HG12 ' A' ' 12' ' ' VAL . 22.8 mtpt -118.87 175.4 5.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 159.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -72.93 145.06 47.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 164.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.52 HD13 HG22 ' A' ' 12' ' ' VAL . 24.2 mm -129.37 123.23 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 178.19 8.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.837 -159.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.74 102.18 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.29 -43.31 74.08 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.39 166.4 28.22 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 117.971 0.35 . . . . 0.0 110.606 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.3 p -170.34 172.64 6.05 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 123.566 0.746 . . . . 0.0 110.487 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.34 -169.49 42.53 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.455 HE21 ' C ' ' A' ' 165' ' ' GLU . 41.1 tt0 -110.66 136.25 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.108 1.363 . . . . 0.0 108.437 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 mt -116.42 43.12 2.26 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.49 1.138 . . . . 0.0 109.644 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.516 ' HB2' ' H ' ' A' ' 5' ' ' THR . 2.0 tp10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 128.248 2.619 . . . . 0.0 108.272 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.376 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.16 165.7 16.38 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.996 1.797 . . . . 0.0 110.079 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 m -131.18 157.44 43.17 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 m -143.7 142.18 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.138 1.375 . . . . 0.0 108.024 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.411 ' HB3' HD11 ' A' ' 164' ' ' LEU . 31.0 p90 -89.94 155.78 18.89 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.462 0.574 . . . . 0.0 109.457 168.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -137.76 105.42 5.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.0 103.68 11.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.86 139.45 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.91 158.79 28.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.917 0.887 . . . . 0.0 110.254 163.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 ' HE2' ' A' ' 154' ' ' LYS . 6.9 t -126.55 105.17 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 54.72 14.04 0.8 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.873 2.069 . . . . 0.0 113.939 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 6.96 60.4 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.551 -1.343 . . . . 0.0 114.066 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.32 123.14 84.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 159.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.7 113.04 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.21 -38.09 52.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.26 -173.39 36.86 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -110.72 151.41 27.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.982 0.896 . . . . 0.0 110.079 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.31 162.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.536 3.134 . . . . 0.0 105.852 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.5 t -147.13 149.8 33.72 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.98 136.41 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.174 0.99 . . . . 0.0 109.453 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -84.57 147.0 27.24 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 160.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.48 118.55 26.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 90' ' ' LEU . 14.1 m-85 -75.26 52.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.353 2.261 . . . . 0.0 112.016 -172.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -13.75 29.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 120.541 -1.349 . . . . 0.0 113.335 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.42 -7.41 59.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.358 0.981 . . . . 0.0 112.953 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.87 -25.25 1.43 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.569 1.077 . . . . 0.0 113.347 -171.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.51 72.32 37.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.051 1.74 . . . . 0.0 107.045 161.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -47.2 -52.27 8.11 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.352 2.701 . . . . 0.0 112.602 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HE3' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.36 -46.58 86.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.841 0.746 . . . . 0.0 109.872 -169.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.485 HG23 ' SD ' ' A' ' 100' ' ' MET . 22.8 m -66.72 -51.21 58.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 125.095 1.358 . . . . 0.0 110.489 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -39.16 80.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.836 0.455 . . . . 0.0 112.142 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.73 -44.3 90.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.112 1.765 . . . . 0.0 109.807 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -56.97 -53.67 55.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.154 0.982 . . . . 0.0 109.715 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.69 -37.22 80.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.865 0.866 . . . . 0.0 112.783 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -54.06 -64.38 0.85 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.235 1.414 . . . . 0.0 109.281 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.29 66.37 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.714 0.634 . . . . 0.0 112.412 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 mt -69.78 -33.51 72.49 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.192 -0.943 . . . . 0.0 111.426 171.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 m -68.49 -49.38 60.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.814 0.734 . . . . 0.0 109.255 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.6 p -64.14 -30.99 72.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.364 0.529 . . . . 0.0 110.523 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.02 -3.88 68.89 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 119.695 1.134 . . . . 0.0 112.068 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.89 -1.38 14.11 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.82 2.048 . . . . 0.0 113.008 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.66 7.8 13.78 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.464 -0.772 . . . . 0.0 112.623 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.04 2.54 89.45 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.087 0.851 . . . . 0.0 111.555 -166.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -174.45 173.26 2.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.3 1.84 . . . . 0.0 106.546 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.62 -167.39 28.12 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -88.7 -8.0 55.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -162.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -64.32 115.02 4.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.743 1.611 . . . . 0.0 108.034 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.07 11.64 85.38 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 -173.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.2 t -66.41 119.09 11.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 163.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.82 139.17 43.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -74.21 99.63 3.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -73.77 -57.09 4.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.9 112.17 24.19 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -168.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.48 105.27 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.42 97.28 42.91 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -53.0 134.07 54.3 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.935 2.423 . . . . 0.0 113.213 -171.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.4 78.17 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.129 1.823 . . . . 0.0 112.918 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -122.9 -75.98 0.59 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.305 1.553 . . . . 0.0 106.816 -173.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.55 18.2 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.141 0.976 . . . . 0.0 109.377 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.8 t -125.75 105.96 9.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -93.84 138.25 32.2 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.672 1.989 . . . . 0.0 110.798 -172.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.55 -168.82 12.83 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.172 1.844 . . . . 0.0 110.109 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.33 9.96 69.01 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.969 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.292 29.9 t0 -84.45 46.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.619 2.209 . . . . 0.0 113.062 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -53.3 -42.65 66.83 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.337 0.655 . . . . 0.0 112.722 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.6 t -72.79 -35.1 67.31 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.396 0.678 . . . . 0.0 111.419 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -125.06 -139.12 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -170.06 23.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.621 1.555 . . . . 0.0 112.948 159.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -134.81 8.69 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.199 1.4 . . . . 0.0 112.742 -159.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.09 -9.29 66.93 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.721 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.5 p -84.16 -18.44 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.827 1.814 . . . . 0.0 111.185 171.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.49 -154.34 7.47 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 124.833 1.206 . . . . 0.0 113.077 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.52 120.57 2.23 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -162.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -142.77 158.03 44.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 158.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -91.22 177.74 6.17 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 124.066 0.854 . . . . 0.0 110.465 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.6 pt -62.62 -31.06 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.607 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -82.68 1.66 37.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.385 1.474 . . . . 0.0 111.605 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.88 156.41 29.11 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -170.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.259 3.1 tm-20 33.79 -142.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.802 2.841 . . . . 0.0 113.429 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -115.0 150.83 35.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.467 1.107 . . . . 0.0 108.115 -167.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.94 175.8 6.72 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.89 154.54 25.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.291 0.567 . . . . 0.0 109.823 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -80.33 88.37 5.55 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 167.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -46.88 -51.61 16.34 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -158.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -159.83 160.48 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.727 -1.578 . . . . 0.0 114.023 168.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.32 24.82 10.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.452 2.301 . . . . 0.0 110.603 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.8 mt -50.47 -46.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.187 0.995 . . . . 0.0 108.994 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 25' ' ' PHE . 96.1 mt -89.29 126.92 35.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.433 1.111 . . . . 0.0 108.278 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -108.86 172.12 7.03 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 126.811 2.044 . . . . 0.0 109.044 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -87.61 73.59 9.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.946 0.898 . . . . 0.0 108.879 -166.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 p -75.29 -4.52 39.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -160.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.86 -179.15 33.79 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.4 1.0 . . . . 0.0 111.886 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.08 159.77 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.072 1.848 . . . . 0.0 110.159 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.31 71.36 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.233 -1.315 . . . . 0.0 112.674 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.63 162.11 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.934 1.867 . . . . 0.0 107.5 166.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.03 132.28 44.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.1 1.76 . . . . 0.0 107.138 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.409 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 34.5 t -146.11 169.8 17.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.883 0.849 . . . . 0.0 110.029 -172.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 7.5 ttm -111.67 120.67 42.82 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.298 1.439 . . . . 0.0 109.1 -161.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.15 94.72 2.47 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -85.31 170.28 12.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 158.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.02 20.31 18.08 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.215 1.406 . . . . 0.0 111.506 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.65 -165.83 25.21 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 -159.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.4 153.75 76.81 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 119.88 1.84 . . . . 0.0 109.672 167.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 45.16 34.36 1.36 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.689 2.796 . . . . 0.0 113.497 169.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -132.53 32.5 3.89 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.932 -1.105 . . . . 0.0 111.573 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.509 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 15.4 p30 -66.29 -154.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.936 2.095 . . . . 0.0 110.916 166.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.14 -81.7 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.6 m -133.83 -16.43 2.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -72.78 139.78 47.29 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.401 1.455 . . . . 0.0 108.201 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -141.56 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.579 1.152 . . . . 0.0 108.511 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.455 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 43.5 p90 -146.17 153.03 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 122.332 1.063 . . . . 0.0 110.852 165.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -84.01 119.33 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 167.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.74 119.88 15.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.8 p -106.94 19.63 20.19 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 109.964 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.08 179.81 8.71 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 166.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.13 102.29 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 160.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.7 p -92.98 58.45 2.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.902 0.858 . . . . 0.0 109.711 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.58 -16.63 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.705 -1.247 . . . . 0.0 114.291 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -69.01 -17.75 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.256 -0.903 . . . . 0.0 111.079 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.455 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 36.3 mt -100.94 -10.26 20.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.069 1.347 . . . . 0.0 110.711 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.52 127.85 33.73 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.401 1.081 . . . . 0.0 109.585 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.73 -8.98 25.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.924 1.25 . . . . 0.0 113.631 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -99.56 -42.44 6.91 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.328 1.451 . . . . 0.0 110.278 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -115.4 155.13 27.98 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.908 1.283 . . . . 0.0 110.967 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.21 104.19 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -174.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.84 122.13 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -134.76 -2.05 2.69 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.441 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.26 26.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.417 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -142.46 147.31 35.9 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.889 1.675 . . . . 0.0 109.203 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.2 t -66.22 110.37 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 158.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -46.68 31.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -146.81 159.12 43.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.358 1.063 . . . . 0.0 108.551 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.2 18.57 60.55 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.532 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 25.7 tpp -51.79 -34.45 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.812 . . . . 0.0 110.709 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.3 -33.45 65.56 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.094 -1.004 . . . . 0.0 113.536 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 119.416 1.007 . . . . 0.0 109.067 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.7 t -59.56 -41.59 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.192 0.905 . . . . 0.0 110.188 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.91 -37.83 83.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.901 0.88 . . . . 0.0 110.856 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.41 72.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.192 -0.943 . . . . 0.0 109.863 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 76.7 mtp -57.79 -44.63 86.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.8 0.84 . . . . 0.0 110.483 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.4 -32.85 72.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.57 -15.0 59.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.214 0.606 . . . . 0.0 111.475 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -97.09 6.41 48.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.694 1.598 . . . . 0.0 111.388 165.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.85 -173.78 46.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.5 p -157.1 158.61 36.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -70.06 -16.23 63.11 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -166.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -29.87 68.99 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.152 0.282 . . . . 0.0 111.36 167.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.65 -29.73 7.05 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 127.871 2.653 . . . . 0.0 112.439 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -68.6 130.94 44.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.774 1.787 . . . . 0.0 109.044 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.5 p -70.88 154.76 41.55 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.919 0.888 . . . . 0.0 110.107 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 p -74.45 -16.62 60.86 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.44 0.696 . . . . 0.0 111.54 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.453 ' HE2' HG12 ' A' ' 12' ' ' VAL . 26.4 mtpt -130.8 169.92 15.07 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.605 1.162 . . . . 0.0 110.848 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -74.42 139.19 43.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 162.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.4 mt -136.52 118.44 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -132.9 160.8 35.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 -169.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -74.05 112.66 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 158.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.78 -56.05 14.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -143.92 155.2 43.98 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.893 0.877 . . . . 0.0 109.354 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -145.82 168.81 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.762 1.625 . . . . 0.0 107.991 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.18 47.16 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 165' ' ' GLU . 6.5 tt0 -87.81 155.38 19.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -172.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 7' ' ' PHE . 55.1 mt -139.99 43.28 1.94 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.559 1.143 . . . . 0.0 109.717 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.471 ' HB3' HE21 ' A' ' 163' ' ' GLN . 10.0 pm0 . . . . . 0 C--O 1.249 1.079 0 C-N-CA 125.404 1.481 . . . . 0.0 114.244 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 C--O 1.235 0.317 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -63.48 135.58 50.29 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.462 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 85.9 m -92.91 155.62 17.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.162 -2.532 . . . . 0.0 104.162 161.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.03 167.16 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.952 1.301 . . . . 0.0 108.556 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.45 158.04 37.07 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.74 0.816 . . . . 0.0 111.477 165.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.41 113.79 13.57 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.116 2.966 . . . . 0.0 104.435 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.85 104.71 15.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 170.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -71.3 148.01 10.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.33 27.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 111.145 159.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.569 HG12 ' HE2' ' A' ' 154' ' ' LYS . 5.4 t -128.31 94.32 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 126.354 1.862 . . . . 0.0 107.434 -164.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' H ' ' HB3' ' A' ' 155' ' ' LYS . 24.7 m-20 50.75 24.48 1.74 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.085 -1.634 . . . . 0.0 111.611 -160.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.21 -4.93 35.64 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.055 1.312 . . . . 0.0 114.146 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 39.4 tt0 -81.44 109.06 12.58 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 127.81 2.444 . . . . 0.0 107.74 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.95 99.2 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.051 2.501 . . . . 0.0 112.054 -168.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.7 tp -79.39 -28.91 41.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.55 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.66 157.28 8.19 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.602 0.637 . . . . 0.0 113.228 171.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -74.8 135.24 41.67 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.419 1.088 . . . . 0.0 108.761 170.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 t -127.21 143.24 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.31 146.05 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.746 0.703 . . . . 0.0 109.238 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -141.27 150.27 42.38 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 109.144 -164.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.15 147.16 26.57 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 163.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.7 mt -127.92 115.04 17.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.445 1.498 . . . . 0.0 107.237 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.36 58.22 1.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.078 1.751 . . . . 0.0 112.638 -169.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -19.05 51.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.678 1.191 . . . . 0.0 113.267 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.82 -30.4 66.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.056 0.843 . . . . 0.0 110.762 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -98.84 -50.55 4.17 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.65 0.78 . . . . 0.0 109.613 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.98 76.19 71.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 125.912 1.685 . . . . 0.0 107.702 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.3 -40.74 56.23 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.672 2.248 . . . . 0.0 111.517 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 1.3 mmpt? -66.43 -47.37 73.44 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -170.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -62.4 -49.69 74.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.961 1.304 . . . . 0.0 110.173 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.51 -46.77 78.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -64.84 -40.12 94.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.482 1.113 . . . . 0.0 110.752 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -54.64 -53.6 52.59 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 124.267 1.027 . . . . 0.0 109.484 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.9 -40.82 91.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 123.612 0.57 . . . . 0.0 112.079 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -50.71 -60.56 2.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.822 2.049 . . . . 0.0 110.099 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.05 63.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.585 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.48 -15.82 36.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.386 1.074 . . . . 0.0 111.808 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -42.72 12.18 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 120.006 1.276 . . . . 0.0 109.884 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -63.54 -33.18 75.03 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 172.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 10.55 74.73 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -16.72 63.74 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.418 1.487 . . . . 0.0 112.4 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -74.01 -3.74 31.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.204 1.402 . . . . 0.0 112.64 170.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.87 90.68 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 119.812 1.187 . . . . 0.0 112.571 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.08 173.08 17.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.067 2.147 . . . . 0.0 106.371 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.62 -179.18 34.46 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.803 -164.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -68.26 -19.5 64.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -51.42 118.61 3.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.446 1.021 . . . . 0.0 108.784 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.84 86.98 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.593 -1.67 . . . . 0.0 114.832 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -76.92 146.34 37.65 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 121.342 2.571 . . . . 0.0 107.738 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.21 148.39 22.24 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -93.67 81.06 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -74.06 -17.94 60.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.964 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.75 84.85 2.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.344 0.974 . . . . 0.0 110.61 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.98 97.06 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.89 104.74 23.29 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.51 142.11 83.22 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.911 1.741 . . . . 0.0 110.483 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.79 14.01 81.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.718 1.151 . . . . 0.0 112.929 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -140.67 -81.26 0.25 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.768 1.284 . . . . 0.0 109.047 -170.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.02 167.77 20.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.485 0.714 . . . . 0.0 112.411 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.3 m -123.43 97.61 5.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.818 2.047 . . . . 0.0 109.415 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.12 138.24 31.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.229 1.412 . . . . 0.0 110.824 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.62 72.35 0.09 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-O 118.635 -1.091 . . . . 0.0 113.524 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.29 14.32 1.45 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.262 1.531 . . . . 0.0 116.274 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -91.03 113.49 25.77 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 164.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -96.29 35.7 1.43 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.759 1.623 . . . . 0.0 110.312 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -155.0 -67.07 0.13 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.198 1.399 . . . . 0.0 107.976 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -85.98 168.59 14.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.126 2.17 . . . . 0.0 105.288 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -139.53 31.76 2.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -167.0 4.7 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.984 -158.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.65 -20.19 22.88 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 120.463 1.483 . . . . 0.0 114.903 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 p -84.53 9.14 14.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.825 1.813 . . . . 0.0 113.865 -169.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.81 -153.58 6.94 Favored Glycine 0 C--N 1.333 0.399 0 O-C-N 120.798 -1.188 . . . . 0.0 113.14 -162.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.96 174.34 46.84 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -158.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -166.91 154.26 9.15 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 125.461 1.505 . . . . 0.0 107.529 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.2 p -76.68 144.96 39.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.37 -25.13 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 122.156 0.183 . . . . 0.0 111.151 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -79.9 -13.74 59.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 113.788 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.67 -95.18 0.14 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 120.692 1.587 . . . . 0.0 111.833 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -159.23 112.43 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.212 1.005 . . . . 0.0 109.015 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt 63.4 158.25 0.07 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.824 3.25 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.71 171.33 15.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.769 0.795 . . . . 0.0 109.013 170.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.02 158.38 16.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.058 1.743 . . . . 0.0 113.265 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.99 90.86 2.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 158.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.64 -59.89 4.5 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.456 HD22 HG13 ' A' ' 89' ' ' ILE . 10.1 p-10 -161.49 158.35 26.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.795 1.283 . . . . 0.0 112.561 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.21 31.04 5.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.617 2.367 . . . . 0.0 109.553 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.456 HG13 HD22 ' A' ' 87' ' ' ASN . 21.2 mt -52.67 -40.02 32.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.586 1.154 . . . . 0.0 108.572 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.76 125.16 34.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -102.84 169.22 8.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.01 1.324 . . . . 0.0 108.899 168.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -73.82 89.26 1.82 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.7 p -72.43 -28.56 63.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.34 44.09 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.839 1.209 . . . . 0.0 111.091 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.53 162.43 10.3 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.315 2.01 . . . . 0.0 111.945 169.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.33 77.37 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.198 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.3 mm -77.07 162.46 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 120.139 1.969 . . . . 0.0 108.834 171.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.66 54.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 108.134 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -146.21 147.62 31.65 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.214 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.404 ' HG3' ' CE1' ' A' ' 129' ' ' PHE . 12.8 mtp -85.54 128.6 34.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.909 1.338 . . . . 0.0 111.423 -172.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.42 73.09 4.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.5 2.32 . . . . 0.0 108.724 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -69.26 -179.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.392 158.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.38 20.44 8.81 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.043 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 134.79 -163.01 24.77 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.62 147.04 89.96 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.053 1.836 . . . . 0.0 109.602 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 46.81 32.01 1.64 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.672 1.989 . . . . 0.0 115.789 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.1 p -118.28 23.56 11.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.536 -1.353 . . . . 0.0 111.503 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -63.12 104.3 0.56 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.21 -75.28 1.03 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.605 1.093 . . . . 0.0 111.383 -170.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.1 p -155.74 -21.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.835 1.254 . . . . 0.0 111.486 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -64.2 143.08 58.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.47 169.32 18.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.563 1.545 . . . . 0.0 106.833 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.539 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 17.7 p90 -136.04 152.84 51.32 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.781 0.8 . . . . 0.0 110.366 163.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.79 113.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 166.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -62.73 124.95 22.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.7 p -115.1 31.67 6.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.898 1.332 . . . . 0.0 108.665 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.71 169.45 19.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 110.03 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -73.24 86.68 1.44 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 163.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -76.81 58.01 1.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.073 0.949 . . . . 0.0 110.219 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.89 -30.5 65.93 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.037 -1.665 . . . . 0.0 111.816 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -70.91 -15.24 62.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.081 1.352 . . . . 0.0 110.541 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.539 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 66.2 mt -98.97 -12.49 20.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.372 1.069 . . . . 0.0 111.172 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.44 144.04 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.363 0.983 . . . . 0.0 109.605 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.06 -4.64 37.96 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.829 1.204 . . . . 0.0 113.728 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.96 -59.65 1.99 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 126.515 1.926 . . . . 0.0 108.978 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -96.69 129.28 44.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.891 1.276 . . . . 0.0 108.396 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.8 t -80.11 104.4 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -170.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.97 127.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.404 ' CE1' ' HG3' ' A' ' 100' ' ' MET . 22.4 p90 -140.74 -0.22 1.55 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.603 1.19 . . . . 0.0 113.441 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.92 -176.56 32.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.636 -1.269 . . . . 0.0 112.065 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.29 151.48 34.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.01 127.42 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -94.51 -38.33 10.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.933 0.893 . . . . 0.0 110.389 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -139.29 153.48 47.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 109.829 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.71 72.18 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.241 -0.755 . . . . 0.0 113.011 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.0 tpp -54.85 -36.39 65.0 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.304 1.552 . . . . 0.0 110.004 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -58.8 -27.88 65.47 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.534 1.061 . . . . 0.0 113.643 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.7 mm -75.17 -42.77 44.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 124.484 1.114 . . . . 0.0 108.268 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.35 -41.33 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.46 -34.23 70.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.018 1.327 . . . . 0.0 111.154 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.05 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.695 0.798 . . . . 0.0 110.636 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.6 mtm -55.77 -45.32 78.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.555 0.616 . . . . 0.0 110.128 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.49 -36.86 72.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.599 1.159 . . . . 0.0 112.683 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -69.56 -14.89 63.08 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.105 -0.997 . . . . 0.0 111.306 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 14.18 25.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 126.793 2.037 . . . . 0.0 111.291 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.94 -172.21 31.47 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.6 p -154.52 164.32 38.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.738 -0.86 . . . . 0.0 109.435 165.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.26 -33.91 63.59 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -71.64 -13.59 61.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.3 -26.68 21.05 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 127.274 2.368 . . . . 0.0 113.361 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -66.52 130.04 41.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.6 1.7 . . . . 0.0 108.779 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.6 p -65.7 153.86 40.54 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.594 0.758 . . . . 0.0 110.102 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.8 p -69.32 -25.5 64.24 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.299 -0.875 . . . . 0.0 110.586 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.569 ' HE2' HG12 ' A' ' 12' ' ' VAL . 42.7 mtpt -130.76 174.46 9.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.284 1.434 . . . . 0.0 111.518 -170.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -63.65 139.28 58.75 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 102.903 -2.999 . . . . 0.0 102.903 158.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -129.06 122.6 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 101.217 -3.623 . . . . 0.0 101.217 160.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.53 153.17 43.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -166.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -74.09 110.83 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.43 -46.48 73.0 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.517 0.599 . . . . 0.0 109.468 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -151.03 163.32 39.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.643 0.377 . . . . 0.0 110.045 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 m -148.43 171.1 16.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 171.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.26 174.82 46.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 160.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.573 ' HG2' ' H ' ' A' ' 165' ' ' GLU . 47.0 tt0 -87.11 154.82 20.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.225 1.01 . . . . 0.0 109.93 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.1 mt -136.94 43.41 2.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.18 2.592 . . . . 0.0 109.915 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.573 ' H ' ' HG2' ' A' ' 163' ' ' GLN . 3.5 tm-20 . . . . . 0 C--O 1.246 0.892 0 C-N-CA 127.182 2.193 . . . . 0.0 106.155 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 156.41 66.2 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 121.18 1.253 . . . . 0.0 110.985 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -117.09 151.63 36.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.34 150.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 119.301 0.955 . . . . 0.0 109.434 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -108.21 161.55 14.89 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.124 0.969 . . . . 0.0 108.811 166.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 4.1 m-85 -144.37 108.76 4.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.052 2.141 . . . . 0.0 107.361 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 98.29 9.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.23 138.54 22.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.93 149.99 42.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.827 1.299 . . . . 0.0 108.514 161.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.558 HG12 ' HE2' ' A' ' 154' ' ' LYS . 2.5 t -106.31 80.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 170.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.523 ' OD2' ' HE3' ' A' ' 154' ' ' LYS 0.378 3.7 p30 61.74 14.09 5.88 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.41 -9.25 15.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -73.99 121.6 85.56 Favored Pre-proline 0 C--N 1.338 0.099 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 164.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.12 103.23 1.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.81 2.34 . . . . 0.0 107.732 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.8 tp -83.0 -34.11 26.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.704 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.5 165.7 11.74 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.507 -1.33 . . . . 0.0 114.993 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.27 136.14 44.53 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.3 t -120.05 158.77 21.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 130.232 3.413 . . . . 0.0 105.823 165.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -152.11 155.35 37.71 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.679 -1.888 . . . . 0.0 111.812 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -141.85 145.28 34.48 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.949 1.299 . . . . 0.0 110.079 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -90.77 150.54 21.56 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.437 1.495 . . . . 0.0 107.315 160.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -128.74 128.5 44.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.017 1.327 . . . . 0.0 108.249 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.435 ' CD2' HD13 ' A' ' 90' ' ' LEU . 16.0 m-85 -81.13 49.54 1.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.6 1.56 . . . . 0.0 112.546 -166.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -4.63 7.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.907 1.283 . . . . 0.0 114.379 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.15 -16.78 36.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.98 1.264 . . . . 0.0 111.974 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -121.94 -30.31 4.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.64 1.176 . . . . 0.0 113.258 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 86' ' ' GLU . 6.1 m -129.88 73.31 81.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 124.685 1.194 . . . . 0.0 107.858 169.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.75 -39.25 43.96 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.575 2.183 . . . . 0.0 113.434 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -51.34 67.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.499 1.045 . . . . 0.0 108.211 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.504 HG23 ' SD ' ' A' ' 100' ' ' MET . 4.8 m -61.55 -49.1 78.05 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.257 1.023 . . . . 0.0 110.732 -170.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.2 -45.4 70.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 112.242 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -63.4 -42.04 98.76 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.466 0.306 . . . . 0.0 111.302 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -56.98 -47.97 79.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.121 1.368 . . . . 0.0 109.439 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.1 -38.64 88.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.856 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -55.23 -58.17 8.79 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.767 0.712 . . . . 0.0 109.135 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.96 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.245 1.418 . . . . 0.0 113.652 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.8 mt -84.04 -26.96 28.67 Favored 'General case' 0 N--CA 1.457 -0.078 0 O-C-N 121.567 -0.708 . . . . 0.0 111.599 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 m -77.52 -43.43 32.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.581 0.752 . . . . 0.0 110.326 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -63.96 -27.35 69.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.89 7.51 62.16 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.41 -27.85 69.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.59 1.156 . . . . 0.0 111.189 -171.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 29.3 mmmt -65.49 -14.71 61.6 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.959 -1.02 . . . . 0.0 112.26 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.93 4.17 48.44 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.251 1.405 . . . . 0.0 112.228 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -163.6 175.99 10.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.078 1.751 . . . . 0.0 107.968 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.77 -149.49 19.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-O 122.029 0.794 . . . . 0.0 112.831 165.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -59.96 -44.74 94.24 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 127.14 2.176 . . . . 0.0 109.655 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -44.62 112.83 0.46 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.015 1.326 . . . . 0.0 110.004 170.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.05 3.64 88.92 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.097 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.3 m -63.86 -62.76 1.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.907 2.354 . . . . 0.0 110.8 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 t 122.85 167.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 131.774 4.03 . . . . 0.0 106.583 -168.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.435 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 51.5 m-85 -119.68 91.96 3.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.583 1.953 . . . . 0.0 106.198 170.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -73.76 -18.34 60.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -164.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.26 104.08 4.22 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.58 103.09 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.0 mt -119.03 91.0 42.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -48.24 122.62 7.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.01 3.14 . . . . 0.0 114.859 -167.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.56 21.27 77.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.133 1.349 . . . . 0.0 112.37 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.11 -75.57 0.55 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.38 170.99 19.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.227 1.011 . . . . 0.0 109.413 167.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 p -130.77 107.97 9.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.797 0.839 . . . . 0.0 110.411 168.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -86.96 140.86 29.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 129.028 2.931 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -148.75 -163.09 10.66 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 124.959 1.266 . . . . 0.0 110.845 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 48' ' ' TYR . . . 91.96 10.68 61.04 Favored Glycine 0 N--CA 1.463 0.496 0 CA-C-N 117.717 0.758 . . . . 0.0 114.89 166.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.82 103.91 13.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 107.552 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -115.45 9.94 15.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.478 1.511 . . . . 0.0 111.747 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.6 t -139.15 -35.41 0.56 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.596 1.158 . . . . 0.0 113.629 -166.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -129.87 -36.54 1.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -167.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.5 m170 61.4 56.8 2.52 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.673 1.189 . . . . 0.0 112.078 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -164.51 -54.05 0.03 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.015 1.326 . . . . 0.0 110.169 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.94 -21.44 0.18 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.751 1.643 . . . . 0.0 113.242 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -84.55 12.12 7.57 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.875 1.837 . . . . 0.0 111.57 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.48 -165.13 15.77 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 124.727 1.156 . . . . 0.0 110.696 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.47 103.75 0.17 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -136.3 144.36 44.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.592 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -70.62 164.4 25.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.256 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.412 ' HB ' ' HE2' ' A' ' 44' ' ' LYS . 41.9 pt -61.32 -31.64 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 121.563 -0.711 . . . . 0.0 110.018 163.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.82 -14.53 61.11 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.516 0.726 . . . . 0.0 112.277 -172.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.01 -85.71 0.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -156.17 132.19 9.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 108.593 163.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttt 52.31 149.88 0.0 OUTLIER 'General case' 0 C--N 1.342 0.281 1 C-N-CA 132.618 4.367 . . . . 0.0 115.375 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -128.69 -172.56 2.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.27 152.37 43.34 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 167.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.64 101.02 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 159.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HG3' HG12 ' A' ' 29' ' ' VAL . 11.0 pt-20 -63.65 -51.02 66.98 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.448 -168.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -151.67 176.24 11.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.373 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -127.78 30.26 5.32 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.618 2.367 . . . . 0.0 109.462 172.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.8 mt -57.27 -46.5 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 25' ' ' PHE . 99.0 mt -74.57 112.57 10.89 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -82.17 164.26 21.38 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.942 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.78 98.41 4.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.2 p -77.87 -32.93 52.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.798 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.6 -174.98 47.35 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 118.964 0.802 . . . . 0.0 113.851 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.72 160.02 26.37 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.486 2.124 . . . . 0.0 110.457 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.29 -5.93 40.01 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.836 -1.536 . . . . 0.0 112.465 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.92 156.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.925 2.362 . . . . 0.0 107.584 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.17 129.33 54.94 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.641 1.177 . . . . 0.0 108.421 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.1 t -138.53 148.98 44.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.026 0.829 . . . . 0.0 109.28 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.504 ' SD ' HG23 ' A' ' 32' ' ' THR . 12.9 ttt -100.45 130.44 46.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -162.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.498 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -75.54 155.64 35.87 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.813 1.245 . . . . 0.0 108.842 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -165.38 -169.1 1.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.922 1.689 . . . . 0.0 108.029 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -119.61 13.66 12.55 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.457 1.103 . . . . 0.0 113.049 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.42 -142.39 13.77 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -168.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.03 157.3 62.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.873 1.715 . . . . 0.0 109.521 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 34.18 51.04 0.4 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 128.163 2.585 . . . . 0.0 112.999 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 p -140.63 13.92 2.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.713 0.805 . . . . 0.0 113.069 -173.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -57.79 96.61 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.754 1.622 . . . . 0.0 110.826 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.19 -84.66 1.08 Allowed Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.048 -1.032 . . . . 0.0 111.529 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -156.29 -17.43 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -55.61 140.52 40.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 167.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.498 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -138.88 169.98 16.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.475 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 19.8 p90 -132.34 147.35 52.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.865 0.84 . . . . 0.0 111.663 166.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.4 mt -83.37 117.43 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 102.413 -3.18 . . . . 0.0 102.413 171.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.1 m -64.38 120.91 13.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.0 p -106.88 22.16 16.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.127 0.571 . . . . 0.0 109.629 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.39 -179.56 7.8 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 163.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -64.12 117.27 6.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 159.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.435 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 49.8 p -114.21 56.88 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.175 0.898 . . . . 0.0 111.327 -174.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -61.31 -25.08 66.88 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 120.86 -1.15 . . . . 0.0 113.959 -169.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.435 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 37.3 p90 -66.11 -21.82 66.37 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.814 0.846 . . . . 0.0 110.708 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.609 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 82.9 mt -88.65 -16.89 31.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.657 0.783 . . . . 0.0 110.569 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.77 149.0 38.07 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.34 69.84 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.611 -0.328 . . . . 0.0 112.34 -169.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.91 -45.11 0.47 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.179 0.99 . . . . 0.0 109.473 164.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -103.82 144.67 31.19 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.863 1.265 . . . . 0.0 109.486 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.3 102.15 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.05 121.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -142.14 1.36 1.43 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.024 -169.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.79 -177.25 35.64 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.973 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 157.84 43.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.138 0.495 . . . . 0.0 109.954 162.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.03 124.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -84.82 -48.01 9.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.329 160.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -146.06 158.29 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.681 1.192 . . . . 0.0 110.292 -168.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.46 20.08 64.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -34.89 60.57 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.539 1.67 . . . . 0.0 111.186 174.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -32.95 69.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.6 mm -78.14 -34.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 119.541 1.064 . . . . 0.0 109.492 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.21 -40.77 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.143 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.18 -37.01 81.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.672 0.789 . . . . 0.0 111.095 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.79 83.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.204 1.366 . . . . 0.0 108.288 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.0 mtm -52.41 -48.53 65.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 118.003 0.365 . . . . 0.0 110.568 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.03 -34.12 72.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -76.92 -15.67 59.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.892 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -89.46 -5.42 57.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.011 0.924 . . . . 0.0 111.806 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.51 -167.98 42.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.852 1.692 . . . . 0.0 109.782 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 51.2 p -161.49 155.74 22.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -18.88 65.54 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -69.43 -7.19 35.59 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.32 -30.29 10.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 127.787 2.613 . . . . 0.0 113.016 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -63.11 129.78 41.82 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.061 0.944 . . . . 0.0 110.56 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 p -80.01 157.97 26.65 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.824 1.25 . . . . 0.0 109.72 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -76.19 -17.73 59.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.286 1.035 . . . . 0.0 111.786 167.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.558 ' HE2' HG12 ' A' ' 12' ' ' VAL . 12.3 mtpt -140.85 165.3 27.9 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.407 1.483 . . . . 0.0 109.572 -168.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 13' ' ' ASP . 30.8 tttt -85.69 80.14 9.09 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.995 1.725 . . . . 0.0 107.515 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -73.87 131.24 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 p -145.69 167.34 23.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 123.488 1.613 . . . . 0.0 110.063 -167.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.408 HD13 ' O ' ' A' ' 48' ' ' TYR . 4.0 mp -83.02 114.56 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 158.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.59 -55.04 12.91 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.04 153.01 33.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.619 1.568 . . . . 0.0 107.076 -161.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 8' ' ' PHE . 7.5 m -159.71 174.16 14.95 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.951 1.701 . . . . 0.0 109.156 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.25 -172.01 44.84 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 165.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -83.49 160.4 21.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.123 0.969 . . . . 0.0 108.578 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.2 mt -128.27 43.28 3.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.197 0.999 . . . . 0.0 108.877 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 N--CA 1.435 -1.218 0 C-N-CA 131.638 3.975 . . . . 0.0 109.821 -168.698 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--O 1.24 0.58 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.84 156.26 66.89 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.863 1.709 . . . . 0.0 109.279 165.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.1 m -135.82 158.77 43.58 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.85 155.43 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 119.493 -2.004 . . . . 0.0 109.228 -169.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -124.38 157.3 35.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.874 1.269 . . . . 0.0 109.947 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 161' ' ' CYS . 88.1 m-85 -147.16 106.23 3.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.204 2.202 . . . . 0.0 107.738 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.49 93.56 3.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.17 143.7 15.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.6 133.54 47.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.443 1.097 . . . . 0.0 110.19 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 t -99.76 96.19 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 128.094 2.558 . . . . 0.0 104.603 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 58.71 17.96 5.56 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.763 2.025 . . . . 0.0 114.037 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.36 -9.72 24.37 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.319 1.914 . . . . 0.0 112.518 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.96 131.94 52.47 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.22 113.67 2.94 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.82 1.68 . . . . 0.0 109.659 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.3 tp -79.59 -37.28 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.554 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.28 171.03 14.0 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -81.68 139.8 34.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.92 153.41 35.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 127.066 2.146 . . . . 0.0 105.395 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.72 139.03 11.15 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 -166.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -134.04 149.76 51.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.621 0.769 . . . . 0.0 111.006 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -87.12 151.67 23.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 158.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 mt -127.46 109.48 11.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -68.97 61.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.84 2.456 . . . . 0.0 112.049 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.38 -30.17 38.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.463 1.905 . . . . 0.0 112.222 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 -19.55 62.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.901 1.681 . . . . 0.0 110.818 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -38.89 2.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.353 2.261 . . . . 0.0 110.664 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 129' ' ' PHE . 3.8 m -141.24 72.71 26.55 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.758 2.023 . . . . 0.0 108.645 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.59 -41.43 39.73 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.845 2.363 . . . . 0.0 113.712 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -57.73 11.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.351 1.432 . . . . 0.0 107.69 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 m -57.77 -44.08 85.92 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.712 0.632 . . . . 0.0 109.841 -169.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.48 67.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.799 0.84 . . . . 0.0 113.257 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -66.75 -39.96 88.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.713 0.688 . . . . 0.0 110.574 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -55.99 -52.53 63.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.75 1.22 . . . . 0.0 109.712 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.511 ' CE2' ' CE2' ' A' ' 112' ' ' PHE . 2.3 t80 -56.12 -49.86 72.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.601 0.36 . . . . 0.0 110.679 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.433 ' HD2' HE21 ' A' ' 163' ' ' GLN . 45.8 ttp85 -50.96 -60.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.011 1.324 . . . . 0.0 109.926 -173.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.54 -27.12 68.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -77.12 -33.85 56.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.922 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.5 p -69.95 -45.55 67.19 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.98 1.264 . . . . 0.0 111.093 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.0 p -64.68 -36.8 85.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.565 0.746 . . . . 0.0 109.085 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.23 14.31 82.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.24 -28.29 67.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.15 1.38 . . . . 0.0 112.031 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -72.33 8.96 1.14 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.529 1.132 . . . . 0.0 112.917 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -3.69 83.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.885 1.231 . . . . 0.0 112.805 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.2 176.45 12.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.5 1.65 . . . . 0.0 108.65 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.55 -146.88 17.6 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.561 ' CE1' ' CE2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -61.24 -38.69 87.59 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.213 1.405 . . . . 0.0 112.532 -163.072 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -47.15 116.78 1.49 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.398 1.079 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.98 4.24 90.34 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.427 -1.763 . . . . 0.0 115.728 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -64.24 -35.21 80.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 121.502 2.651 . . . . 0.0 113.589 -162.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.4 m 86.0 164.93 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.611 2.764 . . . . 0.0 107.868 -158.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -119.01 101.57 8.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 164.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.194 0.907 . . . . 0.0 113.043 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.571 ' HG3' HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -133.12 114.25 13.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.81 120.69 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.571 HD11 ' HG3' ' A' ' 55' ' ' ARG . 4.9 mp -124.89 99.95 34.39 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.2 136.45 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.107 1.871 . . . . 0.0 110.52 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 22.93 78.58 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.766 1.65 . . . . 0.0 112.198 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -146.93 -81.89 0.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.805 1.303 . . . . 0.0 109.144 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.554 ' CE ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -161.77 168.72 22.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.724 0.693 . . . . 0.0 112.301 174.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.0 m -120.84 108.44 13.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.212 1.805 . . . . 0.0 108.003 170.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -95.44 133.4 39.45 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 110.342 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 177.86 29.87 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.02 20.11 4.57 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.492 1.044 . . . . 0.0 112.62 -174.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -84.03 28.88 0.58 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.619 1.968 . . . . 0.0 111.975 -164.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 10.6 p90 -63.34 1.25 0.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.516 1.926 . . . . 0.0 115.731 -167.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.502 HG21 ' HE2' ' A' ' 76' ' ' LYS . 2.1 p -139.21 -69.08 0.43 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.305 1.842 . . . . 0.0 109.57 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -118.75 162.47 18.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 166.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -148.25 33.77 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.582 1.953 . . . . 0.0 108.063 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -144.96 16.27 1.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.838 3.255 . . . . 0.0 109.525 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.65 -28.05 12.37 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.365 1.459 . . . . 0.0 113.57 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.8 p -83.74 12.39 6.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.099 1.95 . . . . 0.0 113.103 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.56 168.8 13.27 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.743 1.163 . . . . 0.0 111.794 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.95 165.17 30.16 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HE2' HG21 ' A' ' 68' ' ' THR . 3.5 pttt 170.69 -177.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.129 4.172 . . . . 0.0 103.914 -160.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.9 p -127.25 178.6 5.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.455 1.025 . . . . 0.0 110.311 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.14 -22.89 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.131 168.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.93 1.78 56.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.514 1.525 . . . . 0.0 111.681 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.69 -112.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.24 -133.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.83 2.052 . . . . 0.0 110.389 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -102.74 154.67 18.94 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.331 -1.48 . . . . 0.0 109.261 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -111.0 165.45 11.86 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 109.888 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 156.17 31.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.175 0.988 . . . . 0.0 110.863 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 101.82 2.78 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.13 -48.98 77.34 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.465 1.106 . . . . 0.0 110.62 -164.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -170.12 176.28 4.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.24 2.216 . . . . 0.0 107.96 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.45 43.21 3.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.72 1.208 . . . . 0.0 108.357 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.0 mt -60.56 -65.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -72.67 143.64 48.03 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.954 1.835 . . . . 0.0 107.32 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -131.55 161.6 32.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 127.057 2.143 . . . . 0.0 109.008 -170.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -84.97 73.13 10.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.597 1.159 . . . . 0.0 109.055 -164.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 p -66.07 -31.58 72.54 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.832 0.853 . . . . 0.0 113.003 -165.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.28 171.34 31.38 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.75 -1.028 . . . . 0.0 110.965 -166.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.8 135.96 54.97 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.314 2.009 . . . . 0.0 111.669 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.35 -8.01 30.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.065 -1.409 . . . . 0.0 111.731 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.5 mm -72.31 148.3 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 121.124 2.462 . . . . 0.0 108.662 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.51 131.45 55.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.403 1.081 . . . . 0.0 108.263 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.3 t -140.51 159.82 41.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.857 0.863 . . . . 0.0 110.005 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.31 137.56 32.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -163.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -90.48 71.48 6.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.11 163.62 27.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.411 158.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.08 16.47 12.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.664 1.586 . . . . 0.0 111.646 -168.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.27 -170.81 28.05 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 -159.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -65.11 172.26 7.7 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 CA-C-N 119.898 1.849 . . . . 0.0 109.86 165.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.93 14.7 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 131.12 3.768 . . . . 0.0 116.221 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -108.63 27.26 9.59 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.857 -1.777 . . . . 0.0 111.03 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.408 2.683 . . . . 0.0 106.459 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.59 -93.75 0.32 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -172.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.5 t -144.34 -11.25 0.63 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.45 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -79.48 135.22 36.59 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CE2' ' CE1' ' A' ' 48' ' ' TYR . 37.1 p90 -145.29 177.27 8.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.679 1.192 . . . . 0.0 108.449 174.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -142.08 151.57 42.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.872 1.32 . . . . 0.0 112.587 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.81 101.9 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 101.569 -3.493 . . . . 0.0 101.569 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.68 94.42 0.3 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.4 p -87.1 25.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.804 0.842 . . . . 0.0 111.009 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.15 -178.22 7.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 163.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -67.2 130.84 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 158.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.6 p -131.62 57.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -14.37 61.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.183 0.993 . . . . 0.0 112.408 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -69.57 -7.95 43.0 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.106 -0.996 . . . . 0.0 111.055 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -109.46 -8.68 14.99 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.479 1.512 . . . . 0.0 111.996 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 149.05 30.17 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.059 0.943 . . . . 0.0 111.011 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.14 18.65 49.34 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.27 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -144.25 -34.33 0.38 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.576 1.15 . . . . 0.0 110.449 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -118.09 139.36 51.35 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.389 1.076 . . . . 0.0 108.194 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.76 96.87 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -167.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.17 127.02 22.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.419 ' HA ' HG21 ' A' ' 29' ' ' VAL . 15.8 p90 -134.83 -6.5 2.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.049 -0.977 . . . . 0.0 113.256 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.13 -179.28 31.05 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.28 -1.438 . . . . 0.0 112.855 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -153.65 138.3 16.93 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -53.73 114.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 125.059 1.344 . . . . 0.0 108.388 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -83.26 -52.27 6.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.83 160.05 40.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.715 1.143 . . . . 0.0 112.116 -168.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.69 77.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.526 1.06 . . . . 0.0 112.098 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -37.99 71.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.86 1.33 . . . . 0.0 110.843 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.22 -29.15 68.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.946 -1.096 . . . . 0.0 112.508 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.6 mm -72.51 -35.46 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.614 1.166 . . . . 0.0 108.98 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.36 -44.05 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.983 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -27.44 68.91 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.962 -1.086 . . . . 0.0 112.779 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.84 -46.32 68.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.939 -1.101 . . . . 0.0 108.474 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 15.8 mtm -53.08 -46.7 68.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.374 0.534 . . . . 0.0 111.234 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -52.29 -42.49 63.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.469 1.108 . . . . 0.0 111.842 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.47 -19.52 64.56 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.922 -0.486 . . . . 0.0 110.822 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.445 ' CB ' HD11 ' A' ' 156' ' ' ILE . 55.1 m-85 -98.02 5.01 49.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.692 1.597 . . . . 0.0 111.664 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.2 -163.93 37.94 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 98.5 p -152.41 163.57 39.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 57' ' ' ILE . 44.9 mtm-85 -67.03 -22.4 65.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.25 -1.531 . . . . 0.0 113.462 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -75.33 -15.69 60.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 168.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 102.06 -27.98 17.98 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-O 117.644 -1.642 . . . . 0.0 114.259 171.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -66.95 124.63 23.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.209 2.005 . . . . 0.0 107.246 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.9 p -73.31 147.85 44.08 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.924 0.889 . . . . 0.0 109.895 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.0 p -77.61 -9.98 59.25 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.23 -0.919 . . . . 0.0 111.784 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -136.96 152.32 50.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.968 1.307 . . . . 0.0 109.546 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -73.06 109.08 6.33 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.445 HD11 ' CB ' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -101.88 130.45 51.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -177.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.2 p -141.84 173.36 11.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.55 1.94 . . . . 0.0 110.552 -170.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.409 HD11 ' CE2' ' A' ' 48' ' ' TYR . 3.2 mt -106.61 116.55 50.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 167.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.12 -60.01 4.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -163.01 176.55 10.01 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.735 1.614 . . . . 0.0 111.388 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 8' ' ' PHE . 1.4 p -169.5 172.4 7.06 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.425 1.09 . . . . 0.0 110.628 -159.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.82 -172.23 45.11 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.433 HE21 ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -90.63 160.47 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.115 0.966 . . . . 0.0 110.327 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 39.0 mt -136.9 43.66 2.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.595 1.558 . . . . 0.0 109.011 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.745 -176.041 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.6 m120 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -76.36 149.95 31.92 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 N-CA-C 109.283 -1.084 . . . . 0.0 109.283 165.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -101.48 151.15 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.78 163.7 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.537 1.535 . . . . 0.0 108.252 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -134.09 158.42 43.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.15 0.98 . . . . 0.0 110.471 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -128.86 123.77 33.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.856 2.462 . . . . 0.0 106.317 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -78.19 98.92 6.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.8 mm -70.28 140.14 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.151 -0.968 . . . . 0.0 109.562 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.49 50.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.581 1.152 . . . . 0.0 110.4 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 6.7 t -132.74 100.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -165.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.24 13.69 0.65 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.599 1.959 . . . . 0.0 112.86 -161.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.19 38.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.525 1.536 . . . . 0.0 113.298 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -80.51 126.87 77.54 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 120.015 1.908 . . . . 0.0 106.188 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 115.89 3.65 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.822 1.681 . . . . 0.0 109.078 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.9 tp -85.2 -39.6 17.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.563 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.97 158.34 9.01 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.495 -0.383 . . . . 0.0 112.218 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -68.97 146.43 52.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 164.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.453 HG12 ' CZ ' ' A' ' 22' ' ' PHE . 39.2 t -135.33 143.29 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 171.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -137.02 153.18 50.72 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.166 0.586 . . . . 0.0 110.031 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.453 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 11.3 m-85 -146.54 146.69 30.58 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.477 1.111 . . . . 0.0 108.909 -165.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.03 145.88 27.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 165.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -118.65 146.78 44.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 108.734 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -97.54 61.66 1.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.543 1.537 . . . . 0.0 111.102 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.2 42.05 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.29 0.636 . . . . 0.0 112.236 171.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.58 -0.89 39.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.931 2.093 . . . . 0.0 113.307 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -127.83 -37.27 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.142 1.337 . . . . 0.0 110.716 166.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.07 73.68 74.69 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.148 1.379 . . . . 0.0 107.457 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.38 -43.09 36.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -49.88 67.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.924 0.783 . . . . 0.0 109.828 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.7 m -55.21 -46.66 75.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.991 1.316 . . . . 0.0 109.769 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -51.9 55.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.621 0.769 . . . . 0.0 111.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.59 -39.0 93.27 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.322 1.049 . . . . 0.0 111.618 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -51.88 -60.92 2.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.191 1.396 . . . . 0.0 109.718 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -66.12 -28.27 68.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.221 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -53.88 -64.11 0.93 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.206 1.402 . . . . 0.0 109.16 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.9 -16.62 61.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.58 -31.37 16.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.879 1.272 . . . . 0.0 110.903 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -79.36 -24.39 42.72 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 111.761 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.6 p -79.24 -39.06 34.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.24 19.72 78.07 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.0 -16.05 63.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.806 1.303 . . . . 0.0 112.942 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -87.48 9.43 20.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.213 1.005 . . . . 0.0 112.032 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.04 16.47 79.53 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.419 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.83 -173.73 4.69 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.968 1.707 . . . . 0.0 108.678 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.71 -146.19 17.89 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CE2' HD11 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -64.04 -27.99 69.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.791 1.636 . . . . 0.0 111.767 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 11.3 tmtt? -62.01 109.64 1.34 Allowed 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.879 -0.513 . . . . 0.0 110.164 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.57 89.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 116.938 -2.035 . . . . 0.0 115.061 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -68.13 151.28 47.24 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 121.89 2.845 . . . . 0.0 108.324 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.427 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 65.2 m -86.15 171.09 11.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 159.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CB ' HD11 ' A' ' 56' ' ' ILE . 55.0 m-85 -116.09 120.08 37.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -73.67 -45.41 52.71 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.73 102.05 6.4 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 123.807 0.692 . . . . 0.0 110.877 -157.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.409 HD11 ' CB ' ' A' ' 53' ' ' PHE . 29.8 mt -130.06 108.42 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -170.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.43 97.47 50.18 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -55.05 128.79 32.04 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.299 1.999 . . . . 0.0 112.705 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 46.31 85.42 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 125.011 1.291 . . . . 0.0 110.156 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -153.55 -79.23 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.58 168.4 16.43 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.805 1.242 . . . . 0.0 109.668 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.81 109.49 7.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.201 . . . . 0.0 111.551 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -101.64 143.02 32.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.439 2.696 . . . . 0.0 110.774 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.34 20.02 0.63 Allowed Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.55 3.39 42.79 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 119.136 1.468 . . . . 0.0 116.045 -159.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -83.98 23.86 0.98 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.485 2.142 . . . . 0.0 112.833 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -33.37 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 1 C-N-CA 133.515 4.726 . . . . 0.0 119.989 -158.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -87.75 -22.28 24.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.865 1.666 . . . . 0.0 111.265 173.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -133.19 177.98 7.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 128.998 2.919 . . . . 0.0 106.867 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -156.17 44.03 0.42 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.84 1.256 . . . . 0.0 108.651 -168.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -140.34 -8.36 1.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 110.824 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.45 56.98 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 117.828 -1.54 . . . . 0.0 113.801 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.2 p -135.57 65.85 1.53 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.375 2.088 . . . . 0.0 110.077 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.17 -154.1 6.95 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' H ' HG22 ' A' ' 68' ' ' THR . . . 81.86 170.67 44.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.115 0.864 . . . . 0.0 112.78 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 150.88 9.97 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.879 1.272 . . . . 0.0 109.327 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.2 p -89.63 35.2 0.82 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -166.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 pt 42.1 -3.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 130.645 3.578 . . . . 0.0 118.049 -162.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -134.28 12.21 3.85 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.644 2.377 . . . . 0.0 110.774 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.15 -156.82 27.38 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -68.5 -132.91 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.444 1.498 . . . . 0.0 108.446 160.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -74.69 170.57 15.55 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.092 -1.63 . . . . 0.0 111.257 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -130.6 178.5 6.58 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.96 1.704 . . . . 0.0 108.038 169.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.74 172.84 2.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.198 0.999 . . . . 0.0 112.11 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -79.46 99.19 7.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 160.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.063 1.345 . . . . 0.0 112.269 -166.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -160.6 175.7 12.4 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.009 1.324 . . . . 0.0 108.32 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.41 26.67 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.169 1.388 . . . . 0.0 109.557 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.38 -46.61 81.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.62 132.25 34.2 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -133.67 154.94 50.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.331 1.853 . . . . 0.0 109.224 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -75.84 85.5 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.047 1.339 . . . . 0.0 110.27 -168.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -7.83 59.63 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 113.962 -172.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.71 -178.8 33.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.37 156.06 53.71 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.864 1.709 . . . . 0.0 110.514 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.85 89.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.981 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.85 160.94 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.241 2.02 . . . . 0.0 107.8 169.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.21 136.59 54.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.239 1.416 . . . . 0.0 107.303 169.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 22.8 t -127.08 138.29 53.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.8 mtp -67.57 152.86 44.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 158.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.89 154.72 36.73 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.531 1.532 . . . . 0.0 108.874 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -138.49 -171.19 3.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.132 2.173 . . . . 0.0 107.301 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.94 25.15 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.76 1.624 . . . . 0.0 110.593 -175.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.67 -161.58 24.79 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.2 154.86 60.1 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 120.474 2.137 . . . . 0.0 109.4 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 43.99 43.66 5.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.716 2.406 . . . . 0.0 114.136 159.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.6 p -132.59 29.79 4.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.258 1.423 . . . . 0.0 110.048 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -71.39 107.69 4.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.79 -95.21 1.55 Allowed Glycine 0 C--O 1.225 -0.423 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 p -129.65 1.7 4.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.787 1.635 . . . . 0.0 110.893 170.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -58.3 141.84 49.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.905 1.682 . . . . 0.0 108.359 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.61 174.39 15.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.544 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 11.5 p90 -147.35 161.08 41.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 158.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.39 129.05 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 159.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.45 118.19 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.7 p -108.09 21.32 17.54 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.673 1.589 . . . . 0.0 109.521 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -156.57 174.75 14.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 167.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -71.53 85.41 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 162.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -78.18 60.34 2.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.273 1.029 . . . . 0.0 110.781 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.34 -15.1 62.99 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.667 -1.27 . . . . 0.0 112.453 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -76.87 -18.04 58.59 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.104 1.361 . . . . 0.0 111.944 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.544 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 69.2 mt -97.74 -7.94 29.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.179 1.392 . . . . 0.0 110.402 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.62 138.3 56.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.93 -11.29 1.97 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.586 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -93.76 -39.0 10.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.666 1.733 . . . . 0.0 108.421 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -130.92 155.6 46.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.092 0.472 . . . . 0.0 111.433 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.29 93.54 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.531 1.532 . . . . 0.0 108.195 -165.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.59 131.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 1.18 0.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.248 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -163.27 -175.16 33.98 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -153.0 150.93 29.71 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.838 0.855 . . . . 0.0 110.016 165.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.98 117.56 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.574 1.549 . . . . 0.0 107.653 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -72.62 -48.31 40.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.318 167.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -149.23 160.29 43.51 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 109.064 -162.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.02 16.29 76.62 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.515 0.579 . . . . 0.0 113.392 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -37.74 67.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.816 1.808 . . . . 0.0 111.195 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.0 -21.08 65.07 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.056 -1.028 . . . . 0.0 113.752 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.4 mm -81.79 -34.43 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.186 1.394 . . . . 0.0 108.835 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.44 -37.1 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.668 -1.27 . . . . 0.0 109.348 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -69.79 -23.75 63.39 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 120.546 -1.346 . . . . 0.0 112.595 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.63 -42.85 77.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.965 -1.084 . . . . 0.0 109.626 168.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 23.0 mtp -62.32 -46.9 86.65 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 122.331 -0.231 . . . . 0.0 110.972 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -66.14 -29.69 70.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -76.49 -15.99 59.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.328 0.967 . . . . 0.0 112.46 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -95.05 18.82 11.39 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 127.088 2.155 . . . . 0.0 112.285 163.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.49 -147.89 15.36 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.418 1.961 . . . . 0.0 110.616 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.3 p -146.14 -81.86 0.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.451 0.625 . . . . 0.0 110.807 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 169.06 -21.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 131.529 3.932 . . . . 0.0 111.215 167.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -19.57 63.93 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.776 1.171 . . . . 0.0 109.855 159.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.03 -26.91 10.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.565 -1.131 . . . . 0.0 111.894 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -70.83 123.63 22.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 119.416 1.608 . . . . 0.0 107.054 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.8 p -72.18 153.98 41.31 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.205 1.802 . . . . 0.0 111.553 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.82 -5.02 59.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.782 1.233 . . . . 0.0 112.426 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.414 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 20.4 mmtt -137.97 161.23 37.22 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.793 2.037 . . . . 0.0 109.212 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -75.1 89.07 2.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 163.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.58 130.7 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.73 162.81 36.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.055 0.942 . . . . 0.0 111.743 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.669 HD11 ' CE2' ' A' ' 48' ' ' TYR . 3.9 mp -91.37 119.55 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 158.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.98 -58.92 6.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 164.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -152.79 167.62 28.42 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 49' ' ' LYS . 15.6 p -162.04 171.83 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.52 0.6 . . . . 0.0 111.414 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.32 176.54 48.06 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -76.25 158.38 31.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.575 1.55 . . . . 0.0 109.284 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.1 mt -137.4 42.74 2.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.102 0.953 . . . . 0.0 109.098 159.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.247 0.959 0 C-N-CA 125.143 1.377 . . . . 0.0 107.862 -177.768 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 117.422 -1.275 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -65.19 133.36 35.02 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 CA-C-N 120.774 1.312 . . . . 0.0 109.66 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -89.41 152.3 21.56 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -135.91 157.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.019 -1.051 . . . . 0.0 109.036 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -124.65 153.5 42.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.227 1.011 . . . . 0.0 108.727 170.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -132.86 117.96 18.37 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.496 1.918 . . . . 0.0 106.053 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.02 97.16 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.7 mm -68.77 147.54 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.72 153.37 45.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.309 1.844 . . . . 0.0 109.577 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.92 108.36 19.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.27 13.95 4.29 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 114.236 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.49 -0.5 63.45 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.55 1.071 . . . . 0.0 112.889 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.12 146.71 90.15 Favored Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 159.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 130.55 27.29 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 N-CA-C 107.819 -1.646 . . . . 0.0 107.819 160.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 tp -91.87 -41.69 10.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 108.98 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.46 156.8 8.16 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 118.115 0.416 . . . . 0.0 112.99 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -82.56 114.08 20.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.801 1.24 . . . . 0.0 109.126 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.08 155.65 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.797 1.639 . . . . 0.0 107.082 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -142.14 148.51 38.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 123.46 1.6 . . . . 0.0 111.322 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -131.71 159.61 37.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 113.524 -1.671 . . . . 0.0 107.899 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -120.52 144.41 48.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.785 1.634 . . . . 0.0 106.785 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.85 114.81 16.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -170.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.56 64.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.854 1.662 . . . . 0.0 110.885 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.85 -14.18 60.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 112.607 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -71.02 -36.21 72.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.506 1.122 . . . . 0.0 110.791 168.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -85.77 -56.18 3.61 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.953 0.901 . . . . 0.0 108.907 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.14 71.01 80.23 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.226 1.81 . . . . 0.0 109.385 -165.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 -30.76 78.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.577 2.185 . . . . 0.0 113.626 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -52.3 57.98 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.786 1.63 . . . . 0.0 108.032 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' SD ' ' A' ' 100' ' ' MET . 16.6 m -63.38 -44.82 93.63 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.577 1.151 . . . . 0.0 110.607 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.26 91.86 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.818 -0.551 . . . . 0.0 111.871 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.37 -44.71 78.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.433 1.093 . . . . 0.0 110.651 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -54.32 -48.39 71.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.678 1.191 . . . . 0.0 109.604 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -64.35 -36.44 84.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.425 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -57.79 -63.35 1.28 Allowed 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.283 1.033 . . . . 0.0 109.521 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.84 71.81 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.806 0.692 . . . . 0.0 111.205 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.0 mt -67.06 -36.09 81.27 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 121.375 -0.828 . . . . 0.0 110.845 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -68.22 -28.76 67.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.345 0.975 . . . . 0.0 111.999 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -93.95 -26.01 17.03 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.076 0.55 . . . . 0.0 111.201 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 -0.29 86.77 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.902 0.774 . . . . 0.0 112.561 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -38.83 77.45 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.552 1.141 . . . . 0.0 111.991 -165.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -72.55 3.85 4.5 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.08 4.54 84.17 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 119.528 1.058 . . . . 0.0 111.506 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.58 169.8 19.52 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.754 1.621 . . . . 0.0 107.167 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.46 -178.51 36.45 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-O 122.775 1.208 . . . . 0.0 110.633 -167.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 6.6 t80 -84.73 -23.88 29.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.124 -1.538 . . . . 0.0 111.6 -159.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -46.62 111.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.04 2.136 . . . . 0.0 109.569 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.38 9.69 83.25 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 117.668 -1.629 . . . . 0.0 116.244 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.1 m -68.64 -21.87 64.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.736 2.768 . . . . 0.0 113.209 -174.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.2 t 67.11 132.81 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 129.273 3.029 . . . . 0.0 112.474 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -77.67 76.87 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.52 1.528 . . . . 0.0 108.326 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.401 ' CD2' HH11 ' A' ' 55' ' ' ARG . 27.7 p-80 -74.1 -7.32 52.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.239 1.416 . . . . 0.0 113.56 -174.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.401 HH11 ' CD2' ' A' ' 54' ' ' HIS . 5.1 mpt_? -123.63 128.43 49.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 159.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.6 mt -134.49 106.64 8.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 161.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.5 mt -111.52 98.09 39.12 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.51 124.59 14.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 123.921 3.081 . . . . 0.0 113.11 -170.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.66 38.54 93.3 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.886 1.707 . . . . 0.0 111.237 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -143.13 -81.36 0.19 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.769 1.284 . . . . 0.0 108.624 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.31 169.91 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.328 168.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m -121.08 107.92 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.249 1.819 . . . . 0.0 108.329 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -99.05 138.26 36.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.13 0.972 . . . . 0.0 108.495 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.02 1.98 0.5 Allowed Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.509 -1.162 . . . . 0.0 115.936 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.12 51.4 4.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.773 1.787 . . . . 0.0 115.284 -162.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.16 69.12 1.34 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.334 1.067 . . . . 0.0 110.896 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 31.9 p90 -70.14 -6.08 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.095 0.958 . . . . 0.0 112.812 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -113.9 -38.99 4.07 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 120.871 -1.143 . . . . 0.0 110.625 -160.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -128.44 -17.78 4.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.203 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 45.27 35.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.977 2.111 . . . . 0.0 112.916 175.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -140.78 10.14 2.21 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.386 -0.821 . . . . 0.0 111.961 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.3 -1.9 79.14 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.966 -1.463 . . . . 0.0 112.884 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 p -95.96 -6.48 38.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 120.007 1.903 . . . . 0.0 110.975 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.32 179.1 38.96 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 118.993 0.815 . . . . 0.0 112.315 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.61 115.69 2.21 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 125.471 1.51 . . . . 0.0 111.245 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HE3' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -133.76 169.44 17.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.495 1.918 . . . . 0.0 107.234 166.149 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.3 p -83.74 -175.18 5.69 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.606 0.639 . . . . 0.0 109.532 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.4 pt -83.48 -20.17 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.841 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -79.74 -35.08 39.34 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.567 0.621 . . . . 0.0 109.422 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.1 -142.07 6.67 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 107.029 -2.428 . . . . 0.0 107.029 -167.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 82' ' ' LYS . 9.7 tt0 -68.82 -156.22 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.033 0.916 . . . . 0.0 110.664 168.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 54.0 mttt -64.96 126.89 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 120.415 -1.428 . . . . 0.0 109.91 -169.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -89.5 175.73 7.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 18.2 pt-20 -77.92 175.28 10.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 11.3 t70 -86.75 104.34 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.883 2.873 . . . . 0.0 108.001 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.15 -41.23 81.88 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.631 -162.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 159.07 157.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 129.354 3.062 . . . . 0.0 111.604 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -106.59 30.14 6.31 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.42 1.888 . . . . 0.0 110.614 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.1 mt -53.01 -48.39 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.209 1.003 . . . . 0.0 108.472 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.89 130.4 36.12 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -130.54 169.57 15.4 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.265 1.426 . . . . 0.0 110.687 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -82.19 81.58 8.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.131 1.372 . . . . 0.0 108.896 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.0 p -75.84 -32.01 59.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.054 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.22 -178.74 44.37 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.628 1.585 . . . . 0.0 110.884 -175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.21 165.1 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.833 2.355 . . . . 0.0 111.226 171.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.44 8.47 75.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.251 -1.305 . . . . 0.0 112.923 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.0 mm -85.61 151.46 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 121.012 2.406 . . . . 0.0 108.953 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.46 131.2 57.0 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.367 -1.458 . . . . 0.0 108.924 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.8 t -148.47 158.27 44.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.497 0.719 . . . . 0.0 111.385 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.481 ' SD ' HG23 ' A' ' 32' ' ' THR . 26.2 mtp -83.49 135.34 34.7 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 124.283 1.033 . . . . 0.0 111.664 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -92.08 71.23 5.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 123.088 1.423 . . . . 0.0 107.558 168.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -75.66 -172.75 1.97 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.27 160.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.21 16.32 9.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.29 1.836 . . . . 0.0 111.423 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.56 -175.37 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.293 1.901 . . . . 0.0 108.782 -164.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.48 142.71 91.41 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.829 1.686 . . . . 0.0 110.017 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 31.3 m-20 64.14 38.26 8.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.931 2.092 . . . . 0.0 112.19 167.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 p -127.87 38.14 4.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.633 0.773 . . . . 0.0 109.81 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -89.88 110.61 21.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.959 1.304 . . . . 0.0 109.139 -172.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.16 -132.57 5.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.2 p -85.49 -18.5 33.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.582 0.753 . . . . 0.0 111.46 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -67.84 126.02 28.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.224 1.012 . . . . 0.0 108.757 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 5.0 p90 -154.03 171.06 19.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 107.73 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 5.2 p90 -141.19 157.95 44.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.433 1.111 . . . . 0.0 112.046 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.25 103.91 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 166.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 9.2 m -60.4 126.12 26.26 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.9 p -116.6 23.15 12.23 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.799 1.24 . . . . 0.0 109.006 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -150.69 175.85 11.57 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.624 -0.673 . . . . 0.0 109.883 162.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -64.69 84.87 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 159.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.444 ' HB ' HD12 ' A' ' 122' ' ' LEU . 8.3 p -82.1 53.4 2.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.086 0.554 . . . . 0.0 111.161 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -63.63 -20.91 66.07 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.148 -1.595 . . . . 0.0 113.159 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -69.98 -4.7 21.95 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.265 1.426 . . . . 0.0 112.079 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 68.6 mt -105.32 -8.17 18.41 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.897 1.279 . . . . 0.0 111.275 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.46 152.47 43.86 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.631 1.105 . . . . 0.0 109.122 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.39 -1.52 65.27 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.726 1.155 . . . . 0.0 113.421 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -132.22 -56.97 0.97 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.891 1.677 . . . . 0.0 108.283 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -99.47 129.29 45.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -170.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.39 104.99 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.92 132.71 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.29 -4.79 1.66 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.8 -173.13 27.9 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.973 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -155.54 146.37 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.507 1.123 . . . . 0.0 108.669 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.68 116.67 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -86.1 -49.95 7.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.99 162.67 34.33 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.211 1.004 . . . . 0.0 112.923 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.98 15.76 66.63 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.142 0.877 . . . . 0.0 112.816 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.3 tpt -55.87 -28.67 57.68 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.749 1.775 . . . . 0.0 111.958 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -62.82 -35.32 79.53 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.244 -0.91 . . . . 0.0 113.194 172.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.98 -39.15 81.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.89 -41.3 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.757 0.708 . . . . 0.0 109.732 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.32 -27.46 69.04 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.703 -1.248 . . . . 0.0 113.244 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.03 -46.57 42.59 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.165 -0.959 . . . . 0.0 109.218 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 79.5 mtp -53.06 -47.58 68.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.249 1.02 . . . . 0.0 110.036 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -62.36 -30.68 71.35 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.702 0.801 . . . . 0.0 112.647 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -24.04 64.45 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.52 -0.738 . . . . 0.0 111.372 174.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -97.08 6.59 48.28 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.872 1.669 . . . . 0.0 112.099 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.07 -173.38 35.92 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 169.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.4 p -157.62 158.88 36.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 166.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.28 -22.39 64.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -6.07 53.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.177 0.899 . . . . 0.0 112.779 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.24 -30.66 9.93 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.09 2.281 . . . . 0.0 112.875 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.04 138.03 26.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.076 0.95 . . . . 0.0 109.498 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.1 p -98.25 138.6 35.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -18.67 63.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.831 0.852 . . . . 0.0 112.12 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.59 161.0 32.51 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.109 0.964 . . . . 0.0 108.875 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 134.78 48.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 mt -132.35 113.56 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -132.48 175.41 9.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.623 1.169 . . . . 0.0 109.657 -166.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.44 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 3.7 mp -100.33 105.61 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 171.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.22 -46.22 87.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.776 0.83 . . . . 0.0 109.976 172.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -151.24 157.4 42.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.0 p -162.68 163.04 27.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.948 0.404 . . . . 0.0 110.64 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.47 -173.01 45.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.551 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 2.6 tp60 -84.78 154.6 22.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.494 1.917 . . . . 0.0 109.358 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.2 mt -131.9 43.69 3.0 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.768 1.27 . . . . 0.0 110.65 160.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.551 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 39.7 tp10 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 102.093 -3.299 . . . . 0.0 102.093 166.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.24 135.92 68.97 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.694 1.596 . . . . 0.0 110.62 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.465 ' H ' ' CB ' ' A' ' 165' ' ' GLU . 52.5 m -94.96 145.04 25.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 m -130.53 149.98 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 171.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -110.65 161.06 16.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.457 1.103 . . . . 0.0 108.779 168.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -139.41 163.17 33.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.153 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.37 99.47 5.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 170.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.4 mm -68.72 148.68 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.0 143.73 51.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.892 0.877 . . . . 0.0 110.421 170.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.99 99.87 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 127.953 2.501 . . . . 0.0 104.338 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.62 13.95 1.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.577 1.951 . . . . 0.0 113.696 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.34 0.49 58.23 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.107 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.22 121.04 81.9 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 159.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.24 112.96 2.24 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 107.364 -1.821 . . . . 0.0 107.364 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.73 -29.42 36.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.029 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.21 167.81 13.84 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.409 0.549 . . . . 0.0 113.145 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -75.57 139.07 41.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 108.886 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -130.24 157.93 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -150.74 155.45 39.31 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.728 -1.233 . . . . 0.0 110.478 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 132' ' ' VAL . 70.6 m-85 -142.23 154.13 44.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.522 1.129 . . . . 0.0 109.447 -170.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.09 141.2 30.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.47 117.69 30.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.968 1.307 . . . . 0.0 107.518 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.29 53.88 0.14 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.906 2.482 . . . . 0.0 114.072 -168.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.47 -28.08 42.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.685 1.994 . . . . 0.0 115.062 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -27.71 67.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.575 1.08 . . . . 0.0 110.151 177.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.57 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -120.36 -21.96 6.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.097 0.959 . . . . 0.0 112.5 -164.219 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 71.63 25.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.68 1.592 . . . . 0.0 107.758 167.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.82 -45.88 37.59 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.951 2.434 . . . . 0.0 111.819 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -54.62 37.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.147 0.885 . . . . 0.0 110.959 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -38.48 86.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.855 -0.528 . . . . 0.0 110.487 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.38 -39.81 64.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.851 -0.531 . . . . 0.0 112.184 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -62.14 -45.81 91.8 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.594 1.158 . . . . 0.0 108.863 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -52.96 -56.37 16.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.745 0.818 . . . . 0.0 108.961 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -26.91 67.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 ttm-85 -55.0 -67.24 0.29 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.497 1.499 . . . . 0.0 107.74 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.782 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -52.28 -38.74 59.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.816 1.246 . . . . 0.0 112.336 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.64 -42.52 86.6 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.619 -0.676 . . . . 0.0 111.132 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -70.71 -34.43 71.93 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.506 -0.746 . . . . 0.0 111.179 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.9 p -79.13 -26.89 42.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.858 -0.526 . . . . 0.0 110.465 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.47 83.08 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.589 1.09 . . . . 0.0 111.834 -176.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.73 -27.82 69.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.854 0.862 . . . . 0.0 112.949 -159.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -74.65 3.56 7.65 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.57 9.3 75.58 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.156 0.889 . . . . 0.0 112.154 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -156.6 174.68 15.09 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.148 1.779 . . . . 0.0 107.601 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.68 -171.07 34.21 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-O 122.808 1.227 . . . . 0.0 114.442 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.407 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -71.27 -25.07 62.3 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.587 2.755 . . . . 0.0 110.369 177.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -52.49 108.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.568 2.347 . . . . 0.0 107.606 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.08 75.66 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.639 -1.089 . . . . 0.0 115.751 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 t -68.12 -10.46 54.24 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.514 1.657 . . . . 0.0 113.323 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t 60.18 176.58 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.82 1.248 . . . . 0.0 110.533 -161.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.05 125.69 46.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 162.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -78.88 -40.0 33.58 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -139.74 110.78 6.9 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 -159.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.49 HD12 ' CG2' ' A' ' 152' ' ' THR . 7.3 mt -128.06 98.14 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -173.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.4 mt -111.12 96.06 28.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -168.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.11 126.64 20.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.051 2.5 . . . . 0.0 112.388 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 36.06 60.4 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.697 1.617 . . . . 0.0 111.77 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -150.32 -76.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.371 1.085 . . . . 0.0 108.545 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.4 171.59 18.8 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.629 0.772 . . . . 0.0 111.121 171.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 30.3 p -128.99 111.64 13.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.309 0.644 . . . . 0.0 111.17 161.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -86.3 135.1 33.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.921 2.489 . . . . 0.0 110.822 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.89 -161.35 9.95 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.751 2.119 . . . . 0.0 108.524 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.79 6.55 67.35 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.086 0.943 . . . . 0.0 113.229 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.72 123.1 29.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 166.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -128.2 7.31 5.96 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.183 1.356 . . . . 0.0 111.989 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.613 HG21 ' CE ' ' A' ' 76' ' ' LYS . 26.5 p -125.03 -13.24 6.87 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.761 1.625 . . . . 0.0 112.203 168.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -132.38 -175.96 3.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 130.171 3.389 . . . . 0.0 105.84 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -164.53 54.0 0.13 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 166.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -159.08 -1.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.415 . . . . 0.0 113.921 -166.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.91 3.12 49.13 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 117.605 -1.664 . . . . 0.0 115.476 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.1 p -131.12 17.67 5.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.095 2.448 . . . . 0.0 115.65 -165.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.35 -94.29 0.64 Allowed Glycine 0 C--N 1.338 0.659 0 O-C-N 120.287 -1.508 . . . . 0.0 112.125 -165.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -7.12 112.63 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 129.077 3.227 . . . . 0.0 115.519 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.613 ' CE ' HG21 ' A' ' 68' ' ' THR . 12.2 pttt -127.47 155.52 43.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 128.792 2.837 . . . . 0.0 108.683 -161.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.0 p -72.15 172.59 9.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.91 1.338 . . . . 0.0 110.389 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 38' ' ' ALA . 38.8 pt -75.53 -20.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.061 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -77.71 -36.71 50.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.196 0.998 . . . . 0.0 110.195 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.59 109.05 0.89 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HB2' ' HE3' ' A' ' 82' ' ' LYS 0.336 0.1 OUTLIER 37.25 -133.5 0.09 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.148 1.779 . . . . 0.0 113.041 177.522 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -87.17 161.9 17.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 121.116 1.78 . . . . 0.0 112.234 -176.222 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -126.52 165.81 18.44 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.144 1.778 . . . . 0.0 110.206 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.78 154.48 36.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.665 0.745 . . . . 0.0 111.968 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.34 123.17 21.07 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.297 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.26 -50.59 69.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.506 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -176.75 171.31 2.26 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.986 2.914 . . . . 0.0 107.502 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -123.03 38.01 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.726 1.61 . . . . 0.0 109.295 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.429 HD12 ' HE2' ' A' ' 28' ' ' LYS . 8.2 mt -63.53 -44.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 174.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 74.4 mt -81.05 128.3 33.57 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 124' ' ' GLY . 3.6 mtmp? -136.46 163.37 30.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.362 -167.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.527 ' H ' ' HB2' ' A' ' 123' ' ' ASP . 31.3 m80 -78.17 90.78 4.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.528 1.131 . . . . 0.0 111.694 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.92 35.07 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.855 -1.153 . . . . 0.0 111.679 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -60.62 165.93 10.71 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.852 2.368 . . . . 0.0 111.75 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.36 -0.16 49.9 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.525 1.059 . . . . 0.0 112.955 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.08 164.31 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.627 1.713 . . . . 0.0 107.914 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.4 HD23 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -136.7 128.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.919 -1.113 . . . . 0.0 109.593 -177.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -143.41 165.29 27.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.328 0.585 . . . . 0.0 110.585 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 108' ' ' ASN . 6.5 ttm -104.75 127.48 52.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -166.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.467 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -78.69 74.99 5.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.052 1.341 . . . . 0.0 108.422 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -70.01 175.05 4.71 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.235 158.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.22 19.73 4.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.264 1.425 . . . . 0.0 111.77 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.84 -167.91 29.34 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.83 159.92 43.42 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-N 119.361 1.58 . . . . 0.0 108.433 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 33.61 54.77 0.52 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.107 3.363 . . . . 0.0 111.944 175.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -131.84 22.49 4.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.743 1.217 . . . . 0.0 111.813 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.46 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 67.8 m-80 -67.29 109.69 3.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.787 2.435 . . . . 0.0 107.69 177.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.05 -85.42 0.91 Allowed Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.315 0.961 . . . . 0.0 111.727 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.0 t -155.92 -30.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.831 1.652 . . . . 0.0 109.381 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -53.91 125.57 19.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.513 1.525 . . . . 0.0 106.983 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.467 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -148.74 170.95 17.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.602 1.561 . . . . 0.0 108.079 -168.693 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -142.03 151.65 42.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.945 0.498 . . . . 0.0 110.86 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.53 122.68 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.43 118.86 12.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.1 p -112.53 27.92 9.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.1 0.952 . . . . 0.0 109.169 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.8 176.04 13.09 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.908 1.283 . . . . 0.0 107.54 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.51 89.17 0.23 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 162.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.8 p -74.77 57.6 0.77 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.449 1.099 . . . . 0.0 111.123 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.34 -20.58 66.46 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.604 -1.31 . . . . 0.0 112.719 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.406 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 29.1 p90 -74.52 -10.57 59.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.994 1.718 . . . . 0.0 111.574 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.406 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.7 mt -113.77 -6.65 13.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.205 1.402 . . . . 0.0 111.226 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.527 ' HB2' ' H ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -76.52 148.76 36.92 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.037 0.935 . . . . 0.0 109.579 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 91' ' ' LYS . . . 62.09 18.6 57.86 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.081 -170.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -140.11 -35.0 0.52 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.488 1.144 . . . . 0.0 109.985 -171.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -112.99 157.95 20.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.366 1.066 . . . . 0.0 109.333 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.3 t -90.18 102.62 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.94 127.61 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 162.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.4 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 29.9 p90 -135.46 1.79 2.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.396 -0.811 . . . . 0.0 112.341 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.47 -177.54 35.58 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 119.632 1.106 . . . . 0.0 112.612 172.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -150.27 153.11 35.59 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.071 1.348 . . . . 0.0 108.253 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' A' ' 22' ' ' PHE . 94.8 t -60.88 125.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.507 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 39.2 mtpt -82.21 -49.79 9.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 162.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -152.08 159.82 43.58 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.948 0.899 . . . . 0.0 111.668 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.94 24.74 61.28 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -54.96 -36.69 65.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.541 1.17 . . . . 0.0 110.704 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -62.18 -27.74 69.18 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.57 -39.91 47.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 CA-C-N 119.788 1.176 . . . . 0.0 108.828 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.98 -44.23 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.45 -29.15 70.21 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.349 -0.845 . . . . 0.0 112.586 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.05 64.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 120.587 -1.32 . . . . 0.0 109.604 173.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.3 mtp -57.62 -45.06 85.87 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.49 -32.79 73.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.469 1.108 . . . . 0.0 113.584 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -72.11 -22.57 61.32 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.538 1.517 . . . . 0.0 110.667 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -94.83 8.94 41.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.359 1.464 . . . . 0.0 111.652 170.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.54 -169.27 41.62 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 126.082 1.801 . . . . 0.0 109.083 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.3 p -156.94 159.21 37.87 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 160.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.4 mtm-85 -69.45 -16.16 63.42 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.228 -1.545 . . . . 0.0 114.516 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -71.94 -14.56 61.95 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.18 -0.95 . . . . 0.0 112.969 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.48 -20.11 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.878 2.18 . . . . 0.0 114.31 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -71.44 128.72 36.8 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.211 2.005 . . . . 0.0 108.104 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.49 ' CG2' HD12 ' A' ' 56' ' ' ILE . 13.1 p -67.62 159.34 30.12 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 110.99 167.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -70.71 -41.3 72.13 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 158.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -99.5 157.97 16.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 0.0 111.869 -168.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.532 ' HE3' HG21 ' A' ' 157' ' ' THR . 3.4 ttpt -69.49 123.78 22.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 158.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.1 mt -120.42 136.04 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.288 1.858 . . . . 0.0 107.924 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.532 HG21 ' HE3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -154.82 169.16 24.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.663 -158.492 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.407 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -104.83 113.39 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 163.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.71 -53.12 52.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -156.75 165.39 36.37 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.192 1.397 . . . . 0.0 108.897 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.8 p -178.51 165.16 1.72 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.553 1.541 . . . . 0.0 109.726 -168.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.58 -175.71 46.61 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.522 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 4.4 tp-100 -79.72 152.06 30.08 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.441 1.496 . . . . 0.0 109.879 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 40.0 mt -137.95 42.73 2.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 120.432 1.469 . . . . 0.0 111.77 159.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.522 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 2.7 tm-20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.956 2.502 . . . . 0.0 107.521 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--O 1.235 0.337 0 CA-C-O 116.508 -1.71 . . . . 0.0 108.619 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HA ' ' CG ' ' A' ' 165' ' ' GLU . 2.0 Cg_endo -57.99 140.06 92.61 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 CA-C-N 121.339 1.514 . . . . 0.0 110.063 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.485 ' CG2' ' HE3' ' A' ' 133' ' ' LYS . 76.1 m -106.0 144.47 32.67 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 165.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.47 134.11 17.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.645 ' HB3' HD11 ' A' ' 164' ' ' LEU . 13.7 p90 -94.59 157.87 15.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.903 0.881 . . . . 0.0 110.865 175.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -145.63 112.95 6.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.097 1.359 . . . . 0.0 107.799 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.26 97.55 6.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.6 mm -66.5 146.53 13.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.284 1.034 . . . . 0.0 109.152 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.13 168.89 18.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.647 1.179 . . . . 0.0 110.389 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 156' ' ' ILE . 2.4 t -131.2 109.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 57.04 13.92 1.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.754 1.622 . . . . 0.0 113.131 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.22 -5.71 31.94 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.63 1.586 . . . . 0.0 113.849 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -81.95 113.26 41.83 Favored Pre-proline 0 CA--C 1.52 -0.187 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.4 121.68 9.57 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.318 1.345 . . . . 0.0 110.241 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.8 tp -93.36 -25.56 17.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.675 0.79 . . . . 0.0 110.922 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.25 162.74 9.6 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.665 0.65 . . . . 0.0 112.034 168.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -79.26 142.21 36.39 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.77 158.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 128.008 2.523 . . . . 0.0 105.808 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -140.58 153.43 46.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.337 1.065 . . . . 0.0 109.137 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 93.2 m-85 -135.28 159.86 40.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.324 -175.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -110.57 145.26 38.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 167.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.3 128.99 50.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.296 1.438 . . . . 0.0 108.685 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.21 61.79 7.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.261 1.025 . . . . 0.0 112.984 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -9.95 25.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.017 -1.052 . . . . 0.0 113.554 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.36 -16.51 58.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.247 1.419 . . . . 0.0 112.138 171.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -47.89 1.07 Allowed 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 0.0 110.511 -166.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.37 78.38 45.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.374 1.47 . . . . 0.0 107.345 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.71 -45.8 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.371 2.047 . . . . 0.0 110.386 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -36.64 84.81 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.242 1.383 . . . . 0.0 109.191 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -69.52 -52.69 24.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.496 0.589 . . . . 0.0 109.805 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.59 91.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.304 0.642 . . . . 0.0 112.242 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.54 -51.32 70.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.259 1.423 . . . . 0.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.04 -49.06 74.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.892 1.277 . . . . 0.0 110.488 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.07 -40.12 94.21 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.345 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -52.85 -56.92 12.28 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.152 0.887 . . . . 0.0 109.476 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.8 48.86 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.412 1.485 . . . . 0.0 113.15 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.29 -32.46 38.13 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.761 0.824 . . . . 0.0 111.431 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 p -78.53 -38.25 40.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.383 0.992 . . . . 0.0 113.293 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -64.08 -31.06 72.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.49 11.71 72.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.98 -33.18 70.38 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.012 1.725 . . . . 0.0 110.716 -172.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -71.46 -4.88 28.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.33 1.052 . . . . 0.0 112.696 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.76 16.12 46.63 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.419 1.009 . . . . 0.0 112.104 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -169.96 175.32 5.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.938 1.695 . . . . 0.0 109.1 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.49 -142.29 13.62 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-O 121.925 0.736 . . . . 0.0 113.307 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.587 ' CE1' HD11 ' A' ' 158' ' ' ILE . 0.6 OUTLIER -63.31 -28.34 69.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.889 2.076 . . . . 0.0 110.997 -167.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.5 tttt -57.41 124.07 17.64 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.683 -0.636 . . . . 0.0 109.389 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 10.37 52.77 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.358 -1.245 . . . . 0.0 114.412 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.6 m -68.01 104.4 1.74 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.117 1.959 . . . . 0.0 106.071 165.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 155' ' ' LYS . 52.8 m -75.38 131.68 40.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -73.69 105.1 4.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.082 0.944 . . . . 0.0 109.068 -169.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -81.01 -32.68 34.09 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.093 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -127.79 86.73 2.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.134 0.879 . . . . 0.0 108.833 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.416 HD12 ' CG2' ' A' ' 152' ' ' THR . 74.3 mt -104.45 109.53 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.32 99.73 52.75 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.98 144.36 99.48 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.551 1.501 . . . . 0.0 112.448 -172.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.87 31.43 61.11 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 126.539 2.018 . . . . 0.0 112.168 -168.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -142.4 -79.93 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.487 1.644 . . . . 0.0 108.545 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 165.15 25.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.798 0.839 . . . . 0.0 110.635 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.0 m -127.1 92.46 3.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.696 1.998 . . . . 0.0 108.77 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.04 132.3 42.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.964 1.306 . . . . 0.0 110.572 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.19 -169.48 11.89 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.074 1.797 . . . . 0.0 108.964 168.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.27 5.49 89.57 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.632 -0.922 . . . . 0.0 114.432 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.97 92.51 7.85 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 166.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -106.24 -5.84 18.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.509 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.6 p -122.29 -24.63 5.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.595 1.558 . . . . 0.0 111.551 -173.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -124.88 179.47 5.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 158.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.8 72.01 0.5 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 169.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.416 ' H ' ' H ' ' A' ' 72' ' ' GLY . 12.6 p30 -168.79 -10.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.886 2.474 . . . . 0.0 111.235 -172.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 71' ' ' ASN . . . 111.41 -6.4 28.34 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.069 -1.406 . . . . 0.0 112.85 169.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.3 p -84.09 -24.33 30.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.741 1.77 . . . . 0.0 112.933 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.92 -135.3 8.09 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 122.515 1.064 . . . . 0.0 114.772 -159.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.11 168.37 4.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.67 1.605 . . . . 0.0 111.776 -162.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -169.59 149.09 3.83 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.1 p -70.56 164.57 24.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.6 pt -56.88 -29.61 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 110.267 162.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -79.25 6.35 10.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.466 1.506 . . . . 0.0 112.584 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.16 -53.76 0.75 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.192 1.36 . . . . 0.0 113.064 166.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -147.72 -139.26 0.1 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -161.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -75.97 166.57 23.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.314 0.961 . . . . 0.0 108.897 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -142.22 177.8 7.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.11 148.19 51.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.192 0.996 . . . . 0.0 113.204 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.477 ' HA ' HD21 ' A' ' 108' ' ' ASN . 1.0 OUTLIER -71.96 73.95 0.89 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.897 2.479 . . . . 0.0 108.01 161.067 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.82 -59.85 3.99 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.255 1.822 . . . . 0.0 112.659 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.48 172.84 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.303 159.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.27 26.44 7.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.264 2.225 . . . . 0.0 110.797 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 mt -57.56 -48.23 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 120.927 -1.108 . . . . 0.0 110.182 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.68 123.72 23.85 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -103.26 165.26 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.072 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -77.91 75.81 4.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.076 1.351 . . . . 0.0 109.581 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -66.01 -27.54 68.2 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.42 -177.35 45.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.95 0.795 . . . . 0.0 111.751 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -59.23 147.14 92.13 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.868 1.712 . . . . 0.0 109.7 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.91 70.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.432 -1.205 . . . . 0.0 112.362 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.67 163.56 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 120.446 2.123 . . . . 0.0 108.9 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.14 127.96 37.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.033 1.333 . . . . 0.0 109.205 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.6 t -140.94 164.24 30.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.773 0.797 . . . . 0.0 110.49 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.99 140.54 29.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 -167.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.08 57.12 1.45 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.68 1.228 . . . . 0.0 108.614 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -61.35 170.51 1.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.951 158.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.23 13.94 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.62 1.168 . . . . 0.0 111.713 -169.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.27 -171.92 27.01 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -160.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -60.6 157.02 38.92 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.145 1.897 . . . . 0.0 110.037 171.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER 34.56 47.27 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.17 2.588 . . . . 0.0 113.716 173.775 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 p -124.19 22.38 8.65 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.811 0.844 . . . . 0.0 111.599 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 85' ' ' ASP . 91.1 m-20 -64.52 122.82 17.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.043 1.737 . . . . 0.0 108.762 173.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.49 -97.2 0.57 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.1 p -134.33 -23.77 1.65 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.079 0.952 . . . . 0.0 112.248 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -62.02 135.01 57.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -141.83 176.19 9.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -139.69 152.27 46.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 109.857 162.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.8 mt -83.17 122.98 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 163.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.3 m -68.5 113.61 6.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 167.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.2 p -108.36 30.68 6.21 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.51 173.51 14.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.814 1.645 . . . . 0.0 107.649 165.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.86 89.82 0.28 Allowed 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 162.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.29 53.75 0.53 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.387 1.475 . . . . 0.0 110.276 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -64.67 -21.74 66.81 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 119.921 -1.737 . . . . 0.0 112.39 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -73.31 -2.22 21.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.532 1.133 . . . . 0.0 111.969 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -115.42 -5.42 12.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.234 1.414 . . . . 0.0 111.528 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.82 142.44 57.94 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.061 0.846 . . . . 0.0 111.45 -172.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.57 12.61 61.84 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.268 -1.296 . . . . 0.0 113.709 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.37 -24.06 1.42 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.2 2.0 . . . . 0.0 113.34 -169.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -125.19 140.96 52.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.961 0.904 . . . . 0.0 110.085 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 63.2 t -78.89 101.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -171.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.51 123.49 16.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 164.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.02 -1.45 2.66 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.4 -173.04 27.33 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 119.296 0.953 . . . . 0.0 111.727 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -154.28 145.25 22.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.031 1.332 . . . . 0.0 108.729 -172.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.43 115.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 161.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.485 ' HE3' ' CG2' ' A' ' 5' ' ' THR . 12.4 ttmm -74.12 -54.38 7.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -153.98 167.09 30.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.322 2.249 . . . . 0.0 109.242 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.33 69.47 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.517 -0.739 . . . . 0.0 112.733 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.6 tpt -55.87 -35.51 66.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.633 1.217 . . . . 0.0 110.9 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -62.92 -31.31 72.36 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.829 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.74 -39.73 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.53 -37.37 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.686 -0.634 . . . . 0.0 109.942 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.487 ' CD ' HH21 ' A' ' 144' ' ' ARG . 3.1 mm-40 -57.86 -42.96 85.59 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 110.529 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.19 95.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.881 0.764 . . . . 0.0 109.027 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.8 mtm -54.94 -44.85 74.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.228 0.211 . . . . 0.0 110.987 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.42 -37.46 75.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.487 HH21 ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -66.4 -24.82 66.53 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.828 1.195 . . . . 0.0 110.35 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.569 ' CB ' HD11 ' A' ' 156' ' ' ILE . 41.3 m-85 -91.03 10.81 25.15 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.475 1.11 . . . . 0.0 112.017 174.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.67 -153.44 6.04 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.855 1.207 . . . . 0.0 111.502 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.5 p -141.62 -86.51 0.17 Allowed 'General case' 0 C--O 1.223 -0.306 0 O-C-N 122.044 -0.68 . . . . 0.0 110.081 160.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 178.14 -17.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 129.798 3.239 . . . . 0.0 110.343 161.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -68.35 -27.06 65.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.001 0.818 . . . . 0.0 110.013 158.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 123.25 -35.3 3.39 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-O 118.606 -1.108 . . . . 0.0 111.748 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -65.13 124.36 21.92 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.391 1.096 . . . . 0.0 108.195 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.416 ' CG2' HD12 ' A' ' 56' ' ' ILE . 18.0 p -64.25 154.04 36.27 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 110.261 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.0 p -68.41 -26.79 65.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.296 0.639 . . . . 0.0 110.789 167.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.489 ' HE2' HG12 ' A' ' 12' ' ' VAL . 30.3 mtpt -132.98 169.76 16.34 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.415 1.086 . . . . 0.0 111.093 -177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.449 ' HE2' ' SG ' ' A' ' 52' ' ' CYS . 75.8 tttt -83.89 84.85 7.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 121.089 1.768 . . . . 0.0 109.677 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.569 HD11 ' CB ' ' A' ' 145' ' ' PHE . 27.0 mm -73.79 126.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.34 163.52 32.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.346 1.069 . . . . 0.0 110.969 -163.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -94.98 115.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 159.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.97 13.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.401 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 1.4 t70 -148.62 163.26 37.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.086 0.554 . . . . 0.0 109.65 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.8 p -167.91 167.9 12.52 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.278 0.631 . . . . 0.0 111.933 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.16 178.52 42.44 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.3 tp60 -76.24 147.02 38.61 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.829 1.652 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 7' ' ' PHE . 12.9 mt -137.87 43.3 2.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.235 1.014 . . . . 0.0 112.455 162.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 19.7 mt-10 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 123.887 0.875 . . . . 0.0 110.913 168.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.56 137.93 48.08 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.415 1.41 . . . . 0.0 110.301 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 88.2 m -95.14 147.33 23.55 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.08 153.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.689 1.195 . . . . 0.0 107.864 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -128.55 157.3 41.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.432 1.093 . . . . 0.0 109.792 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.425 ' CE1' ' CD2' ' A' ' 48' ' ' TYR . 68.9 m-85 -147.81 120.13 8.4 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.056 1.342 . . . . 0.0 107.714 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -85.41 95.53 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.1 mm -71.29 135.84 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.59 163.27 18.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.403 1.881 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG12 ' HE2' ' A' ' 154' ' ' LYS . 3.8 t -138.06 95.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -173.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 57.32 13.94 1.94 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.005 1.722 . . . . 0.0 112.963 -169.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.9 -9.13 29.64 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.958 1.742 . . . . 0.0 113.116 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -77.04 125.5 86.72 Favored Pre-proline 0 CA--C 1.518 -0.282 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.29 113.44 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 120.91 1.074 . . . . 0.0 109.495 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.25 -35.23 23.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.305 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 163.31 10.08 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 167.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -80.28 146.35 31.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.52 154.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.3 2.64 . . . . 0.0 105.419 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -144.99 152.03 39.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.493 1.139 . . . . 0.0 109.904 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CE2' HG22 ' A' ' 132' ' ' VAL . 55.8 m-85 -136.45 153.31 51.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.344 1.458 . . . . 0.0 108.406 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -97.25 146.06 25.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.455 1.902 . . . . 0.0 107.111 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.45 129.35 53.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.395 1.478 . . . . 0.0 107.529 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.61 57.11 1.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.842 1.657 . . . . 0.0 111.812 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.11 60.95 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.247 -1.533 . . . . 0.0 113.429 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -62.29 -53.35 56.41 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.875 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.24 -49.37 8.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.857 0.863 . . . . 0.0 110.541 -169.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 m -127.11 68.37 72.08 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.235 2.214 . . . . 0.0 108.737 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.48 -36.25 98.74 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.536 2.157 . . . . 0.0 112.579 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -52.6 56.73 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.716 1.144 . . . . 0.0 109.191 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 m -64.83 -39.45 93.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.46 0.704 . . . . 0.0 110.102 -174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.21 69.37 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.435 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.56 -43.08 97.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.488 1.115 . . . . 0.0 110.881 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -50.68 -60.02 3.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.365 1.466 . . . . 0.0 109.066 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -65.43 -26.46 67.97 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HG3' HE22 ' A' ' 163' ' ' GLN . 43.1 ttp85 -60.58 -61.72 2.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.447 1.099 . . . . 0.0 109.858 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.09 69.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.74 0.65 . . . . 0.0 111.823 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -71.4 -37.06 71.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.782 -0.574 . . . . 0.0 111.063 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.5 m -70.08 -36.69 75.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.476 0.71 . . . . 0.0 110.86 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -79.6 -18.44 51.61 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.752 0.421 . . . . 0.0 111.378 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.5 7.15 72.74 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 120.554 -1.342 . . . . 0.0 111.518 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.96 4.04 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.774 1.629 . . . . 0.0 113.808 -163.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -116.94 12.65 14.73 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.332 1.453 . . . . 0.0 111.216 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.08 84.66 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.396 0.522 . . . . 0.0 112.305 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -156.93 171.99 19.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.72 39.13 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 116.99 -2.529 . . . . 0.0 114.464 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 8' ' ' PHE . 1.1 t80 -65.64 -27.07 68.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.454 2.301 . . . . 0.0 109.38 175.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -52.21 136.95 29.41 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.827 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 -0.12 46.44 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.671 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -68.74 119.36 13.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.739 2.27 . . . . 0.0 107.561 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.7 t -72.33 137.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.33 104.61 5.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -74.07 -21.51 59.89 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.41 116.72 11.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.494 HD12 HG22 ' A' ' 152' ' ' THR . 38.7 mt -133.44 115.88 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.93 100.7 39.91 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.32 134.25 60.3 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.872 2.381 . . . . 0.0 111.761 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.67 32.61 83.62 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.131 1.824 . . . . 0.0 112.006 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -150.89 -74.02 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.427 1.113 . . . . 0.0 109.307 -172.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.83 167.01 31.75 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.0 m -128.13 100.25 5.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.35 1.86 . . . . 0.0 108.501 166.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -93.07 131.67 37.88 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.136 1.775 . . . . 0.0 109.437 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.99 50.73 0.22 Allowed Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.286 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.99 12.54 24.5 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 118.148 0.974 . . . . 0.0 111.773 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -85.22 23.37 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.479 1.912 . . . . 0.0 113.458 -167.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CD1' HG23 ' A' ' 68' ' ' THR . 11.2 p90 -41.16 -2.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 1 C-N-CA 132.563 4.345 . . . . 0.0 118.754 -176.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.449 HG23 ' CD1' ' A' ' 67' ' ' PHE . 12.1 p -126.39 -49.49 1.54 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.969 2.508 . . . . 0.0 112.144 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 -128.21 89.1 2.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -84.24 61.43 6.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.747 3.219 . . . . 0.0 107.751 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -173.45 -22.94 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 129.235 3.014 . . . . 0.0 107.966 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.24 43.62 2.16 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 126.852 2.168 . . . . 0.0 111.436 161.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.3 p -110.96 39.01 2.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 159.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.06 -174.59 14.97 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 122.548 1.082 . . . . 0.0 112.747 -161.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.33 75.75 0.41 Allowed Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 113.069 -1.566 . . . . 0.0 111.493 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' H ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -65.75 165.87 11.97 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 111.617 -2.291 . . . . 0.0 108.75 158.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.0 p -84.16 177.91 8.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.766 0.793 . . . . 0.0 109.2 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.7 pt -70.03 -27.25 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.994 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -84.86 -21.15 29.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.141 0.976 . . . . 0.0 111.521 -169.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.57 -99.42 0.19 Allowed Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 105.023 -3.231 . . . . 0.0 105.023 -164.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.13 -157.61 0.81 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.208 1.004 . . . . 0.0 109.745 172.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 82' ' ' LYS . 4.5 pttp -63.76 142.16 58.5 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.75 2.82 . . . . 0.0 110.107 -159.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -120.15 177.12 5.13 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.38 1.472 . . . . 0.0 108.923 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.58 163.41 27.37 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.24 87.65 0.82 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 108.988 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -46.38 -53.86 10.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.955 1.302 . . . . 0.0 112.248 -163.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.402 ' C ' HD22 ' A' ' 87' ' ' ASN . 0.1 OUTLIER -161.26 169.62 21.82 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.752 0.421 . . . . 0.0 110.222 158.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.79 13.74 16.18 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.757 1.223 . . . . 0.0 112.91 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 mt -53.22 -40.96 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.621 0.768 . . . . 0.0 109.899 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.77 121.03 29.69 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -110.82 170.18 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 109.433 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -74.18 87.04 1.92 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.742 0.817 . . . . 0.0 109.021 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.4 p -73.77 -11.1 60.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.623 0.769 . . . . 0.0 112.113 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.78 -169.79 38.87 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.011 -1.056 . . . . 0.0 111.708 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.95 158.63 32.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.527 1.485 . . . . 0.0 110.68 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.15 85.13 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 117.927 -1.485 . . . . 0.0 112.248 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -79.35 168.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.185 1.993 . . . . 0.0 108.564 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.68 133.47 27.22 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.319 1.448 . . . . 0.0 109.509 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 t -150.19 158.4 44.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.812 0.445 . . . . 0.0 111.346 -167.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.7 mtp -80.8 122.37 27.1 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.828 0.851 . . . . 0.0 111.203 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.586 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -75.27 61.47 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.645 1.578 . . . . 0.0 109.161 161.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -65.98 -178.18 0.57 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.43 1.11 . . . . 0.0 108.329 159.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.44 14.41 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.206 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.22 -157.45 23.89 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -66.81 148.63 82.86 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.179 1.92 . . . . 0.0 109.634 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 34.21 57.27 0.64 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.449 3.1 . . . . 0.0 111.353 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.5 p -131.88 26.4 4.63 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 109.871 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -75.0 88.74 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.293 1.837 . . . . 0.0 106.947 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.45 -92.44 1.9 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -174.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.8 p -151.01 -13.12 0.22 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 167.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.8 137.71 57.57 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.586 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -143.81 170.92 14.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.749 1.22 . . . . 0.0 108.299 -167.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 31.5 p90 -141.77 154.58 45.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.397 0.679 . . . . 0.0 110.325 158.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.51 125.02 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 161.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 16.5 m -70.91 117.56 12.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 167.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 p -108.7 26.5 10.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.662 0.785 . . . . 0.0 109.576 170.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.38 172.11 17.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -65.52 88.45 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 163.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.416 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 1.1 p -80.48 63.42 4.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.058 1.409 . . . . 0.0 109.663 -173.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -69.85 -10.43 58.45 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.802 1.641 . . . . 0.0 112.794 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.416 ' CZ2' HG22 ' A' ' 119' ' ' THR . 13.4 p90 -84.78 -11.0 56.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 168.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.461 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 49.5 mt -107.87 -8.63 15.92 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 110.913 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.48 146.82 33.93 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.67 1.188 . . . . 0.0 110.503 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.24 0.91 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.192 0.901 . . . . 0.0 114.829 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -93.68 -50.14 5.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 107.876 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.23 132.08 53.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.62 0.768 . . . . 0.0 109.478 -165.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.45 106.95 16.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 126.071 1.748 . . . . 0.0 106.607 -169.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.49 126.81 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 172.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -137.76 -0.4 2.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.59 -178.43 35.51 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 119.443 1.019 . . . . 0.0 112.844 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -150.02 156.12 41.13 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.665 0.786 . . . . 0.0 110.315 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.481 HG22 ' CE2' ' A' ' 22' ' ' PHE . 46.4 t -65.83 118.88 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.403 ' CE ' HG23 ' A' ' 5' ' ' THR . 3.6 mtmp? -78.71 -47.38 17.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.583 -0.698 . . . . 0.0 109.248 163.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -141.98 139.64 32.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.81 1.244 . . . . 0.0 108.654 -158.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.51 25.13 40.21 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.285 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.2 tpt -52.95 -37.26 60.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.261 2.03 . . . . 0.0 110.992 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -64.81 -29.09 70.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.214 0.915 . . . . 0.0 113.091 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.05 -45.94 85.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.42 -39.54 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -67.6 -28.19 67.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.801 -1.187 . . . . 0.0 112.543 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -43.11 60.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.919 1.288 . . . . 0.0 109.4 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.7 mtp -53.12 -42.45 66.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.693 0.797 . . . . 0.0 109.974 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.82 -33.34 75.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.735 1.614 . . . . 0.0 114.477 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -62.52 -30.77 71.53 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 120.342 1.428 . . . . 0.0 109.019 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 156' ' ' ILE . 32.5 m-85 -91.64 18.76 7.06 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.795 1.238 . . . . 0.0 111.617 175.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.24 -168.76 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 p -152.8 155.42 37.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -64.69 -23.16 67.17 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.27 -1.519 . . . . 0.0 113.125 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.06 8.82 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.201 1.0 . . . . 0.0 112.753 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.88 18.27 66.24 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 126.355 1.931 . . . . 0.0 113.949 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -87.49 144.66 26.61 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 120.706 2.253 . . . . 0.0 109.927 158.807 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.494 HG22 HD12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -69.13 153.5 43.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.901 0.88 . . . . 0.0 109.349 162.397 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 p -105.2 -13.85 15.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.035 1.334 . . . . 0.0 111.355 164.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HE2' HG12 ' A' ' 12' ' ' VAL . 22.3 mtpt -135.0 156.11 49.6 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.834 1.254 . . . . 0.0 109.694 169.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -77.14 85.46 3.62 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.445 -0.784 . . . . 0.0 109.488 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.475 HD11 ' HB2' ' A' ' 145' ' ' PHE . 1.8 mp -72.89 120.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.77 149.72 50.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.524 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.421 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -81.48 104.65 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 163.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.58 -53.29 19.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.63 164.72 31.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 7.8 p -172.91 170.45 4.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.421 0.688 . . . . 0.0 111.97 -171.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.9 -162.39 33.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.506 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 8.3 tp60 -87.77 154.23 20.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.829 1.651 . . . . 0.0 110.178 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.38 42.79 2.84 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.081 1.309 . . . . 0.0 109.535 158.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.506 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 15.4 tp10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.159 1.784 . . . . 0.0 109.342 168.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.43 132.59 51.64 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.201 1.934 . . . . 0.0 109.359 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -93.94 152.5 18.81 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.86 142.93 29.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.489 1.515 . . . . 0.0 107.227 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.44 159.3 20.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.32 1.048 . . . . 0.0 110.122 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -148.28 114.17 5.76 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.085 1.354 . . . . 0.0 108.522 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.23 97.93 5.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 165.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.62 144.6 13.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.56 139.07 43.62 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.405 1.082 . . . . 0.0 108.741 171.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.495 HG12 ' HE2' ' A' ' 154' ' ' LYS . 5.6 t -103.11 114.57 43.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.35 13.82 2.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.922 0.889 . . . . 0.0 113.149 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.23 56.04 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.193 . . . . 0.0 113.386 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -74.79 121.53 85.47 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.85 112.87 1.94 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.694 1.596 . . . . 0.0 110.084 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -78.33 -37.2 45.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.17 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.32 169.9 14.51 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -84.86 142.64 29.59 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.483 0.659 . . . . 0.0 109.971 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.2 t -122.79 160.95 24.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 128.94 2.896 . . . . 0.0 105.982 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -148.7 158.46 44.16 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 164.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 63.6 m-85 -136.74 155.75 49.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.237 1.415 . . . . 0.0 108.391 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -108.22 134.37 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -111.54 120.67 42.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -69.04 59.11 0.1 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.571 1.949 . . . . 0.0 112.836 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.88 43.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 112.59 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -23.29 59.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.307 0.503 . . . . 0.0 111.296 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -113.6 -30.14 6.92 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.645 0.778 . . . . 0.0 112.241 -169.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.44 73.17 11.8 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.037 1.735 . . . . 0.0 107.946 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 -45.42 14.73 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.142 1.895 . . . . 0.0 112.805 -167.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.51 -53.37 58.95 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.029 1.286 . . . . 0.0 109.331 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -44.82 79.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.547 1.139 . . . . 0.0 111.243 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.56 65.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.66 0.784 . . . . 0.0 111.953 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -63.98 -40.72 97.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.792 0.837 . . . . 0.0 111.376 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -58.58 2.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.672 1.589 . . . . 0.0 108.96 167.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.99 -39.68 90.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.046 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -53.14 -58.24 7.69 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.098 1.359 . . . . 0.0 109.243 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -21.35 64.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.185 1.394 . . . . 0.0 113.77 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -89.79 -23.97 21.6 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.878 0.871 . . . . 0.0 111.389 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 m -83.4 -37.77 22.82 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.009 1.324 . . . . 0.0 110.779 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 p -67.05 -32.5 73.73 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.422 0.689 . . . . 0.0 109.823 170.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.73 14.81 81.08 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.089 0.852 . . . . 0.0 111.087 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.26 -21.8 66.78 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.572 1.186 . . . . 0.0 112.755 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -80.26 0.25 33.5 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 111.852 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 9.74 86.49 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.778 1.18 . . . . 0.0 112.437 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -156.6 179.04 9.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.499 1.52 . . . . 0.0 108.889 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.35 -142.54 13.86 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 121.723 0.624 . . . . 0.0 112.696 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CE1' HD11 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -70.77 -27.22 63.76 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.435 1.894 . . . . 0.0 110.873 -160.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.0 tttt -64.88 124.12 21.17 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.87 7.08 69.22 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.958 -1.468 . . . . 0.0 112.87 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -67.36 129.49 40.08 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 120.423 2.111 . . . . 0.0 106.244 167.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -76.12 161.7 28.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 163.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.95 114.1 28.11 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -79.2 -49.09 13.08 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.34 128.12 44.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.4 mm -137.2 106.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.2 mt -114.91 93.32 33.89 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.1 117.89 4.02 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.602 2.868 . . . . 0.0 112.006 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.09 14.67 57.32 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.659 1.123 . . . . 0.0 112.952 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.439 ' CD1' ' HG3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -133.11 -72.89 0.5 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.569 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.439 ' HG3' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -166.05 157.74 13.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.1 m -100.64 139.5 36.23 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.96 1.704 . . . . 0.0 108.426 160.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -135.06 122.21 21.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.567 1.531 . . . . 0.0 109.087 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.99 16.85 1.95 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.638 -0.535 . . . . 0.0 114.212 -161.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.72 11.02 53.22 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.053 0.927 . . . . 0.0 114.249 -168.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.72 97.8 9.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 166.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -100.97 -1.03 35.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 p -140.03 -51.68 0.5 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -83.84 -23.85 31.19 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.443 -0.786 . . . . 0.0 112.324 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.0 m170 59.95 31.81 20.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.905 1.682 . . . . 0.0 112.977 169.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -154.07 2.95 0.25 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.91 17.94 4.87 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.141 1.337 . . . . 0.0 113.942 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.4 p -139.33 10.19 2.52 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.229 1.015 . . . . 0.0 112.017 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.97 155.92 49.87 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 120.791 -1.193 . . . . 0.0 113.497 -163.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.9 -156.68 49.54 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 113.56 -1.32 . . . . 0.0 111.582 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.67 160.83 10.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.989 2.116 . . . . 0.0 107.685 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.7 p -71.45 23.16 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.475 1.91 . . . . 0.0 114.605 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.288 1.2 pp 46.29 -19.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 1 C-N-CA 132.234 4.214 . . . . 0.0 117.046 -159.04 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -92.65 -22.22 19.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 119.884 1.22 . . . . 0.0 112.748 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.56 101.07 0.26 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.342 14.5 tt0 41.23 -132.8 0.35 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.291 1.036 . . . . 0.0 111.901 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -88.78 149.06 23.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.831 1.252 . . . . 0.0 109.776 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -117.48 -176.74 3.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.985 1.714 . . . . 0.0 108.274 170.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -81.34 166.02 20.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.069 1.304 . . . . 0.0 114.122 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.37 87.68 3.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 107.582 -172.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -40.13 -64.37 0.51 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.985 2.114 . . . . 0.0 111.586 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.45 156.38 1.53 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.299 0.639 . . . . 0.0 110.844 174.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -111.75 30.29 7.12 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.726 1.61 . . . . 0.0 110.054 -171.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.86 -55.23 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.618 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.71 135.82 35.49 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.78 1.632 . . . . 0.0 107.188 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -122.88 167.2 13.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.667 1.587 . . . . 0.0 109.868 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -84.15 60.31 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.344 1.457 . . . . 0.0 110.849 -162.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 p -62.39 -29.46 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -158.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.4 -179.08 48.71 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 119.232 0.924 . . . . 0.0 112.094 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.11 153.08 54.67 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.411 2.074 . . . . 0.0 110.426 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.59 1.61 71.98 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 117.782 -1.566 . . . . 0.0 112.971 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.16 163.19 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.79 2.295 . . . . 0.0 107.824 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.32 131.07 39.71 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.744 1.218 . . . . 0.0 109.487 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -138.15 158.38 44.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 109.365 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 6.6 ptm -88.13 151.26 22.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.522 0.677 . . . . 0.0 110.913 -173.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.09 59.22 0.83 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.347 1.059 . . . . 0.0 109.134 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -57.79 161.2 3.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.748 163.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.82 19.84 1.14 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.661 2.384 . . . . 0.0 111.904 -166.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.05 176.79 25.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.16 1.362 . . . . 0.0 110.481 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.6 138.77 71.94 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 119.848 1.824 . . . . 0.0 109.664 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.4 55.81 5.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.944 2.098 . . . . 0.0 109.977 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -112.19 23.36 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.592 -1.317 . . . . 0.0 111.305 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.34 91.38 1.33 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 107.472 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.76 -142.83 11.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p -84.0 -15.65 46.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.859 0.863 . . . . 0.0 112.782 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.03 138.91 57.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.41 0.684 . . . . 0.0 109.619 -164.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 12.7 p90 -149.87 167.67 25.93 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.456 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 36.3 p90 -141.01 148.42 40.26 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 124.386 1.054 . . . . 0.0 109.315 162.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -83.69 116.46 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.3 m -64.16 130.85 45.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -118.22 23.94 11.28 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.466 1.106 . . . . 0.0 109.046 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.63 179.49 9.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.998 0.919 . . . . 0.0 108.577 163.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 82.1 tttt -67.83 92.1 0.34 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 160.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.5 p -83.47 58.6 4.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.75 0.705 . . . . 0.0 110.153 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 15.6 pt-20 -74.01 -8.01 54.53 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.182 -1.574 . . . . 0.0 113.767 -171.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -66.37 -10.3 42.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.397 -0.814 . . . . 0.0 110.846 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.456 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 53.4 mt -107.53 0.46 22.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.379 1.872 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 127.27 32.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.974 0.806 . . . . 0.0 112.443 -162.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.82 3.23 20.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.222 0.915 . . . . 0.0 113.22 -168.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -93.9 -53.51 3.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -99.97 157.18 16.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.583 0.753 . . . . 0.0 110.619 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t -98.71 101.68 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.35 128.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -142.46 0.06 1.27 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.77 176.38 29.35 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 119.526 1.057 . . . . 0.0 111.639 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -146.43 155.59 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 22' ' ' PHE . 49.2 t -64.81 123.8 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 2.8 ttpt -86.76 -41.98 13.69 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.868 0.867 . . . . 0.0 109.297 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.54 160.16 43.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.663 0.385 . . . . 0.0 111.065 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.6 36.1 82.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.075 0.845 . . . . 0.0 111.91 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -45.42 78.35 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.704 1.252 . . . . 0.0 108.28 171.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.61 -26.54 61.7 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.1 mm -76.8 -36.96 27.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-N 118.784 0.72 . . . . 0.0 109.143 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.02 -47.27 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.303 0.956 . . . . 0.0 108.759 170.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.55 68.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.188 0.995 . . . . 0.0 111.507 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.48 -42.61 52.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 120.952 -1.093 . . . . 0.0 109.833 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 44.3 mtm -55.65 -48.85 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 118.444 0.565 . . . . 0.0 109.542 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.64 -39.85 71.42 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.948 1.699 . . . . 0.0 111.249 176.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -67.84 -18.04 64.7 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.594 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -94.92 -1.21 53.03 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.557 1.072 . . . . 0.0 112.178 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.32 -163.3 39.24 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 120.871 1.669 . . . . 0.0 112.199 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.3 p -152.14 154.97 36.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -66.73 -20.59 66.0 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.154 -1.591 . . . . 0.0 112.877 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.64 9.16 4.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.428 1.091 . . . . 0.0 112.878 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.51 -28.87 7.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 126.128 1.823 . . . . 0.0 113.65 167.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -69.86 145.16 52.25 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 120.445 2.122 . . . . 0.0 110.91 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.2 p -64.05 145.86 55.16 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.873 1.669 . . . . 0.0 111.425 159.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.4 p -75.92 -43.83 43.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.357 0.663 . . . . 0.0 109.653 158.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.495 ' HE2' HG12 ' A' ' 12' ' ' VAL . 29.8 mtpt -124.47 162.73 23.32 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.43 1.492 . . . . 0.0 110.931 -174.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.61 88.28 2.17 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.128 -0.983 . . . . 0.0 110.358 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.49 124.88 31.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 p -146.09 165.67 28.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.699 0.761 . . . . 0.0 111.453 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.426 HD11 ' CE1' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -89.83 127.33 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 159.005 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.54 -46.68 8.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.613 0.642 . . . . 0.0 109.734 168.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.429 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -147.38 158.51 44.0 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -172.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -172.56 172.46 4.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.098 0.959 . . . . 0.0 113.096 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.35 -178.4 46.19 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.199 1.381 . . . . 0.0 109.906 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -78.83 149.09 32.62 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 110.511 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.7 mt -128.68 43.29 3.17 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.954 0.902 . . . . 0.0 109.419 159.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.252 1.199 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.217 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--O 1.238 0.472 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.774 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 17.9 Cg_endo -64.57 147.66 90.28 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 N-CA-C 107.551 -1.75 . . . . 0.0 107.551 174.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 m -110.51 150.48 28.85 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.92 160.96 29.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.746 0.818 . . . . 0.0 108.841 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -124.95 159.16 31.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.364 1.466 . . . . 0.0 109.998 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -146.56 107.82 4.23 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.69 2.396 . . . . 0.0 106.846 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.01 101.44 3.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.46 134.66 29.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.46 141.4 47.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.84 0.856 . . . . 0.0 109.008 164.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.2 t -96.32 91.28 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 163.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.279 1.3 p30 62.54 14.18 6.84 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.58 -9.64 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 117.442 -1.755 . . . . 0.0 111.406 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -70.48 124.88 91.66 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 162.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.0 117.75 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 N-CA-C 107.261 -1.861 . . . . 0.0 107.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp -88.73 -35.26 16.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.567 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 147.0 161.56 9.43 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -74.59 146.91 42.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.659 0.743 . . . . 0.0 109.233 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.01 151.85 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 128.114 2.566 . . . . 0.0 104.609 171.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 134' ' ' GLU . 21.5 m -146.48 146.65 30.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.212 1.006 . . . . 0.0 109.76 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -120.23 156.61 30.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.956 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -95.74 151.25 19.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 158.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -127.31 121.38 30.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -75.2 51.49 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.936 2.094 . . . . 0.0 112.754 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.26 28.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.963 -1.085 . . . . 0.0 113.365 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.09 -26.52 60.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.124 0.874 . . . . 0.0 111.714 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -111.99 -34.04 6.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.526 1.13 . . . . 0.0 111.635 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.08 71.6 68.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.449 1.9 . . . . 0.0 109.037 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.65 -44.2 27.9 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.593 2.195 . . . . 0.0 113.844 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -49.4 77.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.203 1.365 . . . . 0.0 109.592 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -62.45 -48.39 79.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.854 0.862 . . . . 0.0 109.28 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.66 -48.57 81.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.62 0.768 . . . . 0.0 111.468 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -46.01 91.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.725 1.21 . . . . 0.0 111.688 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -57.28 -51.09 70.79 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.106 0.962 . . . . 0.0 108.609 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.28 -31.68 72.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.523 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 18.3 ttm105 -55.65 -56.81 16.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.963 1.256 . . . . 0.0 108.938 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.23 49.1 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.673 1.189 . . . . 0.0 111.16 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.33 -29.4 69.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.31 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 m -75.17 -10.23 59.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.236 1.414 . . . . 0.0 112.104 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.8 p -112.43 -29.61 7.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.411 0.684 . . . . 0.0 111.725 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.14 82.67 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.356 -0.691 . . . . 0.0 113.56 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -28.81 64.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.499 1.92 . . . . 0.0 113.503 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.59 2.49 1.8 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.519 0.728 . . . . 0.0 112.848 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.48 62.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.871 1.224 . . . . 0.0 111.397 -170.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.35 172.82 12.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.59 2.356 . . . . 0.0 106.728 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.54 -177.18 23.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.639 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 2.3 t80 -81.67 -6.59 59.16 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.881 2.072 . . . . 0.0 112.247 -163.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -59.59 117.87 5.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.2 -0.938 . . . . 0.0 108.588 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.49 5.65 87.96 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 116.92 -2.044 . . . . 0.0 115.766 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.6 m -71.26 -65.77 0.7 Allowed 'General case' 0 C--N 1.342 0.256 0 CA-C-N 121.638 2.719 . . . . 0.0 112.322 -163.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.6 t 130.14 144.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.184 3.793 . . . . 0.0 109.659 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.03 92.03 6.65 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.043 2.137 . . . . 0.0 106.823 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.453 ' CD2' ' H ' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -77.07 -18.4 58.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -164.625 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -140.02 78.25 1.65 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.161 1.346 . . . . 0.0 111.64 -167.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.51 106.34 18.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.805 1.642 . . . . 0.0 107.008 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.6 91.41 12.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.31 120.84 7.4 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.843 3.029 . . . . 0.0 113.114 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.47 11.52 60.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.839 1.685 . . . . 0.0 113.253 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -133.94 -79.61 0.46 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.936 1.294 . . . . 0.0 108.802 -170.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.69 167.95 28.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.799 0.84 . . . . 0.0 110.713 172.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -132.38 98.15 4.3 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.91 1.684 . . . . 0.0 109.04 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.7 146.79 44.18 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.426 1.09 . . . . 0.0 109.985 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.98 -173.64 25.68 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 125.719 1.628 . . . . 0.0 109.88 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.84 -13.23 41.78 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.326 1.441 . . . . 0.0 113.324 170.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -84.07 95.09 8.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.892 0.846 . . . . 0.0 110.709 -167.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CD2' HG23 ' A' ' 68' ' ' THR . 49.8 p90 -95.08 3.5 54.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.178 -176.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 67' ' ' PHE . 50.0 p -137.16 -45.95 0.57 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.893 1.224 . . . . 0.0 113.248 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -88.34 -27.05 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.79 -0.569 . . . . 0.0 111.472 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 54.25 12.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.953 2.901 . . . . 0.0 114.595 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -117.86 -8.04 10.86 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.188 0.995 . . . . 0.0 112.868 -170.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 -3.36 27.36 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.439 -1.2 . . . . 0.0 113.088 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.2 p -84.27 -32.29 24.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.77 1.785 . . . . 0.0 111.04 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.88 165.91 9.35 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-O 123.153 1.419 . . . . 0.0 114.054 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.31 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.469 1.594 . . . . 0.0 111.669 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.58 -178.84 2.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 128.951 2.901 . . . . 0.0 108.814 -160.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.1 p -84.99 -175.1 5.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.76 -23.09 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.033 -1.042 . . . . 0.0 111.745 163.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -82.13 -23.67 35.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.023 0.929 . . . . 0.0 111.149 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.8 -145.72 10.18 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 -166.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -128.75 115.2 17.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.38 148.42 0.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.228 2.611 . . . . 0.0 111.88 -165.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -135.12 173.6 11.54 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 159.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 84' ' ' GLU . 1.9 pm0 -63.84 154.01 34.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.132 0.968 . . . . 0.0 109.714 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.03 99.47 1.82 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 172.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -49.77 -57.31 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.241 1.416 . . . . 0.0 114.516 -158.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.69 154.02 5.25 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.239 1.816 . . . . 0.0 108.846 162.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.98 25.24 10.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.56 1.544 . . . . 0.0 110.049 -169.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mt -45.2 -59.59 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 126.541 1.936 . . . . 0.0 108.556 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.9 mt -74.91 113.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.421 1.488 . . . . 0.0 107.87 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -80.2 157.85 26.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.154 171.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.36 83.76 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.5 p -68.73 -23.53 64.36 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.479 -0.763 . . . . 0.0 112.853 -166.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.76 -176.7 40.54 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.861 1.21 . . . . 0.0 111.86 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.46 149.52 89.24 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 121.732 1.621 . . . . 0.0 110.691 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 10.91 85.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.977 -1.457 . . . . 0.0 112.467 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 mm -82.58 166.2 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 120.674 2.237 . . . . 0.0 108.336 164.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.57 127.94 26.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.097 1.359 . . . . 0.0 108.175 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.8 t -141.29 147.16 37.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.63 -167.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.412 ' HG2' ' CG ' ' A' ' 108' ' ' ASN . 35.9 tpp -77.25 113.97 15.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.177 2.191 . . . . 0.0 108.562 -174.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.445 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -72.56 98.17 2.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 165.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -78.83 -178.2 5.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 159.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.92 15.1 25.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.384 1.874 . . . . 0.0 112.149 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.01 175.73 14.17 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.539 1.543 . . . . 0.0 109.312 -163.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.34 130.21 31.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.198 1.932 . . . . 0.0 111.32 -170.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.81 57.81 3.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 127.495 2.318 . . . . 0.0 111.853 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -142.25 41.74 1.64 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.086 0.555 . . . . 0.0 111.315 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.412 ' CG ' ' HG2' ' A' ' 100' ' ' MET . 3.6 m-20 -55.22 125.85 22.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.266 1.426 . . . . 0.0 109.565 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.75 -125.5 2.31 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 120.695 1.589 . . . . 0.0 112.335 -171.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -89.13 -25.14 22.01 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.606 1.203 . . . . 0.0 112.796 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -85.23 148.26 26.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.715 0.769 . . . . 0.0 111.178 -158.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.445 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 28.2 p90 -142.96 176.67 8.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -141.24 152.8 44.85 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 160.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.1 mt -83.46 119.42 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 163.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.3 m -65.15 122.56 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.8 p -114.86 28.5 8.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.222 1.01 . . . . 0.0 108.553 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.32 178.63 10.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.157 1.783 . . . . 0.0 107.628 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -70.39 92.11 0.79 Allowed 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 161.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 p -78.72 59.36 2.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.694 0.679 . . . . 0.0 109.939 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.01 -13.37 62.41 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.83 1.252 . . . . 0.0 112.914 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -74.1 -15.92 61.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.286 1.035 . . . . 0.0 111.317 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -103.61 -4.59 23.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.854 1.261 . . . . 0.0 111.129 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 126.97 29.75 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.589 1.156 . . . . 0.0 111.129 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.41 1.19 34.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.717 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -103.11 -25.8 13.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.61 1.705 . . . . 0.0 110.553 168.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -137.14 160.96 37.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.111 1.364 . . . . 0.0 108.98 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -110.46 103.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.58 127.46 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.65 -2.08 1.99 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.827 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.75 -176.44 28.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 119.41 1.005 . . . . 0.0 111.974 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -153.37 140.22 19.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.97 103.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 159.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -63.68 -52.71 59.42 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 21' ' ' SER . 10.4 pt-20 -146.87 154.47 41.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 123.356 0.662 . . . . 0.0 111.486 -159.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.88 25.14 67.68 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.884 0.754 . . . . 0.0 113.153 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 mmm -61.22 -29.21 69.68 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.623 2.212 . . . . 0.0 111.609 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -62.61 -30.65 71.5 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.834 -1.166 . . . . 0.0 111.635 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.02 -44.09 92.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.97 -42.26 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.265 0.626 . . . . 0.0 110.166 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -39.74 94.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 174.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.18 -41.52 70.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.919 1.288 . . . . 0.0 109.035 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.3 mtp -53.87 -42.59 68.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.079 1.352 . . . . 0.0 110.154 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.202 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.76 -36.01 81.68 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.402 1.456 . . . . 0.0 108.887 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.59 1.68 40.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.983 0.913 . . . . 0.0 112.783 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.4 -156.21 7.72 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.982 1.753 . . . . 0.0 110.411 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.2 p -142.18 -72.06 0.32 Allowed 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 121.65 -0.912 . . . . 0.0 111.591 168.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 140.67 -27.39 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.346 1 C-N-CA 133.864 4.865 . . . . 0.0 109.772 -173.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.65 -24.84 67.12 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.716 0.689 . . . . 0.0 110.283 158.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.74 -36.05 4.21 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 125.672 1.606 . . . . 0.0 111.764 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.06 131.91 47.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 p -62.77 152.21 36.48 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.908 1.283 . . . . 0.0 107.914 166.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.6 p -57.44 -48.06 80.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -73.43 175.76 6.68 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.943 1.697 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -95.63 139.48 31.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 101.969 -3.345 . . . . 0.0 101.969 157.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.4 mt -127.38 128.96 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.79 22.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.798 0.808 . . . . 0.0 111.542 -158.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.639 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 4.6 mp -98.37 105.13 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.86 96.64 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.484 0.584 . . . . 0.0 109.521 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -157.32 158.82 36.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.575 1.15 . . . . 0.0 108.841 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 p -156.93 165.28 36.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.397 0.679 . . . . 0.0 110.543 174.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.47 -169.18 40.7 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.536 ' HG2' ' H ' ' A' ' 165' ' ' GLU . 41.4 tt0 -103.97 148.85 25.71 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.943 1.297 . . . . 0.0 109.646 -172.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.2 mt -128.37 43.26 3.17 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.253 1.421 . . . . 0.0 109.114 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.536 ' H ' ' HG2' ' A' ' 163' ' ' GLN . 24.1 tt0 . . . . . 0 C--O 1.243 0.734 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 166.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -63.78 146.66 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 120.7 1.286 . . . . 0.0 110.34 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -104.97 146.87 28.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.76 156.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.166 1.386 . . . . 0.0 109.351 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.0 158.91 26.71 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.487 1.115 . . . . 0.0 110.12 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -144.37 111.72 5.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.345 1.858 . . . . 0.0 106.663 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 104.46 10.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 mm -79.34 140.87 16.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.21 162.56 29.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.007 169.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 9.2 t -137.18 92.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 60.21 18.64 8.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.739 1.216 . . . . 0.0 111.516 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.16 9.69 72.89 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.196 -0.94 . . . . 0.0 112.537 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -75.18 118.71 72.7 Favored Pre-proline 0 C--O 1.232 0.179 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 159.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.94 112.36 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.477 1.451 . . . . 0.0 109.436 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.2 tp -82.81 -27.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.112 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.55 169.53 11.75 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.436 1.493 . . . . 0.0 111.759 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.91 139.38 35.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.335 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.45 154.95 40.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.6 t -147.43 149.49 32.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.77 0.795 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -124.57 147.93 48.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.203 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -92.58 151.92 19.88 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 158.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 mt -126.7 122.56 35.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.883 1.673 . . . . 0.0 106.993 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 90' ' ' LEU . 58.1 m-85 -78.52 61.63 2.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.969 0.908 . . . . 0.0 111.846 -172.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.37 -16.33 53.88 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.885 -1.76 . . . . 0.0 113.611 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.33 -16.21 57.94 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.076 0.95 . . . . 0.0 111.918 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -121.95 -39.53 2.6 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.733 1.213 . . . . 0.0 111.3 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.1 m -132.74 70.51 79.09 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.911 1.685 . . . . 0.0 107.457 174.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -50.18 -48.37 20.15 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.146 2.564 . . . . 0.0 112.657 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -55.66 -58.51 7.49 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -174.392 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 -46.43 89.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.391 1.477 . . . . 0.0 111.165 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.57 82.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.083 0.553 . . . . 0.0 111.385 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.38 -43.54 81.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.626 1.17 . . . . 0.0 110.453 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -51.09 -51.08 56.89 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.147 1.379 . . . . 0.0 109.38 170.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.94 -44.21 90.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.423 0.452 . . . . 0.0 112.073 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -53.93 -59.65 4.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.733 1.613 . . . . 0.0 109.108 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.96 -47.8 74.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.465 0.706 . . . . 0.0 110.611 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.67 -23.39 66.77 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -73.3 -48.13 37.12 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.299 0.954 . . . . 0.0 109.303 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 p -66.62 -26.1 66.92 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.989 -0.444 . . . . 0.0 111.913 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.61 -0.11 71.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.436 1.017 . . . . 0.0 112.058 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -59.78 -23.21 63.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.701 1.6 . . . . 0.0 112.632 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -85.47 9.69 15.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.109 1.364 . . . . 0.0 112.095 -172.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.05 81.63 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.846 -0.974 . . . . 0.0 112.423 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.32 172.72 13.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.983 1.713 . . . . 0.0 107.407 166.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.63 174.39 37.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.427 -1.368 . . . . 0.0 113.674 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -73.24 -8.03 54.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -56.08 124.68 18.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.72 4.34 65.82 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.613 -1.659 . . . . 0.0 114.529 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -73.14 156.75 38.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.99 2.395 . . . . 0.0 107.988 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.1 t -106.21 139.89 40.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CB ' HD11 ' A' ' 56' ' ' ILE . 95.6 m-85 -74.83 88.99 2.31 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -73.5 -27.55 61.43 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.406 1.882 . . . . 0.0 111.617 -166.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 86.01 2.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.449 HD12 ' CG2' ' A' ' 152' ' ' THR . 86.3 mt -103.71 112.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 171.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -125.17 97.47 37.59 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -170.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.68 125.45 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.948 2.432 . . . . 0.0 111.027 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.2 5.4 63.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.81 1.671 . . . . 0.0 113.338 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -136.57 -75.64 0.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.105 1.453 . . . . 0.0 108.98 -167.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.1 167.61 18.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 112.08 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.1 m -122.15 94.74 4.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.744 2.018 . . . . 0.0 108.383 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.37 144.32 25.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.532 1.933 . . . . 0.0 109.961 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.12 1.82 0.13 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.84 35.46 3.38 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 -158.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.329 19.3 p-10 -122.73 144.36 49.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.912 2.856 . . . . 0.0 111.292 164.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.28 -3.09 3.08 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.183 2.593 . . . . 0.0 111.317 -160.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -125.6 -19.84 4.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 129.247 3.019 . . . . 0.0 112.173 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -137.46 176.37 8.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 131.538 3.935 . . . . 0.0 103.439 169.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -145.11 53.81 1.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -152.91 -67.37 0.16 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.201 1.4 . . . . 0.0 110.679 -176.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.579 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 173.69 -11.81 0.04 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 118.374 -1.237 . . . . 0.0 115.262 -159.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -127.44 17.04 7.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.285 1.543 . . . . 0.0 113.227 -161.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.27 -86.4 0.37 Allowed Glycine 0 CA--C 1.503 -0.662 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -17.09 113.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.553 0 C-N-CA 128.074 2.749 . . . . 0.0 111.932 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -136.9 155.32 49.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.213 1.805 . . . . 0.0 109.918 -158.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 p -77.94 165.5 24.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 124.293 0.996 . . . . 0.0 109.451 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.93 -24.75 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.596 170.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.39 8.31 25.11 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.166 1.787 . . . . 0.0 111.533 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.29 142.09 12.96 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.403 1.478 . . . . 0.0 109.813 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.26 6.2 pt-20 34.06 -133.8 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.796 2.438 . . . . 0.0 114.343 162.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -75.05 157.97 33.95 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.498 0.59 . . . . 0.0 110.385 165.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -132.13 176.53 8.31 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.66 1.984 . . . . 0.0 107.644 164.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.79 161.17 28.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.071 0.462 . . . . 0.0 110.713 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.57 131.33 48.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -47.08 83.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -173.08 176.13 3.06 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.726 1.211 . . . . 0.0 108.721 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -126.09 56.36 1.43 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.563 1.945 . . . . 0.0 106.144 163.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.55 -39.52 70.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 171.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 25' ' ' PHE . 49.1 mt -95.6 142.24 28.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.447 1.499 . . . . 0.0 107.334 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -120.49 160.21 23.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.433 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -76.26 64.62 2.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.494 2.318 . . . . 0.0 109.666 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.426 1.49 . . . . 0.0 113.494 -161.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 175.49 38.23 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.583 1.083 . . . . 0.0 112.891 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -59.68 137.58 78.0 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.158 1.906 . . . . 0.0 108.147 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.73 64.38 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.512 -1.716 . . . . 0.0 112.623 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.42 159.44 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 120.923 2.361 . . . . 0.0 107.687 169.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.39 131.98 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.456 1.502 . . . . 0.0 108.497 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 32.3 t -148.62 160.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.848 0.459 . . . . 0.0 110.68 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.4 mtp -84.58 120.95 26.94 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.618 0.767 . . . . 0.0 110.421 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 141.73 58.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 162.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -152.46 -172.57 4.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.364 1.066 . . . . 0.0 109.691 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.62 15.08 10.25 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.011 1.724 . . . . 0.0 112.64 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.28 -179.6 17.24 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -167.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.47 141.04 79.1 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.539 2.159 . . . . 0.0 110.481 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.51 46.12 26.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.164 1.786 . . . . 0.0 111.885 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.7 p -123.89 14.07 9.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.301 -0.874 . . . . 0.0 111.262 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -73.69 128.02 34.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.52 -65.31 0.16 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.7 p -144.54 -13.76 0.58 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.579 HE22 ' HA2' ' A' ' 72' ' ' GLY . 34.6 mt-30 -65.4 130.9 44.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -170.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -134.43 162.39 32.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 107.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 44.9 p90 -144.56 153.39 41.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 O-C-N 124.683 1.239 . . . . 0.0 110.263 166.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.79 123.84 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 160.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.14 125.39 24.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.3 p -110.77 32.39 5.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.52 173.11 13.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.341 1.057 . . . . 0.0 109.192 167.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -68.59 89.85 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 158.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 p -83.38 65.88 8.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.819 -0.551 . . . . 0.0 109.892 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -59.22 -23.21 62.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.11 0.964 . . . . 0.0 112.306 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -68.49 -14.82 63.27 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.761 1.224 . . . . 0.0 110.749 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 62.1 mt -104.0 -6.24 21.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.243 1.417 . . . . 0.0 111.54 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.16 145.13 53.54 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.714 0.688 . . . . 0.0 110.498 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.49 16.06 48.7 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.96 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.22 -52.01 1.41 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.924 2.09 . . . . 0.0 108.414 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -105.18 146.69 28.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.814 -173.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.45 100.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -171.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.1 t -59.06 127.29 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 165.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.409 ' HA ' HG21 ' A' ' 29' ' ' VAL . 29.4 p90 -138.25 -3.45 1.75 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.59 -174.19 30.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.36 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -149.83 149.99 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.659 1.183 . . . . 0.0 108.44 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 118.31 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 165.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -75.13 -50.27 16.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -143.34 146.4 33.51 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 126.133 1.773 . . . . 0.0 107.275 -171.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.27 22.34 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.464 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 28.6 tpp -56.61 -35.94 68.85 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 119.526 1.663 . . . . 0.0 110.706 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -62.67 -20.51 64.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.852 1.205 . . . . 0.0 113.391 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.4 mm -83.05 -43.77 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.551 1.14 . . . . 0.0 108.677 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.37 -35.9 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 121.586 -0.696 . . . . 0.0 109.579 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.37 -44.26 84.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.084 1.753 . . . . 0.0 110.913 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.08 85.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.434 ' HB3' HD13 ' A' ' 56' ' ' ILE . 38.4 mtm -53.26 -47.93 68.7 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.734 176.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -53.24 -42.14 66.12 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.537 HH11 ' HG3' ' A' ' 144' ' ' ARG . 15.0 mtt85 -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.085 -177.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.04 5.24 51.62 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.801 1.24 . . . . 0.0 112.446 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.2 -150.89 4.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 120.473 1.488 . . . . 0.0 111.74 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.0 p -142.59 -96.05 0.12 Allowed 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.589 -0.948 . . . . 0.0 108.798 165.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -162.2 -23.4 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 125.858 1.663 . . . . 0.0 110.764 164.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -16.07 58.25 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.977 0.808 . . . . 0.0 111.432 165.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.27 -24.84 6.84 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 118.556 -1.136 . . . . 0.0 113.174 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.14 123.47 17.77 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.224 1.012 . . . . 0.0 108.764 -174.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.449 ' CG2' HD12 ' A' ' 56' ' ' ILE . 12.3 p -74.93 159.99 31.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 108.837 173.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -10.66 59.64 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.031 -1.668 . . . . 0.0 111.362 166.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.422 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -140.73 160.31 40.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 110.117 -161.194 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.52 80.2 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.67 119.16 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 p -139.22 165.74 26.38 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.508 1.123 . . . . 0.0 110.766 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 102.41 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 166.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.4 77.09 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -145.43 161.48 39.6 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 p -162.26 158.17 23.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.282 1.433 . . . . 0.0 108.556 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.71 -176.34 42.96 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -83.05 159.55 22.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.856 -0.79 . . . . 0.0 110.722 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.0 mt -135.58 43.63 2.59 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 158.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.148 0.979 . . . . 0.0 111.458 175.419 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.3 m120 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.23 138.82 48.17 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 N-CA-C 106.502 -2.153 . . . . 0.0 106.502 158.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 m -104.7 147.91 27.16 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.5 140.43 44.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -113.71 150.91 32.61 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 123.936 0.894 . . . . 0.0 110.164 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.431 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 19.3 m-85 -146.13 113.56 6.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.481 1.512 . . . . 0.0 109.317 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.21 101.11 3.88 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 159.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.19 140.93 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 171.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.78 148.06 49.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.929 1.292 . . . . 0.0 108.37 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.647 HG13 HD13 ' A' ' 156' ' ' ILE . 1.5 t -125.35 115.76 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 53.5 13.76 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 0.0 114.489 -167.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.3 57.79 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.381 1.467 . . . . 0.0 112.859 -175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.27 133.23 81.18 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.22 120.19 7.17 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.2 -40.49 30.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.85 177.28 19.56 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 123.68 0.657 . . . . 0.0 112.364 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -77.32 136.62 38.48 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.726 0.81 . . . . 0.0 110.068 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -121.92 158.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 126.578 1.951 . . . . 0.0 106.316 164.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -147.99 140.34 24.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.965 -0.459 . . . . 0.0 110.244 161.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -109.14 162.72 14.0 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -123.38 112.76 17.95 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.479 2.712 . . . . 0.0 104.433 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 mt -97.61 134.65 40.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -169.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CD2' HD13 ' A' ' 90' ' ' LEU . 18.0 m-85 -82.16 51.76 1.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.998 -1.064 . . . . 0.0 112.42 -171.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.9 -27.36 42.42 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.252 -0.905 . . . . 0.0 112.061 173.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -71.39 -7.08 44.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.721 1.608 . . . . 0.0 113.758 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.82 -25.25 0.46 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.032 0.833 . . . . 0.0 112.933 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 75.1 33.64 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.562 1.945 . . . . 0.0 106.793 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.81 -52.65 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.29 1.993 . . . . 0.0 111.644 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -42.95 99.53 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.883 1.22 . . . . 0.0 109.83 -173.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -60.92 -48.21 82.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.433 0.693 . . . . 0.0 110.332 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.78 -51.29 57.47 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.131 0.972 . . . . 0.0 111.764 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.6 -32.41 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.213 2.205 . . . . 0.0 112.085 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -61.98 2.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.019 1.728 . . . . 0.0 108.579 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.07 -30.93 71.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.203 -0.311 . . . . 0.0 111.56 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -53.19 -62.37 1.7 Allowed 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.038 1.335 . . . . 0.0 109.784 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.9 -26.34 68.11 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.95 -32.39 34.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.866 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 m -69.67 -40.87 76.17 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.926 0.89 . . . . 0.0 109.853 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.0 p -70.87 -34.7 71.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.4 -0.6 88.9 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.623 1.106 . . . . 0.0 110.949 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -70.64 -12.07 61.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.037 1.335 . . . . 0.0 112.887 -162.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -75.57 -4.55 40.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.148 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.07 6.42 55.86 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.486 1.041 . . . . 0.0 111.463 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -163.23 170.54 17.56 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.349 1.86 . . . . 0.0 106.146 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.53 178.62 35.62 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 118.217 -1.944 . . . . 0.0 114.052 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.431 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 75.2 t80 -70.68 -17.63 62.84 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 130.51 3.524 . . . . 0.0 113.283 -170.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -55.74 121.8 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 23.72 73.0 Favored Glycine 0 CA--C 1.538 1.496 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.063 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -25.3 67.98 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.853 2.326 . . . . 0.0 110.288 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.4 m 56.38 175.99 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.308 1.443 . . . . 0.0 110.515 -159.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.6 117.99 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -74.27 -39.75 62.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.202 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 125.54 40.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -158.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.2 mm -142.33 114.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.9 mt -125.89 108.84 25.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.19 124.22 13.58 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.36 3.373 . . . . 0.0 114.015 -173.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.64 27.02 69.13 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.215 1.388 . . . . 0.0 112.442 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -125.1 -83.89 0.64 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.22 172.55 15.57 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.497 0.719 . . . . 0.0 110.188 170.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.99 115.84 17.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.231 1.413 . . . . 0.0 109.834 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -101.1 138.22 38.42 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.24 2.216 . . . . 0.0 111.528 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.22 -156.07 7.33 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.863 1.697 . . . . 0.0 109.279 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.8 90.13 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 119.284 -0.731 . . . . 0.0 114.401 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -83.86 138.9 32.97 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 159.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -132.53 6.83 4.11 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.398 1.079 . . . . 0.0 111.326 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.6 -31.57 0.86 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.468 1.107 . . . . 0.0 113.73 -174.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -127.84 -10.95 5.48 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.306 1.412 . . . . 0.0 112.964 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 58.44 30.57 19.86 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.235 1.814 . . . . 0.0 113.091 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -147.04 -27.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.74 2.57 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.889 1.222 . . . . 0.0 114.469 -170.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.9 p -83.89 -4.32 58.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.596 1.198 . . . . 0.0 112.282 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -103.13 -108.34 3.25 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -8.46 91.17 0.01 OUTLIER Glycine 0 C--N 1.334 0.453 0 C-N-CA 129.082 3.23 . . . . 0.0 115.633 -170.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 1.4 ptpt -77.24 150.1 35.41 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 128.224 2.61 . . . . 0.0 110.013 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -84.89 44.93 1.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.26 1.424 . . . . 0.0 112.768 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.257 36.6 pt 49.27 -43.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 1 C-N-CA 133.486 4.714 . . . . 0.0 114.562 -158.921 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -82.04 -4.43 56.76 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.844 1.257 . . . . 0.0 113.724 -159.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.66 -85.36 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 170.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -127.84 -133.23 0.23 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 127.255 2.222 . . . . 0.0 105.381 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.83 155.67 18.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.379 1.445 . . . . 0.0 108.902 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -122.76 177.75 5.33 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.083 0.856 . . . . 0.0 110.565 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -57.47 164.31 1.98 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 112.679 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -64.22 120.01 11.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 158.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -67.2 -48.09 68.95 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.767 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.72 156.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.417 2.687 . . . . 0.0 110.706 170.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -104.61 22.55 14.83 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.923 1.689 . . . . 0.0 110.655 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.34 -49.39 64.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 124.33 1.052 . . . . 0.0 109.853 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD13 ' CD2' ' A' ' 25' ' ' PHE . 96.3 mt -80.67 129.32 34.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.95 160.57 14.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.122 1.769 . . . . 0.0 109.368 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -77.08 85.24 3.58 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 172.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 p -76.47 -24.14 53.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 118.877 -0.582 . . . . 0.0 111.216 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.1 -170.57 43.55 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.041 0.829 . . . . 0.0 112.705 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.95 158.89 19.54 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.629 2.219 . . . . 0.0 110.64 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.65 -4.2 57.36 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 117.084 -1.954 . . . . 0.0 113.06 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -67.84 148.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 121.2 2.5 . . . . 0.0 107.823 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.83 125.33 54.23 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 p -131.73 159.82 37.3 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 122.799 1.285 . . . . 0.0 110.048 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttm -86.71 127.44 34.97 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.376 -163.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.62 41.79 0.34 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.884 2.474 . . . . 0.0 112.346 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -63.03 167.62 4.7 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.868 1.318 . . . . 0.0 110.409 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.36 15.26 13.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.374 -1.739 . . . . 0.0 111.75 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.61 -167.7 32.61 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 -167.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -64.75 171.62 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 119.328 1.564 . . . . 0.0 108.965 158.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 48.85 24.43 0.84 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.458 2.303 . . . . 0.0 115.188 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -128.2 29.15 5.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.399 1.48 . . . . 0.0 109.858 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.471 HD21 HG21 ' A' ' 127' ' ' VAL . 85.7 m-20 -69.19 101.24 1.43 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.902 1.681 . . . . 0.0 107.324 172.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.92 -137.59 7.76 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -90.08 -10.87 43.14 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.733 0.813 . . . . 0.0 112.624 163.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -81.69 146.63 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.743 1.217 . . . . 0.0 111.286 -158.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -154.32 171.75 18.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.28 1.032 . . . . 0.0 109.492 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.597 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 10.6 p90 -135.49 154.66 51.34 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.341 0.591 . . . . 0.0 109.965 159.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.25 117.46 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 36.0 m -65.72 130.3 42.81 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.625 1.17 . . . . 0.0 108.078 168.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.9 p -111.66 22.07 15.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.944 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.95 -176.14 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 161.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.54 93.22 0.23 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 161.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -81.08 55.74 2.59 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.634 1.974 . . . . 0.0 110.014 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.869 -1.144 . . . . 0.0 113.673 -171.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -73.15 -4.47 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.597 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 68.0 mt -114.82 -2.88 12.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.229 1.811 . . . . 0.0 110.89 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.47 143.16 58.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.174 1.39 . . . . 0.0 111.529 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.5 20.26 58.82 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.254 0.93 . . . . 0.0 112.084 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.04 -51.91 0.67 Allowed 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -96.58 117.62 31.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 108' ' ' ASN . 18.6 t -71.23 107.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -170.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.89 122.55 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.384 1.474 . . . . 0.0 108.037 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -145.13 9.27 1.26 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.24 -173.08 37.29 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 121.296 -0.878 . . . . 0.0 111.783 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -147.67 158.36 43.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.144 0.978 . . . . 0.0 109.631 168.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.15 105.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -52.34 62.56 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.41 157.69 44.13 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.977 0.911 . . . . 0.0 111.056 -167.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.7 24.93 54.91 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.458 1.028 . . . . 0.0 112.592 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.8 tpp -55.75 -35.09 65.81 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.554 1.677 . . . . 0.0 110.109 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -57.6 -30.95 65.73 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.424 1.465 . . . . 0.0 113.379 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.8 mm -76.39 -35.07 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.906 0.776 . . . . 0.0 109.483 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.35 -39.4 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.387 0.994 . . . . 0.0 109.645 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -62.49 -31.44 72.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.117 1.367 . . . . 0.0 111.456 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -44.44 28.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.823 1.249 . . . . 0.0 109.215 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 62.5 mtp -49.77 -44.01 48.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.872 1.269 . . . . 0.0 110.316 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -33.31 71.22 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.02 0.928 . . . . 0.0 113.489 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -65.64 -25.73 67.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.699 1.136 . . . . 0.0 110.975 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.662 ' HB2' HD11 ' A' ' 156' ' ' ILE . 59.0 m-85 -91.98 5.12 51.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 177.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.43 -167.81 34.05 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 125.007 1.289 . . . . 0.0 111.721 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 p -153.75 152.55 30.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.262 1.425 . . . . 0.0 107.372 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -63.85 -22.15 66.78 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.198 -1.564 . . . . 0.0 113.16 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -77.04 -6.48 52.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 16.69 68.94 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.355 -1.247 . . . . 0.0 113.243 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.404 ' HE3' ' H ' ' A' ' 152' ' ' THR . 0.0 OUTLIER -86.44 176.13 8.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.583 1.691 . . . . 0.0 109.141 158.613 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.404 ' H ' ' HE3' ' A' ' 151' ' ' LYS . 71.4 p -125.04 129.97 51.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.72 -31.65 70.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.4 0.546 . . . . 0.0 110.575 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.484 ' HB3' HG12 ' A' ' 12' ' ' VAL . 47.0 mtpt -111.75 176.94 4.82 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.163 0.585 . . . . 0.0 109.972 171.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.66 103.4 15.78 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 145' ' ' PHE . 42.3 mm -79.9 126.24 39.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -142.85 172.61 12.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.995 1.318 . . . . 0.0 111.412 -168.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.5 mt -124.0 109.69 23.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.85 87.33 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.375 1.047 . . . . 0.0 110.528 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -160.86 162.2 32.1 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.4 p -160.2 163.52 33.53 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.215 0.462 . . . . 0.0 111.9 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.34 29.34 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -110.05 143.95 39.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.01 1.324 . . . . 0.0 110.092 -172.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.26 43.55 3.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.811 1.645 . . . . 0.0 109.789 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.941 0 O-C-N 121.03 -1.044 . . . . 0.0 111.001 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 117.366 -1.302 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 42.8 Cg_exo -63.04 166.77 13.62 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 CA-C-N 121.623 1.615 . . . . 0.0 112.139 158.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 m -131.11 152.26 50.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 158.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.1 m -139.01 154.9 26.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 108.121 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' HB3' HD11 ' A' ' 164' ' ' LEU . 23.2 p90 -109.83 159.96 16.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.862 0.865 . . . . 0.0 110.612 171.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -144.5 105.02 4.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.831 1.652 . . . . 0.0 107.437 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.29 97.15 5.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 164.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -68.69 141.7 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -125.01 159.9 30.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.397 1.094 . . . . 0.0 109.206 169.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.57 HG22 HD13 ' A' ' 156' ' ' ILE . 16.5 t -137.99 88.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -168.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.44 13.07 1.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.898 1.279 . . . . 0.0 112.35 -165.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.55 -9.43 30.44 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.705 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.68 112.44 8.7 Favored Pre-proline 0 N--CA 1.441 -0.924 0 C-N-CA 126.656 1.982 . . . . 0.0 105.696 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.86 118.63 5.53 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.7 -25.08 30.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.6 -152.03 23.43 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -124.27 114.87 20.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.151 0.975 . . . . 0.0 110.611 159.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.1 t -82.19 161.0 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.732 2.013 . . . . 0.0 108.33 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.7 m -151.4 141.85 22.52 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.315 -1.49 . . . . 0.0 110.205 170.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -117.6 143.47 46.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.894 0.878 . . . . 0.0 109.342 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -87.98 142.28 27.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 161.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -127.39 116.77 21.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -79.64 52.77 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.359 1.064 . . . . 0.0 113.555 -167.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -67.35 -16.17 64.1 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.36 -28.37 65.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.903 1.683 . . . . 0.0 110.705 168.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.27 -32.08 11.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.991 1.716 . . . . 0.0 112.449 -174.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG12 ' HG3' ' A' ' 86' ' ' GLU . 3.3 m -141.8 74.14 22.78 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.469 1.508 . . . . 0.0 109.022 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.53 -43.21 22.9 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.813 2.342 . . . . 0.0 112.342 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.55 -52.2 66.17 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 119.868 1.213 . . . . 0.0 108.515 -177.14 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 m -60.81 -47.65 85.39 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.641 1.177 . . . . 0.0 111.157 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.76 -33.9 46.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.06 -42.81 68.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.436 1.016 . . . . 0.0 110.014 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -45.15 -55.58 5.59 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.548 1.139 . . . . 0.0 108.561 164.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.82 -29.64 70.14 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -61.26 -55.27 33.84 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.984 1.266 . . . . 0.0 109.532 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -54.39 -45.38 72.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.191 1.396 . . . . 0.0 111.434 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 mt -67.13 -38.57 85.79 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.414 -0.804 . . . . 0.0 111.935 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.9 m -71.2 -36.82 72.05 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.822 0.849 . . . . 0.0 110.836 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -73.96 -23.88 59.55 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.272 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.31 74.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.262 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.78 -25.59 63.23 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.61 1.564 . . . . 0.0 113.565 -159.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -88.56 1.31 55.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.944 1.298 . . . . 0.0 112.089 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.89 15.6 59.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.259 0.933 . . . . 0.0 112.449 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -160.43 177.52 10.49 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.7 -147.45 17.56 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.437 ' O ' HD13 ' A' ' 158' ' ' ILE . 4.1 m-85 -84.06 -24.04 30.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 117.928 -1.035 . . . . 0.0 113.593 -159.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -56.57 120.07 7.15 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 57.33 43.72 93.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.65 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -96.18 -5.37 40.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.671 1.736 . . . . 0.0 113.612 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m 47.11 170.29 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.072 2.149 . . . . 0.0 113.831 -159.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.74 146.5 30.77 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 159.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -106.48 -30.52 9.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.096 -170.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.5 124.13 18.37 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 mm -130.83 109.42 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -121.71 95.02 48.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.62 122.98 11.24 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.455 2.77 . . . . 0.0 112.576 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.79 65.65 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 124.66 1.124 . . . . 0.0 112.446 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -134.56 -76.29 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.59 170.03 21.7 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.023 0.929 . . . . 0.0 110.343 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 122.31 28.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.848 1.659 . . . . 0.0 107.61 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.424 HE22 ' CB ' ' A' ' 101' ' ' ALA . 30.6 tp60 -111.92 133.71 53.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 128.339 2.655 . . . . 0.0 110.384 -165.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.37 -173.31 13.98 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.484 1.992 . . . . 0.0 112.566 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.7 29.25 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 124.231 0.919 . . . . 0.0 115.369 161.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.08 68.48 3.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.247 1.523 . . . . 0.0 109.134 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.84 2.62 44.08 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 113.267 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -139.29 -60.66 0.56 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.595 1.089 . . . . 0.0 109.143 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -83.54 162.92 20.72 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 159.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -124.01 21.89 8.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.686 1.194 . . . . 0.0 108.978 -166.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -162.46 -0.9 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.418 1.087 . . . . 0.0 113.468 -158.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.8 14.21 19.91 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.202 1.365 . . . . 0.0 115.581 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.1 p -118.69 16.28 13.61 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.116 1.458 . . . . 0.0 112.866 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.26 -152.64 5.68 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.95 173.32 47.68 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -166.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -153.45 144.0 22.53 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.722 -0.869 . . . . 0.0 110.715 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.479 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 69.5 p -73.74 22.57 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 130.033 3.333 . . . . 0.0 113.835 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.623 HG21 ' HB3' ' A' ' 38' ' ' ALA . 6.4 pt 49.16 -22.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 1 C-N-CA 132.204 4.202 . . . . 0.0 116.127 -158.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -89.41 -19.89 24.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.484 1.914 . . . . 0.0 110.675 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.65 128.96 3.13 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 126.036 1.779 . . . . 0.0 109.336 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.331 48.3 tt0 50.1 -132.57 1.77 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -116.12 171.54 7.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.584 1.554 . . . . 0.0 109.408 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 77' ' ' SER . 0.7 OUTLIER -139.24 -177.48 4.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.597 1.559 . . . . 0.0 110.073 175.571 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -56.62 164.93 1.28 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.538 2.335 . . . . 0.0 113.207 -176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.92 75.44 10.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 164.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.415 ' HG3' HG12 ' A' ' 29' ' ' VAL . 9.7 pt-20 -45.99 -56.86 4.96 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -159.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.412 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -153.73 153.68 32.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 160.31 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.2 16.27 26.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.414 2.286 . . . . 0.0 111.207 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 mt -50.76 -53.17 14.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.882 1.273 . . . . 0.0 109.126 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.33 123.06 23.89 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -118.32 170.56 8.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.409 1.484 . . . . 0.0 109.377 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -81.5 54.12 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.504 1.921 . . . . 0.0 111.007 -167.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.4 p -69.67 -9.72 55.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -158.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.86 177.13 44.65 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.05 1.295 . . . . 0.0 111.802 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.25 155.31 46.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.645 1.563 . . . . 0.0 110.266 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.32 4.54 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.505 -1.72 . . . . 0.0 113.216 -171.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.06 162.32 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 120.795 2.298 . . . . 0.0 107.366 163.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.17 124.74 22.21 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 109.649 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 157.52 43.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.895 0.855 . . . . 0.0 110.941 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 91.4 mmm -64.07 156.01 29.56 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.108 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.424 ' CB ' HE22 ' A' ' 63' ' ' GLN . . . -112.42 136.51 51.81 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -146.2 172.24 13.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.35 1.46 . . . . 0.0 107.822 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.06 15.85 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.239 1.416 . . . . 0.0 111.656 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.63 -165.49 26.79 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -168.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -64.28 166.38 17.19 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 118.95 1.375 . . . . 0.0 110.048 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 37.67 43.91 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.287 3.035 . . . . 0.0 113.55 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -133.31 33.17 3.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.556 1.542 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -79.97 108.06 13.25 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.5 -100.62 2.09 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 89.9 p -145.77 33.88 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.315 0.646 . . . . 0.0 110.674 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -121.06 142.49 49.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -157.24 155.5 30.92 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -165.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 28.0 p90 -134.68 147.34 50.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.504 167.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.1 mt -83.85 117.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 29.1 m -63.69 129.01 38.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 p -117.79 26.3 9.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.19 0.995 . . . . 0.0 109.299 171.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.96 11.88 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 163.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -68.47 96.42 0.69 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 159.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.5 p -83.13 60.1 5.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.116 0.871 . . . . 0.0 109.835 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.64 -14.63 59.0 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.5 1.52 . . . . 0.0 113.086 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -76.45 -10.38 59.35 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.934 -1.104 . . . . 0.0 111.711 169.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 67.6 mt -104.69 -5.89 20.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.807 1.643 . . . . 0.0 110.99 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -63.99 132.12 49.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.48 17.74 74.81 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 122.113 -0.367 . . . . 0.0 113.089 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -128.04 -34.32 2.13 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.003 1.321 . . . . 0.0 110.854 176.517 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -140.35 162.63 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.224 0.92 . . . . 0.0 110.542 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.94 105.86 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.979 2.112 . . . . 0.0 107.434 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.53 131.95 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 166.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -138.33 -0.47 2.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.33 -177.7 27.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.344 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.93 148.17 36.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.261 1.424 . . . . 0.0 107.417 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.9 106.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 162.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -70.05 -50.36 41.98 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 159.19 42.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.53 0.732 . . . . 0.0 110.918 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.84 24.41 60.12 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.146 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -35.2 68.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.969 1.885 . . . . 0.0 110.343 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -64.99 -21.58 66.87 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.77 -34.0 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.156 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.88 -41.52 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.093 167.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.93 -29.1 70.53 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.185 -0.947 . . . . 0.0 112.302 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.46 -42.85 74.36 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.216 0.916 . . . . 0.0 109.566 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.8 mtm -56.28 -45.72 80.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.269 0.486 . . . . 0.0 110.867 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.58 -40.76 65.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 112.47 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -68.82 -20.58 64.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.052 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.442 ' HB2' HD11 ' A' ' 156' ' ' ILE . 22.9 m-85 -91.32 3.99 53.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.013 0.925 . . . . 0.0 112.75 173.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.78 -148.37 14.82 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 121.058 1.754 . . . . 0.0 112.727 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.3 p -163.89 161.2 22.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.314 1.446 . . . . 0.0 107.235 158.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -59.54 -29.99 68.29 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.406 -1.434 . . . . 0.0 114.528 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -75.37 -7.71 54.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.36 -26.38 20.36 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 126.197 1.856 . . . . 0.0 113.726 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.06 123.93 20.76 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.393 1.077 . . . . 0.0 109.418 -171.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.3 p -75.81 143.88 41.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.862 1.665 . . . . 0.0 110.641 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.6 p -84.85 -13.65 50.34 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.106 -1.621 . . . . 0.0 111.938 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.511 ' HD3' ' CG1' ' A' ' 12' ' ' VAL . 78.7 mttt -146.84 157.46 43.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.164 1.785 . . . . 0.0 108.748 -168.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.514 ' HE2' HG21 ' A' ' 157' ' ' THR . 81.3 tttt -76.31 84.56 3.09 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.502 1.046 . . . . 0.0 108.296 174.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.57 HD13 HG22 ' A' ' 12' ' ' VAL . 5.6 mm -73.2 117.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.514 HG21 ' HE2' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -138.72 172.16 13.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.541 1.137 . . . . 0.0 110.585 -170.801 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 48' ' ' TYR . 5.3 mp -103.52 118.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 159.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -73.33 -49.62 26.42 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 167.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.3 152.67 40.28 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.092 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.8 p -164.08 165.5 22.26 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.83 0.852 . . . . 0.0 109.546 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.7 -170.21 43.33 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.55 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.8 tp60 -79.88 146.55 32.11 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.34 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 7' ' ' PHE . 60.8 mt -138.31 42.91 2.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.437 1.495 . . . . 0.0 110.424 161.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.55 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 5.8 mt-10 . . . . . 0 C--O 1.248 0.987 0 O-C-N 120.971 -1.08 . . . . 0.0 111.212 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -62.94 136.76 58.7 Favored 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 121.395 1.396 . . . . 0.0 108.947 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.8 m -98.5 145.93 26.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.68 133.82 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -87.94 157.84 18.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.134 0.968 . . . . 0.0 109.135 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -132.49 149.59 52.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -129.55 93.32 3.52 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 mm -77.18 141.62 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.69 160.82 28.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.635 1.574 . . . . 0.0 108.568 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.02 113.27 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 58.68 14.39 3.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.836 1.254 . . . . 0.0 114.258 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.36 -3.85 40.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.676 2.084 . . . . 0.0 113.17 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.85 115.46 61.0 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -57.83 120.27 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.132 1.888 . . . . 0.0 109.788 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -82.91 -43.46 16.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.44 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.21 152.62 7.03 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -76.78 152.34 35.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -141.33 160.43 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 126.803 2.041 . . . . 0.0 105.93 -174.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -142.87 152.39 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 122.129 0.966 . . . . 0.0 109.622 172.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.88 147.82 49.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.864 1.266 . . . . 0.0 108.857 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.8 139.4 39.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.95 1.7 . . . . 0.0 106.49 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.63 131.6 53.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.944 1.298 . . . . 0.0 107.814 -177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.21 52.64 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.014 0.926 . . . . 0.0 113.316 -166.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -18.89 56.68 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.897 -1.752 . . . . 0.0 115.628 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.15 0.27 53.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.734 1.152 . . . . 0.0 111.801 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -128.52 -29.54 2.41 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.466 1.506 . . . . 0.0 112.628 173.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.79 72.74 76.96 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.515 1.526 . . . . 0.0 108.9 167.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -56.36 -42.72 62.91 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.153 1.902 . . . . 0.0 114.194 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -53.6 53.35 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.5 m -62.13 -48.83 78.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.3 1.44 . . . . 0.0 109.983 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.87 -46.49 74.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -37.47 81.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.471 0.578 . . . . 0.0 109.801 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -56.95 -53.05 62.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -66.01 -32.8 74.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -51.75 -63.9 0.99 Allowed 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 124.351 1.06 . . . . 0.0 109.137 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.979 0.912 . . . . 0.0 113.242 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -71.38 -33.01 69.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.404 1.002 . . . . 0.0 111.523 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -65.55 -51.41 60.01 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.429 1.468 . . . . 0.0 108.965 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -63.83 -33.64 76.14 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.498 0.719 . . . . 0.0 110.432 -171.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.34 90.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.08 -24.28 67.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.713 1.257 . . . . 0.0 112.102 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -68.06 1.62 2.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.588 1.555 . . . . 0.0 112.395 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.82 5.83 84.55 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.644 1.116 . . . . 0.0 112.006 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -153.01 173.97 14.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.657 2.383 . . . . 0.0 106.537 167.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.95 -162.93 29.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 121.713 0.618 . . . . 0.0 111.967 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' CE1' ' HA2' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -69.36 -15.33 63.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.326 2.65 . . . . 0.0 112.631 177.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -62.85 100.06 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.029 -1.045 . . . . 0.0 108.578 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.2 80.01 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.142 -1.921 . . . . 0.0 115.473 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.8 p -64.3 -48.71 74.59 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.206 2.503 . . . . 0.0 111.528 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.4 m 106.76 144.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 1 C-N-CA 133.175 4.59 . . . . 0.0 108.343 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.65 136.2 33.47 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 162.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -119.68 -10.18 9.63 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.6 119.42 15.21 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.23 110.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 170.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.7 mt -116.55 94.65 43.86 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -54.92 121.06 9.18 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.814 3.01 . . . . 0.0 112.999 -168.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.73 26.35 46.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.933 1.254 . . . . 0.0 111.416 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -143.07 -68.8 0.34 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.383 1.092 . . . . 0.0 108.564 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -161.08 161.61 31.31 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.83 117.18 24.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -122.34 132.58 54.46 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.271 1.828 . . . . 0.0 109.339 -166.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.52 32.21 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 142.03 49.86 0.04 OUTLIER Glycine 0 N--CA 1.466 0.674 0 CA-C-N 119.526 1.663 . . . . 0.0 112.593 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -143.0 113.79 7.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -160.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.434 ' CE1' ' HE3' ' A' ' 76' ' ' LYS . 53.7 p90 -130.25 12.27 5.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.702 1.601 . . . . 0.0 110.745 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -122.98 -67.91 0.92 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.906 1.283 . . . . 0.0 108.834 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -106.07 -20.14 13.51 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 60.45 -3.81 0.13 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 119.03 2.974 . . . . 0.0 119.03 166.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -112.15 0.97 16.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.474 1.51 . . . . 0.0 112.842 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.45 -22.74 9.34 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.056 1.788 . . . . 0.0 112.382 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.1 p -85.25 20.54 1.94 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.413 1.106 . . . . 0.0 112.319 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.63 166.16 32.73 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 113.778 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.53 126.84 3.64 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 128.588 2.994 . . . . 0.0 105.996 -159.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HE3' ' CE1' ' A' ' 67' ' ' PHE . 3.5 pttt -143.54 152.87 41.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.085 2.554 . . . . 0.0 105.97 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.0 p -72.38 168.62 18.04 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.972 0.795 . . . . 0.0 109.856 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 pt -64.84 -18.65 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 123.784 0.834 . . . . 0.0 112.222 166.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -96.5 -6.76 36.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.79 -171.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.77 -84.57 0.13 Allowed Glycine 0 C--N 1.34 0.769 0 CA-C-N 119.921 1.237 . . . . 0.0 111.071 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -132.44 -137.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.888 1.675 . . . . 0.0 107.784 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -75.89 154.22 36.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.692 0.797 . . . . 0.0 109.908 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -125.63 177.01 6.48 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.122 0.963 . . . . 0.0 109.005 168.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.0 170.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.956 1.302 . . . . 0.0 112.326 -172.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.6 106.32 2.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 159.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.67 -44.87 92.48 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.264 0.625 . . . . 0.0 111.004 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.16 153.75 1.65 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 125.529 1.768 . . . . 0.0 114.133 158.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.68 15.26 29.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.254 2.222 . . . . 0.0 111.126 -169.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.8 mt -37.57 -46.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 128.045 2.538 . . . . 0.0 110.636 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.2 mt -92.15 121.94 34.17 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.164 1.786 . . . . 0.0 106.87 -173.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -97.16 169.3 9.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 110.45 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -82.27 80.91 8.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 108.055 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -79.74 -20.75 45.64 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.99 175.4 36.37 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.954 1.252 . . . . 0.0 112.768 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.97 134.66 40.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.069 1.846 . . . . 0.0 110.449 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.53 -11.4 28.16 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.311 1.91 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 120.299 2.05 . . . . 0.0 109.185 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.97 132.16 53.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 126.156 1.783 . . . . 0.0 108.556 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.7 t -142.04 153.45 44.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.634 . . . . 0.0 110.304 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 92.4 mmm -80.21 137.66 36.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.074 0.55 . . . . 0.0 110.324 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.74 124.3 30.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 169.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.65 150.63 51.57 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.632 1.173 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.62 14.05 12.57 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.696 1.598 . . . . 0.0 113.068 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.07 -165.24 28.94 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 -165.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -63.45 164.71 19.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 119.249 1.524 . . . . 0.0 109.748 167.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 33.62 48.71 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 131.159 3.784 . . . . 0.0 112.478 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.9 p -138.99 30.84 2.22 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.359 -1.463 . . . . 0.0 112.136 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -86.23 149.71 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.747 -1.221 . . . . 0.0 107.865 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.16 -66.18 0.01 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.7 t -146.5 -28.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.096 0.958 . . . . 0.0 111.092 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -61.54 128.33 35.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -134.52 174.74 10.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.304 1.042 . . . . 0.0 108.265 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 99' ' ' SER . 20.3 p90 -139.58 149.73 44.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.22 1.01 . . . . 0.0 110.847 164.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.1 mt -83.22 116.85 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 100.696 -3.816 . . . . 0.0 100.696 164.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.8 m -67.81 108.13 2.86 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.5 p -102.56 28.46 6.01 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.322 1.049 . . . . 0.0 108.988 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.71 175.75 11.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.723 1.609 . . . . 0.0 107.466 166.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -71.78 86.62 0.95 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 166.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 p -74.87 40.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.239 2.216 . . . . 0.0 112.384 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.24 -20.96 61.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.015 -1.678 . . . . 0.0 114.08 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -68.37 -15.53 63.59 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.414 0.686 . . . . 0.0 111.103 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.5 mt -95.7 -3.22 46.4 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.58 1.552 . . . . 0.0 111.353 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.03 157.53 24.97 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.237 -0.914 . . . . 0.0 110.028 169.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.45 -0.0 14.97 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.295 1.426 . . . . 0.0 113.785 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -129.32 -47.92 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.507 1.523 . . . . 0.0 109.015 -172.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.15 146.12 40.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.458 0.647 . . . . 0.0 111.028 -167.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 t -95.35 100.99 11.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.04 126.83 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -138.87 2.36 2.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.66 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.28 -173.06 34.32 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.086 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -149.84 160.84 43.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.405 1.082 . . . . 0.0 110.724 164.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.25 115.71 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 166.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -49.91 28.6 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.33 159.19 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.994 2.518 . . . . 0.0 108.496 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.56 20.94 13.53 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.422 1.011 . . . . 0.0 113.236 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 33.6 tpp -54.61 -39.51 67.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.518 1.659 . . . . 0.0 111.813 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.34 69.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.806 1.639 . . . . 0.0 112.058 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.58 -45.16 52.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 118.954 0.797 . . . . 0.0 109.158 176.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.85 -47.03 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 0.0 110.368 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.81 -24.7 65.32 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.029 -1.044 . . . . 0.0 111.901 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.79 -43.83 57.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.958 -1.089 . . . . 0.0 109.182 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 66.9 mtp -56.36 -43.06 78.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.247 -0.908 . . . . 0.0 110.138 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.84 -37.21 83.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -71.87 -21.3 61.68 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 120.269 1.395 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.416 ' CB ' HD11 ' A' ' 156' ' ' ILE . 28.9 m-85 -93.11 5.47 51.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.735 1.614 . . . . 0.0 111.519 171.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.57 48.07 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 108.424 -1.871 . . . . 0.0 108.424 167.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.1 p -151.86 163.34 39.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -61.84 -27.87 69.09 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 107.69 -27.03 16.03 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.374 1.464 . . . . 0.0 113.725 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 130.71 43.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.974 1.887 . . . . 0.0 108.015 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.0 p -70.86 138.19 50.02 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.7 p -64.11 -30.55 71.61 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.61 -0.681 . . . . 0.0 110.29 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -125.59 170.56 11.36 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.329 1.452 . . . . 0.0 109.044 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -86.99 87.75 7.54 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.783 -1.198 . . . . 0.0 108.676 -177.333 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.416 HD11 ' CB ' ' A' ' 145' ' ' PHE . 33.5 mm -75.6 120.19 24.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -142.71 172.77 12.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.525 1.155 . . . . 0.0 111.163 -173.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.03 113.81 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.78 -56.87 16.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -157.49 165.59 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.703 1.201 . . . . 0.0 109.873 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 54.3 m -141.6 163.65 32.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 127.327 2.251 . . . . 0.0 105.622 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.62 172.65 42.53 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.33 156.02 29.8 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.944 -0.739 . . . . 0.0 109.271 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 33.2 mt -136.63 43.0 2.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.882 0.373 . . . . 0.0 110.838 159.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 116.932 -1.907 . . . . 0.0 107.028 158.529 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tmm? . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -112.95 170.51 4.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.239 1.016 . . . . 0.0 109.358 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -71.87 127.49 90.65 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.758 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.14 152.14 76.52 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.62 1.547 . . . . 0.0 109.875 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 m -111.18 156.47 21.37 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.58 163.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.208 1.003 . . . . 0.0 110.017 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -125.74 159.07 33.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 125.224 1.41 . . . . 0.0 109.657 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -146.12 118.24 8.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 107.011 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.03 96.85 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 mm -69.5 140.03 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.96 128.28 32.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.844 1.258 . . . . 0.0 109.827 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.497 HG12 ' HE2' ' A' ' 154' ' ' LYS . 22.6 t -95.95 109.48 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.43 13.76 0.99 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.634 1.574 . . . . 0.0 113.664 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.16 -11.78 26.62 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.72 1.629 . . . . 0.0 113.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.71 127.61 72.07 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 119.647 1.723 . . . . 0.0 107.201 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.83 119.13 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.724 1.616 . . . . 0.0 109.451 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -89.0 -32.8 17.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.484 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.09 162.87 10.39 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -68.62 147.85 51.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.21 154.3 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 126.966 2.107 . . . . 0.0 105.568 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.0 t -139.7 153.29 47.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.827 0.823 . . . . 0.0 109.182 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 60.4 m-85 -142.17 155.48 45.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.324 1.05 . . . . 0.0 108.773 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -107.32 146.69 31.23 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.479 1.511 . . . . 0.0 107.243 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.31 114.22 20.49 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -71.91 56.61 0.3 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.397 1.879 . . . . 0.0 113.198 -171.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.37 -28.85 13.67 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.628 1.571 . . . . 0.0 112.077 169.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -19.57 65.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.157 0.983 . . . . 0.0 112.04 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -125.45 -31.4 3.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 m -129.78 71.55 82.12 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.94 -43.06 26.94 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.611 2.207 . . . . 0.0 110.37 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -55.96 28.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -58.66 -46.88 86.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.56 0.744 . . . . 0.0 111.153 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.24 84.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.456 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.74 -43.74 83.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.716 1.206 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -55.82 -51.64 66.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 108.025 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -66.02 -44.89 83.41 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 124.162 0.914 . . . . 0.0 112.238 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -43.79 -59.1 2.38 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.656 1.582 . . . . 0.0 108.976 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.48 71.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.554 1.541 . . . . 0.0 113.308 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.39 -40.04 62.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.275 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -50.67 66.96 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 119.449 1.022 . . . . 0.0 111.066 173.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.1 p -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.397 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 5.95 89.04 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.168 0.89 . . . . 0.0 112.139 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -5.25 27.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.065 1.433 . . . . 0.0 113.954 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -96.96 12.96 30.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.711 1.205 . . . . 0.0 110.846 170.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.15 74.05 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 120.714 -1.241 . . . . 0.0 113.054 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.52 -165.31 1.52 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.871 2.068 . . . . 0.0 106.357 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.69 -138.18 13.47 Favored Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CZ ' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -81.55 -26.4 35.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.38 1.072 . . . . 0.0 113.486 -167.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -57.97 110.03 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.148 0.979 . . . . 0.0 108.966 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.71 90.18 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.952 1.263 . . . . 0.0 115.627 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -100.23 7.46 44.45 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.991 2.395 . . . . 0.0 114.078 -158.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 62.94 174.59 0.15 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 127.925 2.49 . . . . 0.0 116.183 159.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.56 121.03 38.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 112.136 -2.302 . . . . 0.0 106.566 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -108.47 -24.14 11.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.511 1.124 . . . . 0.0 111.03 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.8 105.36 8.19 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 mt -118.73 114.99 46.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.07 95.51 36.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -168.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -41.12 125.97 2.51 Favored 'Trans proline' 0 C--O 1.24 0.586 1 C-N-CA 125.418 4.078 . . . . 0.0 114.538 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.34 29.96 74.73 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.127 1.346 . . . . 0.0 111.777 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -135.84 -79.89 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.06 171.15 20.51 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.2 m -120.19 91.1 3.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.396 2.278 . . . . 0.0 109.379 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -79.93 139.14 37.19 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.486 1.915 . . . . 0.0 110.9 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.42 -171.41 17.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.813 1.673 . . . . 0.0 111.54 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.39 24.73 9.25 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.363 0.506 . . . . 0.0 112.595 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.75 76.07 9.98 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CD1' HG23 ' A' ' 68' ' ' THR . 1.5 p90 -98.61 -11.8 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.582 HG21 ' CE ' ' A' ' 76' ' ' LYS . 17.6 p -134.31 -10.35 2.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.72 1.208 . . . . 0.0 113.253 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.3 mmt-85 -138.61 -172.38 3.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.27 34.32 0.52 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.384 0.993 . . . . 0.0 112.481 -168.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -150.72 12.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.0 1.32 . . . . 0.0 111.838 -163.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.56 32.65 27.08 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 118.987 -0.896 . . . . 0.0 110.885 -175.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -135.76 1.57 2.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.572 1.186 . . . . 0.0 112.185 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.19 166.09 33.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 119.648 1.113 . . . . 0.0 110.725 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 147.03 14.0 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.569 1.094 . . . . 0.0 114.362 165.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' CE ' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -155.46 160.32 40.52 Favored 'General case' 0 C--O 1.238 0.474 1 C-N-CA 132.07 4.148 . . . . 0.0 104.4 -173.966 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.5 p -78.34 171.76 14.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.974 0.806 . . . . 0.0 110.831 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.5 -25.18 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.729 0.412 . . . . 0.0 111.406 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.01 -22.11 24.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.391 0.676 . . . . 0.0 111.143 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.94 172.43 28.24 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.191 0.884 . . . . 0.0 114.044 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.14 112.69 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.949 1.7 . . . . 0.0 108.225 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 48.38 161.41 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.66 1 C-N-CA 133.884 4.874 . . . . 0.0 115.099 -165.219 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -139.29 175.35 9.63 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.819 162.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -65.89 159.8 24.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.354 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 114.61 13.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 161.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.45 -56.62 16.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.893 1.277 . . . . 0.0 110.819 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -169.03 -177.82 3.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.429 1.492 . . . . 0.0 108.702 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -130.44 25.14 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.604 1.962 . . . . 0.0 109.128 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.84 -57.72 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.95 128.11 34.66 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.551 2.34 . . . . 0.0 105.476 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -119.93 165.36 14.74 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.919 1.288 . . . . 0.0 110.244 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -81.77 56.13 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.559 1.543 . . . . 0.0 110.343 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -66.06 -23.25 66.5 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.863 1.265 . . . . 0.0 113.614 -160.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.5 179.36 48.75 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.27 160.58 19.02 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.576 1.517 . . . . 0.0 110.318 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.5 4.23 64.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.637 -1.646 . . . . 0.0 112.46 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.1 mm -79.4 166.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 121.009 2.405 . . . . 0.0 108.09 166.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 132.08 27.8 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.067 1.347 . . . . 0.0 109.61 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 t -143.79 147.24 33.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.016 0.526 . . . . 0.0 111.172 -170.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 97.4 mmm -74.33 117.92 16.69 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.557 1.143 . . . . 0.0 109.984 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -67.66 139.11 56.77 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 162.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -144.06 -178.03 5.74 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.83 2.052 . . . . 0.0 108.215 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.09 16.86 24.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.462 1.105 . . . . 0.0 111.926 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.28 -160.91 21.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.325 1.441 . . . . 0.0 109.659 -167.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -60.94 150.21 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.978 1.785 . . . . 0.0 109.844 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 39.14 48.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.078 2.951 . . . . 0.0 114.13 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.5 p -138.82 21.25 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.909 1.284 . . . . 0.0 110.58 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.77 155.96 25.2 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.923 -1.11 . . . . 0.0 108.278 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.32 -66.53 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.468 1.031 . . . . 0.0 114.782 -166.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -156.22 -5.59 0.11 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.899 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.463 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 2.1 mm-40 -78.63 136.94 37.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CE2' ' CZ ' ' A' ' 48' ' ' TYR . 5.3 p90 -130.97 169.73 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 164.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -130.98 146.43 52.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.887 0.475 . . . . 0.0 109.807 160.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.3 mt -83.5 116.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 169.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 m -60.75 124.15 19.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -110.47 21.57 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.155 0.582 . . . . 0.0 109.683 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.28 179.03 8.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.64 91.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.3 p -83.76 50.73 1.87 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.096 0.862 . . . . 0.0 110.663 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -18.92 51.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.978 1.311 . . . . 0.0 112.797 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -67.02 -19.22 65.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.762 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.8 mt -95.54 -4.34 44.93 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.668 1.587 . . . . 0.0 112.325 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.15 129.27 39.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.607 1.094 . . . . 0.0 108.787 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.81 -1.98 83.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.747 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.6 -20.23 8.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.043 1.922 . . . . 0.0 112.912 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -139.42 153.05 47.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.361 0.982 . . . . 0.0 111.044 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.0 t -88.0 100.01 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.93 126.39 19.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -140.76 -0.7 1.5 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.14 -178.67 28.8 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 119.08 0.855 . . . . 0.0 111.667 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -149.63 153.89 37.76 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.418 1.487 . . . . 0.0 107.591 172.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.85 126.45 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 166.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.428 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 23.9 ttmt -82.93 -52.17 6.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 164.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 162.34 40.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.227 -167.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.09 74.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.729 0.681 . . . . 0.0 113.45 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -38.91 75.27 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.329 1.564 . . . . 0.0 110.098 175.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -61.36 -25.11 66.94 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 172.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mm -77.72 -38.48 25.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.64 -39.84 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.777 0.717 . . . . 0.0 109.54 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -60.87 -34.78 75.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.944 -1.098 . . . . 0.0 111.808 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.39 63.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.384 0.993 . . . . 0.0 109.509 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 69.5 mtp -52.66 -42.26 64.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.236 1.015 . . . . 0.0 110.486 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -62.6 -34.47 77.08 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -30.05 70.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.616 1.098 . . . . 0.0 110.243 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -92.89 5.91 49.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.035 1.734 . . . . 0.0 111.86 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.75 -149.95 7.62 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 170.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 p -146.47 -61.51 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 141.75 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 1 C-N-CA 132.716 4.407 . . . . 0.0 109.726 -169.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 5.12 2.65 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 118.571 0.623 . . . . 0.0 111.454 164.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.54 -42.75 2.96 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 126.589 2.043 . . . . 0.0 111.556 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -60.24 123.89 18.59 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 61.3 p -72.98 164.04 27.28 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 124.343 1.027 . . . . 0.0 110.091 -167.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -88.5 -8.99 53.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.426 0.69 . . . . 0.0 111.239 163.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.497 ' HE2' HG12 ' A' ' 12' ' ' VAL . 15.3 tttt -152.81 149.24 28.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 109.934 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -75.06 123.0 24.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 -172.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 mt -112.62 126.49 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.54 175.84 9.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.151 -158.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.74 112.28 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.0 76.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -150.69 156.48 41.41 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.7 p -161.9 160.64 28.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.523 1.129 . . . . 0.0 109.722 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.93 -171.44 43.55 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -95.11 151.99 18.72 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.1 mt -125.66 42.5 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.601 1.191 . . . . 0.0 108.446 165.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.186 1.394 . . . . 0.0 111.822 176.313 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.03 172.39 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.487 0.661 . . . . 0.0 110.079 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -80.86 108.76 10.94 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 161.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.03 157.37 57.52 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.517 1.22 . . . . 0.0 109.242 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.439 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 32.6 m -110.11 155.69 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 170.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.19 158.72 41.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.563 1.545 . . . . 0.0 107.536 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -135.34 159.61 41.02 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 123.446 0.698 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.629 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 64.4 m-85 -153.29 114.23 4.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.972 1.709 . . . . 0.0 108.596 -173.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -74.4 102.78 4.53 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 163.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.0 mm -67.38 143.02 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.99 129.48 22.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.336 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.548 HG12 ' HE2' ' A' ' 154' ' ' LYS . 78.6 t -93.05 101.13 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 127.409 2.284 . . . . 0.0 104.937 173.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 60.37 13.6 4.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.448 1.022 . . . . 0.0 113.754 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 0.26 53.58 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.407 1.479 . . . . 0.0 113.947 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 110.3 34.25 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 167.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.34 136.23 42.73 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.516 1.478 . . . . 0.0 110.001 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -104.61 -21.19 13.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.9 1.68 . . . . 0.0 110.61 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.39 156.22 7.19 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.045 0.839 . . . . 0.0 112.478 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.18 130.23 42.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.56 150.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.4 m -137.1 147.07 45.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 87.0 m-85 -135.63 136.36 40.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -173.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.39 152.35 39.54 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 162.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.2 mt -126.88 122.22 34.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.416 ' CD2' HD13 ' A' ' 90' ' ' LEU . 57.1 m-85 -69.61 52.71 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.862 2.065 . . . . 0.0 112.065 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.87 -21.99 58.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.081 -1.637 . . . . 0.0 112.222 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.06 4.17 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.047 0.939 . . . . 0.0 113.37 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -125.98 -35.52 2.46 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.329 1.452 . . . . 0.0 110.605 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m -142.12 68.35 22.39 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.148 1.779 . . . . 0.0 108.886 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.03 -37.88 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.063 1.842 . . . . 0.0 113.194 -176.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -55.07 39.12 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.078 1.763 . . . . 0.0 109.773 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.95 -40.79 90.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 122.838 0.455 . . . . 0.0 110.008 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.14 -33.08 67.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.31 -50.09 49.83 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.812 1.645 . . . . 0.0 109.55 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -45.72 -51.37 12.61 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.042 1.737 . . . . 0.0 109.661 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.35 90.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -56.56 -59.25 5.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.753 1.221 . . . . 0.0 107.87 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.72 -50.22 25.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.77 1.228 . . . . 0.0 112.491 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.92 -29.24 68.27 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.951 -1.093 . . . . 0.0 111.547 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -77.62 -43.53 31.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.965 1.257 . . . . 0.0 112.612 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.1 p -65.71 -32.29 73.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 7.02 89.02 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.435 1.017 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.45 -16.93 64.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.842 1.657 . . . . 0.0 114.101 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -83.02 -1.9 53.86 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.014 -1.054 . . . . 0.0 110.581 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.58 8.4 65.82 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.634 1.112 . . . . 0.0 112.842 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -156.18 -172.61 4.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.065 1.432 . . . . 0.0 110.434 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.87 -139.45 10.96 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-O 122.321 0.956 . . . . 0.0 113.417 160.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.629 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 7.3 t80 -62.76 -34.6 77.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.524 1.93 . . . . 0.0 108.69 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.99 124.86 19.13 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.595 1.088 . . . . 0.0 108.888 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.86 -0.39 21.65 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.105 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.1 m -64.36 115.21 4.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 120.949 2.374 . . . . 0.0 105.542 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.3 p -75.86 156.37 34.44 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.699 -0.626 . . . . 0.0 109.61 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 62.1 m-85 -91.72 95.58 9.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.55 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -74.69 -21.05 59.6 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -166.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 82.76 1.85 Allowed 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 121.151 -0.968 . . . . 0.0 109.367 -169.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.487 HD12 ' CG2' ' A' ' 152' ' ' THR . 7.7 mt -102.66 101.9 12.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.18 92.34 45.3 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -167.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -48.64 130.89 23.21 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.34 79.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.185 1.85 . . . . 0.0 112.114 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -142.03 -62.96 0.44 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.547 1.174 . . . . 0.0 109.434 -170.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -168.75 164.25 11.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.902 0.774 . . . . 0.0 112.347 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.9 m -113.32 93.1 4.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 108.277 159.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -76.89 142.99 39.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.002 0.921 . . . . 0.0 109.852 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -152.97 -164.5 12.56 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 124.85 1.214 . . . . 0.0 110.584 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.31 43.0 6.38 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.395 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.02 136.28 49.22 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 119.754 1.777 . . . . 0.0 107.929 159.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -134.39 5.95 3.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 127.91 2.484 . . . . 0.0 109.487 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -114.06 -53.49 2.67 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.391 1.477 . . . . 0.0 107.787 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -117.11 -165.9 1.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 158.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -174.22 46.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -166.85 20.82 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.158 2.183 . . . . 0.0 110.253 -170.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.58 -32.55 4.72 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.458 -1.19 . . . . 0.0 113.52 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.5 p -83.84 6.67 20.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.517 2.158 . . . . 0.0 114.673 -161.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -115.8 -124.47 3.73 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.86 100.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 127.187 2.327 . . . . 0.0 113.547 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -129.34 146.43 51.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.468 1.907 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.0 p -80.84 -178.4 6.81 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.993 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.6 pt -76.73 -6.84 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.472 168.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -90.78 -3.16 57.63 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.16 0.891 . . . . 0.0 112.057 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.76 91.17 1.92 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.267 10.7 tp10 62.17 -133.63 0.54 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.381 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -103.37 131.31 50.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.685 1.13 . . . . 0.0 110.871 -160.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -98.08 169.8 9.36 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.852 0.835 . . . . 0.0 110.107 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -66.7 170.57 6.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.51 1.524 . . . . 0.0 111.226 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -85.95 113.93 22.45 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -43.56 -55.65 4.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.96 1.304 . . . . 0.0 110.989 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -172.52 177.57 2.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.793 2.437 . . . . 0.0 106.479 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -125.49 32.09 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.661 1.184 . . . . 0.0 109.293 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.71 -55.78 20.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.416 HD13 ' CD2' ' A' ' 25' ' ' PHE . 64.2 mt -84.4 130.02 34.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.155 1.382 . . . . 0.0 107.566 -170.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -120.8 165.27 15.38 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 126.947 2.099 . . . . 0.0 109.449 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -85.7 65.76 9.31 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.557 0.743 . . . . 0.0 110.598 -164.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 p -70.97 -19.2 62.58 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -162.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.01 178.8 48.92 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 119.361 0.982 . . . . 0.0 111.918 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -62.1 158.69 37.95 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.545 2.163 . . . . 0.0 110.304 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.6 -6.84 36.26 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 116.974 -2.014 . . . . 0.0 112.934 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.69 156.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-N 121.46 2.63 . . . . 0.0 108.11 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.426 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -134.05 131.14 38.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.172 0.989 . . . . 0.0 110.852 176.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.82 150.23 33.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.29 1.036 . . . . 0.0 110.955 -164.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.62 138.14 54.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.0 50.92 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -59.99 163.35 4.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.065 1.412 . . . . 0.0 109.681 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.48 14.24 13.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.6 -165.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.81 -167.22 27.73 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.713 2.102 . . . . 0.0 107.98 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.44 143.66 58.52 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.284 1.989 . . . . 0.0 110.232 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 50.11 47.78 23.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.551 2.34 . . . . 0.0 112.7 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 p -120.37 23.0 11.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.871 1.268 . . . . 0.0 111.638 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -69.42 135.85 50.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.322 1.049 . . . . 0.0 108.885 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.0 -78.45 0.02 OUTLIER Glycine 0 C--N 1.337 0.588 0 CA-C-N 118.436 0.562 . . . . 0.0 112.867 -168.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -142.21 -47.13 0.35 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.543 0.737 . . . . 0.0 109.963 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -62.46 137.7 58.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 124.082 0.863 . . . . 0.0 108.676 -170.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.429 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 45.4 p90 -141.81 172.75 12.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.871 1.668 . . . . 0.0 107.316 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 48.6 p90 -141.86 151.1 42.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.423 0.63 . . . . 0.0 109.697 158.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.34 120.8 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.76 127.4 31.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.9 p -107.66 19.84 19.62 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.724 0.809 . . . . 0.0 110.023 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.8 -177.89 5.4 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 164.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -60.99 128.02 34.43 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 158.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.43 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 71.9 p -117.67 72.77 0.86 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.61 1.55 . . . . 0.0 110.074 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.42 -12.6 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.415 -0.803 . . . . 0.0 113.139 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.43 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 27.5 p90 -71.81 -13.86 61.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.377 0.671 . . . . 0.0 111.288 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.446 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 61.0 mt -109.95 -8.12 14.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.751 1.221 . . . . 0.0 111.894 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 153.08 43.23 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.55 7.92 43.26 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.211 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -135.53 -40.31 0.72 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.169 1.485 . . . . 0.0 111.388 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -114.56 147.85 38.85 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.941 0.496 . . . . 0.0 111.487 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.13 105.79 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.041 1.736 . . . . 0.0 107.305 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.01 137.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 161.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.3 -3.83 0.72 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.294 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.49 176.83 27.11 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 119.691 1.132 . . . . 0.0 112.053 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.61 149.16 31.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.575 1.15 . . . . 0.0 108.153 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.417 HG22 ' CE2' ' A' ' 22' ' ' PHE . 62.5 t -58.88 126.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 164.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -93.64 -42.3 9.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.967 0.507 . . . . 0.0 109.769 165.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.05 156.7 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.711 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.17 21.26 61.13 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.481 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -52.31 -42.62 63.95 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.498 1.649 . . . . 0.0 111.311 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.77 -13.09 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.035 0.834 . . . . 0.0 112.925 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.6 mm -84.58 -36.46 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.427 1.091 . . . . 0.0 108.484 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.39 -40.78 90.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 121.442 -0.786 . . . . 0.0 108.945 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -62.67 -33.68 75.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.36 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.61 76.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 109.331 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.8 mtm -55.72 -46.07 77.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.45 0.568 . . . . 0.0 110.135 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.35 -36.13 73.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.167 0.587 . . . . 0.0 111.844 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -25.48 68.14 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.496 0.589 . . . . 0.0 111.546 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -97.88 -0.43 45.03 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.076 1.75 . . . . 0.0 112.15 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.18 -173.5 47.46 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 167.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 p -162.37 159.66 25.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -63.17 -16.46 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -4.33 2.89 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 167.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.86 -25.27 2.19 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 127.339 2.399 . . . . 0.0 114.328 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.86 127.43 33.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.487 ' CG2' HD12 ' A' ' 56' ' ' ILE . 16.5 p -66.41 168.44 8.94 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.637 1.175 . . . . 0.0 110.773 168.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.9 p -81.6 -16.54 51.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.806 159.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.548 ' HE2' HG12 ' A' ' 12' ' ' VAL . 41.4 mtpt -143.63 160.6 40.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.01 0.924 . . . . 0.0 111.414 -167.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.433 ' HE2' ' CG2' ' A' ' 157' ' ' THR . 14.8 tttt -84.87 78.41 9.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.36 1.436 . . . . 0.0 109.697 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 12' ' ' VAL . 57.0 mt -76.7 133.27 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.483 0.658 . . . . 0.0 109.404 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.433 ' CG2' ' HE2' ' A' ' 155' ' ' LYS . 74.7 p -148.98 177.03 9.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.905 2.082 . . . . 0.0 110.105 -173.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 48' ' ' TYR . 3.1 mp -92.61 124.35 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 158.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.72 -55.3 10.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.68 161.96 39.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.079 0.552 . . . . 0.0 111.025 -169.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.8 171.28 7.39 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.3 -167.86 40.69 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.606 1.574 . . . . 0.0 109.83 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -95.91 148.5 22.56 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.544 1.137 . . . . 0.0 109.619 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.9 mt -126.87 43.07 3.19 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.534 1.934 . . . . 0.0 110.476 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 5' ' ' THR . 9.2 tm-20 . . . . . 0 C--O 1.255 1.348 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 161.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HE1' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 117.297 -1.335 . . . . 0.0 109.559 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.281 17.1 m 48.15 -172.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.741 1.155 . . . . 0.0 110.759 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.82 116.14 10.46 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 158.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.5 161.39 44.29 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 CA-C-N 120.661 1.272 . . . . 0.0 108.97 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.4 m -102.16 157.18 17.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.96 157.32 33.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.314 1.845 . . . . 0.0 107.648 164.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.66 151.2 30.44 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.543 0.737 . . . . 0.0 109.9 165.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 23.4 m-30 -133.85 104.51 6.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.118 2.167 . . . . 0.0 106.179 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.82 107.16 8.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mm -75.29 142.85 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 109.535 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -122.78 159.79 27.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.019 0.914 . . . . 0.0 109.554 161.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.0 96.37 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 56.07 14.03 1.34 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.629 1.572 . . . . 0.0 112.889 -169.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.65 -13.55 29.94 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.57 1.557 . . . . 0.0 113.18 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.41 127.59 85.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 120.389 2.094 . . . . 0.0 106.627 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.6 108.53 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.675 2.25 . . . . 0.0 109.755 -170.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.6 tp -84.56 -28.04 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.519 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.54 162.27 10.12 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 118.806 0.73 . . . . 0.0 114.458 167.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -77.7 113.96 16.08 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.65 0.78 . . . . 0.0 109.803 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.15 159.36 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 106.215 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.8 m -150.11 152.93 35.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.129 -1.607 . . . . 0.0 110.41 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.25 133.57 29.82 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.006 0.922 . . . . 0.0 109.235 -166.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.71 139.84 35.92 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.08 121.89 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -82.6 62.53 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.961 0.904 . . . . 0.0 112.38 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.05 40.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.941 0.896 . . . . 0.0 112.806 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -9.42 59.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.419 1.088 . . . . 0.0 111.589 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -117.81 -54.23 2.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.422 1.489 . . . . 0.0 108.84 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 m -126.95 72.23 75.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 125.194 1.398 . . . . 0.0 107.711 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.67 -39.39 88.22 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.252 1.968 . . . . 0.0 112.319 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' CA ' ' HE3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.99 -53.47 56.89 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.445 1.475 . . . . 0.0 109.195 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 m -64.39 -41.01 96.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.899 0.879 . . . . 0.0 110.365 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.46 -50.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.556 0.742 . . . . 0.0 112.2 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.69 -40.55 95.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 110.093 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -51.58 -60.46 3.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.086 1.354 . . . . 0.0 109.427 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -60.77 -31.05 70.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HD2' HE22 ' A' ' 163' ' ' GLN . 38.1 ttp85 -55.69 -64.53 0.82 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.358 1.863 . . . . 0.0 110.181 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.7 74.9 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.833 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.29 -34.58 77.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.541 -0.724 . . . . 0.0 111.028 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -69.5 -27.16 64.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.66 0.784 . . . . 0.0 111.625 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.3 p -90.21 -23.71 21.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.267 0.94 . . . . 0.0 111.283 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.41 -1.97 74.1 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.144 1.354 . . . . 0.0 112.707 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.39 -20.38 64.68 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.419 1.888 . . . . 0.0 113.427 -164.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -81.65 11.95 4.29 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.555 -0.716 . . . . 0.0 111.678 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.42 78.09 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 124.175 0.893 . . . . 0.0 112.274 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.09 167.98 26.57 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 125.493 1.517 . . . . 0.0 107.339 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 175.01 34.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 117.796 -2.145 . . . . 0.0 113.328 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 40.8 t80 -61.6 -32.42 72.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 127.794 2.437 . . . . 0.0 111.558 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -45.47 122.35 3.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.71 1.204 . . . . 0.0 109.875 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.35 26.23 61.47 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 116.33 -2.372 . . . . 0.0 115.689 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -66.66 -54.32 24.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 122.128 2.964 . . . . 0.0 107.44 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 32.8 t 113.9 161.91 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 1 C-N-CA 132.393 4.277 . . . . 0.0 106.951 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.97 101.64 12.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -77.45 -15.74 59.16 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.95 111.11 6.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.442 HD12 ' CG2' ' A' ' 152' ' ' THR . 22.2 mt -129.96 105.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.9 mt -116.05 97.96 50.35 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -50.15 126.61 17.63 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 123.552 2.834 . . . . 0.0 112.726 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.85 71.55 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 126.707 2.098 . . . . 0.0 112.033 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.64 -80.36 0.27 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.473 1.136 . . . . 0.0 108.059 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.78 166.65 26.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.278 0.631 . . . . 0.0 111.673 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.8 m -124.06 100.78 6.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.309 2.644 . . . . 0.0 109.284 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -84.36 135.01 34.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.066 1.746 . . . . 0.0 111.101 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.27 -174.15 21.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 126.489 1.995 . . . . 0.0 109.139 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.32 6.18 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 117.405 0.603 . . . . 0.0 113.628 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -110.72 23.76 13.8 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -159.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 43.2 p90 -58.52 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.182 1 C-N-CA 131.827 4.051 . . . . 0.0 116.101 -176.069 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.3 t -148.39 -12.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.237 2.215 . . . . 0.0 112.179 161.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -146.19 -173.93 4.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.291 2.236 . . . . 0.0 106.199 -168.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -169.94 45.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -155.45 -7.33 0.12 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.67 5.29 51.47 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 117.686 -1.619 . . . . 0.0 114.413 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -91.52 -96.01 0.13 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.453 2.126 . . . . 0.0 107.272 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 41.52 -158.88 0.04 OUTLIER Glycine 0 CA--C 1.531 1.038 0 C-N-CA 127.157 2.313 . . . . 0.0 114.672 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.86 117.66 1.3 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-O 121.562 0.535 . . . . 0.0 111.97 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.574 ' HE3' ' CE2' ' A' ' 67' ' ' PHE . 4.0 ptpt -145.56 -170.52 3.47 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.685 2.394 . . . . 0.0 107.187 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.3 p -140.81 177.14 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.475 1.034 . . . . 0.0 110.673 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt -74.64 -0.64 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 111.624 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -108.39 -1.18 20.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.053 1.341 . . . . 0.0 111.363 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.56 -113.8 1.77 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.58 -139.32 0.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.426 0.613 . . . . 0.0 109.469 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -70.05 166.25 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.318 1.047 . . . . 0.0 108.808 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -134.1 -179.65 5.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.761 2.024 . . . . 0.0 106.874 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.45 159.95 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.284 1.04 . . . . 0.0 112.572 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 89.84 1.96 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.238 1.415 . . . . 0.0 107.882 172.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.21 -52.73 64.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.767 1.227 . . . . 0.0 112.867 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -150.19 174.38 12.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 162.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.64 32.05 5.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.964 2.105 . . . . 0.0 110.045 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.81 -48.31 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.25 1.024 . . . . 0.0 108.456 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.64 133.82 35.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.809 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -132.25 171.26 13.92 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.114 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -84.78 87.19 7.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -164.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.2 p -77.7 -17.98 57.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.827 -171.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.9 -178.2 46.73 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.858 1.208 . . . . 0.0 112.671 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.27 142.0 97.14 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.969 1.78 . . . . 0.0 108.917 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.77 -3.44 56.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 117.644 -1.642 . . . . 0.0 112.587 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 128' ' ' VAL . 15.3 mm -74.51 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 121.103 2.452 . . . . 0.0 109.072 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.72 130.34 54.95 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.142 1.377 . . . . 0.0 109.354 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 p -144.22 158.02 43.96 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.563 1.145 . . . . 0.0 112.686 176.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 95.4 mmm -75.37 131.01 39.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.811 1.245 . . . . 0.0 111.851 -168.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.444 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -83.23 81.62 8.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.504 1.522 . . . . 0.0 107.523 168.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -70.48 -179.71 2.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.43 1.092 . . . . 0.0 110.428 165.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.0 36.49 1.03 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.326 2.25 . . . . 0.0 109.244 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.89 -164.1 27.55 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 106.879 -2.488 . . . . 0.0 106.879 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.46 171.35 9.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 119.236 1.518 . . . . 0.0 108.566 159.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m120 41.11 38.23 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.818 2.447 . . . . 0.0 114.12 159.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -125.25 25.9 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.342 2.257 . . . . 0.0 109.108 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -74.96 105.49 6.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 129.961 3.305 . . . . 0.0 103.553 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.67 -93.26 1.24 Allowed Glycine 0 C--O 1.225 -0.456 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.5 p -139.33 -14.4 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.79 0.836 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -70.85 133.55 46.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 13.2 p90 -152.31 -179.42 7.53 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 108.151 -174.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -144.06 152.66 41.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.116 0.484 . . . . 0.0 111.282 162.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.7 mt -83.68 113.37 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 165.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.8 m -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.816 1.246 . . . . 0.0 107.832 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.3 p -116.7 27.26 9.28 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.136 0.974 . . . . 0.0 108.695 172.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.53 178.59 10.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 162.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -72.64 87.46 1.24 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 165.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.7 p -81.03 42.22 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.059 0.544 . . . . 0.0 112.3 -171.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.63 -4.1 21.65 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 119.746 -1.846 . . . . 0.0 114.047 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -61.05 -19.7 61.7 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.018 -1.051 . . . . 0.0 110.734 161.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.2 mt -100.89 1.34 39.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.582 1.953 . . . . 0.0 111.78 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.57 138.88 58.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.231 1.012 . . . . 0.0 109.784 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.92 10.62 61.83 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 122.702 0.192 . . . . 0.0 112.908 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -129.26 -37.02 1.68 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.66 1.584 . . . . 0.0 109.567 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -114.09 121.1 42.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.932 0.893 . . . . 0.0 109.002 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.09 106.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.66 1.584 . . . . 0.0 107.467 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.412 HG13 HG23 ' A' ' 97' ' ' ILE . 67.9 t -70.37 131.68 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 166.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -138.54 -5.68 1.56 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.35 -179.46 31.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.72 -1.229 . . . . 0.0 111.664 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -156.8 148.81 22.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.55 122.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -87.09 -48.52 8.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -148.83 154.7 39.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.367 1.467 . . . . 0.0 111.362 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.55 24.88 27.14 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 123.886 0.755 . . . . 0.0 113.123 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.0 tpt -53.74 -39.9 65.7 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.899 1.349 . . . . 0.0 109.442 168.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -62.4 -27.67 69.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.2 mm -78.0 -39.42 25.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.13 -41.95 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.941 0.791 . . . . 0.0 109.288 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.7 -24.49 67.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.615 1.166 . . . . 0.0 112.644 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.22 -45.43 23.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.043 -1.035 . . . . 0.0 110.143 169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 52.0 mtp -54.74 -44.69 73.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.402 0.681 . . . . 0.0 110.931 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.61 -38.0 74.22 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.915 1.286 . . . . 0.0 112.035 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -69.71 -18.68 63.55 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.991 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -94.7 -2.55 50.98 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.204 1.002 . . . . 0.0 111.721 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.58 -166.96 41.07 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -156.01 163.46 39.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 163.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.16 -17.85 64.45 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -9.86 38.81 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 167.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 88.26 -23.21 15.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 127.044 2.259 . . . . 0.0 113.004 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.68 130.3 40.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.899 1.349 . . . . 0.0 107.693 175.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.442 ' CG2' HD12 ' A' ' 56' ' ' ILE . 1.2 p -70.68 165.36 23.1 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.44 1.496 . . . . 0.0 111.304 177.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.0 p -97.21 -14.39 21.45 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.6 1.16 . . . . 0.0 111.477 163.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -137.77 154.24 49.61 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.575 1.15 . . . . 0.0 110.739 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -81.02 85.98 6.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.107 1.363 . . . . 0.0 107.78 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.59 119.87 34.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -132.74 174.25 10.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.0 1.32 . . . . 0.0 109.669 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.18 96.97 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -56.64 -50.21 72.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.613 1.965 . . . . 0.0 109.195 -177.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.2 164.66 33.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 108.041 175.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.7 p -165.93 164.81 18.43 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.031 0.532 . . . . 0.0 110.821 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.48 -174.15 45.99 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.548 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.9 tp60 -81.22 146.31 30.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.74 1.616 . . . . 0.0 110.172 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.43 43.31 2.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 111.091 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 3.6 pt-20 . . . . . 0 C--O 1.248 0.993 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.32 -176.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.211 1.004 . . . . 0.0 110.547 168.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -56.36 117.3 15.87 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.17 163.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.99 152.87 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 N-CA-C 108.815 -1.264 . . . . 0.0 108.815 159.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.1 m -99.47 152.93 19.44 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.19 150.79 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.473 1.509 . . . . 0.0 107.685 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -121.81 158.71 28.29 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.643 1.177 . . . . 0.0 109.722 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -149.34 109.46 4.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.651 1.58 . . . . 0.0 108.284 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.67 100.95 9.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.3 mm -73.75 139.78 18.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.7 127.26 36.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.332 1.053 . . . . 0.0 109.837 169.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.67 111.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.68 13.37 0.49 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.012 2.125 . . . . 0.0 114.88 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.05 -12.15 14.59 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.331 1.443 . . . . 0.0 113.28 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.21 130.11 55.63 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 119.774 1.787 . . . . 0.0 106.826 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.36 115.36 3.64 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.346 1.364 . . . . 0.0 108.818 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.1 tp -86.83 -32.13 20.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.438 -0.315 . . . . 0.0 110.493 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.55 171.15 13.63 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 123.748 0.689 . . . . 0.0 111.476 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -85.75 141.16 29.9 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 109.683 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.5 160.41 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 127.938 2.495 . . . . 0.0 106.166 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -148.73 148.9 30.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 120.923 -1.111 . . . . 0.0 109.864 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.55 160.77 33.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.311 1.044 . . . . 0.0 108.458 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -124.45 135.37 53.19 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.844 2.457 . . . . 0.0 105.593 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.32 110.51 12.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.104 0.962 . . . . 0.0 109.767 -163.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -74.63 64.2 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.236 1.814 . . . . 0.0 113.681 -167.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.5 -25.62 64.61 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.204 1.002 . . . . 0.0 112.636 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.75 -0.67 44.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.238 1.415 . . . . 0.0 112.795 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -118.1 -37.42 3.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.87 1.268 . . . . 0.0 110.703 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' ' 129' ' ' PHE . 1.6 m -138.87 79.92 26.28 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.619 2.368 . . . . 0.0 108.551 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.95 -46.1 17.43 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.754 1.636 . . . . 0.0 112.864 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -70.5 -41.75 72.23 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -168.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.7 m -66.48 -43.39 85.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 111.434 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.69 -44.24 74.39 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 120.902 -1.124 . . . . 0.0 111.506 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -70.87 -31.77 68.55 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.366 0.666 . . . . 0.0 111.139 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -52.19 -59.18 4.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.022 0.929 . . . . 0.0 110.138 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -66.08 -35.53 80.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -59.77 3.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.649 1.58 . . . . 0.0 109.293 170.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.54 -41.94 91.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.214 1.005 . . . . 0.0 113.009 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.64 -43.06 63.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.704 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 p -62.35 -35.83 80.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.889 1.222 . . . . 0.0 111.3 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.705 HG21 HE21 ' A' ' 163' ' ' GLN . 35.3 p -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.567 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.85 10.35 86.14 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 118.991 0.814 . . . . 0.0 111.595 -166.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -24.2 66.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.964 1.382 . . . . 0.0 112.009 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.51 0.84 24.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.663 1.585 . . . . 0.0 114.098 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.63 11.46 82.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.071 0.851 . . . . 0.0 111.283 -171.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -152.4 169.92 21.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.43 1.892 . . . . 0.0 105.958 159.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 153.88 -175.86 32.02 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 122.096 0.831 . . . . 0.0 111.959 -171.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.59 -17.45 38.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.428 1.491 . . . . 0.0 113.384 -158.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -53.15 126.6 21.39 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.211 1.004 . . . . 0.0 109.337 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.91 79.4 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.846 -1.53 . . . . 0.0 114.218 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 m -85.18 154.42 22.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 120.07 1.935 . . . . 0.0 107.298 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.0 t -81.28 170.28 16.25 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 164.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.82 112.73 25.15 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -79.8 -18.43 50.96 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.57 111.66 9.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.836 1.198 . . . . 0.0 108.3 -170.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.3 mt -136.4 117.9 19.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.6 mt -127.1 89.27 52.32 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -167.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -48.3 121.76 6.65 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.521 2.814 . . . . 0.0 114.985 -167.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.5 67.59 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.222 1.391 . . . . 0.0 112.103 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -137.37 -78.72 0.39 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.72 1.26 . . . . 0.0 108.551 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.97 163.33 29.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.545 0.688 . . . . 0.0 111.736 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 95.02 3.97 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.126 1.771 . . . . 0.0 107.832 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -76.86 141.74 40.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.432 1.11 . . . . 0.0 110.185 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.4 -156.59 8.54 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.41 -13.24 67.03 Favored Glycine 0 C--O 1.229 -0.187 0 O-C-N 121.542 -0.975 . . . . 0.0 112.42 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -84.04 88.49 7.17 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.76 -0.847 . . . . 0.0 109.749 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -74.32 3.42 7.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.876 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.4 p -125.65 -58.39 1.41 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 120.102 1.319 . . . . 0.0 113.843 -159.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -103.94 -158.37 0.66 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.34 41.04 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.5 0.666 . . . . 0.0 109.426 159.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -122.94 -51.59 1.9 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.952 0.901 . . . . 0.0 111.645 -163.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.28 -9.44 0.17 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.812 -1.549 . . . . 0.0 114.256 -169.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.7 p -104.24 -19.99 13.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.498 2.149 . . . . 0.0 112.295 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.25 -170.93 2.29 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 124.711 1.148 . . . . 0.0 115.758 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.57 -172.2 41.13 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 123.75 1.75 . . . . 0.0 115.753 -168.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.31 156.53 38.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.311 3.044 . . . . 0.0 107.254 -171.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.8 p -78.1 166.26 23.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.97 0.89 . . . . 0.0 109.541 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 pt -59.66 -29.91 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.518 167.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -77.93 -10.11 59.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 111.638 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 143.21 12.47 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.5 1.524 . . . . 0.0 109.889 -171.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 34.48 -133.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.658 2.383 . . . . 0.0 113.029 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -120.47 143.38 48.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -173.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.72 -176.62 3.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.865 0.866 . . . . 0.0 109.644 -167.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -63.06 137.94 58.41 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.119 0.961 . . . . 0.0 109.792 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.02 86.57 6.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.08 -65.55 0.39 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.749 2.02 . . . . 0.0 113.437 -159.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -158.2 178.78 9.81 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.009 0.924 . . . . 0.0 109.892 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -129.48 36.07 4.16 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.698 1.999 . . . . 0.0 109.401 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.56 -55.98 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -84.07 132.24 34.73 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -122.69 168.91 11.61 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.57 1.548 . . . . 0.0 109.91 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.469 ' HD1' ' N ' ' A' ' 123' ' ' ASP . 36.5 m80 -74.33 81.64 1.87 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.0 p -80.27 -11.27 59.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.603 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.61 -173.96 43.88 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.601 1.091 . . . . 0.0 112.593 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 165.27 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.809 2.339 . . . . 0.0 110.822 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.58 -17.94 6.19 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 117.315 -1.825 . . . . 0.0 112.261 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.28 151.62 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 121.355 2.577 . . . . 0.0 108.29 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.03 128.01 53.96 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 120.934 -1.104 . . . . 0.0 109.639 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 t -140.34 145.97 37.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.436 1.095 . . . . 0.0 110.496 -172.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 89.9 mmm -78.38 121.95 25.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.486 0.714 . . . . 0.0 109.965 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.546 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -72.62 87.51 1.23 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 164.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -76.59 -169.88 1.37 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.168 0.987 . . . . 0.0 108.584 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.41 24.5 4.8 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 110.607 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.45 -159.87 21.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -164.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -64.45 162.56 30.25 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 CA-C-N 119.558 1.679 . . . . 0.0 109.805 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 34.16 53.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 128.967 2.907 . . . . 0.0 113.382 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.1 p -140.63 23.29 2.3 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.072 1.349 . . . . 0.0 111.382 -175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -88.25 142.99 27.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 170.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.5 -58.31 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -162.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.06 -39.87 0.2 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.76 0.824 . . . . 0.0 110.904 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.441 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 7.1 mm-40 -62.54 135.77 57.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.141 1.376 . . . . 0.0 109.567 -173.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.546 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 1.2 p90 -147.09 174.5 11.51 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.331 1.452 . . . . 0.0 108.559 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -136.53 153.85 50.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.918 0.866 . . . . 0.0 111.488 159.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.31 117.41 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 162.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.31 124.43 23.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -112.96 23.63 13.2 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.069 0.548 . . . . 0.0 109.748 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.5 177.75 10.23 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -70.53 87.55 0.66 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -74.1 43.4 0.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.382 2.273 . . . . 0.0 110.903 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -66.39 -18.16 65.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 119.699 -1.876 . . . . 0.0 113.128 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.444 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 45.7 p90 -67.28 -13.74 62.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.129 0.972 . . . . 0.0 111.217 170.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.444 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -108.95 -6.89 15.53 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.262 1.825 . . . . 0.0 111.8 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.469 ' N ' ' HD1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -70.16 135.62 49.3 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.01 -4.66 82.38 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.477 -1.179 . . . . 0.0 113.084 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -94.51 -40.29 9.95 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.189 1.994 . . . . 0.0 110.435 166.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -131.64 158.12 41.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.155 0.582 . . . . 0.0 111.76 -161.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.67 101.11 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -169.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.81 132.81 32.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.411 ' HA ' HG21 ' A' ' 29' ' ' VAL . 26.4 p90 -139.21 -2.09 1.67 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.05 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.75 -171.02 30.48 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.181 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -155.34 166.37 33.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.323 1.049 . . . . 0.0 109.806 163.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.77 126.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 164.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.4 -55.87 3.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.75 162.48 37.53 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.808 0.692 . . . . 0.0 111.921 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.24 28.05 60.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.731 1.158 . . . . 0.0 112.685 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 10.6 tpt -56.55 -38.38 71.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.237 1.519 . . . . 0.0 111.414 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -64.54 -28.5 69.69 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.169 -0.957 . . . . 0.0 112.329 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.1 mm -70.84 -44.99 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.49 -38.46 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.98 -29.61 66.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.946 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.95 -44.15 50.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.711 1.204 . . . . 0.0 109.787 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.9 mtp -50.85 -42.35 58.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.675 0.79 . . . . 0.0 110.005 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.57 -34.36 76.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.389 1.075 . . . . 0.0 112.905 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -67.49 -27.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 119.418 1.008 . . . . 0.0 110.275 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.406 ' HB2' HD11 ' A' ' 156' ' ' ILE . 27.6 m-85 -89.44 8.16 32.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 111.862 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.4 -151.91 4.04 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.653 1.12 . . . . 0.0 110.318 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -137.8 -70.36 0.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.85 -0.794 . . . . 0.0 110.069 166.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 143.44 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 1 C-N-CA 133.379 4.671 . . . . 0.0 110.934 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.84 -25.36 66.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.063 159.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 118.08 -40.76 2.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 124.86 1.219 . . . . 0.0 110.644 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.36 124.11 20.91 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.8 p -64.11 152.18 41.18 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.282 1.033 . . . . 0.0 110.621 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.4 p -72.62 -28.62 62.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.991 163.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -135.96 140.09 43.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -73.16 103.01 3.75 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 119.907 -1.745 . . . . 0.0 109.849 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 145' ' ' PHE . 1.7 mp -73.42 136.31 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 169.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.32 166.13 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.651 1.581 . . . . 0.0 108.703 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 mt -106.48 105.87 19.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.84 -51.09 66.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -149.81 155.63 40.43 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.5 p -156.5 161.96 39.98 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.881 0.873 . . . . 0.0 109.712 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.45 -172.98 44.93 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.705 HE21 HG21 ' A' ' 41' ' ' THR . 0.5 OUTLIER -96.8 147.99 23.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.877 0.871 . . . . 0.0 109.744 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.09 43.16 3.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.639 0.776 . . . . 0.0 109.003 165.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 117.232 -1.366 . . . . 0.0 113.849 -172.333 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.14 -176.58 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 125.487 1.515 . . . . 0.0 107.029 165.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -53.86 116.19 9.64 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 117.364 -1.303 . . . . 0.0 109.589 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -64.04 144.74 88.38 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 121.357 1.52 . . . . 0.0 109.416 167.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.516 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 60.9 m -103.98 143.66 32.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.04 156.92 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -125.23 159.13 32.35 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.656 0.782 . . . . 0.0 110.197 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.604 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 54.6 m-85 -145.94 104.71 3.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.613 2.365 . . . . 0.0 107.58 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.5 94.07 3.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 167.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.6 mm -66.73 150.06 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.241 1.016 . . . . 0.0 109.625 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.25 160.74 34.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.704 1.601 . . . . 0.0 110.808 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 ' HE2' ' A' ' 154' ' ' LYS . 36.8 t -127.37 98.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.075 2.55 . . . . 0.0 105.23 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 50.88 12.94 0.12 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.558 1.943 . . . . 0.0 114.772 -165.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.7 -13.8 13.12 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.424 1.488 . . . . 0.0 113.247 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -72.82 116.65 52.25 Favored Pre-proline 0 C--O 1.23 0.075 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.93 116.98 3.9 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.615 1.543 . . . . 0.0 110.036 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.0 tp -87.28 -27.6 22.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.214 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.83 162.77 10.08 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.2 ttm105 -75.68 143.23 42.27 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.84 152.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 128.534 2.734 . . . . 0.0 104.724 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -143.34 140.57 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.215 0.461 . . . . 0.0 109.949 175.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -114.14 159.87 19.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.333 1.053 . . . . 0.0 108.764 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -120.37 137.88 54.05 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.121 2.169 . . . . 0.0 105.573 170.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.6 mt -125.02 119.11 27.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -164.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.61 63.18 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.13 1.372 . . . . 0.0 112.123 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -17.06 59.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.893 -1.129 . . . . 0.0 111.881 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 -13.0 59.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.059 1.343 . . . . 0.0 112.94 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -111.91 -44.41 3.46 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.014 1.279 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m -134.07 68.75 74.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.066 1.346 . . . . 0.0 108.897 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.66 -38.8 92.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.201 1.934 . . . . 0.0 113.107 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -50.67 70.89 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.588 1.085 . . . . 0.0 108.965 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -62.53 -45.46 92.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.66 1.184 . . . . 0.0 109.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.96 61.95 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.377 1.071 . . . . 0.0 112.164 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -60.69 -41.99 96.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.663 1.185 . . . . 0.0 110.177 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.41 -51.21 67.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.538 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -64.43 -40.32 95.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 ttp85 -56.2 -59.13 5.37 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.32 1.848 . . . . 0.0 110.901 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.86 69.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.814 0.446 . . . . 0.0 112.165 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -74.49 -32.41 62.53 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.871 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.4 m -68.32 -47.04 68.61 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.819 1.247 . . . . 0.0 110.616 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.4 p -64.45 -38.76 92.14 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.62 11.69 82.67 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -166.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -63.57 -20.22 65.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.793 1.296 . . . . 0.0 111.857 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.534 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.85 -1.44 86.38 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.444 1.02 . . . . 0.0 112.172 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -154.5 172.49 17.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.874 1.27 . . . . 0.0 109.073 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.13 -151.77 19.77 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.902 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.604 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.3 t80 -54.14 -29.44 45.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.347 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -59.28 101.71 0.11 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.557 1.071 . . . . 0.0 110.007 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.08 72.59 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 116.848 -2.084 . . . . 0.0 115.295 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 p -64.55 -58.28 6.82 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.424 2.612 . . . . 0.0 110.609 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.8 t 105.39 161.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.264 3.826 . . . . 0.0 108.292 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -115.97 123.94 49.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -104.87 -17.09 14.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.163 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.95 97.78 3.72 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.409 ' CG2' ' HA ' ' A' ' 143' ' ' GLU . 44.7 mt -124.13 117.61 51.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.19 103.08 14.1 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.5 134.12 45.15 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 124.532 3.488 . . . . 0.0 112.804 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.07 25.36 69.44 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.758 0.694 . . . . 0.0 111.531 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -138.9 -78.29 0.34 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.54 162.81 21.94 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 94.2 m -122.52 96.51 5.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.556 2.343 . . . . 0.0 109.802 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -85.61 132.63 34.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.772 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.64 22.98 0.55 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.528 0.585 . . . . 0.0 114.437 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.18 -3.94 88.56 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.349 -1.089 . . . . 0.0 114.097 -170.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.87 73.25 10.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.173 0.986 . . . . 0.0 108.567 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -66.3 -2.44 4.41 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.503 -1.373 . . . . 0.0 112.126 166.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -121.83 -50.72 2.05 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.328 2.251 . . . . 0.0 111.256 -169.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.4 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 3.9 mpt_? -106.29 -149.23 0.42 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.19 69.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.273 1.397 . . . . 0.0 107.677 158.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.6 -77.12 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.788 -0.57 . . . . 0.0 110.134 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.91 5.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 119.03 -0.872 . . . . 0.0 113.9 -161.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.9 p -83.6 -73.47 0.41 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 163.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 69' ' ' ARG . . . 71.3 169.89 10.4 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 121.065 3.186 . . . . 0.0 121.065 158.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.78 158.72 28.32 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 109.97 -3.115 . . . . 0.0 115.963 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' H ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -86.53 -175.7 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.272 3.429 . . . . 0.0 110.314 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -93.29 -179.04 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.557 0.617 . . . . 0.0 109.614 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.0 pt -72.87 -36.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 120.436 -1.415 . . . . 0.0 110.285 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -73.95 -22.18 59.75 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.822 0.449 . . . . 0.0 110.869 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.71 -105.93 0.28 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.311 -3.116 . . . . 0.0 105.311 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' LYS . 10.4 tt0 -113.99 -175.79 2.76 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.55 1.167 . . . . 0.0 109.454 -171.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 94.9 mttt -64.07 123.84 20.09 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 125.878 1.671 . . . . 0.0 109.102 -165.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -99.65 160.35 14.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.741 1.258 . . . . 0.0 110.516 -169.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.46 162.66 22.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.883 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.67 89.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.08 1.752 . . . . 0.0 109.066 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -55.06 -48.44 73.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.281 1.032 . . . . 0.0 111.526 -159.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.417 HD22 HG13 ' A' ' 89' ' ' ILE . 2.2 p-10 -178.51 155.18 0.84 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 128.128 2.571 . . . . 0.0 106.982 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.84 32.15 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.037 1.335 . . . . 0.0 109.317 -168.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.417 HG13 HD22 ' A' ' 87' ' ' ASN . 15.7 mt -52.25 -41.46 34.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 126.211 1.805 . . . . 0.0 109.761 172.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.98 125.68 41.58 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.74 165.41 11.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.19 1.796 . . . . 0.0 109.134 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -80.63 97.1 7.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.0 p -82.46 -26.46 32.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.753 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.0 -177.07 47.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.147 0.885 . . . . 0.0 112.742 -173.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.81 144.54 97.02 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.105 1.87 . . . . 0.0 109.322 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.93 14.87 60.19 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.729 -1.595 . . . . 0.0 112.689 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mm -86.13 158.42 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 121.046 2.423 . . . . 0.0 108.36 162.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 139.39 53.74 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.374 1.47 . . . . 0.0 109.315 168.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -149.23 162.18 40.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.404 1.082 . . . . 0.0 110.49 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.64 117.08 19.45 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.715 1.206 . . . . 0.0 109.733 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -76.57 62.66 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.117 0.961 . . . . 0.0 109.364 171.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -68.34 -179.25 1.25 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.749 1.261 . . . . 0.0 109.081 170.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.05 16.0 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 126.472 1.909 . . . . 0.0 111.606 -171.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.09 177.06 14.68 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.707 1.622 . . . . 0.0 109.11 -166.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.47 131.93 49.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.831 2.354 . . . . 0.0 110.78 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 71.43 9.39 6.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.225 1.81 . . . . 0.0 114.154 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.4 p -92.14 39.58 1.02 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.209 -1.557 . . . . 0.0 111.082 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -82.86 105.56 13.97 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.85 -109.69 2.68 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -18.56 13.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.415 1.086 . . . . 0.0 111.307 172.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -59.07 113.92 2.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.81 1.244 . . . . 0.0 107.979 172.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.469 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 15.4 p90 -127.43 168.95 14.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.208 2.203 . . . . 0.0 107.139 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -143.45 155.59 44.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.583 0.706 . . . . 0.0 111.398 160.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.4 mt -83.83 125.11 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 164.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.7 m -75.29 115.59 15.1 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 166.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -103.04 22.28 14.25 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.312 0.645 . . . . 0.0 109.917 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.91 -178.43 7.24 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.343 1.057 . . . . 0.0 108.314 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -66.92 96.22 0.41 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 163.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 p -80.24 63.66 4.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.454 1.121 . . . . 0.0 109.594 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.92 -21.14 66.0 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.936 -1.102 . . . . 0.0 112.232 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.43 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 19.2 p90 -70.85 -7.89 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.586 1.154 . . . . 0.0 110.878 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.43 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.5 mt -122.49 6.4 9.54 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 126.617 1.967 . . . . 0.0 111.212 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.96 130.62 42.22 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 166.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.9 -4.68 29.03 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.122 -1.376 . . . . 0.0 114.728 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -93.82 -34.15 13.28 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.144 2.472 . . . . 0.0 110.811 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -143.83 134.2 24.63 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.184 0.594 . . . . 0.0 109.74 -164.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.99 107.33 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 126.287 1.835 . . . . 0.0 107.57 -170.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.14 131.09 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -135.79 -4.72 2.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.11 33.22 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.341 0.973 . . . . 0.0 111.62 -176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -147.66 152.54 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 109.122 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 32.8 t -65.8 110.2 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 164.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -71.61 -50.55 29.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.47 157.45 45.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.537 1.935 . . . . 0.0 110.159 -167.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.67 18.3 79.1 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.854 0.74 . . . . 0.0 114.026 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -35.16 68.74 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.96 1.88 . . . . 0.0 110.677 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -20.5 65.95 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.452 -1.405 . . . . 0.0 113.598 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.8 -37.07 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -37.16 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.767 . . . . 0.0 109.735 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.29 -25.57 67.7 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.448 -1.407 . . . . 0.0 112.65 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.15 -46.96 30.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.815 -1.178 . . . . 0.0 109.733 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.7 mtp -52.3 -41.21 62.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.329 0.968 . . . . 0.0 111.377 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.409 ' HA ' ' CG2' ' A' ' 56' ' ' ILE . 1.4 mm-40 -60.62 -37.03 80.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 112.343 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -71.24 -23.08 61.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.541 1.064 . . . . 0.0 110.638 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.443 ' CB ' HD11 ' A' ' 156' ' ' ILE . 27.3 m-85 -90.45 12.25 19.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.329 1.451 . . . . 0.0 111.637 172.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.39 -150.49 6.66 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.164 1.364 . . . . 0.0 110.296 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.9 p -143.63 -103.3 0.12 Allowed 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 159.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -153.7 -27.03 0.14 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.176 1.79 . . . . 0.0 110.196 159.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -66.53 -19.74 65.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.011 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.27 -30.12 6.41 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.429 1.49 . . . . 0.0 111.514 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 124.48 20.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.092 1.446 . . . . 0.0 107.763 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -66.84 130.0 41.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.269 1.028 . . . . 0.0 108.291 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.17 -22.37 64.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.058 0.943 . . . . 0.0 111.599 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.572 ' HE2' HG12 ' A' ' 12' ' ' VAL . 22.8 mtpt -118.87 175.4 5.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 159.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -72.93 145.06 47.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 164.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.52 HD13 HG22 ' A' ' 12' ' ' VAL . 24.2 mm -129.37 123.23 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 178.19 8.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.837 -159.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.74 102.18 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.29 -43.31 74.08 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.39 166.4 28.22 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 117.971 0.35 . . . . 0.0 110.606 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.3 p -170.34 172.64 6.05 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 123.566 0.746 . . . . 0.0 110.487 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.34 -169.49 42.53 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.455 HE21 ' C ' ' A' ' 165' ' ' GLU . 41.1 tt0 -110.66 136.25 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.108 1.363 . . . . 0.0 108.437 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 mt -116.42 43.12 2.26 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.49 1.138 . . . . 0.0 109.644 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.516 ' HB2' ' H ' ' A' ' 5' ' ' THR . 2.0 tp10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 128.248 2.619 . . . . 0.0 108.272 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.935 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 3' ' ' ASN 0.305 5.5 p 50.66 -173.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.149 0.886 . . . . 0.0 111.688 -171.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.458 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -94.93 108.02 35.25 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 158.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.16 165.7 16.38 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.996 1.797 . . . . 0.0 110.079 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 m -131.18 157.44 43.17 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 m -143.7 142.18 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.138 1.375 . . . . 0.0 108.024 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.411 ' HB3' HD11 ' A' ' 164' ' ' LEU . 31.0 p90 -89.94 155.78 18.89 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.462 0.574 . . . . 0.0 109.457 168.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -137.76 105.42 5.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.0 103.68 11.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.86 139.45 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.91 158.79 28.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.917 0.887 . . . . 0.0 110.254 163.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 ' HE2' ' A' ' 154' ' ' LYS . 6.9 t -126.55 105.17 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 54.72 14.04 0.8 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.873 2.069 . . . . 0.0 113.939 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 6.96 60.4 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.551 -1.343 . . . . 0.0 114.066 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.32 123.14 84.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 159.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.7 113.04 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.21 -38.09 52.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.26 -173.39 36.86 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -110.72 151.41 27.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.982 0.896 . . . . 0.0 110.079 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.31 162.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.536 3.134 . . . . 0.0 105.852 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.5 t -147.13 149.8 33.72 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.98 136.41 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.174 0.99 . . . . 0.0 109.453 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -84.57 147.0 27.24 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 160.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.48 118.55 26.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 90' ' ' LEU . 14.1 m-85 -75.26 52.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.353 2.261 . . . . 0.0 112.016 -172.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -13.75 29.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 120.541 -1.349 . . . . 0.0 113.335 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.42 -7.41 59.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.358 0.981 . . . . 0.0 112.953 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.87 -25.25 1.43 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.569 1.077 . . . . 0.0 113.347 -171.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.51 72.32 37.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.051 1.74 . . . . 0.0 107.045 161.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -47.2 -52.27 8.11 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.352 2.701 . . . . 0.0 112.602 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HE3' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.36 -46.58 86.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.841 0.746 . . . . 0.0 109.872 -169.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.485 HG23 ' SD ' ' A' ' 100' ' ' MET . 22.8 m -66.72 -51.21 58.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 125.095 1.358 . . . . 0.0 110.489 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -39.16 80.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.836 0.455 . . . . 0.0 112.142 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.73 -44.3 90.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.112 1.765 . . . . 0.0 109.807 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -56.97 -53.67 55.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.154 0.982 . . . . 0.0 109.715 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.69 -37.22 80.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.865 0.866 . . . . 0.0 112.783 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -54.06 -64.38 0.85 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.235 1.414 . . . . 0.0 109.281 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.29 66.37 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.714 0.634 . . . . 0.0 112.412 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 mt -69.78 -33.51 72.49 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.192 -0.943 . . . . 0.0 111.426 171.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 m -68.49 -49.38 60.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.814 0.734 . . . . 0.0 109.255 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.6 p -64.14 -30.99 72.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.364 0.529 . . . . 0.0 110.523 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.02 -3.88 68.89 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 119.695 1.134 . . . . 0.0 112.068 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.89 -1.38 14.11 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.82 2.048 . . . . 0.0 113.008 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.66 7.8 13.78 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.464 -0.772 . . . . 0.0 112.623 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.04 2.54 89.45 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.087 0.851 . . . . 0.0 111.555 -166.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -174.45 173.26 2.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.3 1.84 . . . . 0.0 106.546 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.62 -167.39 28.12 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -88.7 -8.0 55.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -162.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -64.32 115.02 4.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.743 1.611 . . . . 0.0 108.034 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.07 11.64 85.38 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 -173.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.2 t -66.41 119.09 11.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 163.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.82 139.17 43.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -74.21 99.63 3.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -73.77 -57.09 4.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.9 112.17 24.19 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -168.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.48 105.27 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.42 97.28 42.91 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -53.0 134.07 54.3 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.935 2.423 . . . . 0.0 113.213 -171.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.4 78.17 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.129 1.823 . . . . 0.0 112.918 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -122.9 -75.98 0.59 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.305 1.553 . . . . 0.0 106.816 -173.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.55 18.2 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.141 0.976 . . . . 0.0 109.377 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.8 t -125.75 105.96 9.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -93.84 138.25 32.2 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.672 1.989 . . . . 0.0 110.798 -172.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.55 -168.82 12.83 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.172 1.844 . . . . 0.0 110.109 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.33 9.96 69.01 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.969 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.292 29.9 t0 -84.45 46.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.619 2.209 . . . . 0.0 113.062 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -53.3 -42.65 66.83 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.337 0.655 . . . . 0.0 112.722 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.6 t -72.79 -35.1 67.31 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.396 0.678 . . . . 0.0 111.419 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -125.06 -139.12 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -170.06 23.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.621 1.555 . . . . 0.0 112.948 159.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -134.81 8.69 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.199 1.4 . . . . 0.0 112.742 -159.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.09 -9.29 66.93 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.721 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.5 p -84.16 -18.44 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.827 1.814 . . . . 0.0 111.185 171.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.49 -154.34 7.47 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 124.833 1.206 . . . . 0.0 113.077 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.52 120.57 2.23 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -162.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -142.77 158.03 44.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 158.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -91.22 177.74 6.17 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 124.066 0.854 . . . . 0.0 110.465 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.6 pt -62.62 -31.06 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.607 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -82.68 1.66 37.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.385 1.474 . . . . 0.0 111.605 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.88 156.41 29.11 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -170.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.259 3.1 tm-20 33.79 -142.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.802 2.841 . . . . 0.0 113.429 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -115.0 150.83 35.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.467 1.107 . . . . 0.0 108.115 -167.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.94 175.8 6.72 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.89 154.54 25.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.291 0.567 . . . . 0.0 109.823 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -80.33 88.37 5.55 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 167.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -46.88 -51.61 16.34 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -158.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -159.83 160.48 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.727 -1.578 . . . . 0.0 114.023 168.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.32 24.82 10.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.452 2.301 . . . . 0.0 110.603 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.8 mt -50.47 -46.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.187 0.995 . . . . 0.0 108.994 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 25' ' ' PHE . 96.1 mt -89.29 126.92 35.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.433 1.111 . . . . 0.0 108.278 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -108.86 172.12 7.03 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 126.811 2.044 . . . . 0.0 109.044 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -87.61 73.59 9.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.946 0.898 . . . . 0.0 108.879 -166.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 p -75.29 -4.52 39.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -160.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.86 -179.15 33.79 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.4 1.0 . . . . 0.0 111.886 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.08 159.77 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.072 1.848 . . . . 0.0 110.159 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.31 71.36 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.233 -1.315 . . . . 0.0 112.674 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.63 162.11 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.934 1.867 . . . . 0.0 107.5 166.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.03 132.28 44.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.1 1.76 . . . . 0.0 107.138 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.409 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 34.5 t -146.11 169.8 17.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.883 0.849 . . . . 0.0 110.029 -172.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 7.5 ttm -111.67 120.67 42.82 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.298 1.439 . . . . 0.0 109.1 -161.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.15 94.72 2.47 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -85.31 170.28 12.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 158.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.02 20.31 18.08 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.215 1.406 . . . . 0.0 111.506 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.65 -165.83 25.21 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 -159.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.4 153.75 76.81 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 119.88 1.84 . . . . 0.0 109.672 167.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 45.16 34.36 1.36 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.689 2.796 . . . . 0.0 113.497 169.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -132.53 32.5 3.89 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.932 -1.105 . . . . 0.0 111.573 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.509 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 15.4 p30 -66.29 -154.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.936 2.095 . . . . 0.0 110.916 166.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.14 -81.7 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.6 m -133.83 -16.43 2.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -72.78 139.78 47.29 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.401 1.455 . . . . 0.0 108.201 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -141.56 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.579 1.152 . . . . 0.0 108.511 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.455 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 43.5 p90 -146.17 153.03 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 122.332 1.063 . . . . 0.0 110.852 165.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -84.01 119.33 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 167.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.74 119.88 15.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.8 p -106.94 19.63 20.19 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 109.964 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.08 179.81 8.71 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 166.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.13 102.29 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 160.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.7 p -92.98 58.45 2.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.902 0.858 . . . . 0.0 109.711 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.58 -16.63 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.705 -1.247 . . . . 0.0 114.291 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -69.01 -17.75 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.256 -0.903 . . . . 0.0 111.079 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.455 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 36.3 mt -100.94 -10.26 20.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.069 1.347 . . . . 0.0 110.711 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.52 127.85 33.73 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.401 1.081 . . . . 0.0 109.585 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.73 -8.98 25.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.924 1.25 . . . . 0.0 113.631 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -99.56 -42.44 6.91 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.328 1.451 . . . . 0.0 110.278 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -115.4 155.13 27.98 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.908 1.283 . . . . 0.0 110.967 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.21 104.19 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -174.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.84 122.13 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -134.76 -2.05 2.69 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.441 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.26 26.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.417 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -142.46 147.31 35.9 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.889 1.675 . . . . 0.0 109.203 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.2 t -66.22 110.37 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 158.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -46.68 31.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -146.81 159.12 43.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.358 1.063 . . . . 0.0 108.551 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.2 18.57 60.55 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.532 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 25.7 tpp -51.79 -34.45 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.812 . . . . 0.0 110.709 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.3 -33.45 65.56 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.094 -1.004 . . . . 0.0 113.536 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 119.416 1.007 . . . . 0.0 109.067 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.7 t -59.56 -41.59 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.192 0.905 . . . . 0.0 110.188 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.91 -37.83 83.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.901 0.88 . . . . 0.0 110.856 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.41 72.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.192 -0.943 . . . . 0.0 109.863 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 76.7 mtp -57.79 -44.63 86.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.8 0.84 . . . . 0.0 110.483 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.4 -32.85 72.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.57 -15.0 59.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.214 0.606 . . . . 0.0 111.475 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -97.09 6.41 48.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.694 1.598 . . . . 0.0 111.388 165.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.85 -173.78 46.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.5 p -157.1 158.61 36.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -70.06 -16.23 63.11 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -166.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -29.87 68.99 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.152 0.282 . . . . 0.0 111.36 167.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.65 -29.73 7.05 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 127.871 2.653 . . . . 0.0 112.439 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -68.6 130.94 44.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.774 1.787 . . . . 0.0 109.044 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.5 p -70.88 154.76 41.55 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.919 0.888 . . . . 0.0 110.107 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 p -74.45 -16.62 60.86 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.44 0.696 . . . . 0.0 111.54 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.453 ' HE2' HG12 ' A' ' 12' ' ' VAL . 26.4 mtpt -130.8 169.92 15.07 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.605 1.162 . . . . 0.0 110.848 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -74.42 139.19 43.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 162.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.4 mt -136.52 118.44 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -132.9 160.8 35.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 -169.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -74.05 112.66 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 158.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.78 -56.05 14.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -143.92 155.2 43.98 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.893 0.877 . . . . 0.0 109.354 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -145.82 168.81 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.762 1.625 . . . . 0.0 107.991 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.18 47.16 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 165' ' ' GLU . 6.5 tt0 -87.81 155.38 19.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -172.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 7' ' ' PHE . 55.1 mt -139.99 43.28 1.94 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.559 1.143 . . . . 0.0 109.717 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.471 ' HB3' HE21 ' A' ' 163' ' ' GLN . 10.0 pm0 . . . . . 0 C--O 1.249 1.079 0 C-N-CA 125.404 1.481 . . . . 0.0 114.244 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 m -126.32 -172.96 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.411 1.884 . . . . 0.0 108.156 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -36.34 112.4 0.52 Allowed Pre-proline 0 C--O 1.235 0.317 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.473 161.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -63.48 135.58 50.29 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.462 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 85.9 m -92.91 155.62 17.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.162 -2.532 . . . . 0.0 104.162 161.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.03 167.16 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.952 1.301 . . . . 0.0 108.556 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.45 158.04 37.07 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.74 0.816 . . . . 0.0 111.477 165.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.41 113.79 13.57 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.116 2.966 . . . . 0.0 104.435 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.85 104.71 15.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 170.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -71.3 148.01 10.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.33 27.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 111.145 159.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.569 HG12 ' HE2' ' A' ' 154' ' ' LYS . 5.4 t -128.31 94.32 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 126.354 1.862 . . . . 0.0 107.434 -164.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' H ' ' HB3' ' A' ' 155' ' ' LYS . 24.7 m-20 50.75 24.48 1.74 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.085 -1.634 . . . . 0.0 111.611 -160.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.21 -4.93 35.64 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.055 1.312 . . . . 0.0 114.146 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 39.4 tt0 -81.44 109.06 12.58 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 127.81 2.444 . . . . 0.0 107.74 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.95 99.2 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.051 2.501 . . . . 0.0 112.054 -168.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.7 tp -79.39 -28.91 41.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.55 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.66 157.28 8.19 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.602 0.637 . . . . 0.0 113.228 171.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -74.8 135.24 41.67 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.419 1.088 . . . . 0.0 108.761 170.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 t -127.21 143.24 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.31 146.05 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.746 0.703 . . . . 0.0 109.238 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -141.27 150.27 42.38 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 109.144 -164.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.15 147.16 26.57 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 163.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.7 mt -127.92 115.04 17.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.445 1.498 . . . . 0.0 107.237 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.36 58.22 1.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.078 1.751 . . . . 0.0 112.638 -169.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -19.05 51.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.678 1.191 . . . . 0.0 113.267 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.82 -30.4 66.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.056 0.843 . . . . 0.0 110.762 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -98.84 -50.55 4.17 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.65 0.78 . . . . 0.0 109.613 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.98 76.19 71.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 125.912 1.685 . . . . 0.0 107.702 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.3 -40.74 56.23 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.672 2.248 . . . . 0.0 111.517 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 1.3 mmpt? -66.43 -47.37 73.44 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -170.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -62.4 -49.69 74.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.961 1.304 . . . . 0.0 110.173 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.51 -46.77 78.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -64.84 -40.12 94.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.482 1.113 . . . . 0.0 110.752 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -54.64 -53.6 52.59 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 124.267 1.027 . . . . 0.0 109.484 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.9 -40.82 91.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 123.612 0.57 . . . . 0.0 112.079 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -50.71 -60.56 2.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.822 2.049 . . . . 0.0 110.099 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.05 63.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.585 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.48 -15.82 36.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.386 1.074 . . . . 0.0 111.808 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -42.72 12.18 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 120.006 1.276 . . . . 0.0 109.884 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -63.54 -33.18 75.03 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 172.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 10.55 74.73 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -16.72 63.74 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.418 1.487 . . . . 0.0 112.4 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -74.01 -3.74 31.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.204 1.402 . . . . 0.0 112.64 170.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.87 90.68 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 119.812 1.187 . . . . 0.0 112.571 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.08 173.08 17.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.067 2.147 . . . . 0.0 106.371 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.62 -179.18 34.46 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.803 -164.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -68.26 -19.5 64.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -51.42 118.61 3.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.446 1.021 . . . . 0.0 108.784 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.84 86.98 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.593 -1.67 . . . . 0.0 114.832 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -76.92 146.34 37.65 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 121.342 2.571 . . . . 0.0 107.738 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.21 148.39 22.24 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -93.67 81.06 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -74.06 -17.94 60.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.964 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.75 84.85 2.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.344 0.974 . . . . 0.0 110.61 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.98 97.06 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.89 104.74 23.29 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.51 142.11 83.22 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.911 1.741 . . . . 0.0 110.483 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.79 14.01 81.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.718 1.151 . . . . 0.0 112.929 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -140.67 -81.26 0.25 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.768 1.284 . . . . 0.0 109.047 -170.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.02 167.77 20.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.485 0.714 . . . . 0.0 112.411 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.3 m -123.43 97.61 5.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.818 2.047 . . . . 0.0 109.415 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.12 138.24 31.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.229 1.412 . . . . 0.0 110.824 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.62 72.35 0.09 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-O 118.635 -1.091 . . . . 0.0 113.524 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.29 14.32 1.45 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.262 1.531 . . . . 0.0 116.274 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -91.03 113.49 25.77 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 164.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -96.29 35.7 1.43 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.759 1.623 . . . . 0.0 110.312 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -155.0 -67.07 0.13 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.198 1.399 . . . . 0.0 107.976 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -85.98 168.59 14.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.126 2.17 . . . . 0.0 105.288 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -139.53 31.76 2.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -167.0 4.7 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.984 -158.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.65 -20.19 22.88 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 120.463 1.483 . . . . 0.0 114.903 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 p -84.53 9.14 14.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.825 1.813 . . . . 0.0 113.865 -169.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.81 -153.58 6.94 Favored Glycine 0 C--N 1.333 0.399 0 O-C-N 120.798 -1.188 . . . . 0.0 113.14 -162.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.96 174.34 46.84 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -158.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -166.91 154.26 9.15 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 125.461 1.505 . . . . 0.0 107.529 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.2 p -76.68 144.96 39.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.37 -25.13 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 122.156 0.183 . . . . 0.0 111.151 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -79.9 -13.74 59.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 113.788 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.67 -95.18 0.14 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 120.692 1.587 . . . . 0.0 111.833 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -159.23 112.43 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.212 1.005 . . . . 0.0 109.015 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt 63.4 158.25 0.07 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.824 3.25 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.71 171.33 15.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.769 0.795 . . . . 0.0 109.013 170.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.02 158.38 16.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.058 1.743 . . . . 0.0 113.265 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.99 90.86 2.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 158.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.64 -59.89 4.5 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.456 HD22 HG13 ' A' ' 89' ' ' ILE . 10.1 p-10 -161.49 158.35 26.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.795 1.283 . . . . 0.0 112.561 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.21 31.04 5.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.617 2.367 . . . . 0.0 109.553 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.456 HG13 HD22 ' A' ' 87' ' ' ASN . 21.2 mt -52.67 -40.02 32.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.586 1.154 . . . . 0.0 108.572 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.76 125.16 34.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -102.84 169.22 8.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.01 1.324 . . . . 0.0 108.899 168.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -73.82 89.26 1.82 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.7 p -72.43 -28.56 63.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.34 44.09 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.839 1.209 . . . . 0.0 111.091 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.53 162.43 10.3 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.315 2.01 . . . . 0.0 111.945 169.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.33 77.37 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.198 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.3 mm -77.07 162.46 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 120.139 1.969 . . . . 0.0 108.834 171.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.66 54.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 108.134 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -146.21 147.62 31.65 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.214 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.404 ' HG3' ' CE1' ' A' ' 129' ' ' PHE . 12.8 mtp -85.54 128.6 34.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.909 1.338 . . . . 0.0 111.423 -172.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.42 73.09 4.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.5 2.32 . . . . 0.0 108.724 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -69.26 -179.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.392 158.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.38 20.44 8.81 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.043 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 134.79 -163.01 24.77 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.62 147.04 89.96 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.053 1.836 . . . . 0.0 109.602 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 46.81 32.01 1.64 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.672 1.989 . . . . 0.0 115.789 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.1 p -118.28 23.56 11.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.536 -1.353 . . . . 0.0 111.503 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -63.12 104.3 0.56 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.21 -75.28 1.03 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.605 1.093 . . . . 0.0 111.383 -170.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.1 p -155.74 -21.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.835 1.254 . . . . 0.0 111.486 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -64.2 143.08 58.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.47 169.32 18.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.563 1.545 . . . . 0.0 106.833 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.539 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 17.7 p90 -136.04 152.84 51.32 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.781 0.8 . . . . 0.0 110.366 163.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.79 113.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 166.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -62.73 124.95 22.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.7 p -115.1 31.67 6.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.898 1.332 . . . . 0.0 108.665 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.71 169.45 19.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 110.03 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -73.24 86.68 1.44 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 163.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -76.81 58.01 1.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.073 0.949 . . . . 0.0 110.219 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.89 -30.5 65.93 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.037 -1.665 . . . . 0.0 111.816 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -70.91 -15.24 62.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.081 1.352 . . . . 0.0 110.541 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.539 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 66.2 mt -98.97 -12.49 20.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.372 1.069 . . . . 0.0 111.172 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.44 144.04 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.363 0.983 . . . . 0.0 109.605 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.06 -4.64 37.96 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.829 1.204 . . . . 0.0 113.728 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.96 -59.65 1.99 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 126.515 1.926 . . . . 0.0 108.978 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -96.69 129.28 44.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.891 1.276 . . . . 0.0 108.396 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.8 t -80.11 104.4 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -170.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.97 127.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.404 ' CE1' ' HG3' ' A' ' 100' ' ' MET . 22.4 p90 -140.74 -0.22 1.55 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.603 1.19 . . . . 0.0 113.441 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.92 -176.56 32.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.636 -1.269 . . . . 0.0 112.065 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.29 151.48 34.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.01 127.42 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -94.51 -38.33 10.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.933 0.893 . . . . 0.0 110.389 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -139.29 153.48 47.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 109.829 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.71 72.18 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.241 -0.755 . . . . 0.0 113.011 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.0 tpp -54.85 -36.39 65.0 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.304 1.552 . . . . 0.0 110.004 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -58.8 -27.88 65.47 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.534 1.061 . . . . 0.0 113.643 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.7 mm -75.17 -42.77 44.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 124.484 1.114 . . . . 0.0 108.268 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.35 -41.33 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.46 -34.23 70.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.018 1.327 . . . . 0.0 111.154 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.05 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.695 0.798 . . . . 0.0 110.636 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.6 mtm -55.77 -45.32 78.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.555 0.616 . . . . 0.0 110.128 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.49 -36.86 72.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.599 1.159 . . . . 0.0 112.683 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -69.56 -14.89 63.08 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.105 -0.997 . . . . 0.0 111.306 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 14.18 25.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 126.793 2.037 . . . . 0.0 111.291 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.94 -172.21 31.47 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.6 p -154.52 164.32 38.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.738 -0.86 . . . . 0.0 109.435 165.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.26 -33.91 63.59 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -71.64 -13.59 61.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.3 -26.68 21.05 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 127.274 2.368 . . . . 0.0 113.361 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -66.52 130.04 41.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.6 1.7 . . . . 0.0 108.779 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.6 p -65.7 153.86 40.54 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.594 0.758 . . . . 0.0 110.102 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.8 p -69.32 -25.5 64.24 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.299 -0.875 . . . . 0.0 110.586 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.569 ' HE2' HG12 ' A' ' 12' ' ' VAL . 42.7 mtpt -130.76 174.46 9.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.284 1.434 . . . . 0.0 111.518 -170.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -63.65 139.28 58.75 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 102.903 -2.999 . . . . 0.0 102.903 158.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -129.06 122.6 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 101.217 -3.623 . . . . 0.0 101.217 160.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.53 153.17 43.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -166.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -74.09 110.83 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.43 -46.48 73.0 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.517 0.599 . . . . 0.0 109.468 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -151.03 163.32 39.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.643 0.377 . . . . 0.0 110.045 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 m -148.43 171.1 16.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 171.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.26 174.82 46.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 160.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.573 ' HG2' ' H ' ' A' ' 165' ' ' GLU . 47.0 tt0 -87.11 154.82 20.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.225 1.01 . . . . 0.0 109.93 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.1 mt -136.94 43.41 2.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.18 2.592 . . . . 0.0 109.915 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.573 ' H ' ' HG2' ' A' ' 163' ' ' GLN . 3.5 tm-20 . . . . . 0 C--O 1.246 0.892 0 C-N-CA 127.182 2.193 . . . . 0.0 106.155 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 tmm? . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.316 28.4 m 50.12 -173.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.512 1.125 . . . . 0.0 111.515 -171.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.85 95.79 35.11 Favored Pre-proline 0 C--N 1.323 -0.559 0 O-C-N 120.49 -1.381 . . . . 0.0 107.953 165.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 156.41 66.2 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 121.18 1.253 . . . . 0.0 110.985 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -117.09 151.63 36.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.34 150.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 119.301 0.955 . . . . 0.0 109.434 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -108.21 161.55 14.89 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.124 0.969 . . . . 0.0 108.811 166.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 4.1 m-85 -144.37 108.76 4.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.052 2.141 . . . . 0.0 107.361 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 98.29 9.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.23 138.54 22.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.93 149.99 42.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.827 1.299 . . . . 0.0 108.514 161.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.558 HG12 ' HE2' ' A' ' 154' ' ' LYS . 2.5 t -106.31 80.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 170.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.523 ' OD2' ' HE3' ' A' ' 154' ' ' LYS 0.378 3.7 p30 61.74 14.09 5.88 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.41 -9.25 15.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -73.99 121.6 85.56 Favored Pre-proline 0 C--N 1.338 0.099 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 164.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.12 103.23 1.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.81 2.34 . . . . 0.0 107.732 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.8 tp -83.0 -34.11 26.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.704 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.5 165.7 11.74 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.507 -1.33 . . . . 0.0 114.993 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.27 136.14 44.53 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.3 t -120.05 158.77 21.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 130.232 3.413 . . . . 0.0 105.823 165.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -152.11 155.35 37.71 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.679 -1.888 . . . . 0.0 111.812 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -141.85 145.28 34.48 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.949 1.299 . . . . 0.0 110.079 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -90.77 150.54 21.56 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.437 1.495 . . . . 0.0 107.315 160.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -128.74 128.5 44.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.017 1.327 . . . . 0.0 108.249 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.435 ' CD2' HD13 ' A' ' 90' ' ' LEU . 16.0 m-85 -81.13 49.54 1.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.6 1.56 . . . . 0.0 112.546 -166.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -4.63 7.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.907 1.283 . . . . 0.0 114.379 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.15 -16.78 36.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.98 1.264 . . . . 0.0 111.974 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -121.94 -30.31 4.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.64 1.176 . . . . 0.0 113.258 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 86' ' ' GLU . 6.1 m -129.88 73.31 81.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 124.685 1.194 . . . . 0.0 107.858 169.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.75 -39.25 43.96 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.575 2.183 . . . . 0.0 113.434 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -51.34 67.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.499 1.045 . . . . 0.0 108.211 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.504 HG23 ' SD ' ' A' ' 100' ' ' MET . 4.8 m -61.55 -49.1 78.05 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.257 1.023 . . . . 0.0 110.732 -170.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.2 -45.4 70.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 112.242 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -63.4 -42.04 98.76 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.466 0.306 . . . . 0.0 111.302 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -56.98 -47.97 79.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.121 1.368 . . . . 0.0 109.439 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.1 -38.64 88.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.856 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -55.23 -58.17 8.79 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.767 0.712 . . . . 0.0 109.135 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.96 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.245 1.418 . . . . 0.0 113.652 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.8 mt -84.04 -26.96 28.67 Favored 'General case' 0 N--CA 1.457 -0.078 0 O-C-N 121.567 -0.708 . . . . 0.0 111.599 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 m -77.52 -43.43 32.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.581 0.752 . . . . 0.0 110.326 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -63.96 -27.35 69.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.89 7.51 62.16 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.41 -27.85 69.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.59 1.156 . . . . 0.0 111.189 -171.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 29.3 mmmt -65.49 -14.71 61.6 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.959 -1.02 . . . . 0.0 112.26 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.93 4.17 48.44 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.251 1.405 . . . . 0.0 112.228 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -163.6 175.99 10.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.078 1.751 . . . . 0.0 107.968 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.77 -149.49 19.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-O 122.029 0.794 . . . . 0.0 112.831 165.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -59.96 -44.74 94.24 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 127.14 2.176 . . . . 0.0 109.655 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -44.62 112.83 0.46 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.015 1.326 . . . . 0.0 110.004 170.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.05 3.64 88.92 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.097 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.3 m -63.86 -62.76 1.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.907 2.354 . . . . 0.0 110.8 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 t 122.85 167.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 131.774 4.03 . . . . 0.0 106.583 -168.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.435 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 51.5 m-85 -119.68 91.96 3.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.583 1.953 . . . . 0.0 106.198 170.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -73.76 -18.34 60.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -164.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.26 104.08 4.22 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.58 103.09 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.0 mt -119.03 91.0 42.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -48.24 122.62 7.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.01 3.14 . . . . 0.0 114.859 -167.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.56 21.27 77.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.133 1.349 . . . . 0.0 112.37 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.11 -75.57 0.55 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.38 170.99 19.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.227 1.011 . . . . 0.0 109.413 167.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 p -130.77 107.97 9.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.797 0.839 . . . . 0.0 110.411 168.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -86.96 140.86 29.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 129.028 2.931 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -148.75 -163.09 10.66 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 124.959 1.266 . . . . 0.0 110.845 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 48' ' ' TYR . . . 91.96 10.68 61.04 Favored Glycine 0 N--CA 1.463 0.496 0 CA-C-N 117.717 0.758 . . . . 0.0 114.89 166.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.82 103.91 13.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 107.552 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -115.45 9.94 15.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.478 1.511 . . . . 0.0 111.747 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.6 t -139.15 -35.41 0.56 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.596 1.158 . . . . 0.0 113.629 -166.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -129.87 -36.54 1.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -167.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.5 m170 61.4 56.8 2.52 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.673 1.189 . . . . 0.0 112.078 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -164.51 -54.05 0.03 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.015 1.326 . . . . 0.0 110.169 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.94 -21.44 0.18 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.751 1.643 . . . . 0.0 113.242 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -84.55 12.12 7.57 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.875 1.837 . . . . 0.0 111.57 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.48 -165.13 15.77 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 124.727 1.156 . . . . 0.0 110.696 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.47 103.75 0.17 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -136.3 144.36 44.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.592 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -70.62 164.4 25.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.256 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.412 ' HB ' ' HE2' ' A' ' 44' ' ' LYS . 41.9 pt -61.32 -31.64 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 121.563 -0.711 . . . . 0.0 110.018 163.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.82 -14.53 61.11 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.516 0.726 . . . . 0.0 112.277 -172.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.01 -85.71 0.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -156.17 132.19 9.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 108.593 163.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttt 52.31 149.88 0.0 OUTLIER 'General case' 0 C--N 1.342 0.281 1 C-N-CA 132.618 4.367 . . . . 0.0 115.375 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -128.69 -172.56 2.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.27 152.37 43.34 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 167.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.64 101.02 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 159.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HG3' HG12 ' A' ' 29' ' ' VAL . 11.0 pt-20 -63.65 -51.02 66.98 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.448 -168.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -151.67 176.24 11.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.373 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -127.78 30.26 5.32 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.618 2.367 . . . . 0.0 109.462 172.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.8 mt -57.27 -46.5 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 25' ' ' PHE . 99.0 mt -74.57 112.57 10.89 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -82.17 164.26 21.38 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.942 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.78 98.41 4.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.2 p -77.87 -32.93 52.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.798 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.6 -174.98 47.35 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 118.964 0.802 . . . . 0.0 113.851 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.72 160.02 26.37 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.486 2.124 . . . . 0.0 110.457 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.29 -5.93 40.01 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.836 -1.536 . . . . 0.0 112.465 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.92 156.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.925 2.362 . . . . 0.0 107.584 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.17 129.33 54.94 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.641 1.177 . . . . 0.0 108.421 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.1 t -138.53 148.98 44.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.026 0.829 . . . . 0.0 109.28 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.504 ' SD ' HG23 ' A' ' 32' ' ' THR . 12.9 ttt -100.45 130.44 46.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -162.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.498 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -75.54 155.64 35.87 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.813 1.245 . . . . 0.0 108.842 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -165.38 -169.1 1.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.922 1.689 . . . . 0.0 108.029 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -119.61 13.66 12.55 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.457 1.103 . . . . 0.0 113.049 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.42 -142.39 13.77 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -168.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.03 157.3 62.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.873 1.715 . . . . 0.0 109.521 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 34.18 51.04 0.4 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 128.163 2.585 . . . . 0.0 112.999 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 p -140.63 13.92 2.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.713 0.805 . . . . 0.0 113.069 -173.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -57.79 96.61 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.754 1.622 . . . . 0.0 110.826 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.19 -84.66 1.08 Allowed Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.048 -1.032 . . . . 0.0 111.529 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -156.29 -17.43 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -55.61 140.52 40.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 167.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.498 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -138.88 169.98 16.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.475 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 19.8 p90 -132.34 147.35 52.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.865 0.84 . . . . 0.0 111.663 166.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.4 mt -83.37 117.43 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 102.413 -3.18 . . . . 0.0 102.413 171.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.1 m -64.38 120.91 13.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.0 p -106.88 22.16 16.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.127 0.571 . . . . 0.0 109.629 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.39 -179.56 7.8 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 163.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -64.12 117.27 6.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 159.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.435 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 49.8 p -114.21 56.88 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.175 0.898 . . . . 0.0 111.327 -174.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -61.31 -25.08 66.88 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 120.86 -1.15 . . . . 0.0 113.959 -169.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.435 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 37.3 p90 -66.11 -21.82 66.37 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.814 0.846 . . . . 0.0 110.708 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.609 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 82.9 mt -88.65 -16.89 31.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.657 0.783 . . . . 0.0 110.569 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.77 149.0 38.07 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.34 69.84 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.611 -0.328 . . . . 0.0 112.34 -169.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.91 -45.11 0.47 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.179 0.99 . . . . 0.0 109.473 164.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -103.82 144.67 31.19 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.863 1.265 . . . . 0.0 109.486 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.3 102.15 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.05 121.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -142.14 1.36 1.43 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.024 -169.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.79 -177.25 35.64 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.973 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 157.84 43.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.138 0.495 . . . . 0.0 109.954 162.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.03 124.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -84.82 -48.01 9.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.329 160.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -146.06 158.29 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.681 1.192 . . . . 0.0 110.292 -168.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.46 20.08 64.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -34.89 60.57 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.539 1.67 . . . . 0.0 111.186 174.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -32.95 69.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.6 mm -78.14 -34.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 119.541 1.064 . . . . 0.0 109.492 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.21 -40.77 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.143 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.18 -37.01 81.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.672 0.789 . . . . 0.0 111.095 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.79 83.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.204 1.366 . . . . 0.0 108.288 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.0 mtm -52.41 -48.53 65.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 118.003 0.365 . . . . 0.0 110.568 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.03 -34.12 72.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -76.92 -15.67 59.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.892 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -89.46 -5.42 57.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.011 0.924 . . . . 0.0 111.806 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.51 -167.98 42.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.852 1.692 . . . . 0.0 109.782 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 51.2 p -161.49 155.74 22.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -18.88 65.54 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -69.43 -7.19 35.59 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.32 -30.29 10.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 127.787 2.613 . . . . 0.0 113.016 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -63.11 129.78 41.82 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.061 0.944 . . . . 0.0 110.56 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 p -80.01 157.97 26.65 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.824 1.25 . . . . 0.0 109.72 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -76.19 -17.73 59.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.286 1.035 . . . . 0.0 111.786 167.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.558 ' HE2' HG12 ' A' ' 12' ' ' VAL . 12.3 mtpt -140.85 165.3 27.9 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.407 1.483 . . . . 0.0 109.572 -168.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 13' ' ' ASP . 30.8 tttt -85.69 80.14 9.09 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.995 1.725 . . . . 0.0 107.515 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -73.87 131.24 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 p -145.69 167.34 23.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 123.488 1.613 . . . . 0.0 110.063 -167.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.408 HD13 ' O ' ' A' ' 48' ' ' TYR . 4.0 mp -83.02 114.56 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 158.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.59 -55.04 12.91 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.04 153.01 33.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.619 1.568 . . . . 0.0 107.076 -161.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 8' ' ' PHE . 7.5 m -159.71 174.16 14.95 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.951 1.701 . . . . 0.0 109.156 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.25 -172.01 44.84 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 165.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -83.49 160.4 21.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.123 0.969 . . . . 0.0 108.578 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.2 mt -128.27 43.28 3.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.197 0.999 . . . . 0.0 108.877 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 N--CA 1.435 -1.218 0 C-N-CA 131.638 3.975 . . . . 0.0 109.821 -168.698 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.58 178.29 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.564 1.146 . . . . 0.0 108.473 161.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -44.48 145.0 1.56 Allowed Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 126.976 2.111 . . . . 0.0 113.057 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.84 156.26 66.89 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.863 1.709 . . . . 0.0 109.279 165.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.1 m -135.82 158.77 43.58 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.85 155.43 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 119.493 -2.004 . . . . 0.0 109.228 -169.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -124.38 157.3 35.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.874 1.269 . . . . 0.0 109.947 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 161' ' ' CYS . 88.1 m-85 -147.16 106.23 3.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.204 2.202 . . . . 0.0 107.738 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.49 93.56 3.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.17 143.7 15.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.6 133.54 47.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.443 1.097 . . . . 0.0 110.19 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 t -99.76 96.19 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 128.094 2.558 . . . . 0.0 104.603 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 58.71 17.96 5.56 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.763 2.025 . . . . 0.0 114.037 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.36 -9.72 24.37 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.319 1.914 . . . . 0.0 112.518 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.96 131.94 52.47 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.22 113.67 2.94 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.82 1.68 . . . . 0.0 109.659 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.3 tp -79.59 -37.28 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.554 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.28 171.03 14.0 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -81.68 139.8 34.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.92 153.41 35.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 127.066 2.146 . . . . 0.0 105.395 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.72 139.03 11.15 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 -166.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -134.04 149.76 51.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.621 0.769 . . . . 0.0 111.006 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -87.12 151.67 23.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 158.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 mt -127.46 109.48 11.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -68.97 61.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.84 2.456 . . . . 0.0 112.049 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.38 -30.17 38.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.463 1.905 . . . . 0.0 112.222 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 -19.55 62.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.901 1.681 . . . . 0.0 110.818 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -38.89 2.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.353 2.261 . . . . 0.0 110.664 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 129' ' ' PHE . 3.8 m -141.24 72.71 26.55 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.758 2.023 . . . . 0.0 108.645 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.59 -41.43 39.73 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.845 2.363 . . . . 0.0 113.712 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -57.73 11.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.351 1.432 . . . . 0.0 107.69 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 m -57.77 -44.08 85.92 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.712 0.632 . . . . 0.0 109.841 -169.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.48 67.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.799 0.84 . . . . 0.0 113.257 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -66.75 -39.96 88.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.713 0.688 . . . . 0.0 110.574 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -55.99 -52.53 63.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.75 1.22 . . . . 0.0 109.712 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.511 ' CE2' ' CE2' ' A' ' 112' ' ' PHE . 2.3 t80 -56.12 -49.86 72.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.601 0.36 . . . . 0.0 110.679 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.433 ' HD2' HE21 ' A' ' 163' ' ' GLN . 45.8 ttp85 -50.96 -60.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.011 1.324 . . . . 0.0 109.926 -173.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.54 -27.12 68.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -77.12 -33.85 56.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.922 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.5 p -69.95 -45.55 67.19 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.98 1.264 . . . . 0.0 111.093 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.0 p -64.68 -36.8 85.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.565 0.746 . . . . 0.0 109.085 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.23 14.31 82.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.24 -28.29 67.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.15 1.38 . . . . 0.0 112.031 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -72.33 8.96 1.14 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.529 1.132 . . . . 0.0 112.917 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -3.69 83.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.885 1.231 . . . . 0.0 112.805 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.2 176.45 12.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.5 1.65 . . . . 0.0 108.65 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.55 -146.88 17.6 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.561 ' CE1' ' CE2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -61.24 -38.69 87.59 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.213 1.405 . . . . 0.0 112.532 -163.072 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -47.15 116.78 1.49 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.398 1.079 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.98 4.24 90.34 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.427 -1.763 . . . . 0.0 115.728 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -64.24 -35.21 80.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 121.502 2.651 . . . . 0.0 113.589 -162.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.4 m 86.0 164.93 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.611 2.764 . . . . 0.0 107.868 -158.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -119.01 101.57 8.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 164.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.194 0.907 . . . . 0.0 113.043 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.571 ' HG3' HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -133.12 114.25 13.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.81 120.69 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.571 HD11 ' HG3' ' A' ' 55' ' ' ARG . 4.9 mp -124.89 99.95 34.39 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.2 136.45 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.107 1.871 . . . . 0.0 110.52 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 22.93 78.58 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.766 1.65 . . . . 0.0 112.198 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -146.93 -81.89 0.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.805 1.303 . . . . 0.0 109.144 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.554 ' CE ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -161.77 168.72 22.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.724 0.693 . . . . 0.0 112.301 174.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.0 m -120.84 108.44 13.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.212 1.805 . . . . 0.0 108.003 170.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -95.44 133.4 39.45 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 110.342 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 177.86 29.87 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.02 20.11 4.57 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.492 1.044 . . . . 0.0 112.62 -174.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -84.03 28.88 0.58 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.619 1.968 . . . . 0.0 111.975 -164.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 10.6 p90 -63.34 1.25 0.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.516 1.926 . . . . 0.0 115.731 -167.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.502 HG21 ' HE2' ' A' ' 76' ' ' LYS . 2.1 p -139.21 -69.08 0.43 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.305 1.842 . . . . 0.0 109.57 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -118.75 162.47 18.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 166.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -148.25 33.77 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.582 1.953 . . . . 0.0 108.063 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -144.96 16.27 1.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.838 3.255 . . . . 0.0 109.525 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.65 -28.05 12.37 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.365 1.459 . . . . 0.0 113.57 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.8 p -83.74 12.39 6.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.099 1.95 . . . . 0.0 113.103 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.56 168.8 13.27 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.743 1.163 . . . . 0.0 111.794 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.95 165.17 30.16 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HE2' HG21 ' A' ' 68' ' ' THR . 3.5 pttt 170.69 -177.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.129 4.172 . . . . 0.0 103.914 -160.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.9 p -127.25 178.6 5.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.455 1.025 . . . . 0.0 110.311 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.14 -22.89 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.131 168.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.93 1.78 56.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.514 1.525 . . . . 0.0 111.681 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.69 -112.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.24 -133.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.83 2.052 . . . . 0.0 110.389 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -102.74 154.67 18.94 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.331 -1.48 . . . . 0.0 109.261 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -111.0 165.45 11.86 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 109.888 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 156.17 31.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.175 0.988 . . . . 0.0 110.863 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 101.82 2.78 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.13 -48.98 77.34 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.465 1.106 . . . . 0.0 110.62 -164.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -170.12 176.28 4.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.24 2.216 . . . . 0.0 107.96 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.45 43.21 3.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.72 1.208 . . . . 0.0 108.357 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.0 mt -60.56 -65.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -72.67 143.64 48.03 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.954 1.835 . . . . 0.0 107.32 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -131.55 161.6 32.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 127.057 2.143 . . . . 0.0 109.008 -170.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -84.97 73.13 10.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.597 1.159 . . . . 0.0 109.055 -164.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 p -66.07 -31.58 72.54 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.832 0.853 . . . . 0.0 113.003 -165.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.28 171.34 31.38 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.75 -1.028 . . . . 0.0 110.965 -166.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.8 135.96 54.97 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.314 2.009 . . . . 0.0 111.669 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.35 -8.01 30.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.065 -1.409 . . . . 0.0 111.731 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.5 mm -72.31 148.3 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 121.124 2.462 . . . . 0.0 108.662 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.51 131.45 55.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.403 1.081 . . . . 0.0 108.263 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.3 t -140.51 159.82 41.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.857 0.863 . . . . 0.0 110.005 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.31 137.56 32.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -163.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -90.48 71.48 6.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.11 163.62 27.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.411 158.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.08 16.47 12.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.664 1.586 . . . . 0.0 111.646 -168.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.27 -170.81 28.05 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 -159.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -65.11 172.26 7.7 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 CA-C-N 119.898 1.849 . . . . 0.0 109.86 165.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.93 14.7 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 131.12 3.768 . . . . 0.0 116.221 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -108.63 27.26 9.59 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.857 -1.777 . . . . 0.0 111.03 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.408 2.683 . . . . 0.0 106.459 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.59 -93.75 0.32 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -172.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.5 t -144.34 -11.25 0.63 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.45 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -79.48 135.22 36.59 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CE2' ' CE1' ' A' ' 48' ' ' TYR . 37.1 p90 -145.29 177.27 8.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.679 1.192 . . . . 0.0 108.449 174.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -142.08 151.57 42.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.872 1.32 . . . . 0.0 112.587 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.81 101.9 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 101.569 -3.493 . . . . 0.0 101.569 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.68 94.42 0.3 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.4 p -87.1 25.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.804 0.842 . . . . 0.0 111.009 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.15 -178.22 7.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 163.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -67.2 130.84 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 158.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.6 p -131.62 57.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -14.37 61.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.183 0.993 . . . . 0.0 112.408 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -69.57 -7.95 43.0 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.106 -0.996 . . . . 0.0 111.055 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -109.46 -8.68 14.99 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.479 1.512 . . . . 0.0 111.996 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 149.05 30.17 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.059 0.943 . . . . 0.0 111.011 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.14 18.65 49.34 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.27 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -144.25 -34.33 0.38 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.576 1.15 . . . . 0.0 110.449 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -118.09 139.36 51.35 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.389 1.076 . . . . 0.0 108.194 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.76 96.87 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -167.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.17 127.02 22.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.419 ' HA ' HG21 ' A' ' 29' ' ' VAL . 15.8 p90 -134.83 -6.5 2.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.049 -0.977 . . . . 0.0 113.256 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.13 -179.28 31.05 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.28 -1.438 . . . . 0.0 112.855 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -153.65 138.3 16.93 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -53.73 114.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 125.059 1.344 . . . . 0.0 108.388 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -83.26 -52.27 6.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.83 160.05 40.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.715 1.143 . . . . 0.0 112.116 -168.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.69 77.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.526 1.06 . . . . 0.0 112.098 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -37.99 71.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.86 1.33 . . . . 0.0 110.843 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.22 -29.15 68.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.946 -1.096 . . . . 0.0 112.508 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.6 mm -72.51 -35.46 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.614 1.166 . . . . 0.0 108.98 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.36 -44.05 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.983 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -27.44 68.91 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.962 -1.086 . . . . 0.0 112.779 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.84 -46.32 68.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.939 -1.101 . . . . 0.0 108.474 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 15.8 mtm -53.08 -46.7 68.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.374 0.534 . . . . 0.0 111.234 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -52.29 -42.49 63.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.469 1.108 . . . . 0.0 111.842 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.47 -19.52 64.56 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.922 -0.486 . . . . 0.0 110.822 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.445 ' CB ' HD11 ' A' ' 156' ' ' ILE . 55.1 m-85 -98.02 5.01 49.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.692 1.597 . . . . 0.0 111.664 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.2 -163.93 37.94 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 98.5 p -152.41 163.57 39.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 57' ' ' ILE . 44.9 mtm-85 -67.03 -22.4 65.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.25 -1.531 . . . . 0.0 113.462 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -75.33 -15.69 60.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 168.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 102.06 -27.98 17.98 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-O 117.644 -1.642 . . . . 0.0 114.259 171.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -66.95 124.63 23.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.209 2.005 . . . . 0.0 107.246 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.9 p -73.31 147.85 44.08 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.924 0.889 . . . . 0.0 109.895 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.0 p -77.61 -9.98 59.25 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.23 -0.919 . . . . 0.0 111.784 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -136.96 152.32 50.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.968 1.307 . . . . 0.0 109.546 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -73.06 109.08 6.33 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.445 HD11 ' CB ' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -101.88 130.45 51.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -177.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.2 p -141.84 173.36 11.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.55 1.94 . . . . 0.0 110.552 -170.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.409 HD11 ' CE2' ' A' ' 48' ' ' TYR . 3.2 mt -106.61 116.55 50.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 167.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.12 -60.01 4.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -163.01 176.55 10.01 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.735 1.614 . . . . 0.0 111.388 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 8' ' ' PHE . 1.4 p -169.5 172.4 7.06 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.425 1.09 . . . . 0.0 110.628 -159.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.82 -172.23 45.11 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.433 HE21 ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -90.63 160.47 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.115 0.966 . . . . 0.0 110.327 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 39.0 mt -136.9 43.66 2.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.595 1.558 . . . . 0.0 109.011 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.745 -176.041 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mmm . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 3' ' ' ASN . 4.9 p -65.86 -174.26 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.973 0.892 . . . . 0.0 109.005 166.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.517 ' H ' HG22 ' A' ' 2' ' ' VAL . 35.6 m120 -27.94 99.98 0.11 Allowed Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 129.466 3.106 . . . . 0.0 114.331 167.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -76.36 149.95 31.92 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 N-CA-C 109.283 -1.084 . . . . 0.0 109.283 165.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -101.48 151.15 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.78 163.7 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.537 1.535 . . . . 0.0 108.252 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -134.09 158.42 43.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.15 0.98 . . . . 0.0 110.471 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -128.86 123.77 33.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.856 2.462 . . . . 0.0 106.317 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -78.19 98.92 6.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.8 mm -70.28 140.14 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.151 -0.968 . . . . 0.0 109.562 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.49 50.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.581 1.152 . . . . 0.0 110.4 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 6.7 t -132.74 100.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -165.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.24 13.69 0.65 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.599 1.959 . . . . 0.0 112.86 -161.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.19 38.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.525 1.536 . . . . 0.0 113.298 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -80.51 126.87 77.54 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 120.015 1.908 . . . . 0.0 106.188 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 115.89 3.65 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.822 1.681 . . . . 0.0 109.078 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.9 tp -85.2 -39.6 17.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.563 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.97 158.34 9.01 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.495 -0.383 . . . . 0.0 112.218 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -68.97 146.43 52.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 164.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.453 HG12 ' CZ ' ' A' ' 22' ' ' PHE . 39.2 t -135.33 143.29 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 171.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -137.02 153.18 50.72 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.166 0.586 . . . . 0.0 110.031 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.453 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 11.3 m-85 -146.54 146.69 30.58 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.477 1.111 . . . . 0.0 108.909 -165.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.03 145.88 27.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 165.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -118.65 146.78 44.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 108.734 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -97.54 61.66 1.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.543 1.537 . . . . 0.0 111.102 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.2 42.05 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.29 0.636 . . . . 0.0 112.236 171.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.58 -0.89 39.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.931 2.093 . . . . 0.0 113.307 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -127.83 -37.27 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.142 1.337 . . . . 0.0 110.716 166.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.07 73.68 74.69 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.148 1.379 . . . . 0.0 107.457 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.38 -43.09 36.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -49.88 67.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.924 0.783 . . . . 0.0 109.828 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.7 m -55.21 -46.66 75.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.991 1.316 . . . . 0.0 109.769 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -51.9 55.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.621 0.769 . . . . 0.0 111.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.59 -39.0 93.27 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.322 1.049 . . . . 0.0 111.618 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -51.88 -60.92 2.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.191 1.396 . . . . 0.0 109.718 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -66.12 -28.27 68.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.221 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -53.88 -64.11 0.93 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.206 1.402 . . . . 0.0 109.16 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.9 -16.62 61.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.58 -31.37 16.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.879 1.272 . . . . 0.0 110.903 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -79.36 -24.39 42.72 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 111.761 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.6 p -79.24 -39.06 34.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.24 19.72 78.07 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.0 -16.05 63.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.806 1.303 . . . . 0.0 112.942 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -87.48 9.43 20.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.213 1.005 . . . . 0.0 112.032 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.04 16.47 79.53 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.419 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.83 -173.73 4.69 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.968 1.707 . . . . 0.0 108.678 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.71 -146.19 17.89 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CE2' HD11 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -64.04 -27.99 69.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.791 1.636 . . . . 0.0 111.767 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 11.3 tmtt? -62.01 109.64 1.34 Allowed 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.879 -0.513 . . . . 0.0 110.164 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.57 89.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 116.938 -2.035 . . . . 0.0 115.061 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -68.13 151.28 47.24 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 121.89 2.845 . . . . 0.0 108.324 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.427 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 65.2 m -86.15 171.09 11.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 159.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CB ' HD11 ' A' ' 56' ' ' ILE . 55.0 m-85 -116.09 120.08 37.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -73.67 -45.41 52.71 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.73 102.05 6.4 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 123.807 0.692 . . . . 0.0 110.877 -157.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.409 HD11 ' CB ' ' A' ' 53' ' ' PHE . 29.8 mt -130.06 108.42 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -170.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.43 97.47 50.18 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -55.05 128.79 32.04 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.299 1.999 . . . . 0.0 112.705 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 46.31 85.42 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 125.011 1.291 . . . . 0.0 110.156 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -153.55 -79.23 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.58 168.4 16.43 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.805 1.242 . . . . 0.0 109.668 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.81 109.49 7.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.201 . . . . 0.0 111.551 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -101.64 143.02 32.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.439 2.696 . . . . 0.0 110.774 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.34 20.02 0.63 Allowed Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.55 3.39 42.79 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 119.136 1.468 . . . . 0.0 116.045 -159.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -83.98 23.86 0.98 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.485 2.142 . . . . 0.0 112.833 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -33.37 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 1 C-N-CA 133.515 4.726 . . . . 0.0 119.989 -158.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -87.75 -22.28 24.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.865 1.666 . . . . 0.0 111.265 173.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -133.19 177.98 7.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 128.998 2.919 . . . . 0.0 106.867 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -156.17 44.03 0.42 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.84 1.256 . . . . 0.0 108.651 -168.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -140.34 -8.36 1.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 110.824 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.45 56.98 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 117.828 -1.54 . . . . 0.0 113.801 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.2 p -135.57 65.85 1.53 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.375 2.088 . . . . 0.0 110.077 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.17 -154.1 6.95 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' H ' HG22 ' A' ' 68' ' ' THR . . . 81.86 170.67 44.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.115 0.864 . . . . 0.0 112.78 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 150.88 9.97 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.879 1.272 . . . . 0.0 109.327 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.2 p -89.63 35.2 0.82 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -166.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 pt 42.1 -3.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 130.645 3.578 . . . . 0.0 118.049 -162.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -134.28 12.21 3.85 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.644 2.377 . . . . 0.0 110.774 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.15 -156.82 27.38 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -68.5 -132.91 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.444 1.498 . . . . 0.0 108.446 160.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -74.69 170.57 15.55 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.092 -1.63 . . . . 0.0 111.257 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -130.6 178.5 6.58 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.96 1.704 . . . . 0.0 108.038 169.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.74 172.84 2.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.198 0.999 . . . . 0.0 112.11 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -79.46 99.19 7.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 160.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.063 1.345 . . . . 0.0 112.269 -166.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -160.6 175.7 12.4 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.009 1.324 . . . . 0.0 108.32 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.41 26.67 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.169 1.388 . . . . 0.0 109.557 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.38 -46.61 81.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.62 132.25 34.2 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -133.67 154.94 50.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.331 1.853 . . . . 0.0 109.224 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -75.84 85.5 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.047 1.339 . . . . 0.0 110.27 -168.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -7.83 59.63 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 113.962 -172.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.71 -178.8 33.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.37 156.06 53.71 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.864 1.709 . . . . 0.0 110.514 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.85 89.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.981 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.85 160.94 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.241 2.02 . . . . 0.0 107.8 169.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.21 136.59 54.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.239 1.416 . . . . 0.0 107.303 169.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 22.8 t -127.08 138.29 53.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.8 mtp -67.57 152.86 44.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 158.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.89 154.72 36.73 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.531 1.532 . . . . 0.0 108.874 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -138.49 -171.19 3.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.132 2.173 . . . . 0.0 107.301 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.94 25.15 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.76 1.624 . . . . 0.0 110.593 -175.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.67 -161.58 24.79 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.2 154.86 60.1 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 120.474 2.137 . . . . 0.0 109.4 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 43.99 43.66 5.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.716 2.406 . . . . 0.0 114.136 159.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.6 p -132.59 29.79 4.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.258 1.423 . . . . 0.0 110.048 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -71.39 107.69 4.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.79 -95.21 1.55 Allowed Glycine 0 C--O 1.225 -0.423 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 p -129.65 1.7 4.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.787 1.635 . . . . 0.0 110.893 170.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -58.3 141.84 49.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.905 1.682 . . . . 0.0 108.359 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.61 174.39 15.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.544 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 11.5 p90 -147.35 161.08 41.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 158.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.39 129.05 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 159.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.45 118.19 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.7 p -108.09 21.32 17.54 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.673 1.589 . . . . 0.0 109.521 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -156.57 174.75 14.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 167.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -71.53 85.41 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 162.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -78.18 60.34 2.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.273 1.029 . . . . 0.0 110.781 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.34 -15.1 62.99 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.667 -1.27 . . . . 0.0 112.453 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -76.87 -18.04 58.59 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.104 1.361 . . . . 0.0 111.944 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.544 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 69.2 mt -97.74 -7.94 29.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.179 1.392 . . . . 0.0 110.402 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.62 138.3 56.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.93 -11.29 1.97 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.586 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -93.76 -39.0 10.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.666 1.733 . . . . 0.0 108.421 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -130.92 155.6 46.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.092 0.472 . . . . 0.0 111.433 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.29 93.54 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.531 1.532 . . . . 0.0 108.195 -165.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.59 131.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 1.18 0.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.248 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -163.27 -175.16 33.98 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -153.0 150.93 29.71 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.838 0.855 . . . . 0.0 110.016 165.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.98 117.56 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.574 1.549 . . . . 0.0 107.653 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -72.62 -48.31 40.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.318 167.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -149.23 160.29 43.51 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 109.064 -162.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.02 16.29 76.62 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.515 0.579 . . . . 0.0 113.392 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -37.74 67.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.816 1.808 . . . . 0.0 111.195 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.0 -21.08 65.07 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.056 -1.028 . . . . 0.0 113.752 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.4 mm -81.79 -34.43 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.186 1.394 . . . . 0.0 108.835 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.44 -37.1 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.668 -1.27 . . . . 0.0 109.348 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -69.79 -23.75 63.39 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 120.546 -1.346 . . . . 0.0 112.595 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.63 -42.85 77.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.965 -1.084 . . . . 0.0 109.626 168.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 23.0 mtp -62.32 -46.9 86.65 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 122.331 -0.231 . . . . 0.0 110.972 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -66.14 -29.69 70.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -76.49 -15.99 59.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.328 0.967 . . . . 0.0 112.46 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -95.05 18.82 11.39 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 127.088 2.155 . . . . 0.0 112.285 163.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.49 -147.89 15.36 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.418 1.961 . . . . 0.0 110.616 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.3 p -146.14 -81.86 0.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.451 0.625 . . . . 0.0 110.807 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 169.06 -21.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 131.529 3.932 . . . . 0.0 111.215 167.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -19.57 63.93 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.776 1.171 . . . . 0.0 109.855 159.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.03 -26.91 10.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.565 -1.131 . . . . 0.0 111.894 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -70.83 123.63 22.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 119.416 1.608 . . . . 0.0 107.054 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.8 p -72.18 153.98 41.31 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.205 1.802 . . . . 0.0 111.553 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.82 -5.02 59.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.782 1.233 . . . . 0.0 112.426 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.414 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 20.4 mmtt -137.97 161.23 37.22 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.793 2.037 . . . . 0.0 109.212 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -75.1 89.07 2.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 163.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.58 130.7 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.73 162.81 36.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.055 0.942 . . . . 0.0 111.743 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.669 HD11 ' CE2' ' A' ' 48' ' ' TYR . 3.9 mp -91.37 119.55 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 158.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.98 -58.92 6.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 164.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -152.79 167.62 28.42 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 49' ' ' LYS . 15.6 p -162.04 171.83 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.52 0.6 . . . . 0.0 111.414 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.32 176.54 48.06 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -76.25 158.38 31.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.575 1.55 . . . . 0.0 109.284 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.1 mt -137.4 42.74 2.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.102 0.953 . . . . 0.0 109.098 159.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.247 0.959 0 C-N-CA 125.143 1.377 . . . . 0.0 107.862 -177.768 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.8 t -68.02 176.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 161.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -48.65 110.8 1.58 Allowed Pre-proline 0 C--O 1.236 0.345 0 CA-C-O 117.422 -1.275 . . . . 0.0 108.922 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -65.19 133.36 35.02 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 CA-C-N 120.774 1.312 . . . . 0.0 109.66 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -89.41 152.3 21.56 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -135.91 157.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.019 -1.051 . . . . 0.0 109.036 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -124.65 153.5 42.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.227 1.011 . . . . 0.0 108.727 170.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -132.86 117.96 18.37 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.496 1.918 . . . . 0.0 106.053 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.02 97.16 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.7 mm -68.77 147.54 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.72 153.37 45.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.309 1.844 . . . . 0.0 109.577 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.92 108.36 19.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.27 13.95 4.29 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 114.236 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.49 -0.5 63.45 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.55 1.071 . . . . 0.0 112.889 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.12 146.71 90.15 Favored Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 159.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 130.55 27.29 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 N-CA-C 107.819 -1.646 . . . . 0.0 107.819 160.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 tp -91.87 -41.69 10.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 108.98 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.46 156.8 8.16 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 118.115 0.416 . . . . 0.0 112.99 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -82.56 114.08 20.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.801 1.24 . . . . 0.0 109.126 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.08 155.65 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.797 1.639 . . . . 0.0 107.082 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -142.14 148.51 38.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 123.46 1.6 . . . . 0.0 111.322 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -131.71 159.61 37.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 113.524 -1.671 . . . . 0.0 107.899 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -120.52 144.41 48.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.785 1.634 . . . . 0.0 106.785 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.85 114.81 16.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -170.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.56 64.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.854 1.662 . . . . 0.0 110.885 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.85 -14.18 60.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 112.607 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -71.02 -36.21 72.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.506 1.122 . . . . 0.0 110.791 168.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -85.77 -56.18 3.61 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.953 0.901 . . . . 0.0 108.907 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.14 71.01 80.23 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.226 1.81 . . . . 0.0 109.385 -165.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 -30.76 78.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.577 2.185 . . . . 0.0 113.626 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -52.3 57.98 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.786 1.63 . . . . 0.0 108.032 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' SD ' ' A' ' 100' ' ' MET . 16.6 m -63.38 -44.82 93.63 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.577 1.151 . . . . 0.0 110.607 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.26 91.86 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.818 -0.551 . . . . 0.0 111.871 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.37 -44.71 78.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.433 1.093 . . . . 0.0 110.651 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -54.32 -48.39 71.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.678 1.191 . . . . 0.0 109.604 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -64.35 -36.44 84.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.425 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -57.79 -63.35 1.28 Allowed 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.283 1.033 . . . . 0.0 109.521 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.84 71.81 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.806 0.692 . . . . 0.0 111.205 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.0 mt -67.06 -36.09 81.27 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 121.375 -0.828 . . . . 0.0 110.845 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -68.22 -28.76 67.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.345 0.975 . . . . 0.0 111.999 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -93.95 -26.01 17.03 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.076 0.55 . . . . 0.0 111.201 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 -0.29 86.77 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.902 0.774 . . . . 0.0 112.561 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -38.83 77.45 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.552 1.141 . . . . 0.0 111.991 -165.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -72.55 3.85 4.5 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.08 4.54 84.17 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 119.528 1.058 . . . . 0.0 111.506 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.58 169.8 19.52 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.754 1.621 . . . . 0.0 107.167 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.46 -178.51 36.45 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-O 122.775 1.208 . . . . 0.0 110.633 -167.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 6.6 t80 -84.73 -23.88 29.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.124 -1.538 . . . . 0.0 111.6 -159.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -46.62 111.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.04 2.136 . . . . 0.0 109.569 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.38 9.69 83.25 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 117.668 -1.629 . . . . 0.0 116.244 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.1 m -68.64 -21.87 64.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.736 2.768 . . . . 0.0 113.209 -174.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.2 t 67.11 132.81 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 129.273 3.029 . . . . 0.0 112.474 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -77.67 76.87 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.52 1.528 . . . . 0.0 108.326 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.401 ' CD2' HH11 ' A' ' 55' ' ' ARG . 27.7 p-80 -74.1 -7.32 52.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.239 1.416 . . . . 0.0 113.56 -174.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.401 HH11 ' CD2' ' A' ' 54' ' ' HIS . 5.1 mpt_? -123.63 128.43 49.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 159.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.6 mt -134.49 106.64 8.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 161.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.5 mt -111.52 98.09 39.12 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.51 124.59 14.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 123.921 3.081 . . . . 0.0 113.11 -170.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.66 38.54 93.3 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.886 1.707 . . . . 0.0 111.237 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -143.13 -81.36 0.19 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.769 1.284 . . . . 0.0 108.624 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.31 169.91 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.328 168.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m -121.08 107.92 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.249 1.819 . . . . 0.0 108.329 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -99.05 138.26 36.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.13 0.972 . . . . 0.0 108.495 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.02 1.98 0.5 Allowed Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.509 -1.162 . . . . 0.0 115.936 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.12 51.4 4.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.773 1.787 . . . . 0.0 115.284 -162.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.16 69.12 1.34 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.334 1.067 . . . . 0.0 110.896 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 31.9 p90 -70.14 -6.08 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.095 0.958 . . . . 0.0 112.812 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -113.9 -38.99 4.07 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 120.871 -1.143 . . . . 0.0 110.625 -160.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -128.44 -17.78 4.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.203 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 45.27 35.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.977 2.111 . . . . 0.0 112.916 175.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -140.78 10.14 2.21 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.386 -0.821 . . . . 0.0 111.961 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.3 -1.9 79.14 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.966 -1.463 . . . . 0.0 112.884 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 p -95.96 -6.48 38.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 120.007 1.903 . . . . 0.0 110.975 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.32 179.1 38.96 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 118.993 0.815 . . . . 0.0 112.315 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.61 115.69 2.21 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 125.471 1.51 . . . . 0.0 111.245 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HE3' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -133.76 169.44 17.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.495 1.918 . . . . 0.0 107.234 166.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.3 p -83.74 -175.18 5.69 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.606 0.639 . . . . 0.0 109.532 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.4 pt -83.48 -20.17 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.841 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -79.74 -35.08 39.34 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.567 0.621 . . . . 0.0 109.422 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.1 -142.07 6.67 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 107.029 -2.428 . . . . 0.0 107.029 -167.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 82' ' ' LYS . 9.7 tt0 -68.82 -156.22 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.033 0.916 . . . . 0.0 110.664 168.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 54.0 mttt -64.96 126.89 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 120.415 -1.428 . . . . 0.0 109.91 -169.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -89.5 175.73 7.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 18.2 pt-20 -77.92 175.28 10.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 11.3 t70 -86.75 104.34 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.883 2.873 . . . . 0.0 108.001 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.15 -41.23 81.88 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.631 -162.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 159.07 157.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 129.354 3.062 . . . . 0.0 111.604 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -106.59 30.14 6.31 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.42 1.888 . . . . 0.0 110.614 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.1 mt -53.01 -48.39 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.209 1.003 . . . . 0.0 108.472 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.89 130.4 36.12 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -130.54 169.57 15.4 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.265 1.426 . . . . 0.0 110.687 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -82.19 81.58 8.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.131 1.372 . . . . 0.0 108.896 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.0 p -75.84 -32.01 59.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.054 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.22 -178.74 44.37 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.628 1.585 . . . . 0.0 110.884 -175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.21 165.1 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.833 2.355 . . . . 0.0 111.226 171.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.44 8.47 75.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.251 -1.305 . . . . 0.0 112.923 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.0 mm -85.61 151.46 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 121.012 2.406 . . . . 0.0 108.953 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.46 131.2 57.0 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.367 -1.458 . . . . 0.0 108.924 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.8 t -148.47 158.27 44.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.497 0.719 . . . . 0.0 111.385 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.481 ' SD ' HG23 ' A' ' 32' ' ' THR . 26.2 mtp -83.49 135.34 34.7 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 124.283 1.033 . . . . 0.0 111.664 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -92.08 71.23 5.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 123.088 1.423 . . . . 0.0 107.558 168.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -75.66 -172.75 1.97 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.27 160.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.21 16.32 9.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.29 1.836 . . . . 0.0 111.423 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.56 -175.37 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.293 1.901 . . . . 0.0 108.782 -164.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.48 142.71 91.41 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.829 1.686 . . . . 0.0 110.017 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 31.3 m-20 64.14 38.26 8.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.931 2.092 . . . . 0.0 112.19 167.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 p -127.87 38.14 4.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.633 0.773 . . . . 0.0 109.81 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -89.88 110.61 21.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.959 1.304 . . . . 0.0 109.139 -172.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.16 -132.57 5.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.2 p -85.49 -18.5 33.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.582 0.753 . . . . 0.0 111.46 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -67.84 126.02 28.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.224 1.012 . . . . 0.0 108.757 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 5.0 p90 -154.03 171.06 19.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 107.73 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 5.2 p90 -141.19 157.95 44.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.433 1.111 . . . . 0.0 112.046 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.25 103.91 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 166.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 9.2 m -60.4 126.12 26.26 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.9 p -116.6 23.15 12.23 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.799 1.24 . . . . 0.0 109.006 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -150.69 175.85 11.57 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.624 -0.673 . . . . 0.0 109.883 162.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -64.69 84.87 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 159.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.444 ' HB ' HD12 ' A' ' 122' ' ' LEU . 8.3 p -82.1 53.4 2.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.086 0.554 . . . . 0.0 111.161 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -63.63 -20.91 66.07 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.148 -1.595 . . . . 0.0 113.159 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -69.98 -4.7 21.95 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.265 1.426 . . . . 0.0 112.079 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 68.6 mt -105.32 -8.17 18.41 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.897 1.279 . . . . 0.0 111.275 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.46 152.47 43.86 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.631 1.105 . . . . 0.0 109.122 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.39 -1.52 65.27 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.726 1.155 . . . . 0.0 113.421 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -132.22 -56.97 0.97 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.891 1.677 . . . . 0.0 108.283 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -99.47 129.29 45.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -170.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.39 104.99 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.92 132.71 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.29 -4.79 1.66 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.8 -173.13 27.9 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.973 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -155.54 146.37 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.507 1.123 . . . . 0.0 108.669 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.68 116.67 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -86.1 -49.95 7.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.99 162.67 34.33 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.211 1.004 . . . . 0.0 112.923 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.98 15.76 66.63 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.142 0.877 . . . . 0.0 112.816 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.3 tpt -55.87 -28.67 57.68 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.749 1.775 . . . . 0.0 111.958 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -62.82 -35.32 79.53 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.244 -0.91 . . . . 0.0 113.194 172.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.98 -39.15 81.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.89 -41.3 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.757 0.708 . . . . 0.0 109.732 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.32 -27.46 69.04 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.703 -1.248 . . . . 0.0 113.244 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.03 -46.57 42.59 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.165 -0.959 . . . . 0.0 109.218 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 79.5 mtp -53.06 -47.58 68.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.249 1.02 . . . . 0.0 110.036 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -62.36 -30.68 71.35 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.702 0.801 . . . . 0.0 112.647 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -24.04 64.45 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.52 -0.738 . . . . 0.0 111.372 174.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -97.08 6.59 48.28 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.872 1.669 . . . . 0.0 112.099 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.07 -173.38 35.92 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 169.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.4 p -157.62 158.88 36.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 166.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.28 -22.39 64.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -6.07 53.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.177 0.899 . . . . 0.0 112.779 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.24 -30.66 9.93 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.09 2.281 . . . . 0.0 112.875 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.04 138.03 26.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.076 0.95 . . . . 0.0 109.498 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.1 p -98.25 138.6 35.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -18.67 63.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.831 0.852 . . . . 0.0 112.12 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.59 161.0 32.51 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.109 0.964 . . . . 0.0 108.875 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 134.78 48.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 mt -132.35 113.56 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -132.48 175.41 9.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.623 1.169 . . . . 0.0 109.657 -166.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.44 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 3.7 mp -100.33 105.61 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 171.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.22 -46.22 87.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.776 0.83 . . . . 0.0 109.976 172.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -151.24 157.4 42.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.0 p -162.68 163.04 27.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.948 0.404 . . . . 0.0 110.64 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.47 -173.01 45.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.551 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 2.6 tp60 -84.78 154.6 22.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.494 1.917 . . . . 0.0 109.358 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.2 mt -131.9 43.69 3.0 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.768 1.27 . . . . 0.0 110.65 160.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.551 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 39.7 tp10 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 102.093 -3.299 . . . . 0.0 102.093 166.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmm? . . . . . 0 CA--C 1.51 -0.567 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.11 155.96 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -65.39 124.8 88.1 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.24 135.92 68.97 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.694 1.596 . . . . 0.0 110.62 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.465 ' H ' ' CB ' ' A' ' 165' ' ' GLU . 52.5 m -94.96 145.04 25.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 m -130.53 149.98 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 171.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -110.65 161.06 16.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.457 1.103 . . . . 0.0 108.779 168.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -139.41 163.17 33.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.153 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.37 99.47 5.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 170.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.4 mm -68.72 148.68 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.0 143.73 51.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.892 0.877 . . . . 0.0 110.421 170.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.99 99.87 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 127.953 2.501 . . . . 0.0 104.338 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.62 13.95 1.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.577 1.951 . . . . 0.0 113.696 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.34 0.49 58.23 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.107 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.22 121.04 81.9 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 159.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.24 112.96 2.24 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 107.364 -1.821 . . . . 0.0 107.364 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.73 -29.42 36.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.029 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.21 167.81 13.84 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.409 0.549 . . . . 0.0 113.145 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -75.57 139.07 41.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 108.886 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -130.24 157.93 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -150.74 155.45 39.31 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.728 -1.233 . . . . 0.0 110.478 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 132' ' ' VAL . 70.6 m-85 -142.23 154.13 44.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.522 1.129 . . . . 0.0 109.447 -170.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.09 141.2 30.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.47 117.69 30.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.968 1.307 . . . . 0.0 107.518 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.29 53.88 0.14 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.906 2.482 . . . . 0.0 114.072 -168.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.47 -28.08 42.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.685 1.994 . . . . 0.0 115.062 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -27.71 67.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.575 1.08 . . . . 0.0 110.151 177.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.57 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -120.36 -21.96 6.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.097 0.959 . . . . 0.0 112.5 -164.219 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 71.63 25.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.68 1.592 . . . . 0.0 107.758 167.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.82 -45.88 37.59 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.951 2.434 . . . . 0.0 111.819 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -54.62 37.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.147 0.885 . . . . 0.0 110.959 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -38.48 86.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.855 -0.528 . . . . 0.0 110.487 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.38 -39.81 64.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.851 -0.531 . . . . 0.0 112.184 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -62.14 -45.81 91.8 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.594 1.158 . . . . 0.0 108.863 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -52.96 -56.37 16.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.745 0.818 . . . . 0.0 108.961 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -26.91 67.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 ttm-85 -55.0 -67.24 0.29 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.497 1.499 . . . . 0.0 107.74 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.782 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -52.28 -38.74 59.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.816 1.246 . . . . 0.0 112.336 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.64 -42.52 86.6 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.619 -0.676 . . . . 0.0 111.132 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -70.71 -34.43 71.93 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.506 -0.746 . . . . 0.0 111.179 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.9 p -79.13 -26.89 42.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.858 -0.526 . . . . 0.0 110.465 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.47 83.08 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.589 1.09 . . . . 0.0 111.834 -176.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.73 -27.82 69.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.854 0.862 . . . . 0.0 112.949 -159.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -74.65 3.56 7.65 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.57 9.3 75.58 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.156 0.889 . . . . 0.0 112.154 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -156.6 174.68 15.09 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.148 1.779 . . . . 0.0 107.601 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.68 -171.07 34.21 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-O 122.808 1.227 . . . . 0.0 114.442 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.407 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -71.27 -25.07 62.3 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.587 2.755 . . . . 0.0 110.369 177.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -52.49 108.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.568 2.347 . . . . 0.0 107.606 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.08 75.66 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.639 -1.089 . . . . 0.0 115.751 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 t -68.12 -10.46 54.24 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.514 1.657 . . . . 0.0 113.323 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t 60.18 176.58 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.82 1.248 . . . . 0.0 110.533 -161.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.05 125.69 46.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 162.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -78.88 -40.0 33.58 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -139.74 110.78 6.9 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 -159.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.49 HD12 ' CG2' ' A' ' 152' ' ' THR . 7.3 mt -128.06 98.14 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -173.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.4 mt -111.12 96.06 28.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -168.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.11 126.64 20.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.051 2.5 . . . . 0.0 112.388 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 36.06 60.4 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.697 1.617 . . . . 0.0 111.77 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -150.32 -76.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.371 1.085 . . . . 0.0 108.545 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.4 171.59 18.8 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.629 0.772 . . . . 0.0 111.121 171.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 30.3 p -128.99 111.64 13.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.309 0.644 . . . . 0.0 111.17 161.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -86.3 135.1 33.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.921 2.489 . . . . 0.0 110.822 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.89 -161.35 9.95 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.751 2.119 . . . . 0.0 108.524 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.79 6.55 67.35 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.086 0.943 . . . . 0.0 113.229 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.72 123.1 29.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 166.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -128.2 7.31 5.96 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.183 1.356 . . . . 0.0 111.989 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.613 HG21 ' CE ' ' A' ' 76' ' ' LYS . 26.5 p -125.03 -13.24 6.87 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.761 1.625 . . . . 0.0 112.203 168.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -132.38 -175.96 3.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 130.171 3.389 . . . . 0.0 105.84 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -164.53 54.0 0.13 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 166.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -159.08 -1.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.415 . . . . 0.0 113.921 -166.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.91 3.12 49.13 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 117.605 -1.664 . . . . 0.0 115.476 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.1 p -131.12 17.67 5.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.095 2.448 . . . . 0.0 115.65 -165.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.35 -94.29 0.64 Allowed Glycine 0 C--N 1.338 0.659 0 O-C-N 120.287 -1.508 . . . . 0.0 112.125 -165.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -7.12 112.63 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 129.077 3.227 . . . . 0.0 115.519 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' CE ' HG21 ' A' ' 68' ' ' THR . 12.2 pttt -127.47 155.52 43.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 128.792 2.837 . . . . 0.0 108.683 -161.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.0 p -72.15 172.59 9.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.91 1.338 . . . . 0.0 110.389 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 38' ' ' ALA . 38.8 pt -75.53 -20.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.061 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -77.71 -36.71 50.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.196 0.998 . . . . 0.0 110.195 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.59 109.05 0.89 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HB2' ' HE3' ' A' ' 82' ' ' LYS 0.336 0.1 OUTLIER 37.25 -133.5 0.09 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.148 1.779 . . . . 0.0 113.041 177.522 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -87.17 161.9 17.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 121.116 1.78 . . . . 0.0 112.234 -176.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -126.52 165.81 18.44 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.144 1.778 . . . . 0.0 110.206 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.78 154.48 36.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.665 0.745 . . . . 0.0 111.968 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.34 123.17 21.07 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.297 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.26 -50.59 69.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.506 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -176.75 171.31 2.26 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.986 2.914 . . . . 0.0 107.502 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -123.03 38.01 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.726 1.61 . . . . 0.0 109.295 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.429 HD12 ' HE2' ' A' ' 28' ' ' LYS . 8.2 mt -63.53 -44.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 174.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 74.4 mt -81.05 128.3 33.57 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 124' ' ' GLY . 3.6 mtmp? -136.46 163.37 30.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.362 -167.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.527 ' H ' ' HB2' ' A' ' 123' ' ' ASP . 31.3 m80 -78.17 90.78 4.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.528 1.131 . . . . 0.0 111.694 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.92 35.07 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.855 -1.153 . . . . 0.0 111.679 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -60.62 165.93 10.71 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.852 2.368 . . . . 0.0 111.75 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.36 -0.16 49.9 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.525 1.059 . . . . 0.0 112.955 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.08 164.31 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.627 1.713 . . . . 0.0 107.914 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.4 HD23 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -136.7 128.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.919 -1.113 . . . . 0.0 109.593 -177.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -143.41 165.29 27.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.328 0.585 . . . . 0.0 110.585 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 108' ' ' ASN . 6.5 ttm -104.75 127.48 52.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -166.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.467 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -78.69 74.99 5.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.052 1.341 . . . . 0.0 108.422 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -70.01 175.05 4.71 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.235 158.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.22 19.73 4.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.264 1.425 . . . . 0.0 111.77 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.84 -167.91 29.34 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.83 159.92 43.42 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-N 119.361 1.58 . . . . 0.0 108.433 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 33.61 54.77 0.52 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.107 3.363 . . . . 0.0 111.944 175.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -131.84 22.49 4.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.743 1.217 . . . . 0.0 111.813 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.46 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 67.8 m-80 -67.29 109.69 3.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.787 2.435 . . . . 0.0 107.69 177.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.05 -85.42 0.91 Allowed Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.315 0.961 . . . . 0.0 111.727 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.0 t -155.92 -30.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.831 1.652 . . . . 0.0 109.381 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -53.91 125.57 19.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.513 1.525 . . . . 0.0 106.983 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.467 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -148.74 170.95 17.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.602 1.561 . . . . 0.0 108.079 -168.693 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -142.03 151.65 42.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.945 0.498 . . . . 0.0 110.86 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.53 122.68 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.43 118.86 12.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.1 p -112.53 27.92 9.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.1 0.952 . . . . 0.0 109.169 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.8 176.04 13.09 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.908 1.283 . . . . 0.0 107.54 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.51 89.17 0.23 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 162.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.8 p -74.77 57.6 0.77 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.449 1.099 . . . . 0.0 111.123 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.34 -20.58 66.46 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.604 -1.31 . . . . 0.0 112.719 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.406 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 29.1 p90 -74.52 -10.57 59.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.994 1.718 . . . . 0.0 111.574 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.406 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.7 mt -113.77 -6.65 13.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.205 1.402 . . . . 0.0 111.226 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.527 ' HB2' ' H ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -76.52 148.76 36.92 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.037 0.935 . . . . 0.0 109.579 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 91' ' ' LYS . . . 62.09 18.6 57.86 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.081 -170.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -140.11 -35.0 0.52 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.488 1.144 . . . . 0.0 109.985 -171.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -112.99 157.95 20.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.366 1.066 . . . . 0.0 109.333 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.3 t -90.18 102.62 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.94 127.61 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 162.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.4 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 29.9 p90 -135.46 1.79 2.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.396 -0.811 . . . . 0.0 112.341 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.47 -177.54 35.58 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 119.632 1.106 . . . . 0.0 112.612 172.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -150.27 153.11 35.59 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.071 1.348 . . . . 0.0 108.253 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' A' ' 22' ' ' PHE . 94.8 t -60.88 125.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.507 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 39.2 mtpt -82.21 -49.79 9.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 162.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -152.08 159.82 43.58 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.948 0.899 . . . . 0.0 111.668 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.94 24.74 61.28 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -54.96 -36.69 65.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.541 1.17 . . . . 0.0 110.704 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -62.18 -27.74 69.18 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.57 -39.91 47.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 CA-C-N 119.788 1.176 . . . . 0.0 108.828 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.98 -44.23 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.45 -29.15 70.21 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.349 -0.845 . . . . 0.0 112.586 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.05 64.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 120.587 -1.32 . . . . 0.0 109.604 173.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.3 mtp -57.62 -45.06 85.87 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.49 -32.79 73.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.469 1.108 . . . . 0.0 113.584 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -72.11 -22.57 61.32 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.538 1.517 . . . . 0.0 110.667 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -94.83 8.94 41.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.359 1.464 . . . . 0.0 111.652 170.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.54 -169.27 41.62 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 126.082 1.801 . . . . 0.0 109.083 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.3 p -156.94 159.21 37.87 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 160.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.4 mtm-85 -69.45 -16.16 63.42 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.228 -1.545 . . . . 0.0 114.516 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -71.94 -14.56 61.95 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.18 -0.95 . . . . 0.0 112.969 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.48 -20.11 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.878 2.18 . . . . 0.0 114.31 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -71.44 128.72 36.8 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.211 2.005 . . . . 0.0 108.104 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.49 ' CG2' HD12 ' A' ' 56' ' ' ILE . 13.1 p -67.62 159.34 30.12 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 110.99 167.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -70.71 -41.3 72.13 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 158.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -99.5 157.97 16.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 0.0 111.869 -168.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.532 ' HE3' HG21 ' A' ' 157' ' ' THR . 3.4 ttpt -69.49 123.78 22.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 158.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.1 mt -120.42 136.04 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.288 1.858 . . . . 0.0 107.924 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.532 HG21 ' HE3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -154.82 169.16 24.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.663 -158.492 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.407 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -104.83 113.39 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 163.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.71 -53.12 52.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -156.75 165.39 36.37 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.192 1.397 . . . . 0.0 108.897 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.8 p -178.51 165.16 1.72 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.553 1.541 . . . . 0.0 109.726 -168.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.58 -175.71 46.61 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.522 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 4.4 tp-100 -79.72 152.06 30.08 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.441 1.496 . . . . 0.0 109.879 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 40.0 mt -137.95 42.73 2.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 120.432 1.469 . . . . 0.0 111.77 159.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.522 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 2.7 tm-20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.956 2.502 . . . . 0.0 107.521 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 3' ' ' ASN . 9.9 p -147.25 -173.98 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.413 ' H ' HG22 ' A' ' 2' ' ' VAL . 1.1 m120 -48.87 112.02 2.2 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 116.508 -1.71 . . . . 0.0 108.619 162.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HA ' ' CG ' ' A' ' 165' ' ' GLU . 2.0 Cg_endo -57.99 140.06 92.61 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 CA-C-N 121.339 1.514 . . . . 0.0 110.063 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.485 ' CG2' ' HE3' ' A' ' 133' ' ' LYS . 76.1 m -106.0 144.47 32.67 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 165.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.47 134.11 17.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.645 ' HB3' HD11 ' A' ' 164' ' ' LEU . 13.7 p90 -94.59 157.87 15.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.903 0.881 . . . . 0.0 110.865 175.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -145.63 112.95 6.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.097 1.359 . . . . 0.0 107.799 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.26 97.55 6.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.6 mm -66.5 146.53 13.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.284 1.034 . . . . 0.0 109.152 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.13 168.89 18.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.647 1.179 . . . . 0.0 110.389 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 156' ' ' ILE . 2.4 t -131.2 109.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 57.04 13.92 1.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.754 1.622 . . . . 0.0 113.131 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.22 -5.71 31.94 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.63 1.586 . . . . 0.0 113.849 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -81.95 113.26 41.83 Favored Pre-proline 0 CA--C 1.52 -0.187 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.4 121.68 9.57 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.318 1.345 . . . . 0.0 110.241 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.8 tp -93.36 -25.56 17.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.675 0.79 . . . . 0.0 110.922 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.25 162.74 9.6 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.665 0.65 . . . . 0.0 112.034 168.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -79.26 142.21 36.39 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.77 158.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 128.008 2.523 . . . . 0.0 105.808 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -140.58 153.43 46.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.337 1.065 . . . . 0.0 109.137 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 93.2 m-85 -135.28 159.86 40.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.324 -175.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -110.57 145.26 38.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 167.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.3 128.99 50.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.296 1.438 . . . . 0.0 108.685 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.21 61.79 7.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.261 1.025 . . . . 0.0 112.984 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -9.95 25.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.017 -1.052 . . . . 0.0 113.554 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.36 -16.51 58.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.247 1.419 . . . . 0.0 112.138 171.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -47.89 1.07 Allowed 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 0.0 110.511 -166.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.37 78.38 45.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.374 1.47 . . . . 0.0 107.345 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.71 -45.8 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.371 2.047 . . . . 0.0 110.386 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -36.64 84.81 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.242 1.383 . . . . 0.0 109.191 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -69.52 -52.69 24.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.496 0.589 . . . . 0.0 109.805 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.59 91.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.304 0.642 . . . . 0.0 112.242 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.54 -51.32 70.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.259 1.423 . . . . 0.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.04 -49.06 74.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.892 1.277 . . . . 0.0 110.488 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.07 -40.12 94.21 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.345 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -52.85 -56.92 12.28 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.152 0.887 . . . . 0.0 109.476 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.8 48.86 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.412 1.485 . . . . 0.0 113.15 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.29 -32.46 38.13 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.761 0.824 . . . . 0.0 111.431 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 p -78.53 -38.25 40.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.383 0.992 . . . . 0.0 113.293 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -64.08 -31.06 72.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.49 11.71 72.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.98 -33.18 70.38 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.012 1.725 . . . . 0.0 110.716 -172.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -71.46 -4.88 28.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.33 1.052 . . . . 0.0 112.696 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.76 16.12 46.63 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.419 1.009 . . . . 0.0 112.104 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -169.96 175.32 5.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.938 1.695 . . . . 0.0 109.1 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.49 -142.29 13.62 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-O 121.925 0.736 . . . . 0.0 113.307 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.587 ' CE1' HD11 ' A' ' 158' ' ' ILE . 0.6 OUTLIER -63.31 -28.34 69.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.889 2.076 . . . . 0.0 110.997 -167.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.5 tttt -57.41 124.07 17.64 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.683 -0.636 . . . . 0.0 109.389 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 10.37 52.77 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.358 -1.245 . . . . 0.0 114.412 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.6 m -68.01 104.4 1.74 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.117 1.959 . . . . 0.0 106.071 165.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 155' ' ' LYS . 52.8 m -75.38 131.68 40.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -73.69 105.1 4.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.082 0.944 . . . . 0.0 109.068 -169.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -81.01 -32.68 34.09 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.093 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -127.79 86.73 2.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.134 0.879 . . . . 0.0 108.833 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.416 HD12 ' CG2' ' A' ' 152' ' ' THR . 74.3 mt -104.45 109.53 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.32 99.73 52.75 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.98 144.36 99.48 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.551 1.501 . . . . 0.0 112.448 -172.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.87 31.43 61.11 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 126.539 2.018 . . . . 0.0 112.168 -168.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -142.4 -79.93 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.487 1.644 . . . . 0.0 108.545 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 165.15 25.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.798 0.839 . . . . 0.0 110.635 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.0 m -127.1 92.46 3.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.696 1.998 . . . . 0.0 108.77 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.04 132.3 42.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.964 1.306 . . . . 0.0 110.572 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.19 -169.48 11.89 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.074 1.797 . . . . 0.0 108.964 168.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.27 5.49 89.57 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.632 -0.922 . . . . 0.0 114.432 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.97 92.51 7.85 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 166.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -106.24 -5.84 18.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.509 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.6 p -122.29 -24.63 5.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.595 1.558 . . . . 0.0 111.551 -173.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -124.88 179.47 5.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 158.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.8 72.01 0.5 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 169.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.416 ' H ' ' H ' ' A' ' 72' ' ' GLY . 12.6 p30 -168.79 -10.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.886 2.474 . . . . 0.0 111.235 -172.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 71' ' ' ASN . . . 111.41 -6.4 28.34 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.069 -1.406 . . . . 0.0 112.85 169.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.3 p -84.09 -24.33 30.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.741 1.77 . . . . 0.0 112.933 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.92 -135.3 8.09 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 122.515 1.064 . . . . 0.0 114.772 -159.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.11 168.37 4.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.67 1.605 . . . . 0.0 111.776 -162.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -169.59 149.09 3.83 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.1 p -70.56 164.57 24.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.6 pt -56.88 -29.61 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 110.267 162.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -79.25 6.35 10.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.466 1.506 . . . . 0.0 112.584 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.16 -53.76 0.75 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.192 1.36 . . . . 0.0 113.064 166.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -147.72 -139.26 0.1 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -161.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -75.97 166.57 23.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.314 0.961 . . . . 0.0 108.897 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -142.22 177.8 7.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.11 148.19 51.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.192 0.996 . . . . 0.0 113.204 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.477 ' HA ' HD21 ' A' ' 108' ' ' ASN . 1.0 OUTLIER -71.96 73.95 0.89 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.897 2.479 . . . . 0.0 108.01 161.067 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.82 -59.85 3.99 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.255 1.822 . . . . 0.0 112.659 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.48 172.84 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.303 159.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.27 26.44 7.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.264 2.225 . . . . 0.0 110.797 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 mt -57.56 -48.23 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 120.927 -1.108 . . . . 0.0 110.182 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.68 123.72 23.85 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -103.26 165.26 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.072 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -77.91 75.81 4.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.076 1.351 . . . . 0.0 109.581 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -66.01 -27.54 68.2 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.42 -177.35 45.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.95 0.795 . . . . 0.0 111.751 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -59.23 147.14 92.13 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.868 1.712 . . . . 0.0 109.7 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.91 70.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.432 -1.205 . . . . 0.0 112.362 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.67 163.56 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 120.446 2.123 . . . . 0.0 108.9 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.14 127.96 37.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.033 1.333 . . . . 0.0 109.205 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.6 t -140.94 164.24 30.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.773 0.797 . . . . 0.0 110.49 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.99 140.54 29.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 -167.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.08 57.12 1.45 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.68 1.228 . . . . 0.0 108.614 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -61.35 170.51 1.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.951 158.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.23 13.94 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.62 1.168 . . . . 0.0 111.713 -169.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.27 -171.92 27.01 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -160.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -60.6 157.02 38.92 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.145 1.897 . . . . 0.0 110.037 171.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER 34.56 47.27 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.17 2.588 . . . . 0.0 113.716 173.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 p -124.19 22.38 8.65 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.811 0.844 . . . . 0.0 111.599 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 85' ' ' ASP . 91.1 m-20 -64.52 122.82 17.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.043 1.737 . . . . 0.0 108.762 173.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.49 -97.2 0.57 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.1 p -134.33 -23.77 1.65 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.079 0.952 . . . . 0.0 112.248 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -62.02 135.01 57.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -141.83 176.19 9.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -139.69 152.27 46.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 109.857 162.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.8 mt -83.17 122.98 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 163.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.3 m -68.5 113.61 6.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 167.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.2 p -108.36 30.68 6.21 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.51 173.51 14.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.814 1.645 . . . . 0.0 107.649 165.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.86 89.82 0.28 Allowed 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 162.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.29 53.75 0.53 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.387 1.475 . . . . 0.0 110.276 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -64.67 -21.74 66.81 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 119.921 -1.737 . . . . 0.0 112.39 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -73.31 -2.22 21.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.532 1.133 . . . . 0.0 111.969 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -115.42 -5.42 12.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.234 1.414 . . . . 0.0 111.528 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.82 142.44 57.94 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.061 0.846 . . . . 0.0 111.45 -172.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.57 12.61 61.84 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.268 -1.296 . . . . 0.0 113.709 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.37 -24.06 1.42 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.2 2.0 . . . . 0.0 113.34 -169.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -125.19 140.96 52.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.961 0.904 . . . . 0.0 110.085 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 63.2 t -78.89 101.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -171.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.51 123.49 16.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 164.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.02 -1.45 2.66 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.4 -173.04 27.33 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 119.296 0.953 . . . . 0.0 111.727 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -154.28 145.25 22.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.031 1.332 . . . . 0.0 108.729 -172.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.43 115.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 161.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.485 ' HE3' ' CG2' ' A' ' 5' ' ' THR . 12.4 ttmm -74.12 -54.38 7.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -153.98 167.09 30.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.322 2.249 . . . . 0.0 109.242 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.33 69.47 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.517 -0.739 . . . . 0.0 112.733 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.6 tpt -55.87 -35.51 66.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.633 1.217 . . . . 0.0 110.9 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -62.92 -31.31 72.36 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.829 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.74 -39.73 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.53 -37.37 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.686 -0.634 . . . . 0.0 109.942 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.487 ' CD ' HH21 ' A' ' 144' ' ' ARG . 3.1 mm-40 -57.86 -42.96 85.59 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 110.529 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.19 95.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.881 0.764 . . . . 0.0 109.027 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.8 mtm -54.94 -44.85 74.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.228 0.211 . . . . 0.0 110.987 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.42 -37.46 75.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.487 HH21 ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -66.4 -24.82 66.53 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.828 1.195 . . . . 0.0 110.35 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.569 ' CB ' HD11 ' A' ' 156' ' ' ILE . 41.3 m-85 -91.03 10.81 25.15 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.475 1.11 . . . . 0.0 112.017 174.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.67 -153.44 6.04 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.855 1.207 . . . . 0.0 111.502 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.5 p -141.62 -86.51 0.17 Allowed 'General case' 0 C--O 1.223 -0.306 0 O-C-N 122.044 -0.68 . . . . 0.0 110.081 160.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 178.14 -17.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 129.798 3.239 . . . . 0.0 110.343 161.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -68.35 -27.06 65.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.001 0.818 . . . . 0.0 110.013 158.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 123.25 -35.3 3.39 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-O 118.606 -1.108 . . . . 0.0 111.748 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -65.13 124.36 21.92 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.391 1.096 . . . . 0.0 108.195 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.416 ' CG2' HD12 ' A' ' 56' ' ' ILE . 18.0 p -64.25 154.04 36.27 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 110.261 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.0 p -68.41 -26.79 65.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.296 0.639 . . . . 0.0 110.789 167.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.489 ' HE2' HG12 ' A' ' 12' ' ' VAL . 30.3 mtpt -132.98 169.76 16.34 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.415 1.086 . . . . 0.0 111.093 -177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.449 ' HE2' ' SG ' ' A' ' 52' ' ' CYS . 75.8 tttt -83.89 84.85 7.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 121.089 1.768 . . . . 0.0 109.677 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.569 HD11 ' CB ' ' A' ' 145' ' ' PHE . 27.0 mm -73.79 126.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.34 163.52 32.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.346 1.069 . . . . 0.0 110.969 -163.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -94.98 115.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 159.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.97 13.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.401 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 1.4 t70 -148.62 163.26 37.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.086 0.554 . . . . 0.0 109.65 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.8 p -167.91 167.9 12.52 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.278 0.631 . . . . 0.0 111.933 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.16 178.52 42.44 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.3 tp60 -76.24 147.02 38.61 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.829 1.652 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 7' ' ' PHE . 12.9 mt -137.87 43.3 2.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.235 1.014 . . . . 0.0 112.455 162.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 19.7 mt-10 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 123.887 0.875 . . . . 0.0 110.913 168.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ppp? . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 71.4 t 63.89 175.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.855 1.662 . . . . 0.0 109.696 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.79 82.63 66.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 170.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.56 137.93 48.08 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.415 1.41 . . . . 0.0 110.301 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 88.2 m -95.14 147.33 23.55 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.08 153.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.689 1.195 . . . . 0.0 107.864 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -128.55 157.3 41.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.432 1.093 . . . . 0.0 109.792 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.425 ' CE1' ' CD2' ' A' ' 48' ' ' TYR . 68.9 m-85 -147.81 120.13 8.4 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.056 1.342 . . . . 0.0 107.714 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -85.41 95.53 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.1 mm -71.29 135.84 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.59 163.27 18.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.403 1.881 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG12 ' HE2' ' A' ' 154' ' ' LYS . 3.8 t -138.06 95.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -173.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 57.32 13.94 1.94 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.005 1.722 . . . . 0.0 112.963 -169.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.9 -9.13 29.64 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.958 1.742 . . . . 0.0 113.116 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -77.04 125.5 86.72 Favored Pre-proline 0 CA--C 1.518 -0.282 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.29 113.44 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 120.91 1.074 . . . . 0.0 109.495 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.25 -35.23 23.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.305 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 163.31 10.08 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 167.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -80.28 146.35 31.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.52 154.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.3 2.64 . . . . 0.0 105.419 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -144.99 152.03 39.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.493 1.139 . . . . 0.0 109.904 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CE2' HG22 ' A' ' 132' ' ' VAL . 55.8 m-85 -136.45 153.31 51.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.344 1.458 . . . . 0.0 108.406 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -97.25 146.06 25.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.455 1.902 . . . . 0.0 107.111 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.45 129.35 53.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.395 1.478 . . . . 0.0 107.529 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.61 57.11 1.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.842 1.657 . . . . 0.0 111.812 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.11 60.95 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.247 -1.533 . . . . 0.0 113.429 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -62.29 -53.35 56.41 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.875 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.24 -49.37 8.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.857 0.863 . . . . 0.0 110.541 -169.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 m -127.11 68.37 72.08 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.235 2.214 . . . . 0.0 108.737 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.48 -36.25 98.74 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.536 2.157 . . . . 0.0 112.579 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -52.6 56.73 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.716 1.144 . . . . 0.0 109.191 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 m -64.83 -39.45 93.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.46 0.704 . . . . 0.0 110.102 -174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.21 69.37 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.435 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.56 -43.08 97.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.488 1.115 . . . . 0.0 110.881 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -50.68 -60.02 3.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.365 1.466 . . . . 0.0 109.066 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -65.43 -26.46 67.97 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HG3' HE22 ' A' ' 163' ' ' GLN . 43.1 ttp85 -60.58 -61.72 2.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.447 1.099 . . . . 0.0 109.858 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.09 69.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.74 0.65 . . . . 0.0 111.823 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -71.4 -37.06 71.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.782 -0.574 . . . . 0.0 111.063 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.5 m -70.08 -36.69 75.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.476 0.71 . . . . 0.0 110.86 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -79.6 -18.44 51.61 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.752 0.421 . . . . 0.0 111.378 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.5 7.15 72.74 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 120.554 -1.342 . . . . 0.0 111.518 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.96 4.04 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.774 1.629 . . . . 0.0 113.808 -163.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -116.94 12.65 14.73 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.332 1.453 . . . . 0.0 111.216 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.08 84.66 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.396 0.522 . . . . 0.0 112.305 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -156.93 171.99 19.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.72 39.13 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 116.99 -2.529 . . . . 0.0 114.464 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 8' ' ' PHE . 1.1 t80 -65.64 -27.07 68.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.454 2.301 . . . . 0.0 109.38 175.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -52.21 136.95 29.41 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.827 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 -0.12 46.44 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.671 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -68.74 119.36 13.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.739 2.27 . . . . 0.0 107.561 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.7 t -72.33 137.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.33 104.61 5.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -74.07 -21.51 59.89 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.41 116.72 11.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.494 HD12 HG22 ' A' ' 152' ' ' THR . 38.7 mt -133.44 115.88 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.93 100.7 39.91 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.32 134.25 60.3 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.872 2.381 . . . . 0.0 111.761 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.67 32.61 83.62 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.131 1.824 . . . . 0.0 112.006 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -150.89 -74.02 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.427 1.113 . . . . 0.0 109.307 -172.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.83 167.01 31.75 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.0 m -128.13 100.25 5.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.35 1.86 . . . . 0.0 108.501 166.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -93.07 131.67 37.88 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.136 1.775 . . . . 0.0 109.437 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.99 50.73 0.22 Allowed Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.286 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.99 12.54 24.5 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 118.148 0.974 . . . . 0.0 111.773 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -85.22 23.37 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.479 1.912 . . . . 0.0 113.458 -167.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CD1' HG23 ' A' ' 68' ' ' THR . 11.2 p90 -41.16 -2.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 1 C-N-CA 132.563 4.345 . . . . 0.0 118.754 -176.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.449 HG23 ' CD1' ' A' ' 67' ' ' PHE . 12.1 p -126.39 -49.49 1.54 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.969 2.508 . . . . 0.0 112.144 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 -128.21 89.1 2.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -84.24 61.43 6.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.747 3.219 . . . . 0.0 107.751 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -173.45 -22.94 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 129.235 3.014 . . . . 0.0 107.966 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.24 43.62 2.16 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 126.852 2.168 . . . . 0.0 111.436 161.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.3 p -110.96 39.01 2.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 159.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.06 -174.59 14.97 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 122.548 1.082 . . . . 0.0 112.747 -161.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.33 75.75 0.41 Allowed Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 113.069 -1.566 . . . . 0.0 111.493 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' H ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -65.75 165.87 11.97 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 111.617 -2.291 . . . . 0.0 108.75 158.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.0 p -84.16 177.91 8.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.766 0.793 . . . . 0.0 109.2 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.7 pt -70.03 -27.25 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.994 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -84.86 -21.15 29.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.141 0.976 . . . . 0.0 111.521 -169.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.57 -99.42 0.19 Allowed Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 105.023 -3.231 . . . . 0.0 105.023 -164.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.13 -157.61 0.81 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.208 1.004 . . . . 0.0 109.745 172.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 82' ' ' LYS . 4.5 pttp -63.76 142.16 58.5 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.75 2.82 . . . . 0.0 110.107 -159.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -120.15 177.12 5.13 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.38 1.472 . . . . 0.0 108.923 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.58 163.41 27.37 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.24 87.65 0.82 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 108.988 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -46.38 -53.86 10.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.955 1.302 . . . . 0.0 112.248 -163.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.402 ' C ' HD22 ' A' ' 87' ' ' ASN . 0.1 OUTLIER -161.26 169.62 21.82 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.752 0.421 . . . . 0.0 110.222 158.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.79 13.74 16.18 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.757 1.223 . . . . 0.0 112.91 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 mt -53.22 -40.96 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.621 0.768 . . . . 0.0 109.899 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.77 121.03 29.69 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -110.82 170.18 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 109.433 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -74.18 87.04 1.92 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.742 0.817 . . . . 0.0 109.021 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.4 p -73.77 -11.1 60.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.623 0.769 . . . . 0.0 112.113 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.78 -169.79 38.87 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.011 -1.056 . . . . 0.0 111.708 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.95 158.63 32.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.527 1.485 . . . . 0.0 110.68 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.15 85.13 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 117.927 -1.485 . . . . 0.0 112.248 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -79.35 168.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.185 1.993 . . . . 0.0 108.564 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.68 133.47 27.22 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.319 1.448 . . . . 0.0 109.509 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 t -150.19 158.4 44.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.812 0.445 . . . . 0.0 111.346 -167.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.7 mtp -80.8 122.37 27.1 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.828 0.851 . . . . 0.0 111.203 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.586 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -75.27 61.47 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.645 1.578 . . . . 0.0 109.161 161.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -65.98 -178.18 0.57 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.43 1.11 . . . . 0.0 108.329 159.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.44 14.41 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.206 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.22 -157.45 23.89 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -66.81 148.63 82.86 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.179 1.92 . . . . 0.0 109.634 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 34.21 57.27 0.64 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.449 3.1 . . . . 0.0 111.353 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.5 p -131.88 26.4 4.63 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 109.871 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -75.0 88.74 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.293 1.837 . . . . 0.0 106.947 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.45 -92.44 1.9 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -174.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.8 p -151.01 -13.12 0.22 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 167.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.8 137.71 57.57 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.586 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -143.81 170.92 14.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.749 1.22 . . . . 0.0 108.299 -167.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 31.5 p90 -141.77 154.58 45.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.397 0.679 . . . . 0.0 110.325 158.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.51 125.02 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 161.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 16.5 m -70.91 117.56 12.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 167.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 p -108.7 26.5 10.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.662 0.785 . . . . 0.0 109.576 170.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.38 172.11 17.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -65.52 88.45 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 163.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.416 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 1.1 p -80.48 63.42 4.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.058 1.409 . . . . 0.0 109.663 -173.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -69.85 -10.43 58.45 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.802 1.641 . . . . 0.0 112.794 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.416 ' CZ2' HG22 ' A' ' 119' ' ' THR . 13.4 p90 -84.78 -11.0 56.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 168.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.461 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 49.5 mt -107.87 -8.63 15.92 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 110.913 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.48 146.82 33.93 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.67 1.188 . . . . 0.0 110.503 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.24 0.91 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.192 0.901 . . . . 0.0 114.829 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -93.68 -50.14 5.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 107.876 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.23 132.08 53.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.62 0.768 . . . . 0.0 109.478 -165.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.45 106.95 16.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 126.071 1.748 . . . . 0.0 106.607 -169.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.49 126.81 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 172.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -137.76 -0.4 2.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.59 -178.43 35.51 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 119.443 1.019 . . . . 0.0 112.844 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -150.02 156.12 41.13 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.665 0.786 . . . . 0.0 110.315 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.481 HG22 ' CE2' ' A' ' 22' ' ' PHE . 46.4 t -65.83 118.88 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.403 ' CE ' HG23 ' A' ' 5' ' ' THR . 3.6 mtmp? -78.71 -47.38 17.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.583 -0.698 . . . . 0.0 109.248 163.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -141.98 139.64 32.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.81 1.244 . . . . 0.0 108.654 -158.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.51 25.13 40.21 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.285 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.2 tpt -52.95 -37.26 60.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.261 2.03 . . . . 0.0 110.992 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -64.81 -29.09 70.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.214 0.915 . . . . 0.0 113.091 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.05 -45.94 85.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.42 -39.54 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -67.6 -28.19 67.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.801 -1.187 . . . . 0.0 112.543 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -43.11 60.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.919 1.288 . . . . 0.0 109.4 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.7 mtp -53.12 -42.45 66.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.693 0.797 . . . . 0.0 109.974 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.82 -33.34 75.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.735 1.614 . . . . 0.0 114.477 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -62.52 -30.77 71.53 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 120.342 1.428 . . . . 0.0 109.019 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 156' ' ' ILE . 32.5 m-85 -91.64 18.76 7.06 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.795 1.238 . . . . 0.0 111.617 175.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.24 -168.76 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 p -152.8 155.42 37.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -64.69 -23.16 67.17 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.27 -1.519 . . . . 0.0 113.125 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.06 8.82 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.201 1.0 . . . . 0.0 112.753 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.88 18.27 66.24 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 126.355 1.931 . . . . 0.0 113.949 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -87.49 144.66 26.61 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 120.706 2.253 . . . . 0.0 109.927 158.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.494 HG22 HD12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -69.13 153.5 43.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.901 0.88 . . . . 0.0 109.349 162.397 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 p -105.2 -13.85 15.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.035 1.334 . . . . 0.0 111.355 164.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HE2' HG12 ' A' ' 12' ' ' VAL . 22.3 mtpt -135.0 156.11 49.6 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.834 1.254 . . . . 0.0 109.694 169.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -77.14 85.46 3.62 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.445 -0.784 . . . . 0.0 109.488 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.475 HD11 ' HB2' ' A' ' 145' ' ' PHE . 1.8 mp -72.89 120.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.77 149.72 50.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.524 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.421 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -81.48 104.65 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 163.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.58 -53.29 19.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.63 164.72 31.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 7.8 p -172.91 170.45 4.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.421 0.688 . . . . 0.0 111.97 -171.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.9 -162.39 33.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.506 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 8.3 tp60 -87.77 154.23 20.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.829 1.651 . . . . 0.0 110.178 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.38 42.79 2.84 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.081 1.309 . . . . 0.0 109.535 158.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.506 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 15.4 tp10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.159 1.784 . . . . 0.0 109.342 168.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptm . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.297 10.8 m 48.16 -173.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.45 0 O-C-N 124.237 0.961 . . . . 0.0 109.557 -154.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -97.6 107.43 39.41 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.43 132.59 51.64 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.201 1.934 . . . . 0.0 109.359 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -93.94 152.5 18.81 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.86 142.93 29.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.489 1.515 . . . . 0.0 107.227 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.44 159.3 20.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.32 1.048 . . . . 0.0 110.122 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -148.28 114.17 5.76 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.085 1.354 . . . . 0.0 108.522 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.23 97.93 5.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 165.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.62 144.6 13.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.56 139.07 43.62 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.405 1.082 . . . . 0.0 108.741 171.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.495 HG12 ' HE2' ' A' ' 154' ' ' LYS . 5.6 t -103.11 114.57 43.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.35 13.82 2.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.922 0.889 . . . . 0.0 113.149 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.23 56.04 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.193 . . . . 0.0 113.386 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -74.79 121.53 85.47 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.85 112.87 1.94 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.694 1.596 . . . . 0.0 110.084 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -78.33 -37.2 45.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.17 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.32 169.9 14.51 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -84.86 142.64 29.59 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.483 0.659 . . . . 0.0 109.971 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.2 t -122.79 160.95 24.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 128.94 2.896 . . . . 0.0 105.982 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -148.7 158.46 44.16 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 164.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 63.6 m-85 -136.74 155.75 49.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.237 1.415 . . . . 0.0 108.391 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -108.22 134.37 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -111.54 120.67 42.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -69.04 59.11 0.1 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.571 1.949 . . . . 0.0 112.836 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.88 43.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 112.59 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -23.29 59.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.307 0.503 . . . . 0.0 111.296 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -113.6 -30.14 6.92 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.645 0.778 . . . . 0.0 112.241 -169.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.44 73.17 11.8 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.037 1.735 . . . . 0.0 107.946 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 -45.42 14.73 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.142 1.895 . . . . 0.0 112.805 -167.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.51 -53.37 58.95 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.029 1.286 . . . . 0.0 109.331 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -44.82 79.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.547 1.139 . . . . 0.0 111.243 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.56 65.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.66 0.784 . . . . 0.0 111.953 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -63.98 -40.72 97.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.792 0.837 . . . . 0.0 111.376 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -58.58 2.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.672 1.589 . . . . 0.0 108.96 167.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.99 -39.68 90.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.046 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -53.14 -58.24 7.69 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.098 1.359 . . . . 0.0 109.243 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -21.35 64.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.185 1.394 . . . . 0.0 113.77 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -89.79 -23.97 21.6 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.878 0.871 . . . . 0.0 111.389 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 m -83.4 -37.77 22.82 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.009 1.324 . . . . 0.0 110.779 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 p -67.05 -32.5 73.73 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.422 0.689 . . . . 0.0 109.823 170.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.73 14.81 81.08 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.089 0.852 . . . . 0.0 111.087 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.26 -21.8 66.78 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.572 1.186 . . . . 0.0 112.755 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -80.26 0.25 33.5 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 111.852 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 9.74 86.49 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.778 1.18 . . . . 0.0 112.437 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -156.6 179.04 9.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.499 1.52 . . . . 0.0 108.889 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.35 -142.54 13.86 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 121.723 0.624 . . . . 0.0 112.696 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CE1' HD11 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -70.77 -27.22 63.76 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.435 1.894 . . . . 0.0 110.873 -160.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.0 tttt -64.88 124.12 21.17 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.87 7.08 69.22 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.958 -1.468 . . . . 0.0 112.87 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -67.36 129.49 40.08 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 120.423 2.111 . . . . 0.0 106.244 167.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -76.12 161.7 28.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 163.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.95 114.1 28.11 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -79.2 -49.09 13.08 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.34 128.12 44.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.4 mm -137.2 106.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.2 mt -114.91 93.32 33.89 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.1 117.89 4.02 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.602 2.868 . . . . 0.0 112.006 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.09 14.67 57.32 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.659 1.123 . . . . 0.0 112.952 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.439 ' CD1' ' HG3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -133.11 -72.89 0.5 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.439 ' HG3' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -166.05 157.74 13.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.1 m -100.64 139.5 36.23 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.96 1.704 . . . . 0.0 108.426 160.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -135.06 122.21 21.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.567 1.531 . . . . 0.0 109.087 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.99 16.85 1.95 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.638 -0.535 . . . . 0.0 114.212 -161.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.72 11.02 53.22 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.053 0.927 . . . . 0.0 114.249 -168.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.72 97.8 9.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 166.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -100.97 -1.03 35.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 p -140.03 -51.68 0.5 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -83.84 -23.85 31.19 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.443 -0.786 . . . . 0.0 112.324 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.0 m170 59.95 31.81 20.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.905 1.682 . . . . 0.0 112.977 169.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -154.07 2.95 0.25 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.91 17.94 4.87 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.141 1.337 . . . . 0.0 113.942 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.4 p -139.33 10.19 2.52 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.229 1.015 . . . . 0.0 112.017 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.97 155.92 49.87 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 120.791 -1.193 . . . . 0.0 113.497 -163.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.9 -156.68 49.54 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 113.56 -1.32 . . . . 0.0 111.582 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.67 160.83 10.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.989 2.116 . . . . 0.0 107.685 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.7 p -71.45 23.16 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.475 1.91 . . . . 0.0 114.605 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.288 1.2 pp 46.29 -19.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 1 C-N-CA 132.234 4.214 . . . . 0.0 117.046 -159.04 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -92.65 -22.22 19.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 119.884 1.22 . . . . 0.0 112.748 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.56 101.07 0.26 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.342 14.5 tt0 41.23 -132.8 0.35 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.291 1.036 . . . . 0.0 111.901 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -88.78 149.06 23.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.831 1.252 . . . . 0.0 109.776 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -117.48 -176.74 3.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.985 1.714 . . . . 0.0 108.274 170.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -81.34 166.02 20.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.069 1.304 . . . . 0.0 114.122 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.37 87.68 3.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 107.582 -172.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -40.13 -64.37 0.51 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.985 2.114 . . . . 0.0 111.586 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.45 156.38 1.53 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.299 0.639 . . . . 0.0 110.844 174.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -111.75 30.29 7.12 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.726 1.61 . . . . 0.0 110.054 -171.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.86 -55.23 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.618 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.71 135.82 35.49 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.78 1.632 . . . . 0.0 107.188 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -122.88 167.2 13.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.667 1.587 . . . . 0.0 109.868 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -84.15 60.31 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.344 1.457 . . . . 0.0 110.849 -162.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 p -62.39 -29.46 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -158.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.4 -179.08 48.71 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 119.232 0.924 . . . . 0.0 112.094 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.11 153.08 54.67 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.411 2.074 . . . . 0.0 110.426 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.59 1.61 71.98 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 117.782 -1.566 . . . . 0.0 112.971 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.16 163.19 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.79 2.295 . . . . 0.0 107.824 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.32 131.07 39.71 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.744 1.218 . . . . 0.0 109.487 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -138.15 158.38 44.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 109.365 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 6.6 ptm -88.13 151.26 22.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.522 0.677 . . . . 0.0 110.913 -173.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.09 59.22 0.83 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.347 1.059 . . . . 0.0 109.134 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -57.79 161.2 3.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.748 163.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.82 19.84 1.14 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.661 2.384 . . . . 0.0 111.904 -166.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.05 176.79 25.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.16 1.362 . . . . 0.0 110.481 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.6 138.77 71.94 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 119.848 1.824 . . . . 0.0 109.664 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.4 55.81 5.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.944 2.098 . . . . 0.0 109.977 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -112.19 23.36 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.592 -1.317 . . . . 0.0 111.305 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.34 91.38 1.33 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 107.472 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.76 -142.83 11.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p -84.0 -15.65 46.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.859 0.863 . . . . 0.0 112.782 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.03 138.91 57.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.41 0.684 . . . . 0.0 109.619 -164.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 12.7 p90 -149.87 167.67 25.93 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.456 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 36.3 p90 -141.01 148.42 40.26 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 124.386 1.054 . . . . 0.0 109.315 162.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -83.69 116.46 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.3 m -64.16 130.85 45.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -118.22 23.94 11.28 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.466 1.106 . . . . 0.0 109.046 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.63 179.49 9.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.998 0.919 . . . . 0.0 108.577 163.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 82.1 tttt -67.83 92.1 0.34 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 160.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.5 p -83.47 58.6 4.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.75 0.705 . . . . 0.0 110.153 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 15.6 pt-20 -74.01 -8.01 54.53 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.182 -1.574 . . . . 0.0 113.767 -171.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -66.37 -10.3 42.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.397 -0.814 . . . . 0.0 110.846 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.456 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 53.4 mt -107.53 0.46 22.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.379 1.872 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 127.27 32.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.974 0.806 . . . . 0.0 112.443 -162.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.82 3.23 20.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.222 0.915 . . . . 0.0 113.22 -168.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -93.9 -53.51 3.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -99.97 157.18 16.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.583 0.753 . . . . 0.0 110.619 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t -98.71 101.68 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.35 128.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -142.46 0.06 1.27 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.77 176.38 29.35 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 119.526 1.057 . . . . 0.0 111.639 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -146.43 155.59 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 22' ' ' PHE . 49.2 t -64.81 123.8 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 2.8 ttpt -86.76 -41.98 13.69 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.868 0.867 . . . . 0.0 109.297 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.54 160.16 43.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.663 0.385 . . . . 0.0 111.065 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.6 36.1 82.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.075 0.845 . . . . 0.0 111.91 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -45.42 78.35 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.704 1.252 . . . . 0.0 108.28 171.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.61 -26.54 61.7 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.1 mm -76.8 -36.96 27.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-N 118.784 0.72 . . . . 0.0 109.143 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.02 -47.27 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.303 0.956 . . . . 0.0 108.759 170.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.55 68.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.188 0.995 . . . . 0.0 111.507 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.48 -42.61 52.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 120.952 -1.093 . . . . 0.0 109.833 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 44.3 mtm -55.65 -48.85 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 118.444 0.565 . . . . 0.0 109.542 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.64 -39.85 71.42 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.948 1.699 . . . . 0.0 111.249 176.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -67.84 -18.04 64.7 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.594 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -94.92 -1.21 53.03 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.557 1.072 . . . . 0.0 112.178 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.32 -163.3 39.24 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 120.871 1.669 . . . . 0.0 112.199 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.3 p -152.14 154.97 36.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -66.73 -20.59 66.0 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.154 -1.591 . . . . 0.0 112.877 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.64 9.16 4.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.428 1.091 . . . . 0.0 112.878 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.51 -28.87 7.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 126.128 1.823 . . . . 0.0 113.65 167.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -69.86 145.16 52.25 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 120.445 2.122 . . . . 0.0 110.91 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.2 p -64.05 145.86 55.16 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.873 1.669 . . . . 0.0 111.425 159.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.4 p -75.92 -43.83 43.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.357 0.663 . . . . 0.0 109.653 158.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.495 ' HE2' HG12 ' A' ' 12' ' ' VAL . 29.8 mtpt -124.47 162.73 23.32 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.43 1.492 . . . . 0.0 110.931 -174.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.61 88.28 2.17 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.128 -0.983 . . . . 0.0 110.358 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.49 124.88 31.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 p -146.09 165.67 28.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.699 0.761 . . . . 0.0 111.453 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.426 HD11 ' CE1' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -89.83 127.33 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 159.005 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.54 -46.68 8.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.613 0.642 . . . . 0.0 109.734 168.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.429 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -147.38 158.51 44.0 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -172.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -172.56 172.46 4.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.098 0.959 . . . . 0.0 113.096 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.35 -178.4 46.19 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.199 1.381 . . . . 0.0 109.906 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -78.83 149.09 32.62 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 110.511 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.7 mt -128.68 43.29 3.17 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.954 0.902 . . . . 0.0 109.419 159.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.252 1.199 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.217 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.587 0.708 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.6 m -122.66 -173.13 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 129.596 3.159 . . . . 0.0 105.965 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -44.97 109.19 0.85 Allowed Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.774 158.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 17.9 Cg_endo -64.57 147.66 90.28 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 N-CA-C 107.551 -1.75 . . . . 0.0 107.551 174.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 m -110.51 150.48 28.85 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.92 160.96 29.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.746 0.818 . . . . 0.0 108.841 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -124.95 159.16 31.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.364 1.466 . . . . 0.0 109.998 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -146.56 107.82 4.23 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.69 2.396 . . . . 0.0 106.846 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.01 101.44 3.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.46 134.66 29.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.46 141.4 47.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.84 0.856 . . . . 0.0 109.008 164.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.2 t -96.32 91.28 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 163.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.279 1.3 p30 62.54 14.18 6.84 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.58 -9.64 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 117.442 -1.755 . . . . 0.0 111.406 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -70.48 124.88 91.66 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 162.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.0 117.75 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 N-CA-C 107.261 -1.861 . . . . 0.0 107.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp -88.73 -35.26 16.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.567 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 147.0 161.56 9.43 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -74.59 146.91 42.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.659 0.743 . . . . 0.0 109.233 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.01 151.85 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 128.114 2.566 . . . . 0.0 104.609 171.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 134' ' ' GLU . 21.5 m -146.48 146.65 30.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.212 1.006 . . . . 0.0 109.76 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -120.23 156.61 30.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.956 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -95.74 151.25 19.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 158.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -127.31 121.38 30.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -75.2 51.49 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.936 2.094 . . . . 0.0 112.754 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.26 28.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.963 -1.085 . . . . 0.0 113.365 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.09 -26.52 60.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.124 0.874 . . . . 0.0 111.714 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -111.99 -34.04 6.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.526 1.13 . . . . 0.0 111.635 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.08 71.6 68.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.449 1.9 . . . . 0.0 109.037 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.65 -44.2 27.9 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.593 2.195 . . . . 0.0 113.844 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -49.4 77.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.203 1.365 . . . . 0.0 109.592 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -62.45 -48.39 79.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.854 0.862 . . . . 0.0 109.28 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.66 -48.57 81.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.62 0.768 . . . . 0.0 111.468 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -46.01 91.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.725 1.21 . . . . 0.0 111.688 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -57.28 -51.09 70.79 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.106 0.962 . . . . 0.0 108.609 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.28 -31.68 72.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.523 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 18.3 ttm105 -55.65 -56.81 16.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.963 1.256 . . . . 0.0 108.938 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.23 49.1 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.673 1.189 . . . . 0.0 111.16 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.33 -29.4 69.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.31 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 m -75.17 -10.23 59.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.236 1.414 . . . . 0.0 112.104 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.8 p -112.43 -29.61 7.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.411 0.684 . . . . 0.0 111.725 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.14 82.67 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.356 -0.691 . . . . 0.0 113.56 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -28.81 64.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.499 1.92 . . . . 0.0 113.503 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.59 2.49 1.8 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.519 0.728 . . . . 0.0 112.848 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.48 62.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.871 1.224 . . . . 0.0 111.397 -170.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.35 172.82 12.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.59 2.356 . . . . 0.0 106.728 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.54 -177.18 23.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.639 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 2.3 t80 -81.67 -6.59 59.16 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.881 2.072 . . . . 0.0 112.247 -163.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -59.59 117.87 5.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.2 -0.938 . . . . 0.0 108.588 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.49 5.65 87.96 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 116.92 -2.044 . . . . 0.0 115.766 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.6 m -71.26 -65.77 0.7 Allowed 'General case' 0 C--N 1.342 0.256 0 CA-C-N 121.638 2.719 . . . . 0.0 112.322 -163.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.6 t 130.14 144.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.184 3.793 . . . . 0.0 109.659 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.03 92.03 6.65 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.043 2.137 . . . . 0.0 106.823 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.453 ' CD2' ' H ' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -77.07 -18.4 58.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -164.625 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -140.02 78.25 1.65 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.161 1.346 . . . . 0.0 111.64 -167.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.51 106.34 18.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.805 1.642 . . . . 0.0 107.008 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.6 91.41 12.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.31 120.84 7.4 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.843 3.029 . . . . 0.0 113.114 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.47 11.52 60.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.839 1.685 . . . . 0.0 113.253 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -133.94 -79.61 0.46 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.936 1.294 . . . . 0.0 108.802 -170.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.69 167.95 28.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.799 0.84 . . . . 0.0 110.713 172.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -132.38 98.15 4.3 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.91 1.684 . . . . 0.0 109.04 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.7 146.79 44.18 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.426 1.09 . . . . 0.0 109.985 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.98 -173.64 25.68 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 125.719 1.628 . . . . 0.0 109.88 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.84 -13.23 41.78 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.326 1.441 . . . . 0.0 113.324 170.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -84.07 95.09 8.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.892 0.846 . . . . 0.0 110.709 -167.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CD2' HG23 ' A' ' 68' ' ' THR . 49.8 p90 -95.08 3.5 54.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.178 -176.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 67' ' ' PHE . 50.0 p -137.16 -45.95 0.57 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.893 1.224 . . . . 0.0 113.248 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -88.34 -27.05 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.79 -0.569 . . . . 0.0 111.472 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 54.25 12.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.953 2.901 . . . . 0.0 114.595 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -117.86 -8.04 10.86 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.188 0.995 . . . . 0.0 112.868 -170.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 -3.36 27.36 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.439 -1.2 . . . . 0.0 113.088 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.2 p -84.27 -32.29 24.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.77 1.785 . . . . 0.0 111.04 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.88 165.91 9.35 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-O 123.153 1.419 . . . . 0.0 114.054 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.31 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.469 1.594 . . . . 0.0 111.669 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.58 -178.84 2.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 128.951 2.901 . . . . 0.0 108.814 -160.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.1 p -84.99 -175.1 5.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.76 -23.09 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.033 -1.042 . . . . 0.0 111.745 163.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -82.13 -23.67 35.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.023 0.929 . . . . 0.0 111.149 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.8 -145.72 10.18 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 -166.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -128.75 115.2 17.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.38 148.42 0.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.228 2.611 . . . . 0.0 111.88 -165.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -135.12 173.6 11.54 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 159.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 84' ' ' GLU . 1.9 pm0 -63.84 154.01 34.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.132 0.968 . . . . 0.0 109.714 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.03 99.47 1.82 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 172.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -49.77 -57.31 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.241 1.416 . . . . 0.0 114.516 -158.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.69 154.02 5.25 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.239 1.816 . . . . 0.0 108.846 162.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.98 25.24 10.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.56 1.544 . . . . 0.0 110.049 -169.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mt -45.2 -59.59 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 126.541 1.936 . . . . 0.0 108.556 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.9 mt -74.91 113.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.421 1.488 . . . . 0.0 107.87 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -80.2 157.85 26.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.154 171.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.36 83.76 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.5 p -68.73 -23.53 64.36 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.479 -0.763 . . . . 0.0 112.853 -166.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.76 -176.7 40.54 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.861 1.21 . . . . 0.0 111.86 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.46 149.52 89.24 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 121.732 1.621 . . . . 0.0 110.691 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 10.91 85.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.977 -1.457 . . . . 0.0 112.467 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 mm -82.58 166.2 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 120.674 2.237 . . . . 0.0 108.336 164.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.57 127.94 26.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.097 1.359 . . . . 0.0 108.175 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.8 t -141.29 147.16 37.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.63 -167.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.412 ' HG2' ' CG ' ' A' ' 108' ' ' ASN . 35.9 tpp -77.25 113.97 15.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.177 2.191 . . . . 0.0 108.562 -174.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.445 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -72.56 98.17 2.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 165.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -78.83 -178.2 5.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 159.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.92 15.1 25.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.384 1.874 . . . . 0.0 112.149 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.01 175.73 14.17 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.539 1.543 . . . . 0.0 109.312 -163.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.34 130.21 31.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.198 1.932 . . . . 0.0 111.32 -170.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.81 57.81 3.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 127.495 2.318 . . . . 0.0 111.853 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -142.25 41.74 1.64 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.086 0.555 . . . . 0.0 111.315 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.412 ' CG ' ' HG2' ' A' ' 100' ' ' MET . 3.6 m-20 -55.22 125.85 22.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.266 1.426 . . . . 0.0 109.565 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.75 -125.5 2.31 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 120.695 1.589 . . . . 0.0 112.335 -171.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -89.13 -25.14 22.01 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.606 1.203 . . . . 0.0 112.796 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -85.23 148.26 26.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.715 0.769 . . . . 0.0 111.178 -158.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.445 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 28.2 p90 -142.96 176.67 8.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -141.24 152.8 44.85 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 160.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.1 mt -83.46 119.42 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 163.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.3 m -65.15 122.56 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.8 p -114.86 28.5 8.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.222 1.01 . . . . 0.0 108.553 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.32 178.63 10.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.157 1.783 . . . . 0.0 107.628 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -70.39 92.11 0.79 Allowed 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 161.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 p -78.72 59.36 2.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.694 0.679 . . . . 0.0 109.939 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.01 -13.37 62.41 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.83 1.252 . . . . 0.0 112.914 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -74.1 -15.92 61.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.286 1.035 . . . . 0.0 111.317 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -103.61 -4.59 23.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.854 1.261 . . . . 0.0 111.129 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 126.97 29.75 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.589 1.156 . . . . 0.0 111.129 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.41 1.19 34.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.717 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -103.11 -25.8 13.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.61 1.705 . . . . 0.0 110.553 168.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -137.14 160.96 37.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.111 1.364 . . . . 0.0 108.98 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -110.46 103.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.58 127.46 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.65 -2.08 1.99 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.827 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.75 -176.44 28.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 119.41 1.005 . . . . 0.0 111.974 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -153.37 140.22 19.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.97 103.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 159.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -63.68 -52.71 59.42 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 21' ' ' SER . 10.4 pt-20 -146.87 154.47 41.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 123.356 0.662 . . . . 0.0 111.486 -159.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.88 25.14 67.68 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.884 0.754 . . . . 0.0 113.153 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 mmm -61.22 -29.21 69.68 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.623 2.212 . . . . 0.0 111.609 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -62.61 -30.65 71.5 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.834 -1.166 . . . . 0.0 111.635 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.02 -44.09 92.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.97 -42.26 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.265 0.626 . . . . 0.0 110.166 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -39.74 94.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 174.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.18 -41.52 70.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.919 1.288 . . . . 0.0 109.035 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.3 mtp -53.87 -42.59 68.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.079 1.352 . . . . 0.0 110.154 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.202 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.76 -36.01 81.68 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.402 1.456 . . . . 0.0 108.887 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.59 1.68 40.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.983 0.913 . . . . 0.0 112.783 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.4 -156.21 7.72 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.982 1.753 . . . . 0.0 110.411 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.2 p -142.18 -72.06 0.32 Allowed 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 121.65 -0.912 . . . . 0.0 111.591 168.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 140.67 -27.39 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.346 1 C-N-CA 133.864 4.865 . . . . 0.0 109.772 -173.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.65 -24.84 67.12 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.716 0.689 . . . . 0.0 110.283 158.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.74 -36.05 4.21 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 125.672 1.606 . . . . 0.0 111.764 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.06 131.91 47.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 p -62.77 152.21 36.48 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.908 1.283 . . . . 0.0 107.914 166.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.6 p -57.44 -48.06 80.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -73.43 175.76 6.68 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.943 1.697 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -95.63 139.48 31.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 101.969 -3.345 . . . . 0.0 101.969 157.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.4 mt -127.38 128.96 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.79 22.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.798 0.808 . . . . 0.0 111.542 -158.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.639 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 4.6 mp -98.37 105.13 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.86 96.64 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.484 0.584 . . . . 0.0 109.521 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -157.32 158.82 36.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.575 1.15 . . . . 0.0 108.841 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 p -156.93 165.28 36.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.397 0.679 . . . . 0.0 110.543 174.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.47 -169.18 40.7 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.536 ' HG2' ' H ' ' A' ' 165' ' ' GLU . 41.4 tt0 -103.97 148.85 25.71 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.943 1.297 . . . . 0.0 109.646 -172.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.2 mt -128.37 43.26 3.17 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.253 1.421 . . . . 0.0 109.114 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.536 ' H ' ' HG2' ' A' ' 163' ' ' GLN . 24.1 tt0 . . . . . 0 C--O 1.243 0.734 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 166.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.3 19.6 m 46.65 -172.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 123.11 1.433 . . . . 0.0 114.007 166.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.16 104.9 54.07 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 158.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -63.78 146.66 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 120.7 1.286 . . . . 0.0 110.34 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -104.97 146.87 28.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.76 156.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.166 1.386 . . . . 0.0 109.351 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.0 158.91 26.71 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.487 1.115 . . . . 0.0 110.12 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -144.37 111.72 5.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.345 1.858 . . . . 0.0 106.663 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 104.46 10.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 mm -79.34 140.87 16.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.21 162.56 29.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.007 169.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 9.2 t -137.18 92.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 60.21 18.64 8.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.739 1.216 . . . . 0.0 111.516 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.16 9.69 72.89 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.196 -0.94 . . . . 0.0 112.537 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -75.18 118.71 72.7 Favored Pre-proline 0 C--O 1.232 0.179 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 159.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.94 112.36 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.477 1.451 . . . . 0.0 109.436 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.2 tp -82.81 -27.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.112 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.55 169.53 11.75 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.436 1.493 . . . . 0.0 111.759 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.91 139.38 35.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.335 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.45 154.95 40.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.6 t -147.43 149.49 32.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.77 0.795 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -124.57 147.93 48.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.203 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -92.58 151.92 19.88 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 158.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 mt -126.7 122.56 35.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.883 1.673 . . . . 0.0 106.993 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 90' ' ' LEU . 58.1 m-85 -78.52 61.63 2.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.969 0.908 . . . . 0.0 111.846 -172.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.37 -16.33 53.88 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.885 -1.76 . . . . 0.0 113.611 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.33 -16.21 57.94 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.076 0.95 . . . . 0.0 111.918 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -121.95 -39.53 2.6 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.733 1.213 . . . . 0.0 111.3 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.1 m -132.74 70.51 79.09 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.911 1.685 . . . . 0.0 107.457 174.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -50.18 -48.37 20.15 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.146 2.564 . . . . 0.0 112.657 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -55.66 -58.51 7.49 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -174.392 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 -46.43 89.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.391 1.477 . . . . 0.0 111.165 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.57 82.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.083 0.553 . . . . 0.0 111.385 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.38 -43.54 81.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.626 1.17 . . . . 0.0 110.453 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -51.09 -51.08 56.89 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.147 1.379 . . . . 0.0 109.38 170.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.94 -44.21 90.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.423 0.452 . . . . 0.0 112.073 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -53.93 -59.65 4.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.733 1.613 . . . . 0.0 109.108 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.96 -47.8 74.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.465 0.706 . . . . 0.0 110.611 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.67 -23.39 66.77 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -73.3 -48.13 37.12 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.299 0.954 . . . . 0.0 109.303 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 p -66.62 -26.1 66.92 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.989 -0.444 . . . . 0.0 111.913 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.61 -0.11 71.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.436 1.017 . . . . 0.0 112.058 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -59.78 -23.21 63.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.701 1.6 . . . . 0.0 112.632 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -85.47 9.69 15.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.109 1.364 . . . . 0.0 112.095 -172.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.05 81.63 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.846 -0.974 . . . . 0.0 112.423 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.32 172.72 13.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.983 1.713 . . . . 0.0 107.407 166.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.63 174.39 37.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.427 -1.368 . . . . 0.0 113.674 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -73.24 -8.03 54.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -56.08 124.68 18.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.72 4.34 65.82 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.613 -1.659 . . . . 0.0 114.529 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -73.14 156.75 38.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.99 2.395 . . . . 0.0 107.988 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.1 t -106.21 139.89 40.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CB ' HD11 ' A' ' 56' ' ' ILE . 95.6 m-85 -74.83 88.99 2.31 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -73.5 -27.55 61.43 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.406 1.882 . . . . 0.0 111.617 -166.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 86.01 2.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.449 HD12 ' CG2' ' A' ' 152' ' ' THR . 86.3 mt -103.71 112.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 171.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -125.17 97.47 37.59 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -170.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.68 125.45 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.948 2.432 . . . . 0.0 111.027 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.2 5.4 63.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.81 1.671 . . . . 0.0 113.338 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -136.57 -75.64 0.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.105 1.453 . . . . 0.0 108.98 -167.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.1 167.61 18.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 112.08 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.1 m -122.15 94.74 4.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.744 2.018 . . . . 0.0 108.383 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.37 144.32 25.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.532 1.933 . . . . 0.0 109.961 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.12 1.82 0.13 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.84 35.46 3.38 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 -158.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.329 19.3 p-10 -122.73 144.36 49.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.912 2.856 . . . . 0.0 111.292 164.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.28 -3.09 3.08 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.183 2.593 . . . . 0.0 111.317 -160.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -125.6 -19.84 4.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 129.247 3.019 . . . . 0.0 112.173 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -137.46 176.37 8.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 131.538 3.935 . . . . 0.0 103.439 169.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -145.11 53.81 1.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -152.91 -67.37 0.16 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.201 1.4 . . . . 0.0 110.679 -176.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.579 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 173.69 -11.81 0.04 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 118.374 -1.237 . . . . 0.0 115.262 -159.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -127.44 17.04 7.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.285 1.543 . . . . 0.0 113.227 -161.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.27 -86.4 0.37 Allowed Glycine 0 CA--C 1.503 -0.662 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -17.09 113.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.553 0 C-N-CA 128.074 2.749 . . . . 0.0 111.932 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -136.9 155.32 49.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.213 1.805 . . . . 0.0 109.918 -158.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 p -77.94 165.5 24.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 124.293 0.996 . . . . 0.0 109.451 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.93 -24.75 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.596 170.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.39 8.31 25.11 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.166 1.787 . . . . 0.0 111.533 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.29 142.09 12.96 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.403 1.478 . . . . 0.0 109.813 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.26 6.2 pt-20 34.06 -133.8 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.796 2.438 . . . . 0.0 114.343 162.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -75.05 157.97 33.95 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.498 0.59 . . . . 0.0 110.385 165.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -132.13 176.53 8.31 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.66 1.984 . . . . 0.0 107.644 164.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.79 161.17 28.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.071 0.462 . . . . 0.0 110.713 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.57 131.33 48.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -47.08 83.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -173.08 176.13 3.06 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.726 1.211 . . . . 0.0 108.721 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -126.09 56.36 1.43 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.563 1.945 . . . . 0.0 106.144 163.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.55 -39.52 70.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 171.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 25' ' ' PHE . 49.1 mt -95.6 142.24 28.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.447 1.499 . . . . 0.0 107.334 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -120.49 160.21 23.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.433 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -76.26 64.62 2.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.494 2.318 . . . . 0.0 109.666 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.426 1.49 . . . . 0.0 113.494 -161.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 175.49 38.23 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.583 1.083 . . . . 0.0 112.891 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -59.68 137.58 78.0 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.158 1.906 . . . . 0.0 108.147 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.73 64.38 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.512 -1.716 . . . . 0.0 112.623 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.42 159.44 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 120.923 2.361 . . . . 0.0 107.687 169.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.39 131.98 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.456 1.502 . . . . 0.0 108.497 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 32.3 t -148.62 160.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.848 0.459 . . . . 0.0 110.68 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.4 mtp -84.58 120.95 26.94 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.618 0.767 . . . . 0.0 110.421 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 141.73 58.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 162.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -152.46 -172.57 4.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.364 1.066 . . . . 0.0 109.691 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.62 15.08 10.25 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.011 1.724 . . . . 0.0 112.64 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.28 -179.6 17.24 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -167.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.47 141.04 79.1 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.539 2.159 . . . . 0.0 110.481 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.51 46.12 26.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.164 1.786 . . . . 0.0 111.885 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.7 p -123.89 14.07 9.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.301 -0.874 . . . . 0.0 111.262 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -73.69 128.02 34.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.52 -65.31 0.16 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.7 p -144.54 -13.76 0.58 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.579 HE22 ' HA2' ' A' ' 72' ' ' GLY . 34.6 mt-30 -65.4 130.9 44.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -170.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -134.43 162.39 32.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 107.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 44.9 p90 -144.56 153.39 41.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 O-C-N 124.683 1.239 . . . . 0.0 110.263 166.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.79 123.84 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 160.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.14 125.39 24.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.3 p -110.77 32.39 5.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.52 173.11 13.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.341 1.057 . . . . 0.0 109.192 167.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -68.59 89.85 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 158.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 p -83.38 65.88 8.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.819 -0.551 . . . . 0.0 109.892 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -59.22 -23.21 62.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.11 0.964 . . . . 0.0 112.306 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -68.49 -14.82 63.27 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.761 1.224 . . . . 0.0 110.749 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 62.1 mt -104.0 -6.24 21.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.243 1.417 . . . . 0.0 111.54 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.16 145.13 53.54 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.714 0.688 . . . . 0.0 110.498 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.49 16.06 48.7 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.96 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.22 -52.01 1.41 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.924 2.09 . . . . 0.0 108.414 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -105.18 146.69 28.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.814 -173.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.45 100.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -171.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.1 t -59.06 127.29 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 165.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.409 ' HA ' HG21 ' A' ' 29' ' ' VAL . 29.4 p90 -138.25 -3.45 1.75 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.59 -174.19 30.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.36 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -149.83 149.99 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.659 1.183 . . . . 0.0 108.44 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 118.31 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 165.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -75.13 -50.27 16.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -143.34 146.4 33.51 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 126.133 1.773 . . . . 0.0 107.275 -171.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.27 22.34 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.464 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 28.6 tpp -56.61 -35.94 68.85 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 119.526 1.663 . . . . 0.0 110.706 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -62.67 -20.51 64.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.852 1.205 . . . . 0.0 113.391 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.4 mm -83.05 -43.77 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.551 1.14 . . . . 0.0 108.677 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.37 -35.9 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 121.586 -0.696 . . . . 0.0 109.579 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.37 -44.26 84.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.084 1.753 . . . . 0.0 110.913 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.08 85.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.434 ' HB3' HD13 ' A' ' 56' ' ' ILE . 38.4 mtm -53.26 -47.93 68.7 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.734 176.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -53.24 -42.14 66.12 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.537 HH11 ' HG3' ' A' ' 144' ' ' ARG . 15.0 mtt85 -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.085 -177.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.04 5.24 51.62 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.801 1.24 . . . . 0.0 112.446 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.2 -150.89 4.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 120.473 1.488 . . . . 0.0 111.74 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.0 p -142.59 -96.05 0.12 Allowed 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.589 -0.948 . . . . 0.0 108.798 165.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -162.2 -23.4 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 125.858 1.663 . . . . 0.0 110.764 164.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -16.07 58.25 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.977 0.808 . . . . 0.0 111.432 165.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.27 -24.84 6.84 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 118.556 -1.136 . . . . 0.0 113.174 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.14 123.47 17.77 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.224 1.012 . . . . 0.0 108.764 -174.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.449 ' CG2' HD12 ' A' ' 56' ' ' ILE . 12.3 p -74.93 159.99 31.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 108.837 173.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -10.66 59.64 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.031 -1.668 . . . . 0.0 111.362 166.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.422 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -140.73 160.31 40.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 110.117 -161.194 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.52 80.2 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.67 119.16 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 p -139.22 165.74 26.38 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.508 1.123 . . . . 0.0 110.766 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 102.41 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 166.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.4 77.09 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -145.43 161.48 39.6 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 p -162.26 158.17 23.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.282 1.433 . . . . 0.0 108.556 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.71 -176.34 42.96 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -83.05 159.55 22.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.856 -0.79 . . . . 0.0 110.722 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.0 mt -135.58 43.63 2.59 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 158.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.148 0.979 . . . . 0.0 111.458 175.419 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HG3' ' H ' ' A' ' 2' ' ' VAL . 7.2 tpt . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.529 HG22 ' H ' ' A' ' 3' ' ' ASN . 4.5 p -69.11 -174.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 164.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.529 ' H ' HG22 ' A' ' 2' ' ' VAL . 29.3 m120 -33.83 104.79 0.25 Allowed Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 127.994 2.518 . . . . 0.0 113.188 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.23 138.82 48.17 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 N-CA-C 106.502 -2.153 . . . . 0.0 106.502 158.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 m -104.7 147.91 27.16 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.5 140.43 44.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -113.71 150.91 32.61 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 123.936 0.894 . . . . 0.0 110.164 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.431 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 19.3 m-85 -146.13 113.56 6.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.481 1.512 . . . . 0.0 109.317 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.21 101.11 3.88 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 159.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.19 140.93 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 171.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.78 148.06 49.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.929 1.292 . . . . 0.0 108.37 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.647 HG13 HD13 ' A' ' 156' ' ' ILE . 1.5 t -125.35 115.76 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 53.5 13.76 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 0.0 114.489 -167.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.3 57.79 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.381 1.467 . . . . 0.0 112.859 -175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.27 133.23 81.18 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.22 120.19 7.17 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.2 -40.49 30.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.85 177.28 19.56 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 123.68 0.657 . . . . 0.0 112.364 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -77.32 136.62 38.48 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.726 0.81 . . . . 0.0 110.068 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -121.92 158.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 126.578 1.951 . . . . 0.0 106.316 164.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -147.99 140.34 24.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.965 -0.459 . . . . 0.0 110.244 161.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -109.14 162.72 14.0 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -123.38 112.76 17.95 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.479 2.712 . . . . 0.0 104.433 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 mt -97.61 134.65 40.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -169.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CD2' HD13 ' A' ' 90' ' ' LEU . 18.0 m-85 -82.16 51.76 1.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.998 -1.064 . . . . 0.0 112.42 -171.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.9 -27.36 42.42 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.252 -0.905 . . . . 0.0 112.061 173.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -71.39 -7.08 44.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.721 1.608 . . . . 0.0 113.758 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.82 -25.25 0.46 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.032 0.833 . . . . 0.0 112.933 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 75.1 33.64 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.562 1.945 . . . . 0.0 106.793 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.81 -52.65 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.29 1.993 . . . . 0.0 111.644 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -42.95 99.53 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.883 1.22 . . . . 0.0 109.83 -173.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -60.92 -48.21 82.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.433 0.693 . . . . 0.0 110.332 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.78 -51.29 57.47 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.131 0.972 . . . . 0.0 111.764 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.6 -32.41 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.213 2.205 . . . . 0.0 112.085 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -61.98 2.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.019 1.728 . . . . 0.0 108.579 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.07 -30.93 71.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.203 -0.311 . . . . 0.0 111.56 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -53.19 -62.37 1.7 Allowed 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.038 1.335 . . . . 0.0 109.784 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.9 -26.34 68.11 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.95 -32.39 34.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.866 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 m -69.67 -40.87 76.17 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.926 0.89 . . . . 0.0 109.853 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.0 p -70.87 -34.7 71.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.4 -0.6 88.9 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.623 1.106 . . . . 0.0 110.949 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -70.64 -12.07 61.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.037 1.335 . . . . 0.0 112.887 -162.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -75.57 -4.55 40.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.148 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.07 6.42 55.86 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.486 1.041 . . . . 0.0 111.463 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -163.23 170.54 17.56 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.349 1.86 . . . . 0.0 106.146 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.53 178.62 35.62 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 118.217 -1.944 . . . . 0.0 114.052 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.431 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 75.2 t80 -70.68 -17.63 62.84 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 130.51 3.524 . . . . 0.0 113.283 -170.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -55.74 121.8 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 23.72 73.0 Favored Glycine 0 CA--C 1.538 1.496 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.063 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -25.3 67.98 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.853 2.326 . . . . 0.0 110.288 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.4 m 56.38 175.99 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.308 1.443 . . . . 0.0 110.515 -159.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.6 117.99 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -74.27 -39.75 62.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.202 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 125.54 40.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -158.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.2 mm -142.33 114.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.9 mt -125.89 108.84 25.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.19 124.22 13.58 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.36 3.373 . . . . 0.0 114.015 -173.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.64 27.02 69.13 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.215 1.388 . . . . 0.0 112.442 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -125.1 -83.89 0.64 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.22 172.55 15.57 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.497 0.719 . . . . 0.0 110.188 170.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.99 115.84 17.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.231 1.413 . . . . 0.0 109.834 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -101.1 138.22 38.42 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.24 2.216 . . . . 0.0 111.528 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.22 -156.07 7.33 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.863 1.697 . . . . 0.0 109.279 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.8 90.13 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 119.284 -0.731 . . . . 0.0 114.401 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -83.86 138.9 32.97 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 159.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -132.53 6.83 4.11 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.398 1.079 . . . . 0.0 111.326 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.6 -31.57 0.86 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.468 1.107 . . . . 0.0 113.73 -174.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -127.84 -10.95 5.48 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.306 1.412 . . . . 0.0 112.964 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 58.44 30.57 19.86 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.235 1.814 . . . . 0.0 113.091 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -147.04 -27.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.74 2.57 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.889 1.222 . . . . 0.0 114.469 -170.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.9 p -83.89 -4.32 58.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.596 1.198 . . . . 0.0 112.282 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -103.13 -108.34 3.25 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -8.46 91.17 0.01 OUTLIER Glycine 0 C--N 1.334 0.453 0 C-N-CA 129.082 3.23 . . . . 0.0 115.633 -170.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 1.4 ptpt -77.24 150.1 35.41 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 128.224 2.61 . . . . 0.0 110.013 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -84.89 44.93 1.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.26 1.424 . . . . 0.0 112.768 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.257 36.6 pt 49.27 -43.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 1 C-N-CA 133.486 4.714 . . . . 0.0 114.562 -158.921 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -82.04 -4.43 56.76 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.844 1.257 . . . . 0.0 113.724 -159.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.66 -85.36 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 170.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -127.84 -133.23 0.23 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 127.255 2.222 . . . . 0.0 105.381 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.83 155.67 18.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.379 1.445 . . . . 0.0 108.902 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -122.76 177.75 5.33 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.083 0.856 . . . . 0.0 110.565 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -57.47 164.31 1.98 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 112.679 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -64.22 120.01 11.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 158.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -67.2 -48.09 68.95 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.767 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.72 156.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.417 2.687 . . . . 0.0 110.706 170.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -104.61 22.55 14.83 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.923 1.689 . . . . 0.0 110.655 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.34 -49.39 64.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 124.33 1.052 . . . . 0.0 109.853 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD13 ' CD2' ' A' ' 25' ' ' PHE . 96.3 mt -80.67 129.32 34.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.95 160.57 14.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.122 1.769 . . . . 0.0 109.368 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -77.08 85.24 3.58 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 172.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 p -76.47 -24.14 53.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 118.877 -0.582 . . . . 0.0 111.216 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.1 -170.57 43.55 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.041 0.829 . . . . 0.0 112.705 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.95 158.89 19.54 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.629 2.219 . . . . 0.0 110.64 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.65 -4.2 57.36 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 117.084 -1.954 . . . . 0.0 113.06 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -67.84 148.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 121.2 2.5 . . . . 0.0 107.823 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.83 125.33 54.23 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 p -131.73 159.82 37.3 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 122.799 1.285 . . . . 0.0 110.048 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttm -86.71 127.44 34.97 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.376 -163.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.62 41.79 0.34 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.884 2.474 . . . . 0.0 112.346 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -63.03 167.62 4.7 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.868 1.318 . . . . 0.0 110.409 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.36 15.26 13.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.374 -1.739 . . . . 0.0 111.75 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.61 -167.7 32.61 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 -167.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -64.75 171.62 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 119.328 1.564 . . . . 0.0 108.965 158.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 48.85 24.43 0.84 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.458 2.303 . . . . 0.0 115.188 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -128.2 29.15 5.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.399 1.48 . . . . 0.0 109.858 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.471 HD21 HG21 ' A' ' 127' ' ' VAL . 85.7 m-20 -69.19 101.24 1.43 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.902 1.681 . . . . 0.0 107.324 172.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.92 -137.59 7.76 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -90.08 -10.87 43.14 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.733 0.813 . . . . 0.0 112.624 163.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -81.69 146.63 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.743 1.217 . . . . 0.0 111.286 -158.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -154.32 171.75 18.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.28 1.032 . . . . 0.0 109.492 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.597 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 10.6 p90 -135.49 154.66 51.34 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.341 0.591 . . . . 0.0 109.965 159.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.25 117.46 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 36.0 m -65.72 130.3 42.81 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.625 1.17 . . . . 0.0 108.078 168.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.9 p -111.66 22.07 15.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.944 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.95 -176.14 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 161.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.54 93.22 0.23 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 161.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -81.08 55.74 2.59 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.634 1.974 . . . . 0.0 110.014 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.869 -1.144 . . . . 0.0 113.673 -171.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -73.15 -4.47 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.597 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 68.0 mt -114.82 -2.88 12.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.229 1.811 . . . . 0.0 110.89 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.47 143.16 58.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.174 1.39 . . . . 0.0 111.529 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.5 20.26 58.82 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.254 0.93 . . . . 0.0 112.084 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.04 -51.91 0.67 Allowed 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -96.58 117.62 31.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 108' ' ' ASN . 18.6 t -71.23 107.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -170.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.89 122.55 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.384 1.474 . . . . 0.0 108.037 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -145.13 9.27 1.26 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.24 -173.08 37.29 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 121.296 -0.878 . . . . 0.0 111.783 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -147.67 158.36 43.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.144 0.978 . . . . 0.0 109.631 168.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.15 105.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -52.34 62.56 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.41 157.69 44.13 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.977 0.911 . . . . 0.0 111.056 -167.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.7 24.93 54.91 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.458 1.028 . . . . 0.0 112.592 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.8 tpp -55.75 -35.09 65.81 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.554 1.677 . . . . 0.0 110.109 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -57.6 -30.95 65.73 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.424 1.465 . . . . 0.0 113.379 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.8 mm -76.39 -35.07 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.906 0.776 . . . . 0.0 109.483 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.35 -39.4 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.387 0.994 . . . . 0.0 109.645 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -62.49 -31.44 72.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.117 1.367 . . . . 0.0 111.456 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -44.44 28.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.823 1.249 . . . . 0.0 109.215 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 62.5 mtp -49.77 -44.01 48.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.872 1.269 . . . . 0.0 110.316 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -33.31 71.22 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.02 0.928 . . . . 0.0 113.489 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -65.64 -25.73 67.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.699 1.136 . . . . 0.0 110.975 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.662 ' HB2' HD11 ' A' ' 156' ' ' ILE . 59.0 m-85 -91.98 5.12 51.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 177.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.43 -167.81 34.05 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 125.007 1.289 . . . . 0.0 111.721 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 p -153.75 152.55 30.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.262 1.425 . . . . 0.0 107.372 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -63.85 -22.15 66.78 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.198 -1.564 . . . . 0.0 113.16 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -77.04 -6.48 52.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 16.69 68.94 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.355 -1.247 . . . . 0.0 113.243 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.404 ' HE3' ' H ' ' A' ' 152' ' ' THR . 0.0 OUTLIER -86.44 176.13 8.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.583 1.691 . . . . 0.0 109.141 158.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.404 ' H ' ' HE3' ' A' ' 151' ' ' LYS . 71.4 p -125.04 129.97 51.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.72 -31.65 70.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.4 0.546 . . . . 0.0 110.575 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.484 ' HB3' HG12 ' A' ' 12' ' ' VAL . 47.0 mtpt -111.75 176.94 4.82 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.163 0.585 . . . . 0.0 109.972 171.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.66 103.4 15.78 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 145' ' ' PHE . 42.3 mm -79.9 126.24 39.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -142.85 172.61 12.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.995 1.318 . . . . 0.0 111.412 -168.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.5 mt -124.0 109.69 23.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.85 87.33 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.375 1.047 . . . . 0.0 110.528 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -160.86 162.2 32.1 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.4 p -160.2 163.52 33.53 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.215 0.462 . . . . 0.0 111.9 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.34 29.34 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -110.05 143.95 39.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.01 1.324 . . . . 0.0 110.092 -172.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.26 43.55 3.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.811 1.645 . . . . 0.0 109.789 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.941 0 O-C-N 121.03 -1.044 . . . . 0.0 111.001 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tmm? . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 74.6 t 52.42 179.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -142.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -58.42 120.07 41.34 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 119.948 -1.72 . . . . 0.0 109.905 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 42.8 Cg_exo -63.04 166.77 13.62 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 CA-C-N 121.623 1.615 . . . . 0.0 112.139 158.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 m -131.11 152.26 50.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 158.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.1 m -139.01 154.9 26.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 108.121 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' HB3' HD11 ' A' ' 164' ' ' LEU . 23.2 p90 -109.83 159.96 16.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.862 0.865 . . . . 0.0 110.612 171.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -144.5 105.02 4.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.831 1.652 . . . . 0.0 107.437 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.29 97.15 5.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 164.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -68.69 141.7 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -125.01 159.9 30.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.397 1.094 . . . . 0.0 109.206 169.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.57 HG22 HD13 ' A' ' 156' ' ' ILE . 16.5 t -137.99 88.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -168.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.44 13.07 1.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.898 1.279 . . . . 0.0 112.35 -165.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.55 -9.43 30.44 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.705 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.68 112.44 8.7 Favored Pre-proline 0 N--CA 1.441 -0.924 0 C-N-CA 126.656 1.982 . . . . 0.0 105.696 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.86 118.63 5.53 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.7 -25.08 30.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.6 -152.03 23.43 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -124.27 114.87 20.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.151 0.975 . . . . 0.0 110.611 159.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.1 t -82.19 161.0 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.732 2.013 . . . . 0.0 108.33 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.7 m -151.4 141.85 22.52 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.315 -1.49 . . . . 0.0 110.205 170.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -117.6 143.47 46.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.894 0.878 . . . . 0.0 109.342 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -87.98 142.28 27.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 161.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -127.39 116.77 21.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -79.64 52.77 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.359 1.064 . . . . 0.0 113.555 -167.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -67.35 -16.17 64.1 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.36 -28.37 65.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.903 1.683 . . . . 0.0 110.705 168.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.27 -32.08 11.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.991 1.716 . . . . 0.0 112.449 -174.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG12 ' HG3' ' A' ' 86' ' ' GLU . 3.3 m -141.8 74.14 22.78 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.469 1.508 . . . . 0.0 109.022 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.53 -43.21 22.9 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.813 2.342 . . . . 0.0 112.342 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.55 -52.2 66.17 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 119.868 1.213 . . . . 0.0 108.515 -177.14 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 m -60.81 -47.65 85.39 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.641 1.177 . . . . 0.0 111.157 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.76 -33.9 46.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.06 -42.81 68.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.436 1.016 . . . . 0.0 110.014 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -45.15 -55.58 5.59 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.548 1.139 . . . . 0.0 108.561 164.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.82 -29.64 70.14 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -61.26 -55.27 33.84 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.984 1.266 . . . . 0.0 109.532 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -54.39 -45.38 72.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.191 1.396 . . . . 0.0 111.434 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 mt -67.13 -38.57 85.79 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.414 -0.804 . . . . 0.0 111.935 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.9 m -71.2 -36.82 72.05 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.822 0.849 . . . . 0.0 110.836 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -73.96 -23.88 59.55 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.272 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.31 74.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.262 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.78 -25.59 63.23 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.61 1.564 . . . . 0.0 113.565 -159.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -88.56 1.31 55.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.944 1.298 . . . . 0.0 112.089 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.89 15.6 59.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.259 0.933 . . . . 0.0 112.449 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -160.43 177.52 10.49 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.7 -147.45 17.56 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.437 ' O ' HD13 ' A' ' 158' ' ' ILE . 4.1 m-85 -84.06 -24.04 30.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 117.928 -1.035 . . . . 0.0 113.593 -159.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -56.57 120.07 7.15 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 57.33 43.72 93.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.65 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -96.18 -5.37 40.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.671 1.736 . . . . 0.0 113.612 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m 47.11 170.29 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.072 2.149 . . . . 0.0 113.831 -159.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.74 146.5 30.77 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 159.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -106.48 -30.52 9.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.096 -170.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.5 124.13 18.37 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 mm -130.83 109.42 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -121.71 95.02 48.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.62 122.98 11.24 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.455 2.77 . . . . 0.0 112.576 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.79 65.65 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 124.66 1.124 . . . . 0.0 112.446 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -134.56 -76.29 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.59 170.03 21.7 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.023 0.929 . . . . 0.0 110.343 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 122.31 28.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.848 1.659 . . . . 0.0 107.61 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.424 HE22 ' CB ' ' A' ' 101' ' ' ALA . 30.6 tp60 -111.92 133.71 53.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 128.339 2.655 . . . . 0.0 110.384 -165.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.37 -173.31 13.98 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.484 1.992 . . . . 0.0 112.566 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.7 29.25 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 124.231 0.919 . . . . 0.0 115.369 161.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.08 68.48 3.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.247 1.523 . . . . 0.0 109.134 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.84 2.62 44.08 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 113.267 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -139.29 -60.66 0.56 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.595 1.089 . . . . 0.0 109.143 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -83.54 162.92 20.72 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 159.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -124.01 21.89 8.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.686 1.194 . . . . 0.0 108.978 -166.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -162.46 -0.9 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.418 1.087 . . . . 0.0 113.468 -158.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.8 14.21 19.91 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.202 1.365 . . . . 0.0 115.581 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.1 p -118.69 16.28 13.61 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.116 1.458 . . . . 0.0 112.866 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.26 -152.64 5.68 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.95 173.32 47.68 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -166.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -153.45 144.0 22.53 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.722 -0.869 . . . . 0.0 110.715 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.479 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 69.5 p -73.74 22.57 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 130.033 3.333 . . . . 0.0 113.835 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.623 HG21 ' HB3' ' A' ' 38' ' ' ALA . 6.4 pt 49.16 -22.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 1 C-N-CA 132.204 4.202 . . . . 0.0 116.127 -158.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -89.41 -19.89 24.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.484 1.914 . . . . 0.0 110.675 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.65 128.96 3.13 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 126.036 1.779 . . . . 0.0 109.336 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.331 48.3 tt0 50.1 -132.57 1.77 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -116.12 171.54 7.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.584 1.554 . . . . 0.0 109.408 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 77' ' ' SER . 0.7 OUTLIER -139.24 -177.48 4.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.597 1.559 . . . . 0.0 110.073 175.571 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -56.62 164.93 1.28 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.538 2.335 . . . . 0.0 113.207 -176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.92 75.44 10.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 164.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' HG3' HG12 ' A' ' 29' ' ' VAL . 9.7 pt-20 -45.99 -56.86 4.96 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -159.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.412 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -153.73 153.68 32.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 160.31 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.2 16.27 26.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.414 2.286 . . . . 0.0 111.207 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 mt -50.76 -53.17 14.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.882 1.273 . . . . 0.0 109.126 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.33 123.06 23.89 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -118.32 170.56 8.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.409 1.484 . . . . 0.0 109.377 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -81.5 54.12 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.504 1.921 . . . . 0.0 111.007 -167.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.4 p -69.67 -9.72 55.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -158.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.86 177.13 44.65 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.05 1.295 . . . . 0.0 111.802 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.25 155.31 46.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.645 1.563 . . . . 0.0 110.266 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.32 4.54 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.505 -1.72 . . . . 0.0 113.216 -171.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.06 162.32 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 120.795 2.298 . . . . 0.0 107.366 163.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.17 124.74 22.21 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 109.649 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 157.52 43.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.895 0.855 . . . . 0.0 110.941 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 91.4 mmm -64.07 156.01 29.56 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.108 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.424 ' CB ' HE22 ' A' ' 63' ' ' GLN . . . -112.42 136.51 51.81 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -146.2 172.24 13.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.35 1.46 . . . . 0.0 107.822 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.06 15.85 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.239 1.416 . . . . 0.0 111.656 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.63 -165.49 26.79 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -168.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -64.28 166.38 17.19 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 118.95 1.375 . . . . 0.0 110.048 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 37.67 43.91 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.287 3.035 . . . . 0.0 113.55 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -133.31 33.17 3.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.556 1.542 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -79.97 108.06 13.25 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.5 -100.62 2.09 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 89.9 p -145.77 33.88 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.315 0.646 . . . . 0.0 110.674 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -121.06 142.49 49.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -157.24 155.5 30.92 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -165.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 28.0 p90 -134.68 147.34 50.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.504 167.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.1 mt -83.85 117.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 29.1 m -63.69 129.01 38.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 p -117.79 26.3 9.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.19 0.995 . . . . 0.0 109.299 171.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.96 11.88 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 163.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -68.47 96.42 0.69 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 159.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.5 p -83.13 60.1 5.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.116 0.871 . . . . 0.0 109.835 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.64 -14.63 59.0 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.5 1.52 . . . . 0.0 113.086 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -76.45 -10.38 59.35 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.934 -1.104 . . . . 0.0 111.711 169.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 67.6 mt -104.69 -5.89 20.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.807 1.643 . . . . 0.0 110.99 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -63.99 132.12 49.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.48 17.74 74.81 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 122.113 -0.367 . . . . 0.0 113.089 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -128.04 -34.32 2.13 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.003 1.321 . . . . 0.0 110.854 176.517 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -140.35 162.63 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.224 0.92 . . . . 0.0 110.542 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.94 105.86 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.979 2.112 . . . . 0.0 107.434 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.53 131.95 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 166.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -138.33 -0.47 2.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.33 -177.7 27.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.344 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.93 148.17 36.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.261 1.424 . . . . 0.0 107.417 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.9 106.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 162.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -70.05 -50.36 41.98 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 159.19 42.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.53 0.732 . . . . 0.0 110.918 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.84 24.41 60.12 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.146 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -35.2 68.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.969 1.885 . . . . 0.0 110.343 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -64.99 -21.58 66.87 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.77 -34.0 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.156 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.88 -41.52 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.093 167.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.93 -29.1 70.53 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.185 -0.947 . . . . 0.0 112.302 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.46 -42.85 74.36 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.216 0.916 . . . . 0.0 109.566 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.8 mtm -56.28 -45.72 80.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.269 0.486 . . . . 0.0 110.867 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.58 -40.76 65.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 112.47 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -68.82 -20.58 64.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.052 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.442 ' HB2' HD11 ' A' ' 156' ' ' ILE . 22.9 m-85 -91.32 3.99 53.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.013 0.925 . . . . 0.0 112.75 173.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.78 -148.37 14.82 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 121.058 1.754 . . . . 0.0 112.727 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.3 p -163.89 161.2 22.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.314 1.446 . . . . 0.0 107.235 158.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -59.54 -29.99 68.29 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.406 -1.434 . . . . 0.0 114.528 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -75.37 -7.71 54.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.36 -26.38 20.36 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 126.197 1.856 . . . . 0.0 113.726 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.06 123.93 20.76 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.393 1.077 . . . . 0.0 109.418 -171.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.3 p -75.81 143.88 41.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.862 1.665 . . . . 0.0 110.641 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.6 p -84.85 -13.65 50.34 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.106 -1.621 . . . . 0.0 111.938 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.511 ' HD3' ' CG1' ' A' ' 12' ' ' VAL . 78.7 mttt -146.84 157.46 43.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.164 1.785 . . . . 0.0 108.748 -168.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.514 ' HE2' HG21 ' A' ' 157' ' ' THR . 81.3 tttt -76.31 84.56 3.09 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.502 1.046 . . . . 0.0 108.296 174.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.57 HD13 HG22 ' A' ' 12' ' ' VAL . 5.6 mm -73.2 117.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.514 HG21 ' HE2' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -138.72 172.16 13.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.541 1.137 . . . . 0.0 110.585 -170.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 48' ' ' TYR . 5.3 mp -103.52 118.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 159.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -73.33 -49.62 26.42 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 167.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.3 152.67 40.28 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.092 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.8 p -164.08 165.5 22.26 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.83 0.852 . . . . 0.0 109.546 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.7 -170.21 43.33 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.55 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.8 tp60 -79.88 146.55 32.11 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.34 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 7' ' ' PHE . 60.8 mt -138.31 42.91 2.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.437 1.495 . . . . 0.0 110.424 161.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.55 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 5.8 mt-10 . . . . . 0 C--O 1.248 0.987 0 O-C-N 120.971 -1.08 . . . . 0.0 111.212 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -55.96 169.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 157.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -29.08 98.24 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 127.496 2.318 . . . . 0.0 114.211 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -62.94 136.76 58.7 Favored 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 121.395 1.396 . . . . 0.0 108.947 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.8 m -98.5 145.93 26.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.68 133.82 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -87.94 157.84 18.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.134 0.968 . . . . 0.0 109.135 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -132.49 149.59 52.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -129.55 93.32 3.52 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 mm -77.18 141.62 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.69 160.82 28.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.635 1.574 . . . . 0.0 108.568 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.02 113.27 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 58.68 14.39 3.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.836 1.254 . . . . 0.0 114.258 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.36 -3.85 40.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.676 2.084 . . . . 0.0 113.17 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.85 115.46 61.0 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -57.83 120.27 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.132 1.888 . . . . 0.0 109.788 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -82.91 -43.46 16.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.44 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.21 152.62 7.03 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -76.78 152.34 35.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -141.33 160.43 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 126.803 2.041 . . . . 0.0 105.93 -174.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -142.87 152.39 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 122.129 0.966 . . . . 0.0 109.622 172.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.88 147.82 49.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.864 1.266 . . . . 0.0 108.857 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.8 139.4 39.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.95 1.7 . . . . 0.0 106.49 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.63 131.6 53.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.944 1.298 . . . . 0.0 107.814 -177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.21 52.64 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.014 0.926 . . . . 0.0 113.316 -166.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -18.89 56.68 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.897 -1.752 . . . . 0.0 115.628 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.15 0.27 53.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.734 1.152 . . . . 0.0 111.801 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -128.52 -29.54 2.41 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.466 1.506 . . . . 0.0 112.628 173.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.79 72.74 76.96 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.515 1.526 . . . . 0.0 108.9 167.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -56.36 -42.72 62.91 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.153 1.902 . . . . 0.0 114.194 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -53.6 53.35 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.5 m -62.13 -48.83 78.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.3 1.44 . . . . 0.0 109.983 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.87 -46.49 74.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -37.47 81.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.471 0.578 . . . . 0.0 109.801 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -56.95 -53.05 62.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -66.01 -32.8 74.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -51.75 -63.9 0.99 Allowed 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 124.351 1.06 . . . . 0.0 109.137 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.979 0.912 . . . . 0.0 113.242 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -71.38 -33.01 69.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.404 1.002 . . . . 0.0 111.523 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -65.55 -51.41 60.01 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.429 1.468 . . . . 0.0 108.965 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -63.83 -33.64 76.14 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.498 0.719 . . . . 0.0 110.432 -171.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.34 90.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.08 -24.28 67.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.713 1.257 . . . . 0.0 112.102 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -68.06 1.62 2.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.588 1.555 . . . . 0.0 112.395 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.82 5.83 84.55 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.644 1.116 . . . . 0.0 112.006 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -153.01 173.97 14.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.657 2.383 . . . . 0.0 106.537 167.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.95 -162.93 29.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 121.713 0.618 . . . . 0.0 111.967 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' CE1' ' HA2' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -69.36 -15.33 63.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.326 2.65 . . . . 0.0 112.631 177.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -62.85 100.06 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.029 -1.045 . . . . 0.0 108.578 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.2 80.01 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.142 -1.921 . . . . 0.0 115.473 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.8 p -64.3 -48.71 74.59 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.206 2.503 . . . . 0.0 111.528 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.4 m 106.76 144.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 1 C-N-CA 133.175 4.59 . . . . 0.0 108.343 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.65 136.2 33.47 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 162.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -119.68 -10.18 9.63 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.6 119.42 15.21 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.23 110.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 170.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.7 mt -116.55 94.65 43.86 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -54.92 121.06 9.18 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.814 3.01 . . . . 0.0 112.999 -168.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.73 26.35 46.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.933 1.254 . . . . 0.0 111.416 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -143.07 -68.8 0.34 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.383 1.092 . . . . 0.0 108.564 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -161.08 161.61 31.31 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.83 117.18 24.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -122.34 132.58 54.46 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.271 1.828 . . . . 0.0 109.339 -166.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.52 32.21 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 142.03 49.86 0.04 OUTLIER Glycine 0 N--CA 1.466 0.674 0 CA-C-N 119.526 1.663 . . . . 0.0 112.593 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -143.0 113.79 7.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -160.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.434 ' CE1' ' HE3' ' A' ' 76' ' ' LYS . 53.7 p90 -130.25 12.27 5.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.702 1.601 . . . . 0.0 110.745 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -122.98 -67.91 0.92 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.906 1.283 . . . . 0.0 108.834 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -106.07 -20.14 13.51 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 60.45 -3.81 0.13 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 119.03 2.974 . . . . 0.0 119.03 166.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -112.15 0.97 16.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.474 1.51 . . . . 0.0 112.842 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.45 -22.74 9.34 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.056 1.788 . . . . 0.0 112.382 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.1 p -85.25 20.54 1.94 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.413 1.106 . . . . 0.0 112.319 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.63 166.16 32.73 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 113.778 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.53 126.84 3.64 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 128.588 2.994 . . . . 0.0 105.996 -159.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HE3' ' CE1' ' A' ' 67' ' ' PHE . 3.5 pttt -143.54 152.87 41.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.085 2.554 . . . . 0.0 105.97 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.0 p -72.38 168.62 18.04 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.972 0.795 . . . . 0.0 109.856 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 pt -64.84 -18.65 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 123.784 0.834 . . . . 0.0 112.222 166.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -96.5 -6.76 36.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.79 -171.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.77 -84.57 0.13 Allowed Glycine 0 C--N 1.34 0.769 0 CA-C-N 119.921 1.237 . . . . 0.0 111.071 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -132.44 -137.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.888 1.675 . . . . 0.0 107.784 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -75.89 154.22 36.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.692 0.797 . . . . 0.0 109.908 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -125.63 177.01 6.48 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.122 0.963 . . . . 0.0 109.005 168.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.0 170.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.956 1.302 . . . . 0.0 112.326 -172.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.6 106.32 2.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 159.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.67 -44.87 92.48 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.264 0.625 . . . . 0.0 111.004 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.16 153.75 1.65 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 125.529 1.768 . . . . 0.0 114.133 158.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.68 15.26 29.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.254 2.222 . . . . 0.0 111.126 -169.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.8 mt -37.57 -46.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 128.045 2.538 . . . . 0.0 110.636 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.2 mt -92.15 121.94 34.17 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.164 1.786 . . . . 0.0 106.87 -173.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -97.16 169.3 9.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 110.45 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -82.27 80.91 8.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 108.055 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -79.74 -20.75 45.64 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.99 175.4 36.37 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.954 1.252 . . . . 0.0 112.768 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.97 134.66 40.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.069 1.846 . . . . 0.0 110.449 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.53 -11.4 28.16 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.311 1.91 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 120.299 2.05 . . . . 0.0 109.185 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.97 132.16 53.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 126.156 1.783 . . . . 0.0 108.556 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.7 t -142.04 153.45 44.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.634 . . . . 0.0 110.304 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 92.4 mmm -80.21 137.66 36.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.074 0.55 . . . . 0.0 110.324 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.74 124.3 30.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 169.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.65 150.63 51.57 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.632 1.173 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.62 14.05 12.57 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.696 1.598 . . . . 0.0 113.068 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.07 -165.24 28.94 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 -165.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -63.45 164.71 19.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 119.249 1.524 . . . . 0.0 109.748 167.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 33.62 48.71 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 131.159 3.784 . . . . 0.0 112.478 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.9 p -138.99 30.84 2.22 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.359 -1.463 . . . . 0.0 112.136 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -86.23 149.71 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.747 -1.221 . . . . 0.0 107.865 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.16 -66.18 0.01 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.7 t -146.5 -28.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.096 0.958 . . . . 0.0 111.092 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -61.54 128.33 35.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -134.52 174.74 10.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.304 1.042 . . . . 0.0 108.265 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 99' ' ' SER . 20.3 p90 -139.58 149.73 44.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.22 1.01 . . . . 0.0 110.847 164.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.1 mt -83.22 116.85 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 100.696 -3.816 . . . . 0.0 100.696 164.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.8 m -67.81 108.13 2.86 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.5 p -102.56 28.46 6.01 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.322 1.049 . . . . 0.0 108.988 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.71 175.75 11.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.723 1.609 . . . . 0.0 107.466 166.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -71.78 86.62 0.95 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 166.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 p -74.87 40.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.239 2.216 . . . . 0.0 112.384 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.24 -20.96 61.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.015 -1.678 . . . . 0.0 114.08 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -68.37 -15.53 63.59 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.414 0.686 . . . . 0.0 111.103 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.5 mt -95.7 -3.22 46.4 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.58 1.552 . . . . 0.0 111.353 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.03 157.53 24.97 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.237 -0.914 . . . . 0.0 110.028 169.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.45 -0.0 14.97 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.295 1.426 . . . . 0.0 113.785 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -129.32 -47.92 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.507 1.523 . . . . 0.0 109.015 -172.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.15 146.12 40.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.458 0.647 . . . . 0.0 111.028 -167.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 t -95.35 100.99 11.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.04 126.83 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -138.87 2.36 2.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.66 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.28 -173.06 34.32 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.086 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -149.84 160.84 43.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.405 1.082 . . . . 0.0 110.724 164.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.25 115.71 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 166.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -49.91 28.6 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.33 159.19 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.994 2.518 . . . . 0.0 108.496 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.56 20.94 13.53 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.422 1.011 . . . . 0.0 113.236 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 33.6 tpp -54.61 -39.51 67.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.518 1.659 . . . . 0.0 111.813 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.34 69.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.806 1.639 . . . . 0.0 112.058 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.58 -45.16 52.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 118.954 0.797 . . . . 0.0 109.158 176.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.85 -47.03 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 0.0 110.368 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.81 -24.7 65.32 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.029 -1.044 . . . . 0.0 111.901 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.79 -43.83 57.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.958 -1.089 . . . . 0.0 109.182 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 66.9 mtp -56.36 -43.06 78.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.247 -0.908 . . . . 0.0 110.138 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.84 -37.21 83.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -71.87 -21.3 61.68 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 120.269 1.395 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.416 ' CB ' HD11 ' A' ' 156' ' ' ILE . 28.9 m-85 -93.11 5.47 51.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.735 1.614 . . . . 0.0 111.519 171.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.57 48.07 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 108.424 -1.871 . . . . 0.0 108.424 167.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.1 p -151.86 163.34 39.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -61.84 -27.87 69.09 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 107.69 -27.03 16.03 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.374 1.464 . . . . 0.0 113.725 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 130.71 43.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.974 1.887 . . . . 0.0 108.015 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.0 p -70.86 138.19 50.02 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.7 p -64.11 -30.55 71.61 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.61 -0.681 . . . . 0.0 110.29 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -125.59 170.56 11.36 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.329 1.452 . . . . 0.0 109.044 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -86.99 87.75 7.54 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.783 -1.198 . . . . 0.0 108.676 -177.333 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.416 HD11 ' CB ' ' A' ' 145' ' ' PHE . 33.5 mm -75.6 120.19 24.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -142.71 172.77 12.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.525 1.155 . . . . 0.0 111.163 -173.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.03 113.81 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.78 -56.87 16.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -157.49 165.59 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.703 1.201 . . . . 0.0 109.873 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 54.3 m -141.6 163.65 32.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 127.327 2.251 . . . . 0.0 105.622 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.62 172.65 42.53 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.33 156.02 29.8 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.944 -0.739 . . . . 0.0 109.271 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 33.2 mt -136.63 43.0 2.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.882 0.373 . . . . 0.0 110.838 159.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 116.932 -1.907 . . . . 0.0 107.028 158.529 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.14 152.14 76.52 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.62 1.547 . . . . 0.0 109.875 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 m -111.18 156.47 21.37 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.58 163.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.208 1.003 . . . . 0.0 110.017 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -125.74 159.07 33.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 125.224 1.41 . . . . 0.0 109.657 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -146.12 118.24 8.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 107.011 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.03 96.85 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 mm -69.5 140.03 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.96 128.28 32.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.844 1.258 . . . . 0.0 109.827 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.497 HG12 ' HE2' ' A' ' 154' ' ' LYS . 22.6 t -95.95 109.48 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.43 13.76 0.99 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.634 1.574 . . . . 0.0 113.664 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.16 -11.78 26.62 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.72 1.629 . . . . 0.0 113.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.71 127.61 72.07 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 119.647 1.723 . . . . 0.0 107.201 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.83 119.13 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.724 1.616 . . . . 0.0 109.451 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -89.0 -32.8 17.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.484 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.09 162.87 10.39 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -68.62 147.85 51.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.21 154.3 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 126.966 2.107 . . . . 0.0 105.568 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.0 t -139.7 153.29 47.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.827 0.823 . . . . 0.0 109.182 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 60.4 m-85 -142.17 155.48 45.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.324 1.05 . . . . 0.0 108.773 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -107.32 146.69 31.23 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.479 1.511 . . . . 0.0 107.243 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.31 114.22 20.49 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -71.91 56.61 0.3 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.397 1.879 . . . . 0.0 113.198 -171.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.37 -28.85 13.67 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.628 1.571 . . . . 0.0 112.077 169.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -19.57 65.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.157 0.983 . . . . 0.0 112.04 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -125.45 -31.4 3.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 m -129.78 71.55 82.12 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.94 -43.06 26.94 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.611 2.207 . . . . 0.0 110.37 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -55.96 28.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -58.66 -46.88 86.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.56 0.744 . . . . 0.0 111.153 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.24 84.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.456 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.74 -43.74 83.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.716 1.206 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.82 -51.64 66.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 108.025 176.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -66.02 -44.89 83.41 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 124.162 0.914 . . . . 0.0 112.238 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -43.79 -59.1 2.38 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.656 1.582 . . . . 0.0 108.976 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.48 71.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.554 1.541 . . . . 0.0 113.308 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.39 -40.04 62.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.275 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -50.67 66.96 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 119.449 1.022 . . . . 0.0 111.066 173.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.1 p -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.397 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 5.95 89.04 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.168 0.89 . . . . 0.0 112.139 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -5.25 27.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.065 1.433 . . . . 0.0 113.954 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -96.96 12.96 30.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.711 1.205 . . . . 0.0 110.846 170.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.15 74.05 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 120.714 -1.241 . . . . 0.0 113.054 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.52 -165.31 1.52 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.871 2.068 . . . . 0.0 106.357 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.69 -138.18 13.47 Favored Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CZ ' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -81.55 -26.4 35.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.38 1.072 . . . . 0.0 113.486 -167.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -57.97 110.03 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.148 0.979 . . . . 0.0 108.966 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.71 90.18 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.952 1.263 . . . . 0.0 115.627 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -100.23 7.46 44.45 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.991 2.395 . . . . 0.0 114.078 -158.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 62.94 174.59 0.15 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 127.925 2.49 . . . . 0.0 116.183 159.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.56 121.03 38.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 112.136 -2.302 . . . . 0.0 106.566 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -108.47 -24.14 11.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.511 1.124 . . . . 0.0 111.03 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.8 105.36 8.19 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 mt -118.73 114.99 46.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.07 95.51 36.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -168.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -41.12 125.97 2.51 Favored 'Trans proline' 0 C--O 1.24 0.586 1 C-N-CA 125.418 4.078 . . . . 0.0 114.538 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.34 29.96 74.73 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.127 1.346 . . . . 0.0 111.777 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -135.84 -79.89 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.06 171.15 20.51 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.2 m -120.19 91.1 3.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.396 2.278 . . . . 0.0 109.379 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -79.93 139.14 37.19 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.486 1.915 . . . . 0.0 110.9 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.42 -171.41 17.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.813 1.673 . . . . 0.0 111.54 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.39 24.73 9.25 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.363 0.506 . . . . 0.0 112.595 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.75 76.07 9.98 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CD1' HG23 ' A' ' 68' ' ' THR . 1.5 p90 -98.61 -11.8 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.582 HG21 ' CE ' ' A' ' 76' ' ' LYS . 17.6 p -134.31 -10.35 2.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.72 1.208 . . . . 0.0 113.253 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.3 mmt-85 -138.61 -172.38 3.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.27 34.32 0.52 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.384 0.993 . . . . 0.0 112.481 -168.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -150.72 12.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.0 1.32 . . . . 0.0 111.838 -163.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.56 32.65 27.08 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 118.987 -0.896 . . . . 0.0 110.885 -175.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -135.76 1.57 2.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.572 1.186 . . . . 0.0 112.185 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.19 166.09 33.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 119.648 1.113 . . . . 0.0 110.725 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 147.03 14.0 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.569 1.094 . . . . 0.0 114.362 165.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' CE ' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -155.46 160.32 40.52 Favored 'General case' 0 C--O 1.238 0.474 1 C-N-CA 132.07 4.148 . . . . 0.0 104.4 -173.966 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.5 p -78.34 171.76 14.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.974 0.806 . . . . 0.0 110.831 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.5 -25.18 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.729 0.412 . . . . 0.0 111.406 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.01 -22.11 24.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.391 0.676 . . . . 0.0 111.143 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.94 172.43 28.24 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.191 0.884 . . . . 0.0 114.044 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.14 112.69 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.949 1.7 . . . . 0.0 108.225 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 48.38 161.41 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.66 1 C-N-CA 133.884 4.874 . . . . 0.0 115.099 -165.219 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -139.29 175.35 9.63 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.819 162.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -65.89 159.8 24.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.354 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 114.61 13.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 161.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.45 -56.62 16.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.893 1.277 . . . . 0.0 110.819 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -169.03 -177.82 3.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.429 1.492 . . . . 0.0 108.702 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -130.44 25.14 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.604 1.962 . . . . 0.0 109.128 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.84 -57.72 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.95 128.11 34.66 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.551 2.34 . . . . 0.0 105.476 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -119.93 165.36 14.74 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.919 1.288 . . . . 0.0 110.244 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -81.77 56.13 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.559 1.543 . . . . 0.0 110.343 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -66.06 -23.25 66.5 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.863 1.265 . . . . 0.0 113.614 -160.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.5 179.36 48.75 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.27 160.58 19.02 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.576 1.517 . . . . 0.0 110.318 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.5 4.23 64.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.637 -1.646 . . . . 0.0 112.46 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.1 mm -79.4 166.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 121.009 2.405 . . . . 0.0 108.09 166.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 132.08 27.8 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.067 1.347 . . . . 0.0 109.61 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 t -143.79 147.24 33.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.016 0.526 . . . . 0.0 111.172 -170.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 97.4 mmm -74.33 117.92 16.69 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.557 1.143 . . . . 0.0 109.984 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -67.66 139.11 56.77 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 162.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -144.06 -178.03 5.74 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.83 2.052 . . . . 0.0 108.215 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.09 16.86 24.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.462 1.105 . . . . 0.0 111.926 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.28 -160.91 21.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.325 1.441 . . . . 0.0 109.659 -167.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -60.94 150.21 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.978 1.785 . . . . 0.0 109.844 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 39.14 48.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.078 2.951 . . . . 0.0 114.13 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.5 p -138.82 21.25 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.909 1.284 . . . . 0.0 110.58 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.77 155.96 25.2 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.923 -1.11 . . . . 0.0 108.278 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.32 -66.53 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.468 1.031 . . . . 0.0 114.782 -166.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -156.22 -5.59 0.11 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.899 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.463 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 2.1 mm-40 -78.63 136.94 37.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CE2' ' CZ ' ' A' ' 48' ' ' TYR . 5.3 p90 -130.97 169.73 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 164.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -130.98 146.43 52.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.887 0.475 . . . . 0.0 109.807 160.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.3 mt -83.5 116.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 169.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 m -60.75 124.15 19.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -110.47 21.57 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.155 0.582 . . . . 0.0 109.683 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.28 179.03 8.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.64 91.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.3 p -83.76 50.73 1.87 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.096 0.862 . . . . 0.0 110.663 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -18.92 51.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.978 1.311 . . . . 0.0 112.797 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -67.02 -19.22 65.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.762 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.8 mt -95.54 -4.34 44.93 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.668 1.587 . . . . 0.0 112.325 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.15 129.27 39.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.607 1.094 . . . . 0.0 108.787 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.81 -1.98 83.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.747 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.6 -20.23 8.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.043 1.922 . . . . 0.0 112.912 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -139.42 153.05 47.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.361 0.982 . . . . 0.0 111.044 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.0 t -88.0 100.01 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.93 126.39 19.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -140.76 -0.7 1.5 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.14 -178.67 28.8 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 119.08 0.855 . . . . 0.0 111.667 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -149.63 153.89 37.76 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.418 1.487 . . . . 0.0 107.591 172.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.85 126.45 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 166.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.428 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 23.9 ttmt -82.93 -52.17 6.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 164.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 162.34 40.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.227 -167.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.09 74.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.729 0.681 . . . . 0.0 113.45 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -38.91 75.27 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.329 1.564 . . . . 0.0 110.098 175.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -61.36 -25.11 66.94 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 172.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mm -77.72 -38.48 25.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.64 -39.84 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.777 0.717 . . . . 0.0 109.54 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -60.87 -34.78 75.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.944 -1.098 . . . . 0.0 111.808 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.39 63.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.384 0.993 . . . . 0.0 109.509 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 69.5 mtp -52.66 -42.26 64.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.236 1.015 . . . . 0.0 110.486 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -62.6 -34.47 77.08 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -30.05 70.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.616 1.098 . . . . 0.0 110.243 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -92.89 5.91 49.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.035 1.734 . . . . 0.0 111.86 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.75 -149.95 7.62 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 170.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 p -146.47 -61.51 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 141.75 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 1 C-N-CA 132.716 4.407 . . . . 0.0 109.726 -169.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 5.12 2.65 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 118.571 0.623 . . . . 0.0 111.454 164.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.54 -42.75 2.96 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 126.589 2.043 . . . . 0.0 111.556 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -60.24 123.89 18.59 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 61.3 p -72.98 164.04 27.28 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 124.343 1.027 . . . . 0.0 110.091 -167.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -88.5 -8.99 53.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.426 0.69 . . . . 0.0 111.239 163.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.497 ' HE2' HG12 ' A' ' 12' ' ' VAL . 15.3 tttt -152.81 149.24 28.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 109.934 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -75.06 123.0 24.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 -172.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 mt -112.62 126.49 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.54 175.84 9.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.151 -158.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.74 112.28 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.0 76.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -150.69 156.48 41.41 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.7 p -161.9 160.64 28.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.523 1.129 . . . . 0.0 109.722 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.93 -171.44 43.55 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -95.11 151.99 18.72 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.1 mt -125.66 42.5 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.601 1.191 . . . . 0.0 108.446 165.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.186 1.394 . . . . 0.0 111.822 176.313 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.03 157.37 57.52 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.517 1.22 . . . . 0.0 109.242 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.439 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 32.6 m -110.11 155.69 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 170.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.19 158.72 41.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.563 1.545 . . . . 0.0 107.536 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -135.34 159.61 41.02 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 123.446 0.698 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.629 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 64.4 m-85 -153.29 114.23 4.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.972 1.709 . . . . 0.0 108.596 -173.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -74.4 102.78 4.53 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 163.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.0 mm -67.38 143.02 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.99 129.48 22.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.336 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.548 HG12 ' HE2' ' A' ' 154' ' ' LYS . 78.6 t -93.05 101.13 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 127.409 2.284 . . . . 0.0 104.937 173.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 60.37 13.6 4.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.448 1.022 . . . . 0.0 113.754 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 0.26 53.58 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.407 1.479 . . . . 0.0 113.947 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 110.3 34.25 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 167.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.34 136.23 42.73 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.516 1.478 . . . . 0.0 110.001 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -104.61 -21.19 13.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.9 1.68 . . . . 0.0 110.61 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.39 156.22 7.19 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.045 0.839 . . . . 0.0 112.478 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.18 130.23 42.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.56 150.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.4 m -137.1 147.07 45.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 87.0 m-85 -135.63 136.36 40.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -173.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.39 152.35 39.54 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 162.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.2 mt -126.88 122.22 34.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.416 ' CD2' HD13 ' A' ' 90' ' ' LEU . 57.1 m-85 -69.61 52.71 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.862 2.065 . . . . 0.0 112.065 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.87 -21.99 58.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.081 -1.637 . . . . 0.0 112.222 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.06 4.17 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.047 0.939 . . . . 0.0 113.37 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -125.98 -35.52 2.46 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.329 1.452 . . . . 0.0 110.605 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m -142.12 68.35 22.39 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.148 1.779 . . . . 0.0 108.886 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.03 -37.88 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.063 1.842 . . . . 0.0 113.194 -176.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -55.07 39.12 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.078 1.763 . . . . 0.0 109.773 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.95 -40.79 90.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 122.838 0.455 . . . . 0.0 110.008 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.14 -33.08 67.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.31 -50.09 49.83 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.812 1.645 . . . . 0.0 109.55 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -45.72 -51.37 12.61 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.042 1.737 . . . . 0.0 109.661 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.35 90.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -56.56 -59.25 5.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.753 1.221 . . . . 0.0 107.87 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.72 -50.22 25.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.77 1.228 . . . . 0.0 112.491 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.92 -29.24 68.27 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.951 -1.093 . . . . 0.0 111.547 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -77.62 -43.53 31.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.965 1.257 . . . . 0.0 112.612 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.1 p -65.71 -32.29 73.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 7.02 89.02 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.435 1.017 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.45 -16.93 64.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.842 1.657 . . . . 0.0 114.101 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -83.02 -1.9 53.86 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.014 -1.054 . . . . 0.0 110.581 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.58 8.4 65.82 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.634 1.112 . . . . 0.0 112.842 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -156.18 -172.61 4.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.065 1.432 . . . . 0.0 110.434 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.87 -139.45 10.96 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-O 122.321 0.956 . . . . 0.0 113.417 160.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.629 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 7.3 t80 -62.76 -34.6 77.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.524 1.93 . . . . 0.0 108.69 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.99 124.86 19.13 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.595 1.088 . . . . 0.0 108.888 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.86 -0.39 21.65 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.105 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.1 m -64.36 115.21 4.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 120.949 2.374 . . . . 0.0 105.542 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.3 p -75.86 156.37 34.44 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.699 -0.626 . . . . 0.0 109.61 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 62.1 m-85 -91.72 95.58 9.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.55 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -74.69 -21.05 59.6 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -166.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 82.76 1.85 Allowed 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 121.151 -0.968 . . . . 0.0 109.367 -169.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.487 HD12 ' CG2' ' A' ' 152' ' ' THR . 7.7 mt -102.66 101.9 12.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.18 92.34 45.3 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -167.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -48.64 130.89 23.21 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.34 79.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.185 1.85 . . . . 0.0 112.114 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -142.03 -62.96 0.44 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.547 1.174 . . . . 0.0 109.434 -170.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -168.75 164.25 11.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.902 0.774 . . . . 0.0 112.347 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.9 m -113.32 93.1 4.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 108.277 159.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -76.89 142.99 39.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.002 0.921 . . . . 0.0 109.852 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -152.97 -164.5 12.56 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 124.85 1.214 . . . . 0.0 110.584 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.31 43.0 6.38 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.395 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.02 136.28 49.22 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 119.754 1.777 . . . . 0.0 107.929 159.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -134.39 5.95 3.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 127.91 2.484 . . . . 0.0 109.487 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -114.06 -53.49 2.67 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.391 1.477 . . . . 0.0 107.787 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -117.11 -165.9 1.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 158.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -174.22 46.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -166.85 20.82 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.158 2.183 . . . . 0.0 110.253 -170.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.58 -32.55 4.72 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.458 -1.19 . . . . 0.0 113.52 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.5 p -83.84 6.67 20.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.517 2.158 . . . . 0.0 114.673 -161.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -115.8 -124.47 3.73 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.86 100.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 127.187 2.327 . . . . 0.0 113.547 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -129.34 146.43 51.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.468 1.907 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.0 p -80.84 -178.4 6.81 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.993 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.6 pt -76.73 -6.84 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.472 168.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -90.78 -3.16 57.63 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.16 0.891 . . . . 0.0 112.057 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.76 91.17 1.92 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.267 10.7 tp10 62.17 -133.63 0.54 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.381 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -103.37 131.31 50.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.685 1.13 . . . . 0.0 110.871 -160.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -98.08 169.8 9.36 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.852 0.835 . . . . 0.0 110.107 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -66.7 170.57 6.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.51 1.524 . . . . 0.0 111.226 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -85.95 113.93 22.45 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -43.56 -55.65 4.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.96 1.304 . . . . 0.0 110.989 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -172.52 177.57 2.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.793 2.437 . . . . 0.0 106.479 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -125.49 32.09 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.661 1.184 . . . . 0.0 109.293 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.71 -55.78 20.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.416 HD13 ' CD2' ' A' ' 25' ' ' PHE . 64.2 mt -84.4 130.02 34.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.155 1.382 . . . . 0.0 107.566 -170.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -120.8 165.27 15.38 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 126.947 2.099 . . . . 0.0 109.449 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -85.7 65.76 9.31 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.557 0.743 . . . . 0.0 110.598 -164.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 p -70.97 -19.2 62.58 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -162.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.01 178.8 48.92 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 119.361 0.982 . . . . 0.0 111.918 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -62.1 158.69 37.95 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.545 2.163 . . . . 0.0 110.304 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.6 -6.84 36.26 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 116.974 -2.014 . . . . 0.0 112.934 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.69 156.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-N 121.46 2.63 . . . . 0.0 108.11 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.426 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -134.05 131.14 38.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.172 0.989 . . . . 0.0 110.852 176.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.82 150.23 33.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.29 1.036 . . . . 0.0 110.955 -164.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.62 138.14 54.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.0 50.92 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -59.99 163.35 4.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.065 1.412 . . . . 0.0 109.681 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.48 14.24 13.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.6 -165.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.81 -167.22 27.73 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.713 2.102 . . . . 0.0 107.98 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.44 143.66 58.52 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.284 1.989 . . . . 0.0 110.232 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 m120 50.11 47.78 23.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.551 2.34 . . . . 0.0 112.7 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 p -120.37 23.0 11.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.871 1.268 . . . . 0.0 111.638 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -69.42 135.85 50.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.322 1.049 . . . . 0.0 108.885 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.0 -78.45 0.02 OUTLIER Glycine 0 C--N 1.337 0.588 0 CA-C-N 118.436 0.562 . . . . 0.0 112.867 -168.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -142.21 -47.13 0.35 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.543 0.737 . . . . 0.0 109.963 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -62.46 137.7 58.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 124.082 0.863 . . . . 0.0 108.676 -170.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.429 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 45.4 p90 -141.81 172.75 12.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.871 1.668 . . . . 0.0 107.316 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 48.6 p90 -141.86 151.1 42.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.423 0.63 . . . . 0.0 109.697 158.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.34 120.8 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.76 127.4 31.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.9 p -107.66 19.84 19.62 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.724 0.809 . . . . 0.0 110.023 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.8 -177.89 5.4 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 164.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -60.99 128.02 34.43 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 158.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.43 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 71.9 p -117.67 72.77 0.86 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.61 1.55 . . . . 0.0 110.074 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.42 -12.6 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.415 -0.803 . . . . 0.0 113.139 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.43 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 27.5 p90 -71.81 -13.86 61.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.377 0.671 . . . . 0.0 111.288 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.446 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 61.0 mt -109.95 -8.12 14.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.751 1.221 . . . . 0.0 111.894 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 153.08 43.23 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.55 7.92 43.26 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.211 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -135.53 -40.31 0.72 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.169 1.485 . . . . 0.0 111.388 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -114.56 147.85 38.85 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.941 0.496 . . . . 0.0 111.487 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.13 105.79 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.041 1.736 . . . . 0.0 107.305 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.01 137.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 161.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.3 -3.83 0.72 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.294 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.49 176.83 27.11 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 119.691 1.132 . . . . 0.0 112.053 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.61 149.16 31.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.575 1.15 . . . . 0.0 108.153 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.417 HG22 ' CE2' ' A' ' 22' ' ' PHE . 62.5 t -58.88 126.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 164.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -93.64 -42.3 9.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.967 0.507 . . . . 0.0 109.769 165.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.05 156.7 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.711 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.17 21.26 61.13 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.481 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -52.31 -42.62 63.95 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.498 1.649 . . . . 0.0 111.311 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.77 -13.09 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.035 0.834 . . . . 0.0 112.925 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.6 mm -84.58 -36.46 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.427 1.091 . . . . 0.0 108.484 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.39 -40.78 90.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 121.442 -0.786 . . . . 0.0 108.945 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -62.67 -33.68 75.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.36 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.61 76.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 109.331 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.8 mtm -55.72 -46.07 77.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.45 0.568 . . . . 0.0 110.135 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.35 -36.13 73.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.167 0.587 . . . . 0.0 111.844 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -25.48 68.14 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.496 0.589 . . . . 0.0 111.546 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -97.88 -0.43 45.03 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.076 1.75 . . . . 0.0 112.15 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.18 -173.5 47.46 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 167.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 p -162.37 159.66 25.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -63.17 -16.46 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -4.33 2.89 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 167.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.86 -25.27 2.19 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 127.339 2.399 . . . . 0.0 114.328 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.86 127.43 33.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.487 ' CG2' HD12 ' A' ' 56' ' ' ILE . 16.5 p -66.41 168.44 8.94 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.637 1.175 . . . . 0.0 110.773 168.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.9 p -81.6 -16.54 51.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.806 159.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.548 ' HE2' HG12 ' A' ' 12' ' ' VAL . 41.4 mtpt -143.63 160.6 40.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.01 0.924 . . . . 0.0 111.414 -167.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.433 ' HE2' ' CG2' ' A' ' 157' ' ' THR . 14.8 tttt -84.87 78.41 9.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.36 1.436 . . . . 0.0 109.697 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 12' ' ' VAL . 57.0 mt -76.7 133.27 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.483 0.658 . . . . 0.0 109.404 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.433 ' CG2' ' HE2' ' A' ' 155' ' ' LYS . 74.7 p -148.98 177.03 9.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.905 2.082 . . . . 0.0 110.105 -173.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 48' ' ' TYR . 3.1 mp -92.61 124.35 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 158.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.72 -55.3 10.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.68 161.96 39.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.079 0.552 . . . . 0.0 111.025 -169.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.8 171.28 7.39 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.3 -167.86 40.69 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.606 1.574 . . . . 0.0 109.83 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -95.91 148.5 22.56 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.544 1.137 . . . . 0.0 109.619 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.9 mt -126.87 43.07 3.19 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.534 1.934 . . . . 0.0 110.476 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 5' ' ' THR . 9.2 tm-20 . . . . . 0 C--O 1.255 1.348 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 161.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.302 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.5 161.39 44.29 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 CA-C-N 120.661 1.272 . . . . 0.0 108.97 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.4 m -102.16 157.18 17.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.96 157.32 33.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.314 1.845 . . . . 0.0 107.648 164.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.66 151.2 30.44 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.543 0.737 . . . . 0.0 109.9 165.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 23.4 m-30 -133.85 104.51 6.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.118 2.167 . . . . 0.0 106.179 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.82 107.16 8.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mm -75.29 142.85 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 109.535 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -122.78 159.79 27.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.019 0.914 . . . . 0.0 109.554 161.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.0 96.37 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 56.07 14.03 1.34 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.629 1.572 . . . . 0.0 112.889 -169.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.65 -13.55 29.94 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.57 1.557 . . . . 0.0 113.18 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.41 127.59 85.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 120.389 2.094 . . . . 0.0 106.627 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.6 108.53 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.675 2.25 . . . . 0.0 109.755 -170.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.6 tp -84.56 -28.04 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.519 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.54 162.27 10.12 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 118.806 0.73 . . . . 0.0 114.458 167.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -77.7 113.96 16.08 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.65 0.78 . . . . 0.0 109.803 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.15 159.36 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 106.215 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.8 m -150.11 152.93 35.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.129 -1.607 . . . . 0.0 110.41 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.25 133.57 29.82 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.006 0.922 . . . . 0.0 109.235 -166.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.71 139.84 35.92 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.08 121.89 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -82.6 62.53 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.961 0.904 . . . . 0.0 112.38 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.05 40.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.941 0.896 . . . . 0.0 112.806 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -9.42 59.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.419 1.088 . . . . 0.0 111.589 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -117.81 -54.23 2.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.422 1.489 . . . . 0.0 108.84 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 m -126.95 72.23 75.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 125.194 1.398 . . . . 0.0 107.711 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.67 -39.39 88.22 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.252 1.968 . . . . 0.0 112.319 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' CA ' ' HE3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.99 -53.47 56.89 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.445 1.475 . . . . 0.0 109.195 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 m -64.39 -41.01 96.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.899 0.879 . . . . 0.0 110.365 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.46 -50.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.556 0.742 . . . . 0.0 112.2 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.69 -40.55 95.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 110.093 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -51.58 -60.46 3.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.086 1.354 . . . . 0.0 109.427 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -60.77 -31.05 70.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HD2' HE22 ' A' ' 163' ' ' GLN . 38.1 ttp85 -55.69 -64.53 0.82 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.358 1.863 . . . . 0.0 110.181 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.7 74.9 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.833 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.29 -34.58 77.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.541 -0.724 . . . . 0.0 111.028 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -69.5 -27.16 64.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.66 0.784 . . . . 0.0 111.625 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.3 p -90.21 -23.71 21.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.267 0.94 . . . . 0.0 111.283 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.41 -1.97 74.1 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.144 1.354 . . . . 0.0 112.707 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.39 -20.38 64.68 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.419 1.888 . . . . 0.0 113.427 -164.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -81.65 11.95 4.29 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.555 -0.716 . . . . 0.0 111.678 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.42 78.09 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 124.175 0.893 . . . . 0.0 112.274 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.09 167.98 26.57 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 125.493 1.517 . . . . 0.0 107.339 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 175.01 34.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 117.796 -2.145 . . . . 0.0 113.328 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 40.8 t80 -61.6 -32.42 72.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 127.794 2.437 . . . . 0.0 111.558 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -45.47 122.35 3.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.71 1.204 . . . . 0.0 109.875 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.35 26.23 61.47 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 116.33 -2.372 . . . . 0.0 115.689 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -66.66 -54.32 24.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 122.128 2.964 . . . . 0.0 107.44 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 32.8 t 113.9 161.91 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 1 C-N-CA 132.393 4.277 . . . . 0.0 106.951 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.97 101.64 12.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -77.45 -15.74 59.16 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.95 111.11 6.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.442 HD12 ' CG2' ' A' ' 152' ' ' THR . 22.2 mt -129.96 105.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.9 mt -116.05 97.96 50.35 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -50.15 126.61 17.63 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 123.552 2.834 . . . . 0.0 112.726 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.85 71.55 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 126.707 2.098 . . . . 0.0 112.033 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.64 -80.36 0.27 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.473 1.136 . . . . 0.0 108.059 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.78 166.65 26.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.278 0.631 . . . . 0.0 111.673 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.8 m -124.06 100.78 6.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.309 2.644 . . . . 0.0 109.284 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -84.36 135.01 34.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.066 1.746 . . . . 0.0 111.101 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.27 -174.15 21.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 126.489 1.995 . . . . 0.0 109.139 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.32 6.18 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 117.405 0.603 . . . . 0.0 113.628 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -110.72 23.76 13.8 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -159.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 43.2 p90 -58.52 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.182 1 C-N-CA 131.827 4.051 . . . . 0.0 116.101 -176.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.3 t -148.39 -12.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.237 2.215 . . . . 0.0 112.179 161.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -146.19 -173.93 4.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.291 2.236 . . . . 0.0 106.199 -168.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -169.94 45.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -155.45 -7.33 0.12 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.67 5.29 51.47 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 117.686 -1.619 . . . . 0.0 114.413 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -91.52 -96.01 0.13 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.453 2.126 . . . . 0.0 107.272 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 41.52 -158.88 0.04 OUTLIER Glycine 0 CA--C 1.531 1.038 0 C-N-CA 127.157 2.313 . . . . 0.0 114.672 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.86 117.66 1.3 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-O 121.562 0.535 . . . . 0.0 111.97 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.574 ' HE3' ' CE2' ' A' ' 67' ' ' PHE . 4.0 ptpt -145.56 -170.52 3.47 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.685 2.394 . . . . 0.0 107.187 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.3 p -140.81 177.14 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.475 1.034 . . . . 0.0 110.673 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt -74.64 -0.64 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 111.624 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -108.39 -1.18 20.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.053 1.341 . . . . 0.0 111.363 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.56 -113.8 1.77 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.58 -139.32 0.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.426 0.613 . . . . 0.0 109.469 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -70.05 166.25 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.318 1.047 . . . . 0.0 108.808 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -134.1 -179.65 5.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.761 2.024 . . . . 0.0 106.874 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.45 159.95 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.284 1.04 . . . . 0.0 112.572 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 89.84 1.96 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.238 1.415 . . . . 0.0 107.882 172.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.21 -52.73 64.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.767 1.227 . . . . 0.0 112.867 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -150.19 174.38 12.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 162.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.64 32.05 5.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.964 2.105 . . . . 0.0 110.045 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.81 -48.31 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.25 1.024 . . . . 0.0 108.456 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.64 133.82 35.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.809 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -132.25 171.26 13.92 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.114 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -84.78 87.19 7.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -164.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.2 p -77.7 -17.98 57.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.827 -171.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.9 -178.2 46.73 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.858 1.208 . . . . 0.0 112.671 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.27 142.0 97.14 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.969 1.78 . . . . 0.0 108.917 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.77 -3.44 56.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 117.644 -1.642 . . . . 0.0 112.587 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 128' ' ' VAL . 15.3 mm -74.51 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 121.103 2.452 . . . . 0.0 109.072 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.72 130.34 54.95 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.142 1.377 . . . . 0.0 109.354 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 p -144.22 158.02 43.96 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.563 1.145 . . . . 0.0 112.686 176.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 95.4 mmm -75.37 131.01 39.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.811 1.245 . . . . 0.0 111.851 -168.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.444 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -83.23 81.62 8.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.504 1.522 . . . . 0.0 107.523 168.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -70.48 -179.71 2.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.43 1.092 . . . . 0.0 110.428 165.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.0 36.49 1.03 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.326 2.25 . . . . 0.0 109.244 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.89 -164.1 27.55 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 106.879 -2.488 . . . . 0.0 106.879 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.46 171.35 9.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 119.236 1.518 . . . . 0.0 108.566 159.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m120 41.11 38.23 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.818 2.447 . . . . 0.0 114.12 159.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -125.25 25.9 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.342 2.257 . . . . 0.0 109.108 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -74.96 105.49 6.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 129.961 3.305 . . . . 0.0 103.553 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.67 -93.26 1.24 Allowed Glycine 0 C--O 1.225 -0.456 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.5 p -139.33 -14.4 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.79 0.836 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -70.85 133.55 46.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 13.2 p90 -152.31 -179.42 7.53 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 108.151 -174.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -144.06 152.66 41.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.116 0.484 . . . . 0.0 111.282 162.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.7 mt -83.68 113.37 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 165.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.8 m -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.816 1.246 . . . . 0.0 107.832 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.3 p -116.7 27.26 9.28 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.136 0.974 . . . . 0.0 108.695 172.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.53 178.59 10.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 162.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -72.64 87.46 1.24 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 165.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.7 p -81.03 42.22 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.059 0.544 . . . . 0.0 112.3 -171.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.63 -4.1 21.65 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 119.746 -1.846 . . . . 0.0 114.047 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -61.05 -19.7 61.7 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.018 -1.051 . . . . 0.0 110.734 161.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.2 mt -100.89 1.34 39.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.582 1.953 . . . . 0.0 111.78 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.57 138.88 58.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.231 1.012 . . . . 0.0 109.784 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.92 10.62 61.83 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 122.702 0.192 . . . . 0.0 112.908 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -129.26 -37.02 1.68 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.66 1.584 . . . . 0.0 109.567 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -114.09 121.1 42.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.932 0.893 . . . . 0.0 109.002 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.09 106.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.66 1.584 . . . . 0.0 107.467 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.412 HG13 HG23 ' A' ' 97' ' ' ILE . 67.9 t -70.37 131.68 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 166.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -138.54 -5.68 1.56 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.35 -179.46 31.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.72 -1.229 . . . . 0.0 111.664 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -156.8 148.81 22.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.55 122.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -87.09 -48.52 8.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -148.83 154.7 39.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.367 1.467 . . . . 0.0 111.362 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.55 24.88 27.14 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 123.886 0.755 . . . . 0.0 113.123 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.0 tpt -53.74 -39.9 65.7 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.899 1.349 . . . . 0.0 109.442 168.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -62.4 -27.67 69.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.2 mm -78.0 -39.42 25.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.13 -41.95 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.941 0.791 . . . . 0.0 109.288 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.7 -24.49 67.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.615 1.166 . . . . 0.0 112.644 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.22 -45.43 23.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.043 -1.035 . . . . 0.0 110.143 169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 52.0 mtp -54.74 -44.69 73.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.402 0.681 . . . . 0.0 110.931 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.61 -38.0 74.22 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.915 1.286 . . . . 0.0 112.035 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -69.71 -18.68 63.55 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.991 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -94.7 -2.55 50.98 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.204 1.002 . . . . 0.0 111.721 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.58 -166.96 41.07 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -156.01 163.46 39.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 163.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.16 -17.85 64.45 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -9.86 38.81 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 167.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 88.26 -23.21 15.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 127.044 2.259 . . . . 0.0 113.004 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.68 130.3 40.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.899 1.349 . . . . 0.0 107.693 175.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.442 ' CG2' HD12 ' A' ' 56' ' ' ILE . 1.2 p -70.68 165.36 23.1 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.44 1.496 . . . . 0.0 111.304 177.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.0 p -97.21 -14.39 21.45 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.6 1.16 . . . . 0.0 111.477 163.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -137.77 154.24 49.61 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.575 1.15 . . . . 0.0 110.739 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -81.02 85.98 6.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.107 1.363 . . . . 0.0 107.78 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.59 119.87 34.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -132.74 174.25 10.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.0 1.32 . . . . 0.0 109.669 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.18 96.97 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -56.64 -50.21 72.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.613 1.965 . . . . 0.0 109.195 -177.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.2 164.66 33.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 108.041 175.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.7 p -165.93 164.81 18.43 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.031 0.532 . . . . 0.0 110.821 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.48 -174.15 45.99 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.548 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.9 tp60 -81.22 146.31 30.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.74 1.616 . . . . 0.0 110.172 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.43 43.31 2.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 111.091 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 3.6 pt-20 . . . . . 0 C--O 1.248 0.993 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 . . . . . 0 C--O 1.234 0.238 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.99 152.87 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 N-CA-C 108.815 -1.264 . . . . 0.0 108.815 159.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.1 m -99.47 152.93 19.44 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.19 150.79 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.473 1.509 . . . . 0.0 107.685 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -121.81 158.71 28.29 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.643 1.177 . . . . 0.0 109.722 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -149.34 109.46 4.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.651 1.58 . . . . 0.0 108.284 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.67 100.95 9.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.3 mm -73.75 139.78 18.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.7 127.26 36.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.332 1.053 . . . . 0.0 109.837 169.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.67 111.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.68 13.37 0.49 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.012 2.125 . . . . 0.0 114.88 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.05 -12.15 14.59 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.331 1.443 . . . . 0.0 113.28 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.21 130.11 55.63 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 119.774 1.787 . . . . 0.0 106.826 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.36 115.36 3.64 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.346 1.364 . . . . 0.0 108.818 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.1 tp -86.83 -32.13 20.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.438 -0.315 . . . . 0.0 110.493 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.55 171.15 13.63 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 123.748 0.689 . . . . 0.0 111.476 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -85.75 141.16 29.9 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 109.683 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.5 160.41 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 127.938 2.495 . . . . 0.0 106.166 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -148.73 148.9 30.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 120.923 -1.111 . . . . 0.0 109.864 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.55 160.77 33.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.311 1.044 . . . . 0.0 108.458 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -124.45 135.37 53.19 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.844 2.457 . . . . 0.0 105.593 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.32 110.51 12.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.104 0.962 . . . . 0.0 109.767 -163.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -74.63 64.2 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.236 1.814 . . . . 0.0 113.681 -167.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.5 -25.62 64.61 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.204 1.002 . . . . 0.0 112.636 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.75 -0.67 44.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.238 1.415 . . . . 0.0 112.795 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -118.1 -37.42 3.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.87 1.268 . . . . 0.0 110.703 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' ' 129' ' ' PHE . 1.6 m -138.87 79.92 26.28 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.619 2.368 . . . . 0.0 108.551 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.95 -46.1 17.43 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.754 1.636 . . . . 0.0 112.864 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -70.5 -41.75 72.23 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -168.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.7 m -66.48 -43.39 85.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 111.434 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.69 -44.24 74.39 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 120.902 -1.124 . . . . 0.0 111.506 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -70.87 -31.77 68.55 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.366 0.666 . . . . 0.0 111.139 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -52.19 -59.18 4.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.022 0.929 . . . . 0.0 110.138 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -66.08 -35.53 80.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.657 ' CZ ' HE22 ' A' ' 163' ' ' GLN . 0.2 OUTLIER -50.94 -59.77 3.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.649 1.58 . . . . 0.0 109.293 170.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.54 -41.94 91.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.214 1.005 . . . . 0.0 113.009 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.64 -43.06 63.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.704 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 p -62.35 -35.83 80.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.889 1.222 . . . . 0.0 111.3 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 p -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.567 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.85 10.35 86.14 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 118.991 0.814 . . . . 0.0 111.595 -166.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -24.2 66.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.964 1.382 . . . . 0.0 112.009 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.51 0.84 24.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.663 1.585 . . . . 0.0 114.098 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.63 11.46 82.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.071 0.851 . . . . 0.0 111.283 -171.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -152.4 169.92 21.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.43 1.892 . . . . 0.0 105.958 159.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 153.88 -175.86 32.02 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 122.096 0.831 . . . . 0.0 111.959 -171.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.59 -17.45 38.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.428 1.491 . . . . 0.0 113.384 -158.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -53.15 126.6 21.39 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.211 1.004 . . . . 0.0 109.337 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.91 79.4 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.846 -1.53 . . . . 0.0 114.218 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 m -85.18 154.42 22.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 120.07 1.935 . . . . 0.0 107.298 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.0 t -81.28 170.28 16.25 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 164.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.82 112.73 25.15 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -79.8 -18.43 50.96 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.57 111.66 9.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.836 1.198 . . . . 0.0 108.3 -170.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.3 mt -136.4 117.9 19.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.6 mt -127.1 89.27 52.32 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -167.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -48.3 121.76 6.65 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.521 2.814 . . . . 0.0 114.985 -167.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.5 67.59 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.222 1.391 . . . . 0.0 112.103 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -137.37 -78.72 0.39 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.72 1.26 . . . . 0.0 108.551 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.97 163.33 29.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.545 0.688 . . . . 0.0 111.736 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 95.02 3.97 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.126 1.771 . . . . 0.0 107.832 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -76.86 141.74 40.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.432 1.11 . . . . 0.0 110.185 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.4 -156.59 8.54 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.41 -13.24 67.03 Favored Glycine 0 C--O 1.229 -0.187 0 O-C-N 121.542 -0.975 . . . . 0.0 112.42 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -84.04 88.49 7.17 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.76 -0.847 . . . . 0.0 109.749 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -74.32 3.42 7.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.876 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.4 p -125.65 -58.39 1.41 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 120.102 1.319 . . . . 0.0 113.843 -159.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -103.94 -158.37 0.66 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.34 41.04 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.5 0.666 . . . . 0.0 109.426 159.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -122.94 -51.59 1.9 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.952 0.901 . . . . 0.0 111.645 -163.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.28 -9.44 0.17 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.812 -1.549 . . . . 0.0 114.256 -169.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.7 p -104.24 -19.99 13.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.498 2.149 . . . . 0.0 112.295 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.25 -170.93 2.29 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 124.711 1.148 . . . . 0.0 115.758 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.57 -172.2 41.13 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 123.75 1.75 . . . . 0.0 115.753 -168.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.31 156.53 38.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.311 3.044 . . . . 0.0 107.254 -171.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.8 p -78.1 166.26 23.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.97 0.89 . . . . 0.0 109.541 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 pt -59.66 -29.91 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.518 167.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -77.93 -10.11 59.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 111.638 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 143.21 12.47 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.5 1.524 . . . . 0.0 109.889 -171.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 34.48 -133.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.658 2.383 . . . . 0.0 113.029 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -120.47 143.38 48.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -173.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.72 -176.62 3.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.865 0.866 . . . . 0.0 109.644 -167.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -63.06 137.94 58.41 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.119 0.961 . . . . 0.0 109.792 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.02 86.57 6.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.08 -65.55 0.39 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.749 2.02 . . . . 0.0 113.437 -159.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -158.2 178.78 9.81 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.009 0.924 . . . . 0.0 109.892 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -129.48 36.07 4.16 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.698 1.999 . . . . 0.0 109.401 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.56 -55.98 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -84.07 132.24 34.73 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -122.69 168.91 11.61 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.57 1.548 . . . . 0.0 109.91 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.469 ' HD1' ' N ' ' A' ' 123' ' ' ASP . 36.5 m80 -74.33 81.64 1.87 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.0 p -80.27 -11.27 59.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.603 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.61 -173.96 43.88 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.601 1.091 . . . . 0.0 112.593 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 165.27 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.809 2.339 . . . . 0.0 110.822 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.58 -17.94 6.19 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 117.315 -1.825 . . . . 0.0 112.261 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.28 151.62 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 121.355 2.577 . . . . 0.0 108.29 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.03 128.01 53.96 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 120.934 -1.104 . . . . 0.0 109.639 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 t -140.34 145.97 37.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.436 1.095 . . . . 0.0 110.496 -172.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 89.9 mmm -78.38 121.95 25.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.486 0.714 . . . . 0.0 109.965 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.546 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -72.62 87.51 1.23 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 164.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -76.59 -169.88 1.37 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.168 0.987 . . . . 0.0 108.584 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.41 24.5 4.8 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 110.607 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.45 -159.87 21.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -164.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -64.45 162.56 30.25 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 CA-C-N 119.558 1.679 . . . . 0.0 109.805 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 34.16 53.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 128.967 2.907 . . . . 0.0 113.382 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.1 p -140.63 23.29 2.3 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.072 1.349 . . . . 0.0 111.382 -175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -88.25 142.99 27.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 170.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.5 -58.31 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -162.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.06 -39.87 0.2 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.76 0.824 . . . . 0.0 110.904 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.441 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 7.1 mm-40 -62.54 135.77 57.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.141 1.376 . . . . 0.0 109.567 -173.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.546 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 1.2 p90 -147.09 174.5 11.51 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.331 1.452 . . . . 0.0 108.559 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -136.53 153.85 50.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.918 0.866 . . . . 0.0 111.488 159.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.31 117.41 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 162.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.31 124.43 23.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -112.96 23.63 13.2 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.069 0.548 . . . . 0.0 109.748 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.5 177.75 10.23 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -70.53 87.55 0.66 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -74.1 43.4 0.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.382 2.273 . . . . 0.0 110.903 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -66.39 -18.16 65.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 119.699 -1.876 . . . . 0.0 113.128 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.444 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 45.7 p90 -67.28 -13.74 62.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.129 0.972 . . . . 0.0 111.217 170.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.444 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -108.95 -6.89 15.53 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.262 1.825 . . . . 0.0 111.8 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.469 ' N ' ' HD1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -70.16 135.62 49.3 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.01 -4.66 82.38 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.477 -1.179 . . . . 0.0 113.084 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -94.51 -40.29 9.95 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.189 1.994 . . . . 0.0 110.435 166.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -131.64 158.12 41.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.155 0.582 . . . . 0.0 111.76 -161.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.67 101.11 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -169.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.81 132.81 32.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.411 ' HA ' HG21 ' A' ' 29' ' ' VAL . 26.4 p90 -139.21 -2.09 1.67 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.05 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.75 -171.02 30.48 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.181 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -155.34 166.37 33.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.323 1.049 . . . . 0.0 109.806 163.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.77 126.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 164.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.4 -55.87 3.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.75 162.48 37.53 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.808 0.692 . . . . 0.0 111.921 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.24 28.05 60.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.731 1.158 . . . . 0.0 112.685 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 10.6 tpt -56.55 -38.38 71.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.237 1.519 . . . . 0.0 111.414 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -64.54 -28.5 69.69 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.169 -0.957 . . . . 0.0 112.329 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.1 mm -70.84 -44.99 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.49 -38.46 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.98 -29.61 66.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.946 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.95 -44.15 50.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.711 1.204 . . . . 0.0 109.787 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.9 mtp -50.85 -42.35 58.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.675 0.79 . . . . 0.0 110.005 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.57 -34.36 76.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.389 1.075 . . . . 0.0 112.905 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -67.49 -27.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 119.418 1.008 . . . . 0.0 110.275 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.406 ' HB2' HD11 ' A' ' 156' ' ' ILE . 27.6 m-85 -89.44 8.16 32.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 111.862 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.4 -151.91 4.04 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.653 1.12 . . . . 0.0 110.318 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -137.8 -70.36 0.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.85 -0.794 . . . . 0.0 110.069 166.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 143.44 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 1 C-N-CA 133.379 4.671 . . . . 0.0 110.934 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.84 -25.36 66.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.063 159.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 118.08 -40.76 2.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 124.86 1.219 . . . . 0.0 110.644 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.36 124.11 20.91 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.8 p -64.11 152.18 41.18 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.282 1.033 . . . . 0.0 110.621 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.4 p -72.62 -28.62 62.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.991 163.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -135.96 140.09 43.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -73.16 103.01 3.75 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 119.907 -1.745 . . . . 0.0 109.849 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 145' ' ' PHE . 1.7 mp -73.42 136.31 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 169.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.32 166.13 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.651 1.581 . . . . 0.0 108.703 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 mt -106.48 105.87 19.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.84 -51.09 66.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -149.81 155.63 40.43 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.5 p -156.5 161.96 39.98 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.881 0.873 . . . . 0.0 109.712 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.45 -172.98 44.93 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.657 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 1.6 mt-30 -96.8 147.99 23.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.877 0.871 . . . . 0.0 109.744 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.09 43.16 3.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.639 0.776 . . . . 0.0 109.003 165.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.577 ' HB3' HE21 ' A' ' 163' ' ' GLN . 13.1 pt-20 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 117.232 -1.366 . . . . 0.0 113.849 -172.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 117.364 -1.303 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -64.04 144.74 88.38 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 121.357 1.52 . . . . 0.0 109.416 167.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.516 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 60.9 m -103.98 143.66 32.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.04 156.92 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -125.23 159.13 32.35 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.656 0.782 . . . . 0.0 110.197 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.604 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 54.6 m-85 -145.94 104.71 3.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.613 2.365 . . . . 0.0 107.58 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.5 94.07 3.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 167.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.6 mm -66.73 150.06 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.241 1.016 . . . . 0.0 109.625 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.25 160.74 34.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.704 1.601 . . . . 0.0 110.808 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 ' HE2' ' A' ' 154' ' ' LYS . 36.8 t -127.37 98.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.075 2.55 . . . . 0.0 105.23 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 50.88 12.94 0.12 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.558 1.943 . . . . 0.0 114.772 -165.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.7 -13.8 13.12 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.424 1.488 . . . . 0.0 113.247 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -72.82 116.65 52.25 Favored Pre-proline 0 C--O 1.23 0.075 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.93 116.98 3.9 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.615 1.543 . . . . 0.0 110.036 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.0 tp -87.28 -27.6 22.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.214 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.83 162.77 10.08 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.2 ttm105 -75.68 143.23 42.27 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.84 152.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 128.534 2.734 . . . . 0.0 104.724 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -143.34 140.57 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.215 0.461 . . . . 0.0 109.949 175.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -114.14 159.87 19.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.333 1.053 . . . . 0.0 108.764 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -120.37 137.88 54.05 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.121 2.169 . . . . 0.0 105.573 170.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.6 mt -125.02 119.11 27.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -164.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.61 63.18 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.13 1.372 . . . . 0.0 112.123 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -17.06 59.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.893 -1.129 . . . . 0.0 111.881 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 -13.0 59.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.059 1.343 . . . . 0.0 112.94 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -111.91 -44.41 3.46 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.014 1.279 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m -134.07 68.75 74.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.066 1.346 . . . . 0.0 108.897 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.66 -38.8 92.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.201 1.934 . . . . 0.0 113.107 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -50.67 70.89 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.588 1.085 . . . . 0.0 108.965 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -62.53 -45.46 92.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.66 1.184 . . . . 0.0 109.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.96 61.95 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.377 1.071 . . . . 0.0 112.164 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -60.69 -41.99 96.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.663 1.185 . . . . 0.0 110.177 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.41 -51.21 67.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.538 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -64.43 -40.32 95.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 ttp85 -56.2 -59.13 5.37 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.32 1.848 . . . . 0.0 110.901 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.86 69.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.814 0.446 . . . . 0.0 112.165 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -74.49 -32.41 62.53 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.871 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.4 m -68.32 -47.04 68.61 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.819 1.247 . . . . 0.0 110.616 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.4 p -64.45 -38.76 92.14 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.62 11.69 82.67 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -166.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -63.57 -20.22 65.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.793 1.296 . . . . 0.0 111.857 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.534 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.85 -1.44 86.38 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.444 1.02 . . . . 0.0 112.172 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -154.5 172.49 17.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.874 1.27 . . . . 0.0 109.073 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.13 -151.77 19.77 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.902 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.604 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.3 t80 -54.14 -29.44 45.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.347 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -59.28 101.71 0.11 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.557 1.071 . . . . 0.0 110.007 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.08 72.59 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 116.848 -2.084 . . . . 0.0 115.295 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 p -64.55 -58.28 6.82 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.424 2.612 . . . . 0.0 110.609 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.8 t 105.39 161.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.264 3.826 . . . . 0.0 108.292 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -115.97 123.94 49.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -104.87 -17.09 14.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.163 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.95 97.78 3.72 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.409 ' CG2' ' HA ' ' A' ' 143' ' ' GLU . 44.7 mt -124.13 117.61 51.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.19 103.08 14.1 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.5 134.12 45.15 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 124.532 3.488 . . . . 0.0 112.804 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.07 25.36 69.44 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.758 0.694 . . . . 0.0 111.531 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -138.9 -78.29 0.34 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.54 162.81 21.94 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 94.2 m -122.52 96.51 5.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.556 2.343 . . . . 0.0 109.802 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -85.61 132.63 34.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.772 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.64 22.98 0.55 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.528 0.585 . . . . 0.0 114.437 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.18 -3.94 88.56 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.349 -1.089 . . . . 0.0 114.097 -170.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.87 73.25 10.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.173 0.986 . . . . 0.0 108.567 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -66.3 -2.44 4.41 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.503 -1.373 . . . . 0.0 112.126 166.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -121.83 -50.72 2.05 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.328 2.251 . . . . 0.0 111.256 -169.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.4 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 3.9 mpt_? -106.29 -149.23 0.42 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.19 69.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.273 1.397 . . . . 0.0 107.677 158.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.6 -77.12 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.788 -0.57 . . . . 0.0 110.134 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.91 5.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 119.03 -0.872 . . . . 0.0 113.9 -161.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.9 p -83.6 -73.47 0.41 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 163.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 69' ' ' ARG . . . 71.3 169.89 10.4 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 121.065 3.186 . . . . 0.0 121.065 158.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.78 158.72 28.32 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 109.97 -3.115 . . . . 0.0 115.963 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' H ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -86.53 -175.7 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.272 3.429 . . . . 0.0 110.314 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -93.29 -179.04 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.557 0.617 . . . . 0.0 109.614 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.0 pt -72.87 -36.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 120.436 -1.415 . . . . 0.0 110.285 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -73.95 -22.18 59.75 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.822 0.449 . . . . 0.0 110.869 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.71 -105.93 0.28 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.311 -3.116 . . . . 0.0 105.311 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' LYS . 10.4 tt0 -113.99 -175.79 2.76 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.55 1.167 . . . . 0.0 109.454 -171.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 94.9 mttt -64.07 123.84 20.09 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 125.878 1.671 . . . . 0.0 109.102 -165.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -99.65 160.35 14.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.741 1.258 . . . . 0.0 110.516 -169.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.46 162.66 22.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.883 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.67 89.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.08 1.752 . . . . 0.0 109.066 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -55.06 -48.44 73.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.281 1.032 . . . . 0.0 111.526 -159.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.417 HD22 HG13 ' A' ' 89' ' ' ILE . 2.2 p-10 -178.51 155.18 0.84 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 128.128 2.571 . . . . 0.0 106.982 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.84 32.15 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.037 1.335 . . . . 0.0 109.317 -168.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.417 HG13 HD22 ' A' ' 87' ' ' ASN . 15.7 mt -52.25 -41.46 34.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 126.211 1.805 . . . . 0.0 109.761 172.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.98 125.68 41.58 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.74 165.41 11.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.19 1.796 . . . . 0.0 109.134 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -80.63 97.1 7.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.0 p -82.46 -26.46 32.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.753 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.0 -177.07 47.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.147 0.885 . . . . 0.0 112.742 -173.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.81 144.54 97.02 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.105 1.87 . . . . 0.0 109.322 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.93 14.87 60.19 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.729 -1.595 . . . . 0.0 112.689 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mm -86.13 158.42 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 121.046 2.423 . . . . 0.0 108.36 162.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 139.39 53.74 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.374 1.47 . . . . 0.0 109.315 168.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -149.23 162.18 40.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.404 1.082 . . . . 0.0 110.49 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.64 117.08 19.45 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.715 1.206 . . . . 0.0 109.733 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -76.57 62.66 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.117 0.961 . . . . 0.0 109.364 171.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -68.34 -179.25 1.25 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.749 1.261 . . . . 0.0 109.081 170.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.05 16.0 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 126.472 1.909 . . . . 0.0 111.606 -171.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.09 177.06 14.68 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.707 1.622 . . . . 0.0 109.11 -166.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.47 131.93 49.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.831 2.354 . . . . 0.0 110.78 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 71.43 9.39 6.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.225 1.81 . . . . 0.0 114.154 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.4 p -92.14 39.58 1.02 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.209 -1.557 . . . . 0.0 111.082 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -82.86 105.56 13.97 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.85 -109.69 2.68 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -18.56 13.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.415 1.086 . . . . 0.0 111.307 172.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -59.07 113.92 2.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.81 1.244 . . . . 0.0 107.979 172.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.469 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 15.4 p90 -127.43 168.95 14.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.208 2.203 . . . . 0.0 107.139 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -143.45 155.59 44.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.583 0.706 . . . . 0.0 111.398 160.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.4 mt -83.83 125.11 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 164.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.7 m -75.29 115.59 15.1 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 166.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -103.04 22.28 14.25 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.312 0.645 . . . . 0.0 109.917 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.91 -178.43 7.24 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.343 1.057 . . . . 0.0 108.314 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -66.92 96.22 0.41 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 163.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 p -80.24 63.66 4.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.454 1.121 . . . . 0.0 109.594 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.92 -21.14 66.0 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.936 -1.102 . . . . 0.0 112.232 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.43 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 19.2 p90 -70.85 -7.89 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.586 1.154 . . . . 0.0 110.878 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.43 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.5 mt -122.49 6.4 9.54 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 126.617 1.967 . . . . 0.0 111.212 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.96 130.62 42.22 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 166.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.9 -4.68 29.03 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.122 -1.376 . . . . 0.0 114.728 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -93.82 -34.15 13.28 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.144 2.472 . . . . 0.0 110.811 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -143.83 134.2 24.63 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.184 0.594 . . . . 0.0 109.74 -164.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.99 107.33 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 126.287 1.835 . . . . 0.0 107.57 -170.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.14 131.09 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -135.79 -4.72 2.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.11 33.22 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.341 0.973 . . . . 0.0 111.62 -176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -147.66 152.54 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 109.122 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 32.8 t -65.8 110.2 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 164.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -71.61 -50.55 29.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.47 157.45 45.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.537 1.935 . . . . 0.0 110.159 -167.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.67 18.3 79.1 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.854 0.74 . . . . 0.0 114.026 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -35.16 68.74 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.96 1.88 . . . . 0.0 110.677 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -20.5 65.95 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.452 -1.405 . . . . 0.0 113.598 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.8 -37.07 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -37.16 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.767 . . . . 0.0 109.735 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.29 -25.57 67.7 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.448 -1.407 . . . . 0.0 112.65 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.15 -46.96 30.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.815 -1.178 . . . . 0.0 109.733 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.7 mtp -52.3 -41.21 62.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.329 0.968 . . . . 0.0 111.377 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.409 ' HA ' ' CG2' ' A' ' 56' ' ' ILE . 1.4 mm-40 -60.62 -37.03 80.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 112.343 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -71.24 -23.08 61.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.541 1.064 . . . . 0.0 110.638 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.443 ' CB ' HD11 ' A' ' 156' ' ' ILE . 27.3 m-85 -90.45 12.25 19.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.329 1.451 . . . . 0.0 111.637 172.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.39 -150.49 6.66 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.164 1.364 . . . . 0.0 110.296 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.9 p -143.63 -103.3 0.12 Allowed 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 159.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -153.7 -27.03 0.14 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.176 1.79 . . . . 0.0 110.196 159.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -66.53 -19.74 65.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.011 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.27 -30.12 6.41 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.429 1.49 . . . . 0.0 111.514 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 124.48 20.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.092 1.446 . . . . 0.0 107.763 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -66.84 130.0 41.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.269 1.028 . . . . 0.0 108.291 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.17 -22.37 64.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.058 0.943 . . . . 0.0 111.599 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.572 ' HE2' HG12 ' A' ' 12' ' ' VAL . 22.8 mtpt -118.87 175.4 5.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 159.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -72.93 145.06 47.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 164.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.52 HD13 HG22 ' A' ' 12' ' ' VAL . 24.2 mm -129.37 123.23 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 178.19 8.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.837 -159.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.74 102.18 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.29 -43.31 74.08 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.39 166.4 28.22 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 117.971 0.35 . . . . 0.0 110.606 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.3 p -170.34 172.64 6.05 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 123.566 0.746 . . . . 0.0 110.487 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.34 -169.49 42.53 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.455 HE21 ' C ' ' A' ' 165' ' ' GLU . 41.1 tt0 -110.66 136.25 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.108 1.363 . . . . 0.0 108.437 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 mt -116.42 43.12 2.26 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.49 1.138 . . . . 0.0 109.644 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.516 ' HB2' ' H ' ' A' ' 5' ' ' THR . 2.0 tp10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 128.248 2.619 . . . . 0.0 108.272 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.376 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.16 165.7 16.38 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.996 1.797 . . . . 0.0 110.079 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 m -131.18 157.44 43.17 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 m -143.7 142.18 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.138 1.375 . . . . 0.0 108.024 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.411 ' HB3' HD11 ' A' ' 164' ' ' LEU . 31.0 p90 -89.94 155.78 18.89 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.462 0.574 . . . . 0.0 109.457 168.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -137.76 105.42 5.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.0 103.68 11.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.86 139.45 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.91 158.79 28.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.917 0.887 . . . . 0.0 110.254 163.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 ' HE2' ' A' ' 154' ' ' LYS . 6.9 t -126.55 105.17 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 54.72 14.04 0.8 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.873 2.069 . . . . 0.0 113.939 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 6.96 60.4 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.551 -1.343 . . . . 0.0 114.066 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.32 123.14 84.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 159.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.7 113.04 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.21 -38.09 52.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.26 -173.39 36.86 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -110.72 151.41 27.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.982 0.896 . . . . 0.0 110.079 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.31 162.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.536 3.134 . . . . 0.0 105.852 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.5 t -147.13 149.8 33.72 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.98 136.41 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.174 0.99 . . . . 0.0 109.453 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -84.57 147.0 27.24 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 160.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.48 118.55 26.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 90' ' ' LEU . 14.1 m-85 -75.26 52.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.353 2.261 . . . . 0.0 112.016 -172.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -13.75 29.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 120.541 -1.349 . . . . 0.0 113.335 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.42 -7.41 59.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.358 0.981 . . . . 0.0 112.953 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.87 -25.25 1.43 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.569 1.077 . . . . 0.0 113.347 -171.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.51 72.32 37.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.051 1.74 . . . . 0.0 107.045 161.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -47.2 -52.27 8.11 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.352 2.701 . . . . 0.0 112.602 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HE3' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.36 -46.58 86.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.841 0.746 . . . . 0.0 109.872 -169.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.485 HG23 ' SD ' ' A' ' 100' ' ' MET . 22.8 m -66.72 -51.21 58.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 125.095 1.358 . . . . 0.0 110.489 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -39.16 80.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.836 0.455 . . . . 0.0 112.142 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.73 -44.3 90.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.112 1.765 . . . . 0.0 109.807 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -56.97 -53.67 55.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.154 0.982 . . . . 0.0 109.715 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.69 -37.22 80.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.865 0.866 . . . . 0.0 112.783 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -54.06 -64.38 0.85 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.235 1.414 . . . . 0.0 109.281 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.29 66.37 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.714 0.634 . . . . 0.0 112.412 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 mt -69.78 -33.51 72.49 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.192 -0.943 . . . . 0.0 111.426 171.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 m -68.49 -49.38 60.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.814 0.734 . . . . 0.0 109.255 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.6 p -64.14 -30.99 72.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.364 0.529 . . . . 0.0 110.523 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.02 -3.88 68.89 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 119.695 1.134 . . . . 0.0 112.068 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.89 -1.38 14.11 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.82 2.048 . . . . 0.0 113.008 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.66 7.8 13.78 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.464 -0.772 . . . . 0.0 112.623 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.04 2.54 89.45 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.087 0.851 . . . . 0.0 111.555 -166.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -174.45 173.26 2.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.3 1.84 . . . . 0.0 106.546 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.62 -167.39 28.12 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -88.7 -8.0 55.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -162.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -64.32 115.02 4.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.743 1.611 . . . . 0.0 108.034 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.07 11.64 85.38 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 -173.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.2 t -66.41 119.09 11.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 163.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.82 139.17 43.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -74.21 99.63 3.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -73.77 -57.09 4.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.9 112.17 24.19 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -168.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.48 105.27 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.42 97.28 42.91 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -53.0 134.07 54.3 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.935 2.423 . . . . 0.0 113.213 -171.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.4 78.17 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.129 1.823 . . . . 0.0 112.918 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -122.9 -75.98 0.59 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.305 1.553 . . . . 0.0 106.816 -173.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.55 18.2 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.141 0.976 . . . . 0.0 109.377 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.8 t -125.75 105.96 9.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -93.84 138.25 32.2 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.672 1.989 . . . . 0.0 110.798 -172.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.55 -168.82 12.83 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.172 1.844 . . . . 0.0 110.109 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.33 9.96 69.01 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.969 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.292 29.9 t0 -84.45 46.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.619 2.209 . . . . 0.0 113.062 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -53.3 -42.65 66.83 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.337 0.655 . . . . 0.0 112.722 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.6 t -72.79 -35.1 67.31 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.396 0.678 . . . . 0.0 111.419 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -125.06 -139.12 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -170.06 23.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.621 1.555 . . . . 0.0 112.948 159.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -134.81 8.69 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.199 1.4 . . . . 0.0 112.742 -159.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.09 -9.29 66.93 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.721 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.5 p -84.16 -18.44 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.827 1.814 . . . . 0.0 111.185 171.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.49 -154.34 7.47 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 124.833 1.206 . . . . 0.0 113.077 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.52 120.57 2.23 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -162.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -142.77 158.03 44.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 158.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -91.22 177.74 6.17 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 124.066 0.854 . . . . 0.0 110.465 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.6 pt -62.62 -31.06 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.607 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -82.68 1.66 37.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.385 1.474 . . . . 0.0 111.605 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.88 156.41 29.11 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -170.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.259 3.1 tm-20 33.79 -142.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.802 2.841 . . . . 0.0 113.429 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -115.0 150.83 35.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.467 1.107 . . . . 0.0 108.115 -167.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.94 175.8 6.72 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.89 154.54 25.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.291 0.567 . . . . 0.0 109.823 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -80.33 88.37 5.55 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 167.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -46.88 -51.61 16.34 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -158.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.83 160.48 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.727 -1.578 . . . . 0.0 114.023 168.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.32 24.82 10.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.452 2.301 . . . . 0.0 110.603 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.8 mt -50.47 -46.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.187 0.995 . . . . 0.0 108.994 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 25' ' ' PHE . 96.1 mt -89.29 126.92 35.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.433 1.111 . . . . 0.0 108.278 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -108.86 172.12 7.03 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 126.811 2.044 . . . . 0.0 109.044 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -87.61 73.59 9.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.946 0.898 . . . . 0.0 108.879 -166.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 p -75.29 -4.52 39.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -160.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.86 -179.15 33.79 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.4 1.0 . . . . 0.0 111.886 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.08 159.77 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.072 1.848 . . . . 0.0 110.159 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.31 71.36 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.233 -1.315 . . . . 0.0 112.674 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.63 162.11 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.934 1.867 . . . . 0.0 107.5 166.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.03 132.28 44.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.1 1.76 . . . . 0.0 107.138 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.409 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 34.5 t -146.11 169.8 17.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.883 0.849 . . . . 0.0 110.029 -172.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 7.5 ttm -111.67 120.67 42.82 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.298 1.439 . . . . 0.0 109.1 -161.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.15 94.72 2.47 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -85.31 170.28 12.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 158.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.02 20.31 18.08 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.215 1.406 . . . . 0.0 111.506 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.65 -165.83 25.21 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 -159.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.4 153.75 76.81 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 119.88 1.84 . . . . 0.0 109.672 167.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 45.16 34.36 1.36 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.689 2.796 . . . . 0.0 113.497 169.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -132.53 32.5 3.89 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.932 -1.105 . . . . 0.0 111.573 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.509 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 15.4 p30 -66.29 -154.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.936 2.095 . . . . 0.0 110.916 166.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.14 -81.7 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.6 m -133.83 -16.43 2.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -72.78 139.78 47.29 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.401 1.455 . . . . 0.0 108.201 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -141.56 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.579 1.152 . . . . 0.0 108.511 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.455 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 43.5 p90 -146.17 153.03 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 122.332 1.063 . . . . 0.0 110.852 165.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -84.01 119.33 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 167.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.74 119.88 15.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.8 p -106.94 19.63 20.19 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 109.964 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.08 179.81 8.71 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 166.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.13 102.29 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 160.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.7 p -92.98 58.45 2.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.902 0.858 . . . . 0.0 109.711 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.58 -16.63 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.705 -1.247 . . . . 0.0 114.291 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -69.01 -17.75 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.256 -0.903 . . . . 0.0 111.079 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.455 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 36.3 mt -100.94 -10.26 20.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.069 1.347 . . . . 0.0 110.711 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.52 127.85 33.73 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.401 1.081 . . . . 0.0 109.585 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.73 -8.98 25.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.924 1.25 . . . . 0.0 113.631 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -99.56 -42.44 6.91 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.328 1.451 . . . . 0.0 110.278 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -115.4 155.13 27.98 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.908 1.283 . . . . 0.0 110.967 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.21 104.19 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -174.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.84 122.13 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -134.76 -2.05 2.69 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.441 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.26 26.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.417 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -142.46 147.31 35.9 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.889 1.675 . . . . 0.0 109.203 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.2 t -66.22 110.37 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 158.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -46.68 31.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -146.81 159.12 43.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.358 1.063 . . . . 0.0 108.551 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.2 18.57 60.55 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.532 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 25.7 tpp -51.79 -34.45 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.812 . . . . 0.0 110.709 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.3 -33.45 65.56 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.094 -1.004 . . . . 0.0 113.536 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 119.416 1.007 . . . . 0.0 109.067 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.7 t -59.56 -41.59 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.192 0.905 . . . . 0.0 110.188 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.91 -37.83 83.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.901 0.88 . . . . 0.0 110.856 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.41 72.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.192 -0.943 . . . . 0.0 109.863 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 76.7 mtp -57.79 -44.63 86.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.8 0.84 . . . . 0.0 110.483 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.4 -32.85 72.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.57 -15.0 59.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.214 0.606 . . . . 0.0 111.475 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -97.09 6.41 48.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.694 1.598 . . . . 0.0 111.388 165.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.85 -173.78 46.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.5 p -157.1 158.61 36.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -70.06 -16.23 63.11 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -166.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -29.87 68.99 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.152 0.282 . . . . 0.0 111.36 167.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.65 -29.73 7.05 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 127.871 2.653 . . . . 0.0 112.439 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -68.6 130.94 44.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.774 1.787 . . . . 0.0 109.044 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.5 p -70.88 154.76 41.55 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.919 0.888 . . . . 0.0 110.107 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 p -74.45 -16.62 60.86 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.44 0.696 . . . . 0.0 111.54 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.453 ' HE2' HG12 ' A' ' 12' ' ' VAL . 26.4 mtpt -130.8 169.92 15.07 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.605 1.162 . . . . 0.0 110.848 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -74.42 139.19 43.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 162.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.4 mt -136.52 118.44 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -132.9 160.8 35.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 -169.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -74.05 112.66 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 158.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.78 -56.05 14.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -143.92 155.2 43.98 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.893 0.877 . . . . 0.0 109.354 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -145.82 168.81 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.762 1.625 . . . . 0.0 107.991 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.18 47.16 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 165' ' ' GLU . 6.5 tt0 -87.81 155.38 19.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -172.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 7' ' ' PHE . 55.1 mt -139.99 43.28 1.94 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.559 1.143 . . . . 0.0 109.717 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.471 ' HB3' HE21 ' A' ' 163' ' ' GLN . 10.0 pm0 . . . . . 0 C--O 1.249 1.079 0 C-N-CA 125.404 1.481 . . . . 0.0 114.244 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 C--O 1.235 0.317 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -63.48 135.58 50.29 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.462 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 85.9 m -92.91 155.62 17.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.162 -2.532 . . . . 0.0 104.162 161.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.03 167.16 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.952 1.301 . . . . 0.0 108.556 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.45 158.04 37.07 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.74 0.816 . . . . 0.0 111.477 165.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.41 113.79 13.57 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.116 2.966 . . . . 0.0 104.435 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.85 104.71 15.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 170.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -71.3 148.01 10.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.33 27.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 111.145 159.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.569 HG12 ' HE2' ' A' ' 154' ' ' LYS . 5.4 t -128.31 94.32 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 126.354 1.862 . . . . 0.0 107.434 -164.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' H ' ' HB3' ' A' ' 155' ' ' LYS . 24.7 m-20 50.75 24.48 1.74 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.085 -1.634 . . . . 0.0 111.611 -160.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.21 -4.93 35.64 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.055 1.312 . . . . 0.0 114.146 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 39.4 tt0 -81.44 109.06 12.58 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 127.81 2.444 . . . . 0.0 107.74 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.95 99.2 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.051 2.501 . . . . 0.0 112.054 -168.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.7 tp -79.39 -28.91 41.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.55 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.66 157.28 8.19 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.602 0.637 . . . . 0.0 113.228 171.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -74.8 135.24 41.67 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.419 1.088 . . . . 0.0 108.761 170.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 t -127.21 143.24 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.31 146.05 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.746 0.703 . . . . 0.0 109.238 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -141.27 150.27 42.38 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 109.144 -164.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.15 147.16 26.57 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 163.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.7 mt -127.92 115.04 17.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.445 1.498 . . . . 0.0 107.237 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.36 58.22 1.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.078 1.751 . . . . 0.0 112.638 -169.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -19.05 51.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.678 1.191 . . . . 0.0 113.267 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.82 -30.4 66.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.056 0.843 . . . . 0.0 110.762 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -98.84 -50.55 4.17 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.65 0.78 . . . . 0.0 109.613 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.98 76.19 71.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 125.912 1.685 . . . . 0.0 107.702 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.3 -40.74 56.23 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.672 2.248 . . . . 0.0 111.517 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 1.3 mmpt? -66.43 -47.37 73.44 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -170.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -62.4 -49.69 74.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.961 1.304 . . . . 0.0 110.173 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.51 -46.77 78.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -64.84 -40.12 94.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.482 1.113 . . . . 0.0 110.752 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -54.64 -53.6 52.59 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 124.267 1.027 . . . . 0.0 109.484 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.9 -40.82 91.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 123.612 0.57 . . . . 0.0 112.079 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -50.71 -60.56 2.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.822 2.049 . . . . 0.0 110.099 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.05 63.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.585 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.48 -15.82 36.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.386 1.074 . . . . 0.0 111.808 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -42.72 12.18 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 120.006 1.276 . . . . 0.0 109.884 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -63.54 -33.18 75.03 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 172.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 10.55 74.73 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -16.72 63.74 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.418 1.487 . . . . 0.0 112.4 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -74.01 -3.74 31.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.204 1.402 . . . . 0.0 112.64 170.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.87 90.68 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 119.812 1.187 . . . . 0.0 112.571 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.08 173.08 17.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.067 2.147 . . . . 0.0 106.371 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.62 -179.18 34.46 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.803 -164.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -68.26 -19.5 64.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -51.42 118.61 3.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.446 1.021 . . . . 0.0 108.784 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.84 86.98 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.593 -1.67 . . . . 0.0 114.832 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -76.92 146.34 37.65 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 121.342 2.571 . . . . 0.0 107.738 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.21 148.39 22.24 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -93.67 81.06 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -74.06 -17.94 60.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.964 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.75 84.85 2.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.344 0.974 . . . . 0.0 110.61 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.98 97.06 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.89 104.74 23.29 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.51 142.11 83.22 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.911 1.741 . . . . 0.0 110.483 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.79 14.01 81.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.718 1.151 . . . . 0.0 112.929 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -140.67 -81.26 0.25 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.768 1.284 . . . . 0.0 109.047 -170.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.02 167.77 20.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.485 0.714 . . . . 0.0 112.411 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.3 m -123.43 97.61 5.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.818 2.047 . . . . 0.0 109.415 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.12 138.24 31.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.229 1.412 . . . . 0.0 110.824 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.62 72.35 0.09 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-O 118.635 -1.091 . . . . 0.0 113.524 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.29 14.32 1.45 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.262 1.531 . . . . 0.0 116.274 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -91.03 113.49 25.77 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 164.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -96.29 35.7 1.43 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.759 1.623 . . . . 0.0 110.312 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -155.0 -67.07 0.13 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.198 1.399 . . . . 0.0 107.976 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -85.98 168.59 14.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.126 2.17 . . . . 0.0 105.288 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -139.53 31.76 2.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -167.0 4.7 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.984 -158.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.644 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 111.65 -20.19 22.88 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 120.463 1.483 . . . . 0.0 114.903 175.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 p -84.53 9.14 14.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.825 1.813 . . . . 0.0 113.865 -169.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.81 -153.58 6.94 Favored Glycine 0 C--N 1.333 0.399 0 O-C-N 120.798 -1.188 . . . . 0.0 113.14 -162.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.96 174.34 46.84 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -158.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -166.91 154.26 9.15 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 125.461 1.505 . . . . 0.0 107.529 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.2 p -76.68 144.96 39.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.37 -25.13 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 122.156 0.183 . . . . 0.0 111.151 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -79.9 -13.74 59.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 113.788 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.67 -95.18 0.14 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 120.692 1.587 . . . . 0.0 111.833 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -159.23 112.43 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.212 1.005 . . . . 0.0 109.015 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt 63.4 158.25 0.07 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.824 3.25 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.71 171.33 15.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.769 0.795 . . . . 0.0 109.013 170.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.02 158.38 16.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.058 1.743 . . . . 0.0 113.265 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.99 90.86 2.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 158.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.64 -59.89 4.5 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.456 HD22 HG13 ' A' ' 89' ' ' ILE . 10.1 p-10 -161.49 158.35 26.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.795 1.283 . . . . 0.0 112.561 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.21 31.04 5.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.617 2.367 . . . . 0.0 109.553 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.456 HG13 HD22 ' A' ' 87' ' ' ASN . 21.2 mt -52.67 -40.02 32.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.586 1.154 . . . . 0.0 108.572 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.76 125.16 34.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -102.84 169.22 8.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.01 1.324 . . . . 0.0 108.899 168.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -73.82 89.26 1.82 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.7 p -72.43 -28.56 63.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.34 44.09 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.839 1.209 . . . . 0.0 111.091 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.53 162.43 10.3 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.315 2.01 . . . . 0.0 111.945 169.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.33 77.37 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.198 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.3 mm -77.07 162.46 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 120.139 1.969 . . . . 0.0 108.834 171.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.66 54.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 108.134 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -146.21 147.62 31.65 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.214 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.404 ' HG3' ' CE1' ' A' ' 129' ' ' PHE . 12.8 mtp -85.54 128.6 34.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.909 1.338 . . . . 0.0 111.423 -172.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.42 73.09 4.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.5 2.32 . . . . 0.0 108.724 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -69.26 -179.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.392 158.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.38 20.44 8.81 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.043 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 134.79 -163.01 24.77 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.62 147.04 89.96 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.053 1.836 . . . . 0.0 109.602 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 46.81 32.01 1.64 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.672 1.989 . . . . 0.0 115.789 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.1 p -118.28 23.56 11.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.536 -1.353 . . . . 0.0 111.503 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -63.12 104.3 0.56 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.21 -75.28 1.03 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.605 1.093 . . . . 0.0 111.383 -170.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.1 p -155.74 -21.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.835 1.254 . . . . 0.0 111.486 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.644 HE22 ' HA2' ' A' ' 72' ' ' GLY . 58.8 mt-30 -64.2 143.08 58.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.47 169.32 18.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.563 1.545 . . . . 0.0 106.833 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.539 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 17.7 p90 -136.04 152.84 51.32 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.781 0.8 . . . . 0.0 110.366 163.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.79 113.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 166.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -62.73 124.95 22.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.7 p -115.1 31.67 6.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.898 1.332 . . . . 0.0 108.665 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.71 169.45 19.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 110.03 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -73.24 86.68 1.44 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 163.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -76.81 58.01 1.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.073 0.949 . . . . 0.0 110.219 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.89 -30.5 65.93 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.037 -1.665 . . . . 0.0 111.816 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -70.91 -15.24 62.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.081 1.352 . . . . 0.0 110.541 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.539 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 66.2 mt -98.97 -12.49 20.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.372 1.069 . . . . 0.0 111.172 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.44 144.04 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.363 0.983 . . . . 0.0 109.605 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.06 -4.64 37.96 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.829 1.204 . . . . 0.0 113.728 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.96 -59.65 1.99 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 126.515 1.926 . . . . 0.0 108.978 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -96.69 129.28 44.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.891 1.276 . . . . 0.0 108.396 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.8 t -80.11 104.4 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -170.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.97 127.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.404 ' CE1' ' HG3' ' A' ' 100' ' ' MET . 22.4 p90 -140.74 -0.22 1.55 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.603 1.19 . . . . 0.0 113.441 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.92 -176.56 32.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.636 -1.269 . . . . 0.0 112.065 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.29 151.48 34.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.01 127.42 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -94.51 -38.33 10.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.933 0.893 . . . . 0.0 110.389 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -139.29 153.48 47.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 109.829 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.71 72.18 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.241 -0.755 . . . . 0.0 113.011 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.0 tpp -54.85 -36.39 65.0 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.304 1.552 . . . . 0.0 110.004 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -58.8 -27.88 65.47 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.534 1.061 . . . . 0.0 113.643 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.7 mm -75.17 -42.77 44.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 124.484 1.114 . . . . 0.0 108.268 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.35 -41.33 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.46 -34.23 70.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.018 1.327 . . . . 0.0 111.154 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.05 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.695 0.798 . . . . 0.0 110.636 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.6 mtm -55.77 -45.32 78.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.555 0.616 . . . . 0.0 110.128 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.49 -36.86 72.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.599 1.159 . . . . 0.0 112.683 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -69.56 -14.89 63.08 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.105 -0.997 . . . . 0.0 111.306 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 14.18 25.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 126.793 2.037 . . . . 0.0 111.291 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.94 -172.21 31.47 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.6 p -154.52 164.32 38.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.738 -0.86 . . . . 0.0 109.435 165.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.26 -33.91 63.59 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -71.64 -13.59 61.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.3 -26.68 21.05 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 127.274 2.368 . . . . 0.0 113.361 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -66.52 130.04 41.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.6 1.7 . . . . 0.0 108.779 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.6 p -65.7 153.86 40.54 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.594 0.758 . . . . 0.0 110.102 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.8 p -69.32 -25.5 64.24 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.299 -0.875 . . . . 0.0 110.586 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.569 ' HE2' HG12 ' A' ' 12' ' ' VAL . 42.7 mtpt -130.76 174.46 9.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.284 1.434 . . . . 0.0 111.518 -170.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -63.65 139.28 58.75 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 102.903 -2.999 . . . . 0.0 102.903 158.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -129.06 122.6 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 101.217 -3.623 . . . . 0.0 101.217 160.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.53 153.17 43.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -166.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -74.09 110.83 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.43 -46.48 73.0 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.517 0.599 . . . . 0.0 109.468 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -151.03 163.32 39.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.643 0.377 . . . . 0.0 110.045 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 m -148.43 171.1 16.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 171.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.26 174.82 46.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 160.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.573 ' HG2' ' H ' ' A' ' 165' ' ' GLU . 47.0 tt0 -87.11 154.82 20.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.225 1.01 . . . . 0.0 109.93 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.1 mt -136.94 43.41 2.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.18 2.592 . . . . 0.0 109.915 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.573 ' H ' ' HG2' ' A' ' 163' ' ' GLN . 3.5 tm-20 . . . . . 0 C--O 1.246 0.892 0 C-N-CA 127.182 2.193 . . . . 0.0 106.155 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 156.41 66.2 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 121.18 1.253 . . . . 0.0 110.985 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -117.09 151.63 36.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.34 150.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 119.301 0.955 . . . . 0.0 109.434 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -108.21 161.55 14.89 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.124 0.969 . . . . 0.0 108.811 166.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 4.1 m-85 -144.37 108.76 4.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.052 2.141 . . . . 0.0 107.361 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 98.29 9.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.23 138.54 22.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.93 149.99 42.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.827 1.299 . . . . 0.0 108.514 161.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.558 HG12 ' HE2' ' A' ' 154' ' ' LYS . 2.5 t -106.31 80.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 170.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.523 ' OD2' ' HE3' ' A' ' 154' ' ' LYS 0.378 3.7 p30 61.74 14.09 5.88 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.41 -9.25 15.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -73.99 121.6 85.56 Favored Pre-proline 0 C--N 1.338 0.099 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 164.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.12 103.23 1.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.81 2.34 . . . . 0.0 107.732 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.8 tp -83.0 -34.11 26.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.704 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.5 165.7 11.74 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.507 -1.33 . . . . 0.0 114.993 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.27 136.14 44.53 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.3 t -120.05 158.77 21.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 130.232 3.413 . . . . 0.0 105.823 165.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -152.11 155.35 37.71 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.679 -1.888 . . . . 0.0 111.812 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -141.85 145.28 34.48 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.949 1.299 . . . . 0.0 110.079 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -90.77 150.54 21.56 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.437 1.495 . . . . 0.0 107.315 160.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -128.74 128.5 44.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.017 1.327 . . . . 0.0 108.249 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.435 ' CD2' HD13 ' A' ' 90' ' ' LEU . 16.0 m-85 -81.13 49.54 1.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.6 1.56 . . . . 0.0 112.546 -166.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -4.63 7.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.907 1.283 . . . . 0.0 114.379 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.15 -16.78 36.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.98 1.264 . . . . 0.0 111.974 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -121.94 -30.31 4.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.64 1.176 . . . . 0.0 113.258 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 86' ' ' GLU . 6.1 m -129.88 73.31 81.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 124.685 1.194 . . . . 0.0 107.858 169.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.75 -39.25 43.96 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.575 2.183 . . . . 0.0 113.434 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -51.34 67.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.499 1.045 . . . . 0.0 108.211 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.504 HG23 ' SD ' ' A' ' 100' ' ' MET . 4.8 m -61.55 -49.1 78.05 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.257 1.023 . . . . 0.0 110.732 -170.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.2 -45.4 70.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 112.242 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -63.4 -42.04 98.76 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.466 0.306 . . . . 0.0 111.302 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -56.98 -47.97 79.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.121 1.368 . . . . 0.0 109.439 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.1 -38.64 88.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.856 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -55.23 -58.17 8.79 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.767 0.712 . . . . 0.0 109.135 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.96 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.245 1.418 . . . . 0.0 113.652 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.8 mt -84.04 -26.96 28.67 Favored 'General case' 0 N--CA 1.457 -0.078 0 O-C-N 121.567 -0.708 . . . . 0.0 111.599 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 m -77.52 -43.43 32.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.581 0.752 . . . . 0.0 110.326 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -63.96 -27.35 69.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.89 7.51 62.16 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.41 -27.85 69.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.59 1.156 . . . . 0.0 111.189 -171.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 29.3 mmmt -65.49 -14.71 61.6 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.959 -1.02 . . . . 0.0 112.26 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.93 4.17 48.44 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.251 1.405 . . . . 0.0 112.228 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -163.6 175.99 10.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.078 1.751 . . . . 0.0 107.968 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.77 -149.49 19.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-O 122.029 0.794 . . . . 0.0 112.831 165.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -59.96 -44.74 94.24 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 127.14 2.176 . . . . 0.0 109.655 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -44.62 112.83 0.46 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.015 1.326 . . . . 0.0 110.004 170.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.05 3.64 88.92 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.097 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.3 m -63.86 -62.76 1.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.907 2.354 . . . . 0.0 110.8 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 t 122.85 167.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 131.774 4.03 . . . . 0.0 106.583 -168.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.435 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 51.5 m-85 -119.68 91.96 3.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.583 1.953 . . . . 0.0 106.198 170.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -73.76 -18.34 60.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -164.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.26 104.08 4.22 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.58 103.09 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.0 mt -119.03 91.0 42.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -48.24 122.62 7.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.01 3.14 . . . . 0.0 114.859 -167.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.56 21.27 77.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.133 1.349 . . . . 0.0 112.37 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.11 -75.57 0.55 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.38 170.99 19.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.227 1.011 . . . . 0.0 109.413 167.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 p -130.77 107.97 9.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.797 0.839 . . . . 0.0 110.411 168.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -86.96 140.86 29.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 129.028 2.931 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -148.75 -163.09 10.66 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 124.959 1.266 . . . . 0.0 110.845 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 48' ' ' TYR . . . 91.96 10.68 61.04 Favored Glycine 0 N--CA 1.463 0.496 0 CA-C-N 117.717 0.758 . . . . 0.0 114.89 166.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.82 103.91 13.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 107.552 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -115.45 9.94 15.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.478 1.511 . . . . 0.0 111.747 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.6 t -139.15 -35.41 0.56 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.596 1.158 . . . . 0.0 113.629 -166.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -129.87 -36.54 1.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -167.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.5 m170 61.4 56.8 2.52 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.673 1.189 . . . . 0.0 112.078 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -164.51 -54.05 0.03 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.015 1.326 . . . . 0.0 110.169 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.94 -21.44 0.18 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.751 1.643 . . . . 0.0 113.242 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -84.55 12.12 7.57 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.875 1.837 . . . . 0.0 111.57 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.48 -165.13 15.77 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 124.727 1.156 . . . . 0.0 110.696 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.47 103.75 0.17 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -136.3 144.36 44.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.592 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -70.62 164.4 25.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.256 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.412 ' HB ' ' HE2' ' A' ' 44' ' ' LYS . 41.9 pt -61.32 -31.64 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 121.563 -0.711 . . . . 0.0 110.018 163.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.82 -14.53 61.11 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.516 0.726 . . . . 0.0 112.277 -172.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.01 -85.71 0.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -156.17 132.19 9.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 108.593 163.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttt 52.31 149.88 0.0 OUTLIER 'General case' 0 C--N 1.342 0.281 1 C-N-CA 132.618 4.367 . . . . 0.0 115.375 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -128.69 -172.56 2.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.27 152.37 43.34 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 167.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.64 101.02 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 159.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HG3' HG12 ' A' ' 29' ' ' VAL . 11.0 pt-20 -63.65 -51.02 66.98 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.448 -168.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -151.67 176.24 11.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.373 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -127.78 30.26 5.32 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.618 2.367 . . . . 0.0 109.462 172.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.8 mt -57.27 -46.5 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 25' ' ' PHE . 99.0 mt -74.57 112.57 10.89 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -82.17 164.26 21.38 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.942 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.78 98.41 4.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.2 p -77.87 -32.93 52.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.798 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.6 -174.98 47.35 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 118.964 0.802 . . . . 0.0 113.851 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.72 160.02 26.37 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.486 2.124 . . . . 0.0 110.457 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.29 -5.93 40.01 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.836 -1.536 . . . . 0.0 112.465 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.92 156.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.925 2.362 . . . . 0.0 107.584 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.17 129.33 54.94 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.641 1.177 . . . . 0.0 108.421 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.1 t -138.53 148.98 44.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.026 0.829 . . . . 0.0 109.28 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.504 ' SD ' HG23 ' A' ' 32' ' ' THR . 12.9 ttt -100.45 130.44 46.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -162.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.498 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -75.54 155.64 35.87 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.813 1.245 . . . . 0.0 108.842 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -165.38 -169.1 1.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.922 1.689 . . . . 0.0 108.029 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -119.61 13.66 12.55 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.457 1.103 . . . . 0.0 113.049 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.42 -142.39 13.77 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -168.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.03 157.3 62.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.873 1.715 . . . . 0.0 109.521 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 34.18 51.04 0.4 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 128.163 2.585 . . . . 0.0 112.999 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 p -140.63 13.92 2.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.713 0.805 . . . . 0.0 113.069 -173.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -57.79 96.61 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.754 1.622 . . . . 0.0 110.826 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.19 -84.66 1.08 Allowed Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.048 -1.032 . . . . 0.0 111.529 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -156.29 -17.43 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -55.61 140.52 40.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 167.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.498 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -138.88 169.98 16.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 19.8 p90 -132.34 147.35 52.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.865 0.84 . . . . 0.0 111.663 166.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.4 mt -83.37 117.43 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 102.413 -3.18 . . . . 0.0 102.413 171.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.1 m -64.38 120.91 13.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.0 p -106.88 22.16 16.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.127 0.571 . . . . 0.0 109.629 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.39 -179.56 7.8 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 163.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -64.12 117.27 6.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 159.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.435 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 49.8 p -114.21 56.88 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.175 0.898 . . . . 0.0 111.327 -174.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -61.31 -25.08 66.88 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 120.86 -1.15 . . . . 0.0 113.959 -169.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.435 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 37.3 p90 -66.11 -21.82 66.37 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.814 0.846 . . . . 0.0 110.708 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.609 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 82.9 mt -88.65 -16.89 31.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.657 0.783 . . . . 0.0 110.569 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.77 149.0 38.07 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.34 69.84 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.611 -0.328 . . . . 0.0 112.34 -169.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.91 -45.11 0.47 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.179 0.99 . . . . 0.0 109.473 164.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -103.82 144.67 31.19 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.863 1.265 . . . . 0.0 109.486 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.3 102.15 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.05 121.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -142.14 1.36 1.43 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.024 -169.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.79 -177.25 35.64 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.973 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 157.84 43.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.138 0.495 . . . . 0.0 109.954 162.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.03 124.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -84.82 -48.01 9.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.329 160.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -146.06 158.29 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.681 1.192 . . . . 0.0 110.292 -168.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.46 20.08 64.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -34.89 60.57 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.539 1.67 . . . . 0.0 111.186 174.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -32.95 69.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.6 mm -78.14 -34.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 119.541 1.064 . . . . 0.0 109.492 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.21 -40.77 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.143 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.18 -37.01 81.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.672 0.789 . . . . 0.0 111.095 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.79 83.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.204 1.366 . . . . 0.0 108.288 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.0 mtm -52.41 -48.53 65.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 118.003 0.365 . . . . 0.0 110.568 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.03 -34.12 72.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -76.92 -15.67 59.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.892 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -89.46 -5.42 57.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.011 0.924 . . . . 0.0 111.806 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.51 -167.98 42.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.852 1.692 . . . . 0.0 109.782 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 51.2 p -161.49 155.74 22.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -18.88 65.54 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -69.43 -7.19 35.59 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.32 -30.29 10.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 127.787 2.613 . . . . 0.0 113.016 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -63.11 129.78 41.82 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.061 0.944 . . . . 0.0 110.56 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 p -80.01 157.97 26.65 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.824 1.25 . . . . 0.0 109.72 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -76.19 -17.73 59.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.286 1.035 . . . . 0.0 111.786 167.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.558 ' HE2' HG12 ' A' ' 12' ' ' VAL . 12.3 mtpt -140.85 165.3 27.9 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.407 1.483 . . . . 0.0 109.572 -168.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 13' ' ' ASP . 30.8 tttt -85.69 80.14 9.09 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.995 1.725 . . . . 0.0 107.515 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -73.87 131.24 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 p -145.69 167.34 23.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 123.488 1.613 . . . . 0.0 110.063 -167.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.408 HD13 ' O ' ' A' ' 48' ' ' TYR . 4.0 mp -83.02 114.56 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 158.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.59 -55.04 12.91 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.04 153.01 33.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.619 1.568 . . . . 0.0 107.076 -161.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 8' ' ' PHE . 7.5 m -159.71 174.16 14.95 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.951 1.701 . . . . 0.0 109.156 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.25 -172.01 44.84 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 165.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -83.49 160.4 21.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.123 0.969 . . . . 0.0 108.578 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.2 mt -128.27 43.28 3.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.197 0.999 . . . . 0.0 108.877 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 N--CA 1.435 -1.218 0 C-N-CA 131.638 3.975 . . . . 0.0 109.821 -168.698 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--O 1.24 0.58 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.84 156.26 66.89 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.863 1.709 . . . . 0.0 109.279 165.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.1 m -135.82 158.77 43.58 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.85 155.43 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 119.493 -2.004 . . . . 0.0 109.228 -169.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -124.38 157.3 35.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.874 1.269 . . . . 0.0 109.947 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 161' ' ' CYS . 88.1 m-85 -147.16 106.23 3.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.204 2.202 . . . . 0.0 107.738 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.49 93.56 3.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.17 143.7 15.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.6 133.54 47.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.443 1.097 . . . . 0.0 110.19 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 t -99.76 96.19 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 128.094 2.558 . . . . 0.0 104.603 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 58.71 17.96 5.56 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.763 2.025 . . . . 0.0 114.037 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.36 -9.72 24.37 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.319 1.914 . . . . 0.0 112.518 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.96 131.94 52.47 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.22 113.67 2.94 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.82 1.68 . . . . 0.0 109.659 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.3 tp -79.59 -37.28 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.554 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.28 171.03 14.0 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -81.68 139.8 34.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.92 153.41 35.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 127.066 2.146 . . . . 0.0 105.395 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.72 139.03 11.15 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 -166.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -134.04 149.76 51.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.621 0.769 . . . . 0.0 111.006 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -87.12 151.67 23.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 158.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 mt -127.46 109.48 11.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -68.97 61.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.84 2.456 . . . . 0.0 112.049 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.38 -30.17 38.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.463 1.905 . . . . 0.0 112.222 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 -19.55 62.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.901 1.681 . . . . 0.0 110.818 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -38.89 2.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.353 2.261 . . . . 0.0 110.664 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 129' ' ' PHE . 3.8 m -141.24 72.71 26.55 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.758 2.023 . . . . 0.0 108.645 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.59 -41.43 39.73 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.845 2.363 . . . . 0.0 113.712 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -57.73 11.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.351 1.432 . . . . 0.0 107.69 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 m -57.77 -44.08 85.92 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.712 0.632 . . . . 0.0 109.841 -169.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.48 67.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.799 0.84 . . . . 0.0 113.257 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -66.75 -39.96 88.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.713 0.688 . . . . 0.0 110.574 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -55.99 -52.53 63.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.75 1.22 . . . . 0.0 109.712 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.511 ' CE2' ' CE2' ' A' ' 112' ' ' PHE . 2.3 t80 -56.12 -49.86 72.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.601 0.36 . . . . 0.0 110.679 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.433 ' HD2' HE21 ' A' ' 163' ' ' GLN . 45.8 ttp85 -50.96 -60.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.011 1.324 . . . . 0.0 109.926 -173.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.54 -27.12 68.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -77.12 -33.85 56.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.922 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.5 p -69.95 -45.55 67.19 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.98 1.264 . . . . 0.0 111.093 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.0 p -64.68 -36.8 85.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.565 0.746 . . . . 0.0 109.085 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.23 14.31 82.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.24 -28.29 67.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.15 1.38 . . . . 0.0 112.031 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -72.33 8.96 1.14 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.529 1.132 . . . . 0.0 112.917 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -3.69 83.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.885 1.231 . . . . 0.0 112.805 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.2 176.45 12.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.5 1.65 . . . . 0.0 108.65 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.55 -146.88 17.6 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.561 ' CE1' ' CE2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -61.24 -38.69 87.59 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.213 1.405 . . . . 0.0 112.532 -163.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -47.15 116.78 1.49 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.398 1.079 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.98 4.24 90.34 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.427 -1.763 . . . . 0.0 115.728 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -64.24 -35.21 80.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 121.502 2.651 . . . . 0.0 113.589 -162.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.4 m 86.0 164.93 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.611 2.764 . . . . 0.0 107.868 -158.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -119.01 101.57 8.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 164.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.194 0.907 . . . . 0.0 113.043 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.571 ' HG3' HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -133.12 114.25 13.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.81 120.69 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.571 HD11 ' HG3' ' A' ' 55' ' ' ARG . 4.9 mp -124.89 99.95 34.39 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.2 136.45 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.107 1.871 . . . . 0.0 110.52 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 22.93 78.58 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.766 1.65 . . . . 0.0 112.198 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -146.93 -81.89 0.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.805 1.303 . . . . 0.0 109.144 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.554 ' CE ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -161.77 168.72 22.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.724 0.693 . . . . 0.0 112.301 174.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.0 m -120.84 108.44 13.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.212 1.805 . . . . 0.0 108.003 170.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -95.44 133.4 39.45 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 110.342 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 177.86 29.87 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.02 20.11 4.57 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.492 1.044 . . . . 0.0 112.62 -174.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -84.03 28.88 0.58 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.619 1.968 . . . . 0.0 111.975 -164.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 10.6 p90 -63.34 1.25 0.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.516 1.926 . . . . 0.0 115.731 -167.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.502 HG21 ' HE2' ' A' ' 76' ' ' LYS . 2.1 p -139.21 -69.08 0.43 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.305 1.842 . . . . 0.0 109.57 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -118.75 162.47 18.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 166.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -148.25 33.77 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.582 1.953 . . . . 0.0 108.063 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -144.96 16.27 1.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.838 3.255 . . . . 0.0 109.525 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.65 -28.05 12.37 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.365 1.459 . . . . 0.0 113.57 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.8 p -83.74 12.39 6.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.099 1.95 . . . . 0.0 113.103 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.56 168.8 13.27 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.743 1.163 . . . . 0.0 111.794 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.95 165.17 30.16 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HE2' HG21 ' A' ' 68' ' ' THR . 3.5 pttt 170.69 -177.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.129 4.172 . . . . 0.0 103.914 -160.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.9 p -127.25 178.6 5.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.455 1.025 . . . . 0.0 110.311 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.14 -22.89 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.131 168.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.93 1.78 56.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.514 1.525 . . . . 0.0 111.681 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.69 -112.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.24 -133.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.83 2.052 . . . . 0.0 110.389 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -102.74 154.67 18.94 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.331 -1.48 . . . . 0.0 109.261 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -111.0 165.45 11.86 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 109.888 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 156.17 31.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.175 0.988 . . . . 0.0 110.863 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 101.82 2.78 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.13 -48.98 77.34 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.465 1.106 . . . . 0.0 110.62 -164.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -170.12 176.28 4.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.24 2.216 . . . . 0.0 107.96 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.45 43.21 3.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.72 1.208 . . . . 0.0 108.357 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.0 mt -60.56 -65.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -72.67 143.64 48.03 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.954 1.835 . . . . 0.0 107.32 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -131.55 161.6 32.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 127.057 2.143 . . . . 0.0 109.008 -170.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -84.97 73.13 10.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.597 1.159 . . . . 0.0 109.055 -164.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 p -66.07 -31.58 72.54 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.832 0.853 . . . . 0.0 113.003 -165.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.28 171.34 31.38 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.75 -1.028 . . . . 0.0 110.965 -166.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.8 135.96 54.97 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.314 2.009 . . . . 0.0 111.669 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.35 -8.01 30.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.065 -1.409 . . . . 0.0 111.731 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.5 mm -72.31 148.3 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 121.124 2.462 . . . . 0.0 108.662 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.51 131.45 55.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.403 1.081 . . . . 0.0 108.263 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.3 t -140.51 159.82 41.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.857 0.863 . . . . 0.0 110.005 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.31 137.56 32.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -163.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -90.48 71.48 6.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.11 163.62 27.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.411 158.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.08 16.47 12.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.664 1.586 . . . . 0.0 111.646 -168.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.27 -170.81 28.05 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 -159.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -65.11 172.26 7.7 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 CA-C-N 119.898 1.849 . . . . 0.0 109.86 165.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.93 14.7 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 131.12 3.768 . . . . 0.0 116.221 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -108.63 27.26 9.59 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.857 -1.777 . . . . 0.0 111.03 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.408 2.683 . . . . 0.0 106.459 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.59 -93.75 0.32 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -172.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.5 t -144.34 -11.25 0.63 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.45 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -79.48 135.22 36.59 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CE2' ' CE1' ' A' ' 48' ' ' TYR . 37.1 p90 -145.29 177.27 8.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.679 1.192 . . . . 0.0 108.449 174.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -142.08 151.57 42.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.872 1.32 . . . . 0.0 112.587 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.81 101.9 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 101.569 -3.493 . . . . 0.0 101.569 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.68 94.42 0.3 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.4 p -87.1 25.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.804 0.842 . . . . 0.0 111.009 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.15 -178.22 7.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 163.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -67.2 130.84 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 158.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.6 p -131.62 57.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -14.37 61.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.183 0.993 . . . . 0.0 112.408 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -69.57 -7.95 43.0 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.106 -0.996 . . . . 0.0 111.055 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -109.46 -8.68 14.99 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.479 1.512 . . . . 0.0 111.996 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 149.05 30.17 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.059 0.943 . . . . 0.0 111.011 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.14 18.65 49.34 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.27 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -144.25 -34.33 0.38 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.576 1.15 . . . . 0.0 110.449 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -118.09 139.36 51.35 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.389 1.076 . . . . 0.0 108.194 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.76 96.87 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -167.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.17 127.02 22.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.419 ' HA ' HG21 ' A' ' 29' ' ' VAL . 15.8 p90 -134.83 -6.5 2.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.049 -0.977 . . . . 0.0 113.256 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.13 -179.28 31.05 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.28 -1.438 . . . . 0.0 112.855 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -153.65 138.3 16.93 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -53.73 114.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 125.059 1.344 . . . . 0.0 108.388 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -83.26 -52.27 6.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.83 160.05 40.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.715 1.143 . . . . 0.0 112.116 -168.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.69 77.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.526 1.06 . . . . 0.0 112.098 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -37.99 71.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.86 1.33 . . . . 0.0 110.843 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.22 -29.15 68.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.946 -1.096 . . . . 0.0 112.508 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.6 mm -72.51 -35.46 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.614 1.166 . . . . 0.0 108.98 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.36 -44.05 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.983 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -27.44 68.91 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.962 -1.086 . . . . 0.0 112.779 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.84 -46.32 68.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.939 -1.101 . . . . 0.0 108.474 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 15.8 mtm -53.08 -46.7 68.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.374 0.534 . . . . 0.0 111.234 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -52.29 -42.49 63.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.469 1.108 . . . . 0.0 111.842 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.47 -19.52 64.56 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.922 -0.486 . . . . 0.0 110.822 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.445 ' CB ' HD11 ' A' ' 156' ' ' ILE . 55.1 m-85 -98.02 5.01 49.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.692 1.597 . . . . 0.0 111.664 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.2 -163.93 37.94 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 98.5 p -152.41 163.57 39.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 57' ' ' ILE . 44.9 mtm-85 -67.03 -22.4 65.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.25 -1.531 . . . . 0.0 113.462 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -75.33 -15.69 60.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 168.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 102.06 -27.98 17.98 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-O 117.644 -1.642 . . . . 0.0 114.259 171.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -66.95 124.63 23.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.209 2.005 . . . . 0.0 107.246 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.9 p -73.31 147.85 44.08 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.924 0.889 . . . . 0.0 109.895 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.0 p -77.61 -9.98 59.25 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.23 -0.919 . . . . 0.0 111.784 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -136.96 152.32 50.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.968 1.307 . . . . 0.0 109.546 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -73.06 109.08 6.33 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.445 HD11 ' CB ' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -101.88 130.45 51.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -177.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.2 p -141.84 173.36 11.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.55 1.94 . . . . 0.0 110.552 -170.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.409 HD11 ' CE2' ' A' ' 48' ' ' TYR . 3.2 mt -106.61 116.55 50.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 167.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.12 -60.01 4.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -163.01 176.55 10.01 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.735 1.614 . . . . 0.0 111.388 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 8' ' ' PHE . 1.4 p -169.5 172.4 7.06 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.425 1.09 . . . . 0.0 110.628 -159.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.82 -172.23 45.11 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.433 HE21 ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -90.63 160.47 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.115 0.966 . . . . 0.0 110.327 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 39.0 mt -136.9 43.66 2.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.595 1.558 . . . . 0.0 109.011 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.745 -176.041 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.6 m120 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -76.36 149.95 31.92 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 N-CA-C 109.283 -1.084 . . . . 0.0 109.283 165.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -101.48 151.15 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.78 163.7 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.537 1.535 . . . . 0.0 108.252 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -134.09 158.42 43.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.15 0.98 . . . . 0.0 110.471 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -128.86 123.77 33.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.856 2.462 . . . . 0.0 106.317 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -78.19 98.92 6.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.8 mm -70.28 140.14 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.151 -0.968 . . . . 0.0 109.562 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.49 50.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.581 1.152 . . . . 0.0 110.4 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 6.7 t -132.74 100.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -165.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.24 13.69 0.65 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.599 1.959 . . . . 0.0 112.86 -161.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.19 38.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.525 1.536 . . . . 0.0 113.298 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -80.51 126.87 77.54 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 120.015 1.908 . . . . 0.0 106.188 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 115.89 3.65 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.822 1.681 . . . . 0.0 109.078 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.9 tp -85.2 -39.6 17.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.563 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.97 158.34 9.01 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.495 -0.383 . . . . 0.0 112.218 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -68.97 146.43 52.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 164.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.453 HG12 ' CZ ' ' A' ' 22' ' ' PHE . 39.2 t -135.33 143.29 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 171.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -137.02 153.18 50.72 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.166 0.586 . . . . 0.0 110.031 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.453 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 11.3 m-85 -146.54 146.69 30.58 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.477 1.111 . . . . 0.0 108.909 -165.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.03 145.88 27.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 165.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -118.65 146.78 44.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 108.734 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -97.54 61.66 1.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.543 1.537 . . . . 0.0 111.102 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.2 42.05 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.29 0.636 . . . . 0.0 112.236 171.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.58 -0.89 39.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.931 2.093 . . . . 0.0 113.307 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -127.83 -37.27 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.142 1.337 . . . . 0.0 110.716 166.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.07 73.68 74.69 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.148 1.379 . . . . 0.0 107.457 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.38 -43.09 36.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -49.88 67.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.924 0.783 . . . . 0.0 109.828 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.7 m -55.21 -46.66 75.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.991 1.316 . . . . 0.0 109.769 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -51.9 55.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.621 0.769 . . . . 0.0 111.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.59 -39.0 93.27 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.322 1.049 . . . . 0.0 111.618 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -51.88 -60.92 2.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.191 1.396 . . . . 0.0 109.718 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -66.12 -28.27 68.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.221 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -53.88 -64.11 0.93 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.206 1.402 . . . . 0.0 109.16 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.9 -16.62 61.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.58 -31.37 16.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.879 1.272 . . . . 0.0 110.903 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -79.36 -24.39 42.72 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 111.761 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.6 p -79.24 -39.06 34.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.24 19.72 78.07 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.0 -16.05 63.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.806 1.303 . . . . 0.0 112.942 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -87.48 9.43 20.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.213 1.005 . . . . 0.0 112.032 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.04 16.47 79.53 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.419 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.83 -173.73 4.69 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.968 1.707 . . . . 0.0 108.678 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.71 -146.19 17.89 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CE2' HD11 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -64.04 -27.99 69.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.791 1.636 . . . . 0.0 111.767 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 11.3 tmtt? -62.01 109.64 1.34 Allowed 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.879 -0.513 . . . . 0.0 110.164 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.57 89.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 116.938 -2.035 . . . . 0.0 115.061 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -68.13 151.28 47.24 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 121.89 2.845 . . . . 0.0 108.324 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.427 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 65.2 m -86.15 171.09 11.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 159.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CB ' HD11 ' A' ' 56' ' ' ILE . 55.0 m-85 -116.09 120.08 37.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -73.67 -45.41 52.71 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.73 102.05 6.4 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 123.807 0.692 . . . . 0.0 110.877 -157.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.409 HD11 ' CB ' ' A' ' 53' ' ' PHE . 29.8 mt -130.06 108.42 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -170.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.43 97.47 50.18 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -55.05 128.79 32.04 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.299 1.999 . . . . 0.0 112.705 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 46.31 85.42 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 125.011 1.291 . . . . 0.0 110.156 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -153.55 -79.23 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.58 168.4 16.43 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.805 1.242 . . . . 0.0 109.668 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.81 109.49 7.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.201 . . . . 0.0 111.551 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -101.64 143.02 32.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.439 2.696 . . . . 0.0 110.774 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.34 20.02 0.63 Allowed Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.55 3.39 42.79 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 119.136 1.468 . . . . 0.0 116.045 -159.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -83.98 23.86 0.98 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.485 2.142 . . . . 0.0 112.833 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -33.37 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 1 C-N-CA 133.515 4.726 . . . . 0.0 119.989 -158.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -87.75 -22.28 24.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.865 1.666 . . . . 0.0 111.265 173.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -133.19 177.98 7.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 128.998 2.919 . . . . 0.0 106.867 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -156.17 44.03 0.42 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.84 1.256 . . . . 0.0 108.651 -168.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -140.34 -8.36 1.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 110.824 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.45 56.98 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 117.828 -1.54 . . . . 0.0 113.801 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.2 p -135.57 65.85 1.53 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.375 2.088 . . . . 0.0 110.077 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.17 -154.1 6.95 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' H ' HG22 ' A' ' 68' ' ' THR . . . 81.86 170.67 44.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.115 0.864 . . . . 0.0 112.78 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 150.88 9.97 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.879 1.272 . . . . 0.0 109.327 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.2 p -89.63 35.2 0.82 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -166.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 pt 42.1 -3.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 130.645 3.578 . . . . 0.0 118.049 -162.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -134.28 12.21 3.85 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.644 2.377 . . . . 0.0 110.774 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.15 -156.82 27.38 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -68.5 -132.91 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.444 1.498 . . . . 0.0 108.446 160.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -74.69 170.57 15.55 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.092 -1.63 . . . . 0.0 111.257 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -130.6 178.5 6.58 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.96 1.704 . . . . 0.0 108.038 169.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.74 172.84 2.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.198 0.999 . . . . 0.0 112.11 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -79.46 99.19 7.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 160.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.063 1.345 . . . . 0.0 112.269 -166.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -160.6 175.7 12.4 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.009 1.324 . . . . 0.0 108.32 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.41 26.67 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.169 1.388 . . . . 0.0 109.557 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.38 -46.61 81.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.62 132.25 34.2 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -133.67 154.94 50.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.331 1.853 . . . . 0.0 109.224 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -75.84 85.5 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.047 1.339 . . . . 0.0 110.27 -168.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -7.83 59.63 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 113.962 -172.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.71 -178.8 33.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.37 156.06 53.71 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.864 1.709 . . . . 0.0 110.514 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.85 89.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.981 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.85 160.94 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.241 2.02 . . . . 0.0 107.8 169.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.21 136.59 54.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.239 1.416 . . . . 0.0 107.303 169.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 22.8 t -127.08 138.29 53.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.8 mtp -67.57 152.86 44.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 158.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.89 154.72 36.73 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.531 1.532 . . . . 0.0 108.874 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -138.49 -171.19 3.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.132 2.173 . . . . 0.0 107.301 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.94 25.15 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.76 1.624 . . . . 0.0 110.593 -175.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.67 -161.58 24.79 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.2 154.86 60.1 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 120.474 2.137 . . . . 0.0 109.4 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 43.99 43.66 5.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.716 2.406 . . . . 0.0 114.136 159.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.6 p -132.59 29.79 4.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.258 1.423 . . . . 0.0 110.048 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -71.39 107.69 4.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.79 -95.21 1.55 Allowed Glycine 0 C--O 1.225 -0.423 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 p -129.65 1.7 4.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.787 1.635 . . . . 0.0 110.893 170.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -58.3 141.84 49.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.905 1.682 . . . . 0.0 108.359 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.61 174.39 15.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.544 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 11.5 p90 -147.35 161.08 41.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 158.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.39 129.05 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 159.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.45 118.19 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.7 p -108.09 21.32 17.54 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.673 1.589 . . . . 0.0 109.521 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -156.57 174.75 14.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 167.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -71.53 85.41 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 162.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -78.18 60.34 2.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.273 1.029 . . . . 0.0 110.781 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.34 -15.1 62.99 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.667 -1.27 . . . . 0.0 112.453 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -76.87 -18.04 58.59 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.104 1.361 . . . . 0.0 111.944 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.544 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 69.2 mt -97.74 -7.94 29.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.179 1.392 . . . . 0.0 110.402 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.62 138.3 56.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.93 -11.29 1.97 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.586 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -93.76 -39.0 10.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.666 1.733 . . . . 0.0 108.421 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -130.92 155.6 46.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.092 0.472 . . . . 0.0 111.433 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.29 93.54 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.531 1.532 . . . . 0.0 108.195 -165.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.59 131.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 1.18 0.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.248 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -163.27 -175.16 33.98 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -153.0 150.93 29.71 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.838 0.855 . . . . 0.0 110.016 165.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.98 117.56 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.574 1.549 . . . . 0.0 107.653 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -72.62 -48.31 40.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.318 167.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -149.23 160.29 43.51 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 109.064 -162.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.02 16.29 76.62 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.515 0.579 . . . . 0.0 113.392 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -37.74 67.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.816 1.808 . . . . 0.0 111.195 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.0 -21.08 65.07 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.056 -1.028 . . . . 0.0 113.752 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.4 mm -81.79 -34.43 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.186 1.394 . . . . 0.0 108.835 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.44 -37.1 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.668 -1.27 . . . . 0.0 109.348 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -69.79 -23.75 63.39 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 120.546 -1.346 . . . . 0.0 112.595 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.63 -42.85 77.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.965 -1.084 . . . . 0.0 109.626 168.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 23.0 mtp -62.32 -46.9 86.65 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 122.331 -0.231 . . . . 0.0 110.972 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -66.14 -29.69 70.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -76.49 -15.99 59.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.328 0.967 . . . . 0.0 112.46 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -95.05 18.82 11.39 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 127.088 2.155 . . . . 0.0 112.285 163.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.49 -147.89 15.36 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.418 1.961 . . . . 0.0 110.616 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.3 p -146.14 -81.86 0.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.451 0.625 . . . . 0.0 110.807 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 169.06 -21.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 131.529 3.932 . . . . 0.0 111.215 167.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -19.57 63.93 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.776 1.171 . . . . 0.0 109.855 159.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.03 -26.91 10.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.565 -1.131 . . . . 0.0 111.894 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -70.83 123.63 22.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 119.416 1.608 . . . . 0.0 107.054 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.8 p -72.18 153.98 41.31 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.205 1.802 . . . . 0.0 111.553 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.82 -5.02 59.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.782 1.233 . . . . 0.0 112.426 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.414 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 20.4 mmtt -137.97 161.23 37.22 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.793 2.037 . . . . 0.0 109.212 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -75.1 89.07 2.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 163.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.58 130.7 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.73 162.81 36.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.055 0.942 . . . . 0.0 111.743 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.669 HD11 ' CE2' ' A' ' 48' ' ' TYR . 3.9 mp -91.37 119.55 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 158.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.98 -58.92 6.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 164.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -152.79 167.62 28.42 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 49' ' ' LYS . 15.6 p -162.04 171.83 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.52 0.6 . . . . 0.0 111.414 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.32 176.54 48.06 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -76.25 158.38 31.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.575 1.55 . . . . 0.0 109.284 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.1 mt -137.4 42.74 2.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.102 0.953 . . . . 0.0 109.098 159.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.247 0.959 0 C-N-CA 125.143 1.377 . . . . 0.0 107.862 -177.768 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 117.422 -1.275 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -65.19 133.36 35.02 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 CA-C-N 120.774 1.312 . . . . 0.0 109.66 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -89.41 152.3 21.56 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -135.91 157.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.019 -1.051 . . . . 0.0 109.036 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -124.65 153.5 42.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.227 1.011 . . . . 0.0 108.727 170.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -132.86 117.96 18.37 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.496 1.918 . . . . 0.0 106.053 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.02 97.16 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.7 mm -68.77 147.54 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.72 153.37 45.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.309 1.844 . . . . 0.0 109.577 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.92 108.36 19.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.27 13.95 4.29 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 114.236 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.49 -0.5 63.45 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.55 1.071 . . . . 0.0 112.889 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.12 146.71 90.15 Favored Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 159.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 130.55 27.29 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 N-CA-C 107.819 -1.646 . . . . 0.0 107.819 160.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 tp -91.87 -41.69 10.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 108.98 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.46 156.8 8.16 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 118.115 0.416 . . . . 0.0 112.99 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -82.56 114.08 20.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.801 1.24 . . . . 0.0 109.126 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.08 155.65 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.797 1.639 . . . . 0.0 107.082 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -142.14 148.51 38.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 123.46 1.6 . . . . 0.0 111.322 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -131.71 159.61 37.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 113.524 -1.671 . . . . 0.0 107.899 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -120.52 144.41 48.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.785 1.634 . . . . 0.0 106.785 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.85 114.81 16.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -170.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.56 64.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.854 1.662 . . . . 0.0 110.885 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.85 -14.18 60.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 112.607 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -71.02 -36.21 72.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.506 1.122 . . . . 0.0 110.791 168.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -85.77 -56.18 3.61 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.953 0.901 . . . . 0.0 108.907 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.14 71.01 80.23 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.226 1.81 . . . . 0.0 109.385 -165.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 -30.76 78.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.577 2.185 . . . . 0.0 113.626 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -52.3 57.98 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.786 1.63 . . . . 0.0 108.032 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' SD ' ' A' ' 100' ' ' MET . 16.6 m -63.38 -44.82 93.63 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.577 1.151 . . . . 0.0 110.607 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.26 91.86 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.818 -0.551 . . . . 0.0 111.871 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.37 -44.71 78.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.433 1.093 . . . . 0.0 110.651 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -54.32 -48.39 71.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.678 1.191 . . . . 0.0 109.604 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -64.35 -36.44 84.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.425 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -57.79 -63.35 1.28 Allowed 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.283 1.033 . . . . 0.0 109.521 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.84 71.81 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.806 0.692 . . . . 0.0 111.205 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.0 mt -67.06 -36.09 81.27 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 121.375 -0.828 . . . . 0.0 110.845 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -68.22 -28.76 67.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.345 0.975 . . . . 0.0 111.999 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -93.95 -26.01 17.03 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.076 0.55 . . . . 0.0 111.201 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 -0.29 86.77 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.902 0.774 . . . . 0.0 112.561 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -38.83 77.45 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.552 1.141 . . . . 0.0 111.991 -165.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -72.55 3.85 4.5 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.08 4.54 84.17 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 119.528 1.058 . . . . 0.0 111.506 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.58 169.8 19.52 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.754 1.621 . . . . 0.0 107.167 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.46 -178.51 36.45 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-O 122.775 1.208 . . . . 0.0 110.633 -167.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 6.6 t80 -84.73 -23.88 29.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.124 -1.538 . . . . 0.0 111.6 -159.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -46.62 111.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.04 2.136 . . . . 0.0 109.569 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.38 9.69 83.25 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 117.668 -1.629 . . . . 0.0 116.244 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.1 m -68.64 -21.87 64.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.736 2.768 . . . . 0.0 113.209 -174.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.2 t 67.11 132.81 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 129.273 3.029 . . . . 0.0 112.474 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -77.67 76.87 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.52 1.528 . . . . 0.0 108.326 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.401 ' CD2' HH11 ' A' ' 55' ' ' ARG . 27.7 p-80 -74.1 -7.32 52.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.239 1.416 . . . . 0.0 113.56 -174.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.401 HH11 ' CD2' ' A' ' 54' ' ' HIS . 5.1 mpt_? -123.63 128.43 49.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 159.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.6 mt -134.49 106.64 8.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 161.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.5 mt -111.52 98.09 39.12 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.51 124.59 14.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 123.921 3.081 . . . . 0.0 113.11 -170.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.66 38.54 93.3 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.886 1.707 . . . . 0.0 111.237 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -143.13 -81.36 0.19 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.769 1.284 . . . . 0.0 108.624 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.31 169.91 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.328 168.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m -121.08 107.92 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.249 1.819 . . . . 0.0 108.329 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -99.05 138.26 36.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.13 0.972 . . . . 0.0 108.495 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.02 1.98 0.5 Allowed Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.509 -1.162 . . . . 0.0 115.936 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.12 51.4 4.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.773 1.787 . . . . 0.0 115.284 -162.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.16 69.12 1.34 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.334 1.067 . . . . 0.0 110.896 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 31.9 p90 -70.14 -6.08 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.095 0.958 . . . . 0.0 112.812 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -113.9 -38.99 4.07 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 120.871 -1.143 . . . . 0.0 110.625 -160.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -128.44 -17.78 4.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.203 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 45.27 35.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.977 2.111 . . . . 0.0 112.916 175.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -140.78 10.14 2.21 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.386 -0.821 . . . . 0.0 111.961 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.3 -1.9 79.14 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.966 -1.463 . . . . 0.0 112.884 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 p -95.96 -6.48 38.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 120.007 1.903 . . . . 0.0 110.975 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.32 179.1 38.96 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 118.993 0.815 . . . . 0.0 112.315 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.61 115.69 2.21 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 125.471 1.51 . . . . 0.0 111.245 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HE3' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -133.76 169.44 17.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.495 1.918 . . . . 0.0 107.234 166.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.3 p -83.74 -175.18 5.69 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.606 0.639 . . . . 0.0 109.532 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.4 pt -83.48 -20.17 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.841 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -79.74 -35.08 39.34 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.567 0.621 . . . . 0.0 109.422 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.1 -142.07 6.67 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 107.029 -2.428 . . . . 0.0 107.029 -167.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 82' ' ' LYS . 9.7 tt0 -68.82 -156.22 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.033 0.916 . . . . 0.0 110.664 168.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 54.0 mttt -64.96 126.89 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 120.415 -1.428 . . . . 0.0 109.91 -169.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -89.5 175.73 7.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 18.2 pt-20 -77.92 175.28 10.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 11.3 t70 -86.75 104.34 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.883 2.873 . . . . 0.0 108.001 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.15 -41.23 81.88 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.631 -162.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 159.07 157.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 129.354 3.062 . . . . 0.0 111.604 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -106.59 30.14 6.31 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.42 1.888 . . . . 0.0 110.614 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.1 mt -53.01 -48.39 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.209 1.003 . . . . 0.0 108.472 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.89 130.4 36.12 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -130.54 169.57 15.4 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.265 1.426 . . . . 0.0 110.687 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -82.19 81.58 8.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.131 1.372 . . . . 0.0 108.896 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.0 p -75.84 -32.01 59.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.054 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.22 -178.74 44.37 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.628 1.585 . . . . 0.0 110.884 -175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.21 165.1 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.833 2.355 . . . . 0.0 111.226 171.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.44 8.47 75.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.251 -1.305 . . . . 0.0 112.923 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.0 mm -85.61 151.46 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 121.012 2.406 . . . . 0.0 108.953 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.46 131.2 57.0 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.367 -1.458 . . . . 0.0 108.924 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.8 t -148.47 158.27 44.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.497 0.719 . . . . 0.0 111.385 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.481 ' SD ' HG23 ' A' ' 32' ' ' THR . 26.2 mtp -83.49 135.34 34.7 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 124.283 1.033 . . . . 0.0 111.664 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -92.08 71.23 5.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 123.088 1.423 . . . . 0.0 107.558 168.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -75.66 -172.75 1.97 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.27 160.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.21 16.32 9.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.29 1.836 . . . . 0.0 111.423 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.56 -175.37 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.293 1.901 . . . . 0.0 108.782 -164.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.48 142.71 91.41 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.829 1.686 . . . . 0.0 110.017 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 31.3 m-20 64.14 38.26 8.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.931 2.092 . . . . 0.0 112.19 167.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 p -127.87 38.14 4.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.633 0.773 . . . . 0.0 109.81 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -89.88 110.61 21.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.959 1.304 . . . . 0.0 109.139 -172.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.16 -132.57 5.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.2 p -85.49 -18.5 33.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.582 0.753 . . . . 0.0 111.46 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -67.84 126.02 28.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.224 1.012 . . . . 0.0 108.757 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 5.0 p90 -154.03 171.06 19.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 107.73 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 5.2 p90 -141.19 157.95 44.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.433 1.111 . . . . 0.0 112.046 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.25 103.91 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 166.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 9.2 m -60.4 126.12 26.26 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.9 p -116.6 23.15 12.23 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.799 1.24 . . . . 0.0 109.006 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -150.69 175.85 11.57 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.624 -0.673 . . . . 0.0 109.883 162.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -64.69 84.87 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 159.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.444 ' HB ' HD12 ' A' ' 122' ' ' LEU . 8.3 p -82.1 53.4 2.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.086 0.554 . . . . 0.0 111.161 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -63.63 -20.91 66.07 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.148 -1.595 . . . . 0.0 113.159 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -69.98 -4.7 21.95 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.265 1.426 . . . . 0.0 112.079 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 68.6 mt -105.32 -8.17 18.41 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.897 1.279 . . . . 0.0 111.275 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.46 152.47 43.86 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.631 1.105 . . . . 0.0 109.122 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.39 -1.52 65.27 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.726 1.155 . . . . 0.0 113.421 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -132.22 -56.97 0.97 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.891 1.677 . . . . 0.0 108.283 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -99.47 129.29 45.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -170.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.39 104.99 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.92 132.71 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.29 -4.79 1.66 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.8 -173.13 27.9 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.973 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -155.54 146.37 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.507 1.123 . . . . 0.0 108.669 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.68 116.67 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -86.1 -49.95 7.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.99 162.67 34.33 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.211 1.004 . . . . 0.0 112.923 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.98 15.76 66.63 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.142 0.877 . . . . 0.0 112.816 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.3 tpt -55.87 -28.67 57.68 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.749 1.775 . . . . 0.0 111.958 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -62.82 -35.32 79.53 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.244 -0.91 . . . . 0.0 113.194 172.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.98 -39.15 81.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.89 -41.3 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.757 0.708 . . . . 0.0 109.732 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.32 -27.46 69.04 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.703 -1.248 . . . . 0.0 113.244 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.03 -46.57 42.59 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.165 -0.959 . . . . 0.0 109.218 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 79.5 mtp -53.06 -47.58 68.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.249 1.02 . . . . 0.0 110.036 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -62.36 -30.68 71.35 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.702 0.801 . . . . 0.0 112.647 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -24.04 64.45 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.52 -0.738 . . . . 0.0 111.372 174.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -97.08 6.59 48.28 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.872 1.669 . . . . 0.0 112.099 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.07 -173.38 35.92 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 169.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.4 p -157.62 158.88 36.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 166.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.28 -22.39 64.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -6.07 53.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.177 0.899 . . . . 0.0 112.779 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.24 -30.66 9.93 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.09 2.281 . . . . 0.0 112.875 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.04 138.03 26.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.076 0.95 . . . . 0.0 109.498 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.1 p -98.25 138.6 35.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -18.67 63.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.831 0.852 . . . . 0.0 112.12 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.59 161.0 32.51 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.109 0.964 . . . . 0.0 108.875 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 134.78 48.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 mt -132.35 113.56 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -132.48 175.41 9.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.623 1.169 . . . . 0.0 109.657 -166.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.44 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 3.7 mp -100.33 105.61 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 171.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.22 -46.22 87.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.776 0.83 . . . . 0.0 109.976 172.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -151.24 157.4 42.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.0 p -162.68 163.04 27.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.948 0.404 . . . . 0.0 110.64 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.47 -173.01 45.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.551 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 0.0 OUTLIER -84.78 154.6 22.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.494 1.917 . . . . 0.0 109.358 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.2 mt -131.9 43.69 3.0 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.768 1.27 . . . . 0.0 110.65 160.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.551 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 39.7 tp10 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 102.093 -3.299 . . . . 0.0 102.093 166.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.571 ' CB ' HE22 ' A' ' 163' ' ' GLN . 12.8 Cg_endo -59.24 135.92 68.97 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.694 1.596 . . . . 0.0 110.62 -176.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.465 ' H ' ' CB ' ' A' ' 165' ' ' GLU . 52.5 m -94.96 145.04 25.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 m -130.53 149.98 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 171.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -110.65 161.06 16.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.457 1.103 . . . . 0.0 108.779 168.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -139.41 163.17 33.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.153 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.37 99.47 5.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 170.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.4 mm -68.72 148.68 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.0 143.73 51.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.892 0.877 . . . . 0.0 110.421 170.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.99 99.87 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 127.953 2.501 . . . . 0.0 104.338 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.62 13.95 1.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.577 1.951 . . . . 0.0 113.696 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.34 0.49 58.23 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.107 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.22 121.04 81.9 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 159.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.24 112.96 2.24 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 107.364 -1.821 . . . . 0.0 107.364 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.73 -29.42 36.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.029 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.21 167.81 13.84 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.409 0.549 . . . . 0.0 113.145 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -75.57 139.07 41.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 108.886 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -130.24 157.93 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -150.74 155.45 39.31 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.728 -1.233 . . . . 0.0 110.478 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 132' ' ' VAL . 70.6 m-85 -142.23 154.13 44.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.522 1.129 . . . . 0.0 109.447 -170.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.09 141.2 30.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.47 117.69 30.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.968 1.307 . . . . 0.0 107.518 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.29 53.88 0.14 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.906 2.482 . . . . 0.0 114.072 -168.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.47 -28.08 42.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.685 1.994 . . . . 0.0 115.062 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -27.71 67.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.575 1.08 . . . . 0.0 110.151 177.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.57 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -120.36 -21.96 6.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.097 0.959 . . . . 0.0 112.5 -164.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 71.63 25.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.68 1.592 . . . . 0.0 107.758 167.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.82 -45.88 37.59 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.951 2.434 . . . . 0.0 111.819 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -54.62 37.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.147 0.885 . . . . 0.0 110.959 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -38.48 86.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.855 -0.528 . . . . 0.0 110.487 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.38 -39.81 64.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.851 -0.531 . . . . 0.0 112.184 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -62.14 -45.81 91.8 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.594 1.158 . . . . 0.0 108.863 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.96 -56.37 16.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.745 0.818 . . . . 0.0 108.961 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -26.91 67.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 ttm-85 -55.0 -67.24 0.29 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.497 1.499 . . . . 0.0 107.74 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.782 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -52.28 -38.74 59.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.816 1.246 . . . . 0.0 112.336 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.64 -42.52 86.6 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.619 -0.676 . . . . 0.0 111.132 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -70.71 -34.43 71.93 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.506 -0.746 . . . . 0.0 111.179 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.9 p -79.13 -26.89 42.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.858 -0.526 . . . . 0.0 110.465 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.47 83.08 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.589 1.09 . . . . 0.0 111.834 -176.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.73 -27.82 69.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.854 0.862 . . . . 0.0 112.949 -159.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -74.65 3.56 7.65 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.57 9.3 75.58 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.156 0.889 . . . . 0.0 112.154 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -156.6 174.68 15.09 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.148 1.779 . . . . 0.0 107.601 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.68 -171.07 34.21 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-O 122.808 1.227 . . . . 0.0 114.442 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.407 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -71.27 -25.07 62.3 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.587 2.755 . . . . 0.0 110.369 177.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -52.49 108.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.568 2.347 . . . . 0.0 107.606 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.08 75.66 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.639 -1.089 . . . . 0.0 115.751 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 t -68.12 -10.46 54.24 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.514 1.657 . . . . 0.0 113.323 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t 60.18 176.58 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.82 1.248 . . . . 0.0 110.533 -161.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.05 125.69 46.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 162.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -78.88 -40.0 33.58 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -139.74 110.78 6.9 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 -159.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.49 HD12 ' CG2' ' A' ' 152' ' ' THR . 7.3 mt -128.06 98.14 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -173.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.4 mt -111.12 96.06 28.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -168.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.11 126.64 20.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.051 2.5 . . . . 0.0 112.388 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 36.06 60.4 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.697 1.617 . . . . 0.0 111.77 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -150.32 -76.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.371 1.085 . . . . 0.0 108.545 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.4 171.59 18.8 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.629 0.772 . . . . 0.0 111.121 171.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 30.3 p -128.99 111.64 13.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.309 0.644 . . . . 0.0 111.17 161.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -86.3 135.1 33.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.921 2.489 . . . . 0.0 110.822 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.89 -161.35 9.95 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.751 2.119 . . . . 0.0 108.524 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.79 6.55 67.35 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.086 0.943 . . . . 0.0 113.229 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.72 123.1 29.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 166.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -128.2 7.31 5.96 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.183 1.356 . . . . 0.0 111.989 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.613 HG21 ' CE ' ' A' ' 76' ' ' LYS . 26.5 p -125.03 -13.24 6.87 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.761 1.625 . . . . 0.0 112.203 168.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -132.38 -175.96 3.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 130.171 3.389 . . . . 0.0 105.84 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -164.53 54.0 0.13 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 166.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -159.08 -1.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.415 . . . . 0.0 113.921 -166.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.91 3.12 49.13 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 117.605 -1.664 . . . . 0.0 115.476 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.1 p -131.12 17.67 5.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.095 2.448 . . . . 0.0 115.65 -165.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.35 -94.29 0.64 Allowed Glycine 0 C--N 1.338 0.659 0 O-C-N 120.287 -1.508 . . . . 0.0 112.125 -165.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -7.12 112.63 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 129.077 3.227 . . . . 0.0 115.519 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.613 ' CE ' HG21 ' A' ' 68' ' ' THR . 12.2 pttt -127.47 155.52 43.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 128.792 2.837 . . . . 0.0 108.683 -161.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.0 p -72.15 172.59 9.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.91 1.338 . . . . 0.0 110.389 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 38' ' ' ALA . 38.8 pt -75.53 -20.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.061 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -77.71 -36.71 50.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.196 0.998 . . . . 0.0 110.195 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.59 109.05 0.89 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HB2' ' HE3' ' A' ' 82' ' ' LYS 0.336 0.1 OUTLIER 37.25 -133.5 0.09 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.148 1.779 . . . . 0.0 113.041 177.522 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -87.17 161.9 17.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 121.116 1.78 . . . . 0.0 112.234 -176.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -126.52 165.81 18.44 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.144 1.778 . . . . 0.0 110.206 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.78 154.48 36.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.665 0.745 . . . . 0.0 111.968 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.34 123.17 21.07 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.297 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.26 -50.59 69.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.506 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -176.75 171.31 2.26 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.986 2.914 . . . . 0.0 107.502 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -123.03 38.01 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.726 1.61 . . . . 0.0 109.295 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.429 HD12 ' HE2' ' A' ' 28' ' ' LYS . 8.2 mt -63.53 -44.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 174.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 74.4 mt -81.05 128.3 33.57 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 124' ' ' GLY . 3.6 mtmp? -136.46 163.37 30.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.362 -167.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.527 ' H ' ' HB2' ' A' ' 123' ' ' ASP . 31.3 m80 -78.17 90.78 4.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.528 1.131 . . . . 0.0 111.694 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.92 35.07 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.855 -1.153 . . . . 0.0 111.679 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -60.62 165.93 10.71 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.852 2.368 . . . . 0.0 111.75 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.36 -0.16 49.9 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.525 1.059 . . . . 0.0 112.955 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.08 164.31 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.627 1.713 . . . . 0.0 107.914 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.4 HD23 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -136.7 128.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.919 -1.113 . . . . 0.0 109.593 -177.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -143.41 165.29 27.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.328 0.585 . . . . 0.0 110.585 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 108' ' ' ASN . 6.5 ttm -104.75 127.48 52.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -166.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.467 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -78.69 74.99 5.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.052 1.341 . . . . 0.0 108.422 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -70.01 175.05 4.71 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.235 158.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.22 19.73 4.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.264 1.425 . . . . 0.0 111.77 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.84 -167.91 29.34 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.83 159.92 43.42 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-N 119.361 1.58 . . . . 0.0 108.433 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 33.61 54.77 0.52 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.107 3.363 . . . . 0.0 111.944 175.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -131.84 22.49 4.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.743 1.217 . . . . 0.0 111.813 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.46 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 67.8 m-80 -67.29 109.69 3.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.787 2.435 . . . . 0.0 107.69 177.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.05 -85.42 0.91 Allowed Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.315 0.961 . . . . 0.0 111.727 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.0 t -155.92 -30.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.831 1.652 . . . . 0.0 109.381 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -53.91 125.57 19.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.513 1.525 . . . . 0.0 106.983 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.467 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -148.74 170.95 17.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.602 1.561 . . . . 0.0 108.079 -168.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -142.03 151.65 42.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.945 0.498 . . . . 0.0 110.86 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.53 122.68 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.43 118.86 12.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.1 p -112.53 27.92 9.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.1 0.952 . . . . 0.0 109.169 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.8 176.04 13.09 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.908 1.283 . . . . 0.0 107.54 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.51 89.17 0.23 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 162.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.8 p -74.77 57.6 0.77 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.449 1.099 . . . . 0.0 111.123 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.34 -20.58 66.46 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.604 -1.31 . . . . 0.0 112.719 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.406 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 29.1 p90 -74.52 -10.57 59.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.994 1.718 . . . . 0.0 111.574 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.406 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.7 mt -113.77 -6.65 13.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.205 1.402 . . . . 0.0 111.226 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.527 ' HB2' ' H ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -76.52 148.76 36.92 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.037 0.935 . . . . 0.0 109.579 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 91' ' ' LYS . . . 62.09 18.6 57.86 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.081 -170.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -140.11 -35.0 0.52 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.488 1.144 . . . . 0.0 109.985 -171.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -112.99 157.95 20.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.366 1.066 . . . . 0.0 109.333 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.3 t -90.18 102.62 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.94 127.61 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 162.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.4 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 29.9 p90 -135.46 1.79 2.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.396 -0.811 . . . . 0.0 112.341 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.47 -177.54 35.58 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 119.632 1.106 . . . . 0.0 112.612 172.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -150.27 153.11 35.59 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.071 1.348 . . . . 0.0 108.253 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' A' ' 22' ' ' PHE . 94.8 t -60.88 125.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.507 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 39.2 mtpt -82.21 -49.79 9.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 162.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -152.08 159.82 43.58 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.948 0.899 . . . . 0.0 111.668 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.94 24.74 61.28 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -54.96 -36.69 65.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.541 1.17 . . . . 0.0 110.704 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -62.18 -27.74 69.18 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.57 -39.91 47.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 CA-C-N 119.788 1.176 . . . . 0.0 108.828 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.98 -44.23 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.45 -29.15 70.21 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.349 -0.845 . . . . 0.0 112.586 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.05 64.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 120.587 -1.32 . . . . 0.0 109.604 173.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.3 mtp -57.62 -45.06 85.87 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.49 -32.79 73.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.469 1.108 . . . . 0.0 113.584 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -72.11 -22.57 61.32 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.538 1.517 . . . . 0.0 110.667 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -94.83 8.94 41.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.359 1.464 . . . . 0.0 111.652 170.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.54 -169.27 41.62 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 126.082 1.801 . . . . 0.0 109.083 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.3 p -156.94 159.21 37.87 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 160.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.4 mtm-85 -69.45 -16.16 63.42 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.228 -1.545 . . . . 0.0 114.516 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -71.94 -14.56 61.95 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.18 -0.95 . . . . 0.0 112.969 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.48 -20.11 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.878 2.18 . . . . 0.0 114.31 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -71.44 128.72 36.8 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.211 2.005 . . . . 0.0 108.104 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.49 ' CG2' HD12 ' A' ' 56' ' ' ILE . 13.1 p -67.62 159.34 30.12 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 110.99 167.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -70.71 -41.3 72.13 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 158.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -99.5 157.97 16.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 0.0 111.869 -168.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.532 ' HE3' HG21 ' A' ' 157' ' ' THR . 3.4 ttpt -69.49 123.78 22.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 158.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.1 mt -120.42 136.04 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.288 1.858 . . . . 0.0 107.924 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.532 HG21 ' HE3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -154.82 169.16 24.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.663 -158.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.407 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -104.83 113.39 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 163.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.71 -53.12 52.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -156.75 165.39 36.37 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.192 1.397 . . . . 0.0 108.897 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.8 p -178.51 165.16 1.72 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.553 1.541 . . . . 0.0 109.726 -168.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.58 -175.71 46.61 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.571 HE22 ' CB ' ' A' ' 4' ' ' PRO . 35.6 tp60 -79.72 152.06 30.08 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.441 1.496 . . . . 0.0 109.879 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 40.0 mt -137.95 42.73 2.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 120.432 1.469 . . . . 0.0 111.77 159.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.522 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 2.7 tm-20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.956 2.502 . . . . 0.0 107.521 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--O 1.235 0.337 0 CA-C-O 116.508 -1.71 . . . . 0.0 108.619 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HA ' ' CG ' ' A' ' 165' ' ' GLU . 2.0 Cg_endo -57.99 140.06 92.61 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 CA-C-N 121.339 1.514 . . . . 0.0 110.063 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.485 ' CG2' ' HE3' ' A' ' 133' ' ' LYS . 76.1 m -106.0 144.47 32.67 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 165.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.47 134.11 17.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.645 ' HB3' HD11 ' A' ' 164' ' ' LEU . 13.7 p90 -94.59 157.87 15.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.903 0.881 . . . . 0.0 110.865 175.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -145.63 112.95 6.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.097 1.359 . . . . 0.0 107.799 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.26 97.55 6.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.6 mm -66.5 146.53 13.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.284 1.034 . . . . 0.0 109.152 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.13 168.89 18.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.647 1.179 . . . . 0.0 110.389 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 156' ' ' ILE . 2.4 t -131.2 109.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 57.04 13.92 1.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.754 1.622 . . . . 0.0 113.131 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.22 -5.71 31.94 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.63 1.586 . . . . 0.0 113.849 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -81.95 113.26 41.83 Favored Pre-proline 0 CA--C 1.52 -0.187 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.4 121.68 9.57 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.318 1.345 . . . . 0.0 110.241 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.8 tp -93.36 -25.56 17.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.675 0.79 . . . . 0.0 110.922 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.25 162.74 9.6 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.665 0.65 . . . . 0.0 112.034 168.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -79.26 142.21 36.39 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.77 158.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 128.008 2.523 . . . . 0.0 105.808 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -140.58 153.43 46.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.337 1.065 . . . . 0.0 109.137 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 93.2 m-85 -135.28 159.86 40.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.324 -175.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -110.57 145.26 38.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 167.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.3 128.99 50.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.296 1.438 . . . . 0.0 108.685 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.21 61.79 7.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.261 1.025 . . . . 0.0 112.984 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -9.95 25.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.017 -1.052 . . . . 0.0 113.554 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.36 -16.51 58.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.247 1.419 . . . . 0.0 112.138 171.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -47.89 1.07 Allowed 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 0.0 110.511 -166.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.37 78.38 45.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.374 1.47 . . . . 0.0 107.345 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.71 -45.8 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.371 2.047 . . . . 0.0 110.386 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -36.64 84.81 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.242 1.383 . . . . 0.0 109.191 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -69.52 -52.69 24.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.496 0.589 . . . . 0.0 109.805 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.59 91.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.304 0.642 . . . . 0.0 112.242 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.54 -51.32 70.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.259 1.423 . . . . 0.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.04 -49.06 74.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.892 1.277 . . . . 0.0 110.488 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.07 -40.12 94.21 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.345 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -52.85 -56.92 12.28 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.152 0.887 . . . . 0.0 109.476 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.8 48.86 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.412 1.485 . . . . 0.0 113.15 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.29 -32.46 38.13 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.761 0.824 . . . . 0.0 111.431 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 p -78.53 -38.25 40.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.383 0.992 . . . . 0.0 113.293 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -64.08 -31.06 72.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.49 11.71 72.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.98 -33.18 70.38 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.012 1.725 . . . . 0.0 110.716 -172.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -71.46 -4.88 28.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.33 1.052 . . . . 0.0 112.696 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.76 16.12 46.63 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.419 1.009 . . . . 0.0 112.104 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -169.96 175.32 5.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.938 1.695 . . . . 0.0 109.1 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.49 -142.29 13.62 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-O 121.925 0.736 . . . . 0.0 113.307 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.587 ' CE1' HD11 ' A' ' 158' ' ' ILE . 0.6 OUTLIER -63.31 -28.34 69.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.889 2.076 . . . . 0.0 110.997 -167.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.5 tttt -57.41 124.07 17.64 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.683 -0.636 . . . . 0.0 109.389 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 10.37 52.77 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.358 -1.245 . . . . 0.0 114.412 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.6 m -68.01 104.4 1.74 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.117 1.959 . . . . 0.0 106.071 165.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 155' ' ' LYS . 52.8 m -75.38 131.68 40.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -73.69 105.1 4.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.082 0.944 . . . . 0.0 109.068 -169.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -81.01 -32.68 34.09 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.093 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -127.79 86.73 2.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.134 0.879 . . . . 0.0 108.833 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.416 HD12 ' CG2' ' A' ' 152' ' ' THR . 74.3 mt -104.45 109.53 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.32 99.73 52.75 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.98 144.36 99.48 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.551 1.501 . . . . 0.0 112.448 -172.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.87 31.43 61.11 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 126.539 2.018 . . . . 0.0 112.168 -168.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -142.4 -79.93 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.487 1.644 . . . . 0.0 108.545 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 165.15 25.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.798 0.839 . . . . 0.0 110.635 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.0 m -127.1 92.46 3.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.696 1.998 . . . . 0.0 108.77 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.04 132.3 42.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.964 1.306 . . . . 0.0 110.572 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.19 -169.48 11.89 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.074 1.797 . . . . 0.0 108.964 168.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.27 5.49 89.57 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.632 -0.922 . . . . 0.0 114.432 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.97 92.51 7.85 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 166.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -106.24 -5.84 18.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.509 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.6 p -122.29 -24.63 5.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.595 1.558 . . . . 0.0 111.551 -173.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -124.88 179.47 5.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 158.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.8 72.01 0.5 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 169.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.416 ' H ' ' H ' ' A' ' 72' ' ' GLY . 12.6 p30 -168.79 -10.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.886 2.474 . . . . 0.0 111.235 -172.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 71' ' ' ASN . . . 111.41 -6.4 28.34 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.069 -1.406 . . . . 0.0 112.85 169.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.3 p -84.09 -24.33 30.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.741 1.77 . . . . 0.0 112.933 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.92 -135.3 8.09 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 122.515 1.064 . . . . 0.0 114.772 -159.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.11 168.37 4.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.67 1.605 . . . . 0.0 111.776 -162.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -169.59 149.09 3.83 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.1 p -70.56 164.57 24.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.6 pt -56.88 -29.61 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 110.267 162.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -79.25 6.35 10.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.466 1.506 . . . . 0.0 112.584 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.16 -53.76 0.75 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.192 1.36 . . . . 0.0 113.064 166.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -147.72 -139.26 0.1 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -161.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -75.97 166.57 23.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.314 0.961 . . . . 0.0 108.897 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -142.22 177.8 7.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.11 148.19 51.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.192 0.996 . . . . 0.0 113.204 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.477 ' HA ' HD21 ' A' ' 108' ' ' ASN . 1.0 OUTLIER -71.96 73.95 0.89 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.897 2.479 . . . . 0.0 108.01 161.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.82 -59.85 3.99 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.255 1.822 . . . . 0.0 112.659 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.48 172.84 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.303 159.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.27 26.44 7.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.264 2.225 . . . . 0.0 110.797 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 mt -57.56 -48.23 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 120.927 -1.108 . . . . 0.0 110.182 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.68 123.72 23.85 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -103.26 165.26 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.072 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -77.91 75.81 4.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.076 1.351 . . . . 0.0 109.581 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -66.01 -27.54 68.2 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.42 -177.35 45.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.95 0.795 . . . . 0.0 111.751 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -59.23 147.14 92.13 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.868 1.712 . . . . 0.0 109.7 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.91 70.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.432 -1.205 . . . . 0.0 112.362 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.67 163.56 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 120.446 2.123 . . . . 0.0 108.9 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.14 127.96 37.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.033 1.333 . . . . 0.0 109.205 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.6 t -140.94 164.24 30.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.773 0.797 . . . . 0.0 110.49 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.99 140.54 29.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 -167.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.08 57.12 1.45 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.68 1.228 . . . . 0.0 108.614 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -61.35 170.51 1.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.951 158.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.23 13.94 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.62 1.168 . . . . 0.0 111.713 -169.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.27 -171.92 27.01 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -160.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -60.6 157.02 38.92 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.145 1.897 . . . . 0.0 110.037 171.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER 34.56 47.27 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.17 2.588 . . . . 0.0 113.716 173.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 p -124.19 22.38 8.65 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.811 0.844 . . . . 0.0 111.599 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 85' ' ' ASP . 91.1 m-20 -64.52 122.82 17.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.043 1.737 . . . . 0.0 108.762 173.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.49 -97.2 0.57 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.1 p -134.33 -23.77 1.65 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.079 0.952 . . . . 0.0 112.248 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.02 135.01 57.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -141.83 176.19 9.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -139.69 152.27 46.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 109.857 162.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.8 mt -83.17 122.98 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 163.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.3 m -68.5 113.61 6.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 167.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.2 p -108.36 30.68 6.21 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.51 173.51 14.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.814 1.645 . . . . 0.0 107.649 165.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.86 89.82 0.28 Allowed 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 162.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.29 53.75 0.53 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.387 1.475 . . . . 0.0 110.276 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -64.67 -21.74 66.81 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 119.921 -1.737 . . . . 0.0 112.39 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -73.31 -2.22 21.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.532 1.133 . . . . 0.0 111.969 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -115.42 -5.42 12.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.234 1.414 . . . . 0.0 111.528 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.82 142.44 57.94 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.061 0.846 . . . . 0.0 111.45 -172.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.57 12.61 61.84 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.268 -1.296 . . . . 0.0 113.709 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.37 -24.06 1.42 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.2 2.0 . . . . 0.0 113.34 -169.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -125.19 140.96 52.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.961 0.904 . . . . 0.0 110.085 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 63.2 t -78.89 101.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -171.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.51 123.49 16.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 164.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.02 -1.45 2.66 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.4 -173.04 27.33 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 119.296 0.953 . . . . 0.0 111.727 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -154.28 145.25 22.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.031 1.332 . . . . 0.0 108.729 -172.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.43 115.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 161.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.485 ' HE3' ' CG2' ' A' ' 5' ' ' THR . 12.4 ttmm -74.12 -54.38 7.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -153.98 167.09 30.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.322 2.249 . . . . 0.0 109.242 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.33 69.47 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.517 -0.739 . . . . 0.0 112.733 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.6 tpt -55.87 -35.51 66.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.633 1.217 . . . . 0.0 110.9 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -62.92 -31.31 72.36 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.829 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.74 -39.73 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.53 -37.37 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.686 -0.634 . . . . 0.0 109.942 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.487 ' CD ' HH21 ' A' ' 144' ' ' ARG . 3.1 mm-40 -57.86 -42.96 85.59 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 110.529 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.19 95.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.881 0.764 . . . . 0.0 109.027 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.8 mtm -54.94 -44.85 74.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.228 0.211 . . . . 0.0 110.987 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.42 -37.46 75.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.487 HH21 ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -66.4 -24.82 66.53 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.828 1.195 . . . . 0.0 110.35 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.569 ' CB ' HD11 ' A' ' 156' ' ' ILE . 41.3 m-85 -91.03 10.81 25.15 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.475 1.11 . . . . 0.0 112.017 174.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.67 -153.44 6.04 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.855 1.207 . . . . 0.0 111.502 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.5 p -141.62 -86.51 0.17 Allowed 'General case' 0 C--O 1.223 -0.306 0 O-C-N 122.044 -0.68 . . . . 0.0 110.081 160.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 178.14 -17.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 129.798 3.239 . . . . 0.0 110.343 161.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -68.35 -27.06 65.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.001 0.818 . . . . 0.0 110.013 158.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 123.25 -35.3 3.39 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-O 118.606 -1.108 . . . . 0.0 111.748 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -65.13 124.36 21.92 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.391 1.096 . . . . 0.0 108.195 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.416 ' CG2' HD12 ' A' ' 56' ' ' ILE . 18.0 p -64.25 154.04 36.27 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 110.261 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.0 p -68.41 -26.79 65.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.296 0.639 . . . . 0.0 110.789 167.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.489 ' HE2' HG12 ' A' ' 12' ' ' VAL . 30.3 mtpt -132.98 169.76 16.34 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.415 1.086 . . . . 0.0 111.093 -177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.449 ' HE2' ' SG ' ' A' ' 52' ' ' CYS . 75.8 tttt -83.89 84.85 7.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 121.089 1.768 . . . . 0.0 109.677 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.569 HD11 ' CB ' ' A' ' 145' ' ' PHE . 27.0 mm -73.79 126.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.34 163.52 32.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.346 1.069 . . . . 0.0 110.969 -163.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -94.98 115.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 159.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.97 13.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.401 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 1.4 t70 -148.62 163.26 37.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.086 0.554 . . . . 0.0 109.65 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.8 p -167.91 167.9 12.52 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.278 0.631 . . . . 0.0 111.933 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.16 178.52 42.44 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.3 tp60 -76.24 147.02 38.61 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.829 1.652 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 7' ' ' PHE . 12.9 mt -137.87 43.3 2.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.235 1.014 . . . . 0.0 112.455 162.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 19.7 mt-10 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 123.887 0.875 . . . . 0.0 110.913 168.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.56 137.93 48.08 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.415 1.41 . . . . 0.0 110.301 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 88.2 m -95.14 147.33 23.55 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.08 153.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.689 1.195 . . . . 0.0 107.864 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -128.55 157.3 41.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.432 1.093 . . . . 0.0 109.792 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.425 ' CE1' ' CD2' ' A' ' 48' ' ' TYR . 68.9 m-85 -147.81 120.13 8.4 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.056 1.342 . . . . 0.0 107.714 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -85.41 95.53 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.1 mm -71.29 135.84 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.59 163.27 18.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.403 1.881 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG12 ' HE2' ' A' ' 154' ' ' LYS . 3.8 t -138.06 95.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -173.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 57.32 13.94 1.94 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.005 1.722 . . . . 0.0 112.963 -169.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.9 -9.13 29.64 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.958 1.742 . . . . 0.0 113.116 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -77.04 125.5 86.72 Favored Pre-proline 0 CA--C 1.518 -0.282 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.29 113.44 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 120.91 1.074 . . . . 0.0 109.495 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.25 -35.23 23.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.305 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 163.31 10.08 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 167.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -80.28 146.35 31.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.52 154.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.3 2.64 . . . . 0.0 105.419 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -144.99 152.03 39.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.493 1.139 . . . . 0.0 109.904 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CE2' HG22 ' A' ' 132' ' ' VAL . 55.8 m-85 -136.45 153.31 51.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.344 1.458 . . . . 0.0 108.406 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -97.25 146.06 25.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.455 1.902 . . . . 0.0 107.111 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.45 129.35 53.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.395 1.478 . . . . 0.0 107.529 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.61 57.11 1.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.842 1.657 . . . . 0.0 111.812 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.11 60.95 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.247 -1.533 . . . . 0.0 113.429 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -62.29 -53.35 56.41 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.875 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.24 -49.37 8.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.857 0.863 . . . . 0.0 110.541 -169.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 m -127.11 68.37 72.08 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.235 2.214 . . . . 0.0 108.737 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.48 -36.25 98.74 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.536 2.157 . . . . 0.0 112.579 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -52.6 56.73 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.716 1.144 . . . . 0.0 109.191 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 m -64.83 -39.45 93.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.46 0.704 . . . . 0.0 110.102 -174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.21 69.37 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.435 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.56 -43.08 97.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.488 1.115 . . . . 0.0 110.881 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -50.68 -60.02 3.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.365 1.466 . . . . 0.0 109.066 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -65.43 -26.46 67.97 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HG3' HE22 ' A' ' 163' ' ' GLN . 43.1 ttp85 -60.58 -61.72 2.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.447 1.099 . . . . 0.0 109.858 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.09 69.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.74 0.65 . . . . 0.0 111.823 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -71.4 -37.06 71.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.782 -0.574 . . . . 0.0 111.063 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.5 m -70.08 -36.69 75.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.476 0.71 . . . . 0.0 110.86 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -79.6 -18.44 51.61 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.752 0.421 . . . . 0.0 111.378 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.5 7.15 72.74 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 120.554 -1.342 . . . . 0.0 111.518 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.96 4.04 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.774 1.629 . . . . 0.0 113.808 -163.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -116.94 12.65 14.73 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.332 1.453 . . . . 0.0 111.216 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.08 84.66 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.396 0.522 . . . . 0.0 112.305 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -156.93 171.99 19.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.72 39.13 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 116.99 -2.529 . . . . 0.0 114.464 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 8' ' ' PHE . 1.1 t80 -65.64 -27.07 68.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.454 2.301 . . . . 0.0 109.38 175.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -52.21 136.95 29.41 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.827 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 -0.12 46.44 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.671 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -68.74 119.36 13.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.739 2.27 . . . . 0.0 107.561 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.7 t -72.33 137.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.33 104.61 5.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -74.07 -21.51 59.89 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.41 116.72 11.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.494 HD12 HG22 ' A' ' 152' ' ' THR . 38.7 mt -133.44 115.88 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.93 100.7 39.91 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.32 134.25 60.3 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.872 2.381 . . . . 0.0 111.761 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.67 32.61 83.62 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.131 1.824 . . . . 0.0 112.006 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -150.89 -74.02 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.427 1.113 . . . . 0.0 109.307 -172.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.83 167.01 31.75 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.0 m -128.13 100.25 5.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.35 1.86 . . . . 0.0 108.501 166.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -93.07 131.67 37.88 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.136 1.775 . . . . 0.0 109.437 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.99 50.73 0.22 Allowed Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.286 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.99 12.54 24.5 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 118.148 0.974 . . . . 0.0 111.773 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -85.22 23.37 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.479 1.912 . . . . 0.0 113.458 -167.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CD1' HG23 ' A' ' 68' ' ' THR . 11.2 p90 -41.16 -2.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 1 C-N-CA 132.563 4.345 . . . . 0.0 118.754 -176.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.449 HG23 ' CD1' ' A' ' 67' ' ' PHE . 12.1 p -126.39 -49.49 1.54 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.969 2.508 . . . . 0.0 112.144 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 -128.21 89.1 2.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -84.24 61.43 6.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.747 3.219 . . . . 0.0 107.751 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -173.45 -22.94 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 129.235 3.014 . . . . 0.0 107.966 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.24 43.62 2.16 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 126.852 2.168 . . . . 0.0 111.436 161.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.3 p -110.96 39.01 2.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 159.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.06 -174.59 14.97 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 122.548 1.082 . . . . 0.0 112.747 -161.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.33 75.75 0.41 Allowed Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 113.069 -1.566 . . . . 0.0 111.493 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' H ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -65.75 165.87 11.97 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 111.617 -2.291 . . . . 0.0 108.75 158.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.0 p -84.16 177.91 8.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.766 0.793 . . . . 0.0 109.2 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.7 pt -70.03 -27.25 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.994 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -84.86 -21.15 29.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.141 0.976 . . . . 0.0 111.521 -169.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.57 -99.42 0.19 Allowed Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 105.023 -3.231 . . . . 0.0 105.023 -164.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.13 -157.61 0.81 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.208 1.004 . . . . 0.0 109.745 172.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 82' ' ' LYS . 4.5 pttp -63.76 142.16 58.5 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.75 2.82 . . . . 0.0 110.107 -159.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -120.15 177.12 5.13 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.38 1.472 . . . . 0.0 108.923 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.58 163.41 27.37 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.24 87.65 0.82 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 108.988 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -46.38 -53.86 10.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.955 1.302 . . . . 0.0 112.248 -163.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.402 ' C ' HD22 ' A' ' 87' ' ' ASN . 0.1 OUTLIER -161.26 169.62 21.82 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.752 0.421 . . . . 0.0 110.222 158.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.79 13.74 16.18 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.757 1.223 . . . . 0.0 112.91 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 mt -53.22 -40.96 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.621 0.768 . . . . 0.0 109.899 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.77 121.03 29.69 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -110.82 170.18 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 109.433 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -74.18 87.04 1.92 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.742 0.817 . . . . 0.0 109.021 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.4 p -73.77 -11.1 60.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.623 0.769 . . . . 0.0 112.113 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.78 -169.79 38.87 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.011 -1.056 . . . . 0.0 111.708 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.95 158.63 32.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.527 1.485 . . . . 0.0 110.68 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.15 85.13 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 117.927 -1.485 . . . . 0.0 112.248 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -79.35 168.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.185 1.993 . . . . 0.0 108.564 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.68 133.47 27.22 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.319 1.448 . . . . 0.0 109.509 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 t -150.19 158.4 44.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.812 0.445 . . . . 0.0 111.346 -167.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.7 mtp -80.8 122.37 27.1 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.828 0.851 . . . . 0.0 111.203 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.586 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -75.27 61.47 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.645 1.578 . . . . 0.0 109.161 161.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -65.98 -178.18 0.57 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.43 1.11 . . . . 0.0 108.329 159.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.44 14.41 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.206 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.22 -157.45 23.89 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -66.81 148.63 82.86 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.179 1.92 . . . . 0.0 109.634 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 34.21 57.27 0.64 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.449 3.1 . . . . 0.0 111.353 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.5 p -131.88 26.4 4.63 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 109.871 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -75.0 88.74 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.293 1.837 . . . . 0.0 106.947 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.45 -92.44 1.9 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -174.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.8 p -151.01 -13.12 0.22 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 167.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.8 137.71 57.57 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.586 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -143.81 170.92 14.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.749 1.22 . . . . 0.0 108.299 -167.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 31.5 p90 -141.77 154.58 45.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.397 0.679 . . . . 0.0 110.325 158.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.51 125.02 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 161.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 16.5 m -70.91 117.56 12.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 167.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 p -108.7 26.5 10.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.662 0.785 . . . . 0.0 109.576 170.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.38 172.11 17.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -65.52 88.45 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 163.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.416 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 1.1 p -80.48 63.42 4.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.058 1.409 . . . . 0.0 109.663 -173.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -69.85 -10.43 58.45 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.802 1.641 . . . . 0.0 112.794 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.416 ' CZ2' HG22 ' A' ' 119' ' ' THR . 13.4 p90 -84.78 -11.0 56.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 168.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.461 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 49.5 mt -107.87 -8.63 15.92 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 110.913 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.48 146.82 33.93 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.67 1.188 . . . . 0.0 110.503 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.24 0.91 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.192 0.901 . . . . 0.0 114.829 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -93.68 -50.14 5.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 107.876 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.23 132.08 53.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.62 0.768 . . . . 0.0 109.478 -165.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.45 106.95 16.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 126.071 1.748 . . . . 0.0 106.607 -169.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.49 126.81 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 172.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -137.76 -0.4 2.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.59 -178.43 35.51 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 119.443 1.019 . . . . 0.0 112.844 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -150.02 156.12 41.13 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.665 0.786 . . . . 0.0 110.315 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.481 HG22 ' CE2' ' A' ' 22' ' ' PHE . 46.4 t -65.83 118.88 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.403 ' CE ' HG23 ' A' ' 5' ' ' THR . 3.6 mtmp? -78.71 -47.38 17.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.583 -0.698 . . . . 0.0 109.248 163.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -141.98 139.64 32.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.81 1.244 . . . . 0.0 108.654 -158.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.51 25.13 40.21 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.285 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.2 tpt -52.95 -37.26 60.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.261 2.03 . . . . 0.0 110.992 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -64.81 -29.09 70.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.214 0.915 . . . . 0.0 113.091 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.05 -45.94 85.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.42 -39.54 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -67.6 -28.19 67.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.801 -1.187 . . . . 0.0 112.543 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -43.11 60.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.919 1.288 . . . . 0.0 109.4 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.7 mtp -53.12 -42.45 66.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.693 0.797 . . . . 0.0 109.974 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.82 -33.34 75.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.735 1.614 . . . . 0.0 114.477 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -62.52 -30.77 71.53 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 120.342 1.428 . . . . 0.0 109.019 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 156' ' ' ILE . 32.5 m-85 -91.64 18.76 7.06 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.795 1.238 . . . . 0.0 111.617 175.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.24 -168.76 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 p -152.8 155.42 37.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -64.69 -23.16 67.17 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.27 -1.519 . . . . 0.0 113.125 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.06 8.82 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.201 1.0 . . . . 0.0 112.753 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.88 18.27 66.24 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 126.355 1.931 . . . . 0.0 113.949 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -87.49 144.66 26.61 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 120.706 2.253 . . . . 0.0 109.927 158.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.494 HG22 HD12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -69.13 153.5 43.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.901 0.88 . . . . 0.0 109.349 162.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 p -105.2 -13.85 15.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.035 1.334 . . . . 0.0 111.355 164.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HE2' HG12 ' A' ' 12' ' ' VAL . 22.3 mtpt -135.0 156.11 49.6 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.834 1.254 . . . . 0.0 109.694 169.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -77.14 85.46 3.62 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.445 -0.784 . . . . 0.0 109.488 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.475 HD11 ' HB2' ' A' ' 145' ' ' PHE . 1.8 mp -72.89 120.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.77 149.72 50.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.524 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.421 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -81.48 104.65 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 163.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.58 -53.29 19.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.63 164.72 31.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 7.8 p -172.91 170.45 4.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.421 0.688 . . . . 0.0 111.97 -171.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.9 -162.39 33.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.506 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 8.3 tp60 -87.77 154.23 20.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.829 1.651 . . . . 0.0 110.178 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.38 42.79 2.84 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.081 1.309 . . . . 0.0 109.535 158.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.506 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 15.4 tp10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.159 1.784 . . . . 0.0 109.342 168.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.43 132.59 51.64 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.201 1.934 . . . . 0.0 109.359 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -93.94 152.5 18.81 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.86 142.93 29.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.489 1.515 . . . . 0.0 107.227 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.44 159.3 20.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.32 1.048 . . . . 0.0 110.122 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -148.28 114.17 5.76 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.085 1.354 . . . . 0.0 108.522 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.23 97.93 5.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 165.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.62 144.6 13.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.56 139.07 43.62 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.405 1.082 . . . . 0.0 108.741 171.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.495 HG12 ' HE2' ' A' ' 154' ' ' LYS . 5.6 t -103.11 114.57 43.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.35 13.82 2.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.922 0.889 . . . . 0.0 113.149 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.23 56.04 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.193 . . . . 0.0 113.386 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -74.79 121.53 85.47 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.85 112.87 1.94 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.694 1.596 . . . . 0.0 110.084 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -78.33 -37.2 45.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.17 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.32 169.9 14.51 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -84.86 142.64 29.59 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.483 0.659 . . . . 0.0 109.971 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.2 t -122.79 160.95 24.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 128.94 2.896 . . . . 0.0 105.982 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -148.7 158.46 44.16 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 164.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 63.6 m-85 -136.74 155.75 49.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.237 1.415 . . . . 0.0 108.391 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -108.22 134.37 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -111.54 120.67 42.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -69.04 59.11 0.1 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.571 1.949 . . . . 0.0 112.836 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.88 43.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 112.59 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -23.29 59.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.307 0.503 . . . . 0.0 111.296 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -113.6 -30.14 6.92 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.645 0.778 . . . . 0.0 112.241 -169.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.44 73.17 11.8 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.037 1.735 . . . . 0.0 107.946 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 -45.42 14.73 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.142 1.895 . . . . 0.0 112.805 -167.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.51 -53.37 58.95 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.029 1.286 . . . . 0.0 109.331 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -44.82 79.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.547 1.139 . . . . 0.0 111.243 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.56 65.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.66 0.784 . . . . 0.0 111.953 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -63.98 -40.72 97.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.792 0.837 . . . . 0.0 111.376 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -58.58 2.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.672 1.589 . . . . 0.0 108.96 167.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.99 -39.68 90.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.046 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -53.14 -58.24 7.69 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.098 1.359 . . . . 0.0 109.243 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -21.35 64.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.185 1.394 . . . . 0.0 113.77 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -89.79 -23.97 21.6 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.878 0.871 . . . . 0.0 111.389 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 m -83.4 -37.77 22.82 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.009 1.324 . . . . 0.0 110.779 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 p -67.05 -32.5 73.73 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.422 0.689 . . . . 0.0 109.823 170.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.73 14.81 81.08 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.089 0.852 . . . . 0.0 111.087 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.26 -21.8 66.78 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.572 1.186 . . . . 0.0 112.755 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -80.26 0.25 33.5 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 111.852 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 9.74 86.49 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.778 1.18 . . . . 0.0 112.437 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -156.6 179.04 9.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.499 1.52 . . . . 0.0 108.889 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.35 -142.54 13.86 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 121.723 0.624 . . . . 0.0 112.696 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CE1' HD11 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -70.77 -27.22 63.76 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.435 1.894 . . . . 0.0 110.873 -160.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.0 tttt -64.88 124.12 21.17 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.87 7.08 69.22 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.958 -1.468 . . . . 0.0 112.87 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -67.36 129.49 40.08 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 120.423 2.111 . . . . 0.0 106.244 167.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -76.12 161.7 28.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 163.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.95 114.1 28.11 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -79.2 -49.09 13.08 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.34 128.12 44.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.4 mm -137.2 106.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.2 mt -114.91 93.32 33.89 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.1 117.89 4.02 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.602 2.868 . . . . 0.0 112.006 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.09 14.67 57.32 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.659 1.123 . . . . 0.0 112.952 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.439 ' CD1' ' HG3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -133.11 -72.89 0.5 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.439 ' HG3' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -166.05 157.74 13.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.1 m -100.64 139.5 36.23 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.96 1.704 . . . . 0.0 108.426 160.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -135.06 122.21 21.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.567 1.531 . . . . 0.0 109.087 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.99 16.85 1.95 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.638 -0.535 . . . . 0.0 114.212 -161.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.72 11.02 53.22 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.053 0.927 . . . . 0.0 114.249 -168.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.72 97.8 9.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 166.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -100.97 -1.03 35.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 p -140.03 -51.68 0.5 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -83.84 -23.85 31.19 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.443 -0.786 . . . . 0.0 112.324 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.0 m170 59.95 31.81 20.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.905 1.682 . . . . 0.0 112.977 169.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -154.07 2.95 0.25 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.91 17.94 4.87 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.141 1.337 . . . . 0.0 113.942 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.4 p -139.33 10.19 2.52 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.229 1.015 . . . . 0.0 112.017 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.97 155.92 49.87 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 120.791 -1.193 . . . . 0.0 113.497 -163.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.9 -156.68 49.54 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 113.56 -1.32 . . . . 0.0 111.582 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.67 160.83 10.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.989 2.116 . . . . 0.0 107.685 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.7 p -71.45 23.16 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.475 1.91 . . . . 0.0 114.605 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.288 1.2 pp 46.29 -19.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 1 C-N-CA 132.234 4.214 . . . . 0.0 117.046 -159.04 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -92.65 -22.22 19.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 119.884 1.22 . . . . 0.0 112.748 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.56 101.07 0.26 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.342 14.5 tt0 41.23 -132.8 0.35 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.291 1.036 . . . . 0.0 111.901 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -88.78 149.06 23.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.831 1.252 . . . . 0.0 109.776 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -117.48 -176.74 3.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.985 1.714 . . . . 0.0 108.274 170.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -81.34 166.02 20.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.069 1.304 . . . . 0.0 114.122 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.37 87.68 3.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 107.582 -172.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -40.13 -64.37 0.51 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.985 2.114 . . . . 0.0 111.586 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.45 156.38 1.53 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.299 0.639 . . . . 0.0 110.844 174.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -111.75 30.29 7.12 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.726 1.61 . . . . 0.0 110.054 -171.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.86 -55.23 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.618 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.71 135.82 35.49 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.78 1.632 . . . . 0.0 107.188 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -122.88 167.2 13.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.667 1.587 . . . . 0.0 109.868 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -84.15 60.31 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.344 1.457 . . . . 0.0 110.849 -162.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 p -62.39 -29.46 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -158.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.4 -179.08 48.71 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 119.232 0.924 . . . . 0.0 112.094 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.11 153.08 54.67 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.411 2.074 . . . . 0.0 110.426 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.59 1.61 71.98 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 117.782 -1.566 . . . . 0.0 112.971 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.16 163.19 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.79 2.295 . . . . 0.0 107.824 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.32 131.07 39.71 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.744 1.218 . . . . 0.0 109.487 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -138.15 158.38 44.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 109.365 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 6.6 ptm -88.13 151.26 22.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.522 0.677 . . . . 0.0 110.913 -173.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.09 59.22 0.83 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.347 1.059 . . . . 0.0 109.134 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -57.79 161.2 3.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.748 163.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.82 19.84 1.14 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.661 2.384 . . . . 0.0 111.904 -166.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.05 176.79 25.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.16 1.362 . . . . 0.0 110.481 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.6 138.77 71.94 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 119.848 1.824 . . . . 0.0 109.664 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.4 55.81 5.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.944 2.098 . . . . 0.0 109.977 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -112.19 23.36 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.592 -1.317 . . . . 0.0 111.305 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -72.34 91.38 1.33 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 107.472 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.76 -142.83 11.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p -84.0 -15.65 46.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.859 0.863 . . . . 0.0 112.782 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.03 138.91 57.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.41 0.684 . . . . 0.0 109.619 -164.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 12.7 p90 -149.87 167.67 25.93 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.456 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 36.3 p90 -141.01 148.42 40.26 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 124.386 1.054 . . . . 0.0 109.315 162.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -83.69 116.46 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.3 m -64.16 130.85 45.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -118.22 23.94 11.28 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.466 1.106 . . . . 0.0 109.046 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.63 179.49 9.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.998 0.919 . . . . 0.0 108.577 163.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 82.1 tttt -67.83 92.1 0.34 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 160.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.5 p -83.47 58.6 4.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.75 0.705 . . . . 0.0 110.153 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 15.6 pt-20 -74.01 -8.01 54.53 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.182 -1.574 . . . . 0.0 113.767 -171.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -66.37 -10.3 42.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.397 -0.814 . . . . 0.0 110.846 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.456 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 53.4 mt -107.53 0.46 22.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.379 1.872 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 127.27 32.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.974 0.806 . . . . 0.0 112.443 -162.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.82 3.23 20.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.222 0.915 . . . . 0.0 113.22 -168.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -93.9 -53.51 3.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -99.97 157.18 16.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.583 0.753 . . . . 0.0 110.619 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t -98.71 101.68 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.35 128.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -142.46 0.06 1.27 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.77 176.38 29.35 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 119.526 1.057 . . . . 0.0 111.639 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -146.43 155.59 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 22' ' ' PHE . 49.2 t -64.81 123.8 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 2.8 ttpt -86.76 -41.98 13.69 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.868 0.867 . . . . 0.0 109.297 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.54 160.16 43.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.663 0.385 . . . . 0.0 111.065 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.6 36.1 82.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.075 0.845 . . . . 0.0 111.91 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -45.42 78.35 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.704 1.252 . . . . 0.0 108.28 171.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.61 -26.54 61.7 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.1 mm -76.8 -36.96 27.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-N 118.784 0.72 . . . . 0.0 109.143 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.02 -47.27 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.303 0.956 . . . . 0.0 108.759 170.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.55 68.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.188 0.995 . . . . 0.0 111.507 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.48 -42.61 52.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 120.952 -1.093 . . . . 0.0 109.833 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 44.3 mtm -55.65 -48.85 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 118.444 0.565 . . . . 0.0 109.542 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.64 -39.85 71.42 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.948 1.699 . . . . 0.0 111.249 176.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -67.84 -18.04 64.7 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.594 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -94.92 -1.21 53.03 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.557 1.072 . . . . 0.0 112.178 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.32 -163.3 39.24 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 120.871 1.669 . . . . 0.0 112.199 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.3 p -152.14 154.97 36.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -66.73 -20.59 66.0 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.154 -1.591 . . . . 0.0 112.877 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.64 9.16 4.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.428 1.091 . . . . 0.0 112.878 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.51 -28.87 7.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 126.128 1.823 . . . . 0.0 113.65 167.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -69.86 145.16 52.25 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 120.445 2.122 . . . . 0.0 110.91 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.2 p -64.05 145.86 55.16 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.873 1.669 . . . . 0.0 111.425 159.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.4 p -75.92 -43.83 43.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.357 0.663 . . . . 0.0 109.653 158.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.495 ' HE2' HG12 ' A' ' 12' ' ' VAL . 29.8 mtpt -124.47 162.73 23.32 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.43 1.492 . . . . 0.0 110.931 -174.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.61 88.28 2.17 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.128 -0.983 . . . . 0.0 110.358 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.49 124.88 31.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 p -146.09 165.67 28.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.699 0.761 . . . . 0.0 111.453 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.426 HD11 ' CE1' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -89.83 127.33 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 159.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.54 -46.68 8.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.613 0.642 . . . . 0.0 109.734 168.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.429 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -147.38 158.51 44.0 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -172.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -172.56 172.46 4.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.098 0.959 . . . . 0.0 113.096 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.35 -178.4 46.19 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.199 1.381 . . . . 0.0 109.906 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -78.83 149.09 32.62 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 110.511 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.7 mt -128.68 43.29 3.17 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.954 0.902 . . . . 0.0 109.419 159.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.252 1.199 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.217 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--O 1.238 0.472 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.774 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 17.9 Cg_endo -64.57 147.66 90.28 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 N-CA-C 107.551 -1.75 . . . . 0.0 107.551 174.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 m -110.51 150.48 28.85 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.92 160.96 29.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.746 0.818 . . . . 0.0 108.841 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -124.95 159.16 31.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.364 1.466 . . . . 0.0 109.998 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -146.56 107.82 4.23 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.69 2.396 . . . . 0.0 106.846 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.01 101.44 3.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.46 134.66 29.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.46 141.4 47.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.84 0.856 . . . . 0.0 109.008 164.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.2 t -96.32 91.28 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 163.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.279 1.3 p30 62.54 14.18 6.84 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.58 -9.64 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 117.442 -1.755 . . . . 0.0 111.406 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -70.48 124.88 91.66 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 162.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.0 117.75 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 N-CA-C 107.261 -1.861 . . . . 0.0 107.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp -88.73 -35.26 16.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.567 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 147.0 161.56 9.43 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -74.59 146.91 42.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.659 0.743 . . . . 0.0 109.233 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.01 151.85 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 128.114 2.566 . . . . 0.0 104.609 171.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 134' ' ' GLU . 21.5 m -146.48 146.65 30.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.212 1.006 . . . . 0.0 109.76 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -120.23 156.61 30.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.956 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -95.74 151.25 19.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 158.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -127.31 121.38 30.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -75.2 51.49 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.936 2.094 . . . . 0.0 112.754 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.26 28.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.963 -1.085 . . . . 0.0 113.365 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.09 -26.52 60.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.124 0.874 . . . . 0.0 111.714 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -111.99 -34.04 6.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.526 1.13 . . . . 0.0 111.635 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.08 71.6 68.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.449 1.9 . . . . 0.0 109.037 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.65 -44.2 27.9 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.593 2.195 . . . . 0.0 113.844 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -49.4 77.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.203 1.365 . . . . 0.0 109.592 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -62.45 -48.39 79.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.854 0.862 . . . . 0.0 109.28 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.66 -48.57 81.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.62 0.768 . . . . 0.0 111.468 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -46.01 91.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.725 1.21 . . . . 0.0 111.688 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -57.28 -51.09 70.79 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.106 0.962 . . . . 0.0 108.609 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.28 -31.68 72.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.523 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 18.3 ttm105 -55.65 -56.81 16.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.963 1.256 . . . . 0.0 108.938 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.23 49.1 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.673 1.189 . . . . 0.0 111.16 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.33 -29.4 69.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.31 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 m -75.17 -10.23 59.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.236 1.414 . . . . 0.0 112.104 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.8 p -112.43 -29.61 7.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.411 0.684 . . . . 0.0 111.725 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.14 82.67 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.356 -0.691 . . . . 0.0 113.56 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -28.81 64.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.499 1.92 . . . . 0.0 113.503 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.59 2.49 1.8 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.519 0.728 . . . . 0.0 112.848 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.48 62.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.871 1.224 . . . . 0.0 111.397 -170.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.35 172.82 12.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.59 2.356 . . . . 0.0 106.728 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.54 -177.18 23.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.639 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 2.3 t80 -81.67 -6.59 59.16 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.881 2.072 . . . . 0.0 112.247 -163.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -59.59 117.87 5.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.2 -0.938 . . . . 0.0 108.588 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.49 5.65 87.96 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 116.92 -2.044 . . . . 0.0 115.766 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.6 m -71.26 -65.77 0.7 Allowed 'General case' 0 C--N 1.342 0.256 0 CA-C-N 121.638 2.719 . . . . 0.0 112.322 -163.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.6 t 130.14 144.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.184 3.793 . . . . 0.0 109.659 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.03 92.03 6.65 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.043 2.137 . . . . 0.0 106.823 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -18.4 58.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -164.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -140.02 78.25 1.65 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.161 1.346 . . . . 0.0 111.64 -167.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.51 106.34 18.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.805 1.642 . . . . 0.0 107.008 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.6 91.41 12.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.31 120.84 7.4 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.843 3.029 . . . . 0.0 113.114 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.47 11.52 60.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.839 1.685 . . . . 0.0 113.253 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -133.94 -79.61 0.46 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.936 1.294 . . . . 0.0 108.802 -170.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.69 167.95 28.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.799 0.84 . . . . 0.0 110.713 172.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -132.38 98.15 4.3 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.91 1.684 . . . . 0.0 109.04 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.7 146.79 44.18 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.426 1.09 . . . . 0.0 109.985 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.98 -173.64 25.68 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 125.719 1.628 . . . . 0.0 109.88 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.84 -13.23 41.78 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.326 1.441 . . . . 0.0 113.324 170.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -84.07 95.09 8.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.892 0.846 . . . . 0.0 110.709 -167.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CD2' HG23 ' A' ' 68' ' ' THR . 49.8 p90 -95.08 3.5 54.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.178 -176.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 67' ' ' PHE . 50.0 p -137.16 -45.95 0.57 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.893 1.224 . . . . 0.0 113.248 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -88.34 -27.05 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.79 -0.569 . . . . 0.0 111.472 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 54.25 12.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.953 2.901 . . . . 0.0 114.595 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -117.86 -8.04 10.86 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.188 0.995 . . . . 0.0 112.868 -170.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 -3.36 27.36 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.439 -1.2 . . . . 0.0 113.088 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.2 p -84.27 -32.29 24.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.77 1.785 . . . . 0.0 111.04 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.88 165.91 9.35 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-O 123.153 1.419 . . . . 0.0 114.054 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.31 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.469 1.594 . . . . 0.0 111.669 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.58 -178.84 2.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 128.951 2.901 . . . . 0.0 108.814 -160.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.1 p -84.99 -175.1 5.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.76 -23.09 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.033 -1.042 . . . . 0.0 111.745 163.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -82.13 -23.67 35.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.023 0.929 . . . . 0.0 111.149 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.8 -145.72 10.18 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 -166.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -128.75 115.2 17.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.38 148.42 0.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.228 2.611 . . . . 0.0 111.88 -165.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -135.12 173.6 11.54 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 159.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 84' ' ' GLU . 1.9 pm0 -63.84 154.01 34.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.132 0.968 . . . . 0.0 109.714 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.03 99.47 1.82 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 172.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -49.77 -57.31 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.241 1.416 . . . . 0.0 114.516 -158.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.69 154.02 5.25 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.239 1.816 . . . . 0.0 108.846 162.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.98 25.24 10.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.56 1.544 . . . . 0.0 110.049 -169.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mt -45.2 -59.59 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 126.541 1.936 . . . . 0.0 108.556 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.9 mt -74.91 113.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.421 1.488 . . . . 0.0 107.87 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -80.2 157.85 26.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.154 171.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.36 83.76 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.5 p -68.73 -23.53 64.36 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.479 -0.763 . . . . 0.0 112.853 -166.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.76 -176.7 40.54 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.861 1.21 . . . . 0.0 111.86 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.46 149.52 89.24 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 121.732 1.621 . . . . 0.0 110.691 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 10.91 85.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.977 -1.457 . . . . 0.0 112.467 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 mm -82.58 166.2 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 120.674 2.237 . . . . 0.0 108.336 164.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.57 127.94 26.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.097 1.359 . . . . 0.0 108.175 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.8 t -141.29 147.16 37.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.63 -167.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.412 ' HG2' ' CG ' ' A' ' 108' ' ' ASN . 35.9 tpp -77.25 113.97 15.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.177 2.191 . . . . 0.0 108.562 -174.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.445 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -72.56 98.17 2.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 165.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -78.83 -178.2 5.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 159.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.92 15.1 25.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.384 1.874 . . . . 0.0 112.149 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.01 175.73 14.17 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.539 1.543 . . . . 0.0 109.312 -163.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.34 130.21 31.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.198 1.932 . . . . 0.0 111.32 -170.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.81 57.81 3.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 127.495 2.318 . . . . 0.0 111.853 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -142.25 41.74 1.64 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.086 0.555 . . . . 0.0 111.315 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.412 ' CG ' ' HG2' ' A' ' 100' ' ' MET . 1.0 OUTLIER -55.22 125.85 22.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.266 1.426 . . . . 0.0 109.565 175.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.75 -125.5 2.31 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 120.695 1.589 . . . . 0.0 112.335 -171.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -89.13 -25.14 22.01 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.606 1.203 . . . . 0.0 112.796 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -85.23 148.26 26.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.715 0.769 . . . . 0.0 111.178 -158.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.445 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 28.2 p90 -142.96 176.67 8.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -141.24 152.8 44.85 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 160.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.1 mt -83.46 119.42 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 163.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.3 m -65.15 122.56 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.8 p -114.86 28.5 8.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.222 1.01 . . . . 0.0 108.553 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.32 178.63 10.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.157 1.783 . . . . 0.0 107.628 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -70.39 92.11 0.79 Allowed 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 161.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 p -78.72 59.36 2.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.694 0.679 . . . . 0.0 109.939 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.01 -13.37 62.41 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.83 1.252 . . . . 0.0 112.914 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -74.1 -15.92 61.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.286 1.035 . . . . 0.0 111.317 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -103.61 -4.59 23.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.854 1.261 . . . . 0.0 111.129 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 126.97 29.75 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.589 1.156 . . . . 0.0 111.129 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.41 1.19 34.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.717 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -103.11 -25.8 13.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.61 1.705 . . . . 0.0 110.553 168.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -137.14 160.96 37.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.111 1.364 . . . . 0.0 108.98 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -110.46 103.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.58 127.46 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.65 -2.08 1.99 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.827 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.75 -176.44 28.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 119.41 1.005 . . . . 0.0 111.974 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -153.37 140.22 19.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.97 103.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 159.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -63.68 -52.71 59.42 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 21' ' ' SER . 10.4 pt-20 -146.87 154.47 41.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 123.356 0.662 . . . . 0.0 111.486 -159.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.88 25.14 67.68 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.884 0.754 . . . . 0.0 113.153 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 mmm -61.22 -29.21 69.68 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.623 2.212 . . . . 0.0 111.609 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -62.61 -30.65 71.5 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.834 -1.166 . . . . 0.0 111.635 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.02 -44.09 92.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.97 -42.26 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.265 0.626 . . . . 0.0 110.166 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -39.74 94.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 174.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.18 -41.52 70.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.919 1.288 . . . . 0.0 109.035 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.3 mtp -53.87 -42.59 68.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.079 1.352 . . . . 0.0 110.154 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.202 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.76 -36.01 81.68 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.402 1.456 . . . . 0.0 108.887 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.59 1.68 40.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.983 0.913 . . . . 0.0 112.783 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.4 -156.21 7.72 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.982 1.753 . . . . 0.0 110.411 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.2 p -142.18 -72.06 0.32 Allowed 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 121.65 -0.912 . . . . 0.0 111.591 168.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 140.67 -27.39 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.346 1 C-N-CA 133.864 4.865 . . . . 0.0 109.772 -173.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.65 -24.84 67.12 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.716 0.689 . . . . 0.0 110.283 158.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.74 -36.05 4.21 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 125.672 1.606 . . . . 0.0 111.764 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.06 131.91 47.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 p -62.77 152.21 36.48 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.908 1.283 . . . . 0.0 107.914 166.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.6 p -57.44 -48.06 80.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -73.43 175.76 6.68 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.943 1.697 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -95.63 139.48 31.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 101.969 -3.345 . . . . 0.0 101.969 157.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.4 mt -127.38 128.96 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.79 22.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.798 0.808 . . . . 0.0 111.542 -158.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.639 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 4.6 mp -98.37 105.13 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.86 96.64 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.484 0.584 . . . . 0.0 109.521 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -157.32 158.82 36.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.575 1.15 . . . . 0.0 108.841 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 p -156.93 165.28 36.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.397 0.679 . . . . 0.0 110.543 174.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.47 -169.18 40.7 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.536 ' HG2' ' H ' ' A' ' 165' ' ' GLU . 41.4 tt0 -103.97 148.85 25.71 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.943 1.297 . . . . 0.0 109.646 -172.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.2 mt -128.37 43.26 3.17 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.253 1.421 . . . . 0.0 109.114 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.536 ' H ' ' HG2' ' A' ' 163' ' ' GLN . 24.1 tt0 . . . . . 0 C--O 1.243 0.734 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 166.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -63.78 146.66 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 120.7 1.286 . . . . 0.0 110.34 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -104.97 146.87 28.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.76 156.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.166 1.386 . . . . 0.0 109.351 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.0 158.91 26.71 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.487 1.115 . . . . 0.0 110.12 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -144.37 111.72 5.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.345 1.858 . . . . 0.0 106.663 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 104.46 10.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 mm -79.34 140.87 16.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.21 162.56 29.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.007 169.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 9.2 t -137.18 92.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 60.21 18.64 8.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.739 1.216 . . . . 0.0 111.516 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.16 9.69 72.89 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.196 -0.94 . . . . 0.0 112.537 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -75.18 118.71 72.7 Favored Pre-proline 0 C--O 1.232 0.179 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 159.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.94 112.36 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.477 1.451 . . . . 0.0 109.436 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.2 tp -82.81 -27.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.112 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.55 169.53 11.75 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.436 1.493 . . . . 0.0 111.759 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.91 139.38 35.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.335 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.45 154.95 40.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.6 t -147.43 149.49 32.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.77 0.795 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -124.57 147.93 48.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.203 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -92.58 151.92 19.88 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 158.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 mt -126.7 122.56 35.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.883 1.673 . . . . 0.0 106.993 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 90' ' ' LEU . 58.1 m-85 -78.52 61.63 2.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.969 0.908 . . . . 0.0 111.846 -172.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.37 -16.33 53.88 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.885 -1.76 . . . . 0.0 113.611 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.33 -16.21 57.94 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.076 0.95 . . . . 0.0 111.918 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -121.95 -39.53 2.6 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.733 1.213 . . . . 0.0 111.3 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.1 m -132.74 70.51 79.09 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.911 1.685 . . . . 0.0 107.457 174.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -50.18 -48.37 20.15 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.146 2.564 . . . . 0.0 112.657 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -55.66 -58.51 7.49 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -174.392 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 -46.43 89.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.391 1.477 . . . . 0.0 111.165 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.57 82.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.083 0.553 . . . . 0.0 111.385 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.38 -43.54 81.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.626 1.17 . . . . 0.0 110.453 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -51.09 -51.08 56.89 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.147 1.379 . . . . 0.0 109.38 170.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.94 -44.21 90.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.423 0.452 . . . . 0.0 112.073 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -53.93 -59.65 4.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.733 1.613 . . . . 0.0 109.108 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.96 -47.8 74.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.465 0.706 . . . . 0.0 110.611 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.67 -23.39 66.77 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -73.3 -48.13 37.12 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.299 0.954 . . . . 0.0 109.303 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 p -66.62 -26.1 66.92 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.989 -0.444 . . . . 0.0 111.913 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.61 -0.11 71.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.436 1.017 . . . . 0.0 112.058 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -59.78 -23.21 63.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.701 1.6 . . . . 0.0 112.632 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -85.47 9.69 15.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.109 1.364 . . . . 0.0 112.095 -172.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.05 81.63 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.846 -0.974 . . . . 0.0 112.423 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.32 172.72 13.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.983 1.713 . . . . 0.0 107.407 166.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.63 174.39 37.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.427 -1.368 . . . . 0.0 113.674 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -73.24 -8.03 54.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -56.08 124.68 18.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.72 4.34 65.82 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.613 -1.659 . . . . 0.0 114.529 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -73.14 156.75 38.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.99 2.395 . . . . 0.0 107.988 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.1 t -106.21 139.89 40.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CB ' HD11 ' A' ' 56' ' ' ILE . 95.6 m-85 -74.83 88.99 2.31 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -73.5 -27.55 61.43 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.406 1.882 . . . . 0.0 111.617 -166.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 86.01 2.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.449 HD12 ' CG2' ' A' ' 152' ' ' THR . 86.3 mt -103.71 112.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 171.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -125.17 97.47 37.59 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -170.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.68 125.45 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.948 2.432 . . . . 0.0 111.027 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.2 5.4 63.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.81 1.671 . . . . 0.0 113.338 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -136.57 -75.64 0.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.105 1.453 . . . . 0.0 108.98 -167.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.1 167.61 18.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 112.08 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.1 m -122.15 94.74 4.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.744 2.018 . . . . 0.0 108.383 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.37 144.32 25.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.532 1.933 . . . . 0.0 109.961 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.12 1.82 0.13 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.84 35.46 3.38 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 -158.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.329 19.3 p-10 -122.73 144.36 49.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.912 2.856 . . . . 0.0 111.292 164.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.28 -3.09 3.08 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.183 2.593 . . . . 0.0 111.317 -160.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -125.6 -19.84 4.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 129.247 3.019 . . . . 0.0 112.173 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -137.46 176.37 8.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 131.538 3.935 . . . . 0.0 103.439 169.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -145.11 53.81 1.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -152.91 -67.37 0.16 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.201 1.4 . . . . 0.0 110.679 -176.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.47 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 173.69 -11.81 0.04 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 118.374 -1.237 . . . . 0.0 115.262 -159.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -127.44 17.04 7.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.285 1.543 . . . . 0.0 113.227 -161.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.27 -86.4 0.37 Allowed Glycine 0 CA--C 1.503 -0.662 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -17.09 113.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.553 0 C-N-CA 128.074 2.749 . . . . 0.0 111.932 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -136.9 155.32 49.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.213 1.805 . . . . 0.0 109.918 -158.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 p -77.94 165.5 24.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 124.293 0.996 . . . . 0.0 109.451 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.93 -24.75 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.596 170.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.39 8.31 25.11 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.166 1.787 . . . . 0.0 111.533 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.29 142.09 12.96 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.403 1.478 . . . . 0.0 109.813 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.26 6.2 pt-20 34.06 -133.8 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.796 2.438 . . . . 0.0 114.343 162.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -75.05 157.97 33.95 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.498 0.59 . . . . 0.0 110.385 165.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -132.13 176.53 8.31 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.66 1.984 . . . . 0.0 107.644 164.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.79 161.17 28.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.071 0.462 . . . . 0.0 110.713 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.57 131.33 48.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -47.08 83.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -173.08 176.13 3.06 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.726 1.211 . . . . 0.0 108.721 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -126.09 56.36 1.43 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.563 1.945 . . . . 0.0 106.144 163.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.55 -39.52 70.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 171.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 25' ' ' PHE . 49.1 mt -95.6 142.24 28.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.447 1.499 . . . . 0.0 107.334 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -120.49 160.21 23.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.433 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -76.26 64.62 2.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.494 2.318 . . . . 0.0 109.666 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.426 1.49 . . . . 0.0 113.494 -161.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 175.49 38.23 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.583 1.083 . . . . 0.0 112.891 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -59.68 137.58 78.0 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.158 1.906 . . . . 0.0 108.147 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.73 64.38 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.512 -1.716 . . . . 0.0 112.623 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.42 159.44 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 120.923 2.361 . . . . 0.0 107.687 169.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.39 131.98 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.456 1.502 . . . . 0.0 108.497 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 32.3 t -148.62 160.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.848 0.459 . . . . 0.0 110.68 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.4 mtp -84.58 120.95 26.94 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.618 0.767 . . . . 0.0 110.421 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 141.73 58.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 162.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -152.46 -172.57 4.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.364 1.066 . . . . 0.0 109.691 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.62 15.08 10.25 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.011 1.724 . . . . 0.0 112.64 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.28 -179.6 17.24 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -167.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.47 141.04 79.1 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.539 2.159 . . . . 0.0 110.481 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.51 46.12 26.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.164 1.786 . . . . 0.0 111.885 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.7 p -123.89 14.07 9.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.301 -0.874 . . . . 0.0 111.262 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -73.69 128.02 34.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.52 -65.31 0.16 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.7 p -144.54 -13.76 0.58 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.47 HE22 ' HA2' ' A' ' 72' ' ' GLY . 78.9 mt-30 -65.4 130.9 44.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -170.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -134.43 162.39 32.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 107.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 44.9 p90 -144.56 153.39 41.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 O-C-N 124.683 1.239 . . . . 0.0 110.263 166.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.79 123.84 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 160.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.14 125.39 24.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.3 p -110.77 32.39 5.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.52 173.11 13.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.341 1.057 . . . . 0.0 109.192 167.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -68.59 89.85 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 158.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 p -83.38 65.88 8.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.819 -0.551 . . . . 0.0 109.892 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -59.22 -23.21 62.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.11 0.964 . . . . 0.0 112.306 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -68.49 -14.82 63.27 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.761 1.224 . . . . 0.0 110.749 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 62.1 mt -104.0 -6.24 21.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.243 1.417 . . . . 0.0 111.54 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.16 145.13 53.54 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.714 0.688 . . . . 0.0 110.498 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.49 16.06 48.7 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.96 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.22 -52.01 1.41 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.924 2.09 . . . . 0.0 108.414 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -105.18 146.69 28.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.814 -173.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.45 100.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -171.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.1 t -59.06 127.29 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 165.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.409 ' HA ' HG21 ' A' ' 29' ' ' VAL . 29.4 p90 -138.25 -3.45 1.75 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.59 -174.19 30.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.36 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -149.83 149.99 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.659 1.183 . . . . 0.0 108.44 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 118.31 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 165.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -75.13 -50.27 16.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -143.34 146.4 33.51 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 126.133 1.773 . . . . 0.0 107.275 -171.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.27 22.34 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.464 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 28.6 tpp -56.61 -35.94 68.85 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 119.526 1.663 . . . . 0.0 110.706 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -62.67 -20.51 64.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.852 1.205 . . . . 0.0 113.391 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.4 mm -83.05 -43.77 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.551 1.14 . . . . 0.0 108.677 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.37 -35.9 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 121.586 -0.696 . . . . 0.0 109.579 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.37 -44.26 84.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.084 1.753 . . . . 0.0 110.913 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.08 85.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.434 ' HB3' HD13 ' A' ' 56' ' ' ILE . 38.4 mtm -53.26 -47.93 68.7 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.734 176.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -53.24 -42.14 66.12 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.537 HH11 ' HG3' ' A' ' 144' ' ' ARG . 15.0 mtt85 -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.085 -177.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.04 5.24 51.62 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.801 1.24 . . . . 0.0 112.446 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.2 -150.89 4.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 120.473 1.488 . . . . 0.0 111.74 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.0 p -142.59 -96.05 0.12 Allowed 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.589 -0.948 . . . . 0.0 108.798 165.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -162.2 -23.4 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 125.858 1.663 . . . . 0.0 110.764 164.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -16.07 58.25 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.977 0.808 . . . . 0.0 111.432 165.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.27 -24.84 6.84 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 118.556 -1.136 . . . . 0.0 113.174 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.14 123.47 17.77 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.224 1.012 . . . . 0.0 108.764 -174.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.449 ' CG2' HD12 ' A' ' 56' ' ' ILE . 12.3 p -74.93 159.99 31.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 108.837 173.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -10.66 59.64 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.031 -1.668 . . . . 0.0 111.362 166.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.422 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -140.73 160.31 40.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 110.117 -161.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.52 80.2 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.67 119.16 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 p -139.22 165.74 26.38 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.508 1.123 . . . . 0.0 110.766 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 102.41 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 166.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.4 77.09 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -145.43 161.48 39.6 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 p -162.26 158.17 23.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.282 1.433 . . . . 0.0 108.556 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.71 -176.34 42.96 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -83.05 159.55 22.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.856 -0.79 . . . . 0.0 110.722 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.0 mt -135.58 43.63 2.59 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 158.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.148 0.979 . . . . 0.0 111.458 175.419 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.3 m120 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.23 138.82 48.17 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 N-CA-C 106.502 -2.153 . . . . 0.0 106.502 158.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 m -104.7 147.91 27.16 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.5 140.43 44.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -113.71 150.91 32.61 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 123.936 0.894 . . . . 0.0 110.164 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.431 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 19.3 m-85 -146.13 113.56 6.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.481 1.512 . . . . 0.0 109.317 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.21 101.11 3.88 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 159.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.19 140.93 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 171.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.78 148.06 49.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.929 1.292 . . . . 0.0 108.37 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.647 HG13 HD13 ' A' ' 156' ' ' ILE . 1.5 t -125.35 115.76 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 53.5 13.76 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 0.0 114.489 -167.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.3 57.79 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.381 1.467 . . . . 0.0 112.859 -175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.27 133.23 81.18 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.22 120.19 7.17 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.2 -40.49 30.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.85 177.28 19.56 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 123.68 0.657 . . . . 0.0 112.364 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -77.32 136.62 38.48 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.726 0.81 . . . . 0.0 110.068 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -121.92 158.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 126.578 1.951 . . . . 0.0 106.316 164.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -147.99 140.34 24.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.965 -0.459 . . . . 0.0 110.244 161.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -109.14 162.72 14.0 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -123.38 112.76 17.95 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.479 2.712 . . . . 0.0 104.433 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 mt -97.61 134.65 40.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -169.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CD2' HD13 ' A' ' 90' ' ' LEU . 18.0 m-85 -82.16 51.76 1.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.998 -1.064 . . . . 0.0 112.42 -171.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.9 -27.36 42.42 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.252 -0.905 . . . . 0.0 112.061 173.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -71.39 -7.08 44.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.721 1.608 . . . . 0.0 113.758 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.82 -25.25 0.46 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.032 0.833 . . . . 0.0 112.933 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 75.1 33.64 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.562 1.945 . . . . 0.0 106.793 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.81 -52.65 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.29 1.993 . . . . 0.0 111.644 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -42.95 99.53 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.883 1.22 . . . . 0.0 109.83 -173.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -60.92 -48.21 82.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.433 0.693 . . . . 0.0 110.332 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.78 -51.29 57.47 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.131 0.972 . . . . 0.0 111.764 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.6 -32.41 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.213 2.205 . . . . 0.0 112.085 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -61.98 2.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.019 1.728 . . . . 0.0 108.579 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.07 -30.93 71.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.203 -0.311 . . . . 0.0 111.56 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -53.19 -62.37 1.7 Allowed 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.038 1.335 . . . . 0.0 109.784 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.9 -26.34 68.11 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.95 -32.39 34.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.866 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 m -69.67 -40.87 76.17 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.926 0.89 . . . . 0.0 109.853 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.0 p -70.87 -34.7 71.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.4 -0.6 88.9 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.623 1.106 . . . . 0.0 110.949 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -70.64 -12.07 61.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.037 1.335 . . . . 0.0 112.887 -162.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -75.57 -4.55 40.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.148 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.07 6.42 55.86 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.486 1.041 . . . . 0.0 111.463 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -163.23 170.54 17.56 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.349 1.86 . . . . 0.0 106.146 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.53 178.62 35.62 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 118.217 -1.944 . . . . 0.0 114.052 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.431 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 75.2 t80 -70.68 -17.63 62.84 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 130.51 3.524 . . . . 0.0 113.283 -170.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -55.74 121.8 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 23.72 73.0 Favored Glycine 0 CA--C 1.538 1.496 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.063 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -25.3 67.98 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.853 2.326 . . . . 0.0 110.288 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.4 m 56.38 175.99 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.308 1.443 . . . . 0.0 110.515 -159.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.6 117.99 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -74.27 -39.75 62.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.202 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 125.54 40.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -158.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.2 mm -142.33 114.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.9 mt -125.89 108.84 25.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.19 124.22 13.58 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.36 3.373 . . . . 0.0 114.015 -173.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.64 27.02 69.13 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.215 1.388 . . . . 0.0 112.442 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -125.1 -83.89 0.64 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.22 172.55 15.57 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.497 0.719 . . . . 0.0 110.188 170.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.99 115.84 17.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.231 1.413 . . . . 0.0 109.834 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -101.1 138.22 38.42 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.24 2.216 . . . . 0.0 111.528 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.22 -156.07 7.33 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.863 1.697 . . . . 0.0 109.279 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.8 90.13 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 119.284 -0.731 . . . . 0.0 114.401 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -83.86 138.9 32.97 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 159.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -132.53 6.83 4.11 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.398 1.079 . . . . 0.0 111.326 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.6 -31.57 0.86 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.468 1.107 . . . . 0.0 113.73 -174.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -127.84 -10.95 5.48 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.306 1.412 . . . . 0.0 112.964 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 58.44 30.57 19.86 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.235 1.814 . . . . 0.0 113.091 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -147.04 -27.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.74 2.57 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.889 1.222 . . . . 0.0 114.469 -170.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.9 p -83.89 -4.32 58.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.596 1.198 . . . . 0.0 112.282 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -103.13 -108.34 3.25 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -8.46 91.17 0.01 OUTLIER Glycine 0 C--N 1.334 0.453 0 C-N-CA 129.082 3.23 . . . . 0.0 115.633 -170.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 1.4 ptpt -77.24 150.1 35.41 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 128.224 2.61 . . . . 0.0 110.013 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -84.89 44.93 1.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.26 1.424 . . . . 0.0 112.768 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.257 36.6 pt 49.27 -43.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 1 C-N-CA 133.486 4.714 . . . . 0.0 114.562 -158.921 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -82.04 -4.43 56.76 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.844 1.257 . . . . 0.0 113.724 -159.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.66 -85.36 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 170.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -127.84 -133.23 0.23 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 127.255 2.222 . . . . 0.0 105.381 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.83 155.67 18.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.379 1.445 . . . . 0.0 108.902 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -122.76 177.75 5.33 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.083 0.856 . . . . 0.0 110.565 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.452 ' HA ' HD22 ' A' ' 106' ' ' ASN . 15.9 pt-20 -57.47 164.31 1.98 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 112.679 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -64.22 120.01 11.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 158.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -67.2 -48.09 68.95 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.767 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.72 156.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.417 2.687 . . . . 0.0 110.706 170.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -104.61 22.55 14.83 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.923 1.689 . . . . 0.0 110.655 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.34 -49.39 64.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 124.33 1.052 . . . . 0.0 109.853 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD13 ' CD2' ' A' ' 25' ' ' PHE . 96.3 mt -80.67 129.32 34.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.95 160.57 14.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.122 1.769 . . . . 0.0 109.368 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -77.08 85.24 3.58 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 172.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 p -76.47 -24.14 53.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 118.877 -0.582 . . . . 0.0 111.216 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.1 -170.57 43.55 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.041 0.829 . . . . 0.0 112.705 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.95 158.89 19.54 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.629 2.219 . . . . 0.0 110.64 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.65 -4.2 57.36 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 117.084 -1.954 . . . . 0.0 113.06 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -67.84 148.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 121.2 2.5 . . . . 0.0 107.823 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.83 125.33 54.23 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 p -131.73 159.82 37.3 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 122.799 1.285 . . . . 0.0 110.048 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttm -86.71 127.44 34.97 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.376 -163.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.62 41.79 0.34 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.884 2.474 . . . . 0.0 112.346 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -63.03 167.62 4.7 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.868 1.318 . . . . 0.0 110.409 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.36 15.26 13.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.374 -1.739 . . . . 0.0 111.75 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.61 -167.7 32.61 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 -167.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -64.75 171.62 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 119.328 1.564 . . . . 0.0 108.965 158.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 84' ' ' GLU . 6.8 m120 48.85 24.43 0.84 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.458 2.303 . . . . 0.0 115.188 168.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -128.2 29.15 5.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.399 1.48 . . . . 0.0 109.858 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.471 HD21 HG21 ' A' ' 127' ' ' VAL . 85.7 m-20 -69.19 101.24 1.43 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.902 1.681 . . . . 0.0 107.324 172.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.92 -137.59 7.76 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -90.08 -10.87 43.14 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.733 0.813 . . . . 0.0 112.624 163.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -81.69 146.63 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.743 1.217 . . . . 0.0 111.286 -158.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -154.32 171.75 18.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.28 1.032 . . . . 0.0 109.492 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.597 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 10.6 p90 -135.49 154.66 51.34 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.341 0.591 . . . . 0.0 109.965 159.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.25 117.46 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 36.0 m -65.72 130.3 42.81 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.625 1.17 . . . . 0.0 108.078 168.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.9 p -111.66 22.07 15.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.944 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.95 -176.14 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 161.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.54 93.22 0.23 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 161.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -81.08 55.74 2.59 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.634 1.974 . . . . 0.0 110.014 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.869 -1.144 . . . . 0.0 113.673 -171.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -73.15 -4.47 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.597 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 68.0 mt -114.82 -2.88 12.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.229 1.811 . . . . 0.0 110.89 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.47 143.16 58.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.174 1.39 . . . . 0.0 111.529 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.5 20.26 58.82 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.254 0.93 . . . . 0.0 112.084 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.04 -51.91 0.67 Allowed 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -96.58 117.62 31.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 108' ' ' ASN . 18.6 t -71.23 107.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -170.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.89 122.55 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.384 1.474 . . . . 0.0 108.037 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -145.13 9.27 1.26 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.24 -173.08 37.29 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 121.296 -0.878 . . . . 0.0 111.783 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -147.67 158.36 43.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.144 0.978 . . . . 0.0 109.631 168.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.15 105.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -52.34 62.56 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.41 157.69 44.13 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.977 0.911 . . . . 0.0 111.056 -167.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.7 24.93 54.91 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.458 1.028 . . . . 0.0 112.592 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.8 tpp -55.75 -35.09 65.81 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.554 1.677 . . . . 0.0 110.109 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -57.6 -30.95 65.73 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.424 1.465 . . . . 0.0 113.379 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.8 mm -76.39 -35.07 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.906 0.776 . . . . 0.0 109.483 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.35 -39.4 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.387 0.994 . . . . 0.0 109.645 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -62.49 -31.44 72.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.117 1.367 . . . . 0.0 111.456 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -44.44 28.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.823 1.249 . . . . 0.0 109.215 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 62.5 mtp -49.77 -44.01 48.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.872 1.269 . . . . 0.0 110.316 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -33.31 71.22 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.02 0.928 . . . . 0.0 113.489 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -65.64 -25.73 67.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.699 1.136 . . . . 0.0 110.975 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.662 ' HB2' HD11 ' A' ' 156' ' ' ILE . 59.0 m-85 -91.98 5.12 51.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 177.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.43 -167.81 34.05 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 125.007 1.289 . . . . 0.0 111.721 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 p -153.75 152.55 30.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.262 1.425 . . . . 0.0 107.372 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -63.85 -22.15 66.78 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.198 -1.564 . . . . 0.0 113.16 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -77.04 -6.48 52.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 16.69 68.94 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.355 -1.247 . . . . 0.0 113.243 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.404 ' HE3' ' H ' ' A' ' 152' ' ' THR . 0.0 OUTLIER -86.44 176.13 8.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.583 1.691 . . . . 0.0 109.141 158.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.404 ' H ' ' HE3' ' A' ' 151' ' ' LYS . 71.4 p -125.04 129.97 51.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.72 -31.65 70.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.4 0.546 . . . . 0.0 110.575 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.484 ' HB3' HG12 ' A' ' 12' ' ' VAL . 47.0 mtpt -111.75 176.94 4.82 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.163 0.585 . . . . 0.0 109.972 171.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.66 103.4 15.78 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 145' ' ' PHE . 42.3 mm -79.9 126.24 39.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -142.85 172.61 12.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.995 1.318 . . . . 0.0 111.412 -168.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.5 mt -124.0 109.69 23.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.85 87.33 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.375 1.047 . . . . 0.0 110.528 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -160.86 162.2 32.1 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.4 p -160.2 163.52 33.53 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.215 0.462 . . . . 0.0 111.9 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.34 29.34 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -110.05 143.95 39.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.01 1.324 . . . . 0.0 110.092 -172.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.26 43.55 3.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.811 1.645 . . . . 0.0 109.789 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.941 0 O-C-N 121.03 -1.044 . . . . 0.0 111.001 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 117.366 -1.302 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 42.8 Cg_exo -63.04 166.77 13.62 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 CA-C-N 121.623 1.615 . . . . 0.0 112.139 158.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 m -131.11 152.26 50.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 158.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.1 m -139.01 154.9 26.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 108.121 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' HB3' HD11 ' A' ' 164' ' ' LEU . 23.2 p90 -109.83 159.96 16.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.862 0.865 . . . . 0.0 110.612 171.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -144.5 105.02 4.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.831 1.652 . . . . 0.0 107.437 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.29 97.15 5.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 164.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -68.69 141.7 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -125.01 159.9 30.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.397 1.094 . . . . 0.0 109.206 169.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.57 HG22 HD13 ' A' ' 156' ' ' ILE . 16.5 t -137.99 88.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -168.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.44 13.07 1.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.898 1.279 . . . . 0.0 112.35 -165.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.55 -9.43 30.44 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.705 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.68 112.44 8.7 Favored Pre-proline 0 N--CA 1.441 -0.924 0 C-N-CA 126.656 1.982 . . . . 0.0 105.696 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.86 118.63 5.53 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.7 -25.08 30.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.6 -152.03 23.43 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -124.27 114.87 20.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.151 0.975 . . . . 0.0 110.611 159.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.1 t -82.19 161.0 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.732 2.013 . . . . 0.0 108.33 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.7 m -151.4 141.85 22.52 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.315 -1.49 . . . . 0.0 110.205 170.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -117.6 143.47 46.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.894 0.878 . . . . 0.0 109.342 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -87.98 142.28 27.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 161.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -127.39 116.77 21.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -79.64 52.77 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.359 1.064 . . . . 0.0 113.555 -167.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -67.35 -16.17 64.1 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.36 -28.37 65.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.903 1.683 . . . . 0.0 110.705 168.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.27 -32.08 11.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.991 1.716 . . . . 0.0 112.449 -174.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG12 ' HG3' ' A' ' 86' ' ' GLU . 3.3 m -141.8 74.14 22.78 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.469 1.508 . . . . 0.0 109.022 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.53 -43.21 22.9 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.813 2.342 . . . . 0.0 112.342 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.55 -52.2 66.17 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 119.868 1.213 . . . . 0.0 108.515 -177.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 m -60.81 -47.65 85.39 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.641 1.177 . . . . 0.0 111.157 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.76 -33.9 46.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.06 -42.81 68.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.436 1.016 . . . . 0.0 110.014 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -45.15 -55.58 5.59 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.548 1.139 . . . . 0.0 108.561 164.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.82 -29.64 70.14 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -61.26 -55.27 33.84 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.984 1.266 . . . . 0.0 109.532 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -54.39 -45.38 72.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.191 1.396 . . . . 0.0 111.434 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 mt -67.13 -38.57 85.79 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.414 -0.804 . . . . 0.0 111.935 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.9 m -71.2 -36.82 72.05 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.822 0.849 . . . . 0.0 110.836 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -73.96 -23.88 59.55 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.272 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.31 74.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.262 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.78 -25.59 63.23 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.61 1.564 . . . . 0.0 113.565 -159.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -88.56 1.31 55.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.944 1.298 . . . . 0.0 112.089 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.89 15.6 59.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.259 0.933 . . . . 0.0 112.449 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -160.43 177.52 10.49 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.7 -147.45 17.56 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.437 ' O ' HD13 ' A' ' 158' ' ' ILE . 4.1 m-85 -84.06 -24.04 30.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 117.928 -1.035 . . . . 0.0 113.593 -159.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -56.57 120.07 7.15 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 57.33 43.72 93.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.65 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -96.18 -5.37 40.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.671 1.736 . . . . 0.0 113.612 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m 47.11 170.29 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.072 2.149 . . . . 0.0 113.831 -159.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.74 146.5 30.77 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 159.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -106.48 -30.52 9.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.096 -170.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.5 124.13 18.37 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 mm -130.83 109.42 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -121.71 95.02 48.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.62 122.98 11.24 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.455 2.77 . . . . 0.0 112.576 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.79 65.65 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 124.66 1.124 . . . . 0.0 112.446 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -134.56 -76.29 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.59 170.03 21.7 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.023 0.929 . . . . 0.0 110.343 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 122.31 28.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.848 1.659 . . . . 0.0 107.61 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.424 HE22 ' CB ' ' A' ' 101' ' ' ALA . 30.6 tp60 -111.92 133.71 53.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 128.339 2.655 . . . . 0.0 110.384 -165.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.37 -173.31 13.98 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.484 1.992 . . . . 0.0 112.566 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.7 29.25 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 124.231 0.919 . . . . 0.0 115.369 161.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.08 68.48 3.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.247 1.523 . . . . 0.0 109.134 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.84 2.62 44.08 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 113.267 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -139.29 -60.66 0.56 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.595 1.089 . . . . 0.0 109.143 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -83.54 162.92 20.72 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 159.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -124.01 21.89 8.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.686 1.194 . . . . 0.0 108.978 -166.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -162.46 -0.9 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.418 1.087 . . . . 0.0 113.468 -158.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.8 14.21 19.91 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.202 1.365 . . . . 0.0 115.581 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.1 p -118.69 16.28 13.61 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.116 1.458 . . . . 0.0 112.866 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.26 -152.64 5.68 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.95 173.32 47.68 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -166.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -153.45 144.0 22.53 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.722 -0.869 . . . . 0.0 110.715 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.479 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 69.5 p -73.74 22.57 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 130.033 3.333 . . . . 0.0 113.835 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.623 HG21 ' HB3' ' A' ' 38' ' ' ALA . 6.4 pt 49.16 -22.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 1 C-N-CA 132.204 4.202 . . . . 0.0 116.127 -158.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -89.41 -19.89 24.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.484 1.914 . . . . 0.0 110.675 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.65 128.96 3.13 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 126.036 1.779 . . . . 0.0 109.336 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.331 48.3 tt0 50.1 -132.57 1.77 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -116.12 171.54 7.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.584 1.554 . . . . 0.0 109.408 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 77' ' ' SER . 0.7 OUTLIER -139.24 -177.48 4.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.597 1.559 . . . . 0.0 110.073 175.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -56.62 164.93 1.28 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.538 2.335 . . . . 0.0 113.207 -176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.92 75.44 10.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 164.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.415 ' HG3' HG12 ' A' ' 29' ' ' VAL . 9.7 pt-20 -45.99 -56.86 4.96 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -159.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.412 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -153.73 153.68 32.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 160.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.2 16.27 26.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.414 2.286 . . . . 0.0 111.207 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 mt -50.76 -53.17 14.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.882 1.273 . . . . 0.0 109.126 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.33 123.06 23.89 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -118.32 170.56 8.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.409 1.484 . . . . 0.0 109.377 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -81.5 54.12 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.504 1.921 . . . . 0.0 111.007 -167.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.4 p -69.67 -9.72 55.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -158.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.86 177.13 44.65 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.05 1.295 . . . . 0.0 111.802 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.25 155.31 46.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.645 1.563 . . . . 0.0 110.266 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.32 4.54 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.505 -1.72 . . . . 0.0 113.216 -171.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.06 162.32 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 120.795 2.298 . . . . 0.0 107.366 163.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.17 124.74 22.21 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 109.649 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 157.52 43.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.895 0.855 . . . . 0.0 110.941 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 91.4 mmm -64.07 156.01 29.56 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.108 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.424 ' CB ' HE22 ' A' ' 63' ' ' GLN . . . -112.42 136.51 51.81 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -146.2 172.24 13.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.35 1.46 . . . . 0.0 107.822 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.06 15.85 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.239 1.416 . . . . 0.0 111.656 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.63 -165.49 26.79 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -168.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -64.28 166.38 17.19 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 118.95 1.375 . . . . 0.0 110.048 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 37.67 43.91 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.287 3.035 . . . . 0.0 113.55 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -133.31 33.17 3.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.556 1.542 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -79.97 108.06 13.25 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.5 -100.62 2.09 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 89.9 p -145.77 33.88 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.315 0.646 . . . . 0.0 110.674 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -121.06 142.49 49.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -157.24 155.5 30.92 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -165.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 28.0 p90 -134.68 147.34 50.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.504 167.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.1 mt -83.85 117.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 29.1 m -63.69 129.01 38.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 p -117.79 26.3 9.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.19 0.995 . . . . 0.0 109.299 171.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.96 11.88 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 163.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -68.47 96.42 0.69 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 159.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.5 p -83.13 60.1 5.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.116 0.871 . . . . 0.0 109.835 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.64 -14.63 59.0 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.5 1.52 . . . . 0.0 113.086 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -76.45 -10.38 59.35 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.934 -1.104 . . . . 0.0 111.711 169.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 67.6 mt -104.69 -5.89 20.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.807 1.643 . . . . 0.0 110.99 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -63.99 132.12 49.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.48 17.74 74.81 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 122.113 -0.367 . . . . 0.0 113.089 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -128.04 -34.32 2.13 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.003 1.321 . . . . 0.0 110.854 176.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -140.35 162.63 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.224 0.92 . . . . 0.0 110.542 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.94 105.86 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.979 2.112 . . . . 0.0 107.434 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.53 131.95 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 166.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -138.33 -0.47 2.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.33 -177.7 27.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.344 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.93 148.17 36.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.261 1.424 . . . . 0.0 107.417 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.9 106.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 162.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -70.05 -50.36 41.98 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 159.19 42.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.53 0.732 . . . . 0.0 110.918 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.84 24.41 60.12 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.146 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -35.2 68.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.969 1.885 . . . . 0.0 110.343 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -64.99 -21.58 66.87 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.77 -34.0 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.156 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.88 -41.52 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.093 167.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.93 -29.1 70.53 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.185 -0.947 . . . . 0.0 112.302 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.46 -42.85 74.36 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.216 0.916 . . . . 0.0 109.566 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.8 mtm -56.28 -45.72 80.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.269 0.486 . . . . 0.0 110.867 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.58 -40.76 65.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 112.47 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -68.82 -20.58 64.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.052 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.442 ' HB2' HD11 ' A' ' 156' ' ' ILE . 22.9 m-85 -91.32 3.99 53.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.013 0.925 . . . . 0.0 112.75 173.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.78 -148.37 14.82 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 121.058 1.754 . . . . 0.0 112.727 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.3 p -163.89 161.2 22.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.314 1.446 . . . . 0.0 107.235 158.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -59.54 -29.99 68.29 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.406 -1.434 . . . . 0.0 114.528 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -75.37 -7.71 54.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.36 -26.38 20.36 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 126.197 1.856 . . . . 0.0 113.726 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.06 123.93 20.76 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.393 1.077 . . . . 0.0 109.418 -171.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.3 p -75.81 143.88 41.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.862 1.665 . . . . 0.0 110.641 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.6 p -84.85 -13.65 50.34 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.106 -1.621 . . . . 0.0 111.938 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.511 ' HD3' ' CG1' ' A' ' 12' ' ' VAL . 78.7 mttt -146.84 157.46 43.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.164 1.785 . . . . 0.0 108.748 -168.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.514 ' HE2' HG21 ' A' ' 157' ' ' THR . 81.3 tttt -76.31 84.56 3.09 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.502 1.046 . . . . 0.0 108.296 174.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.57 HD13 HG22 ' A' ' 12' ' ' VAL . 5.6 mm -73.2 117.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.514 HG21 ' HE2' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -138.72 172.16 13.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.541 1.137 . . . . 0.0 110.585 -170.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 48' ' ' TYR . 5.3 mp -103.52 118.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 159.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -73.33 -49.62 26.42 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 167.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.3 152.67 40.28 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.092 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.8 p -164.08 165.5 22.26 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.83 0.852 . . . . 0.0 109.546 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.7 -170.21 43.33 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.55 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.8 tp60 -79.88 146.55 32.11 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.34 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 7' ' ' PHE . 60.8 mt -138.31 42.91 2.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.437 1.495 . . . . 0.0 110.424 161.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.55 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 5.8 mt-10 . . . . . 0 C--O 1.248 0.987 0 O-C-N 120.971 -1.08 . . . . 0.0 111.212 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -62.94 136.76 58.7 Favored 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 121.395 1.396 . . . . 0.0 108.947 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.8 m -98.5 145.93 26.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.68 133.82 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -87.94 157.84 18.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.134 0.968 . . . . 0.0 109.135 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -132.49 149.59 52.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -129.55 93.32 3.52 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 mm -77.18 141.62 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.69 160.82 28.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.635 1.574 . . . . 0.0 108.568 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.02 113.27 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 58.68 14.39 3.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.836 1.254 . . . . 0.0 114.258 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.36 -3.85 40.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.676 2.084 . . . . 0.0 113.17 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.85 115.46 61.0 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -57.83 120.27 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.132 1.888 . . . . 0.0 109.788 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -82.91 -43.46 16.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.44 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.21 152.62 7.03 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -76.78 152.34 35.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -141.33 160.43 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 126.803 2.041 . . . . 0.0 105.93 -174.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -142.87 152.39 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 122.129 0.966 . . . . 0.0 109.622 172.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.88 147.82 49.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.864 1.266 . . . . 0.0 108.857 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.8 139.4 39.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.95 1.7 . . . . 0.0 106.49 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.63 131.6 53.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.944 1.298 . . . . 0.0 107.814 -177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.21 52.64 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.014 0.926 . . . . 0.0 113.316 -166.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -18.89 56.68 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.897 -1.752 . . . . 0.0 115.628 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.15 0.27 53.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.734 1.152 . . . . 0.0 111.801 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -128.52 -29.54 2.41 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.466 1.506 . . . . 0.0 112.628 173.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.79 72.74 76.96 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.515 1.526 . . . . 0.0 108.9 167.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -56.36 -42.72 62.91 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.153 1.902 . . . . 0.0 114.194 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -53.6 53.35 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.5 m -62.13 -48.83 78.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.3 1.44 . . . . 0.0 109.983 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.87 -46.49 74.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -37.47 81.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.471 0.578 . . . . 0.0 109.801 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -56.95 -53.05 62.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -66.01 -32.8 74.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -51.75 -63.9 0.99 Allowed 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 124.351 1.06 . . . . 0.0 109.137 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.979 0.912 . . . . 0.0 113.242 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -71.38 -33.01 69.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.404 1.002 . . . . 0.0 111.523 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -65.55 -51.41 60.01 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.429 1.468 . . . . 0.0 108.965 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -63.83 -33.64 76.14 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.498 0.719 . . . . 0.0 110.432 -171.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.34 90.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.08 -24.28 67.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.713 1.257 . . . . 0.0 112.102 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -68.06 1.62 2.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.588 1.555 . . . . 0.0 112.395 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.82 5.83 84.55 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.644 1.116 . . . . 0.0 112.006 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -153.01 173.97 14.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.657 2.383 . . . . 0.0 106.537 167.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.95 -162.93 29.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 121.713 0.618 . . . . 0.0 111.967 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' CE1' ' HA2' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -69.36 -15.33 63.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.326 2.65 . . . . 0.0 112.631 177.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -62.85 100.06 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.029 -1.045 . . . . 0.0 108.578 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.2 80.01 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.142 -1.921 . . . . 0.0 115.473 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.8 p -64.3 -48.71 74.59 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.206 2.503 . . . . 0.0 111.528 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.4 m 106.76 144.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 1 C-N-CA 133.175 4.59 . . . . 0.0 108.343 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.65 136.2 33.47 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 162.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -119.68 -10.18 9.63 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.6 119.42 15.21 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.23 110.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 170.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.7 mt -116.55 94.65 43.86 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -54.92 121.06 9.18 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.814 3.01 . . . . 0.0 112.999 -168.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.73 26.35 46.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.933 1.254 . . . . 0.0 111.416 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -143.07 -68.8 0.34 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.383 1.092 . . . . 0.0 108.564 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -161.08 161.61 31.31 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.83 117.18 24.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -122.34 132.58 54.46 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.271 1.828 . . . . 0.0 109.339 -166.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.52 32.21 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 142.03 49.86 0.04 OUTLIER Glycine 0 N--CA 1.466 0.674 0 CA-C-N 119.526 1.663 . . . . 0.0 112.593 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' HB3' HE21 ' A' ' 111' ' ' GLN . 5.5 p-10 -143.0 113.79 7.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -160.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.434 ' CE1' ' HE3' ' A' ' 76' ' ' LYS . 53.7 p90 -130.25 12.27 5.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.702 1.601 . . . . 0.0 110.745 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -122.98 -67.91 0.92 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.906 1.283 . . . . 0.0 108.834 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -106.07 -20.14 13.51 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 60.45 -3.81 0.13 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 119.03 2.974 . . . . 0.0 119.03 166.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -112.15 0.97 16.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.474 1.51 . . . . 0.0 112.842 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.472 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 118.45 -22.74 9.34 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.056 1.788 . . . . 0.0 112.382 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.1 p -85.25 20.54 1.94 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.413 1.106 . . . . 0.0 112.319 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.63 166.16 32.73 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 113.778 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.53 126.84 3.64 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 128.588 2.994 . . . . 0.0 105.996 -159.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HE3' ' CE1' ' A' ' 67' ' ' PHE . 3.5 pttt -143.54 152.87 41.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.085 2.554 . . . . 0.0 105.97 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.0 p -72.38 168.62 18.04 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.972 0.795 . . . . 0.0 109.856 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 pt -64.84 -18.65 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 123.784 0.834 . . . . 0.0 112.222 166.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -96.5 -6.76 36.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.79 -171.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.77 -84.57 0.13 Allowed Glycine 0 C--N 1.34 0.769 0 CA-C-N 119.921 1.237 . . . . 0.0 111.071 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -132.44 -137.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.888 1.675 . . . . 0.0 107.784 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -75.89 154.22 36.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.692 0.797 . . . . 0.0 109.908 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -125.63 177.01 6.48 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.122 0.963 . . . . 0.0 109.005 168.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.0 170.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.956 1.302 . . . . 0.0 112.326 -172.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.6 106.32 2.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 159.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.67 -44.87 92.48 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.264 0.625 . . . . 0.0 111.004 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.16 153.75 1.65 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 125.529 1.768 . . . . 0.0 114.133 158.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.68 15.26 29.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.254 2.222 . . . . 0.0 111.126 -169.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.8 mt -37.57 -46.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 128.045 2.538 . . . . 0.0 110.636 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.2 mt -92.15 121.94 34.17 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.164 1.786 . . . . 0.0 106.87 -173.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -97.16 169.3 9.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 110.45 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -82.27 80.91 8.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 108.055 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -79.74 -20.75 45.64 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.99 175.4 36.37 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.954 1.252 . . . . 0.0 112.768 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.97 134.66 40.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.069 1.846 . . . . 0.0 110.449 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.53 -11.4 28.16 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.311 1.91 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 120.299 2.05 . . . . 0.0 109.185 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.97 132.16 53.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 126.156 1.783 . . . . 0.0 108.556 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.7 t -142.04 153.45 44.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.634 . . . . 0.0 110.304 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 92.4 mmm -80.21 137.66 36.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.074 0.55 . . . . 0.0 110.324 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.74 124.3 30.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 169.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.65 150.63 51.57 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.632 1.173 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.62 14.05 12.57 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.696 1.598 . . . . 0.0 113.068 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.07 -165.24 28.94 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 -165.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -63.45 164.71 19.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 119.249 1.524 . . . . 0.0 109.748 167.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 33.62 48.71 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 131.159 3.784 . . . . 0.0 112.478 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.9 p -138.99 30.84 2.22 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.359 -1.463 . . . . 0.0 112.136 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -86.23 149.71 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.747 -1.221 . . . . 0.0 107.865 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.16 -66.18 0.01 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.7 t -146.5 -28.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.096 0.958 . . . . 0.0 111.092 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.472 HE22 ' HA2' ' A' ' 72' ' ' GLY . 19.8 mt-30 -61.54 128.33 35.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -134.52 174.74 10.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.304 1.042 . . . . 0.0 108.265 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 99' ' ' SER . 20.3 p90 -139.58 149.73 44.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.22 1.01 . . . . 0.0 110.847 164.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.1 mt -83.22 116.85 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 100.696 -3.816 . . . . 0.0 100.696 164.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.8 m -67.81 108.13 2.86 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.5 p -102.56 28.46 6.01 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.322 1.049 . . . . 0.0 108.988 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.71 175.75 11.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.723 1.609 . . . . 0.0 107.466 166.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -71.78 86.62 0.95 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 166.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 p -74.87 40.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.239 2.216 . . . . 0.0 112.384 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.24 -20.96 61.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.015 -1.678 . . . . 0.0 114.08 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -68.37 -15.53 63.59 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.414 0.686 . . . . 0.0 111.103 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.5 mt -95.7 -3.22 46.4 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.58 1.552 . . . . 0.0 111.353 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.03 157.53 24.97 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.237 -0.914 . . . . 0.0 110.028 169.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.45 -0.0 14.97 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.295 1.426 . . . . 0.0 113.785 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -129.32 -47.92 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.507 1.523 . . . . 0.0 109.015 -172.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.15 146.12 40.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.458 0.647 . . . . 0.0 111.028 -167.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 t -95.35 100.99 11.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.04 126.83 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -138.87 2.36 2.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.66 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.28 -173.06 34.32 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.086 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -149.84 160.84 43.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.405 1.082 . . . . 0.0 110.724 164.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.25 115.71 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 166.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -49.91 28.6 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.33 159.19 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.994 2.518 . . . . 0.0 108.496 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.56 20.94 13.53 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.422 1.011 . . . . 0.0 113.236 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 33.6 tpp -54.61 -39.51 67.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.518 1.659 . . . . 0.0 111.813 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.34 69.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.806 1.639 . . . . 0.0 112.058 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.58 -45.16 52.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 118.954 0.797 . . . . 0.0 109.158 176.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.85 -47.03 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 0.0 110.368 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.81 -24.7 65.32 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.029 -1.044 . . . . 0.0 111.901 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.79 -43.83 57.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.958 -1.089 . . . . 0.0 109.182 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 66.9 mtp -56.36 -43.06 78.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.247 -0.908 . . . . 0.0 110.138 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.84 -37.21 83.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -71.87 -21.3 61.68 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 120.269 1.395 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.416 ' CB ' HD11 ' A' ' 156' ' ' ILE . 28.9 m-85 -93.11 5.47 51.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.735 1.614 . . . . 0.0 111.519 171.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.57 48.07 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 108.424 -1.871 . . . . 0.0 108.424 167.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.1 p -151.86 163.34 39.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -61.84 -27.87 69.09 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 107.69 -27.03 16.03 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.374 1.464 . . . . 0.0 113.725 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 130.71 43.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.974 1.887 . . . . 0.0 108.015 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.0 p -70.86 138.19 50.02 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.7 p -64.11 -30.55 71.61 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.61 -0.681 . . . . 0.0 110.29 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -125.59 170.56 11.36 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.329 1.452 . . . . 0.0 109.044 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -86.99 87.75 7.54 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.783 -1.198 . . . . 0.0 108.676 -177.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.416 HD11 ' CB ' ' A' ' 145' ' ' PHE . 33.5 mm -75.6 120.19 24.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -142.71 172.77 12.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.525 1.155 . . . . 0.0 111.163 -173.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.03 113.81 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.78 -56.87 16.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -157.49 165.59 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.703 1.201 . . . . 0.0 109.873 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 54.3 m -141.6 163.65 32.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 127.327 2.251 . . . . 0.0 105.622 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.62 172.65 42.53 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.33 156.02 29.8 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.944 -0.739 . . . . 0.0 109.271 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 33.2 mt -136.63 43.0 2.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.882 0.373 . . . . 0.0 110.838 159.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 116.932 -1.907 . . . . 0.0 107.028 158.529 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tmm? . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -112.95 170.51 4.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.239 1.016 . . . . 0.0 109.358 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -71.87 127.49 90.65 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.758 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.14 152.14 76.52 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.62 1.547 . . . . 0.0 109.875 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 m -111.18 156.47 21.37 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.58 163.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.208 1.003 . . . . 0.0 110.017 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -125.74 159.07 33.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 125.224 1.41 . . . . 0.0 109.657 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -146.12 118.24 8.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 107.011 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.03 96.85 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 mm -69.5 140.03 19.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.96 128.28 32.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.844 1.258 . . . . 0.0 109.827 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.497 HG12 ' HE2' ' A' ' 154' ' ' LYS . 22.6 t -95.95 109.48 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.43 13.76 0.99 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.634 1.574 . . . . 0.0 113.664 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.16 -11.78 26.62 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.72 1.629 . . . . 0.0 113.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -81.71 127.61 72.07 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 119.647 1.723 . . . . 0.0 107.201 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.83 119.13 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.724 1.616 . . . . 0.0 109.451 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -89.0 -32.8 17.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.484 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.09 162.87 10.39 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -68.62 147.85 51.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.21 154.3 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 126.966 2.107 . . . . 0.0 105.568 169.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.0 t -139.7 153.29 47.21 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.827 0.823 . . . . 0.0 109.182 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 60.4 m-85 -142.17 155.48 45.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.324 1.05 . . . . 0.0 108.773 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -107.32 146.69 31.23 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.479 1.511 . . . . 0.0 107.243 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -122.31 114.22 20.49 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -71.91 56.61 0.3 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.397 1.879 . . . . 0.0 113.198 -171.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.37 -28.85 13.67 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.628 1.571 . . . . 0.0 112.077 169.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -19.57 65.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.157 0.983 . . . . 0.0 112.04 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -125.45 -31.4 3.01 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 m -129.78 71.55 82.12 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.94 -43.06 26.94 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.611 2.207 . . . . 0.0 110.37 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -55.96 28.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -58.66 -46.88 86.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.56 0.744 . . . . 0.0 111.153 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.24 84.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.456 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.74 -43.74 83.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.716 1.206 . . . . 0.0 111.333 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.82 -51.64 66.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 108.025 176.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -66.02 -44.89 83.41 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 124.162 0.914 . . . . 0.0 112.238 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -43.79 -59.1 2.38 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.656 1.582 . . . . 0.0 108.976 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.48 71.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.554 1.541 . . . . 0.0 113.308 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.39 -40.04 62.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.275 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.29 -50.67 66.96 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 119.449 1.022 . . . . 0.0 111.066 173.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.1 p -67.35 -17.62 64.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.397 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 5.95 89.04 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.168 0.89 . . . . 0.0 112.139 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -5.25 27.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.065 1.433 . . . . 0.0 113.954 -171.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -96.96 12.96 30.54 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.711 1.205 . . . . 0.0 110.846 170.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.15 74.05 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 120.714 -1.241 . . . . 0.0 113.054 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.52 -165.31 1.52 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.871 2.068 . . . . 0.0 106.357 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.69 -138.18 13.47 Favored Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CZ ' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -81.55 -26.4 35.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.38 1.072 . . . . 0.0 113.486 -167.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -57.97 110.03 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.148 0.979 . . . . 0.0 108.966 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.71 90.18 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.952 1.263 . . . . 0.0 115.627 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -100.23 7.46 44.45 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.991 2.395 . . . . 0.0 114.078 -158.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 62.94 174.59 0.15 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 127.925 2.49 . . . . 0.0 116.183 159.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.56 121.03 38.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 112.136 -2.302 . . . . 0.0 106.566 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -108.47 -24.14 11.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.511 1.124 . . . . 0.0 111.03 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.8 105.36 8.19 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 mt -118.73 114.99 46.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.07 95.51 36.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -168.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -41.12 125.97 2.51 Favored 'Trans proline' 0 C--O 1.24 0.586 1 C-N-CA 125.418 4.078 . . . . 0.0 114.538 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.34 29.96 74.73 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.127 1.346 . . . . 0.0 111.777 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -135.84 -79.89 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.06 171.15 20.51 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.2 m -120.19 91.1 3.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.396 2.278 . . . . 0.0 109.379 170.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -79.93 139.14 37.19 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.486 1.915 . . . . 0.0 110.9 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.42 -171.41 17.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.813 1.673 . . . . 0.0 111.54 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.39 24.73 9.25 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 123.363 0.506 . . . . 0.0 112.595 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.75 76.07 9.98 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CD1' HG23 ' A' ' 68' ' ' THR . 1.5 p90 -98.61 -11.8 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.582 HG21 ' CE ' ' A' ' 76' ' ' LYS . 17.6 p -134.31 -10.35 2.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.72 1.208 . . . . 0.0 113.253 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.3 mmt-85 -138.61 -172.38 3.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.27 34.32 0.52 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.384 0.993 . . . . 0.0 112.481 -168.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -150.72 12.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.0 1.32 . . . . 0.0 111.838 -163.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.56 32.65 27.08 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 118.987 -0.896 . . . . 0.0 110.885 -175.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -135.76 1.57 2.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.572 1.186 . . . . 0.0 112.185 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.19 166.09 33.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 119.648 1.113 . . . . 0.0 110.725 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 147.03 14.0 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.569 1.094 . . . . 0.0 114.362 165.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' CE ' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -155.46 160.32 40.52 Favored 'General case' 0 C--O 1.238 0.474 1 C-N-CA 132.07 4.148 . . . . 0.0 104.4 -173.966 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.5 p -78.34 171.76 14.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.974 0.806 . . . . 0.0 110.831 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.5 -25.18 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.729 0.412 . . . . 0.0 111.406 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.01 -22.11 24.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.391 0.676 . . . . 0.0 111.143 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.94 172.43 28.24 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.191 0.884 . . . . 0.0 114.044 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -65.14 112.69 3.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.949 1.7 . . . . 0.0 108.225 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 48.38 161.41 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.66 1 C-N-CA 133.884 4.874 . . . . 0.0 115.099 -165.219 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -139.29 175.35 9.63 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.819 162.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -65.89 159.8 24.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.354 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 114.61 13.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 161.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.45 -56.62 16.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.893 1.277 . . . . 0.0 110.819 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -169.03 -177.82 3.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.429 1.492 . . . . 0.0 108.702 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -130.44 25.14 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.604 1.962 . . . . 0.0 109.128 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.84 -57.72 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.95 128.11 34.66 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.551 2.34 . . . . 0.0 105.476 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -119.93 165.36 14.74 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.919 1.288 . . . . 0.0 110.244 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -81.77 56.13 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.559 1.543 . . . . 0.0 110.343 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -66.06 -23.25 66.5 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.863 1.265 . . . . 0.0 113.614 -160.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.5 179.36 48.75 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.27 160.58 19.02 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.576 1.517 . . . . 0.0 110.318 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.5 4.23 64.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.637 -1.646 . . . . 0.0 112.46 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.1 mm -79.4 166.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 121.009 2.405 . . . . 0.0 108.09 166.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 132.08 27.8 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.067 1.347 . . . . 0.0 109.61 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.6 t -143.79 147.24 33.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.016 0.526 . . . . 0.0 111.172 -170.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 97.4 mmm -74.33 117.92 16.69 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.557 1.143 . . . . 0.0 109.984 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -67.66 139.11 56.77 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 162.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -144.06 -178.03 5.74 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.83 2.052 . . . . 0.0 108.215 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.09 16.86 24.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.462 1.105 . . . . 0.0 111.926 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.28 -160.91 21.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.325 1.441 . . . . 0.0 109.659 -167.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -60.94 150.21 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.978 1.785 . . . . 0.0 109.844 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 39.14 48.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.078 2.951 . . . . 0.0 114.13 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.5 p -138.82 21.25 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.909 1.284 . . . . 0.0 110.58 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.77 155.96 25.2 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.923 -1.11 . . . . 0.0 108.278 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.32 -66.53 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-N 119.468 1.031 . . . . 0.0 114.782 -166.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -156.22 -5.59 0.11 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 118.341 -0.838 . . . . 0.0 112.899 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.463 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 2.1 mm-40 -78.63 136.94 37.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CE2' ' CZ ' ' A' ' 48' ' ' TYR . 5.3 p90 -130.97 169.73 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 164.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -130.98 146.43 52.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.887 0.475 . . . . 0.0 109.807 160.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.3 mt -83.5 116.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 169.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 m -60.75 124.15 19.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 168.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -110.47 21.57 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.155 0.582 . . . . 0.0 109.683 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.28 179.03 8.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.64 91.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.3 p -83.76 50.73 1.87 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.096 0.862 . . . . 0.0 110.663 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -18.92 51.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.978 1.311 . . . . 0.0 112.797 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -67.02 -19.22 65.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.762 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.8 mt -95.54 -4.34 44.93 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.668 1.587 . . . . 0.0 112.325 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.15 129.27 39.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.607 1.094 . . . . 0.0 108.787 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.81 -1.98 83.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.111 -1.383 . . . . 0.0 112.747 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -118.6 -20.23 8.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.043 1.922 . . . . 0.0 112.912 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -139.42 153.05 47.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.361 0.982 . . . . 0.0 111.044 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.0 t -88.0 100.01 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.93 126.39 19.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 163.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -140.76 -0.7 1.5 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.14 -178.67 28.8 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 119.08 0.855 . . . . 0.0 111.667 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -149.63 153.89 37.76 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.418 1.487 . . . . 0.0 107.591 172.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.85 126.45 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 166.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.428 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 23.9 ttmt -82.93 -52.17 6.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 164.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 162.34 40.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.227 -167.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.14 26.09 74.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.729 0.681 . . . . 0.0 113.45 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -38.91 75.27 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.329 1.564 . . . . 0.0 110.098 175.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -61.36 -25.11 66.94 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 172.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mm -77.72 -38.48 25.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.64 -39.84 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.777 0.717 . . . . 0.0 109.54 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -60.87 -34.78 75.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.944 -1.098 . . . . 0.0 111.808 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.39 63.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.384 0.993 . . . . 0.0 109.509 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 69.5 mtp -52.66 -42.26 64.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.236 1.015 . . . . 0.0 110.486 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -62.6 -34.47 77.08 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -30.05 70.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.616 1.098 . . . . 0.0 110.243 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -92.89 5.91 49.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.035 1.734 . . . . 0.0 111.86 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.75 -149.95 7.62 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 170.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 p -146.47 -61.51 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 141.75 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 1 C-N-CA 132.716 4.407 . . . . 0.0 109.726 -169.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 5.12 2.65 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 118.571 0.623 . . . . 0.0 111.454 164.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.54 -42.75 2.96 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 126.589 2.043 . . . . 0.0 111.556 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -60.24 123.89 18.59 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 61.3 p -72.98 164.04 27.28 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 124.343 1.027 . . . . 0.0 110.091 -167.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -88.5 -8.99 53.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.426 0.69 . . . . 0.0 111.239 163.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.497 ' HE2' HG12 ' A' ' 12' ' ' VAL . 15.3 tttt -152.81 149.24 28.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 109.934 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -75.06 123.0 24.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 -172.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 mt -112.62 126.49 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.54 175.84 9.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.151 -158.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.74 112.28 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.0 76.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -150.69 156.48 41.41 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.7 p -161.9 160.64 28.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.523 1.129 . . . . 0.0 109.722 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.93 -171.44 43.55 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -95.11 151.99 18.72 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.1 mt -125.66 42.5 3.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.601 1.191 . . . . 0.0 108.446 165.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.186 1.394 . . . . 0.0 111.822 176.313 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.03 172.39 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.487 0.661 . . . . 0.0 110.079 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -80.86 108.76 10.94 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 161.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.03 157.37 57.52 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.517 1.22 . . . . 0.0 109.242 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.439 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 32.6 m -110.11 155.69 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 170.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.19 158.72 41.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.563 1.545 . . . . 0.0 107.536 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -135.34 159.61 41.02 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 123.446 0.698 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.629 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 64.4 m-85 -153.29 114.23 4.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.972 1.709 . . . . 0.0 108.596 -173.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -74.4 102.78 4.53 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 163.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.0 mm -67.38 143.02 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.99 129.48 22.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.336 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.548 HG12 ' HE2' ' A' ' 154' ' ' LYS . 78.6 t -93.05 101.13 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 127.409 2.284 . . . . 0.0 104.937 173.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 60.37 13.6 4.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.448 1.022 . . . . 0.0 113.754 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 0.26 53.58 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.407 1.479 . . . . 0.0 113.947 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 110.3 34.25 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 167.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.34 136.23 42.73 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.516 1.478 . . . . 0.0 110.001 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -104.61 -21.19 13.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.9 1.68 . . . . 0.0 110.61 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.39 156.22 7.19 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.045 0.839 . . . . 0.0 112.478 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.18 130.23 42.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.56 150.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.4 m -137.1 147.07 45.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 87.0 m-85 -135.63 136.36 40.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -173.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.39 152.35 39.54 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 162.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.2 mt -126.88 122.22 34.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.416 ' CD2' HD13 ' A' ' 90' ' ' LEU . 57.1 m-85 -69.61 52.71 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.862 2.065 . . . . 0.0 112.065 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.87 -21.99 58.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.081 -1.637 . . . . 0.0 112.222 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.06 4.17 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.047 0.939 . . . . 0.0 113.37 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -125.98 -35.52 2.46 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.329 1.452 . . . . 0.0 110.605 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m -142.12 68.35 22.39 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.148 1.779 . . . . 0.0 108.886 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.03 -37.88 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.063 1.842 . . . . 0.0 113.194 -176.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -55.07 39.12 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.078 1.763 . . . . 0.0 109.773 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.95 -40.79 90.21 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 122.838 0.455 . . . . 0.0 110.008 -175.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.14 -33.08 67.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.31 -50.09 49.83 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.812 1.645 . . . . 0.0 109.55 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -45.72 -51.37 12.61 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 126.042 1.737 . . . . 0.0 109.661 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.35 90.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -56.56 -59.25 5.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.753 1.221 . . . . 0.0 107.87 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.72 -50.22 25.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.77 1.228 . . . . 0.0 112.491 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.92 -29.24 68.27 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.951 -1.093 . . . . 0.0 111.547 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.3 p -77.62 -43.53 31.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.965 1.257 . . . . 0.0 112.612 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.1 p -65.71 -32.29 73.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 7.02 89.02 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.435 1.017 . . . . 0.0 111.741 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.45 -16.93 64.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.842 1.657 . . . . 0.0 114.101 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -83.02 -1.9 53.86 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.014 -1.054 . . . . 0.0 110.581 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.58 8.4 65.82 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.634 1.112 . . . . 0.0 112.842 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -156.18 -172.61 4.16 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.065 1.432 . . . . 0.0 110.434 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.87 -139.45 10.96 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-O 122.321 0.956 . . . . 0.0 113.417 160.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.629 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 7.3 t80 -62.76 -34.6 77.56 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.524 1.93 . . . . 0.0 108.69 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.99 124.86 19.13 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.595 1.088 . . . . 0.0 108.888 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.86 -0.39 21.65 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.105 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.1 m -64.36 115.21 4.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 120.949 2.374 . . . . 0.0 105.542 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.3 p -75.86 156.37 34.44 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.699 -0.626 . . . . 0.0 109.61 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 62.1 m-85 -91.72 95.58 9.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.55 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -74.69 -21.05 59.6 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -166.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 82.76 1.85 Allowed 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 121.151 -0.968 . . . . 0.0 109.367 -169.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.487 HD12 ' CG2' ' A' ' 152' ' ' THR . 7.7 mt -102.66 101.9 12.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.18 92.34 45.3 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -167.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -48.64 130.89 23.21 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.75 19.34 79.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.185 1.85 . . . . 0.0 112.114 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -142.03 -62.96 0.44 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.547 1.174 . . . . 0.0 109.434 -170.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -168.75 164.25 11.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.902 0.774 . . . . 0.0 112.347 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.9 m -113.32 93.1 4.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 108.277 159.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -76.89 142.99 39.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.002 0.921 . . . . 0.0 109.852 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -152.97 -164.5 12.56 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 124.85 1.214 . . . . 0.0 110.584 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.31 43.0 6.38 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.395 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -130.02 136.28 49.22 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 119.754 1.777 . . . . 0.0 107.929 159.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -134.39 5.95 3.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 127.91 2.484 . . . . 0.0 109.487 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -114.06 -53.49 2.67 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.391 1.477 . . . . 0.0 107.787 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -117.11 -165.9 1.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 158.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -174.22 46.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -166.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -166.85 20.82 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.158 2.183 . . . . 0.0 110.253 -170.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.58 -32.55 4.72 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.458 -1.19 . . . . 0.0 113.52 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.5 p -83.84 6.67 20.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.517 2.158 . . . . 0.0 114.673 -161.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -115.8 -124.47 3.73 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.86 100.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 127.187 2.327 . . . . 0.0 113.547 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -129.34 146.43 51.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.468 1.907 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.0 p -80.84 -178.4 6.81 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.993 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.6 pt -76.73 -6.84 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.472 168.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -90.78 -3.16 57.63 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.16 0.891 . . . . 0.0 112.057 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.76 91.17 1.92 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.267 10.7 tp10 62.17 -133.63 0.54 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.381 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -103.37 131.31 50.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.685 1.13 . . . . 0.0 110.871 -160.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -98.08 169.8 9.36 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.852 0.835 . . . . 0.0 110.107 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -66.7 170.57 6.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.51 1.524 . . . . 0.0 111.226 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -85.95 113.93 22.45 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -43.56 -55.65 4.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.96 1.304 . . . . 0.0 110.989 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -172.52 177.57 2.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.793 2.437 . . . . 0.0 106.479 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -125.49 32.09 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.661 1.184 . . . . 0.0 109.293 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.71 -55.78 20.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.416 HD13 ' CD2' ' A' ' 25' ' ' PHE . 64.2 mt -84.4 130.02 34.82 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.155 1.382 . . . . 0.0 107.566 -170.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -120.8 165.27 15.38 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 126.947 2.099 . . . . 0.0 109.449 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -85.7 65.76 9.31 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.557 0.743 . . . . 0.0 110.598 -164.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 p -70.97 -19.2 62.58 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -162.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.01 178.8 48.92 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 119.361 0.982 . . . . 0.0 111.918 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -62.1 158.69 37.95 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.545 2.163 . . . . 0.0 110.304 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.6 -6.84 36.26 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 116.974 -2.014 . . . . 0.0 112.934 -173.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.69 156.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-N 121.46 2.63 . . . . 0.0 108.11 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.426 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -134.05 131.14 38.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.172 0.989 . . . . 0.0 110.852 176.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.82 150.23 33.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.29 1.036 . . . . 0.0 110.955 -164.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.62 138.14 54.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.0 50.92 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -59.99 163.35 4.77 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.065 1.412 . . . . 0.0 109.681 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.48 14.24 13.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.6 -165.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.81 -167.22 27.73 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.713 2.102 . . . . 0.0 107.98 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.44 143.66 58.52 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.284 1.989 . . . . 0.0 110.232 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 m120 50.11 47.78 23.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.551 2.34 . . . . 0.0 112.7 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 p -120.37 23.0 11.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.871 1.268 . . . . 0.0 111.638 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -69.42 135.85 50.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.322 1.049 . . . . 0.0 108.885 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.0 -78.45 0.02 OUTLIER Glycine 0 C--N 1.337 0.588 0 CA-C-N 118.436 0.562 . . . . 0.0 112.867 -168.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -142.21 -47.13 0.35 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.543 0.737 . . . . 0.0 109.963 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -62.46 137.7 58.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 124.082 0.863 . . . . 0.0 108.676 -170.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.429 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 45.4 p90 -141.81 172.75 12.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.871 1.668 . . . . 0.0 107.316 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 48.6 p90 -141.86 151.1 42.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.423 0.63 . . . . 0.0 109.697 158.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.34 120.8 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.76 127.4 31.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.9 p -107.66 19.84 19.62 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.724 0.809 . . . . 0.0 110.023 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.8 -177.89 5.4 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 164.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -60.99 128.02 34.43 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 158.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.43 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 71.9 p -117.67 72.77 0.86 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.61 1.55 . . . . 0.0 110.074 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.42 -12.6 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.415 -0.803 . . . . 0.0 113.139 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.43 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 27.5 p90 -71.81 -13.86 61.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.377 0.671 . . . . 0.0 111.288 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.446 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 61.0 mt -109.95 -8.12 14.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.751 1.221 . . . . 0.0 111.894 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 153.08 43.23 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.55 7.92 43.26 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.211 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -135.53 -40.31 0.72 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.169 1.485 . . . . 0.0 111.388 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -114.56 147.85 38.85 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.941 0.496 . . . . 0.0 111.487 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.13 105.79 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.041 1.736 . . . . 0.0 107.305 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.01 137.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 161.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.3 -3.83 0.72 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.294 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.49 176.83 27.11 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 119.691 1.132 . . . . 0.0 112.053 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.61 149.16 31.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.575 1.15 . . . . 0.0 108.153 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.417 HG22 ' CE2' ' A' ' 22' ' ' PHE . 62.5 t -58.88 126.09 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 164.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -93.64 -42.3 9.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.967 0.507 . . . . 0.0 109.769 165.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.05 156.7 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.711 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.17 21.26 61.13 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.481 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -52.31 -42.62 63.95 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.498 1.649 . . . . 0.0 111.311 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.77 -13.09 62.17 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.035 0.834 . . . . 0.0 112.925 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.6 mm -84.58 -36.46 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.427 1.091 . . . . 0.0 108.484 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.39 -40.78 90.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 121.442 -0.786 . . . . 0.0 108.945 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -62.67 -33.68 75.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.36 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.61 76.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 109.331 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.8 mtm -55.72 -46.07 77.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.45 0.568 . . . . 0.0 110.135 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -58.35 -36.13 73.0 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.167 0.587 . . . . 0.0 111.844 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -25.48 68.14 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.496 0.589 . . . . 0.0 111.546 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -97.88 -0.43 45.03 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.076 1.75 . . . . 0.0 112.15 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.18 -173.5 47.46 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 167.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 p -162.37 159.66 25.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -63.17 -16.46 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -4.33 2.89 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 167.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.86 -25.27 2.19 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 127.339 2.399 . . . . 0.0 114.328 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.86 127.43 33.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.487 ' CG2' HD12 ' A' ' 56' ' ' ILE . 16.5 p -66.41 168.44 8.94 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.637 1.175 . . . . 0.0 110.773 168.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.9 p -81.6 -16.54 51.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.806 159.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.548 ' HE2' HG12 ' A' ' 12' ' ' VAL . 41.4 mtpt -143.63 160.6 40.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.01 0.924 . . . . 0.0 111.414 -167.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.433 ' HE2' ' CG2' ' A' ' 157' ' ' THR . 14.8 tttt -84.87 78.41 9.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.36 1.436 . . . . 0.0 109.697 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 12' ' ' VAL . 57.0 mt -76.7 133.27 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.483 0.658 . . . . 0.0 109.404 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.433 ' CG2' ' HE2' ' A' ' 155' ' ' LYS . 74.7 p -148.98 177.03 9.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.905 2.082 . . . . 0.0 110.105 -173.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 48' ' ' TYR . 3.1 mp -92.61 124.35 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 158.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.72 -55.3 10.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.68 161.96 39.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.079 0.552 . . . . 0.0 111.025 -169.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.8 171.28 7.39 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.3 -167.86 40.69 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.606 1.574 . . . . 0.0 109.83 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -95.91 148.5 22.56 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.544 1.137 . . . . 0.0 109.619 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.9 mt -126.87 43.07 3.19 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.534 1.934 . . . . 0.0 110.476 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 5' ' ' THR . 9.2 tm-20 . . . . . 0 C--O 1.255 1.348 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 161.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HE1' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 117.297 -1.335 . . . . 0.0 109.559 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.281 17.1 m 48.15 -172.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.741 1.155 . . . . 0.0 110.759 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.82 116.14 10.46 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 158.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.5 161.39 44.29 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 CA-C-N 120.661 1.272 . . . . 0.0 108.97 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.4 m -102.16 157.18 17.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 158.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.96 157.32 33.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.314 1.845 . . . . 0.0 107.648 164.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.66 151.2 30.44 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.543 0.737 . . . . 0.0 109.9 165.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 23.4 m-30 -133.85 104.51 6.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.118 2.167 . . . . 0.0 106.179 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.82 107.16 8.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mm -75.29 142.85 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.452 -0.78 . . . . 0.0 109.535 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -122.78 159.79 27.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.019 0.914 . . . . 0.0 109.554 161.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.0 96.37 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 56.07 14.03 1.34 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.629 1.572 . . . . 0.0 112.889 -169.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.65 -13.55 29.94 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.57 1.557 . . . . 0.0 113.18 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.41 127.59 85.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 120.389 2.094 . . . . 0.0 106.627 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.6 108.53 2.68 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.675 2.25 . . . . 0.0 109.755 -170.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.6 tp -84.56 -28.04 26.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.519 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.54 162.27 10.12 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 118.806 0.73 . . . . 0.0 114.458 167.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -77.7 113.96 16.08 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.65 0.78 . . . . 0.0 109.803 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.15 159.36 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 106.215 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.8 m -150.11 152.93 35.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.129 -1.607 . . . . 0.0 110.41 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.25 133.57 29.82 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.006 0.922 . . . . 0.0 109.235 -166.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.71 139.84 35.92 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 167.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.2 mt -124.08 121.89 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -82.6 62.53 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.961 0.904 . . . . 0.0 112.38 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.05 40.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.941 0.896 . . . . 0.0 112.806 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -9.42 59.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.419 1.088 . . . . 0.0 111.589 175.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -117.81 -54.23 2.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.422 1.489 . . . . 0.0 108.84 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 m -126.95 72.23 75.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 125.194 1.398 . . . . 0.0 107.711 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.67 -39.39 88.22 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.252 1.968 . . . . 0.0 112.319 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' CA ' ' HE3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.99 -53.47 56.89 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.445 1.475 . . . . 0.0 109.195 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 m -64.39 -41.01 96.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.899 0.879 . . . . 0.0 110.365 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.46 -50.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.556 0.742 . . . . 0.0 112.2 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.69 -40.55 95.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 110.093 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -51.58 -60.46 3.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.086 1.354 . . . . 0.0 109.427 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -60.77 -31.05 70.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HD2' HE22 ' A' ' 163' ' ' GLN . 38.1 ttp85 -55.69 -64.53 0.82 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.358 1.863 . . . . 0.0 110.181 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.7 74.9 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.833 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.29 -34.58 77.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.541 -0.724 . . . . 0.0 111.028 175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -69.5 -27.16 64.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.66 0.784 . . . . 0.0 111.625 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.3 p -90.21 -23.71 21.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.267 0.94 . . . . 0.0 111.283 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.41 -1.97 74.1 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.144 1.354 . . . . 0.0 112.707 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.39 -20.38 64.68 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.419 1.888 . . . . 0.0 113.427 -164.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -81.65 11.95 4.29 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.555 -0.716 . . . . 0.0 111.678 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.42 78.09 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 124.175 0.893 . . . . 0.0 112.274 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.09 167.98 26.57 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 125.493 1.517 . . . . 0.0 107.339 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 175.01 34.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 117.796 -2.145 . . . . 0.0 113.328 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 40.8 t80 -61.6 -32.42 72.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 127.794 2.437 . . . . 0.0 111.558 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -45.47 122.35 3.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.71 1.204 . . . . 0.0 109.875 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.35 26.23 61.47 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 116.33 -2.372 . . . . 0.0 115.689 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -66.66 -54.32 24.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 122.128 2.964 . . . . 0.0 107.44 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 32.8 t 113.9 161.91 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 1 C-N-CA 132.393 4.277 . . . . 0.0 106.951 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.97 101.64 12.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 170.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -77.45 -15.74 59.16 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.95 111.11 6.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -171.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.442 HD12 ' CG2' ' A' ' 152' ' ' THR . 22.2 mt -129.96 105.42 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.9 mt -116.05 97.96 50.35 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -50.15 126.61 17.63 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 123.552 2.834 . . . . 0.0 112.726 -175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.85 71.55 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 126.707 2.098 . . . . 0.0 112.033 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.64 -80.36 0.27 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.473 1.136 . . . . 0.0 108.059 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.78 166.65 26.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.278 0.631 . . . . 0.0 111.673 169.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.8 m -124.06 100.78 6.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 128.309 2.644 . . . . 0.0 109.284 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -84.36 135.01 34.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.066 1.746 . . . . 0.0 111.101 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.27 -174.15 21.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 126.489 1.995 . . . . 0.0 109.139 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.32 6.18 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 117.405 0.603 . . . . 0.0 113.628 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -110.72 23.76 13.8 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -159.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 43.2 p90 -58.52 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.182 1 C-N-CA 131.827 4.051 . . . . 0.0 116.101 -176.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.3 t -148.39 -12.96 0.35 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.237 2.215 . . . . 0.0 112.179 161.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -146.19 -173.93 4.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.291 2.236 . . . . 0.0 106.199 -168.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -169.94 45.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -155.45 -7.33 0.12 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.67 5.29 51.47 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 117.686 -1.619 . . . . 0.0 114.413 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -91.52 -96.01 0.13 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.453 2.126 . . . . 0.0 107.272 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 41.52 -158.88 0.04 OUTLIER Glycine 0 CA--C 1.531 1.038 0 C-N-CA 127.157 2.313 . . . . 0.0 114.672 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.86 117.66 1.3 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-O 121.562 0.535 . . . . 0.0 111.97 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.574 ' HE3' ' CE2' ' A' ' 67' ' ' PHE . 4.0 ptpt -145.56 -170.52 3.47 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.685 2.394 . . . . 0.0 107.187 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.3 p -140.81 177.14 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.475 1.034 . . . . 0.0 110.673 171.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt -74.64 -0.64 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 111.624 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -108.39 -1.18 20.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.053 1.341 . . . . 0.0 111.363 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.56 -113.8 1.77 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.58 -139.32 0.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.426 0.613 . . . . 0.0 109.469 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -70.05 166.25 20.16 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.318 1.047 . . . . 0.0 108.808 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -134.1 -179.65 5.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.761 2.024 . . . . 0.0 106.874 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.45 159.95 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.284 1.04 . . . . 0.0 112.572 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 89.84 1.96 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.238 1.415 . . . . 0.0 107.882 172.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.21 -52.73 64.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.767 1.227 . . . . 0.0 112.867 -168.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -150.19 174.38 12.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 162.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.64 32.05 5.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.964 2.105 . . . . 0.0 110.045 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 mt -53.81 -48.31 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.25 1.024 . . . . 0.0 108.456 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.64 133.82 35.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.809 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -132.25 171.26 13.92 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.152 -1.84 . . . . 0.0 109.114 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -84.78 87.19 7.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -164.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.2 p -77.7 -17.98 57.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.827 -171.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.9 -178.2 46.73 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.858 1.208 . . . . 0.0 112.671 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.27 142.0 97.14 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.969 1.78 . . . . 0.0 108.917 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.77 -3.44 56.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 117.644 -1.642 . . . . 0.0 112.587 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 128' ' ' VAL . 15.3 mm -74.51 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 121.103 2.452 . . . . 0.0 109.072 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.72 130.34 54.95 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.142 1.377 . . . . 0.0 109.354 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 p -144.22 158.02 43.96 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.563 1.145 . . . . 0.0 112.686 176.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 95.4 mmm -75.37 131.01 39.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.811 1.245 . . . . 0.0 111.851 -168.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.444 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -83.23 81.62 8.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.504 1.522 . . . . 0.0 107.523 168.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -70.48 -179.71 2.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.43 1.092 . . . . 0.0 110.428 165.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.0 36.49 1.03 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.326 2.25 . . . . 0.0 109.244 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.89 -164.1 27.55 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 106.879 -2.488 . . . . 0.0 106.879 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.46 171.35 9.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 119.236 1.518 . . . . 0.0 108.566 159.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m120 41.11 38.23 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.818 2.447 . . . . 0.0 114.12 159.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p -125.25 25.9 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.342 2.257 . . . . 0.0 109.108 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -74.96 105.49 6.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 129.961 3.305 . . . . 0.0 103.553 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.67 -93.26 1.24 Allowed Glycine 0 C--O 1.225 -0.456 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.5 p -139.33 -14.4 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.79 0.836 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -70.85 133.55 46.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 13.2 p90 -152.31 -179.42 7.53 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 108.151 -174.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -144.06 152.66 41.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.116 0.484 . . . . 0.0 111.282 162.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.7 mt -83.68 113.37 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 165.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.8 m -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.816 1.246 . . . . 0.0 107.832 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.3 p -116.7 27.26 9.28 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 124.136 0.974 . . . . 0.0 108.695 172.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.53 178.59 10.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 162.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -72.64 87.46 1.24 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 165.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.7 p -81.03 42.22 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.059 0.544 . . . . 0.0 112.3 -171.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.63 -4.1 21.65 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 119.746 -1.846 . . . . 0.0 114.047 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -61.05 -19.7 61.7 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.018 -1.051 . . . . 0.0 110.734 161.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.2 mt -100.89 1.34 39.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.582 1.953 . . . . 0.0 111.78 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.57 138.88 58.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.231 1.012 . . . . 0.0 109.784 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.92 10.62 61.83 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 122.702 0.192 . . . . 0.0 112.908 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -129.26 -37.02 1.68 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.66 1.584 . . . . 0.0 109.567 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -114.09 121.1 42.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.932 0.893 . . . . 0.0 109.002 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.09 106.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.66 1.584 . . . . 0.0 107.467 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.412 HG13 HG23 ' A' ' 97' ' ' ILE . 67.9 t -70.37 131.68 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 166.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -138.54 -5.68 1.56 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.35 -179.46 31.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.72 -1.229 . . . . 0.0 111.664 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -156.8 148.81 22.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.55 122.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -87.09 -48.52 8.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 167.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -148.83 154.7 39.89 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.367 1.467 . . . . 0.0 111.362 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.55 24.88 27.14 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 123.886 0.755 . . . . 0.0 113.123 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.0 tpt -53.74 -39.9 65.7 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.899 1.349 . . . . 0.0 109.442 168.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -62.4 -27.67 69.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.2 mm -78.0 -39.42 25.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.13 -41.95 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.941 0.791 . . . . 0.0 109.288 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.7 -24.49 67.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.615 1.166 . . . . 0.0 112.644 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.22 -45.43 23.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.043 -1.035 . . . . 0.0 110.143 169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 52.0 mtp -54.74 -44.69 73.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.402 0.681 . . . . 0.0 110.931 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.61 -38.0 74.22 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.915 1.286 . . . . 0.0 112.035 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -69.71 -18.68 63.55 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.991 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -94.7 -2.55 50.98 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.204 1.002 . . . . 0.0 111.721 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.58 -166.96 41.07 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -156.01 163.46 39.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 163.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.16 -17.85 64.45 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -9.86 38.81 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 167.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 88.26 -23.21 15.88 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 127.044 2.259 . . . . 0.0 113.004 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.68 130.3 40.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.899 1.349 . . . . 0.0 107.693 175.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.442 ' CG2' HD12 ' A' ' 56' ' ' ILE . 1.2 p -70.68 165.36 23.1 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.44 1.496 . . . . 0.0 111.304 177.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.0 p -97.21 -14.39 21.45 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.6 1.16 . . . . 0.0 111.477 163.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -137.77 154.24 49.61 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.575 1.15 . . . . 0.0 110.739 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -81.02 85.98 6.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.107 1.363 . . . . 0.0 107.78 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.59 119.87 34.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.6 p -132.74 174.25 10.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.0 1.32 . . . . 0.0 109.669 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.18 96.97 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -56.64 -50.21 72.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.613 1.965 . . . . 0.0 109.195 -177.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.2 164.66 33.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 108.041 175.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.7 p -165.93 164.81 18.43 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.031 0.532 . . . . 0.0 110.821 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.48 -174.15 45.99 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.548 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.9 tp60 -81.22 146.31 30.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.74 1.616 . . . . 0.0 110.172 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.43 43.31 2.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 111.091 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 3.6 pt-20 . . . . . 0 C--O 1.248 0.993 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.32 -176.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.211 1.004 . . . . 0.0 110.547 168.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -56.36 117.3 15.87 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.17 163.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.99 152.87 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 N-CA-C 108.815 -1.264 . . . . 0.0 108.815 159.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.1 m -99.47 152.93 19.44 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.19 150.79 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.473 1.509 . . . . 0.0 107.685 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -121.81 158.71 28.29 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.643 1.177 . . . . 0.0 109.722 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -149.34 109.46 4.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.651 1.58 . . . . 0.0 108.284 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.67 100.95 9.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.3 mm -73.75 139.78 18.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.7 127.26 36.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.332 1.053 . . . . 0.0 109.837 169.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.67 111.51 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.68 13.37 0.49 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.012 2.125 . . . . 0.0 114.88 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.05 -12.15 14.59 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.331 1.443 . . . . 0.0 113.28 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.21 130.11 55.63 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 119.774 1.787 . . . . 0.0 106.826 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.36 115.36 3.64 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.346 1.364 . . . . 0.0 108.818 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.1 tp -86.83 -32.13 20.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.438 -0.315 . . . . 0.0 110.493 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.55 171.15 13.63 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 123.748 0.689 . . . . 0.0 111.476 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -85.75 141.16 29.9 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 109.683 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -128.5 160.41 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 127.938 2.495 . . . . 0.0 106.166 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -148.73 148.9 30.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 120.923 -1.111 . . . . 0.0 109.864 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.55 160.77 33.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.311 1.044 . . . . 0.0 108.458 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -124.45 135.37 53.19 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.844 2.457 . . . . 0.0 105.593 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.32 110.51 12.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.104 0.962 . . . . 0.0 109.767 -163.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -74.63 64.2 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.236 1.814 . . . . 0.0 113.681 -167.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.5 -25.62 64.61 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.204 1.002 . . . . 0.0 112.636 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -81.75 -0.67 44.12 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.238 1.415 . . . . 0.0 112.795 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -118.1 -37.42 3.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.87 1.268 . . . . 0.0 110.703 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' ' 129' ' ' PHE . 1.6 m -138.87 79.92 26.28 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.619 2.368 . . . . 0.0 108.551 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.95 -46.1 17.43 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.754 1.636 . . . . 0.0 112.864 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -70.5 -41.75 72.23 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -168.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.7 m -66.48 -43.39 85.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 111.434 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.69 -44.24 74.39 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 120.902 -1.124 . . . . 0.0 111.506 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -70.87 -31.77 68.55 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.366 0.666 . . . . 0.0 111.139 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -52.19 -59.18 4.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.022 0.929 . . . . 0.0 110.138 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -66.08 -35.53 80.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.657 ' CZ ' HE22 ' A' ' 163' ' ' GLN . 0.2 OUTLIER -50.94 -59.77 3.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.649 1.58 . . . . 0.0 109.293 170.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.54 -41.94 91.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.214 1.005 . . . . 0.0 113.009 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.64 -43.06 63.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.704 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 p -62.35 -35.83 80.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.889 1.222 . . . . 0.0 111.3 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 p -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.567 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.85 10.35 86.14 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 118.991 0.814 . . . . 0.0 111.595 -166.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -24.2 66.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.964 1.382 . . . . 0.0 112.009 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.51 0.84 24.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.663 1.585 . . . . 0.0 114.098 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.63 11.46 82.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.071 0.851 . . . . 0.0 111.283 -171.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -152.4 169.92 21.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.43 1.892 . . . . 0.0 105.958 159.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 153.88 -175.86 32.02 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 122.096 0.831 . . . . 0.0 111.959 -171.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.59 -17.45 38.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.428 1.491 . . . . 0.0 113.384 -158.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -53.15 126.6 21.39 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.211 1.004 . . . . 0.0 109.337 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.91 79.4 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.846 -1.53 . . . . 0.0 114.218 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 m -85.18 154.42 22.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 120.07 1.935 . . . . 0.0 107.298 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.0 t -81.28 170.28 16.25 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 164.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.82 112.73 25.15 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 164.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -79.8 -18.43 50.96 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.57 111.66 9.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.836 1.198 . . . . 0.0 108.3 -170.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.3 mt -136.4 117.9 19.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.6 mt -127.1 89.27 52.32 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -167.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -48.3 121.76 6.65 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.521 2.814 . . . . 0.0 114.985 -167.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.5 67.59 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.222 1.391 . . . . 0.0 112.103 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -137.37 -78.72 0.39 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.72 1.26 . . . . 0.0 108.551 -172.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.97 163.33 29.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.545 0.688 . . . . 0.0 111.736 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.91 95.02 3.97 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.126 1.771 . . . . 0.0 107.832 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -76.86 141.74 40.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.432 1.11 . . . . 0.0 110.185 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.4 -156.59 8.54 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.41 -13.24 67.03 Favored Glycine 0 C--O 1.229 -0.187 0 O-C-N 121.542 -0.975 . . . . 0.0 112.42 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -84.04 88.49 7.17 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.76 -0.847 . . . . 0.0 109.749 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -74.32 3.42 7.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.876 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.4 p -125.65 -58.39 1.41 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 120.102 1.319 . . . . 0.0 113.843 -159.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -103.94 -158.37 0.66 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.34 41.04 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.5 0.666 . . . . 0.0 109.426 159.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -122.94 -51.59 1.9 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.952 0.901 . . . . 0.0 111.645 -163.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.28 -9.44 0.17 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.812 -1.549 . . . . 0.0 114.256 -169.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.7 p -104.24 -19.99 13.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.498 2.149 . . . . 0.0 112.295 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.25 -170.93 2.29 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 124.711 1.148 . . . . 0.0 115.758 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.57 -172.2 41.13 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 123.75 1.75 . . . . 0.0 115.753 -168.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.31 156.53 38.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.311 3.044 . . . . 0.0 107.254 -171.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.8 p -78.1 166.26 23.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.97 0.89 . . . . 0.0 109.541 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 pt -59.66 -29.91 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.518 167.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -77.93 -10.11 59.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 111.638 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 143.21 12.47 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.5 1.524 . . . . 0.0 109.889 -171.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 34.48 -133.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.658 2.383 . . . . 0.0 113.029 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -120.47 143.38 48.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -173.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.72 -176.62 3.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.865 0.866 . . . . 0.0 109.644 -167.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -63.06 137.94 58.41 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.119 0.961 . . . . 0.0 109.792 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.02 86.57 6.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.08 -65.55 0.39 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.749 2.02 . . . . 0.0 113.437 -159.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -158.2 178.78 9.81 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 124.009 0.924 . . . . 0.0 109.892 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -129.48 36.07 4.16 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.698 1.999 . . . . 0.0 109.401 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.56 -55.98 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.6 mt -84.07 132.24 34.73 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -122.69 168.91 11.61 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.57 1.548 . . . . 0.0 109.91 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.469 ' HD1' ' N ' ' A' ' 123' ' ' ASP . 36.5 m80 -74.33 81.64 1.87 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.0 p -80.27 -11.27 59.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.603 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.61 -173.96 43.88 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.601 1.091 . . . . 0.0 112.593 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 165.27 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.809 2.339 . . . . 0.0 110.822 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.58 -17.94 6.19 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 117.315 -1.825 . . . . 0.0 112.261 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.28 151.62 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 121.355 2.577 . . . . 0.0 108.29 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.03 128.01 53.96 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 120.934 -1.104 . . . . 0.0 109.639 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 t -140.34 145.97 37.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.436 1.095 . . . . 0.0 110.496 -172.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 89.9 mmm -78.38 121.95 25.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.486 0.714 . . . . 0.0 109.965 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.546 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -72.62 87.51 1.23 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 164.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -76.59 -169.88 1.37 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.168 0.987 . . . . 0.0 108.584 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.41 24.5 4.8 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 110.607 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.45 -159.87 21.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -164.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -64.45 162.56 30.25 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 CA-C-N 119.558 1.679 . . . . 0.0 109.805 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 34.16 53.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 128.967 2.907 . . . . 0.0 113.382 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.1 p -140.63 23.29 2.3 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.072 1.349 . . . . 0.0 111.382 -175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -88.25 142.99 27.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 170.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.5 -58.31 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -162.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.06 -39.87 0.2 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.76 0.824 . . . . 0.0 110.904 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.441 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 7.1 mm-40 -62.54 135.77 57.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.141 1.376 . . . . 0.0 109.567 -173.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.546 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 1.2 p90 -147.09 174.5 11.51 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.331 1.452 . . . . 0.0 108.559 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -136.53 153.85 50.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.918 0.866 . . . . 0.0 111.488 159.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.4 mt -83.31 117.41 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 162.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.31 124.43 23.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -112.96 23.63 13.2 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.069 0.548 . . . . 0.0 109.748 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.5 177.75 10.23 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -70.53 87.55 0.66 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -74.1 43.4 0.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.382 2.273 . . . . 0.0 110.903 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -66.39 -18.16 65.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 119.699 -1.876 . . . . 0.0 113.128 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.444 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 45.7 p90 -67.28 -13.74 62.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.129 0.972 . . . . 0.0 111.217 170.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.444 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -108.95 -6.89 15.53 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.262 1.825 . . . . 0.0 111.8 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.469 ' N ' ' HD1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -70.16 135.62 49.3 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.01 -4.66 82.38 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.477 -1.179 . . . . 0.0 113.084 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -94.51 -40.29 9.95 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.189 1.994 . . . . 0.0 110.435 166.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -131.64 158.12 41.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.155 0.582 . . . . 0.0 111.76 -161.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.67 101.11 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -169.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.81 132.81 32.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.411 ' HA ' HG21 ' A' ' 29' ' ' VAL . 26.4 p90 -139.21 -2.09 1.67 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.05 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.75 -171.02 30.48 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.181 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -155.34 166.37 33.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.323 1.049 . . . . 0.0 109.806 163.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.77 126.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 164.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.4 -55.87 3.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 165.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.75 162.48 37.53 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.808 0.692 . . . . 0.0 111.921 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.24 28.05 60.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.731 1.158 . . . . 0.0 112.685 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 10.6 tpt -56.55 -38.38 71.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.237 1.519 . . . . 0.0 111.414 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -64.54 -28.5 69.69 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.169 -0.957 . . . . 0.0 112.329 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.1 mm -70.84 -44.99 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.49 -38.46 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.98 -29.61 66.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.946 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.95 -44.15 50.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.711 1.204 . . . . 0.0 109.787 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.9 mtp -50.85 -42.35 58.62 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.675 0.79 . . . . 0.0 110.005 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.57 -34.36 76.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.389 1.075 . . . . 0.0 112.905 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -67.49 -27.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 119.418 1.008 . . . . 0.0 110.275 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.406 ' HB2' HD11 ' A' ' 156' ' ' ILE . 27.6 m-85 -89.44 8.16 32.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 111.862 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.4 -151.91 4.04 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.653 1.12 . . . . 0.0 110.318 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -137.8 -70.36 0.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.85 -0.794 . . . . 0.0 110.069 166.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 143.44 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 1 C-N-CA 133.379 4.671 . . . . 0.0 110.934 -175.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.84 -25.36 66.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.063 159.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 118.08 -40.76 2.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 124.86 1.219 . . . . 0.0 110.644 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.36 124.11 20.91 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.8 p -64.11 152.18 41.18 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.282 1.033 . . . . 0.0 110.621 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.4 p -72.62 -28.62 62.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.991 163.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -135.96 140.09 43.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -73.16 103.01 3.75 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 119.907 -1.745 . . . . 0.0 109.849 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 145' ' ' PHE . 1.7 mp -73.42 136.31 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 169.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.32 166.13 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.651 1.581 . . . . 0.0 108.703 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 mt -106.48 105.87 19.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.84 -51.09 66.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -149.81 155.63 40.43 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.5 p -156.5 161.96 39.98 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.881 0.873 . . . . 0.0 109.712 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.45 -172.98 44.93 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.657 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 1.6 mt-30 -96.8 147.99 23.37 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.877 0.871 . . . . 0.0 109.744 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 44.9 mt -127.09 43.16 3.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.639 0.776 . . . . 0.0 109.003 165.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.577 ' HB3' HE21 ' A' ' 163' ' ' GLN . 13.1 pt-20 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 117.232 -1.366 . . . . 0.0 113.849 -172.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.14 -176.58 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 125.487 1.515 . . . . 0.0 107.029 165.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -53.86 116.19 9.64 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 117.364 -1.303 . . . . 0.0 109.589 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -64.04 144.74 88.38 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 121.357 1.52 . . . . 0.0 109.416 167.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.516 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 60.9 m -103.98 143.66 32.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.04 156.92 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -125.23 159.13 32.35 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.656 0.782 . . . . 0.0 110.197 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.604 ' CE1' ' CD1' ' A' ' 48' ' ' TYR . 54.6 m-85 -145.94 104.71 3.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.613 2.365 . . . . 0.0 107.58 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.5 94.07 3.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 167.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.6 mm -66.73 150.06 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.241 1.016 . . . . 0.0 109.625 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.25 160.74 34.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.704 1.601 . . . . 0.0 110.808 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 ' HE2' ' A' ' 154' ' ' LYS . 36.8 t -127.37 98.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.075 2.55 . . . . 0.0 105.23 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 50.88 12.94 0.12 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.558 1.943 . . . . 0.0 114.772 -165.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.7 -13.8 13.12 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.424 1.488 . . . . 0.0 113.247 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -72.82 116.65 52.25 Favored Pre-proline 0 C--O 1.23 0.075 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.93 116.98 3.9 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.615 1.543 . . . . 0.0 110.036 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.0 tp -87.28 -27.6 22.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.214 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.83 162.77 10.08 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.2 ttm105 -75.68 143.23 42.27 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.84 152.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 128.534 2.734 . . . . 0.0 104.724 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -143.34 140.57 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.215 0.461 . . . . 0.0 109.949 175.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -114.14 159.87 19.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.333 1.053 . . . . 0.0 108.764 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -120.37 137.88 54.05 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.121 2.169 . . . . 0.0 105.573 170.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.6 mt -125.02 119.11 27.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -164.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.61 63.18 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.13 1.372 . . . . 0.0 112.123 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.63 -17.06 59.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.893 -1.129 . . . . 0.0 111.881 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -79.52 -13.0 59.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.059 1.343 . . . . 0.0 112.94 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -111.91 -44.41 3.46 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.014 1.279 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 m -134.07 68.75 74.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.066 1.346 . . . . 0.0 108.897 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.66 -38.8 92.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.201 1.934 . . . . 0.0 113.107 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -50.67 70.89 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.588 1.085 . . . . 0.0 108.965 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -62.53 -45.46 92.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.66 1.184 . . . . 0.0 109.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.96 61.95 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.377 1.071 . . . . 0.0 112.164 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -60.69 -41.99 96.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.663 1.185 . . . . 0.0 110.177 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.41 -51.21 67.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.835 0.854 . . . . 0.0 109.538 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -64.43 -40.32 95.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 ttp85 -56.2 -59.13 5.37 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.32 1.848 . . . . 0.0 110.901 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -27.86 69.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.814 0.446 . . . . 0.0 112.165 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -74.49 -32.41 62.53 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.871 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.4 m -68.32 -47.04 68.61 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.819 1.247 . . . . 0.0 110.616 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.4 p -64.45 -38.76 92.14 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.62 11.69 82.67 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -166.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -63.57 -20.22 65.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.793 1.296 . . . . 0.0 111.857 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.838 0.855 . . . . 0.0 112.534 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.85 -1.44 86.38 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.444 1.02 . . . . 0.0 112.172 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -154.5 172.49 17.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.874 1.27 . . . . 0.0 109.073 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.13 -151.77 19.77 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.902 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.604 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.3 t80 -54.14 -29.44 45.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.347 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -59.28 101.71 0.11 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.557 1.071 . . . . 0.0 110.007 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 26.08 72.59 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 116.848 -2.084 . . . . 0.0 115.295 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 p -64.55 -58.28 6.82 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.424 2.612 . . . . 0.0 110.609 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.8 t 105.39 161.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.264 3.826 . . . . 0.0 108.292 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -115.97 123.94 49.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -104.87 -17.09 14.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.356 -0.83 . . . . 0.0 113.163 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.95 97.78 3.72 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.409 ' CG2' ' HA ' ' A' ' 143' ' ' GLU . 44.7 mt -124.13 117.61 51.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.19 103.08 14.1 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.5 134.12 45.15 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 124.532 3.488 . . . . 0.0 112.804 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.07 25.36 69.44 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.758 0.694 . . . . 0.0 111.531 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -138.9 -78.29 0.34 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.54 162.81 21.94 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 94.2 m -122.52 96.51 5.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.556 2.343 . . . . 0.0 109.802 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -85.61 132.63 34.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.772 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.64 22.98 0.55 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.528 0.585 . . . . 0.0 114.437 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.18 -3.94 88.56 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.349 -1.089 . . . . 0.0 114.097 -170.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.87 73.25 10.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.173 0.986 . . . . 0.0 108.567 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -66.3 -2.44 4.41 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.503 -1.373 . . . . 0.0 112.126 166.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -121.83 -50.72 2.05 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.328 2.251 . . . . 0.0 111.256 -169.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.4 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 3.9 mpt_? -106.29 -149.23 0.42 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.19 69.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.273 1.397 . . . . 0.0 107.677 158.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.6 -77.12 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.788 -0.57 . . . . 0.0 110.134 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.91 5.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 119.03 -0.872 . . . . 0.0 113.9 -161.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.9 p -83.6 -73.47 0.41 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 163.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 69' ' ' ARG . . . 71.3 169.89 10.4 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 121.065 3.186 . . . . 0.0 121.065 158.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.78 158.72 28.32 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 109.97 -3.115 . . . . 0.0 115.963 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' H ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -86.53 -175.7 5.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.272 3.429 . . . . 0.0 110.314 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -93.29 -179.04 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.557 0.617 . . . . 0.0 109.614 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.0 pt -72.87 -36.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 120.436 -1.415 . . . . 0.0 110.285 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -73.95 -22.18 59.75 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 122.822 0.449 . . . . 0.0 110.869 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.71 -105.93 0.28 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 105.311 -3.116 . . . . 0.0 105.311 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' LYS . 10.4 tt0 -113.99 -175.79 2.76 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.55 1.167 . . . . 0.0 109.454 -171.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 94.9 mttt -64.07 123.84 20.09 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 125.878 1.671 . . . . 0.0 109.102 -165.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -99.65 160.35 14.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.741 1.258 . . . . 0.0 110.516 -169.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.46 162.66 22.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.883 -174.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.67 89.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.08 1.752 . . . . 0.0 109.066 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -55.06 -48.44 73.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.281 1.032 . . . . 0.0 111.526 -159.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.417 HD22 HG13 ' A' ' 89' ' ' ILE . 2.2 p-10 -178.51 155.18 0.84 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 128.128 2.571 . . . . 0.0 106.982 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.84 32.15 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.037 1.335 . . . . 0.0 109.317 -168.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.417 HG13 HD22 ' A' ' 87' ' ' ASN . 15.7 mt -52.25 -41.46 34.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 126.211 1.805 . . . . 0.0 109.761 172.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.98 125.68 41.58 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.74 165.41 11.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.19 1.796 . . . . 0.0 109.134 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -80.63 97.1 7.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.0 p -82.46 -26.46 32.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.753 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.0 -177.07 47.72 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.147 0.885 . . . . 0.0 112.742 -173.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.81 144.54 97.02 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.105 1.87 . . . . 0.0 109.322 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.93 14.87 60.19 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 117.729 -1.595 . . . . 0.0 112.689 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mm -86.13 158.42 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 121.046 2.423 . . . . 0.0 108.36 162.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 139.39 53.74 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.374 1.47 . . . . 0.0 109.315 168.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -149.23 162.18 40.53 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.404 1.082 . . . . 0.0 110.49 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 82.4 mmm -78.64 117.08 19.45 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.715 1.206 . . . . 0.0 109.733 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -76.57 62.66 1.95 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.117 0.961 . . . . 0.0 109.364 171.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -68.34 -179.25 1.25 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.749 1.261 . . . . 0.0 109.081 170.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.05 16.0 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 126.472 1.909 . . . . 0.0 111.606 -171.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.09 177.06 14.68 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.707 1.622 . . . . 0.0 109.11 -166.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.47 131.93 49.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.831 2.354 . . . . 0.0 110.78 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 71.43 9.39 6.46 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.225 1.81 . . . . 0.0 114.154 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.4 p -92.14 39.58 1.02 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.209 -1.557 . . . . 0.0 111.082 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -82.86 105.56 13.97 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.85 -109.69 2.68 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -18.56 13.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.415 1.086 . . . . 0.0 111.307 172.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -59.07 113.92 2.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.81 1.244 . . . . 0.0 107.979 172.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.469 ' CE1' ' CE2' ' A' ' 48' ' ' TYR . 15.4 p90 -127.43 168.95 14.17 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 127.208 2.203 . . . . 0.0 107.139 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -143.45 155.59 44.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.583 0.706 . . . . 0.0 111.398 160.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.4 mt -83.83 125.11 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 164.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.7 m -75.29 115.59 15.1 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 166.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -103.04 22.28 14.25 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.312 0.645 . . . . 0.0 109.917 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -158.91 -178.43 7.24 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.343 1.057 . . . . 0.0 108.314 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -66.92 96.22 0.41 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 163.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 p -80.24 63.66 4.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 122.454 1.121 . . . . 0.0 109.594 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.92 -21.14 66.0 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.936 -1.102 . . . . 0.0 112.232 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.43 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 19.2 p90 -70.85 -7.89 48.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.586 1.154 . . . . 0.0 110.878 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.43 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.5 mt -122.49 6.4 9.54 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 126.617 1.967 . . . . 0.0 111.212 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.96 130.62 42.22 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 166.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.9 -4.68 29.03 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.122 -1.376 . . . . 0.0 114.728 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -93.82 -34.15 13.28 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 121.144 2.472 . . . . 0.0 110.811 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -143.83 134.2 24.63 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.184 0.594 . . . . 0.0 109.74 -164.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.99 107.33 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 126.287 1.835 . . . . 0.0 107.57 -170.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.14 131.09 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -135.79 -4.72 2.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.11 33.22 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.341 0.973 . . . . 0.0 111.62 -176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -147.66 152.54 38.0 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 109.122 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 32.8 t -65.8 110.2 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 164.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -71.61 -50.55 29.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.47 157.45 45.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.537 1.935 . . . . 0.0 110.159 -167.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.67 18.3 79.1 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.854 0.74 . . . . 0.0 114.026 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -35.16 68.74 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.96 1.88 . . . . 0.0 110.677 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -20.5 65.95 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.452 -1.405 . . . . 0.0 113.598 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.8 -37.07 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -37.16 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.767 . . . . 0.0 109.735 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.29 -25.57 67.7 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.448 -1.407 . . . . 0.0 112.65 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.15 -46.96 30.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.815 -1.178 . . . . 0.0 109.733 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.7 mtp -52.3 -41.21 62.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.329 0.968 . . . . 0.0 111.377 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.409 ' HA ' ' CG2' ' A' ' 56' ' ' ILE . 1.4 mm-40 -60.62 -37.03 80.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 112.343 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -71.24 -23.08 61.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.541 1.064 . . . . 0.0 110.638 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.443 ' CB ' HD11 ' A' ' 156' ' ' ILE . 27.3 m-85 -90.45 12.25 19.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.329 1.451 . . . . 0.0 111.637 172.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.39 -150.49 6.66 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.164 1.364 . . . . 0.0 110.296 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 31.9 p -143.63 -103.3 0.12 Allowed 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 159.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -153.7 -27.03 0.14 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.176 1.79 . . . . 0.0 110.196 159.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -66.53 -19.74 65.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.011 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.27 -30.12 6.41 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.429 1.49 . . . . 0.0 111.514 172.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 124.48 20.35 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.092 1.446 . . . . 0.0 107.763 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -66.84 130.0 41.71 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.269 1.028 . . . . 0.0 108.291 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.17 -22.37 64.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.058 0.943 . . . . 0.0 111.599 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.572 ' HE2' HG12 ' A' ' 12' ' ' VAL . 22.8 mtpt -118.87 175.4 5.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 159.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -72.93 145.06 47.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 164.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.52 HD13 HG22 ' A' ' 12' ' ' VAL . 24.2 mm -129.37 123.23 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 178.19 8.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.837 -159.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.74 102.18 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.29 -43.31 74.08 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.39 166.4 28.22 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 117.971 0.35 . . . . 0.0 110.606 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.3 p -170.34 172.64 6.05 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 123.566 0.746 . . . . 0.0 110.487 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.34 -169.49 42.53 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.455 HE21 ' C ' ' A' ' 165' ' ' GLU . 41.1 tt0 -110.66 136.25 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.108 1.363 . . . . 0.0 108.437 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 mt -116.42 43.12 2.26 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.49 1.138 . . . . 0.0 109.644 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.516 ' HB2' ' H ' ' A' ' 5' ' ' THR . 2.0 tp10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 128.248 2.619 . . . . 0.0 108.272 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.935 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 3' ' ' ASN 0.305 5.5 p 50.66 -173.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.149 0.886 . . . . 0.0 111.688 -171.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.458 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -94.93 108.02 35.25 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 158.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.16 165.7 16.38 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.996 1.797 . . . . 0.0 110.079 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 m -131.18 157.44 43.17 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 m -143.7 142.18 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.138 1.375 . . . . 0.0 108.024 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.411 ' HB3' HD11 ' A' ' 164' ' ' LEU . 31.0 p90 -89.94 155.78 18.89 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.462 0.574 . . . . 0.0 109.457 168.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -137.76 105.42 5.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.0 103.68 11.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.86 139.45 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.91 158.79 28.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.917 0.887 . . . . 0.0 110.254 163.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 ' HE2' ' A' ' 154' ' ' LYS . 6.9 t -126.55 105.17 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.968 -2.604 . . . . 0.0 103.968 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 54.72 14.04 0.8 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.873 2.069 . . . . 0.0 113.939 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 6.96 60.4 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.551 -1.343 . . . . 0.0 114.066 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.32 123.14 84.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 159.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.7 113.04 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.21 -38.09 52.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.26 -173.39 36.86 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -110.72 151.41 27.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.982 0.896 . . . . 0.0 110.079 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.31 162.21 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.536 3.134 . . . . 0.0 105.852 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.5 t -147.13 149.8 33.72 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.98 136.41 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.174 0.99 . . . . 0.0 109.453 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -84.57 147.0 27.24 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 160.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.48 118.55 26.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 90' ' ' LEU . 14.1 m-85 -75.26 52.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.353 2.261 . . . . 0.0 112.016 -172.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.06 -13.75 29.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 120.541 -1.349 . . . . 0.0 113.335 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.42 -7.41 59.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.358 0.981 . . . . 0.0 112.953 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.87 -25.25 1.43 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.569 1.077 . . . . 0.0 113.347 -171.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.51 72.32 37.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.051 1.74 . . . . 0.0 107.045 161.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -47.2 -52.27 8.11 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.352 2.701 . . . . 0.0 112.602 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HE3' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.36 -46.58 86.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.841 0.746 . . . . 0.0 109.872 -169.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.485 HG23 ' SD ' ' A' ' 100' ' ' MET . 22.8 m -66.72 -51.21 58.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 125.095 1.358 . . . . 0.0 110.489 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -39.16 80.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.836 0.455 . . . . 0.0 112.142 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.73 -44.3 90.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.112 1.765 . . . . 0.0 109.807 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -56.97 -53.67 55.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.154 0.982 . . . . 0.0 109.715 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.69 -37.22 80.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.865 0.866 . . . . 0.0 112.783 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -54.06 -64.38 0.85 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.235 1.414 . . . . 0.0 109.281 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.82 -25.29 66.37 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.714 0.634 . . . . 0.0 112.412 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 mt -69.78 -33.51 72.49 Favored 'General case' 0 C--N 1.34 0.168 0 O-C-N 121.192 -0.943 . . . . 0.0 111.426 171.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.8 m -68.49 -49.38 60.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.814 0.734 . . . . 0.0 109.255 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.6 p -64.14 -30.99 72.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.364 0.529 . . . . 0.0 110.523 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.02 -3.88 68.89 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 119.695 1.134 . . . . 0.0 112.068 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.89 -1.38 14.11 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.82 2.048 . . . . 0.0 113.008 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.66 7.8 13.78 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.464 -0.772 . . . . 0.0 112.623 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.04 2.54 89.45 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.087 0.851 . . . . 0.0 111.555 -166.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -174.45 173.26 2.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.3 1.84 . . . . 0.0 106.546 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.62 -167.39 28.12 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -88.7 -8.0 55.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -162.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -64.32 115.02 4.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.743 1.611 . . . . 0.0 108.034 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.07 11.64 85.38 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 -173.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.2 t -66.41 119.09 11.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 163.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.82 139.17 43.06 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -74.21 99.63 3.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -73.77 -57.09 4.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.9 112.17 24.19 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -168.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.48 105.27 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.42 97.28 42.91 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -53.0 134.07 54.3 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.935 2.423 . . . . 0.0 113.213 -171.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.4 78.17 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.129 1.823 . . . . 0.0 112.918 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -122.9 -75.98 0.59 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.305 1.553 . . . . 0.0 106.816 -173.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.55 18.2 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.141 0.976 . . . . 0.0 109.377 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.8 t -125.75 105.96 9.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -93.84 138.25 32.2 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.672 1.989 . . . . 0.0 110.798 -172.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.55 -168.82 12.83 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.172 1.844 . . . . 0.0 110.109 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.33 9.96 69.01 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.639 -1.09 . . . . 0.0 114.969 170.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.292 29.9 t0 -84.45 46.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.619 2.209 . . . . 0.0 113.062 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -53.3 -42.65 66.83 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.337 0.655 . . . . 0.0 112.722 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.6 t -72.79 -35.1 67.31 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.396 0.678 . . . . 0.0 111.419 -171.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -125.06 -139.12 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -170.06 23.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.621 1.555 . . . . 0.0 112.948 159.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -134.81 8.69 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.199 1.4 . . . . 0.0 112.742 -159.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.09 -9.29 66.93 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.721 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.5 p -84.16 -18.44 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.827 1.814 . . . . 0.0 111.185 171.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.49 -154.34 7.47 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 124.833 1.206 . . . . 0.0 113.077 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.52 120.57 2.23 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -162.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -142.77 158.03 44.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 158.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -91.22 177.74 6.17 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 124.066 0.854 . . . . 0.0 110.465 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.6 pt -62.62 -31.06 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.607 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -82.68 1.66 37.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.385 1.474 . . . . 0.0 111.605 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.88 156.41 29.11 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -170.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.259 3.1 tm-20 33.79 -142.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.802 2.841 . . . . 0.0 113.429 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -115.0 150.83 35.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.467 1.107 . . . . 0.0 108.115 -167.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -123.94 175.8 6.72 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.89 154.54 25.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.291 0.567 . . . . 0.0 109.823 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -80.33 88.37 5.55 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 167.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -46.88 -51.61 16.34 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -158.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.83 160.48 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.727 -1.578 . . . . 0.0 114.023 168.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.32 24.82 10.72 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.452 2.301 . . . . 0.0 110.603 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.8 mt -50.47 -46.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.187 0.995 . . . . 0.0 108.994 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 25' ' ' PHE . 96.1 mt -89.29 126.92 35.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.433 1.111 . . . . 0.0 108.278 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -108.86 172.12 7.03 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 126.811 2.044 . . . . 0.0 109.044 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -87.61 73.59 9.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.946 0.898 . . . . 0.0 108.879 -166.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 p -75.29 -4.52 39.64 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -160.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.86 -179.15 33.79 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.4 1.0 . . . . 0.0 111.886 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.08 159.77 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.072 1.848 . . . . 0.0 110.159 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.31 71.36 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.233 -1.315 . . . . 0.0 112.674 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.8 mm -77.63 162.11 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.934 1.867 . . . . 0.0 107.5 166.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.03 132.28 44.85 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.1 1.76 . . . . 0.0 107.138 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.409 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 34.5 t -146.11 169.8 17.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.883 0.849 . . . . 0.0 110.029 -172.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 7.5 ttm -111.67 120.67 42.82 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.298 1.439 . . . . 0.0 109.1 -161.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.15 94.72 2.47 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -85.31 170.28 12.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 158.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -110.02 20.31 18.08 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.215 1.406 . . . . 0.0 111.506 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.65 -165.83 25.21 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 -159.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.4 153.75 76.81 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 119.88 1.84 . . . . 0.0 109.672 167.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 45.16 34.36 1.36 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.689 2.796 . . . . 0.0 113.497 169.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -132.53 32.5 3.89 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.932 -1.105 . . . . 0.0 111.573 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.509 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 15.4 p30 -66.29 -154.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.936 2.095 . . . . 0.0 110.916 166.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.14 -81.7 0.19 Allowed Glycine 0 C--O 1.225 -0.446 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.6 m -133.83 -16.43 2.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -72.78 139.78 47.29 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.401 1.455 . . . . 0.0 108.201 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -141.56 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.579 1.152 . . . . 0.0 108.511 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.455 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 43.5 p90 -146.17 153.03 40.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 122.332 1.063 . . . . 0.0 110.852 165.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -84.01 119.33 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 167.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.74 119.88 15.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.8 p -106.94 19.63 20.19 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 109.964 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.08 179.81 8.71 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 166.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.13 102.29 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 160.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.7 p -92.98 58.45 2.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.902 0.858 . . . . 0.0 109.711 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.58 -16.63 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.705 -1.247 . . . . 0.0 114.291 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -69.01 -17.75 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.256 -0.903 . . . . 0.0 111.079 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.455 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 36.3 mt -100.94 -10.26 20.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.069 1.347 . . . . 0.0 110.711 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.52 127.85 33.73 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.401 1.081 . . . . 0.0 109.585 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.73 -8.98 25.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.924 1.25 . . . . 0.0 113.631 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -99.56 -42.44 6.91 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.328 1.451 . . . . 0.0 110.278 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -115.4 155.13 27.98 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.908 1.283 . . . . 0.0 110.967 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.21 104.19 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -174.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.84 122.13 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -134.76 -2.05 2.69 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.441 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.26 26.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.417 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -142.46 147.31 35.9 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.889 1.675 . . . . 0.0 109.203 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.2 t -66.22 110.37 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 158.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -46.68 31.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -146.81 159.12 43.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.358 1.063 . . . . 0.0 108.551 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.2 18.57 60.55 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.532 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 25.7 tpp -51.79 -34.45 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.812 . . . . 0.0 110.709 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -56.3 -33.45 65.56 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.094 -1.004 . . . . 0.0 113.536 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.6 -41.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 119.416 1.007 . . . . 0.0 109.067 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.7 t -59.56 -41.59 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.192 0.905 . . . . 0.0 110.188 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -60.91 -37.83 83.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.901 0.88 . . . . 0.0 110.856 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.41 72.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.192 -0.943 . . . . 0.0 109.863 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 76.7 mtp -57.79 -44.63 86.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.8 0.84 . . . . 0.0 110.483 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.4 -32.85 72.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.57 -15.0 59.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.214 0.606 . . . . 0.0 111.475 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -97.09 6.41 48.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.694 1.598 . . . . 0.0 111.388 165.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.85 -173.78 46.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.5 p -157.1 158.61 36.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -70.06 -16.23 63.11 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -166.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -29.87 68.99 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.152 0.282 . . . . 0.0 111.36 167.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.65 -29.73 7.05 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 127.871 2.653 . . . . 0.0 112.439 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -68.6 130.94 44.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.774 1.787 . . . . 0.0 109.044 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.5 p -70.88 154.76 41.55 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.919 0.888 . . . . 0.0 110.107 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 p -74.45 -16.62 60.86 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.44 0.696 . . . . 0.0 111.54 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.453 ' HE2' HG12 ' A' ' 12' ' ' VAL . 26.4 mtpt -130.8 169.92 15.07 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.605 1.162 . . . . 0.0 110.848 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -74.42 139.19 43.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 162.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.4 mt -136.52 118.44 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -132.9 160.8 35.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 -169.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -74.05 112.66 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 158.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.78 -56.05 14.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -143.92 155.2 43.98 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.893 0.877 . . . . 0.0 109.354 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -145.82 168.81 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.762 1.625 . . . . 0.0 107.991 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.18 47.16 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 165' ' ' GLU . 6.5 tt0 -87.81 155.38 19.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -172.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 7' ' ' PHE . 55.1 mt -139.99 43.28 1.94 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.559 1.143 . . . . 0.0 109.717 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.471 ' HB3' HE21 ' A' ' 163' ' ' GLN . 10.0 pm0 . . . . . 0 C--O 1.249 1.079 0 C-N-CA 125.404 1.481 . . . . 0.0 114.244 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 m -126.32 -172.96 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.411 1.884 . . . . 0.0 108.156 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -36.34 112.4 0.52 Allowed Pre-proline 0 C--O 1.235 0.317 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.473 161.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -63.48 135.58 50.29 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.462 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 85.9 m -92.91 155.62 17.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.162 -2.532 . . . . 0.0 104.162 161.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.03 167.16 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.952 1.301 . . . . 0.0 108.556 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.45 158.04 37.07 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.74 0.816 . . . . 0.0 111.477 165.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.41 113.79 13.57 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 129.116 2.966 . . . . 0.0 104.435 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.85 104.71 15.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 170.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -71.3 148.01 10.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.33 27.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.442 0.639 . . . . 0.0 111.145 159.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.569 HG12 ' HE2' ' A' ' 154' ' ' LYS . 5.4 t -128.31 94.32 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 126.354 1.862 . . . . 0.0 107.434 -164.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' H ' ' HB3' ' A' ' 155' ' ' LYS . 24.7 m-20 50.75 24.48 1.74 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.085 -1.634 . . . . 0.0 111.611 -160.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.21 -4.93 35.64 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.055 1.312 . . . . 0.0 114.146 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 39.4 tt0 -81.44 109.06 12.58 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 127.81 2.444 . . . . 0.0 107.74 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.95 99.2 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.051 2.501 . . . . 0.0 112.054 -168.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.7 tp -79.39 -28.91 41.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.55 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.66 157.28 8.19 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.602 0.637 . . . . 0.0 113.228 171.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -74.8 135.24 41.67 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.419 1.088 . . . . 0.0 108.761 170.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 t -127.21 143.24 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.31 146.05 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.746 0.703 . . . . 0.0 109.238 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -141.27 150.27 42.38 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.762 0.825 . . . . 0.0 109.144 -164.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.15 147.16 26.57 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 163.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.7 mt -127.92 115.04 17.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.445 1.498 . . . . 0.0 107.237 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.36 58.22 1.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.078 1.751 . . . . 0.0 112.638 -169.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -19.05 51.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.678 1.191 . . . . 0.0 113.267 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.82 -30.4 66.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.056 0.843 . . . . 0.0 110.762 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -98.84 -50.55 4.17 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.65 0.78 . . . . 0.0 109.613 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.98 76.19 71.5 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 125.912 1.685 . . . . 0.0 107.702 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.3 -40.74 56.23 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.672 2.248 . . . . 0.0 111.517 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 1.3 mmpt? -66.43 -47.37 73.44 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -170.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -62.4 -49.69 74.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.961 1.304 . . . . 0.0 110.173 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.51 -46.77 78.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -64.84 -40.12 94.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.482 1.113 . . . . 0.0 110.752 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -54.64 -53.6 52.59 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 124.267 1.027 . . . . 0.0 109.484 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.9 -40.82 91.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 123.612 0.57 . . . . 0.0 112.079 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -50.71 -60.56 2.92 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.822 2.049 . . . . 0.0 110.099 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.05 63.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.585 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.48 -15.82 36.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.386 1.074 . . . . 0.0 111.808 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -42.72 12.18 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 120.006 1.276 . . . . 0.0 109.884 172.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -63.54 -33.18 75.03 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 172.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 10.55 74.73 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -16.72 63.74 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.418 1.487 . . . . 0.0 112.4 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -74.01 -3.74 31.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.204 1.402 . . . . 0.0 112.64 170.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.87 90.68 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 119.812 1.187 . . . . 0.0 112.571 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.08 173.08 17.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.067 2.147 . . . . 0.0 106.371 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.62 -179.18 34.46 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.803 -164.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -68.26 -19.5 64.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -51.42 118.61 3.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.446 1.021 . . . . 0.0 108.784 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.33 7.84 86.98 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.593 -1.67 . . . . 0.0 114.832 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 m -76.92 146.34 37.65 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 121.342 2.571 . . . . 0.0 107.738 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.21 148.39 22.24 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -93.67 81.06 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -74.06 -17.94 60.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.964 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.75 84.85 2.15 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 119.344 0.974 . . . . 0.0 110.61 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.98 97.06 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.89 104.74 23.29 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.51 142.11 83.22 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.911 1.741 . . . . 0.0 110.483 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.79 14.01 81.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.718 1.151 . . . . 0.0 112.929 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -140.67 -81.26 0.25 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.768 1.284 . . . . 0.0 109.047 -170.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.02 167.77 20.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.485 0.714 . . . . 0.0 112.411 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.3 m -123.43 97.61 5.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.818 2.047 . . . . 0.0 109.415 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.12 138.24 31.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.229 1.412 . . . . 0.0 110.824 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.62 72.35 0.09 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-O 118.635 -1.091 . . . . 0.0 113.524 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.29 14.32 1.45 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.262 1.531 . . . . 0.0 116.274 -171.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -91.03 113.49 25.77 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 164.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -96.29 35.7 1.43 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.759 1.623 . . . . 0.0 110.312 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -155.0 -67.07 0.13 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.198 1.399 . . . . 0.0 107.976 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -85.98 168.59 14.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.126 2.17 . . . . 0.0 105.288 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -139.53 31.76 2.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -167.0 4.7 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.984 -158.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.644 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 111.65 -20.19 22.88 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 120.463 1.483 . . . . 0.0 114.903 175.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 p -84.53 9.14 14.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.825 1.813 . . . . 0.0 113.865 -169.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.81 -153.58 6.94 Favored Glycine 0 C--N 1.333 0.399 0 O-C-N 120.798 -1.188 . . . . 0.0 113.14 -162.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.96 174.34 46.84 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 -158.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -166.91 154.26 9.15 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 125.461 1.505 . . . . 0.0 107.529 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.2 p -76.68 144.96 39.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.37 -25.13 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 122.156 0.183 . . . . 0.0 111.151 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -79.9 -13.74 59.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 113.788 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 160.67 -95.18 0.14 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 120.692 1.587 . . . . 0.0 111.833 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -159.23 112.43 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.212 1.005 . . . . 0.0 109.015 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt 63.4 158.25 0.07 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.824 3.25 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.71 171.33 15.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.769 0.795 . . . . 0.0 109.013 170.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.02 158.38 16.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.058 1.743 . . . . 0.0 113.265 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.99 90.86 2.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 158.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.64 -59.89 4.5 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.456 HD22 HG13 ' A' ' 89' ' ' ILE . 10.1 p-10 -161.49 158.35 26.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.795 1.283 . . . . 0.0 112.561 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.21 31.04 5.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.617 2.367 . . . . 0.0 109.553 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.456 HG13 HD22 ' A' ' 87' ' ' ASN . 21.2 mt -52.67 -40.02 32.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.586 1.154 . . . . 0.0 108.572 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.76 125.16 34.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -102.84 169.22 8.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.01 1.324 . . . . 0.0 108.899 168.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -73.82 89.26 1.82 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.7 p -72.43 -28.56 63.03 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.34 44.09 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.839 1.209 . . . . 0.0 111.091 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.53 162.43 10.3 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.315 2.01 . . . . 0.0 111.945 169.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.33 77.37 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.198 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.3 mm -77.07 162.46 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 120.139 1.969 . . . . 0.0 108.834 171.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.66 54.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 108.134 169.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -146.21 147.62 31.65 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.612 0.765 . . . . 0.0 110.214 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.404 ' HG3' ' CE1' ' A' ' 129' ' ' PHE . 12.8 mtp -85.54 128.6 34.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.909 1.338 . . . . 0.0 111.423 -172.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.42 73.09 4.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.5 2.32 . . . . 0.0 108.724 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -69.26 -179.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.392 158.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.38 20.44 8.81 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.043 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 134.79 -163.01 24.77 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -64.62 147.04 89.96 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.053 1.836 . . . . 0.0 109.602 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 46.81 32.01 1.64 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.672 1.989 . . . . 0.0 115.789 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.1 p -118.28 23.56 11.49 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.536 -1.353 . . . . 0.0 111.503 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -63.12 104.3 0.56 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.21 -75.28 1.03 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.605 1.093 . . . . 0.0 111.383 -170.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.1 p -155.74 -21.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.835 1.254 . . . . 0.0 111.486 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.644 HE22 ' HA2' ' A' ' 72' ' ' GLY . 58.8 mt-30 -64.2 143.08 58.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.47 169.32 18.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.563 1.545 . . . . 0.0 106.833 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.539 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 17.7 p90 -136.04 152.84 51.32 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.781 0.8 . . . . 0.0 110.366 163.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.79 113.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 166.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -62.73 124.95 22.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.7 p -115.1 31.67 6.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.898 1.332 . . . . 0.0 108.665 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -162.71 169.45 19.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.414 1.086 . . . . 0.0 110.03 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -73.24 86.68 1.44 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 163.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -76.81 58.01 1.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.073 0.949 . . . . 0.0 110.219 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.89 -30.5 65.93 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.037 -1.665 . . . . 0.0 111.816 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -70.91 -15.24 62.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.081 1.352 . . . . 0.0 110.541 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.539 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 66.2 mt -98.97 -12.49 20.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 124.372 1.069 . . . . 0.0 111.172 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.44 144.04 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.363 0.983 . . . . 0.0 109.605 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.06 -4.64 37.96 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.829 1.204 . . . . 0.0 113.728 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.96 -59.65 1.99 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 126.515 1.926 . . . . 0.0 108.978 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -96.69 129.28 44.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.891 1.276 . . . . 0.0 108.396 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.8 t -80.11 104.4 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -170.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.97 127.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.404 ' CE1' ' HG3' ' A' ' 100' ' ' MET . 22.4 p90 -140.74 -0.22 1.55 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.603 1.19 . . . . 0.0 113.441 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.92 -176.56 32.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.636 -1.269 . . . . 0.0 112.065 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.29 151.48 34.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.01 127.42 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -94.51 -38.33 10.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.933 0.893 . . . . 0.0 110.389 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -139.29 153.48 47.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 109.829 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.71 72.18 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 119.241 -0.755 . . . . 0.0 113.011 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.0 tpp -54.85 -36.39 65.0 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.304 1.552 . . . . 0.0 110.004 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -58.8 -27.88 65.47 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.534 1.061 . . . . 0.0 113.643 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.7 mm -75.17 -42.77 44.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 124.484 1.114 . . . . 0.0 108.268 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.35 -41.33 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.46 -34.23 70.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.018 1.327 . . . . 0.0 111.154 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.05 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.695 0.798 . . . . 0.0 110.636 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.6 mtm -55.77 -45.32 78.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.555 0.616 . . . . 0.0 110.128 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.49 -36.86 72.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.599 1.159 . . . . 0.0 112.683 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -69.56 -14.89 63.08 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.105 -0.997 . . . . 0.0 111.306 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 14.18 25.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 126.793 2.037 . . . . 0.0 111.291 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.94 -172.21 31.47 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.6 p -154.52 164.32 38.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.738 -0.86 . . . . 0.0 109.435 165.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -55.26 -33.91 63.59 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -71.64 -13.59 61.8 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.3 -26.68 21.05 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 127.274 2.368 . . . . 0.0 113.361 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -66.52 130.04 41.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.6 1.7 . . . . 0.0 108.779 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.6 p -65.7 153.86 40.54 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.594 0.758 . . . . 0.0 110.102 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.8 p -69.32 -25.5 64.24 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.299 -0.875 . . . . 0.0 110.586 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.569 ' HE2' HG12 ' A' ' 12' ' ' VAL . 42.7 mtpt -130.76 174.46 9.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.284 1.434 . . . . 0.0 111.518 -170.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -63.65 139.28 58.75 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 102.903 -2.999 . . . . 0.0 102.903 158.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -129.06 122.6 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 101.217 -3.623 . . . . 0.0 101.217 160.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.53 153.17 43.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -166.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -74.09 110.83 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.43 -46.48 73.0 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.517 0.599 . . . . 0.0 109.468 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -151.03 163.32 39.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.643 0.377 . . . . 0.0 110.045 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 m -148.43 171.1 16.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 171.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.26 174.82 46.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 160.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.573 ' HG2' ' H ' ' A' ' 165' ' ' GLU . 47.0 tt0 -87.11 154.82 20.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.225 1.01 . . . . 0.0 109.93 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.1 mt -136.94 43.41 2.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.18 2.592 . . . . 0.0 109.915 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.573 ' H ' ' HG2' ' A' ' 163' ' ' GLN . 3.5 tm-20 . . . . . 0 C--O 1.246 0.892 0 C-N-CA 127.182 2.193 . . . . 0.0 106.155 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 tmm? . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.316 28.4 m 50.12 -173.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.512 1.125 . . . . 0.0 111.515 -171.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.85 95.79 35.11 Favored Pre-proline 0 C--N 1.323 -0.559 0 O-C-N 120.49 -1.381 . . . . 0.0 107.953 165.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 156.41 66.2 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 121.18 1.253 . . . . 0.0 110.985 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -117.09 151.63 36.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.34 150.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 119.301 0.955 . . . . 0.0 109.434 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -108.21 161.55 14.89 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.124 0.969 . . . . 0.0 108.811 166.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 4.1 m-85 -144.37 108.76 4.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.052 2.141 . . . . 0.0 107.361 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 98.29 9.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 164.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.23 138.54 22.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.93 149.99 42.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.827 1.299 . . . . 0.0 108.514 161.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.558 HG12 ' HE2' ' A' ' 154' ' ' LYS . 2.5 t -106.31 80.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 170.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.523 ' OD2' ' HE3' ' A' ' 154' ' ' LYS 0.378 3.7 p30 61.74 14.09 5.88 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -179.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.41 -9.25 15.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -73.99 121.6 85.56 Favored Pre-proline 0 C--N 1.338 0.099 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 164.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.12 103.23 1.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.81 2.34 . . . . 0.0 107.732 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.8 tp -83.0 -34.11 26.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.704 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.5 165.7 11.74 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.507 -1.33 . . . . 0.0 114.993 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.27 136.14 44.53 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.3 t -120.05 158.77 21.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 130.232 3.413 . . . . 0.0 105.823 165.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -152.11 155.35 37.71 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.679 -1.888 . . . . 0.0 111.812 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -141.85 145.28 34.48 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.949 1.299 . . . . 0.0 110.079 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -90.77 150.54 21.56 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.437 1.495 . . . . 0.0 107.315 160.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -128.74 128.5 44.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.017 1.327 . . . . 0.0 108.249 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.435 ' CD2' HD13 ' A' ' 90' ' ' LEU . 16.0 m-85 -81.13 49.54 1.27 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.6 1.56 . . . . 0.0 112.546 -166.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -4.63 7.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.907 1.283 . . . . 0.0 114.379 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.15 -16.78 36.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.98 1.264 . . . . 0.0 111.974 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -121.94 -30.31 4.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.64 1.176 . . . . 0.0 113.258 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 86' ' ' GLU . 6.1 m -129.88 73.31 81.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 124.685 1.194 . . . . 0.0 107.858 169.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.75 -39.25 43.96 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.575 2.183 . . . . 0.0 113.434 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -51.34 67.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.499 1.045 . . . . 0.0 108.211 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.504 HG23 ' SD ' ' A' ' 100' ' ' MET . 4.8 m -61.55 -49.1 78.05 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.257 1.023 . . . . 0.0 110.732 -170.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.2 -45.4 70.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 112.242 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -63.4 -42.04 98.76 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.466 0.306 . . . . 0.0 111.302 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -56.98 -47.97 79.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.121 1.368 . . . . 0.0 109.439 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.1 -38.64 88.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.856 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -55.23 -58.17 8.79 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.767 0.712 . . . . 0.0 109.135 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -29.96 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.245 1.418 . . . . 0.0 113.652 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.8 mt -84.04 -26.96 28.67 Favored 'General case' 0 N--CA 1.457 -0.078 0 O-C-N 121.567 -0.708 . . . . 0.0 111.599 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 m -77.52 -43.43 32.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.581 0.752 . . . . 0.0 110.326 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.4 p -63.96 -27.35 69.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.89 7.51 62.16 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -62.41 -27.85 69.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.59 1.156 . . . . 0.0 111.189 -171.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 29.3 mmmt -65.49 -14.71 61.6 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.959 -1.02 . . . . 0.0 112.26 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.93 4.17 48.44 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.251 1.405 . . . . 0.0 112.228 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -163.6 175.99 10.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.078 1.751 . . . . 0.0 107.968 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.77 -149.49 19.55 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-O 122.029 0.794 . . . . 0.0 112.831 165.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -59.96 -44.74 94.24 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 127.14 2.176 . . . . 0.0 109.655 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -44.62 112.83 0.46 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.015 1.326 . . . . 0.0 110.004 170.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.05 3.64 88.92 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.097 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.3 m -63.86 -62.76 1.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.907 2.354 . . . . 0.0 110.8 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 t 122.85 167.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 131.774 4.03 . . . . 0.0 106.583 -168.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.435 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 51.5 m-85 -119.68 91.96 3.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.583 1.953 . . . . 0.0 106.198 170.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -73.76 -18.34 60.99 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -164.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.26 104.08 4.22 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.58 103.09 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.0 mt -119.03 91.0 42.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -48.24 122.62 7.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.01 3.14 . . . . 0.0 114.859 -167.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.56 21.27 77.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.133 1.349 . . . . 0.0 112.37 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.11 -75.57 0.55 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.38 170.99 19.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.227 1.011 . . . . 0.0 109.413 167.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 p -130.77 107.97 9.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.797 0.839 . . . . 0.0 110.411 168.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -86.96 140.86 29.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 129.028 2.931 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -148.75 -163.09 10.66 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 124.959 1.266 . . . . 0.0 110.845 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 48' ' ' TYR . . . 91.96 10.68 61.04 Favored Glycine 0 N--CA 1.463 0.496 0 CA-C-N 117.717 0.758 . . . . 0.0 114.89 166.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.82 103.91 13.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 107.552 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -115.45 9.94 15.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.478 1.511 . . . . 0.0 111.747 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.6 t -139.15 -35.41 0.56 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.596 1.158 . . . . 0.0 113.629 -166.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -129.87 -36.54 1.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -167.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.5 m170 61.4 56.8 2.52 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.673 1.189 . . . . 0.0 112.078 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -164.51 -54.05 0.03 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.015 1.326 . . . . 0.0 110.169 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.94 -21.44 0.18 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.751 1.643 . . . . 0.0 113.242 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -84.55 12.12 7.57 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.875 1.837 . . . . 0.0 111.57 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.48 -165.13 15.77 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 124.727 1.156 . . . . 0.0 110.696 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.47 103.75 0.17 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -136.3 144.36 44.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.163 -1.018 . . . . 0.0 109.592 162.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -70.62 164.4 25.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.256 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.412 ' HB ' ' HE2' ' A' ' 44' ' ' LYS . 41.9 pt -61.32 -31.64 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 121.563 -0.711 . . . . 0.0 110.018 163.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.82 -14.53 61.11 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.516 0.726 . . . . 0.0 112.277 -172.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.01 -85.71 0.15 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -156.17 132.19 9.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 108.593 163.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 pttt 52.31 149.88 0.0 OUTLIER 'General case' 0 C--N 1.342 0.281 1 C-N-CA 132.618 4.367 . . . . 0.0 115.375 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -128.69 -172.56 2.74 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.27 152.37 43.34 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.993 -1.067 . . . . 0.0 109.609 167.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.64 101.02 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 159.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HG3' HG12 ' A' ' 29' ' ' VAL . 11.0 pt-20 -63.65 -51.02 66.98 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.448 -168.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -151.67 176.24 11.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.373 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -127.78 30.26 5.32 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.618 2.367 . . . . 0.0 109.462 172.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.8 mt -57.27 -46.5 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 25' ' ' PHE . 99.0 mt -74.57 112.57 10.89 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -82.17 164.26 21.38 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.942 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -76.78 98.41 4.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.2 p -77.87 -32.93 52.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.798 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.6 -174.98 47.35 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 118.964 0.802 . . . . 0.0 113.851 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.72 160.02 26.37 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.486 2.124 . . . . 0.0 110.457 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.29 -5.93 40.01 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 117.836 -1.536 . . . . 0.0 112.465 -172.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.92 156.18 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.925 2.362 . . . . 0.0 107.584 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.17 129.33 54.94 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.641 1.177 . . . . 0.0 108.421 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.1 t -138.53 148.98 44.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.026 0.829 . . . . 0.0 109.28 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.504 ' SD ' HG23 ' A' ' 32' ' ' THR . 12.9 ttt -100.45 130.44 46.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -162.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.498 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -75.54 155.64 35.87 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.813 1.245 . . . . 0.0 108.842 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -165.38 -169.1 1.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.922 1.689 . . . . 0.0 108.029 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -119.61 13.66 12.55 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.457 1.103 . . . . 0.0 113.049 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.42 -142.39 13.77 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -168.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.03 157.3 62.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.873 1.715 . . . . 0.0 109.521 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 34.18 51.04 0.4 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 128.163 2.585 . . . . 0.0 112.999 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 p -140.63 13.92 2.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.713 0.805 . . . . 0.0 113.069 -173.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -57.79 96.61 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.754 1.622 . . . . 0.0 110.826 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.19 -84.66 1.08 Allowed Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.048 -1.032 . . . . 0.0 111.529 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -156.29 -17.43 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -55.61 140.52 40.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 167.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.498 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -138.88 169.98 16.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 19.8 p90 -132.34 147.35 52.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.865 0.84 . . . . 0.0 111.663 166.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.4 mt -83.37 117.43 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 102.413 -3.18 . . . . 0.0 102.413 171.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.1 m -64.38 120.91 13.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.0 p -106.88 22.16 16.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.127 0.571 . . . . 0.0 109.629 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.39 -179.56 7.8 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 163.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -64.12 117.27 6.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 159.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.435 ' HA ' ' CZ3' ' A' ' 121' ' ' TRP . 49.8 p -114.21 56.88 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.175 0.898 . . . . 0.0 111.327 -174.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -61.31 -25.08 66.88 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 120.86 -1.15 . . . . 0.0 113.959 -169.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.435 ' CZ3' ' HA ' ' A' ' 119' ' ' THR . 37.3 p90 -66.11 -21.82 66.37 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.814 0.846 . . . . 0.0 110.708 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.609 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 82.9 mt -88.65 -16.89 31.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 123.657 0.783 . . . . 0.0 110.569 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.77 149.0 38.07 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.34 69.84 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.611 -0.328 . . . . 0.0 112.34 -169.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.91 -45.11 0.47 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.179 0.99 . . . . 0.0 109.473 164.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -103.82 144.67 31.19 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.863 1.265 . . . . 0.0 109.486 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.3 102.15 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.05 121.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -142.14 1.36 1.43 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.024 -169.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.79 -177.25 35.64 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.973 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 157.84 43.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.138 0.495 . . . . 0.0 109.954 162.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.03 124.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -84.82 -48.01 9.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.329 160.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -146.06 158.29 43.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.681 1.192 . . . . 0.0 110.292 -168.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.46 20.08 64.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.86 0.704 . . . . 0.0 114.86 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -34.89 60.57 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.539 1.67 . . . . 0.0 111.186 174.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -32.95 69.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.6 mm -78.14 -34.17 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 119.541 1.064 . . . . 0.0 109.492 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.21 -40.77 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.143 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.18 -37.01 81.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.672 0.789 . . . . 0.0 111.095 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.79 83.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.204 1.366 . . . . 0.0 108.288 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.0 mtm -52.41 -48.53 65.63 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 118.003 0.365 . . . . 0.0 110.568 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.03 -34.12 72.95 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -76.92 -15.67 59.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.892 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -89.46 -5.42 57.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.011 0.924 . . . . 0.0 111.806 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.51 -167.98 42.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.852 1.692 . . . . 0.0 109.782 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 51.2 p -161.49 155.74 22.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -18.88 65.54 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -69.43 -7.19 35.59 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.32 -30.29 10.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 127.787 2.613 . . . . 0.0 113.016 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -63.11 129.78 41.82 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.061 0.944 . . . . 0.0 110.56 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 p -80.01 157.97 26.65 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.824 1.25 . . . . 0.0 109.72 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -76.19 -17.73 59.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.286 1.035 . . . . 0.0 111.786 167.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.558 ' HE2' HG12 ' A' ' 12' ' ' VAL . 12.3 mtpt -140.85 165.3 27.9 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.407 1.483 . . . . 0.0 109.572 -168.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 13' ' ' ASP . 30.8 tttt -85.69 80.14 9.09 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.995 1.725 . . . . 0.0 107.515 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mt -73.87 131.24 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -173.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 p -145.69 167.34 23.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 123.488 1.613 . . . . 0.0 110.063 -167.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.408 HD13 ' O ' ' A' ' 48' ' ' TYR . 4.0 mp -83.02 114.56 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 158.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.59 -55.04 12.91 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.04 153.01 33.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.619 1.568 . . . . 0.0 107.076 -161.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 8' ' ' PHE . 7.5 m -159.71 174.16 14.95 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.951 1.701 . . . . 0.0 109.156 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.25 -172.01 44.84 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 165.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -83.49 160.4 21.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.123 0.969 . . . . 0.0 108.578 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 68.2 mt -128.27 43.28 3.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.197 0.999 . . . . 0.0 108.877 162.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 N--CA 1.435 -1.218 0 C-N-CA 131.638 3.975 . . . . 0.0 109.821 -168.698 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.58 178.29 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.564 1.146 . . . . 0.0 108.473 161.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -44.48 145.0 1.56 Allowed Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 126.976 2.111 . . . . 0.0 113.057 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.84 156.26 66.89 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.863 1.709 . . . . 0.0 109.279 165.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.1 m -135.82 158.77 43.58 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.85 155.43 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 119.493 -2.004 . . . . 0.0 109.228 -169.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -124.38 157.3 35.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.874 1.269 . . . . 0.0 109.947 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 161' ' ' CYS . 88.1 m-85 -147.16 106.23 3.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.204 2.202 . . . . 0.0 107.738 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.49 93.56 3.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.17 143.7 15.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.6 133.54 47.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.443 1.097 . . . . 0.0 110.19 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 t -99.76 96.19 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 128.094 2.558 . . . . 0.0 104.603 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 58.71 17.96 5.56 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.763 2.025 . . . . 0.0 114.037 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.36 -9.72 24.37 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.319 1.914 . . . . 0.0 112.518 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.96 131.94 52.47 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.22 113.67 2.94 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.82 1.68 . . . . 0.0 109.659 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.3 tp -79.59 -37.28 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.554 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.28 171.03 14.0 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -81.68 139.8 34.73 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.92 153.41 35.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 127.066 2.146 . . . . 0.0 105.395 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.72 139.03 11.15 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 -166.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -134.04 149.76 51.18 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.621 0.769 . . . . 0.0 111.006 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -87.12 151.67 23.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 158.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 mt -127.46 109.48 11.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -68.97 61.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.84 2.456 . . . . 0.0 112.049 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.38 -30.17 38.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.463 1.905 . . . . 0.0 112.222 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 -19.55 62.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.901 1.681 . . . . 0.0 110.818 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -38.89 2.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.353 2.261 . . . . 0.0 110.664 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 129' ' ' PHE . 3.8 m -141.24 72.71 26.55 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.758 2.023 . . . . 0.0 108.645 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.59 -41.43 39.73 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.845 2.363 . . . . 0.0 113.712 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -57.73 11.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.351 1.432 . . . . 0.0 107.69 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 m -57.77 -44.08 85.92 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.712 0.632 . . . . 0.0 109.841 -169.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.48 67.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.799 0.84 . . . . 0.0 113.257 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -66.75 -39.96 88.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.713 0.688 . . . . 0.0 110.574 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -55.99 -52.53 63.85 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.75 1.22 . . . . 0.0 109.712 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.511 ' CE2' ' CE2' ' A' ' 112' ' ' PHE . 2.3 t80 -56.12 -49.86 72.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.601 0.36 . . . . 0.0 110.679 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.433 ' HD2' HE21 ' A' ' 163' ' ' GLN . 45.8 ttp85 -50.96 -60.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.011 1.324 . . . . 0.0 109.926 -173.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.54 -27.12 68.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -77.12 -33.85 56.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.922 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.5 p -69.95 -45.55 67.19 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.98 1.264 . . . . 0.0 111.093 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.0 p -64.68 -36.8 85.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.565 0.746 . . . . 0.0 109.085 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.23 14.31 82.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.24 -28.29 67.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.15 1.38 . . . . 0.0 112.031 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -72.33 8.96 1.14 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.529 1.132 . . . . 0.0 112.917 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -3.69 83.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.885 1.231 . . . . 0.0 112.805 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.2 176.45 12.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.5 1.65 . . . . 0.0 108.65 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.55 -146.88 17.6 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 174.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.561 ' CE1' ' CE2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -61.24 -38.69 87.59 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.213 1.405 . . . . 0.0 112.532 -163.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -47.15 116.78 1.49 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.398 1.079 . . . . 0.0 109.976 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.98 4.24 90.34 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.427 -1.763 . . . . 0.0 115.728 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -64.24 -35.21 80.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 121.502 2.651 . . . . 0.0 113.589 -162.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.4 m 86.0 164.93 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.611 2.764 . . . . 0.0 107.868 -158.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -119.01 101.57 8.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 164.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.194 0.907 . . . . 0.0 113.043 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.571 ' HG3' HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -133.12 114.25 13.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.81 120.69 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.571 HD11 ' HG3' ' A' ' 55' ' ' ARG . 4.9 mp -124.89 99.95 34.39 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.2 136.45 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.107 1.871 . . . . 0.0 110.52 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 22.93 78.58 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.766 1.65 . . . . 0.0 112.198 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -146.93 -81.89 0.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.805 1.303 . . . . 0.0 109.144 -173.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.554 ' CE ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -161.77 168.72 22.68 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.724 0.693 . . . . 0.0 112.301 174.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.0 m -120.84 108.44 13.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.212 1.805 . . . . 0.0 108.003 170.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -95.44 133.4 39.45 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 110.342 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.34 177.86 29.87 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.02 20.11 4.57 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.492 1.044 . . . . 0.0 112.62 -174.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -84.03 28.88 0.58 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.619 1.968 . . . . 0.0 111.975 -164.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 10.6 p90 -63.34 1.25 0.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.516 1.926 . . . . 0.0 115.731 -167.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.502 HG21 ' HE2' ' A' ' 76' ' ' LYS . 2.1 p -139.21 -69.08 0.43 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.305 1.842 . . . . 0.0 109.57 -169.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -118.75 162.47 18.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 166.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -148.25 33.77 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.582 1.953 . . . . 0.0 108.063 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -144.96 16.27 1.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.838 3.255 . . . . 0.0 109.525 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.65 -28.05 12.37 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.365 1.459 . . . . 0.0 113.57 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.8 p -83.74 12.39 6.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.099 1.95 . . . . 0.0 113.103 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.56 168.8 13.27 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.743 1.163 . . . . 0.0 111.794 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.95 165.17 30.16 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HE2' HG21 ' A' ' 68' ' ' THR . 3.5 pttt 170.69 -177.34 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.129 4.172 . . . . 0.0 103.914 -160.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.9 p -127.25 178.6 5.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.455 1.025 . . . . 0.0 110.311 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.14 -22.89 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.131 168.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.93 1.78 56.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.514 1.525 . . . . 0.0 111.681 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.69 -112.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.24 -133.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.83 2.052 . . . . 0.0 110.389 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -102.74 154.67 18.94 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.331 -1.48 . . . . 0.0 109.261 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -111.0 165.45 11.86 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 109.888 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 156.17 31.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.175 0.988 . . . . 0.0 110.863 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 101.82 2.78 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.13 -48.98 77.34 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.465 1.106 . . . . 0.0 110.62 -164.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -170.12 176.28 4.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.24 2.216 . . . . 0.0 107.96 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -129.45 43.21 3.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.72 1.208 . . . . 0.0 108.357 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.0 mt -60.56 -65.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -72.67 143.64 48.03 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.954 1.835 . . . . 0.0 107.32 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -131.55 161.6 32.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 127.057 2.143 . . . . 0.0 109.008 -170.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -84.97 73.13 10.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.597 1.159 . . . . 0.0 109.055 -164.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 p -66.07 -31.58 72.54 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.832 0.853 . . . . 0.0 113.003 -165.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.28 171.34 31.38 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 118.75 -1.028 . . . . 0.0 110.965 -166.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.8 135.96 54.97 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.314 2.009 . . . . 0.0 111.669 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.35 -8.01 30.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.065 -1.409 . . . . 0.0 111.731 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.5 mm -72.31 148.3 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 121.124 2.462 . . . . 0.0 108.662 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.51 131.45 55.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.403 1.081 . . . . 0.0 108.263 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.3 t -140.51 159.82 41.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.857 0.863 . . . . 0.0 110.005 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.31 137.56 32.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -163.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -90.48 71.48 6.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.11 163.62 27.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.411 158.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.08 16.47 12.44 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.664 1.586 . . . . 0.0 111.646 -168.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.27 -170.81 28.05 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 -159.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -65.11 172.26 7.7 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 CA-C-N 119.898 1.849 . . . . 0.0 109.86 165.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.93 14.7 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 131.12 3.768 . . . . 0.0 116.221 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -108.63 27.26 9.59 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 119.857 -1.777 . . . . 0.0 111.03 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.408 2.683 . . . . 0.0 106.459 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.59 -93.75 0.32 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -172.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.5 t -144.34 -11.25 0.63 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.45 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -79.48 135.22 36.59 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CE2' ' CE1' ' A' ' 48' ' ' TYR . 37.1 p90 -145.29 177.27 8.93 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.679 1.192 . . . . 0.0 108.449 174.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -142.08 151.57 42.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.872 1.32 . . . . 0.0 112.587 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.81 101.9 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 101.569 -3.493 . . . . 0.0 101.569 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.68 94.42 0.3 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.4 p -87.1 25.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.804 0.842 . . . . 0.0 111.009 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.15 -178.22 7.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 163.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -67.2 130.84 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 158.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.6 p -131.62 57.76 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -14.37 61.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.183 0.993 . . . . 0.0 112.408 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -69.57 -7.95 43.0 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.106 -0.996 . . . . 0.0 111.055 170.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -109.46 -8.68 14.99 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.479 1.512 . . . . 0.0 111.996 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 149.05 30.17 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.059 0.943 . . . . 0.0 111.011 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.14 18.65 49.34 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.27 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -144.25 -34.33 0.38 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.576 1.15 . . . . 0.0 110.449 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -118.09 139.36 51.35 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.389 1.076 . . . . 0.0 108.194 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.76 96.87 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -167.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.17 127.02 22.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.419 ' HA ' HG21 ' A' ' 29' ' ' VAL . 15.8 p90 -134.83 -6.5 2.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.049 -0.977 . . . . 0.0 113.256 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.13 -179.28 31.05 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.28 -1.438 . . . . 0.0 112.855 -173.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -153.65 138.3 16.93 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -53.73 114.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 125.059 1.344 . . . . 0.0 108.388 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -83.26 -52.27 6.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.83 160.05 40.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.715 1.143 . . . . 0.0 112.116 -168.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.69 77.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.526 1.06 . . . . 0.0 112.098 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -37.99 71.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.86 1.33 . . . . 0.0 110.843 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.22 -29.15 68.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.946 -1.096 . . . . 0.0 112.508 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.6 mm -72.51 -35.46 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.614 1.166 . . . . 0.0 108.98 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.36 -44.05 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.983 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -27.44 68.91 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.962 -1.086 . . . . 0.0 112.779 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.84 -46.32 68.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.939 -1.101 . . . . 0.0 108.474 170.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 15.8 mtm -53.08 -46.7 68.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 118.374 0.534 . . . . 0.0 111.234 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -52.29 -42.49 63.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.469 1.108 . . . . 0.0 111.842 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.47 -19.52 64.56 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.922 -0.486 . . . . 0.0 110.822 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.445 ' CB ' HD11 ' A' ' 156' ' ' ILE . 55.1 m-85 -98.02 5.01 49.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.692 1.597 . . . . 0.0 111.664 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.2 -163.93 37.94 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 98.5 p -152.41 163.57 39.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 161.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 57' ' ' ILE . 44.9 mtm-85 -67.03 -22.4 65.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.25 -1.531 . . . . 0.0 113.462 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -75.33 -15.69 60.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 168.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 102.06 -27.98 17.98 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-O 117.644 -1.642 . . . . 0.0 114.259 171.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -66.95 124.63 23.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 120.209 2.005 . . . . 0.0 107.246 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.9 p -73.31 147.85 44.08 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 123.924 0.889 . . . . 0.0 109.895 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.0 p -77.61 -9.98 59.25 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.23 -0.919 . . . . 0.0 111.784 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -136.96 152.32 50.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.968 1.307 . . . . 0.0 109.546 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -73.06 109.08 6.33 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.445 HD11 ' CB ' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -101.88 130.45 51.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -177.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 42.2 p -141.84 173.36 11.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.55 1.94 . . . . 0.0 110.552 -170.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.409 HD11 ' CE2' ' A' ' 48' ' ' TYR . 3.2 mt -106.61 116.55 50.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 167.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.12 -60.01 4.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -163.01 176.55 10.01 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.735 1.614 . . . . 0.0 111.388 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 8' ' ' PHE . 1.4 p -169.5 172.4 7.06 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.425 1.09 . . . . 0.0 110.628 -159.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.82 -172.23 45.11 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.433 HE21 ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -90.63 160.47 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.115 0.966 . . . . 0.0 110.327 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 39.0 mt -136.9 43.66 2.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.595 1.558 . . . . 0.0 109.011 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.745 -176.041 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mmm . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 3' ' ' ASN . 4.9 p -65.86 -174.26 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.973 0.892 . . . . 0.0 109.005 166.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.517 ' H ' HG22 ' A' ' 2' ' ' VAL . 35.6 m120 -27.94 99.98 0.11 Allowed Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 129.466 3.106 . . . . 0.0 114.331 167.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -76.36 149.95 31.92 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 N-CA-C 109.283 -1.084 . . . . 0.0 109.283 165.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 m -101.48 151.15 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.78 163.7 32.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.537 1.535 . . . . 0.0 108.252 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -134.09 158.42 43.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.15 0.98 . . . . 0.0 110.471 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -128.86 123.77 33.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.856 2.462 . . . . 0.0 106.317 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -78.19 98.92 6.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.8 mm -70.28 140.14 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.151 -0.968 . . . . 0.0 109.562 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.49 50.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.581 1.152 . . . . 0.0 110.4 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 6.7 t -132.74 100.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -165.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.24 13.69 0.65 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.599 1.959 . . . . 0.0 112.86 -161.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.19 38.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.525 1.536 . . . . 0.0 113.298 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -80.51 126.87 77.54 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 120.015 1.908 . . . . 0.0 106.188 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 115.89 3.65 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.822 1.681 . . . . 0.0 109.078 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.9 tp -85.2 -39.6 17.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.563 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.97 158.34 9.01 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.495 -0.383 . . . . 0.0 112.218 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -68.97 146.43 52.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 164.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.453 HG12 ' CZ ' ' A' ' 22' ' ' PHE . 39.2 t -135.33 143.29 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 171.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -137.02 153.18 50.72 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.166 0.586 . . . . 0.0 110.031 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.453 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 11.3 m-85 -146.54 146.69 30.58 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.477 1.111 . . . . 0.0 108.909 -165.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.03 145.88 27.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 165.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -118.65 146.78 44.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.366 1.066 . . . . 0.0 108.734 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -97.54 61.66 1.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.543 1.537 . . . . 0.0 111.102 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.2 42.05 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.29 0.636 . . . . 0.0 112.236 171.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -80.58 -0.89 39.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.931 2.093 . . . . 0.0 113.307 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -127.83 -37.27 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.142 1.337 . . . . 0.0 110.716 166.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.07 73.68 74.69 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.148 1.379 . . . . 0.0 107.457 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.38 -43.09 36.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -49.88 67.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.924 0.783 . . . . 0.0 109.828 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.7 m -55.21 -46.66 75.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.991 1.316 . . . . 0.0 109.769 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -51.9 55.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.621 0.769 . . . . 0.0 111.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.59 -39.0 93.27 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.322 1.049 . . . . 0.0 111.618 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -51.88 -60.92 2.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.191 1.396 . . . . 0.0 109.718 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -66.12 -28.27 68.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.221 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -53.88 -64.11 0.93 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.206 1.402 . . . . 0.0 109.16 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.9 -16.62 61.86 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.58 -31.37 16.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.879 1.272 . . . . 0.0 110.903 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -79.36 -24.39 42.72 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 111.761 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.6 p -79.24 -39.06 34.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.24 19.72 78.07 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.0 -16.05 63.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.806 1.303 . . . . 0.0 112.942 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -87.48 9.43 20.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.213 1.005 . . . . 0.0 112.032 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.04 16.47 79.53 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.972 -0.904 . . . . 0.0 112.419 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.83 -173.73 4.69 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.968 1.707 . . . . 0.0 108.678 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.71 -146.19 17.89 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CE2' HD11 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -64.04 -27.99 69.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.791 1.636 . . . . 0.0 111.767 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 11.3 tmtt? -62.01 109.64 1.34 Allowed 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.879 -0.513 . . . . 0.0 110.164 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.57 89.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 116.938 -2.035 . . . . 0.0 115.061 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -68.13 151.28 47.24 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 121.89 2.845 . . . . 0.0 108.324 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.427 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 65.2 m -86.15 171.09 11.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 159.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CB ' HD11 ' A' ' 56' ' ' ILE . 55.0 m-85 -116.09 120.08 37.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -73.67 -45.41 52.71 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.73 102.05 6.4 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 123.807 0.692 . . . . 0.0 110.877 -157.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.409 HD11 ' CB ' ' A' ' 53' ' ' PHE . 29.8 mt -130.06 108.42 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -170.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.43 97.47 50.18 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -55.05 128.79 32.04 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.299 1.999 . . . . 0.0 112.705 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 46.31 85.42 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 125.011 1.291 . . . . 0.0 110.156 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -153.55 -79.23 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.58 168.4 16.43 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.805 1.242 . . . . 0.0 109.668 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.81 109.49 7.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.704 1.201 . . . . 0.0 111.551 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -101.64 143.02 32.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.439 2.696 . . . . 0.0 110.774 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.34 20.02 0.63 Allowed Glycine 0 CA--C 1.536 1.372 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.55 3.39 42.79 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 119.136 1.468 . . . . 0.0 116.045 -159.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -83.98 23.86 0.98 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.485 2.142 . . . . 0.0 112.833 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -33.37 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 1 C-N-CA 133.515 4.726 . . . . 0.0 119.989 -158.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -87.75 -22.28 24.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.865 1.666 . . . . 0.0 111.265 173.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -133.19 177.98 7.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 128.998 2.919 . . . . 0.0 106.867 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -156.17 44.03 0.42 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.84 1.256 . . . . 0.0 108.651 -168.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -140.34 -8.36 1.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 110.824 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.39 5.45 56.98 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 117.828 -1.54 . . . . 0.0 113.801 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.2 p -135.57 65.85 1.53 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 120.375 2.088 . . . . 0.0 110.077 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.17 -154.1 6.95 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 167.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' H ' HG22 ' A' ' 68' ' ' THR . . . 81.86 170.67 44.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.115 0.864 . . . . 0.0 112.78 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 150.88 9.97 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.879 1.272 . . . . 0.0 109.327 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.2 p -89.63 35.2 0.82 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -166.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 pt 42.1 -3.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 130.645 3.578 . . . . 0.0 118.049 -162.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -134.28 12.21 3.85 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.644 2.377 . . . . 0.0 110.774 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.15 -156.82 27.38 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -68.5 -132.91 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.444 1.498 . . . . 0.0 108.446 160.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -74.69 170.57 15.55 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.092 -1.63 . . . . 0.0 111.257 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -130.6 178.5 6.58 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.96 1.704 . . . . 0.0 108.038 169.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.74 172.84 2.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.198 0.999 . . . . 0.0 112.11 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -79.46 99.19 7.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 160.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.063 1.345 . . . . 0.0 112.269 -166.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -160.6 175.7 12.4 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.009 1.324 . . . . 0.0 108.32 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.41 26.67 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.169 1.388 . . . . 0.0 109.557 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.38 -46.61 81.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.62 132.25 34.2 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -133.67 154.94 50.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.331 1.853 . . . . 0.0 109.224 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -75.84 85.5 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.047 1.339 . . . . 0.0 110.27 -168.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.86 -7.83 59.63 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.888 1.275 . . . . 0.0 113.962 -172.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.71 -178.8 33.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.37 156.06 53.71 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.864 1.709 . . . . 0.0 110.514 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.85 89.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.981 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.6 mm -77.85 160.94 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.241 2.02 . . . . 0.0 107.8 169.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.21 136.59 54.8 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 125.239 1.416 . . . . 0.0 107.303 169.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 22.8 t -127.08 138.29 53.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.8 mtp -67.57 152.86 44.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 158.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -121.89 154.72 36.73 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.531 1.532 . . . . 0.0 108.874 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -138.49 -171.19 3.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.132 2.173 . . . . 0.0 107.301 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.94 25.15 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.76 1.624 . . . . 0.0 110.593 -175.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.67 -161.58 24.79 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 -165.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -62.2 154.86 60.1 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 120.474 2.137 . . . . 0.0 109.4 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 43.99 43.66 5.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.716 2.406 . . . . 0.0 114.136 159.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.6 p -132.59 29.79 4.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.258 1.423 . . . . 0.0 110.048 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -71.39 107.69 4.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.79 -95.21 1.55 Allowed Glycine 0 C--O 1.225 -0.423 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 p -129.65 1.7 4.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.787 1.635 . . . . 0.0 110.893 170.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -58.3 141.84 49.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.905 1.682 . . . . 0.0 108.359 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.61 174.39 15.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.544 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 11.5 p90 -147.35 161.08 41.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 158.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.39 129.05 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 159.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.5 m -79.45 118.19 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.7 p -108.09 21.32 17.54 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.673 1.589 . . . . 0.0 109.521 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -156.57 174.75 14.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 167.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -71.53 85.41 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 162.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -78.18 60.34 2.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.273 1.029 . . . . 0.0 110.781 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.34 -15.1 62.99 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.667 -1.27 . . . . 0.0 112.453 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -76.87 -18.04 58.59 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.104 1.361 . . . . 0.0 111.944 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.544 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 69.2 mt -97.74 -7.94 29.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.179 1.392 . . . . 0.0 110.402 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.62 138.3 56.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.93 -11.29 1.97 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.586 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -93.76 -39.0 10.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.666 1.733 . . . . 0.0 108.421 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -130.92 155.6 46.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.092 0.472 . . . . 0.0 111.433 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.29 93.54 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.531 1.532 . . . . 0.0 108.195 -165.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.59 131.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 1.18 0.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.248 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -163.27 -175.16 33.98 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 119.458 1.026 . . . . 0.0 112.345 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -153.0 150.93 29.71 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.838 0.855 . . . . 0.0 110.016 165.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.98 117.56 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.574 1.549 . . . . 0.0 107.653 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -72.62 -48.31 40.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.318 167.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -149.23 160.29 43.51 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 109.064 -162.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.02 16.29 76.62 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.515 0.579 . . . . 0.0 113.392 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -37.74 67.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.816 1.808 . . . . 0.0 111.195 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.0 -21.08 65.07 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.056 -1.028 . . . . 0.0 113.752 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.4 mm -81.79 -34.43 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.186 1.394 . . . . 0.0 108.835 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.44 -37.1 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 120.668 -1.27 . . . . 0.0 109.348 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -69.79 -23.75 63.39 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 120.546 -1.346 . . . . 0.0 112.595 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.63 -42.85 77.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.965 -1.084 . . . . 0.0 109.626 168.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 23.0 mtp -62.32 -46.9 86.65 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 122.331 -0.231 . . . . 0.0 110.972 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -66.14 -29.69 70.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -76.49 -15.99 59.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.328 0.967 . . . . 0.0 112.46 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -95.05 18.82 11.39 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 127.088 2.155 . . . . 0.0 112.285 163.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.49 -147.89 15.36 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.418 1.961 . . . . 0.0 110.616 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.3 p -146.14 -81.86 0.14 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.451 0.625 . . . . 0.0 110.807 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 169.06 -21.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 131.529 3.932 . . . . 0.0 111.215 167.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -19.57 63.93 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.776 1.171 . . . . 0.0 109.855 159.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.03 -26.91 10.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.565 -1.131 . . . . 0.0 111.894 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -70.83 123.63 22.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 119.416 1.608 . . . . 0.0 107.054 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.8 p -72.18 153.98 41.31 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.205 1.802 . . . . 0.0 111.553 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.82 -5.02 59.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.782 1.233 . . . . 0.0 112.426 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.414 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 20.4 mmtt -137.97 161.23 37.22 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.793 2.037 . . . . 0.0 109.212 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -75.1 89.07 2.45 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 163.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.58 130.7 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.73 162.81 36.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.055 0.942 . . . . 0.0 111.743 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.669 HD11 ' CE2' ' A' ' 48' ' ' TYR . 3.9 mp -91.37 119.55 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 158.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.98 -58.92 6.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 164.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -152.79 167.62 28.42 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 49' ' ' LYS . 15.6 p -162.04 171.83 16.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.52 0.6 . . . . 0.0 111.414 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.32 176.54 48.06 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -76.25 158.38 31.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.575 1.55 . . . . 0.0 109.284 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.1 mt -137.4 42.74 2.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 122.102 0.953 . . . . 0.0 109.098 159.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.247 0.959 0 C-N-CA 125.143 1.377 . . . . 0.0 107.862 -177.768 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.8 t -68.02 176.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 161.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -48.65 110.8 1.58 Allowed Pre-proline 0 C--O 1.236 0.345 0 CA-C-O 117.422 -1.275 . . . . 0.0 108.922 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -65.19 133.36 35.02 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 CA-C-N 120.774 1.312 . . . . 0.0 109.66 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -89.41 152.3 21.56 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -135.91 157.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 121.019 -1.051 . . . . 0.0 109.036 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -124.65 153.5 42.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.227 1.011 . . . . 0.0 108.727 170.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -132.86 117.96 18.37 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.496 1.918 . . . . 0.0 106.053 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.02 97.16 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 164.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.7 mm -68.77 147.54 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.72 153.37 45.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.309 1.844 . . . . 0.0 109.577 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.92 108.36 19.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.27 13.95 4.29 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.747 1.619 . . . . 0.0 114.236 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.49 -0.5 63.45 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.55 1.071 . . . . 0.0 112.889 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.12 146.71 90.15 Favored Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 159.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 130.55 27.29 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 N-CA-C 107.819 -1.646 . . . . 0.0 107.819 160.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 tp -91.87 -41.69 10.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 108.98 169.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.46 156.8 8.16 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 118.115 0.416 . . . . 0.0 112.99 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -82.56 114.08 20.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.801 1.24 . . . . 0.0 109.126 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.08 155.65 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.797 1.639 . . . . 0.0 107.082 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -142.14 148.51 38.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 123.46 1.6 . . . . 0.0 111.322 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -131.71 159.61 37.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 113.524 -1.671 . . . . 0.0 107.899 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -120.52 144.41 48.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.785 1.634 . . . . 0.0 106.785 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.85 114.81 16.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -170.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.56 64.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.854 1.662 . . . . 0.0 110.885 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.85 -14.18 60.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 112.607 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -71.02 -36.21 72.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.506 1.122 . . . . 0.0 110.791 168.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -85.77 -56.18 3.61 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.953 0.901 . . . . 0.0 108.907 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.14 71.01 80.23 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.226 1.81 . . . . 0.0 109.385 -165.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.76 -30.76 78.43 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.577 2.185 . . . . 0.0 113.626 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -52.3 57.98 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.786 1.63 . . . . 0.0 108.032 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' SD ' ' A' ' 100' ' ' MET . 16.6 m -63.38 -44.82 93.63 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.577 1.151 . . . . 0.0 110.607 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.26 91.86 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.818 -0.551 . . . . 0.0 111.871 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.37 -44.71 78.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.433 1.093 . . . . 0.0 110.651 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -54.32 -48.39 71.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.678 1.191 . . . . 0.0 109.604 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -64.35 -36.44 84.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.425 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -57.79 -63.35 1.28 Allowed 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.283 1.033 . . . . 0.0 109.521 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.84 71.81 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.806 0.692 . . . . 0.0 111.205 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.0 mt -67.06 -36.09 81.27 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 121.375 -0.828 . . . . 0.0 110.845 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 m -68.22 -28.76 67.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.345 0.975 . . . . 0.0 111.999 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -93.95 -26.01 17.03 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.076 0.55 . . . . 0.0 111.201 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.81 -0.29 86.77 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.902 0.774 . . . . 0.0 112.561 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -38.83 77.45 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.552 1.141 . . . . 0.0 111.991 -165.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -72.55 3.85 4.5 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.08 4.54 84.17 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 119.528 1.058 . . . . 0.0 111.506 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.58 169.8 19.52 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.754 1.621 . . . . 0.0 107.167 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.46 -178.51 36.45 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-O 122.775 1.208 . . . . 0.0 110.633 -167.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 6.6 t80 -84.73 -23.88 29.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.124 -1.538 . . . . 0.0 111.6 -159.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -46.62 111.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.04 2.136 . . . . 0.0 109.569 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.38 9.69 83.25 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 117.668 -1.629 . . . . 0.0 116.244 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.1 m -68.64 -21.87 64.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.736 2.768 . . . . 0.0 113.209 -174.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.2 t 67.11 132.81 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 129.273 3.029 . . . . 0.0 112.474 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -77.67 76.87 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.52 1.528 . . . . 0.0 108.326 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.401 ' CD2' HH11 ' A' ' 55' ' ' ARG . 27.7 p-80 -74.1 -7.32 52.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.239 1.416 . . . . 0.0 113.56 -174.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.401 HH11 ' CD2' ' A' ' 54' ' ' HIS . 5.1 mpt_? -123.63 128.43 49.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 159.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.6 mt -134.49 106.64 8.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 161.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.5 mt -111.52 98.09 39.12 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.51 124.59 14.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 123.921 3.081 . . . . 0.0 113.11 -170.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.66 38.54 93.3 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.886 1.707 . . . . 0.0 111.237 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -143.13 -81.36 0.19 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.769 1.284 . . . . 0.0 108.624 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.31 169.91 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.528 0.731 . . . . 0.0 111.328 168.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m -121.08 107.92 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.249 1.819 . . . . 0.0 108.329 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -99.05 138.26 36.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.13 0.972 . . . . 0.0 108.495 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.02 1.98 0.5 Allowed Glycine 0 CA--C 1.526 0.763 0 CA-C-O 118.509 -1.162 . . . . 0.0 115.936 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.12 51.4 4.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.773 1.787 . . . . 0.0 115.284 -162.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.16 69.12 1.34 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.334 1.067 . . . . 0.0 110.896 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HE3' ' A' ' 76' ' ' LYS . 31.9 p90 -70.14 -6.08 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.095 0.958 . . . . 0.0 112.812 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -113.9 -38.99 4.07 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 120.871 -1.143 . . . . 0.0 110.625 -160.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -128.44 -17.78 4.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.203 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 45.27 35.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.977 2.111 . . . . 0.0 112.916 175.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -140.78 10.14 2.21 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.386 -0.821 . . . . 0.0 111.961 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.3 -1.9 79.14 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.966 -1.463 . . . . 0.0 112.884 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 p -95.96 -6.48 38.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 120.007 1.903 . . . . 0.0 110.975 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.32 179.1 38.96 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 118.993 0.815 . . . . 0.0 112.315 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.61 115.69 2.21 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 125.471 1.51 . . . . 0.0 111.245 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HE3' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -133.76 169.44 17.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.495 1.918 . . . . 0.0 107.234 166.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.3 p -83.74 -175.18 5.69 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.606 0.639 . . . . 0.0 109.532 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.4 pt -83.48 -20.17 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.841 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -79.74 -35.08 39.34 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.567 0.621 . . . . 0.0 109.422 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.1 -142.07 6.67 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 107.029 -2.428 . . . . 0.0 107.029 -167.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 82' ' ' LYS . 9.7 tt0 -68.82 -156.22 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.033 0.916 . . . . 0.0 110.664 168.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 54.0 mttt -64.96 126.89 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 120.415 -1.428 . . . . 0.0 109.91 -169.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -89.5 175.73 7.18 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 106' ' ' ASN . 18.2 pt-20 -77.92 175.28 10.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 106' ' ' ASN . 11.3 t70 -86.75 104.34 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 128.883 2.873 . . . . 0.0 108.001 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.15 -41.23 81.88 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 119.09 -0.481 . . . . 0.0 111.631 -162.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 159.07 157.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 129.354 3.062 . . . . 0.0 111.604 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -106.59 30.14 6.31 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.42 1.888 . . . . 0.0 110.614 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.1 mt -53.01 -48.39 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.209 1.003 . . . . 0.0 108.472 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.89 130.4 36.12 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -130.54 169.57 15.4 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.265 1.426 . . . . 0.0 110.687 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -82.19 81.58 8.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.131 1.372 . . . . 0.0 108.896 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.0 p -75.84 -32.01 59.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.054 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.22 -178.74 44.37 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.628 1.585 . . . . 0.0 110.884 -175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.21 165.1 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.833 2.355 . . . . 0.0 111.226 171.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.44 8.47 75.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.251 -1.305 . . . . 0.0 112.923 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.0 mm -85.61 151.46 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 121.012 2.406 . . . . 0.0 108.953 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.46 131.2 57.0 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.367 -1.458 . . . . 0.0 108.924 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.8 t -148.47 158.27 44.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.497 0.719 . . . . 0.0 111.385 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.481 ' SD ' HG23 ' A' ' 32' ' ' THR . 26.2 mtp -83.49 135.34 34.7 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 124.283 1.033 . . . . 0.0 111.664 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -92.08 71.23 5.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 123.088 1.423 . . . . 0.0 107.558 168.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -75.66 -172.75 1.97 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.27 160.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -124.21 16.32 9.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.29 1.836 . . . . 0.0 111.423 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.56 -175.37 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.293 1.901 . . . . 0.0 108.782 -164.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.48 142.71 91.41 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.829 1.686 . . . . 0.0 110.017 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 31.3 m-20 64.14 38.26 8.41 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.931 2.092 . . . . 0.0 112.19 167.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 p -127.87 38.14 4.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.633 0.773 . . . . 0.0 109.81 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -89.88 110.61 21.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.959 1.304 . . . . 0.0 109.139 -172.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -115.16 -132.57 5.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.2 p -85.49 -18.5 33.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.582 0.753 . . . . 0.0 111.46 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -67.84 126.02 28.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.224 1.012 . . . . 0.0 108.757 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 5.0 p90 -154.03 171.06 19.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 107.73 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 5.2 p90 -141.19 157.95 44.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 122.433 1.111 . . . . 0.0 112.046 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.25 103.91 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 166.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 9.2 m -60.4 126.12 26.26 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.9 p -116.6 23.15 12.23 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.799 1.24 . . . . 0.0 109.006 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -150.69 175.85 11.57 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.624 -0.673 . . . . 0.0 109.883 162.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -64.69 84.87 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 159.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.444 ' HB ' HD12 ' A' ' 122' ' ' LEU . 8.3 p -82.1 53.4 2.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.086 0.554 . . . . 0.0 111.161 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -63.63 -20.91 66.07 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 120.148 -1.595 . . . . 0.0 113.159 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -69.98 -4.7 21.95 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.265 1.426 . . . . 0.0 112.079 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 68.6 mt -105.32 -8.17 18.41 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.897 1.279 . . . . 0.0 111.275 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.46 152.47 43.86 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.631 1.105 . . . . 0.0 109.122 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.39 -1.52 65.27 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.726 1.155 . . . . 0.0 113.421 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -132.22 -56.97 0.97 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.891 1.677 . . . . 0.0 108.283 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -99.47 129.29 45.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -170.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.39 104.99 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.92 132.71 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.29 -4.79 1.66 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.8 -173.13 27.9 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.973 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -155.54 146.37 22.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.507 1.123 . . . . 0.0 108.669 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.68 116.67 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -86.1 -49.95 7.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.99 162.67 34.33 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.211 1.004 . . . . 0.0 112.923 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.98 15.76 66.63 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.142 0.877 . . . . 0.0 112.816 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.3 tpt -55.87 -28.67 57.68 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.749 1.775 . . . . 0.0 111.958 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -62.82 -35.32 79.53 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.244 -0.91 . . . . 0.0 113.194 172.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.98 -39.15 81.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.89 -41.3 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.757 0.708 . . . . 0.0 109.732 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.32 -27.46 69.04 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.703 -1.248 . . . . 0.0 113.244 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.03 -46.57 42.59 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.165 -0.959 . . . . 0.0 109.218 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 79.5 mtp -53.06 -47.58 68.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.249 1.02 . . . . 0.0 110.036 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -62.36 -30.68 71.35 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.702 0.801 . . . . 0.0 112.647 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -24.04 64.45 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.52 -0.738 . . . . 0.0 111.372 174.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -97.08 6.59 48.28 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.872 1.669 . . . . 0.0 112.099 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.07 -173.38 35.92 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 169.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.4 p -157.62 158.88 36.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 166.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.28 -22.39 64.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -6.07 53.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.177 0.899 . . . . 0.0 112.779 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.24 -30.66 9.93 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.09 2.281 . . . . 0.0 112.875 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.04 138.03 26.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.076 0.95 . . . . 0.0 109.498 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.1 p -98.25 138.6 35.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -18.67 63.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.831 0.852 . . . . 0.0 112.12 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.59 161.0 32.51 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.109 0.964 . . . . 0.0 108.875 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 134.78 48.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 166.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 mt -132.35 113.56 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -132.48 175.41 9.32 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.623 1.169 . . . . 0.0 109.657 -166.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.44 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 3.7 mp -100.33 105.61 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 171.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.22 -46.22 87.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.776 0.83 . . . . 0.0 109.976 172.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -151.24 157.4 42.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.0 p -162.68 163.04 27.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.948 0.404 . . . . 0.0 110.64 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.47 -173.01 45.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.551 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 0.0 OUTLIER -84.78 154.6 22.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.494 1.917 . . . . 0.0 109.358 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.2 mt -131.9 43.69 3.0 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.768 1.27 . . . . 0.0 110.65 160.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.551 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 39.7 tp10 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 102.093 -3.299 . . . . 0.0 102.093 166.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmm? . . . . . 0 CA--C 1.51 -0.567 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.11 155.96 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -65.39 124.8 88.1 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.571 ' CB ' HE22 ' A' ' 163' ' ' GLN . 12.8 Cg_endo -59.24 135.92 68.97 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.694 1.596 . . . . 0.0 110.62 -176.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.465 ' H ' ' CB ' ' A' ' 165' ' ' GLU . 52.5 m -94.96 145.04 25.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 m -130.53 149.98 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 171.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -110.65 161.06 16.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.457 1.103 . . . . 0.0 108.779 168.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -139.41 163.17 33.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.153 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.37 99.47 5.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 170.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.4 mm -68.72 148.68 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.0 143.73 51.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.892 0.877 . . . . 0.0 110.421 170.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.99 99.87 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 127.953 2.501 . . . . 0.0 104.338 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.62 13.95 1.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.577 1.951 . . . . 0.0 113.696 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.34 0.49 58.23 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.107 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.22 121.04 81.9 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 159.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.24 112.96 2.24 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 107.364 -1.821 . . . . 0.0 107.364 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.73 -29.42 36.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.029 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.21 167.81 13.84 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 118.409 0.549 . . . . 0.0 113.145 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -75.57 139.07 41.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 108.886 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -130.24 157.93 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -150.74 155.45 39.31 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.728 -1.233 . . . . 0.0 110.478 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 132' ' ' VAL . 70.6 m-85 -142.23 154.13 44.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.522 1.129 . . . . 0.0 109.447 -170.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.09 141.2 30.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.47 117.69 30.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.968 1.307 . . . . 0.0 107.518 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.29 53.88 0.14 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.906 2.482 . . . . 0.0 114.072 -168.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.47 -28.08 42.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.685 1.994 . . . . 0.0 115.062 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -27.71 67.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.575 1.08 . . . . 0.0 110.151 177.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.57 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -120.36 -21.96 6.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.097 0.959 . . . . 0.0 112.5 -164.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.64 71.63 25.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.68 1.592 . . . . 0.0 107.758 167.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.82 -45.88 37.59 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.951 2.434 . . . . 0.0 111.819 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -54.62 37.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.147 0.885 . . . . 0.0 110.959 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.77 -38.48 86.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.855 -0.528 . . . . 0.0 110.487 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.38 -39.81 64.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.851 -0.531 . . . . 0.0 112.184 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -62.14 -45.81 91.8 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.594 1.158 . . . . 0.0 108.863 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.96 -56.37 16.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 123.745 0.818 . . . . 0.0 108.961 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -26.91 67.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 ttm-85 -55.0 -67.24 0.29 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.497 1.499 . . . . 0.0 107.74 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.782 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -52.28 -38.74 59.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.816 1.246 . . . . 0.0 112.336 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.64 -42.52 86.6 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.619 -0.676 . . . . 0.0 111.132 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -70.71 -34.43 71.93 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.506 -0.746 . . . . 0.0 111.179 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.9 p -79.13 -26.89 42.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.858 -0.526 . . . . 0.0 110.465 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.47 83.08 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.589 1.09 . . . . 0.0 111.834 -176.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.73 -27.82 69.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.854 0.862 . . . . 0.0 112.949 -159.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -74.65 3.56 7.65 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.57 9.3 75.58 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.156 0.889 . . . . 0.0 112.154 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -156.6 174.68 15.09 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.148 1.779 . . . . 0.0 107.601 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.68 -171.07 34.21 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-O 122.808 1.227 . . . . 0.0 114.442 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.407 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -71.27 -25.07 62.3 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 128.587 2.755 . . . . 0.0 110.369 177.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -52.49 108.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.568 2.347 . . . . 0.0 107.606 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.08 75.66 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.639 -1.089 . . . . 0.0 115.751 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 t -68.12 -10.46 54.24 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.514 1.657 . . . . 0.0 113.323 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t 60.18 176.58 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.82 1.248 . . . . 0.0 110.533 -161.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -122.05 125.69 46.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 162.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -78.88 -40.0 33.58 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -139.74 110.78 6.9 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 -159.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.49 HD12 ' CG2' ' A' ' 152' ' ' THR . 7.3 mt -128.06 98.14 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -173.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.4 mt -111.12 96.06 28.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -168.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.11 126.64 20.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.051 2.5 . . . . 0.0 112.388 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 36.06 60.4 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.697 1.617 . . . . 0.0 111.77 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -150.32 -76.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.371 1.085 . . . . 0.0 108.545 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.4 171.59 18.8 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.629 0.772 . . . . 0.0 111.121 171.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 30.3 p -128.99 111.64 13.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.309 0.644 . . . . 0.0 111.17 161.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -86.3 135.1 33.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.921 2.489 . . . . 0.0 110.822 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.89 -161.35 9.95 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.751 2.119 . . . . 0.0 108.524 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.79 6.55 67.35 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.086 0.943 . . . . 0.0 113.229 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.72 123.1 29.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 166.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -128.2 7.31 5.96 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.183 1.356 . . . . 0.0 111.989 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.613 HG21 ' CE ' ' A' ' 76' ' ' LYS . 26.5 p -125.03 -13.24 6.87 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.761 1.625 . . . . 0.0 112.203 168.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -132.38 -175.96 3.92 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 130.171 3.389 . . . . 0.0 105.84 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -164.53 54.0 0.13 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 166.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -159.08 -1.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.415 . . . . 0.0 113.921 -166.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.91 3.12 49.13 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 117.605 -1.664 . . . . 0.0 115.476 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.1 p -131.12 17.67 5.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.095 2.448 . . . . 0.0 115.65 -165.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.35 -94.29 0.64 Allowed Glycine 0 C--N 1.338 0.659 0 O-C-N 120.287 -1.508 . . . . 0.0 112.125 -165.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -7.12 112.63 0.01 OUTLIER Glycine 0 CA--C 1.533 1.172 0 C-N-CA 129.077 3.227 . . . . 0.0 115.519 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' CE ' HG21 ' A' ' 68' ' ' THR . 12.2 pttt -127.47 155.52 43.57 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 128.792 2.837 . . . . 0.0 108.683 -161.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.0 p -72.15 172.59 9.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.91 1.338 . . . . 0.0 110.389 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 38' ' ' ALA . 38.8 pt -75.53 -20.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.061 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -77.71 -36.71 50.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.196 0.998 . . . . 0.0 110.195 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 137.59 109.05 0.89 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HB2' ' HE3' ' A' ' 82' ' ' LYS 0.336 0.1 OUTLIER 37.25 -133.5 0.09 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.148 1.779 . . . . 0.0 113.041 177.522 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -87.17 161.9 17.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 121.116 1.78 . . . . 0.0 112.234 -176.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -126.52 165.81 18.44 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.144 1.778 . . . . 0.0 110.206 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.78 154.48 36.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.665 0.745 . . . . 0.0 111.968 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.34 123.17 21.07 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.297 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.26 -50.59 69.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.506 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -176.75 171.31 2.26 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.986 2.914 . . . . 0.0 107.502 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -123.03 38.01 4.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.726 1.61 . . . . 0.0 109.295 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.429 HD12 ' HE2' ' A' ' 28' ' ' LYS . 8.2 mt -63.53 -44.73 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 174.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 74.4 mt -81.05 128.3 33.57 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 124' ' ' GLY . 3.6 mtmp? -136.46 163.37 30.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.362 -167.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.527 ' H ' ' HB2' ' A' ' 123' ' ' ASP . 31.3 m80 -78.17 90.78 4.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.528 1.131 . . . . 0.0 111.694 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.92 35.07 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.855 -1.153 . . . . 0.0 111.679 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -60.62 165.93 10.71 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.852 2.368 . . . . 0.0 111.75 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.36 -0.16 49.9 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.525 1.059 . . . . 0.0 112.955 -176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.08 164.31 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.627 1.713 . . . . 0.0 107.914 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.4 HD23 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -136.7 128.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.919 -1.113 . . . . 0.0 109.593 -177.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 t -143.41 165.29 27.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.328 0.585 . . . . 0.0 110.585 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 108' ' ' ASN . 6.5 ttm -104.75 127.48 52.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -166.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.467 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -78.69 74.99 5.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.052 1.341 . . . . 0.0 108.422 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -70.01 175.05 4.71 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.235 158.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.22 19.73 4.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.264 1.425 . . . . 0.0 111.77 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.84 -167.91 29.34 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -168.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.83 159.92 43.42 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-N 119.361 1.58 . . . . 0.0 108.433 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 33.61 54.77 0.52 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 130.107 3.363 . . . . 0.0 111.944 175.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.8 p -131.84 22.49 4.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.743 1.217 . . . . 0.0 111.813 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.46 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 67.8 m-80 -67.29 109.69 3.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.787 2.435 . . . . 0.0 107.69 177.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.05 -85.42 0.91 Allowed Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.315 0.961 . . . . 0.0 111.727 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.0 t -155.92 -30.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.831 1.652 . . . . 0.0 109.381 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -53.91 125.57 19.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.513 1.525 . . . . 0.0 106.983 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.467 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -148.74 170.95 17.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.602 1.561 . . . . 0.0 108.079 -168.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -142.03 151.65 42.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.945 0.498 . . . . 0.0 110.86 166.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.53 122.68 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.43 118.86 12.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.1 p -112.53 27.92 9.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.1 0.952 . . . . 0.0 109.169 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.8 176.04 13.09 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.908 1.283 . . . . 0.0 107.54 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.51 89.17 0.23 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 162.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.8 p -74.77 57.6 0.77 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.449 1.099 . . . . 0.0 111.123 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.34 -20.58 66.46 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.604 -1.31 . . . . 0.0 112.719 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.406 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 29.1 p90 -74.52 -10.57 59.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.994 1.718 . . . . 0.0 111.574 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.406 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.7 mt -113.77 -6.65 13.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.205 1.402 . . . . 0.0 111.226 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.527 ' HB2' ' H ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -76.52 148.76 36.92 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.037 0.935 . . . . 0.0 109.579 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 91' ' ' LYS . . . 62.09 18.6 57.86 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.081 -170.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -140.11 -35.0 0.52 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.488 1.144 . . . . 0.0 109.985 -171.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -112.99 157.95 20.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.366 1.066 . . . . 0.0 109.333 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 36.3 t -90.18 102.62 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.94 127.61 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 162.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.4 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 29.9 p90 -135.46 1.79 2.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.396 -0.811 . . . . 0.0 112.341 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.47 -177.54 35.58 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 119.632 1.106 . . . . 0.0 112.612 172.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -150.27 153.11 35.59 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.071 1.348 . . . . 0.0 108.253 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' A' ' 22' ' ' PHE . 94.8 t -60.88 125.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.507 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 39.2 mtpt -82.21 -49.79 9.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 162.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -152.08 159.82 43.58 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.948 0.899 . . . . 0.0 111.668 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.94 24.74 61.28 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.7 tpt -54.96 -36.69 65.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.541 1.17 . . . . 0.0 110.704 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -62.18 -27.74 69.18 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.4 mm -74.57 -39.91 47.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 CA-C-N 119.788 1.176 . . . . 0.0 108.828 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.98 -44.23 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.45 -29.15 70.21 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.349 -0.845 . . . . 0.0 112.586 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.05 64.96 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 120.587 -1.32 . . . . 0.0 109.604 173.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 48.3 mtp -57.62 -45.06 85.87 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.49 -32.79 73.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.469 1.108 . . . . 0.0 113.584 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -72.11 -22.57 61.32 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.538 1.517 . . . . 0.0 110.667 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -94.83 8.94 41.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.359 1.464 . . . . 0.0 111.652 170.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.54 -169.27 41.62 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 126.082 1.801 . . . . 0.0 109.083 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.3 p -156.94 159.21 37.87 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 160.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.4 mtm-85 -69.45 -16.16 63.42 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.228 -1.545 . . . . 0.0 114.516 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -71.94 -14.56 61.95 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.18 -0.95 . . . . 0.0 112.969 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.48 -20.11 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 126.878 2.18 . . . . 0.0 114.31 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -71.44 128.72 36.8 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.211 2.005 . . . . 0.0 108.104 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.49 ' CG2' HD12 ' A' ' 56' ' ' ILE . 13.1 p -67.62 159.34 30.12 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 110.99 167.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -70.71 -41.3 72.13 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 158.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -99.5 157.97 16.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.921 1.688 . . . . 0.0 111.869 -168.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.532 ' HE3' HG21 ' A' ' 157' ' ' THR . 3.4 ttpt -69.49 123.78 22.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 158.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.1 mt -120.42 136.04 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.288 1.858 . . . . 0.0 107.924 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.532 HG21 ' HE3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -154.82 169.16 24.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.663 -158.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.407 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -104.83 113.39 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 163.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.71 -53.12 52.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -156.75 165.39 36.37 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.192 1.397 . . . . 0.0 108.897 -171.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.8 p -178.51 165.16 1.72 Allowed 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.553 1.541 . . . . 0.0 109.726 -168.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.58 -175.71 46.61 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.571 HE22 ' CB ' ' A' ' 4' ' ' PRO . 35.6 tp60 -79.72 152.06 30.08 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.441 1.496 . . . . 0.0 109.879 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 40.0 mt -137.95 42.73 2.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 120.432 1.469 . . . . 0.0 111.77 159.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.522 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 2.7 tm-20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.956 2.502 . . . . 0.0 107.521 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 3' ' ' ASN . 9.9 p -147.25 -173.98 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.413 ' H ' HG22 ' A' ' 2' ' ' VAL . 1.1 m120 -48.87 112.02 2.2 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 116.508 -1.71 . . . . 0.0 108.619 162.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HA ' ' CG ' ' A' ' 165' ' ' GLU . 2.0 Cg_endo -57.99 140.06 92.61 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 CA-C-N 121.339 1.514 . . . . 0.0 110.063 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.485 ' CG2' ' HE3' ' A' ' 133' ' ' LYS . 76.1 m -106.0 144.47 32.67 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 165.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.47 134.11 17.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.645 ' HB3' HD11 ' A' ' 164' ' ' LEU . 13.7 p90 -94.59 157.87 15.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.903 0.881 . . . . 0.0 110.865 175.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -145.63 112.95 6.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.097 1.359 . . . . 0.0 107.799 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.26 97.55 6.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.6 mm -66.5 146.53 13.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.284 1.034 . . . . 0.0 109.152 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.13 168.89 18.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.647 1.179 . . . . 0.0 110.389 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 156' ' ' ILE . 2.4 t -131.2 109.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 57.04 13.92 1.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.754 1.622 . . . . 0.0 113.131 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.22 -5.71 31.94 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.63 1.586 . . . . 0.0 113.849 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -81.95 113.26 41.83 Favored Pre-proline 0 CA--C 1.52 -0.187 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.4 121.68 9.57 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.318 1.345 . . . . 0.0 110.241 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.8 tp -93.36 -25.56 17.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.675 0.79 . . . . 0.0 110.922 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.25 162.74 9.6 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.665 0.65 . . . . 0.0 112.034 168.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -79.26 142.21 36.39 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.77 158.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 128.008 2.523 . . . . 0.0 105.808 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -140.58 153.43 46.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.337 1.065 . . . . 0.0 109.137 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 93.2 m-85 -135.28 159.86 40.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.324 -175.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -110.57 145.26 38.14 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 167.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.3 128.99 50.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.296 1.438 . . . . 0.0 108.685 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.21 61.79 7.04 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.261 1.025 . . . . 0.0 112.984 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -9.95 25.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.017 -1.052 . . . . 0.0 113.554 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.36 -16.51 58.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.247 1.419 . . . . 0.0 112.138 171.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 -47.89 1.07 Allowed 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 0.0 110.511 -166.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.37 78.38 45.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.374 1.47 . . . . 0.0 107.345 174.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.71 -45.8 6.03 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.371 2.047 . . . . 0.0 110.386 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -36.64 84.81 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.242 1.383 . . . . 0.0 109.191 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 m -69.52 -52.69 24.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.496 0.589 . . . . 0.0 109.805 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.59 91.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.304 0.642 . . . . 0.0 112.242 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.54 -51.32 70.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.259 1.423 . . . . 0.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.04 -49.06 74.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.892 1.277 . . . . 0.0 110.488 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.07 -40.12 94.21 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.345 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -52.85 -56.92 12.28 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.152 0.887 . . . . 0.0 109.476 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.8 48.86 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.412 1.485 . . . . 0.0 113.15 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.29 -32.46 38.13 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.761 0.824 . . . . 0.0 111.431 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 p -78.53 -38.25 40.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.383 0.992 . . . . 0.0 113.293 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -64.08 -31.06 72.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.49 11.71 72.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.98 -33.18 70.38 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.012 1.725 . . . . 0.0 110.716 -172.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -71.46 -4.88 28.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.33 1.052 . . . . 0.0 112.696 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.76 16.12 46.63 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.419 1.009 . . . . 0.0 112.104 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -169.96 175.32 5.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.938 1.695 . . . . 0.0 109.1 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.49 -142.29 13.62 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-O 121.925 0.736 . . . . 0.0 113.307 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.587 ' CE1' HD11 ' A' ' 158' ' ' ILE . 0.6 OUTLIER -63.31 -28.34 69.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.889 2.076 . . . . 0.0 110.997 -167.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.5 tttt -57.41 124.07 17.64 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.683 -0.636 . . . . 0.0 109.389 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.34 10.37 52.77 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.358 -1.245 . . . . 0.0 114.412 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.6 m -68.01 104.4 1.74 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.117 1.959 . . . . 0.0 106.071 165.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 155' ' ' LYS . 52.8 m -75.38 131.68 40.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -73.69 105.1 4.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.082 0.944 . . . . 0.0 109.068 -169.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -81.01 -32.68 34.09 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.093 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -127.79 86.73 2.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.134 0.879 . . . . 0.0 108.833 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.416 HD12 ' CG2' ' A' ' 152' ' ' THR . 74.3 mt -104.45 109.53 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 mt -115.32 99.73 52.75 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -59.98 144.36 99.48 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.551 1.501 . . . . 0.0 112.448 -172.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.87 31.43 61.11 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 126.539 2.018 . . . . 0.0 112.168 -168.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -142.4 -79.93 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.487 1.644 . . . . 0.0 108.545 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 165.15 25.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.798 0.839 . . . . 0.0 110.635 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.0 m -127.1 92.46 3.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.696 1.998 . . . . 0.0 108.77 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.04 132.3 42.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.964 1.306 . . . . 0.0 110.572 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.19 -169.48 11.89 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.074 1.797 . . . . 0.0 108.964 168.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.27 5.49 89.57 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.632 -0.922 . . . . 0.0 114.432 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.97 92.51 7.85 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 166.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -106.24 -5.84 18.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.509 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.6 p -122.29 -24.63 5.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.595 1.558 . . . . 0.0 111.551 -173.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -124.88 179.47 5.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 158.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.8 72.01 0.5 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 169.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.416 ' H ' ' H ' ' A' ' 72' ' ' GLY . 12.6 p30 -168.79 -10.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.886 2.474 . . . . 0.0 111.235 -172.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 71' ' ' ASN . . . 111.41 -6.4 28.34 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.069 -1.406 . . . . 0.0 112.85 169.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.3 p -84.09 -24.33 30.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.741 1.77 . . . . 0.0 112.933 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.92 -135.3 8.09 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 122.515 1.064 . . . . 0.0 114.772 -159.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.11 168.37 4.51 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.67 1.605 . . . . 0.0 111.776 -162.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -169.59 149.09 3.83 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.1 p -70.56 164.57 24.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.6 pt -56.88 -29.61 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 110.267 162.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -79.25 6.35 10.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.466 1.506 . . . . 0.0 112.584 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.16 -53.76 0.75 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.192 1.36 . . . . 0.0 113.064 166.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -147.72 -139.26 0.1 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -161.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -75.97 166.57 23.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.314 0.961 . . . . 0.0 108.897 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -142.22 177.8 7.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.11 148.19 51.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.192 0.996 . . . . 0.0 113.204 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.477 ' HA ' HD21 ' A' ' 108' ' ' ASN . 1.0 OUTLIER -71.96 73.95 0.89 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.897 2.479 . . . . 0.0 108.01 161.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.82 -59.85 3.99 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.255 1.822 . . . . 0.0 112.659 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.48 172.84 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.303 159.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.27 26.44 7.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.264 2.225 . . . . 0.0 110.797 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 mt -57.56 -48.23 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 120.927 -1.108 . . . . 0.0 110.182 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.68 123.72 23.85 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -103.26 165.26 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.084 1.354 . . . . 0.0 111.072 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -77.91 75.81 4.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.076 1.351 . . . . 0.0 109.581 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -66.01 -27.54 68.2 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.42 -177.35 45.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.95 0.795 . . . . 0.0 111.751 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -59.23 147.14 92.13 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.868 1.712 . . . . 0.0 109.7 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.91 70.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.432 -1.205 . . . . 0.0 112.362 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.67 163.56 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 120.446 2.123 . . . . 0.0 108.9 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.14 127.96 37.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.033 1.333 . . . . 0.0 109.205 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.6 t -140.94 164.24 30.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.773 0.797 . . . . 0.0 110.49 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.99 140.54 29.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 -167.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.08 57.12 1.45 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.68 1.228 . . . . 0.0 108.614 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -61.35 170.51 1.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.951 158.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -125.23 13.94 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.62 1.168 . . . . 0.0 111.713 -169.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.27 -171.92 27.01 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -160.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -60.6 157.02 38.92 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.145 1.897 . . . . 0.0 110.037 171.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER 34.56 47.27 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.17 2.588 . . . . 0.0 113.716 173.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 p -124.19 22.38 8.65 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.811 0.844 . . . . 0.0 111.599 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 85' ' ' ASP . 91.1 m-20 -64.52 122.82 17.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.043 1.737 . . . . 0.0 108.762 173.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.49 -97.2 0.57 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.1 p -134.33 -23.77 1.65 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.079 0.952 . . . . 0.0 112.248 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.02 135.01 57.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -141.83 176.19 9.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -139.69 152.27 46.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.553 0.692 . . . . 0.0 109.857 162.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.8 mt -83.17 122.98 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 163.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.3 m -68.5 113.61 6.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 167.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.2 p -108.36 30.68 6.21 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.51 173.51 14.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.814 1.645 . . . . 0.0 107.649 165.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.86 89.82 0.28 Allowed 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 162.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.29 53.75 0.53 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.387 1.475 . . . . 0.0 110.276 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -64.67 -21.74 66.81 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 119.921 -1.737 . . . . 0.0 112.39 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -73.31 -2.22 21.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.532 1.133 . . . . 0.0 111.969 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -115.42 -5.42 12.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.234 1.414 . . . . 0.0 111.528 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.82 142.44 57.94 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.061 0.846 . . . . 0.0 111.45 -172.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.57 12.61 61.84 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.268 -1.296 . . . . 0.0 113.709 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.37 -24.06 1.42 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.2 2.0 . . . . 0.0 113.34 -169.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -125.19 140.96 52.4 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.961 0.904 . . . . 0.0 110.085 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 63.2 t -78.89 101.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -171.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.51 123.49 16.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 164.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.02 -1.45 2.66 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.4 -173.04 27.33 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 119.296 0.953 . . . . 0.0 111.727 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -154.28 145.25 22.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.031 1.332 . . . . 0.0 108.729 -172.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.43 115.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 161.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.485 ' HE3' ' CG2' ' A' ' 5' ' ' THR . 12.4 ttmm -74.12 -54.38 7.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -153.98 167.09 30.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.322 2.249 . . . . 0.0 109.242 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.25 17.33 69.47 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.517 -0.739 . . . . 0.0 112.733 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.6 tpt -55.87 -35.51 66.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.633 1.217 . . . . 0.0 110.9 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -62.92 -31.31 72.36 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.14 0.882 . . . . 0.0 112.829 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.74 -39.73 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.53 -37.37 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.686 -0.634 . . . . 0.0 109.942 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.487 ' CD ' HH21 ' A' ' 144' ' ' ARG . 3.1 mm-40 -57.86 -42.96 85.59 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.391 -0.818 . . . . 0.0 110.529 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.19 95.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.881 0.764 . . . . 0.0 109.027 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.8 mtm -54.94 -44.85 74.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.228 0.211 . . . . 0.0 110.987 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.42 -37.46 75.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.487 HH21 ' CD ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -66.4 -24.82 66.53 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.828 1.195 . . . . 0.0 110.35 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.569 ' CB ' HD11 ' A' ' 156' ' ' ILE . 41.3 m-85 -91.03 10.81 25.15 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.475 1.11 . . . . 0.0 112.017 174.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.67 -153.44 6.04 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.855 1.207 . . . . 0.0 111.502 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.5 p -141.62 -86.51 0.17 Allowed 'General case' 0 C--O 1.223 -0.306 0 O-C-N 122.044 -0.68 . . . . 0.0 110.081 160.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 178.14 -17.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 129.798 3.239 . . . . 0.0 110.343 161.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -68.35 -27.06 65.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.001 0.818 . . . . 0.0 110.013 158.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 123.25 -35.3 3.39 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-O 118.606 -1.108 . . . . 0.0 111.748 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -65.13 124.36 21.92 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.391 1.096 . . . . 0.0 108.195 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.416 ' CG2' HD12 ' A' ' 56' ' ' ILE . 18.0 p -64.25 154.04 36.27 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.28 1.432 . . . . 0.0 110.261 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.0 p -68.41 -26.79 65.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.296 0.639 . . . . 0.0 110.789 167.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.489 ' HE2' HG12 ' A' ' 12' ' ' VAL . 30.3 mtpt -132.98 169.76 16.34 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.415 1.086 . . . . 0.0 111.093 -177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.449 ' HE2' ' SG ' ' A' ' 52' ' ' CYS . 75.8 tttt -83.89 84.85 7.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 121.089 1.768 . . . . 0.0 109.677 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.569 HD11 ' CB ' ' A' ' 145' ' ' PHE . 27.0 mm -73.79 126.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.34 163.52 32.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.346 1.069 . . . . 0.0 110.969 -163.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -94.98 115.11 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 159.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.97 13.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.401 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 1.4 t70 -148.62 163.26 37.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.086 0.554 . . . . 0.0 109.65 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.8 p -167.91 167.9 12.52 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.278 0.631 . . . . 0.0 111.933 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.16 178.52 42.44 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.3 tp60 -76.24 147.02 38.61 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.829 1.652 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 7' ' ' PHE . 12.9 mt -137.87 43.3 2.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.235 1.014 . . . . 0.0 112.455 162.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 19.7 mt-10 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 123.887 0.875 . . . . 0.0 110.913 168.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ppp? . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 71.4 t 63.89 175.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.855 1.662 . . . . 0.0 109.696 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.79 82.63 66.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 170.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.56 137.93 48.08 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.415 1.41 . . . . 0.0 110.301 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 165' ' ' GLU . 88.2 m -95.14 147.33 23.55 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.08 153.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.689 1.195 . . . . 0.0 107.864 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -128.55 157.3 41.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.432 1.093 . . . . 0.0 109.792 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.425 ' CE1' ' CD2' ' A' ' 48' ' ' TYR . 68.9 m-85 -147.81 120.13 8.4 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.056 1.342 . . . . 0.0 107.714 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -85.41 95.53 9.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.1 mm -71.29 135.84 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.59 163.27 18.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.403 1.881 . . . . 0.0 109.267 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG12 ' HE2' ' A' ' 154' ' ' LYS . 3.8 t -138.06 95.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -173.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 57.32 13.94 1.94 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.005 1.722 . . . . 0.0 112.963 -169.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.9 -9.13 29.64 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.958 1.742 . . . . 0.0 113.116 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -77.04 125.5 86.72 Favored Pre-proline 0 CA--C 1.518 -0.282 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.29 113.44 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 120.91 1.074 . . . . 0.0 109.495 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.25 -35.23 23.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.305 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 163.31 10.08 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 167.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -80.28 146.35 31.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.52 154.36 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.3 2.64 . . . . 0.0 105.419 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -144.99 152.03 39.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.493 1.139 . . . . 0.0 109.904 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CE2' HG22 ' A' ' 132' ' ' VAL . 55.8 m-85 -136.45 153.31 51.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.344 1.458 . . . . 0.0 108.406 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -97.25 146.06 25.48 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.455 1.902 . . . . 0.0 107.111 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -120.45 129.35 53.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.395 1.478 . . . . 0.0 107.529 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.61 57.11 1.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.842 1.657 . . . . 0.0 111.812 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.11 60.95 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.247 -1.533 . . . . 0.0 113.429 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -62.29 -53.35 56.41 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.875 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.24 -49.37 8.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.857 0.863 . . . . 0.0 110.541 -169.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 m -127.11 68.37 72.08 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 127.235 2.214 . . . . 0.0 108.737 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.48 -36.25 98.74 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.536 2.157 . . . . 0.0 112.579 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -52.6 56.73 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.716 1.144 . . . . 0.0 109.191 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 m -64.83 -39.45 93.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.46 0.704 . . . . 0.0 110.102 -174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.21 69.37 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.435 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.56 -43.08 97.65 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.488 1.115 . . . . 0.0 110.881 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -50.68 -60.02 3.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.365 1.466 . . . . 0.0 109.066 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -65.43 -26.46 67.97 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HG3' HE22 ' A' ' 163' ' ' GLN . 43.1 ttp85 -60.58 -61.72 2.39 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.447 1.099 . . . . 0.0 109.858 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.09 69.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.74 0.65 . . . . 0.0 111.823 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -71.4 -37.06 71.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.782 -0.574 . . . . 0.0 111.063 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.5 m -70.08 -36.69 75.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.476 0.71 . . . . 0.0 110.86 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -79.6 -18.44 51.61 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.752 0.421 . . . . 0.0 111.378 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.5 7.15 72.74 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 120.554 -1.342 . . . . 0.0 111.518 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.96 4.04 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.774 1.629 . . . . 0.0 113.808 -163.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -116.94 12.65 14.73 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.332 1.453 . . . . 0.0 111.216 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.54 12.08 84.66 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.396 0.522 . . . . 0.0 112.305 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -156.93 171.99 19.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.72 39.13 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 116.99 -2.529 . . . . 0.0 114.464 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 8' ' ' PHE . 1.1 t80 -65.64 -27.07 68.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 127.454 2.301 . . . . 0.0 109.38 175.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -52.21 136.95 29.41 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.827 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 -0.12 46.44 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.671 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -68.74 119.36 13.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 120.739 2.27 . . . . 0.0 107.561 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.7 t -72.33 137.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.33 104.61 5.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -74.07 -21.51 59.89 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.41 116.72 11.21 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.494 HD12 HG22 ' A' ' 152' ' ' THR . 38.7 mt -133.44 115.88 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.93 100.7 39.91 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 103.699 -2.704 . . . . 0.0 103.699 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.32 134.25 60.3 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.872 2.381 . . . . 0.0 111.761 -174.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.67 32.61 83.62 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.131 1.824 . . . . 0.0 112.006 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -150.89 -74.02 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.427 1.113 . . . . 0.0 109.307 -172.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.83 167.01 31.75 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 67.0 m -128.13 100.25 5.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.35 1.86 . . . . 0.0 108.501 166.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -93.07 131.67 37.88 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.136 1.775 . . . . 0.0 109.437 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.99 50.73 0.22 Allowed Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.286 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.99 12.54 24.5 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 118.148 0.974 . . . . 0.0 111.773 176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -85.22 23.37 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.479 1.912 . . . . 0.0 113.458 -167.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CD1' HG23 ' A' ' 68' ' ' THR . 11.2 p90 -41.16 -2.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 1 C-N-CA 132.563 4.345 . . . . 0.0 118.754 -176.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.449 HG23 ' CD1' ' A' ' 67' ' ' PHE . 12.1 p -126.39 -49.49 1.54 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.969 2.508 . . . . 0.0 112.144 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 -128.21 89.1 2.86 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -84.24 61.43 6.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.747 3.219 . . . . 0.0 107.751 -167.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -173.45 -22.94 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 129.235 3.014 . . . . 0.0 107.966 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.24 43.62 2.16 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 126.852 2.168 . . . . 0.0 111.436 161.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.3 p -110.96 39.01 2.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 159.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.06 -174.59 14.97 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 122.548 1.082 . . . . 0.0 112.747 -161.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.33 75.75 0.41 Allowed Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 113.069 -1.566 . . . . 0.0 111.493 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' H ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -65.75 165.87 11.97 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 111.617 -2.291 . . . . 0.0 108.75 158.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.0 p -84.16 177.91 8.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.766 0.793 . . . . 0.0 109.2 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.7 pt -70.03 -27.25 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.994 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -84.86 -21.15 29.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.141 0.976 . . . . 0.0 111.521 -169.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.57 -99.42 0.19 Allowed Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 105.023 -3.231 . . . . 0.0 105.023 -164.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.13 -157.61 0.81 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.208 1.004 . . . . 0.0 109.745 172.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 82' ' ' LYS . 4.5 pttp -63.76 142.16 58.5 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.75 2.82 . . . . 0.0 110.107 -159.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -120.15 177.12 5.13 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.38 1.472 . . . . 0.0 108.923 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.58 163.41 27.37 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.24 87.65 0.82 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.483 1.513 . . . . 0.0 108.988 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -46.38 -53.86 10.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.955 1.302 . . . . 0.0 112.248 -163.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.402 ' C ' HD22 ' A' ' 87' ' ' ASN . 0.1 OUTLIER -161.26 169.62 21.82 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.752 0.421 . . . . 0.0 110.222 158.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.79 13.74 16.18 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.757 1.223 . . . . 0.0 112.91 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 mt -53.22 -40.96 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.621 0.768 . . . . 0.0 109.899 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.77 121.03 29.69 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -110.82 170.18 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 109.433 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -74.18 87.04 1.92 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.742 0.817 . . . . 0.0 109.021 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.4 p -73.77 -11.1 60.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.623 0.769 . . . . 0.0 112.113 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.78 -169.79 38.87 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.011 -1.056 . . . . 0.0 111.708 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.95 158.63 32.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.527 1.485 . . . . 0.0 110.68 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.15 85.13 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 117.927 -1.485 . . . . 0.0 112.248 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -79.35 168.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 120.185 1.993 . . . . 0.0 108.564 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.68 133.47 27.22 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.319 1.448 . . . . 0.0 109.509 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 t -150.19 158.4 44.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.812 0.445 . . . . 0.0 111.346 -167.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.7 mtp -80.8 122.37 27.1 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.828 0.851 . . . . 0.0 111.203 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.586 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -75.27 61.47 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.645 1.578 . . . . 0.0 109.161 161.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -65.98 -178.18 0.57 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.43 1.11 . . . . 0.0 108.329 159.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.44 14.41 9.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.206 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.22 -157.45 23.89 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -66.81 148.63 82.86 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.179 1.92 . . . . 0.0 109.634 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 34.21 57.27 0.64 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.449 3.1 . . . . 0.0 111.353 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.5 p -131.88 26.4 4.63 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 109.871 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -75.0 88.74 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.293 1.837 . . . . 0.0 106.947 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.45 -92.44 1.9 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -174.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.8 p -151.01 -13.12 0.22 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 167.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.8 137.71 57.57 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.586 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -143.81 170.92 14.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.749 1.22 . . . . 0.0 108.299 -167.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 31.5 p90 -141.77 154.58 45.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.397 0.679 . . . . 0.0 110.325 158.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.0 mt -83.51 125.02 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 161.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 16.5 m -70.91 117.56 12.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 167.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 p -108.7 26.5 10.47 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.662 0.785 . . . . 0.0 109.576 170.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.38 172.11 17.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -65.52 88.45 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 163.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.416 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 1.1 p -80.48 63.42 4.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.058 1.409 . . . . 0.0 109.663 -173.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -69.85 -10.43 58.45 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.802 1.641 . . . . 0.0 112.794 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.416 ' CZ2' HG22 ' A' ' 119' ' ' THR . 13.4 p90 -84.78 -11.0 56.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.495 1.118 . . . . 0.0 112.262 168.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.461 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 49.5 mt -107.87 -8.63 15.92 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 110.913 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.48 146.82 33.93 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.67 1.188 . . . . 0.0 110.503 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.24 0.91 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.192 0.901 . . . . 0.0 114.829 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -93.68 -50.14 5.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 107.876 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.23 132.08 53.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.62 0.768 . . . . 0.0 109.478 -165.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.45 106.95 16.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 126.071 1.748 . . . . 0.0 106.607 -169.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.49 126.81 25.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 172.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -137.76 -0.4 2.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.59 -178.43 35.51 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 119.443 1.019 . . . . 0.0 112.844 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -150.02 156.12 41.13 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.665 0.786 . . . . 0.0 110.315 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.481 HG22 ' CE2' ' A' ' 22' ' ' PHE . 46.4 t -65.83 118.88 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.403 ' CE ' HG23 ' A' ' 5' ' ' THR . 3.6 mtmp? -78.71 -47.38 17.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.583 -0.698 . . . . 0.0 109.248 163.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -141.98 139.64 32.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.81 1.244 . . . . 0.0 108.654 -158.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.51 25.13 40.21 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.757 -1.024 . . . . 0.0 114.285 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.2 tpt -52.95 -37.26 60.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.261 2.03 . . . . 0.0 110.992 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -64.81 -29.09 70.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.214 0.915 . . . . 0.0 113.091 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.05 -45.94 85.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.42 -39.54 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -67.6 -28.19 67.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.801 -1.187 . . . . 0.0 112.543 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -43.11 60.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.919 1.288 . . . . 0.0 109.4 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 59.7 mtp -53.12 -42.45 66.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.693 0.797 . . . . 0.0 109.974 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.82 -33.34 75.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.735 1.614 . . . . 0.0 114.477 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -62.52 -30.77 71.53 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 120.342 1.428 . . . . 0.0 109.019 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 156' ' ' ILE . 32.5 m-85 -91.64 18.76 7.06 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.795 1.238 . . . . 0.0 111.617 175.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.24 -168.76 23.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 170.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 p -152.8 155.42 37.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -64.69 -23.16 67.17 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.27 -1.519 . . . . 0.0 113.125 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.06 8.82 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.201 1.0 . . . . 0.0 112.753 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.88 18.27 66.24 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 126.355 1.931 . . . . 0.0 113.949 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -87.49 144.66 26.61 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 120.706 2.253 . . . . 0.0 109.927 158.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.494 HG22 HD12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -69.13 153.5 43.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.901 0.88 . . . . 0.0 109.349 162.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 p -105.2 -13.85 15.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.035 1.334 . . . . 0.0 111.355 164.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HE2' HG12 ' A' ' 12' ' ' VAL . 22.3 mtpt -135.0 156.11 49.6 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.834 1.254 . . . . 0.0 109.694 169.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -77.14 85.46 3.62 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.445 -0.784 . . . . 0.0 109.488 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.475 HD11 ' HB2' ' A' ' 145' ' ' PHE . 1.8 mp -72.89 120.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.77 149.72 50.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.524 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.421 HD11 ' CE1' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -81.48 104.65 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 163.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.58 -53.29 19.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.63 164.72 31.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 7.8 p -172.91 170.45 4.53 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.421 0.688 . . . . 0.0 111.97 -171.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.9 -162.39 33.06 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.506 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 8.3 tp60 -87.77 154.23 20.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.829 1.651 . . . . 0.0 110.178 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 mt -134.38 42.79 2.84 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.081 1.309 . . . . 0.0 109.535 158.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.506 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 15.4 tp10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.159 1.784 . . . . 0.0 109.342 168.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptm . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.297 10.8 m 48.16 -173.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.45 0 O-C-N 124.237 0.961 . . . . 0.0 109.557 -154.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -97.6 107.43 39.41 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.43 132.59 51.64 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.201 1.934 . . . . 0.0 109.359 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -93.94 152.5 18.81 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.86 142.93 29.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.489 1.515 . . . . 0.0 107.227 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.44 159.3 20.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.32 1.048 . . . . 0.0 110.122 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -148.28 114.17 5.76 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.085 1.354 . . . . 0.0 108.522 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.23 97.93 5.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 165.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.62 144.6 13.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.56 139.07 43.62 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.405 1.082 . . . . 0.0 108.741 171.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.495 HG12 ' HE2' ' A' ' 154' ' ' LYS . 5.6 t -103.11 114.57 43.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.35 13.82 2.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.922 0.889 . . . . 0.0 113.149 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.23 56.04 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.193 . . . . 0.0 113.386 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -74.79 121.53 85.47 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.85 112.87 1.94 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.694 1.596 . . . . 0.0 110.084 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -78.33 -37.2 45.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.17 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.32 169.9 14.51 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -84.86 142.64 29.59 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.483 0.659 . . . . 0.0 109.971 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.2 t -122.79 160.95 24.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 128.94 2.896 . . . . 0.0 105.982 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -148.7 158.46 44.16 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.334 -0.854 . . . . 0.0 109.728 164.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HA ' ' H ' ' A' ' 133' ' ' LYS . 63.6 m-85 -136.74 155.75 49.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.237 1.415 . . . . 0.0 108.391 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -108.22 134.37 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -111.54 120.67 42.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -69.04 59.11 0.1 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.571 1.949 . . . . 0.0 112.836 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.88 43.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.253 1.821 . . . . 0.0 112.59 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -23.29 59.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.307 0.503 . . . . 0.0 111.296 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -113.6 -30.14 6.92 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 123.645 0.778 . . . . 0.0 112.241 -169.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.44 73.17 11.8 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.037 1.735 . . . . 0.0 107.946 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 -45.42 14.73 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.142 1.895 . . . . 0.0 112.805 -167.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.51 -53.37 58.95 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.029 1.286 . . . . 0.0 109.331 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.14 -44.82 79.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.547 1.139 . . . . 0.0 111.243 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.56 65.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.66 0.784 . . . . 0.0 111.953 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -63.98 -40.72 97.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.792 0.837 . . . . 0.0 111.376 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -58.58 2.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.672 1.589 . . . . 0.0 108.96 167.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.99 -39.68 90.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.046 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -53.14 -58.24 7.69 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.098 1.359 . . . . 0.0 109.243 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -21.35 64.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.185 1.394 . . . . 0.0 113.77 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.4 mt -89.79 -23.97 21.6 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.878 0.871 . . . . 0.0 111.389 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 m -83.4 -37.77 22.82 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.009 1.324 . . . . 0.0 110.779 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 p -67.05 -32.5 73.73 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.422 0.689 . . . . 0.0 109.823 170.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.73 14.81 81.08 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.089 0.852 . . . . 0.0 111.087 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.26 -21.8 66.78 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.572 1.186 . . . . 0.0 112.755 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -80.26 0.25 33.5 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 111.852 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 9.74 86.49 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.778 1.18 . . . . 0.0 112.437 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -156.6 179.04 9.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.499 1.52 . . . . 0.0 108.889 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.35 -142.54 13.86 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 121.723 0.624 . . . . 0.0 112.696 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CE1' HD11 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -70.77 -27.22 63.76 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.435 1.894 . . . . 0.0 110.873 -160.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 160' ' ' ASP . 70.0 tttt -64.88 124.12 21.17 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.87 7.08 69.22 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 117.958 -1.468 . . . . 0.0 112.87 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -67.36 129.49 40.08 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 120.423 2.111 . . . . 0.0 106.244 167.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -76.12 161.7 28.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 163.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.95 114.1 28.11 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -79.2 -49.09 13.08 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.34 128.12 44.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.4 mm -137.2 106.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.2 mt -114.91 93.32 33.89 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.1 117.89 4.02 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.602 2.868 . . . . 0.0 112.006 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.09 14.67 57.32 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.659 1.123 . . . . 0.0 112.952 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.439 ' CD1' ' HG3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -133.11 -72.89 0.5 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.439 ' HG3' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -166.05 157.74 13.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.1 m -100.64 139.5 36.23 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.96 1.704 . . . . 0.0 108.426 160.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -135.06 122.21 21.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.567 1.531 . . . . 0.0 109.087 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.99 16.85 1.95 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.638 -0.535 . . . . 0.0 114.212 -161.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.72 11.02 53.22 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.053 0.927 . . . . 0.0 114.249 -168.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.72 97.8 9.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 166.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -100.97 -1.03 35.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 p -140.03 -51.68 0.5 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -83.84 -23.85 31.19 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.443 -0.786 . . . . 0.0 112.324 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.0 m170 59.95 31.81 20.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.905 1.682 . . . . 0.0 112.977 169.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -154.07 2.95 0.25 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.91 17.94 4.87 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.141 1.337 . . . . 0.0 113.942 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.4 p -139.33 10.19 2.52 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.229 1.015 . . . . 0.0 112.017 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.97 155.92 49.87 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 120.791 -1.193 . . . . 0.0 113.497 -163.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.9 -156.68 49.54 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 113.56 -1.32 . . . . 0.0 111.582 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.67 160.83 10.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.989 2.116 . . . . 0.0 107.685 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.7 p -71.45 23.16 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.475 1.91 . . . . 0.0 114.605 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.288 1.2 pp 46.29 -19.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 1 C-N-CA 132.234 4.214 . . . . 0.0 117.046 -159.04 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -92.65 -22.22 19.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 119.884 1.22 . . . . 0.0 112.748 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.56 101.07 0.26 Allowed Glycine 0 C--N 1.333 0.391 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.342 14.5 tt0 41.23 -132.8 0.35 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.291 1.036 . . . . 0.0 111.901 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -88.78 149.06 23.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.831 1.252 . . . . 0.0 109.776 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -117.48 -176.74 3.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.985 1.714 . . . . 0.0 108.274 170.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -81.34 166.02 20.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.069 1.304 . . . . 0.0 114.122 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.37 87.68 3.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 107.582 -172.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -40.13 -64.37 0.51 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.985 2.114 . . . . 0.0 111.586 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.45 156.38 1.53 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.299 0.639 . . . . 0.0 110.844 174.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -111.75 30.29 7.12 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.726 1.61 . . . . 0.0 110.054 -171.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.86 -55.23 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.618 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.71 135.82 35.49 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.78 1.632 . . . . 0.0 107.188 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -122.88 167.2 13.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.667 1.587 . . . . 0.0 109.868 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -84.15 60.31 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.344 1.457 . . . . 0.0 110.849 -162.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 p -62.39 -29.46 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -158.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.4 -179.08 48.71 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 119.232 0.924 . . . . 0.0 112.094 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -59.11 153.08 54.67 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.411 2.074 . . . . 0.0 110.426 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.59 1.61 71.98 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 117.782 -1.566 . . . . 0.0 112.971 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -73.16 163.19 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 120.79 2.295 . . . . 0.0 107.824 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.32 131.07 39.71 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.744 1.218 . . . . 0.0 109.487 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -138.15 158.38 44.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 109.365 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 6.6 ptm -88.13 151.26 22.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.522 0.677 . . . . 0.0 110.913 -173.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.09 59.22 0.83 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.347 1.059 . . . . 0.0 109.134 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -57.79 161.2 3.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.748 163.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.82 19.84 1.14 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.661 2.384 . . . . 0.0 111.904 -166.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.05 176.79 25.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.16 1.362 . . . . 0.0 110.481 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.6 138.77 71.94 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 119.848 1.824 . . . . 0.0 109.664 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.4 55.81 5.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.944 2.098 . . . . 0.0 109.977 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -112.19 23.36 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.592 -1.317 . . . . 0.0 111.305 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -72.34 91.38 1.33 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 107.472 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.76 -142.83 11.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p -84.0 -15.65 46.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.859 0.863 . . . . 0.0 112.782 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.03 138.91 57.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.41 0.684 . . . . 0.0 109.619 -164.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 12.7 p90 -149.87 167.67 25.93 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.456 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 36.3 p90 -141.01 148.42 40.26 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 124.386 1.054 . . . . 0.0 109.315 162.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -83.69 116.46 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.3 m -64.16 130.85 45.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -118.22 23.94 11.28 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.466 1.106 . . . . 0.0 109.046 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.63 179.49 9.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.998 0.919 . . . . 0.0 108.577 163.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 82.1 tttt -67.83 92.1 0.34 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 160.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.5 p -83.47 58.6 4.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.75 0.705 . . . . 0.0 110.153 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 15.6 pt-20 -74.01 -8.01 54.53 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.182 -1.574 . . . . 0.0 113.767 -171.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -66.37 -10.3 42.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.397 -0.814 . . . . 0.0 110.846 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.456 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 53.4 mt -107.53 0.46 22.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.379 1.872 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.74 127.27 32.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.974 0.806 . . . . 0.0 112.443 -162.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.82 3.23 20.8 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.222 0.915 . . . . 0.0 113.22 -168.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -93.9 -53.51 3.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -99.97 157.18 16.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.583 0.753 . . . . 0.0 110.619 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t -98.71 101.68 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.35 128.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -142.46 0.06 1.27 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.77 176.38 29.35 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 119.526 1.057 . . . . 0.0 111.639 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -146.43 155.59 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 22' ' ' PHE . 49.2 t -64.81 123.8 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 22' ' ' PHE . 2.8 ttpt -86.76 -41.98 13.69 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.868 0.867 . . . . 0.0 109.297 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.54 160.16 43.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.663 0.385 . . . . 0.0 111.065 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.6 36.1 82.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.075 0.845 . . . . 0.0 111.91 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -45.42 78.35 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.704 1.252 . . . . 0.0 108.28 171.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.61 -26.54 61.7 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.1 mm -76.8 -36.96 27.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-N 118.784 0.72 . . . . 0.0 109.143 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.02 -47.27 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.303 0.956 . . . . 0.0 108.759 170.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.55 68.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.188 0.995 . . . . 0.0 111.507 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.48 -42.61 52.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 120.952 -1.093 . . . . 0.0 109.833 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 44.3 mtm -55.65 -48.85 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 118.444 0.565 . . . . 0.0 109.542 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.64 -39.85 71.42 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.948 1.699 . . . . 0.0 111.249 176.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -67.84 -18.04 64.7 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.594 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -94.92 -1.21 53.03 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 119.557 1.072 . . . . 0.0 112.178 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.32 -163.3 39.24 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 120.871 1.669 . . . . 0.0 112.199 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.3 p -152.14 154.97 36.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -66.73 -20.59 66.0 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.154 -1.591 . . . . 0.0 112.877 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -78.64 9.16 4.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.428 1.091 . . . . 0.0 112.878 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.51 -28.87 7.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 126.128 1.823 . . . . 0.0 113.65 167.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -69.86 145.16 52.25 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 120.445 2.122 . . . . 0.0 110.91 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.2 p -64.05 145.86 55.16 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.873 1.669 . . . . 0.0 111.425 159.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.4 p -75.92 -43.83 43.14 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.357 0.663 . . . . 0.0 109.653 158.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.495 ' HE2' HG12 ' A' ' 12' ' ' VAL . 29.8 mtpt -124.47 162.73 23.32 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.43 1.492 . . . . 0.0 110.931 -174.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -74.61 88.28 2.17 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.128 -0.983 . . . . 0.0 110.358 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.49 124.88 31.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 p -146.09 165.67 28.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.699 0.761 . . . . 0.0 111.453 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.426 HD11 ' CE1' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -89.83 127.33 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 159.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.54 -46.68 8.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.613 0.642 . . . . 0.0 109.734 168.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.429 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -147.38 158.51 44.0 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -172.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 p -172.56 172.46 4.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.098 0.959 . . . . 0.0 113.096 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.35 -178.4 46.19 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.199 1.381 . . . . 0.0 109.906 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -78.83 149.09 32.62 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.327 1.051 . . . . 0.0 110.511 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.7 mt -128.68 43.29 3.17 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.954 0.902 . . . . 0.0 109.419 159.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.252 1.199 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.217 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.587 0.708 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.6 m -122.66 -173.13 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 129.596 3.159 . . . . 0.0 105.965 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -44.97 109.19 0.85 Allowed Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.774 158.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 17.9 Cg_endo -64.57 147.66 90.28 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 N-CA-C 107.551 -1.75 . . . . 0.0 107.551 174.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 m -110.51 150.48 28.85 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.92 160.96 29.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.746 0.818 . . . . 0.0 108.841 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -124.95 159.16 31.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.364 1.466 . . . . 0.0 109.998 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -146.56 107.82 4.23 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.69 2.396 . . . . 0.0 106.846 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.01 101.44 3.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.46 134.66 29.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.46 141.4 47.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.84 0.856 . . . . 0.0 109.008 164.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.2 t -96.32 91.28 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 163.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.279 1.3 p30 62.54 14.18 6.84 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.58 -9.64 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 117.442 -1.755 . . . . 0.0 111.406 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -70.48 124.88 91.66 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 162.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.0 117.75 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 N-CA-C 107.261 -1.861 . . . . 0.0 107.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp -88.73 -35.26 16.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.567 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 147.0 161.56 9.43 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -74.59 146.91 42.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.659 0.743 . . . . 0.0 109.233 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.01 151.85 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 128.114 2.566 . . . . 0.0 104.609 171.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 134' ' ' GLU . 21.5 m -146.48 146.65 30.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.212 1.006 . . . . 0.0 109.76 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -120.23 156.61 30.82 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.956 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -95.74 151.25 19.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 158.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -127.31 121.38 30.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -75.2 51.49 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.936 2.094 . . . . 0.0 112.754 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.26 28.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.963 -1.085 . . . . 0.0 113.365 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.09 -26.52 60.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.124 0.874 . . . . 0.0 111.714 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -111.99 -34.04 6.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.526 1.13 . . . . 0.0 111.635 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.6 m -135.08 71.6 68.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.449 1.9 . . . . 0.0 109.037 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.65 -44.2 27.9 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.593 2.195 . . . . 0.0 113.844 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -49.4 77.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.203 1.365 . . . . 0.0 109.592 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -62.45 -48.39 79.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.854 0.862 . . . . 0.0 109.28 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.66 -48.57 81.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.62 0.768 . . . . 0.0 111.468 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -46.01 91.55 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.725 1.21 . . . . 0.0 111.688 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -57.28 -51.09 70.79 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.106 0.962 . . . . 0.0 108.609 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.28 -31.68 72.64 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.523 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 18.3 ttm105 -55.65 -56.81 16.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.963 1.256 . . . . 0.0 108.938 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.48 -51.23 49.1 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.673 1.189 . . . . 0.0 111.16 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.33 -29.4 69.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 119.225 -0.417 . . . . 0.0 111.31 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 m -75.17 -10.23 59.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.236 1.414 . . . . 0.0 112.104 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.8 p -112.43 -29.61 7.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.411 0.684 . . . . 0.0 111.725 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.14 82.67 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.356 -0.691 . . . . 0.0 113.56 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -28.81 64.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.499 1.92 . . . . 0.0 113.503 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.59 2.49 1.8 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.519 0.728 . . . . 0.0 112.848 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.48 62.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.871 1.224 . . . . 0.0 111.397 -170.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -146.35 172.82 12.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.59 2.356 . . . . 0.0 106.728 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.54 -177.18 23.27 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.639 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 2.3 t80 -81.67 -6.59 59.16 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.881 2.072 . . . . 0.0 112.247 -163.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -59.59 117.87 5.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.2 -0.938 . . . . 0.0 108.588 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.49 5.65 87.96 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 116.92 -2.044 . . . . 0.0 115.766 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.6 m -71.26 -65.77 0.7 Allowed 'General case' 0 C--N 1.342 0.256 0 CA-C-N 121.638 2.719 . . . . 0.0 112.322 -163.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.6 t 130.14 144.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.184 3.793 . . . . 0.0 109.659 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.03 92.03 6.65 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.043 2.137 . . . . 0.0 106.823 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -18.4 58.07 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -164.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -140.02 78.25 1.65 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.161 1.346 . . . . 0.0 111.64 -167.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.51 106.34 18.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.805 1.642 . . . . 0.0 107.008 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.6 91.41 12.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.31 120.84 7.4 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.843 3.029 . . . . 0.0 113.114 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.47 11.52 60.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.839 1.685 . . . . 0.0 113.253 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -133.94 -79.61 0.46 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.936 1.294 . . . . 0.0 108.802 -170.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.69 167.95 28.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.799 0.84 . . . . 0.0 110.713 172.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -132.38 98.15 4.3 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.91 1.684 . . . . 0.0 109.04 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.7 146.79 44.18 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.426 1.09 . . . . 0.0 109.985 -175.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.98 -173.64 25.68 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 125.719 1.628 . . . . 0.0 109.88 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.84 -13.23 41.78 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.326 1.441 . . . . 0.0 113.324 170.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -84.07 95.09 8.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.892 0.846 . . . . 0.0 110.709 -167.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CD2' HG23 ' A' ' 68' ' ' THR . 49.8 p90 -95.08 3.5 54.74 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.178 -176.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 67' ' ' PHE . 50.0 p -137.16 -45.95 0.57 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.893 1.224 . . . . 0.0 113.248 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -88.34 -27.05 21.9 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.79 -0.569 . . . . 0.0 111.472 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 54.25 12.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.953 2.901 . . . . 0.0 114.595 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -117.86 -8.04 10.86 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.188 0.995 . . . . 0.0 112.868 -170.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 -3.36 27.36 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.439 -1.2 . . . . 0.0 113.088 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.2 p -84.27 -32.29 24.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.77 1.785 . . . . 0.0 111.04 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.88 165.91 9.35 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-O 123.153 1.419 . . . . 0.0 114.054 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.31 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.469 1.594 . . . . 0.0 111.669 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.58 -178.84 2.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 128.951 2.901 . . . . 0.0 108.814 -160.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.1 p -84.99 -175.1 5.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.76 -23.09 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.033 -1.042 . . . . 0.0 111.745 163.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -82.13 -23.67 35.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.023 0.929 . . . . 0.0 111.149 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.8 -145.72 10.18 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 -166.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -128.75 115.2 17.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.38 148.42 0.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.228 2.611 . . . . 0.0 111.88 -165.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -135.12 173.6 11.54 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 159.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 84' ' ' GLU . 1.9 pm0 -63.84 154.01 34.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.132 0.968 . . . . 0.0 109.714 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.03 99.47 1.82 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 172.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -49.77 -57.31 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.241 1.416 . . . . 0.0 114.516 -158.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.69 154.02 5.25 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.239 1.816 . . . . 0.0 108.846 162.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.98 25.24 10.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.56 1.544 . . . . 0.0 110.049 -169.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mt -45.2 -59.59 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 126.541 1.936 . . . . 0.0 108.556 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.9 mt -74.91 113.96 12.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.421 1.488 . . . . 0.0 107.87 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -80.2 157.85 26.42 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.154 171.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.36 83.76 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.5 p -68.73 -23.53 64.36 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.479 -0.763 . . . . 0.0 112.853 -166.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.76 -176.7 40.54 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.861 1.21 . . . . 0.0 111.86 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.46 149.52 89.24 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 121.732 1.621 . . . . 0.0 110.691 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.61 10.91 85.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.977 -1.457 . . . . 0.0 112.467 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 mm -82.58 166.2 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 120.674 2.237 . . . . 0.0 108.336 164.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.57 127.94 26.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.097 1.359 . . . . 0.0 108.175 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.8 t -141.29 147.16 37.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.204 0.526 . . . . 0.0 110.63 -167.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.412 ' HG2' ' CG ' ' A' ' 108' ' ' ASN . 35.9 tpp -77.25 113.97 15.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.177 2.191 . . . . 0.0 108.562 -174.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.445 ' H ' ' HA ' ' A' ' 112' ' ' PHE . . . -72.56 98.17 2.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 165.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -78.83 -178.2 5.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 159.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.92 15.1 25.78 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.384 1.874 . . . . 0.0 112.149 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.01 175.73 14.17 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.539 1.543 . . . . 0.0 109.312 -163.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.34 130.21 31.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.198 1.932 . . . . 0.0 111.32 -170.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 58.81 57.81 3.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 127.495 2.318 . . . . 0.0 111.853 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -142.25 41.74 1.64 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.086 0.555 . . . . 0.0 111.315 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.412 ' CG ' ' HG2' ' A' ' 100' ' ' MET . 1.0 OUTLIER -55.22 125.85 22.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.266 1.426 . . . . 0.0 109.565 175.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.75 -125.5 2.31 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 120.695 1.589 . . . . 0.0 112.335 -171.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -89.13 -25.14 22.01 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.606 1.203 . . . . 0.0 112.796 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -85.23 148.26 26.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.715 0.769 . . . . 0.0 111.178 -158.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.445 ' HA ' ' H ' ' A' ' 101' ' ' ALA . 28.2 p90 -142.96 176.67 8.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -141.24 152.8 44.85 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 160.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.1 mt -83.46 119.42 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 163.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.3 m -65.15 122.56 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.8 p -114.86 28.5 8.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.222 1.01 . . . . 0.0 108.553 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.32 178.63 10.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.157 1.783 . . . . 0.0 107.628 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -70.39 92.11 0.79 Allowed 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 161.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 p -78.72 59.36 2.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.694 0.679 . . . . 0.0 109.939 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.01 -13.37 62.41 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.83 1.252 . . . . 0.0 112.914 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -74.1 -15.92 61.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.286 1.035 . . . . 0.0 111.317 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -103.61 -4.59 23.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.854 1.261 . . . . 0.0 111.129 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 126.97 29.75 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.589 1.156 . . . . 0.0 111.129 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.41 1.19 34.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.717 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -103.11 -25.8 13.27 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.61 1.705 . . . . 0.0 110.553 168.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -137.14 160.96 37.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.111 1.364 . . . . 0.0 108.98 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -110.46 103.99 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.58 127.46 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 168.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -137.65 -2.08 1.99 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.827 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.75 -176.44 28.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 119.41 1.005 . . . . 0.0 111.974 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -153.37 140.22 19.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.97 103.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 159.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -63.68 -52.71 59.42 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 21' ' ' SER . 10.4 pt-20 -146.87 154.47 41.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 123.356 0.662 . . . . 0.0 111.486 -159.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.88 25.14 67.68 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.884 0.754 . . . . 0.0 113.153 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 mmm -61.22 -29.21 69.68 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.623 2.212 . . . . 0.0 111.609 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -62.61 -30.65 71.5 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.834 -1.166 . . . . 0.0 111.635 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 25.8 mm -66.02 -44.09 92.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.97 -42.26 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.265 0.626 . . . . 0.0 110.166 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -39.74 94.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.92 0.888 . . . . 0.0 111.917 174.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.18 -41.52 70.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.919 1.288 . . . . 0.0 109.035 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.3 mtp -53.87 -42.59 68.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.079 1.352 . . . . 0.0 110.154 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.202 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.76 -36.01 81.68 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.402 1.456 . . . . 0.0 108.887 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.59 1.68 40.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.983 0.913 . . . . 0.0 112.783 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.4 -156.21 7.72 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.982 1.753 . . . . 0.0 110.411 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.2 p -142.18 -72.06 0.32 Allowed 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 121.65 -0.912 . . . . 0.0 111.591 168.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 140.67 -27.39 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.346 1 C-N-CA 133.864 4.865 . . . . 0.0 109.772 -173.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -65.65 -24.84 67.12 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.716 0.689 . . . . 0.0 110.283 158.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.74 -36.05 4.21 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 125.672 1.606 . . . . 0.0 111.764 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.06 131.91 47.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.4 p -62.77 152.21 36.48 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.908 1.283 . . . . 0.0 107.914 166.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.6 p -57.44 -48.06 80.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -73.43 175.76 6.68 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.943 1.697 . . . . 0.0 111.101 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -95.63 139.48 31.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 101.969 -3.345 . . . . 0.0 101.969 157.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.4 mt -127.38 128.96 70.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.79 22.04 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.798 0.808 . . . . 0.0 111.542 -158.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.639 HD11 ' CZ ' ' A' ' 48' ' ' TYR . 4.6 mp -98.37 105.13 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.86 96.64 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.484 0.584 . . . . 0.0 109.521 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -157.32 158.82 36.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.575 1.15 . . . . 0.0 108.841 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 p -156.93 165.28 36.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.397 0.679 . . . . 0.0 110.543 174.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.47 -169.18 40.7 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.536 ' HG2' ' H ' ' A' ' 165' ' ' GLU . 41.4 tt0 -103.97 148.85 25.71 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.943 1.297 . . . . 0.0 109.646 -172.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.2 mt -128.37 43.26 3.17 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.253 1.421 . . . . 0.0 109.114 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.536 ' H ' ' HG2' ' A' ' 163' ' ' GLN . 24.1 tt0 . . . . . 0 C--O 1.243 0.734 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 166.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.3 19.6 m 46.65 -172.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 123.11 1.433 . . . . 0.0 114.007 166.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.16 104.9 54.07 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 158.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -63.78 146.66 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 120.7 1.286 . . . . 0.0 110.34 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -104.97 146.87 28.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.76 156.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.166 1.386 . . . . 0.0 109.351 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.0 158.91 26.71 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.487 1.115 . . . . 0.0 110.12 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -144.37 111.72 5.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.345 1.858 . . . . 0.0 106.663 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 104.46 10.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 mm -79.34 140.87 16.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.21 162.56 29.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.009 0.909 . . . . 0.0 110.007 169.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' CG1' ' HE3' ' A' ' 154' ' ' LYS . 9.2 t -137.18 92.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -173.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 60.21 18.64 8.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.739 1.216 . . . . 0.0 111.516 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.16 9.69 72.89 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.196 -0.94 . . . . 0.0 112.537 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -75.18 118.71 72.7 Favored Pre-proline 0 C--O 1.232 0.179 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 159.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.94 112.36 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.477 1.451 . . . . 0.0 109.436 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.2 tp -82.81 -27.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.112 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.55 169.53 11.75 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.436 1.493 . . . . 0.0 111.759 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.91 139.38 35.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.335 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.45 154.95 40.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.6 t -147.43 149.49 32.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.77 0.795 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -124.57 147.93 48.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.203 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -92.58 151.92 19.88 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 158.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 mt -126.7 122.56 35.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.883 1.673 . . . . 0.0 106.993 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 90' ' ' LEU . 58.1 m-85 -78.52 61.63 2.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.969 0.908 . . . . 0.0 111.846 -172.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.37 -16.33 53.88 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 119.885 -1.76 . . . . 0.0 113.611 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.33 -16.21 57.94 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.076 0.95 . . . . 0.0 111.918 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -121.95 -39.53 2.6 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.733 1.213 . . . . 0.0 111.3 -169.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 129' ' ' PHE . 4.1 m -132.74 70.51 79.09 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.911 1.685 . . . . 0.0 107.457 174.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -50.18 -48.37 20.15 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.146 2.564 . . . . 0.0 112.657 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 0.9 OUTLIER -55.66 -58.51 7.49 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -174.392 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.91 -46.43 89.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 125.391 1.477 . . . . 0.0 111.165 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.57 82.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.083 0.553 . . . . 0.0 111.385 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.38 -43.54 81.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.626 1.17 . . . . 0.0 110.453 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -51.09 -51.08 56.89 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.147 1.379 . . . . 0.0 109.38 170.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.94 -44.21 90.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.423 0.452 . . . . 0.0 112.073 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -53.93 -59.65 4.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.733 1.613 . . . . 0.0 109.108 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.96 -47.8 74.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.465 0.706 . . . . 0.0 110.611 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.67 -23.39 66.77 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -73.3 -48.13 37.12 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.299 0.954 . . . . 0.0 109.303 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 p -66.62 -26.1 66.92 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.989 -0.444 . . . . 0.0 111.913 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.61 -0.11 71.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.436 1.017 . . . . 0.0 112.058 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -59.78 -23.21 63.07 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.701 1.6 . . . . 0.0 112.632 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -85.47 9.69 15.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.109 1.364 . . . . 0.0 112.095 -172.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.05 81.63 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 118.846 -0.974 . . . . 0.0 112.423 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.32 172.72 13.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.983 1.713 . . . . 0.0 107.407 166.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.63 174.39 37.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.427 -1.368 . . . . 0.0 113.674 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -73.24 -8.03 54.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -56.08 124.68 18.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.72 4.34 65.82 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.613 -1.659 . . . . 0.0 114.529 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -73.14 156.75 38.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.99 2.395 . . . . 0.0 107.988 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.1 t -106.21 139.89 40.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CB ' HD11 ' A' ' 56' ' ' ILE . 95.6 m-85 -74.83 88.99 2.31 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -73.5 -27.55 61.43 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.406 1.882 . . . . 0.0 111.617 -166.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 86.01 2.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.449 HD12 ' CG2' ' A' ' 152' ' ' THR . 86.3 mt -103.71 112.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 171.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -125.17 97.47 37.59 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -170.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.68 125.45 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.948 2.432 . . . . 0.0 111.027 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.2 5.4 63.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.81 1.671 . . . . 0.0 113.338 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -136.57 -75.64 0.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.105 1.453 . . . . 0.0 108.98 -167.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -165.1 167.61 18.09 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 112.08 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.1 m -122.15 94.74 4.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.744 2.018 . . . . 0.0 108.383 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.37 144.32 25.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.532 1.933 . . . . 0.0 109.961 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.12 1.82 0.13 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.84 35.46 3.38 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 -158.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.329 19.3 p-10 -122.73 144.36 49.21 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 121.912 2.856 . . . . 0.0 111.292 164.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.28 -3.09 3.08 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.183 2.593 . . . . 0.0 111.317 -160.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -125.6 -19.84 4.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 129.247 3.019 . . . . 0.0 112.173 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -137.46 176.37 8.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 131.538 3.935 . . . . 0.0 103.439 169.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -145.11 53.81 1.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -152.91 -67.37 0.16 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.201 1.4 . . . . 0.0 110.679 -176.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.47 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 173.69 -11.81 0.04 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 118.374 -1.237 . . . . 0.0 115.262 -159.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -127.44 17.04 7.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.285 1.543 . . . . 0.0 113.227 -161.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.27 -86.4 0.37 Allowed Glycine 0 CA--C 1.503 -0.662 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -17.09 113.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.553 0 C-N-CA 128.074 2.749 . . . . 0.0 111.932 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -136.9 155.32 49.91 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.213 1.805 . . . . 0.0 109.918 -158.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 p -77.94 165.5 24.01 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 124.293 0.996 . . . . 0.0 109.451 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.7 pt -64.93 -24.75 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.596 170.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.39 8.31 25.11 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.166 1.787 . . . . 0.0 111.533 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.29 142.09 12.96 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.403 1.478 . . . . 0.0 109.813 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.26 6.2 pt-20 34.06 -133.8 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.796 2.438 . . . . 0.0 114.343 162.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -75.05 157.97 33.95 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.498 0.59 . . . . 0.0 110.385 165.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -132.13 176.53 8.31 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.66 1.984 . . . . 0.0 107.644 164.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.79 161.17 28.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.071 0.462 . . . . 0.0 110.713 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.57 131.33 48.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 159.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -47.08 83.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -173.08 176.13 3.06 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.726 1.211 . . . . 0.0 108.721 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -126.09 56.36 1.43 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.563 1.945 . . . . 0.0 106.144 163.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.0 mt -71.55 -39.52 70.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 171.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 25' ' ' PHE . 49.1 mt -95.6 142.24 28.15 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.447 1.499 . . . . 0.0 107.334 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -120.49 160.21 23.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.433 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -76.26 64.62 2.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.494 2.318 . . . . 0.0 109.666 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.426 1.49 . . . . 0.0 113.494 -161.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 175.49 38.23 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.583 1.083 . . . . 0.0 112.891 170.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -59.68 137.58 78.0 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.158 1.906 . . . . 0.0 108.147 172.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.67 -9.73 64.38 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 117.512 -1.716 . . . . 0.0 112.623 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.42 159.44 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 120.923 2.361 . . . . 0.0 107.687 169.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.39 131.98 45.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.456 1.502 . . . . 0.0 108.497 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 32.3 t -148.62 160.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.848 0.459 . . . . 0.0 110.68 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.4 mtp -84.58 120.95 26.94 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.618 0.767 . . . . 0.0 110.421 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 141.73 58.67 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 162.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -152.46 -172.57 4.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.364 1.066 . . . . 0.0 109.691 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.62 15.08 10.25 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.011 1.724 . . . . 0.0 112.64 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.28 -179.6 17.24 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -167.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.47 141.04 79.1 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.539 2.159 . . . . 0.0 110.481 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 53.51 46.12 26.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.164 1.786 . . . . 0.0 111.885 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.7 p -123.89 14.07 9.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.301 -0.874 . . . . 0.0 111.262 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -73.69 128.02 34.37 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.52 -65.31 0.16 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.7 p -144.54 -13.76 0.58 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.47 HE22 ' HA2' ' A' ' 72' ' ' GLY . 78.9 mt-30 -65.4 130.9 44.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -170.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -134.43 162.39 32.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 107.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 44.9 p90 -144.56 153.39 41.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 O-C-N 124.683 1.239 . . . . 0.0 110.263 166.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.79 123.84 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 160.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.14 125.39 24.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.3 p -110.77 32.39 5.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.52 173.11 13.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.341 1.057 . . . . 0.0 109.192 167.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -68.59 89.85 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 158.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 p -83.38 65.88 8.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.819 -0.551 . . . . 0.0 109.892 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -59.22 -23.21 62.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.11 0.964 . . . . 0.0 112.306 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -68.49 -14.82 63.27 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.761 1.224 . . . . 0.0 110.749 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 62.1 mt -104.0 -6.24 21.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.243 1.417 . . . . 0.0 111.54 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.16 145.13 53.54 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.714 0.688 . . . . 0.0 110.498 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.49 16.06 48.7 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.96 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.22 -52.01 1.41 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.924 2.09 . . . . 0.0 108.414 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -105.18 146.69 28.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.814 -173.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.45 100.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -171.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.1 t -59.06 127.29 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 165.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.409 ' HA ' HG21 ' A' ' 29' ' ' VAL . 29.4 p90 -138.25 -3.45 1.75 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.59 -174.19 30.1 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.36 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -149.83 149.99 31.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.659 1.183 . . . . 0.0 108.44 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 118.31 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 165.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -75.13 -50.27 16.89 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -143.34 146.4 33.51 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 126.133 1.773 . . . . 0.0 107.275 -171.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.45 14.27 22.34 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.464 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 28.6 tpp -56.61 -35.94 68.85 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 119.526 1.663 . . . . 0.0 110.706 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -62.67 -20.51 64.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.852 1.205 . . . . 0.0 113.391 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.4 mm -83.05 -43.77 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.551 1.14 . . . . 0.0 108.677 174.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 41.1 t -62.37 -35.9 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 121.586 -0.696 . . . . 0.0 109.579 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.37 -44.26 84.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.084 1.753 . . . . 0.0 110.913 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.08 85.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.434 ' HB3' HD13 ' A' ' 56' ' ' ILE . 38.4 mtm -53.26 -47.93 68.7 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.734 176.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -53.24 -42.14 66.12 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.537 HH11 ' HG3' ' A' ' 144' ' ' ARG . 15.0 mtt85 -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.085 -177.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.04 5.24 51.62 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.801 1.24 . . . . 0.0 112.446 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.2 -150.89 4.09 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 120.473 1.488 . . . . 0.0 111.74 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.0 p -142.59 -96.05 0.12 Allowed 'General case' 0 C--O 1.224 -0.242 0 O-C-N 121.589 -0.948 . . . . 0.0 108.798 165.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -162.2 -23.4 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 125.858 1.663 . . . . 0.0 110.764 164.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.16 -16.07 58.25 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.977 0.808 . . . . 0.0 111.432 165.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.27 -24.84 6.84 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 118.556 -1.136 . . . . 0.0 113.174 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.14 123.47 17.77 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.224 1.012 . . . . 0.0 108.764 -174.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.449 ' CG2' HD12 ' A' ' 56' ' ' ILE . 12.3 p -74.93 159.99 31.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.385 1.074 . . . . 0.0 108.837 173.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -10.66 59.64 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.031 -1.668 . . . . 0.0 111.362 166.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.422 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -140.73 160.31 40.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 110.117 -161.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.52 80.2 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.67 119.16 32.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.3 p -139.22 165.74 26.38 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.508 1.123 . . . . 0.0 110.766 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 102.41 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 166.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.4 77.09 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -145.43 161.48 39.6 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 p -162.26 158.17 23.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.282 1.433 . . . . 0.0 108.556 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.71 -176.34 42.96 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -83.05 159.55 22.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.856 -0.79 . . . . 0.0 110.722 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 21.0 mt -135.58 43.63 2.59 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 158.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.148 0.979 . . . . 0.0 111.458 175.419 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HG3' ' H ' ' A' ' 2' ' ' VAL . 7.2 tpt . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.529 HG22 ' H ' ' A' ' 3' ' ' ASN . 4.5 p -69.11 -174.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 164.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.529 ' H ' HG22 ' A' ' 2' ' ' VAL . 29.3 m120 -33.83 104.79 0.25 Allowed Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 127.994 2.518 . . . . 0.0 113.188 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.23 138.82 48.17 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 N-CA-C 106.502 -2.153 . . . . 0.0 106.502 158.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 m -104.7 147.91 27.16 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.5 140.43 44.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -174.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -113.71 150.91 32.61 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 123.936 0.894 . . . . 0.0 110.164 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.431 ' CZ ' ' CE2' ' A' ' 48' ' ' TYR . 19.3 m-85 -146.13 113.56 6.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.481 1.512 . . . . 0.0 109.317 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.21 101.11 3.88 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 159.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.19 140.93 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 171.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.78 148.06 49.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.929 1.292 . . . . 0.0 108.37 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.647 HG13 HD13 ' A' ' 156' ' ' ILE . 1.5 t -125.35 115.76 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 53.5 13.76 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 0.0 114.489 -167.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.3 57.79 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.381 1.467 . . . . 0.0 112.859 -175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.27 133.23 81.18 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.22 120.19 7.17 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.2 -40.49 30.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.85 177.28 19.56 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 123.68 0.657 . . . . 0.0 112.364 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -77.32 136.62 38.48 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.726 0.81 . . . . 0.0 110.068 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -121.92 158.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 126.578 1.951 . . . . 0.0 106.316 164.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -147.99 140.34 24.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.965 -0.459 . . . . 0.0 110.244 161.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -109.14 162.72 14.0 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -123.38 112.76 17.95 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.479 2.712 . . . . 0.0 104.433 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 mt -97.61 134.65 40.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -169.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CD2' HD13 ' A' ' 90' ' ' LEU . 18.0 m-85 -82.16 51.76 1.85 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.998 -1.064 . . . . 0.0 112.42 -171.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.9 -27.36 42.42 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.252 -0.905 . . . . 0.0 112.061 173.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -71.39 -7.08 44.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.721 1.608 . . . . 0.0 113.758 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.82 -25.25 0.46 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.032 0.833 . . . . 0.0 112.933 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 75.1 33.64 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.562 1.945 . . . . 0.0 106.793 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.81 -52.65 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.29 1.993 . . . . 0.0 111.644 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -42.95 99.53 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.883 1.22 . . . . 0.0 109.83 -173.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -60.92 -48.21 82.85 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.433 0.693 . . . . 0.0 110.332 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.78 -51.29 57.47 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.131 0.972 . . . . 0.0 111.764 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.6 -32.41 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.213 2.205 . . . . 0.0 112.085 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -61.98 2.06 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.019 1.728 . . . . 0.0 108.579 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.07 -30.93 71.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.203 -0.311 . . . . 0.0 111.56 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -53.19 -62.37 1.7 Allowed 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.038 1.335 . . . . 0.0 109.784 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.9 -26.34 68.11 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.95 -32.39 34.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.866 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.1 m -69.67 -40.87 76.17 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 123.926 0.89 . . . . 0.0 109.853 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.0 p -70.87 -34.7 71.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.4 -0.6 88.9 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.623 1.106 . . . . 0.0 110.949 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -70.64 -12.07 61.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.037 1.335 . . . . 0.0 112.887 -162.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -75.57 -4.55 40.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.148 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.07 6.42 55.86 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.486 1.041 . . . . 0.0 111.463 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -163.23 170.54 17.56 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.349 1.86 . . . . 0.0 106.146 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.53 178.62 35.62 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 118.217 -1.944 . . . . 0.0 114.052 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.431 ' CE2' ' CZ ' ' A' ' 8' ' ' PHE . 75.2 t80 -70.68 -17.63 62.84 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 130.51 3.524 . . . . 0.0 113.283 -170.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -55.74 121.8 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 23.72 73.0 Favored Glycine 0 CA--C 1.538 1.496 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.063 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -25.3 67.98 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.853 2.326 . . . . 0.0 110.288 169.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.4 m 56.38 175.99 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.308 1.443 . . . . 0.0 110.515 -159.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.6 117.99 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 159.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -74.27 -39.75 62.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.202 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 125.54 40.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -158.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.2 mm -142.33 114.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.9 mt -125.89 108.84 25.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.19 124.22 13.58 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.36 3.373 . . . . 0.0 114.015 -173.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.64 27.02 69.13 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.215 1.388 . . . . 0.0 112.442 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -125.1 -83.89 0.64 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.22 172.55 15.57 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.497 0.719 . . . . 0.0 110.188 170.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -130.99 115.84 17.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.231 1.413 . . . . 0.0 109.834 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -101.1 138.22 38.42 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.24 2.216 . . . . 0.0 111.528 -169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.22 -156.07 7.33 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.863 1.697 . . . . 0.0 109.279 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.8 90.13 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 119.284 -0.731 . . . . 0.0 114.401 169.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -83.86 138.9 32.97 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 159.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -132.53 6.83 4.11 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.398 1.079 . . . . 0.0 111.326 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.6 -31.57 0.86 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.468 1.107 . . . . 0.0 113.73 -174.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -127.84 -10.95 5.48 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.306 1.412 . . . . 0.0 112.964 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 58.44 30.57 19.86 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.235 1.814 . . . . 0.0 113.091 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -147.04 -27.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.74 2.57 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.889 1.222 . . . . 0.0 114.469 -170.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.9 p -83.89 -4.32 58.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.596 1.198 . . . . 0.0 112.282 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -103.13 -108.34 3.25 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -8.46 91.17 0.01 OUTLIER Glycine 0 C--N 1.334 0.453 0 C-N-CA 129.082 3.23 . . . . 0.0 115.633 -170.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 1.4 ptpt -77.24 150.1 35.41 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 128.224 2.61 . . . . 0.0 110.013 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -84.89 44.93 1.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.26 1.424 . . . . 0.0 112.768 -169.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.257 36.6 pt 49.27 -43.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 1 C-N-CA 133.486 4.714 . . . . 0.0 114.562 -158.921 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -82.04 -4.43 56.76 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.844 1.257 . . . . 0.0 113.724 -159.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.66 -85.36 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 170.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -127.84 -133.23 0.23 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 127.255 2.222 . . . . 0.0 105.381 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.83 155.67 18.59 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.379 1.445 . . . . 0.0 108.902 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -122.76 177.75 5.33 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.083 0.856 . . . . 0.0 110.565 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.452 ' HA ' HD22 ' A' ' 106' ' ' ASN . 15.9 pt-20 -57.47 164.31 1.98 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 112.679 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -64.22 120.01 11.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 158.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -67.2 -48.09 68.95 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.767 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.72 156.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.417 2.687 . . . . 0.0 110.706 170.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -104.61 22.55 14.83 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.923 1.689 . . . . 0.0 110.655 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.34 -49.39 64.57 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 124.33 1.052 . . . . 0.0 109.853 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD13 ' CD2' ' A' ' 25' ' ' PHE . 96.3 mt -80.67 129.32 34.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -101.95 160.57 14.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.122 1.769 . . . . 0.0 109.368 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -77.08 85.24 3.58 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 172.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 p -76.47 -24.14 53.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 118.877 -0.582 . . . . 0.0 111.216 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.1 -170.57 43.55 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.041 0.829 . . . . 0.0 112.705 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.95 158.89 19.54 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.629 2.219 . . . . 0.0 110.64 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.65 -4.2 57.36 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 117.084 -1.954 . . . . 0.0 113.06 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -67.84 148.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 121.2 2.5 . . . . 0.0 107.823 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.83 125.33 54.23 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 p -131.73 159.82 37.3 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 122.799 1.285 . . . . 0.0 110.048 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttm -86.71 127.44 34.97 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.376 -163.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.62 41.79 0.34 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.884 2.474 . . . . 0.0 112.346 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -63.03 167.62 4.7 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.868 1.318 . . . . 0.0 110.409 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -118.36 15.26 13.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.374 -1.739 . . . . 0.0 111.75 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.61 -167.7 32.61 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 -167.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -64.75 171.62 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 119.328 1.564 . . . . 0.0 108.965 158.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 84' ' ' GLU . 6.8 m120 48.85 24.43 0.84 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.458 2.303 . . . . 0.0 115.188 168.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -128.2 29.15 5.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.399 1.48 . . . . 0.0 109.858 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.471 HD21 HG21 ' A' ' 127' ' ' VAL . 85.7 m-20 -69.19 101.24 1.43 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.902 1.681 . . . . 0.0 107.324 172.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.92 -137.59 7.76 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -90.08 -10.87 43.14 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.733 0.813 . . . . 0.0 112.624 163.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -81.69 146.63 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.743 1.217 . . . . 0.0 111.286 -158.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -154.32 171.75 18.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.28 1.032 . . . . 0.0 109.492 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.597 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 10.6 p90 -135.49 154.66 51.34 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.341 0.591 . . . . 0.0 109.965 159.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.25 117.46 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 36.0 m -65.72 130.3 42.81 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.625 1.17 . . . . 0.0 108.078 168.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.9 p -111.66 22.07 15.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.944 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.95 -176.14 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 161.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.54 93.22 0.23 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 161.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -81.08 55.74 2.59 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.634 1.974 . . . . 0.0 110.014 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.44 -20.74 64.82 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.869 -1.144 . . . . 0.0 113.673 -171.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -73.15 -4.47 32.96 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.597 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 68.0 mt -114.82 -2.88 12.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.229 1.811 . . . . 0.0 110.89 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.47 143.16 58.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.174 1.39 . . . . 0.0 111.529 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.5 20.26 58.82 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.254 0.93 . . . . 0.0 112.084 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.04 -51.91 0.67 Allowed 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -96.58 117.62 31.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 108' ' ' ASN . 18.6 t -71.23 107.19 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -170.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.89 122.55 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.384 1.474 . . . . 0.0 108.037 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -145.13 9.27 1.26 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.24 -173.08 37.29 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 121.296 -0.878 . . . . 0.0 111.783 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -147.67 158.36 43.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.144 0.978 . . . . 0.0 109.631 168.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.15 105.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -52.34 62.56 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.41 157.69 44.13 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.977 0.911 . . . . 0.0 111.056 -167.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.7 24.93 54.91 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.458 1.028 . . . . 0.0 112.592 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.8 tpp -55.75 -35.09 65.81 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.554 1.677 . . . . 0.0 110.109 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -57.6 -30.95 65.73 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.424 1.465 . . . . 0.0 113.379 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.8 mm -76.39 -35.07 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.906 0.776 . . . . 0.0 109.483 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.35 -39.4 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.387 0.994 . . . . 0.0 109.645 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -62.49 -31.44 72.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.117 1.367 . . . . 0.0 111.456 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -44.44 28.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.823 1.249 . . . . 0.0 109.215 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 62.5 mtp -49.77 -44.01 48.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.872 1.269 . . . . 0.0 110.316 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -59.53 -33.31 71.22 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.02 0.928 . . . . 0.0 113.489 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -65.64 -25.73 67.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 119.699 1.136 . . . . 0.0 110.975 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.662 ' HB2' HD11 ' A' ' 156' ' ' ILE . 59.0 m-85 -91.98 5.12 51.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 177.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.43 -167.81 34.05 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 125.007 1.289 . . . . 0.0 111.721 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 p -153.75 152.55 30.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.262 1.425 . . . . 0.0 107.372 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -63.85 -22.15 66.78 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.198 -1.564 . . . . 0.0 113.16 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -77.04 -6.48 52.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 16.69 68.94 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.355 -1.247 . . . . 0.0 113.243 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.404 ' HE3' ' H ' ' A' ' 152' ' ' THR . 0.0 OUTLIER -86.44 176.13 8.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.583 1.691 . . . . 0.0 109.141 158.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.404 ' H ' ' HE3' ' A' ' 151' ' ' LYS . 71.4 p -125.04 129.97 51.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 p -68.72 -31.65 70.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.4 0.546 . . . . 0.0 110.575 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.484 ' HB3' HG12 ' A' ' 12' ' ' VAL . 47.0 mtpt -111.75 176.94 4.82 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.163 0.585 . . . . 0.0 109.972 171.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.66 103.4 15.78 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 145' ' ' PHE . 42.3 mm -79.9 126.24 39.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -142.85 172.61 12.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.995 1.318 . . . . 0.0 111.412 -168.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.5 mt -124.0 109.69 23.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.85 87.33 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.375 1.047 . . . . 0.0 110.528 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -160.86 162.2 32.1 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.4 p -160.2 163.52 33.53 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.215 0.462 . . . . 0.0 111.9 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.34 29.34 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -110.05 143.95 39.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.01 1.324 . . . . 0.0 110.092 -172.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.26 43.55 3.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.811 1.645 . . . . 0.0 109.789 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.941 0 O-C-N 121.03 -1.044 . . . . 0.0 111.001 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tmm? . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 74.6 t 52.42 179.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -142.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -58.42 120.07 41.34 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 119.948 -1.72 . . . . 0.0 109.905 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 42.8 Cg_exo -63.04 166.77 13.62 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 CA-C-N 121.623 1.615 . . . . 0.0 112.139 158.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.2 m -131.11 152.26 50.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 158.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.1 m -139.01 154.9 26.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 108.121 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' HB3' HD11 ' A' ' 164' ' ' LEU . 23.2 p90 -109.83 159.96 16.76 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.862 0.865 . . . . 0.0 110.612 171.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -144.5 105.02 4.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.831 1.652 . . . . 0.0 107.437 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.29 97.15 5.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 164.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -68.69 141.7 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -125.01 159.9 30.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.397 1.094 . . . . 0.0 109.206 169.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.57 HG22 HD13 ' A' ' 156' ' ' ILE . 16.5 t -137.99 88.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -168.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.44 13.07 1.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.898 1.279 . . . . 0.0 112.35 -165.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.55 -9.43 30.44 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.705 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.68 112.44 8.7 Favored Pre-proline 0 N--CA 1.441 -0.924 0 C-N-CA 126.656 1.982 . . . . 0.0 105.696 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.86 118.63 5.53 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.7 -25.08 30.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.6 -152.03 23.43 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -124.27 114.87 20.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.151 0.975 . . . . 0.0 110.611 159.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.1 t -82.19 161.0 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.732 2.013 . . . . 0.0 108.33 165.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.7 m -151.4 141.85 22.52 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.315 -1.49 . . . . 0.0 110.205 170.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -117.6 143.47 46.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.894 0.878 . . . . 0.0 109.342 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -87.98 142.28 27.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 161.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -127.39 116.77 21.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -79.64 52.77 1.47 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.359 1.064 . . . . 0.0 113.555 -167.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -67.35 -16.17 64.1 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.36 -28.37 65.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.903 1.683 . . . . 0.0 110.705 168.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -99.27 -32.08 11.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.991 1.716 . . . . 0.0 112.449 -174.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG12 ' HG3' ' A' ' 86' ' ' GLU . 3.3 m -141.8 74.14 22.78 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.469 1.508 . . . . 0.0 109.022 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.53 -43.21 22.9 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.813 2.342 . . . . 0.0 112.342 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.55 -52.2 66.17 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 119.868 1.213 . . . . 0.0 108.515 -177.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 m -60.81 -47.65 85.39 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.641 1.177 . . . . 0.0 111.157 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.76 -33.9 46.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.06 -42.81 68.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.436 1.016 . . . . 0.0 110.014 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -45.15 -55.58 5.59 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.548 1.139 . . . . 0.0 108.561 164.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.82 -29.64 70.14 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -61.26 -55.27 33.84 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.984 1.266 . . . . 0.0 109.532 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -54.39 -45.38 72.88 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.191 1.396 . . . . 0.0 111.434 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 mt -67.13 -38.57 85.79 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.414 -0.804 . . . . 0.0 111.935 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.9 m -71.2 -36.82 72.05 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.822 0.849 . . . . 0.0 110.836 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -73.96 -23.88 59.55 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.272 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.31 74.62 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.262 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.78 -25.59 63.23 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.61 1.564 . . . . 0.0 113.565 -159.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -88.56 1.31 55.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.944 1.298 . . . . 0.0 112.089 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.89 15.6 59.23 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.259 0.933 . . . . 0.0 112.449 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -160.43 177.52 10.49 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.7 -147.45 17.56 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.437 ' O ' HD13 ' A' ' 158' ' ' ILE . 4.1 m-85 -84.06 -24.04 30.59 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 117.928 -1.035 . . . . 0.0 113.593 -159.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -56.57 120.07 7.15 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 57.33 43.72 93.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.65 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -96.18 -5.37 40.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.671 1.736 . . . . 0.0 113.612 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m 47.11 170.29 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.072 2.149 . . . . 0.0 113.831 -159.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.74 146.5 30.77 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 159.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -106.48 -30.52 9.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.096 -170.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.5 124.13 18.37 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 mm -130.83 109.42 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -121.71 95.02 48.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.62 122.98 11.24 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.455 2.77 . . . . 0.0 112.576 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.79 65.65 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 124.66 1.124 . . . . 0.0 112.446 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -134.56 -76.29 0.46 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.59 170.03 21.7 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.023 0.929 . . . . 0.0 110.343 168.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 122.31 28.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.848 1.659 . . . . 0.0 107.61 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.424 HE22 ' CB ' ' A' ' 101' ' ' ALA . 30.6 tp60 -111.92 133.71 53.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 128.339 2.655 . . . . 0.0 110.384 -165.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.37 -173.31 13.98 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 126.484 1.992 . . . . 0.0 112.566 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.7 29.25 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 124.231 0.919 . . . . 0.0 115.369 161.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.08 68.48 3.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 119.247 1.523 . . . . 0.0 109.134 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.84 2.62 44.08 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 113.267 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -139.29 -60.66 0.56 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.595 1.089 . . . . 0.0 109.143 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -83.54 162.92 20.72 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 159.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -124.01 21.89 8.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.686 1.194 . . . . 0.0 108.978 -166.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -162.46 -0.9 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.418 1.087 . . . . 0.0 113.468 -158.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.8 14.21 19.91 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 120.202 1.365 . . . . 0.0 115.581 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.1 p -118.69 16.28 13.61 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.116 1.458 . . . . 0.0 112.866 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.26 -152.64 5.68 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.95 173.32 47.68 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -166.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -153.45 144.0 22.53 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.722 -0.869 . . . . 0.0 110.715 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.479 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 69.5 p -73.74 22.57 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 130.033 3.333 . . . . 0.0 113.835 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.623 HG21 ' HB3' ' A' ' 38' ' ' ALA . 6.4 pt 49.16 -22.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 1 C-N-CA 132.204 4.202 . . . . 0.0 116.127 -158.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -89.41 -19.89 24.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.484 1.914 . . . . 0.0 110.675 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.65 128.96 3.13 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 126.036 1.779 . . . . 0.0 109.336 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . 0.331 48.3 tt0 50.1 -132.57 1.77 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -116.12 171.54 7.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.584 1.554 . . . . 0.0 109.408 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 77' ' ' SER . 0.7 OUTLIER -139.24 -177.48 4.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.597 1.559 . . . . 0.0 110.073 175.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -56.62 164.93 1.28 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.538 2.335 . . . . 0.0 113.207 -176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.92 75.44 10.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 164.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' HG3' HG12 ' A' ' 29' ' ' VAL . 9.7 pt-20 -45.99 -56.86 4.96 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -159.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.412 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -153.73 153.68 32.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 160.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.2 16.27 26.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.414 2.286 . . . . 0.0 111.207 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 mt -50.76 -53.17 14.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.882 1.273 . . . . 0.0 109.126 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -74.33 123.06 23.89 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -118.32 170.56 8.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.409 1.484 . . . . 0.0 109.377 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -81.5 54.12 2.27 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.504 1.921 . . . . 0.0 111.007 -167.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.4 p -69.67 -9.72 55.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -158.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.86 177.13 44.65 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.05 1.295 . . . . 0.0 111.802 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.25 155.31 46.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.645 1.563 . . . . 0.0 110.266 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.32 4.54 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.505 -1.72 . . . . 0.0 113.216 -171.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.6 mm -71.06 162.32 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 120.795 2.298 . . . . 0.0 107.366 163.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.17 124.74 22.21 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 109.649 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.0 t -131.24 157.52 43.04 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.895 0.855 . . . . 0.0 110.941 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 91.4 mmm -64.07 156.01 29.56 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.108 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.424 ' CB ' HE22 ' A' ' 63' ' ' GLN . . . -112.42 136.51 51.81 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -146.2 172.24 13.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.35 1.46 . . . . 0.0 107.822 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.06 15.85 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.239 1.416 . . . . 0.0 111.656 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.63 -165.49 26.79 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -168.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -64.28 166.38 17.19 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 118.95 1.375 . . . . 0.0 110.048 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 37.67 43.91 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.287 3.035 . . . . 0.0 113.55 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 p -133.31 33.17 3.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.556 1.542 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -79.97 108.06 13.25 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.5 -100.62 2.09 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 89.9 p -145.77 33.88 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.315 0.646 . . . . 0.0 110.674 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -121.06 142.49 49.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -157.24 155.5 30.92 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -165.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 28.0 p90 -134.68 147.34 50.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.504 167.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.1 mt -83.85 117.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 29.1 m -63.69 129.01 38.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.7 p -117.79 26.3 9.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.19 0.995 . . . . 0.0 109.299 171.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.96 11.88 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 163.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -68.47 96.42 0.69 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 159.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.5 p -83.13 60.1 5.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 119.116 0.871 . . . . 0.0 109.835 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.64 -14.63 59.0 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.5 1.52 . . . . 0.0 113.086 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -76.45 -10.38 59.35 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.934 -1.104 . . . . 0.0 111.711 169.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' CZ ' ' A' ' 113' ' ' PHE . 67.6 mt -104.69 -5.89 20.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.807 1.643 . . . . 0.0 110.99 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -63.99 132.12 49.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.48 17.74 74.81 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 122.113 -0.367 . . . . 0.0 113.089 -171.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -128.04 -34.32 2.13 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.003 1.321 . . . . 0.0 110.854 176.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -140.35 162.63 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.224 0.92 . . . . 0.0 110.542 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.94 105.86 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 126.979 2.112 . . . . 0.0 107.434 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.53 131.95 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 166.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -138.33 -0.47 2.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.33 -177.7 27.99 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.837 -1.173 . . . . 0.0 112.344 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.93 148.17 36.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.261 1.424 . . . . 0.0 107.417 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.9 106.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 162.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -70.05 -50.36 41.98 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 159.19 42.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.53 0.732 . . . . 0.0 110.918 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.84 24.41 60.12 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.146 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -35.2 68.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.969 1.885 . . . . 0.0 110.343 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -64.99 -21.58 66.87 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.77 -34.0 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.156 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.88 -41.52 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.093 167.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.93 -29.1 70.53 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.185 -0.947 . . . . 0.0 112.302 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.46 -42.85 74.36 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.216 0.916 . . . . 0.0 109.566 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.8 mtm -56.28 -45.72 80.05 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.269 0.486 . . . . 0.0 110.867 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.58 -40.76 65.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 112.47 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -68.82 -20.58 64.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.052 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.442 ' HB2' HD11 ' A' ' 156' ' ' ILE . 22.9 m-85 -91.32 3.99 53.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.013 0.925 . . . . 0.0 112.75 173.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.78 -148.37 14.82 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 121.058 1.754 . . . . 0.0 112.727 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.3 p -163.89 161.2 22.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.314 1.446 . . . . 0.0 107.235 158.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -59.54 -29.99 68.29 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.406 -1.434 . . . . 0.0 114.528 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -75.37 -7.71 54.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.36 -26.38 20.36 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 126.197 1.856 . . . . 0.0 113.726 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.06 123.93 20.76 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.393 1.077 . . . . 0.0 109.418 -171.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.3 p -75.81 143.88 41.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.862 1.665 . . . . 0.0 110.641 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.6 p -84.85 -13.65 50.34 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.106 -1.621 . . . . 0.0 111.938 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.511 ' HD3' ' CG1' ' A' ' 12' ' ' VAL . 78.7 mttt -146.84 157.46 43.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.164 1.785 . . . . 0.0 108.748 -168.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.514 ' HE2' HG21 ' A' ' 157' ' ' THR . 81.3 tttt -76.31 84.56 3.09 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.502 1.046 . . . . 0.0 108.296 174.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.57 HD13 HG22 ' A' ' 12' ' ' VAL . 5.6 mm -73.2 117.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.514 HG21 ' HE2' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -138.72 172.16 13.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.541 1.137 . . . . 0.0 110.585 -170.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 48' ' ' TYR . 5.3 mp -103.52 118.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 159.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -73.33 -49.62 26.42 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 167.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.3 152.67 40.28 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.092 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 4.8 p -164.08 165.5 22.26 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.83 0.852 . . . . 0.0 109.546 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.7 -170.21 43.33 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.55 ' HG3' ' H ' ' A' ' 165' ' ' GLU . 6.8 tp60 -79.88 146.55 32.11 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.34 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 7' ' ' PHE . 60.8 mt -138.31 42.91 2.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.437 1.495 . . . . 0.0 110.424 161.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.55 ' H ' ' HG3' ' A' ' 163' ' ' GLN . 5.8 mt-10 . . . . . 0 C--O 1.248 0.987 0 O-C-N 120.971 -1.08 . . . . 0.0 111.212 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -55.96 169.75 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 157.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -29.08 98.24 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 127.496 2.318 . . . . 0.0 114.211 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -62.94 136.76 58.7 Favored 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 121.395 1.396 . . . . 0.0 108.947 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.8 m -98.5 145.93 26.28 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.68 133.82 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -87.94 157.84 18.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.134 0.968 . . . . 0.0 109.135 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -132.49 149.59 52.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -129.55 93.32 3.52 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 mm -77.18 141.62 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.69 160.82 28.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.635 1.574 . . . . 0.0 108.568 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.02 113.27 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 58.68 14.39 3.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.836 1.254 . . . . 0.0 114.258 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.36 -3.85 40.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.676 2.084 . . . . 0.0 113.17 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.85 115.46 61.0 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -57.83 120.27 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.132 1.888 . . . . 0.0 109.788 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 tp -82.91 -43.46 16.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.44 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.21 152.62 7.03 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -76.78 152.34 35.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -141.33 160.43 22.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 126.803 2.041 . . . . 0.0 105.93 -174.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -142.87 152.39 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 122.129 0.966 . . . . 0.0 109.622 172.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.88 147.82 49.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.864 1.266 . . . . 0.0 108.857 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.8 139.4 39.63 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.95 1.7 . . . . 0.0 106.49 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -124.63 131.6 53.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.944 1.298 . . . . 0.0 107.814 -177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.21 52.64 2.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.014 0.926 . . . . 0.0 113.316 -166.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -18.89 56.68 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 119.897 -1.752 . . . . 0.0 115.628 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.15 0.27 53.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.734 1.152 . . . . 0.0 111.801 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -128.52 -29.54 2.41 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.466 1.506 . . . . 0.0 112.628 173.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.79 72.74 76.96 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.515 1.526 . . . . 0.0 108.9 167.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -56.36 -42.72 62.91 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.153 1.902 . . . . 0.0 114.194 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -53.6 53.35 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.5 m -62.13 -48.83 78.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.3 1.44 . . . . 0.0 109.983 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.87 -46.49 74.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -37.47 81.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.471 0.578 . . . . 0.0 109.801 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -56.95 -53.05 62.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -66.01 -32.8 74.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -51.75 -63.9 0.99 Allowed 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 124.351 1.06 . . . . 0.0 109.137 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.979 0.912 . . . . 0.0 113.242 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -71.38 -33.01 69.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.404 1.002 . . . . 0.0 111.523 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 83.2 p -65.55 -51.41 60.01 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.429 1.468 . . . . 0.0 108.965 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -63.83 -33.64 76.14 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.498 0.719 . . . . 0.0 110.432 -171.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.34 90.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.08 -24.28 67.83 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.713 1.257 . . . . 0.0 112.102 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -68.06 1.62 2.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.588 1.555 . . . . 0.0 112.395 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.82 5.83 84.55 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.644 1.116 . . . . 0.0 112.006 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -153.01 173.97 14.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.657 2.383 . . . . 0.0 106.537 167.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.95 -162.93 29.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 121.713 0.618 . . . . 0.0 111.967 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' CE1' ' HA2' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -69.36 -15.33 63.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 128.326 2.65 . . . . 0.0 112.631 177.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -62.85 100.06 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.029 -1.045 . . . . 0.0 108.578 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.2 80.01 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.142 -1.921 . . . . 0.0 115.473 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.8 p -64.3 -48.71 74.59 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 121.206 2.503 . . . . 0.0 111.528 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.4 m 106.76 144.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 1 C-N-CA 133.175 4.59 . . . . 0.0 108.343 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.65 136.2 33.47 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 162.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -119.68 -10.18 9.63 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.6 119.42 15.21 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.23 110.92 17.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 170.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.7 mt -116.55 94.65 43.86 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -54.92 121.06 9.18 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.814 3.01 . . . . 0.0 112.999 -168.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.73 26.35 46.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.933 1.254 . . . . 0.0 111.416 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -143.07 -68.8 0.34 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.383 1.092 . . . . 0.0 108.564 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -161.08 161.61 31.31 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.83 117.18 24.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -122.34 132.58 54.46 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.271 1.828 . . . . 0.0 109.339 -166.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.52 32.21 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 48' ' ' TYR . . . 142.03 49.86 0.04 OUTLIER Glycine 0 N--CA 1.466 0.674 0 CA-C-N 119.526 1.663 . . . . 0.0 112.593 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' HB3' HE21 ' A' ' 111' ' ' GLN . 5.5 p-10 -143.0 113.79 7.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -160.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.434 ' CE1' ' HE3' ' A' ' 76' ' ' LYS . 53.7 p90 -130.25 12.27 5.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.702 1.601 . . . . 0.0 110.745 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -122.98 -67.91 0.92 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.906 1.283 . . . . 0.0 108.834 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -106.07 -20.14 13.51 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 60.45 -3.81 0.13 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 119.03 2.974 . . . . 0.0 119.03 166.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -112.15 0.97 16.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.474 1.51 . . . . 0.0 112.842 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.472 ' HA2' HE22 ' A' ' 111' ' ' GLN . . . 118.45 -22.74 9.34 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.056 1.788 . . . . 0.0 112.382 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.1 p -85.25 20.54 1.94 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.413 1.106 . . . . 0.0 112.319 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.63 166.16 32.73 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 121.207 -0.933 . . . . 0.0 113.778 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.53 126.84 3.64 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 128.588 2.994 . . . . 0.0 105.996 -159.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HE3' ' CE1' ' A' ' 67' ' ' PHE . 3.5 pttt -143.54 152.87 41.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.085 2.554 . . . . 0.0 105.97 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.0 p -72.38 168.62 18.04 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.972 0.795 . . . . 0.0 109.856 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 pt -64.84 -18.65 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 123.784 0.834 . . . . 0.0 112.222 166.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -96.5 -6.76 36.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.79 -171.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.77 -84.57 0.13 Allowed Glycine 0 C--N 1.34 0.769 0 CA-C-N 119.921 1.237 . . . . 0.0 111.071 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -132.44 -137.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.888 1.675 . . . . 0.0 107.784 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -75.89 154.22 36.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.692 0.797 . . . . 0.0 109.908 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -125.63 177.01 6.48 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 122.122 0.963 . . . . 0.0 109.005 168.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -72.0 170.36 13.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.956 1.302 . . . . 0.0 112.326 -172.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.6 106.32 2.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 159.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.67 -44.87 92.48 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.264 0.625 . . . . 0.0 111.004 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.16 153.75 1.65 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 125.529 1.768 . . . . 0.0 114.133 158.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.68 15.26 29.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.254 2.222 . . . . 0.0 111.126 -169.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.8 mt -37.57 -46.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 128.045 2.538 . . . . 0.0 110.636 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.2 mt -92.15 121.94 34.17 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.164 1.786 . . . . 0.0 106.87 -173.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -97.16 169.3 9.89 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 110.45 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -82.27 80.91 8.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 108.055 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -79.74 -20.75 45.64 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -164.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.99 175.4 36.37 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.954 1.252 . . . . 0.0 112.768 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.97 134.66 40.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.069 1.846 . . . . 0.0 110.449 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.53 -11.4 28.16 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.311 1.91 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 120.299 2.05 . . . . 0.0 109.185 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.97 132.16 53.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 126.156 1.783 . . . . 0.0 108.556 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.7 t -142.04 153.45 44.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.634 . . . . 0.0 110.304 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 92.4 mmm -80.21 137.66 36.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.074 0.55 . . . . 0.0 110.324 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.74 124.3 30.74 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 169.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.65 150.63 51.57 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.632 1.173 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.62 14.05 12.57 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.696 1.598 . . . . 0.0 113.068 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.07 -165.24 28.94 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 -165.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -63.45 164.71 19.72 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 119.249 1.524 . . . . 0.0 109.748 167.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 33.62 48.71 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 131.159 3.784 . . . . 0.0 112.478 175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.9 p -138.99 30.84 2.22 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.359 -1.463 . . . . 0.0 112.136 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -86.23 149.71 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.747 -1.221 . . . . 0.0 107.865 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.16 -66.18 0.01 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.7 t -146.5 -28.86 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.096 0.958 . . . . 0.0 111.092 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.472 HE22 ' HA2' ' A' ' 72' ' ' GLY . 19.8 mt-30 -61.54 128.33 35.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -134.52 174.74 10.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.304 1.042 . . . . 0.0 108.265 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 99' ' ' SER . 20.3 p90 -139.58 149.73 44.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.22 1.01 . . . . 0.0 110.847 164.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.1 mt -83.22 116.85 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 100.696 -3.816 . . . . 0.0 100.696 164.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.8 m -67.81 108.13 2.86 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.5 p -102.56 28.46 6.01 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.322 1.049 . . . . 0.0 108.988 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.71 175.75 11.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.723 1.609 . . . . 0.0 107.466 166.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -71.78 86.62 0.95 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 166.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 p -74.87 40.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.239 2.216 . . . . 0.0 112.384 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.24 -20.96 61.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.015 -1.678 . . . . 0.0 114.08 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -68.37 -15.53 63.59 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.414 0.686 . . . . 0.0 111.103 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.5 mt -95.7 -3.22 46.4 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.58 1.552 . . . . 0.0 111.353 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.03 157.53 24.97 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.237 -0.914 . . . . 0.0 110.028 169.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.45 -0.0 14.97 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.295 1.426 . . . . 0.0 113.785 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -129.32 -47.92 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.507 1.523 . . . . 0.0 109.015 -172.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.15 146.12 40.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.458 0.647 . . . . 0.0 111.028 -167.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 t -95.35 100.99 11.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -171.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.04 126.83 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -138.87 2.36 2.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.66 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.28 -173.06 34.32 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.086 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -149.84 160.84 43.25 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.405 1.082 . . . . 0.0 110.724 164.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.25 115.71 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 166.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -49.91 28.6 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.33 159.19 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.994 2.518 . . . . 0.0 108.496 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.56 20.94 13.53 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.422 1.011 . . . . 0.0 113.236 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 33.6 tpp -54.61 -39.51 67.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.518 1.659 . . . . 0.0 111.813 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.34 69.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.806 1.639 . . . . 0.0 112.058 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.58 -45.16 52.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 118.954 0.797 . . . . 0.0 109.158 176.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.85 -47.03 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 0.0 110.368 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.81 -24.7 65.32 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.029 -1.044 . . . . 0.0 111.901 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.79 -43.83 57.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.958 -1.089 . . . . 0.0 109.182 172.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 66.9 mtp -56.36 -43.06 78.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.247 -0.908 . . . . 0.0 110.138 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.84 -37.21 83.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.5 ptt-85 -71.87 -21.3 61.68 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 120.269 1.395 . . . . 0.0 110.941 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.416 ' CB ' HD11 ' A' ' 156' ' ' ILE . 28.9 m-85 -93.11 5.47 51.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.735 1.614 . . . . 0.0 111.519 171.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.57 48.07 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 108.424 -1.871 . . . . 0.0 108.424 167.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 85.1 p -151.86 163.34 39.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.0 mtp85 -61.84 -27.87 69.09 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 107.69 -27.03 16.03 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.374 1.464 . . . . 0.0 113.725 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 130.71 43.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.974 1.887 . . . . 0.0 108.015 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.0 p -70.86 138.19 50.02 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.7 p -64.11 -30.55 71.61 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.61 -0.681 . . . . 0.0 110.29 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -125.59 170.56 11.36 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.329 1.452 . . . . 0.0 109.044 -175.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -86.99 87.75 7.54 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.783 -1.198 . . . . 0.0 108.676 -177.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.416 HD11 ' CB ' ' A' ' 145' ' ' PHE . 33.5 mm -75.6 120.19 24.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.1 p -142.71 172.77 12.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.525 1.155 . . . . 0.0 111.163 -173.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.03 113.81 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.78 -56.87 16.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -157.49 165.59 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.703 1.201 . . . . 0.0 109.873 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 54.3 m -141.6 163.65 32.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 127.327 2.251 . . . . 0.0 105.622 172.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.62 172.65 42.53 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.33 156.02 29.8 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.944 -0.739 . . . . 0.0 109.271 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 33.2 mt -136.63 43.0 2.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.882 0.373 . . . . 0.0 110.838 159.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 116.932 -1.907 . . . . 0.0 107.028 158.529 . . . . . . . . 0 0 . 1 stop_ save_